source,destination,score
hsa-miR-551a,diffuse large B-cell lymphoma,0.8887544274330139
hsa-miR-339-5p,miR-675-y,0.888059675693512
hsa-miR-23a-3p,miR-675-y,0.888059675693512
hsa-miR-542-5p,synovial sarcoma,0.887004554271698
hsa-miR-29b-1,synovial sarcoma,0.887004554271698
hsa-miR-496,synovial sarcoma,0.887004554271698
hsa-miR-1283,synovial sarcoma,0.887004554271698
hsa-miR-766-3p-587,synovial sarcoma,0.887004554271698
hsa-miR-6516-3p,synovial sarcoma,0.887004554271698
hsa-miR-8057,synovial sarcoma,0.887004554271698
hsa-miR-7156-3p,synovial sarcoma,0.887004554271698
hsa-miR-6127,synovial sarcoma,0.887004554271698
hsa-miR-628,synovial sarcoma,0.887004554271698
hsa-miR-4726-5p,synovial sarcoma,0.887004554271698
hsa-miR-199a-5p,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-6827-5p,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-496,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-513b,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-363-5p,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-6824-5p,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-6720-3p,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-4793-3p,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-425*,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-96-5p,"squamous cell breast carcinoma, acantholytic variant",0.886959433555603
hsa-miR-181d,"Luminal B,triple negative",0.886884331703186
hsa-miR-425*,"Luminal B,triple negative",0.886884331703186
hsa-miR-361-3p,"Luminal B,triple negative",0.886884331703186
hsa-miR-569,solid pseudopapillary neoplasm of pancreas,0.8864606618881226
hsa-miR-6127,solid pseudopapillary neoplasm of pancreas,0.8864606618881226
hsa-miRPlus-A1083,castration-resistant prostate cancer,0.8864213824272156
hsa-miRPlus-A1031,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-8064,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-125a,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-522*,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-496,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-3647-3p,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-6824-5p,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-6515-5p,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-8057,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-5695,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-548j-5p,castration-resistant prostate cancer,0.8864213824272156
hsa-miR-29b-1,sarcoma,0.8861002326011658
hsa-miR-3647-3p,sarcoma,0.8861002326011658
hsa-miR-4297,sarcoma,0.8861002326011658
hsa-miR-4639-5p,miR-142-y,0.8860621452331543
hsa-miR-6127,miR-142-y,0.8860621452331543
hsa-miR-181d,miR-142-y,0.8860621452331543
hsa-miR-425*,miR-142-y,0.8860621452331543
hsa-miR-374b-3p,diffuse large B-cell lymphoma,0.8854121565818787
hsa-miR-1271-3p,diffuse large B-cell lymphoma,0.8854121565818787
hsa-miR-144-5p,diffuse large B-cell lymphoma,0.8854121565818787
hsa-miR-513c,diffuse large B-cell lymphoma,0.8854121565818787
hsa-miR-3151-5p,miR-675-y,0.8846991658210754
hsa-miR-598-5p,miR-675-y,0.8846991658210754
hsa-miR-5585-5p,miR-675-y,0.8846991658210754
hsa-miR-6777-3p,synovial sarcoma,0.8836166262626648
hsa-miR-4442,synovial sarcoma,0.8836166262626648
hsa-miR-423-5p_2,"squamous cell breast carcinoma, acantholytic variant",0.8835703134536743
hsa-miR-4709-5p,"squamous cell breast carcinoma, acantholytic variant",0.8835703134536743
hsa-miR-181c*,"squamous cell breast carcinoma, acantholytic variant",0.8835703134536743
hsa-miR-5585-5p,"squamous cell breast carcinoma, acantholytic variant",0.8835703134536743
hsa-miR-423-5p_2,"Luminal B,triple negative",0.8834931254386902
hsa-miR-513c,"Luminal B,triple negative",0.8834931254386902
hsa-miR-135a*,"Luminal B,triple negative",0.8834931254386902
hsa-miR-105-1,brain cancer,0.8830924034118652
hsa-miR-548c-3p,solid pseudopapillary neoplasm of pancreas,0.8830586075782776
hsa-miR-615,castration-resistant prostate cancer,0.8830183148384094
hsa-miR-512-5p-384,castration-resistant prostate cancer,0.8830183148384094
hsa-miR-598-5p,castration-resistant prostate cancer,0.8830183148384094
hsa-miR-6500-5p,castration-resistant prostate cancer,0.8830183148384094
hsa-miR-4694-5p,castration-resistant prostate cancer,0.8830183148384094
hsa-miR-548b-3p,diffuse large B-cell lymphoma,0.8829812407493591
hsa-miR-642,diffuse large B-cell lymphoma,0.8829812407493591
hsa-miRPlus-G1065-5p,diffuse large B-cell lymphoma,0.8829812407493591
hsa-miR-100-3p,diffuse large B-cell lymphoma,0.8829812407493591
hsa-miR-6508-3p,diffuse large B-cell lymphoma,0.8829812407493591
hsa-miR-598-5p,sarcoma,0.8826887607574463
hsa-miR-423-5p_2,miR-142-y,0.8826497793197632
hsa-miR-548c-3p,miR-142-y,0.8826497793197632
hsa-miR-144-5p,miR-142-y,0.8826497793197632
hsa-miR-6744-3p,miR-142-y,0.8826497793197632
hsa-miR-135a*,miR-142-y,0.8826497793197632
hsa-miR-3660,miR-675-y,0.8822551369667053
hsa-miR-34c-3p,miR-675-y,0.8822551369667053
hsa-let-7g-5p,miR-675-y,0.8822551369667053
hsa-miR-3677-3p,miR-675-y,0.881868302822113
hsa-miR-337,miR-675-y,0.881868302822113
hsa-miR-6132,miR-675-y,0.8817641735076904
hsa-miR-4433-3p,miR-675-y,0.8817641735076904
hsa-miR-15a-5p,miR-675-y,0.8817641735076904
hsa-miR-515-5p,follicular thyroid carcinoma,0.8816819787025452
hsa-miR-361-3p,follicular thyroid carcinoma,0.8816819787025452
hsa-miR-602,synovial sarcoma,0.8811526894569397
hsa-miR-362-3p,synovial sarcoma,0.8811526894569397
hsa-miR-5192,synovial sarcoma,0.8811526894569397
hsa-miR-601,synovial sarcoma,0.8811526894569397
hsa-miR-129-1-3p,synovial sarcoma,0.8811526894569397
hsa-miR-4480,synovial sarcoma,0.8811526894569397
hsa-miR-3660,synovial sarcoma,0.8811526894569397
hsa-miR-2115-5p,synovial sarcoma,0.8811526894569397
hsa-miR-3677,synovial sarcoma,0.8811526894569397
hsa-miR-320e-1095,synovial sarcoma,0.8811526894569397
hsa-miR-3649,synovial sarcoma,0.8811526894569397
hsa-miR-302b*,synovial sarcoma,0.8811526894569397
hsa-miR-6499-3p,synovial sarcoma,0.8811526894569397
hsa-miR-30c-1,synovial sarcoma,0.8811526894569397
hsa-miR-219a-5p,synovial sarcoma,0.8811526894569397
hsa-miR-181a-3p,synovial sarcoma,0.8811526894569397
hsa-miR-4687-5p,synovial sarcoma,0.8811526894569397
hsa-miR-508,synovial sarcoma,0.8811526894569397
hsa-miR-4435,synovial sarcoma,0.8811526894569397
hsa-miR-656-5p,synovial sarcoma,0.8811526894569397
hsa-miR-6724-5p,synovial sarcoma,0.8811526894569397
hsa-miR-5192,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-4748,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-106b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-7-1*,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-649,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-129-1-3p,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-6775-3p,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-4423-5p,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-4511,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-450a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-4687-5p,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-6724-5p,"squamous cell breast carcinoma, acantholytic variant",0.8811054825782776
hsa-miR-362-3p,"Luminal B,triple negative",0.8810270428657532
hsa-miR-5192,"Luminal B,triple negative",0.8810270428657532
hsa-miR-6861-5p,solid pseudopapillary neoplasm of pancreas,0.8805843591690063
hsa-miR-6510-5p,solid pseudopapillary neoplasm of pancreas,0.8805843591690063
hsa-miR-602,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-3154,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-362-3p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-5192,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-4748,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-6861-5p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-4281,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-4496,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-106b-5p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-3199,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-649,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-1306-5p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-3677,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-4441,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-3913-3p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-135a-3p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-6796-5p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-4757-5p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-937-3p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-30c-1,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-6508-3p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-3614-3p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-506,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-181a-3p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-450a-3p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-4435,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-4765,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-3680*,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-6826-3p,castration-resistant prostate cancer,0.8805434107780457
hsa-miR-1247,miR-675-y,0.8804826140403748
hsa-miR-517-5p,miR-675-y,0.8804826140403748
hsa-miR-5196-5p,miR-675-y,0.8804826140403748
hsa-miR-291-5p,miR-675-y,0.8803941011428833
hsa-miR-6736-5p,miR-675-y,0.8803941011428833
hsa-miR-567,ovarian carcinoma,0.8803742527961731
hsa-miR-507,ovarian carcinoma,0.8803742527961731
hsa-miR-542-5p,ovarian carcinoma,0.8803742527961731
hsa-miR-339-5p,ovarian carcinoma,0.8803742527961731
hsa-miR-4748,sarcoma,0.8802077770233154
hsa-miR-3157-5p,sarcoma,0.8802077770233154
hsa-miR-6888-3p,sarcoma,0.8802077770233154
hsa-miR-98-5p,sarcoma,0.8802077770233154
hsa-miR-129-1-3p,miR-142-y,0.880168080329895
hsa-miR-4441,miR-142-y,0.880168080329895
hsa-miR-3909,miR-142-y,0.880168080329895
hsa-miR-302b*,miR-142-y,0.880168080329895
hsa-miR-6775-3p,miR-142-y,0.880168080329895
hsa-miR-3614-3p,miR-142-y,0.880168080329895
hsa-miR-454,miR-142-y,0.880168080329895
hsa-miR-5004-5p,miR-142-y,0.880168080329895
hsa-miR-1288-3p,miR-142-y,0.880168080329895
hsa-miR-4722-5p,miR-142-y,0.880168080329895
hsa-miR-625,solid pseudopapillary neoplasm of pancreas,0.8800588250160217
hsa-miR-1185-1-3p,brain cancer,0.8799604177474976
hsa-miR-92a-2-5p,Luminal B Her2+,0.8798767924308777
hsa-miR-616*,solid pseudopapillary neoplasm of pancreas,0.8796294927597046
hsa-miR-513-3p,miR-142-y,0.8790771961212158
hsa-miR-15a-5p,miR-142-y,0.8789709806442261
hsa-miR-6888-5p,miR-142-y,0.8789709806442261
hsa-miR-125b-1*,miR-142-y,0.8789709806442261
hsa-miR-511-2,papillary thyroid carcinoma,0.8787626624107361
hsa-miR-569,Leptomeningeal metastasis,0.8785139322280884
hsa-miR-328-3p,miR-675-y,0.8782532811164856
hsa-miR-942,solid pseudopapillary neoplasm of pancreas,0.8781577348709106
hsa-miR-6790-3p,solid pseudopapillary neoplasm of pancreas,0.8781453371047974
hsa-miR-518f,solid pseudopapillary neoplasm of pancreas,0.8781453371047974
hsa-miR-488-5p,solid pseudopapillary neoplasm of pancreas,0.8781453371047974
hsa-miR-339-5p,high grade serous papillary ovarian cancer,0.8776764869689941
hsa-miR-636,high grade serous papillary ovarian cancer,0.8776764869689941
hsa-miR-766-3p-587,high grade serous papillary ovarian cancer,0.8776764869689941
hsa-miR-3691-3p,high grade serous papillary ovarian cancer,0.8776764869689941
hsa-miR-6837-5p,high grade serous papillary ovarian cancer,0.8776764869689941
hsa-miR-4454,miR-142-y,0.877663254737854
hsa-miRPlus-C1114,miR-142-y,0.8775730729103088
hsa-miR-378,miR-142-y,0.8775730729103088
hsa-miR-6760-5p,"Luminal B,triple negative",0.8774416446685791
hsa-miR-1468,"Luminal B,triple negative",0.8774416446685791
hsa-miR-3529-3p,"Luminal B,triple negative",0.8774416446685791
hsa-miR-676,"Luminal B,triple negative",0.8774416446685791
hsa-miR-638,rhabdomyosarcomas,0.8774337768554688
hsa-miR-511-2,rhabdomyosarcomas,0.8774337768554688
hsa-miR-4430,rhabdomyosarcomas,0.8774337768554688
hsa-miR-199a-5p,rhabdomyosarcomas,0.8774337768554688
hsa-miR-554,miR-675-y,0.8769062757492065
hsa-miR-377,ovarian carcinoma,0.8768150806427002
hsa-miR-1271-3p,ovarian carcinoma,0.8768150806427002
hsa-miR-30e*,ovarian carcinoma,0.8768150806427002
hsa-miR-3151-5p,ovarian carcinoma,0.8768150806427002
hsa-miR-519b-5p,ovarian carcinoma,0.8768150806427002
hsa-miR-449b*,ovarian carcinoma,0.8768150806427002
hsa-miR-6757-5p,ovarian carcinoma,0.8768150806427002
hsa-miR-513-3p,"squamous cell breast carcinoma, acantholytic variant",0.8768025040626526
hsa-miR-6850-3p,"squamous cell breast carcinoma, acantholytic variant",0.8768025040626526
hsa-miR-221*,"squamous cell breast carcinoma, acantholytic variant",0.8766945600509644
hsa-miR-1468,"squamous cell breast carcinoma, acantholytic variant",0.8766945600509644
hsa-miR-1538,follicular thyroid carcinoma,0.8764804601669312
hsa-miR-503,solid pseudopapillary neoplasm of pancreas,0.87643963098526
hsa-miR-1258,solid pseudopapillary neoplasm of pancreas,0.87643963098526
hsa-miR-376a-5p,solid pseudopapillary neoplasm of pancreas,0.87643963098526
hsa-miR-5584-3p,brain cancer,0.876295268535614
hsa-miR-337,diffuse large B-cell lymphoma,0.8762319087982178
hsa-miR-6850-3p,diffuse large B-cell lymphoma,0.8762319087982178
hsa-miR-455-3p,"Luminal B,triple negative",0.8761197924613953
hsa-miR-3682-5p,"Luminal B,triple negative",0.8761197924613953
hsa-miR-34b-3p,"Luminal B,triple negative",0.8761197924613953
hsa-miR-499,"Luminal B,triple negative",0.8761197924613953
hsa-miR-1199-3p,"Luminal B,triple negative",0.8761197924613953
hsa-miR-526b*,pilocytic astrocytoma,0.8760631680488586
hsa-miR-3151,"Luminal B,triple negative",0.8760285973548889
hsa-miR-215-5p,miR-675-y,0.8758684992790222
hsa-miR-6831-5p,miR-675-y,0.8758684992790222
hsa-miR-4716-5p,miR-675-y,0.8758684992790222
hsa-miR-8064,miR-675-y,0.8758462071418762
hsa-miR-628,miR-675-y,0.8758462071418762
hsa-miR-1233-5p,miR-675-y,0.8758462071418762
hsa-miR-423-5p_2,miR-675-y,0.8754271268844604
hsa-miR-720,miR-675-y,0.8754271268844604
hsa-miR-135a*,miR-675-y,0.8754271268844604
hsa-miR-6728-5p,miR-142-y,0.8753888607025146
hsa-miR-518a,miR-142-y,0.8753888607025146
hsa-miR-3170,miR-142-y,0.8753888607025146
hsa-miR-1-3p,miR-142-y,0.8753888607025146
hsa-miR-3198,miR-142-y,0.8753888607025146
hsa-miR-22-5p,"squamous cell breast carcinoma, acantholytic variant",0.8752740621566772
hsa-miR-431-5p,"squamous cell breast carcinoma, acantholytic variant",0.8752740621566772
hsa-miR-664a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8752740621566772
hsa-miR-423-5p_2,papillary thyroid carcinoma,0.8751624226570129
hsa-miR-4323,solid pseudopapillary neoplasm of pancreas,0.8750014901161194
hsa-miR-1247,diffuse large B-cell lymphoma,0.8747896552085876
hsa-miR-5187-5p,diffuse large B-cell lymphoma,0.8747896552085876
hsa-miR-188-3p,diffuse large B-cell lymphoma,0.8747896552085876
hsa-miR-610,castration-resistant prostate cancer,0.8747394680976868
hsa-miR-4735-5p,castration-resistant prostate cancer,0.8747394680976868
hsa-miR-4482,castration-resistant prostate cancer,0.8747394680976868
hsa-miR-525-5p,castration-resistant prostate cancer,0.8746300339698792
hsa-miR-4530,castration-resistant prostate cancer,0.8746300339698792
hsa-miR-4433-3p,castration-resistant prostate cancer,0.8746300339698792
hsa-miR-4750-5p,castration-resistant prostate cancer,0.8746300339698792
hsa-miR-3529-3p,castration-resistant prostate cancer,0.8746300339698792
hsa-miR-1250-3p,castration-resistant prostate cancer,0.8746300339698792
hsa-miR-708-5p,sarcoma,0.8745684027671814
hsa-miR-519a,sarcoma,0.874458909034729
hsa-miR-548av-5p,synovial sarcoma,0.8744515180587769
hsa-miR-3691-5p,synovial sarcoma,0.8743417859077454
hsa-miR-15a-5p,synovial sarcoma,0.8743417859077454
hsa-miR-6819-3p,synovial sarcoma,0.8743417859077454
hsa-miR-409-5p,miR-675-y,0.8743302822113037
hsa-miR-7158-3p,miR-675-y,0.8743302822113037
hsa-miR-642,ovarian carcinoma,0.8742275834083557
hsa-miR-487b-5p,ovarian carcinoma,0.8742275834083557
hsa-miR-5587-5p,ovarian carcinoma,0.8742275834083557
hsa-miR-378c,ovarian carcinoma,0.8742275834083557
hsa-miR-601,ovarian carcinoma,0.8742275834083557
hsa-miR-4281,ovarian carcinoma,0.8742275834083557
hsa-miR-4278,ovarian carcinoma,0.8742275834083557
hsa-miR-4265,ovarian carcinoma,0.8742275834083557
hsa-miR-135a-2,ovarian carcinoma,0.8742275834083557
hsa-miR-6090,ovarian carcinoma,0.8742275834083557
hsa-miR-20b-5p,ovarian carcinoma,0.8742275834083557
hsa-miR-1973,ovarian carcinoma,0.8742275834083557
hsa-miR-6865-5p,ovarian carcinoma,0.8742275834083557
hsa-miR-6788-3p,ovarian carcinoma,0.8742275834083557
hsa-miR-6733-5p,ovarian carcinoma,0.8742275834083557
hsa-miRPlus-K1303*,high grade serous papillary ovarian cancer,0.8740484118461609
hsa-miR-519b-5p,high grade serous papillary ovarian cancer,0.8740484118461609
hsa-miR-512-5p-384,high grade serous papillary ovarian cancer,0.8740484118461609
hsa-miR-6744-3p,high grade serous papillary ovarian cancer,0.8740484118461609
hsa-miR-4536-3p,high grade serous papillary ovarian cancer,0.8740484118461609
hsa-miR-409-5p,miR-142-y,0.8740146160125732
hsa-miR-376a-3p,"Luminal B,triple negative",0.8738209009170532
hsa-miR-616,solid pseudopapillary neoplasm of pancreas,0.8738008737564087
hsa-miR-1-1,solid pseudopapillary neoplasm of pancreas,0.8738008737564087
hsa-miR-374b-3p,rhabdomyosarcomas,0.8737998008728027
hsa-miR-199a-5p,aryngeal squamous cell carcinoma,0.8737414479255676
hsa-miR-6838-3p,aryngeal squamous cell carcinoma,0.8737414479255676
hsa-miR-23a-3p,aryngeal squamous cell carcinoma,0.8737414479255676
hsa-miR-525-3p,brain cancer,0.8735702633857727
hsa-miR-148a,brain cancer,0.8735280632972717
hsa-miR-30e-3p,miR-675-y,0.8735169768333435
hsa-miR-101-5p,miR-675-y,0.8735169768333435
hsa-miR-3653-5p,pilocytic astrocytoma,0.8734621405601501
hsa-miR-939-5p,diffuse large B-cell lymphoma,0.8734092116355896
hsa-miR-7158-3p,diffuse large B-cell lymphoma,0.8734092116355896
hsa-miR-6802-5p,solid pseudopapillary neoplasm of pancreas,0.8733021020889282
hsa-miR-3189-5p,solid pseudopapillary neoplasm of pancreas,0.8733021020889282
hsa-miR-6771-5p,solid pseudopapillary neoplasm of pancreas,0.8733021020889282
hsa-miRPlus-C1066,castration-resistant prostate cancer,0.8732821941375732
hsa-miR-3678-3p,castration-resistant prostate cancer,0.8732821941375732
hsa-miR-455-3p,castration-resistant prostate cancer,0.8732821941375732
hsa-miR-4655-5p,castration-resistant prostate cancer,0.8732821941375732
hsa-miR-188-3p,castration-resistant prostate cancer,0.8732821941375732
hsa-miR-141-3p,castration-resistant prostate cancer,0.8732821941375732
hsa-miR-5002-5p,follicular thyroid carcinoma,0.8732190728187561
hsa-miR-4690-5p,castration-resistant prostate cancer,0.8731892108917236
hsa-miR-291-5p,castration-resistant prostate cancer,0.8731892108917236
hsa-miR-664*,castration-resistant prostate cancer,0.8731892108917236
hsa-miR-3151,castration-resistant prostate cancer,0.8731892108917236
hsa-miR-664a-3p,castration-resistant prostate cancer,0.8731892108917236
hsa-miR-092,sarcoma,0.8731094002723694
hsa-miR-4753-5p,sarcoma,0.8731094002723694
hsa-miR-487b-3p,sarcoma,0.8731094002723694
hsa-miR-761,sarcoma,0.8731094002723694
hsa-miR-499,sarcoma,0.8731094002723694
hsa-miR-3121,miR-675-y,0.8731014132499695
hsa-miR-5584-3p,"squamous cell breast carcinoma, acantholytic variant",0.8730548620223999
hsa-miR-6082,"squamous cell breast carcinoma, acantholytic variant",0.8730548620223999
hsa-miR-4652-5p,"squamous cell breast carcinoma, acantholytic variant",0.8730548620223999
hsa-miR-886,"squamous cell breast carcinoma, acantholytic variant",0.8730548620223999
hsa-miR-6069,"squamous cell breast carcinoma, acantholytic variant",0.8730548620223999
hsa-miR-1-3p,"squamous cell breast carcinoma, acantholytic variant",0.8730548620223999
hsa-miR-4727-5p,sarcoma,0.873016357421875
hsa-miR-302c,synovial sarcoma,0.8729914426803589
hsa-miR-5196-5p,synovial sarcoma,0.8729914426803589
hsa-miR-30c-2-3p,miR-142-y,0.8729560971260071
hsa-miR-7975,miR-142-y,0.8729560971260071
hsa-miR-545-5p,miR-142-y,0.8729560971260071
hsa-miR-4444,miR-142-y,0.8729560971260071
hsa-miR-3160-3p,miR-142-y,0.8729560971260071
hsa-miR-1587,miR-142-y,0.8729560971260071
hsa-miR-291-5p,synovial sarcoma,0.8728981614112854
hsa-miR-664*,synovial sarcoma,0.8728981614112854
hsa-miR-8053,synovial sarcoma,0.8728981614112854
hsa-miR-664a-3p,synovial sarcoma,0.8728981614112854
hsa-miR-548ah-3p,solid pseudopapillary neoplasm of pancreas,0.8728126883506775
hsa-miR-602,miR-675-y,0.8727614879608154
hsa-miR-642,miR-675-y,0.8727614879608154
hsa-miR-501-3p,miR-675-y,0.8727614879608154
hsa-miR-7-1*,miR-675-y,0.8727614879608154
hsa-miR-4480,miR-675-y,0.8727614879608154
hsa-miRPlus-G1065-5p,miR-675-y,0.8727614879608154
hsa-miR-6796-5p,miR-675-y,0.8727614879608154
hsa-miR-100-3p,miR-675-y,0.8727614879608154
hsa-miR-556,miR-675-y,0.8727614879608154
hsa-miR-513b,miR-142-y,0.8727297186851501
hsa-miR-6720-3p,miR-142-y,0.8727297186851501
hsa-miR-4793-3p,miR-142-y,0.8727297186851501
hsa-miR-124a,miR-142-y,0.8727297186851501
hsa-miR-4314,miR-675-y,0.8726322054862976
hsa-miR-4685-5p,miR-675-y,0.8726322054862976
hsa-miR-548b-3p,papillary thyroid carcinoma,0.8725454211235046
hsa-miR-4748,papillary thyroid carcinoma,0.8725454211235046
hsa-miR-344,papillary thyroid carcinoma,0.8725454211235046
hsa-miR-921,miR-675-y,0.8724685311317444
hsa-miR-454,miR-675-y,0.8724685311317444
hsa-miR-615-3p,miR-675-y,0.8724685311317444
hsa-miR-450a-3p,miR-675-y,0.8724685311317444
hsa-miR-6733-5p,miR-675-y,0.8724685311317444
hsa-miR-339-5p,"Luminal B,triple negative",0.8723631501197815
hsa-miR-3152-3p,"Luminal B,triple negative",0.8723631501197815
hsa-miR-3177,"Luminal B,triple negative",0.8723631501197815
hsa-miR-200b-3p,"Luminal B,triple negative",0.8723631501197815
hsa-miR-623,solid pseudopapillary neoplasm of pancreas,0.872288167476654
hsa-miR-920,solid pseudopapillary neoplasm of pancreas,0.872288167476654
hsa-miR-3660,Leptomeningeal metastasis,0.8722857236862183
hsa-miR-132*,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-361,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-125b-2*,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-6506-3p,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-500,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-372,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-491-5p,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-8079,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-4302,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-128b,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-4500,solid pseudopapillary neoplasm of pancreas,0.8720325827598572
hsa-miR-500b,solid pseudopapillary neoplasm of pancreas,0.8718974590301514
hsa-miR-6767-5p,solid pseudopapillary neoplasm of pancreas,0.8718974590301514
hsa-miR-3144-3p,solid pseudopapillary neoplasm of pancreas,0.8718974590301514
hsa-miR-449b-3p,solid pseudopapillary neoplasm of pancreas,0.8718974590301514
hsa-miR-3178,solid pseudopapillary neoplasm of pancreas,0.8718974590301514
hsa-miR-4539,solid pseudopapillary neoplasm of pancreas,0.8718974590301514
hsa-miR-556-3p,solid pseudopapillary neoplasm of pancreas,0.8717743754386902
hsa-miR-4259,solid pseudopapillary neoplasm of pancreas,0.8717743754386902
hsa-miR-514a-3p,solid pseudopapillary neoplasm of pancreas,0.8717743754386902
hsa-miR-527,solid pseudopapillary neoplasm of pancreas,0.8717743754386902
hsa-miR-4761-5p,solid pseudopapillary neoplasm of pancreas,0.8717731833457947
hsa-miR-625-3p,follicular thyroid carcinoma,0.8717489838600159
hsa-miR-542-5p,"squamous cell breast carcinoma, acantholytic variant",0.8716626763343811
hsa-miR-339-5p,"squamous cell breast carcinoma, acantholytic variant",0.8716626763343811
hsa-miR-29b-1,"squamous cell breast carcinoma, acantholytic variant",0.8716626763343811
hsa-miR-6515-5p,"squamous cell breast carcinoma, acantholytic variant",0.8716626763343811
hsa-miR-6745,"squamous cell breast carcinoma, acantholytic variant",0.8716626763343811
hsa-miR-4465,solid pseudopapillary neoplasm of pancreas,0.8716609477996826
hsa-miR-6886-5p,solid pseudopapillary neoplasm of pancreas,0.8716609477996826
hsa-miR-6807-3p,solid pseudopapillary neoplasm of pancreas,0.8716609477996826
hsa-miR-6509-3p,solid pseudopapillary neoplasm of pancreas,0.8716609477996826
hsa-miR-888*,solid pseudopapillary neoplasm of pancreas,0.8716609477996826
hsa-miR-744-3p,solid pseudopapillary neoplasm of pancreas,0.8716609477996826
hsa-miR-1287,"squamous cell breast carcinoma, acantholytic variant",0.8716586828231812
hsa-miR-187*,solid pseudopapillary neoplasm of pancreas,0.8716089129447937
hsa-miR-548ay-5p,solid pseudopapillary neoplasm of pancreas,0.8715655207633972
hsa-miR-323-5p,solid pseudopapillary neoplasm of pancreas,0.8714877367019653
hsa-miR-6502-5p,solid pseudopapillary neoplasm of pancreas,0.8714877367019653
hsa-miR-3616-5p,synovial sarcoma,0.871452808380127
hsa-miR-4649-3p,synovial sarcoma,0.871452808380127
hsa-miR-939-5p,synovial sarcoma,0.871452808380127
hsa-miR-498,synovial sarcoma,0.871452808380127
hsa-miR-5587-5p,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR128b,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-649,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-431*,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-1306-5p,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-6090,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-3913-3p,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-921,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-100-3p,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-454,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-450a-3p,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-508,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-656-5p,high grade serous papillary ovarian cancer,0.8714115023612976
hsa-miR-199a-5p,miR-675-y,0.871408224105835
hsa-miR-496,miR-675-y,0.871408224105835
hsa-miR-6823-5p,miR-675-y,0.871408224105835
hsa-miR-7158-3p,"squamous cell breast carcinoma, acantholytic variant",0.8714022636413574
hsa-miR-6834-5p,"squamous cell breast carcinoma, acantholytic variant",0.8714022636413574
hsa-miR-7975,"Luminal B,triple negative",0.8713619709014893
hsa-miR-4258,"Luminal B,triple negative",0.8713619709014893
hsa-miR-4484,"Luminal B,triple negative",0.8713183403015137
hsa-miR-6074,solid pseudopapillary neoplasm of pancreas,0.8712945580482483
hsa-miR-383-5p,solid pseudopapillary neoplasm of pancreas,0.8712945580482483
hsa-miR-7974,"squamous cell breast carcinoma, acantholytic variant",0.8712318539619446
hsa-miR-6889-5p,"squamous cell breast carcinoma, acantholytic variant",0.8712318539619446
hsa-miR-600,miR-675-y,0.8712174892425537
hsa-miR-490-3p,miR-675-y,0.8712174892425537
hsa-miR-196-2,miR-675-y,0.8712174892425537
hsa-miR-513a-3p,rhabdomyosarcomas,0.8711583018302917
hsa-miR-4479,rhabdomyosarcomas,0.8711583018302917
hsa-miR-344,rhabdomyosarcomas,0.8711583018302917
hsa-miR-1292-3p,primary central nervous system lymphomas,0.8711410164833069
hsa-miR-720,primary central nervous system lymphomas,0.8711410164833069
hsa-miR-145,solid pseudopapillary neoplasm of pancreas,0.8711262941360474
hsa-miR-6836-3p,solid pseudopapillary neoplasm of pancreas,0.8711262941360474
hsa-miR-7154-5p,solid pseudopapillary neoplasm of pancreas,0.8711262941360474
hsa-miR-4538,diffuse large B-cell lymphoma,0.8710678219795227
hsa-miR-3676,solid pseudopapillary neoplasm of pancreas,0.8709638118743896
hsa-miR-6738-5p,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-6728-5p,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-5584-3p,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-505,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-321,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-1273h-3p,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-295,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-2355-3p,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-95-5p,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-3170,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-328-3p,castration-resistant prostate cancer,0.8709383010864258
hsa-miR-7-1-3p,solid pseudopapillary neoplasm of pancreas,0.8708449602127075
hsa-miR-7108-5p,solid pseudopapillary neoplasm of pancreas,0.870839536190033
hsa-miR-7-1-3p,"Luminal B,triple negative",0.870810866355896
hsa-miR-498,"Luminal B,triple negative",0.870810866355896
hsa-miR-6834-5p,"Luminal B,triple negative",0.870810866355896
hsa-miR-760,solid pseudopapillary neoplasm of pancreas,0.8708077669143677
hsa-miR-129-2-3p,solid pseudopapillary neoplasm of pancreas,0.8708077669143677
hsa-miR-1226-3p,solid pseudopapillary neoplasm of pancreas,0.8708077669143677
hsa-miR-4433b-5p,castration-resistant prostate cancer,0.8708010911941528
hsa-miR-7-3,castration-resistant prostate cancer,0.8708010911941528
hsa-miR-7-1-3p,castration-resistant prostate cancer,0.8708010911941528
hsa-miR-203a,castration-resistant prostate cancer,0.8708010911941528
hsa-miR-5584-3p,sarcoma,0.870762825012207
hsa-miR-376a-3p,sarcoma,0.870762825012207
hsa-miR-340-3p,solid pseudopapillary neoplasm of pancreas,0.8707493543624878
hsa-let-7f-1-3p,solid pseudopapillary neoplasm of pancreas,0.8707234263420105
hsa-miR-19b-1,solid pseudopapillary neoplasm of pancreas,0.8706862330436707
hsa-miR-4700-5p,solid pseudopapillary neoplasm of pancreas,0.8706862330436707
hsa-miR-4654,solid pseudopapillary neoplasm of pancreas,0.870658278465271
hsa-miR-4771,solid pseudopapillary neoplasm of pancreas,0.8706556558609009
hsa-miR-3175,solid pseudopapillary neoplasm of pancreas,0.8706556558609009
hsa-miR-181a-2*,solid pseudopapillary neoplasm of pancreas,0.8706545829772949
hsa-miR-654,solid pseudopapillary neoplasm of pancreas,0.8706486821174622
hsa-miR-4436a,synovial sarcoma,0.870642900466919
hsa-miR-4526,synovial sarcoma,0.870642900466919
hsa-miR-199b-5p,synovial sarcoma,0.870642900466919
hsa-miR-4652-5p,synovial sarcoma,0.870642900466919
hsa-miR-95-5p,synovial sarcoma,0.870642900466919
hsa-miR-4645-3p,synovial sarcoma,0.870642900466919
hsa-miR-4633-5p,synovial sarcoma,0.870642900466919
hsa-miR-4691-3p,synovial sarcoma,0.870642900466919
hsa-miR-664b-3p,synovial sarcoma,0.870642900466919
hsa-miR-3659,"squamous cell breast carcinoma, acantholytic variant",0.8705832958221436
hsa-miR-3617-3p,"squamous cell breast carcinoma, acantholytic variant",0.8705832958221436
hsa-miR-4258,"squamous cell breast carcinoma, acantholytic variant",0.8705832958221436
hsa-miR-215-5p,"squamous cell breast carcinoma, acantholytic variant",0.8705832958221436
hsa-miR-1587,"squamous cell breast carcinoma, acantholytic variant",0.8705832958221436
hsa-miR-188-3p,miR-675-y,0.8705682158470154
hsa-miR-6780b-5p,miR-142-y,0.8705575466156006
hsa-miR-520g,miR-142-y,0.8705575466156006
hsa-miR-1284,miR-142-y,0.8705575466156006
hsa-miR-561-3p,miR-142-y,0.8705575466156006
hsa-miR-505-3p,follicular thyroid carcinoma,0.8705216646194458
hsa-miR-548c-3p,breast cancer brain metastasis,0.8704491257667542
hsa-miR-720,breast cancer brain metastasis,0.8704491257667542
hsa-miR-513c,breast cancer brain metastasis,0.8704491257667542
hsa-miR-193a-5p,brain cancer,0.870437502861023
hsa-miR-4795-5p,brain cancer,0.8704312443733215
hsa-miR-1287,miR-142-y,0.8703996539115906
hsa-miR-463,miR-142-y,0.8703996539115906
hsa-miR-655-3p,solid pseudopapillary neoplasm of pancreas,0.8703044652938843
hsa-miR-572,solid pseudopapillary neoplasm of pancreas,0.8703044652938843
hsa-miR-376b-5p,miR-142-y,0.8701335787773132
hsa-miR-1292-3p,miR-142-y,0.8701335787773132
hsa-miR-548aj-5p,miR-142-y,0.8701335787773132
hsa-miR-4314,"squamous cell breast carcinoma, acantholytic variant",0.8701037168502808
hsa-miR-512-5p-384,aryngeal squamous cell carcinoma,0.8700141906738281
hsa-miR-3121,aryngeal squamous cell carcinoma,0.8700141906738281
hsa-miR-3123,follicular thyroid carcinoma,0.8700120449066162
hsa-miR-4299,diffuse large B-cell lymphoma,0.8699882626533508
hsa-miR-642,miR-142-y,0.869579017162323
hsa-miR-105-1,miR-142-y,0.869579017162323
hsa-miR-7-1*,miR-142-y,0.869579017162323
hsa-miR-649,miR-142-y,0.869579017162323
hsa-miR-615-5p,miR-142-y,0.869579017162323
hsa-miR-1234,miR-142-y,0.869579017162323
hsa-miR-4687-5p,miR-142-y,0.869579017162323
hsa-miR-4435,miR-142-y,0.869579017162323
hsa-miR-6724-5p,miR-142-y,0.869579017162323
hsa-miR-1287,castration-resistant prostate cancer,0.8695223331451416
hsa-miR-548at-3p,castration-resistant prostate cancer,0.8695223331451416
hsa-miR-362-3p,miR-142-y,0.8694882392883301
hsa-miR-1973,miR-142-y,0.8694882392883301
hsa-miR-6852-3p,miR-142-y,0.8694882392883301
hsa-miR-7976,miR-142-y,0.8694882392883301
hsa-miR-342-5p,miR-142-y,0.8694882392883301
hsa-miR-6888-3p,miR-142-y,0.8694882392883301
hsa-miR-1915-3p,miR-142-y,0.8694882392883301
hsa-miR-556,miR-142-y,0.8694882392883301
hsa-miR-6832-3p,miR-142-y,0.8694882392883301
hsa-miR-3616-5p,sarcoma,0.8693451881408691
hsa-miR-636,sarcoma,0.8693323731422424
hsa-miR-23a-3p,sarcoma,0.8693323731422424
hsa-miR-5695,sarcoma,0.8693323731422424
hsa-miR-4793-3p,sarcoma,0.8693323731422424
hsa-miR-1827,sarcoma,0.8693323731422424
hsa-miR-194-1,synovial sarcoma,0.8692241907119751
hsa-miR-4421,synovial sarcoma,0.8692241907119751
hsa-miR-4685-5p,synovial sarcoma,0.8692241907119751
hsa-miR-642,"Luminal B,triple negative",0.8692047595977783
hsa-miR-4284,"Luminal B,triple negative",0.8692047595977783
hsa-miR-410-5p,"Luminal B,triple negative",0.8692047595977783
hsa-miR-6865-5p,"Luminal B,triple negative",0.8692047595977783
hsa-miR-1915-3p,"Luminal B,triple negative",0.8692047595977783
hsa-miR-4765,"Luminal B,triple negative",0.8692047595977783
hsa-miR-3180-5p,miR-675-y,0.8690233826637268
hsa-miR-16-2*,miR-675-y,0.8690233826637268
hsa-miR-181a-5p,miR-675-y,0.8690233826637268
hsa-miR-759,miR-675-y,0.8690233826637268
hsa-miR-146b-5p,miR-675-y,0.8690233826637268
hsa-miR-1909-5p,miR-675-y,0.8690233826637268
hsa-miR-1226-5p,follicular thyroid carcinoma,0.8689757585525513
hsa-miR-6780b-5p,"Luminal B,triple negative",0.8689377903938293
hsa-miRPlus-K1303*,sarcoma,0.8688947558403015
hsa-miR-181c*,sarcoma,0.8688947558403015
hsa-miR-6744-3p,sarcoma,0.8688947558403015
hsa-miR-602,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-642,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-5587-5p,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-4307,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-921,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-548o,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-100-3p,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-4757-5p,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-30c-1,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-342-5p,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-656-5p,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-4765,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-5003-3p,"squamous cell breast carcinoma, acantholytic variant",0.8684899210929871
hsa-miR-3157-5p,primary central nervous system lymphomas,0.8684521913528442
hsa-miR-431*,primary central nervous system lymphomas,0.8684521913528442
hsa-miR-144*,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-3607-5p,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-668-3p,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-4299,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-518e,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-660,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-3659,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-6743-5p,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-3714,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-341,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-301a-5p,castration-resistant prostate cancer,0.8684317469596863
hsa-miR-6838-3p,miR-142-y,0.8684068918228149
hsa-miR-6515-5p,miR-142-y,0.8684068918228149
hsa-miR-628,miR-142-y,0.8684068918228149
hsa-miR-124a,diffuse large B-cell lymphoma,0.8683765530586243
hsa-miR-630,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-567,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-339-5p,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-21-3p,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-636,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-6838-3p,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-23a-3p,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-766-3p-587,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-4297,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-6715a-3p,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-6745,castration-resistant prostate cancer,0.8683085441589355
hsa-miR-518e,sarcoma,0.8682534098625183
hsa-miR-191-3p,sarcoma,0.8682534098625183
hsa-miR-944,follicular thyroid carcinoma,0.8682370185852051
hsa-miR-3189-5p,miR-142-y,0.8682122826576233
hsa-miR-6089,miR-142-y,0.8682122826576233
hsa-miR-3147,miR-142-y,0.8682122826576233
hsa-miR-548au-3p,miR-142-y,0.8682122826576233
hsa-miR-744*,miR-142-y,0.8682122826576233
hsa-miR-4784,miR-142-y,0.8682122826576233
hsa-miR-101-5p,"squamous cell breast carcinoma, acantholytic variant",0.8681466579437256
hsa-miR-4740-3p,"squamous cell breast carcinoma, acantholytic variant",0.8681466579437256
hsa-miR-1284,"squamous cell breast carcinoma, acantholytic variant",0.8681466579437256
hsa-miR-1274b,"squamous cell breast carcinoma, acantholytic variant",0.8681466579437256
hsa-miR-5707,synovial sarcoma,0.8681315183639526
hsa-miR-30c-2-3p,synovial sarcoma,0.8681315183639526
hsa-miR-5094,synovial sarcoma,0.8681315183639526
hsa-miR-6512-3p,synovial sarcoma,0.8681315183639526
hsa-miR-1587,synovial sarcoma,0.8681315183639526
hsa-miR-6831-5p,synovial sarcoma,0.8681315183639526
hsa-miR-1255a,follicular thyroid carcinoma,0.8680551648139954
hsa-miR-4738-5p,solid pseudopapillary neoplasm of pancreas,0.8680101633071899
hsa-miR-423-5p_2,diffuse large B-cell lymphoma,0.8679362535476685
hsa-miR-6088,castration-resistant prostate cancer,0.8678678274154663
hsa-miR-548c-3p,castration-resistant prostate cancer,0.8678678274154663
hsa-miRPlus-K1303*,castration-resistant prostate cancer,0.8678678274154663
hsa-miR-4709-5p,castration-resistant prostate cancer,0.8678678274154663
hsa-miR-3121,castration-resistant prostate cancer,0.8678678274154663
hsa-miR-506,"Luminal B,triple negative",0.8678570985794067
hsa-miR-4433b-5p,sarcoma,0.867749035358429
hsa-miR-602,breast cancer brain metastasis,0.8677481412887573
hsa-miR-642,breast cancer brain metastasis,0.8677481412887573
hsa-miR-548c-3p,"squamous cell breast carcinoma, acantholytic variant",0.8677160143852234
hsa-miR-720,"squamous cell breast carcinoma, acantholytic variant",0.8677160143852234
hsa-miR-513c,"squamous cell breast carcinoma, acantholytic variant",0.8677160143852234
hsa-miR-6744-3p,"squamous cell breast carcinoma, acantholytic variant",0.8677160143852234
hsa-miR-17,"squamous cell breast carcinoma, acantholytic variant",0.8677160143852234
hsa-miR-2355,diffuse large B-cell lymphoma,0.8675420880317688
hsa-miR-101-5p,diffuse large B-cell lymphoma,0.8675420880317688
hsa-miR-3939,follicular thyroid carcinoma,0.8675307631492615
hsa-miR-092,miR-142-y,0.8673391938209534
hsa-miR-455-3p,miR-142-y,0.8673391938209534
hsa-miR-302c,miR-142-y,0.8673391938209534
hsa-miR-34b-3p,miR-142-y,0.8673391938209534
hsa-miR-188-3p,miR-142-y,0.8673391938209534
hsa-miR-761,miR-142-y,0.8673391938209534
hsa-miR-4777-3p,miR-142-y,0.8673391938209534
hsa-miR-6790-5p,miR-142-y,0.8673391938209534
hsa-miR-135a-2,aryngeal squamous cell carcinoma,0.8673054575920105
hsa-miR-6770-3p,aryngeal squamous cell carcinoma,0.8673054575920105
hsa-miR-6845-3p,aryngeal squamous cell carcinoma,0.8673054575920105
hsa-miR-33a*,miR-675-y,0.8672481775283813
hsa-miR-1468,miR-675-y,0.8672481775283813
hsa-miR-3121,diffuse large B-cell lymphoma,0.8671098351478577
hsa-miR-3157-5p,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR128b,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-615-5p,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-431*,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-3660,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-1234,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-20b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miRPlus-G1065-5p,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-937-3p,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-454,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-615-3p,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-4435,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-4633-3p,"squamous cell breast carcinoma, acantholytic variant",0.8670605421066284
hsa-miR-4655-5p,"Luminal B,triple negative",0.8669595718383789
hsa-miR-188-3p,"Luminal B,triple negative",0.8669595718383789
hsa-miR-487b-3p,"Luminal B,triple negative",0.8669595718383789
hsa-miR-653-5p,"Luminal B,triple negative",0.8669595718383789
hsa-miR-6740-3p,"Luminal B,triple negative",0.8669595718383789
hsa-miR-497*,brain cancer,0.8669394850730896
hsa-miR-202-5p,miR-675-y,0.8669339418411255
hsa-miR-326,miR-675-y,0.8669339418411255
hsa-miR-3927-3p,ovarian carcinoma,0.8669297099113464
hsa-miR-1185-1-3p,ovarian carcinoma,0.8669297099113464
hsa-miR-19b-2-5p,ovarian carcinoma,0.8668145537376404
hsa-miR-518d,ovarian carcinoma,0.8668145537376404
hsa-miR-221*,ovarian carcinoma,0.8668145537376404
hsa-miR-128-1,ovarian carcinoma,0.8668145537376404
hsa-miR-3190,"Luminal B,triple negative",0.8667643666267395
hsa-miR-513b,"Luminal B,triple negative",0.8667643666267395
hsa-miR-6824-5p,"Luminal B,triple negative",0.8667643666267395
hsa-miR-766-3p-587,"Luminal B,triple negative",0.8667643666267395
hsa-miR-628,"Luminal B,triple negative",0.8667643666267395
hsa-miR-148a,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-3616-5p,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-194-1,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-4671-5p,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-4421,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-463,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-939-5p,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-877-5p,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-4314,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-4798-3p,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-7110-5p,castration-resistant prostate cancer,0.8667146563529968
hsa-miR-2964a-3p,"Luminal B,triple negative",0.8665676712989807
hsa-miR-5186,"Luminal B,triple negative",0.8665676712989807
hsa-miR-220a,"Luminal B,triple negative",0.8665676712989807
hsa-miR-4433b-5p,solid pseudopapillary neoplasm of pancreas,0.8665669560432434
hsa-miR-513a-3p,diffuse large B-cell lymphoma,0.8664517402648926
hsa-miR-362-3p,diffuse large B-cell lymphoma,0.8664517402648926
hsa-miR-136*,diffuse large B-cell lymphoma,0.8664517402648926
hsa-miR-302b*,diffuse large B-cell lymphoma,0.8664517402648926
hsa-miR-1277-3p,diffuse large B-cell lymphoma,0.8664517402648926
hsa-miR-550a-3-5p,diffuse large B-cell lymphoma,0.8664517402648926
hsa-miR-7706,diffuse large B-cell lymphoma,0.8664517402648926
hsa-miR-092,"squamous cell breast carcinoma, acantholytic variant",0.866234302520752
hsa-miR-4454,"squamous cell breast carcinoma, acantholytic variant",0.866234302520752
hsa-miR-1247,"squamous cell breast carcinoma, acantholytic variant",0.866234302520752
hsa-miR-517-5p,"squamous cell breast carcinoma, acantholytic variant",0.866234302520752
hsa-miR-34b-3p,"squamous cell breast carcinoma, acantholytic variant",0.866234302520752
hsa-miR-499,"squamous cell breast carcinoma, acantholytic variant",0.866234302520752
hsa-miR-181d-5p,"squamous cell breast carcinoma, acantholytic variant",0.866234302520752
hsa-miR-1199-3p,"squamous cell breast carcinoma, acantholytic variant",0.866234302520752
hsa-miR-344,sarcoma,0.8661104440689087
hsa-miR-4517,sarcoma,0.8661104440689087
hsa-miR-1306-5p,sarcoma,0.8661104440689087
hsa-miR-2115-5p,sarcoma,0.8661104440689087
hsa-miR-652-5p,sarcoma,0.8661104440689087
hsa-miR-921,sarcoma,0.8661104440689087
hsa-miR-6510-5p,sarcoma,0.8661104440689087
hsa-miR-4511,sarcoma,0.8661104440689087
hsa-miR-34c-3p,sarcoma,0.8661104440689087
hsa-miR-371b-3p,miR-675-y,0.8660275936126709
hsa-miR-5088,miR-142-y,0.865975022315979
hsa-miR-642a,miR-142-y,0.865975022315979
hsa-miR-1236-5p,miR-142-y,0.865975022315979
hsa-miR-6848-5p,miR-142-y,0.865975022315979
hsa-miR-146b-5p,miR-142-y,0.865975022315979
hsa-miR-4514,miR-142-y,0.865975022315979
hsa-miR-196a-5p,miR-142-y,0.865975022315979
hsa-miR-6515-3p,miR-142-y,0.865975022315979
hsa-miR-511-2,"squamous cell breast carcinoma, acantholytic variant",0.865962028503418
hsa-miR-522*,"squamous cell breast carcinoma, acantholytic variant",0.865962028503418
hsa-miR-3647-3p,"squamous cell breast carcinoma, acantholytic variant",0.865962028503418
hsa-miR-6838-3p,"squamous cell breast carcinoma, acantholytic variant",0.865962028503418
hsa-miR-766-3p-587,"squamous cell breast carcinoma, acantholytic variant",0.865962028503418
hsa-miR-4297,"squamous cell breast carcinoma, acantholytic variant",0.865962028503418
hsa-miR-200b-3p,"squamous cell breast carcinoma, acantholytic variant",0.865962028503418
hsa-miR-923,castration-resistant prostate cancer,0.8659608960151672
hsa-miR-6780b-5p,castration-resistant prostate cancer,0.8659608960151672
hsa-miR-6071,castration-resistant prostate cancer,0.8659608960151672
hsa-miR-499-5p,castration-resistant prostate cancer,0.8659608960151672
hsa-miR-4760-3p,castration-resistant prostate cancer,0.8659608960151672
hsa-miR-5008-3p,castration-resistant prostate cancer,0.8659608960151672
hsa-miR-4740-3p,castration-resistant prostate cancer,0.8659608960151672
hsa-let-7c-3p,castration-resistant prostate cancer,0.8659608960151672
hsa-miR-561-3p,castration-resistant prostate cancer,0.8659608960151672
hsa-miR-4742-5p,castration-resistant prostate cancer,0.8659608960151672
hsa-miR-186,miR-675-y,0.8658766746520996
hsa-miR-3614-5p,solid pseudopapillary neoplasm of pancreas,0.865875244140625
hsa-miR-548w,solid pseudopapillary neoplasm of pancreas,0.865875244140625
hsa-miR-3605-3p,sarcoma,0.8657796382904053
hsa-miR-30e-3p,sarcoma,0.8657796382904053
hsa-miR-4760-3p,sarcoma,0.8657796382904053
hsa-miR-520g,sarcoma,0.8657796382904053
hsa-miR-6820-5p,miR-675-y,0.8657676577568054
hsa-miR-320B,"squamous cell breast carcinoma, acantholytic variant",0.8657644391059875
hsa-miR-657,synovial sarcoma,0.865655779838562
hsa-miR-20a*,synovial sarcoma,0.865655779838562
hsa-miR-499-5p,synovial sarcoma,0.865655779838562
hsa-miR-548w,synovial sarcoma,0.865655779838562
hsa-miR-6874-5p,synovial sarcoma,0.865655779838562
hsa-let-7c-3p,synovial sarcoma,0.865655779838562
hsa-miR-4788,synovial sarcoma,0.865655779838562
hsa-miR-6874-3p,synovial sarcoma,0.865655779838562
hsa-miR-548t-5p,synovial sarcoma,0.865655779838562
hsa-miR-1271-3p,castration-resistant prostate cancer,0.8655242323875427
hsa-miR-376b-5p,castration-resistant prostate cancer,0.8655242323875427
hsa-miR-1292-3p,castration-resistant prostate cancer,0.8655242323875427
hsa-miR-720,castration-resistant prostate cancer,0.8655242323875427
hsa-miR-513c,castration-resistant prostate cancer,0.8655242323875427
hsa-miR-6819-5p,castration-resistant prostate cancer,0.8655242323875427
hsa-miR-4536-3p,castration-resistant prostate cancer,0.8655242323875427
hsa-miR-454*,miR-675-y,0.8654603958129883
hsa-miR-3927-3p,miR-675-y,0.8654593825340271
hsa-miR-4497,solid pseudopapillary neoplasm of pancreas,0.8654554486274719
hsa-miR-5094,solid pseudopapillary neoplasm of pancreas,0.8654554486274719
hsa-miR-5582-3p,ovarian carcinoma,0.8653955459594727
hsa-miR-092,ovarian carcinoma,0.8653955459594727
hsa-miRPlus-C1066,ovarian carcinoma,0.8653955459594727
hsa-miR-34b-3p,ovarian carcinoma,0.8653955459594727
hsa-miR-4430,diffuse large B-cell lymphoma,0.8653491139411926
hsa-miR-199a-5p,diffuse large B-cell lymphoma,0.8653491139411926
hsa-miR-496,diffuse large B-cell lymphoma,0.8653491139411926
hsa-miR-589,sarcoma,0.8653424382209778
hsa-miR-4709-5p,sarcoma,0.8653424382209778
hsa-miR-7974,sarcoma,0.8653424382209778
hsa-miR-3934-3p,miR-675-y,0.8653212189674377
hsa-miR-4690-5p,ovarian carcinoma,0.8652977347373962
hsa-miR-572,ovarian carcinoma,0.8652977347373962
hsa-miR-19b-2*,ovarian carcinoma,0.8652977347373962
hsa-miR-1260a,ovarian carcinoma,0.8652977347373962
hsa-miR-374b-3p,synovial sarcoma,0.8652182817459106
hsa-miR-423-5p_2,synovial sarcoma,0.8652182817459106
hsa-miR-3151-5p,synovial sarcoma,0.8652182817459106
hsa-miR-513c,synovial sarcoma,0.8652182817459106
hsa-miR-6744-3p,synovial sarcoma,0.8652182817459106
hsa-miR-598-5p,synovial sarcoma,0.8652182817459106
hsa-miR-3121,synovial sarcoma,0.8652182817459106
hsa-miR-17,synovial sarcoma,0.8652182817459106
hsa-miR-3175,miR-675-y,0.8651708364486694
hsa-miR-193a-3p,diffuse large B-cell lymphoma,0.8651506304740906
hsa-miR-600,diffuse large B-cell lymphoma,0.8651506304740906
hsa-miR-106b-5p,diffuse large B-cell lymphoma,0.8651348352432251
hsa-miR-20b-5p,diffuse large B-cell lymphoma,0.8651348352432251
hsa-miR-4687-5p,diffuse large B-cell lymphoma,0.8651348352432251
hsa-miR-556,diffuse large B-cell lymphoma,0.8651348352432251
hsa-miR-6777-5p,miR-675-y,0.8650910258293152
hsa-miR-3669,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-4795-5p,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-9-3,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-557,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-136*,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-2115-5p,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-4307,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-4265,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-320e-1095,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-4284,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-302b*,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-4674,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-1537-3p,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-4729,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-4511,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-410-5p,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-6832-3p,castration-resistant prostate cancer,0.8650655150413513
hsa-miR-940,miR-675-y,0.8650619983673096
hsa-miR-330-3p,miR-675-y,0.8650619983673096
hsa-miR-7160-5p,miR-675-y,0.8650619983673096
hsa-miR-129-5p,miR-675-y,0.8650093674659729
hsa-miR-579-3p,miR-675-y,0.8649269342422485
hsa-miR-676*,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-513a-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-548b-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-579,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-487b-5p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-329-2,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-5587-5p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-193a-5p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-501-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-4278,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-6717-5p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-1234,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-124a-3,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-4684-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-548b,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-1973,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-1277-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-6510-5p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-101-2,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-345-5p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-100-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-6775-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-6499-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-1237-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-6770-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-6888-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-34c-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-2467-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-615-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-6858-5p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-1915-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-7706,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-124-3,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-548aj,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-6845-3p,castration-resistant prostate cancer,0.8648595213890076
hsa-miR-6795-3p,brain cancer,0.8648219108581543
hsa-miR-1185-1-3p,rhabdomyosarcomas,0.86475670337677
hsa-miR-518d-3p,miR-675-y,0.8647512793540955
hsa-miR-636,synovial sarcoma,0.8647250533103943
hsa-miR-6838-3p,synovial sarcoma,0.8647250533103943
hsa-miR-363-5p,synovial sarcoma,0.8647250533103943
hsa-miR-4297,synovial sarcoma,0.8647250533103943
hsa-miR-4639-5p,synovial sarcoma,0.8647250533103943
hsa-miR-6715a-3p,synovial sarcoma,0.8647250533103943
hsa-miR-5695,synovial sarcoma,0.8647250533103943
hsa-miR-3177,synovial sarcoma,0.8647250533103943
hsa-miR-6745,synovial sarcoma,0.8647250533103943
hsa-miR-361-3p,synovial sarcoma,0.8647250533103943
hsa-miR-6837-5p,synovial sarcoma,0.8647250533103943
hsa-miR-103-2,high grade serous papillary ovarian cancer,0.8646899461746216
hsa-miR-7113-5p,high grade serous papillary ovarian cancer,0.8646899461746216
hsa-miR-4265,sarcoma,0.8646770119667053
hsa-miR-345-5p,sarcoma,0.8646770119667053
hsa-miR-1537-3p,sarcoma,0.8646770119667053
hsa-miR-4423-5p,sarcoma,0.8646770119667053
hsa-miR-519a,high grade serous papillary ovarian cancer,0.8645730018615723
hsa-miR-3529-3p,high grade serous papillary ovarian cancer,0.8645730018615723
hsa-miR-501-3p,synovial sarcoma,0.86455237865448
hsa-miR-106b-5p,synovial sarcoma,0.86455237865448
hsa-miR-4517,synovial sarcoma,0.86455237865448
hsa-miR-649,synovial sarcoma,0.86455237865448
hsa-miR-518f-5p,synovial sarcoma,0.86455237865448
hsa-miR-4307,synovial sarcoma,0.86455237865448
hsa-miR-20b-5p,synovial sarcoma,0.86455237865448
hsa-miR-4674,synovial sarcoma,0.86455237865448
hsa-miR-345-5p,synovial sarcoma,0.86455237865448
hsa-miR-100-3p,synovial sarcoma,0.86455237865448
hsa-miR-937-3p,synovial sarcoma,0.86455237865448
hsa-miR-6508-3p,synovial sarcoma,0.86455237865448
hsa-miR-410-5p,synovial sarcoma,0.86455237865448
hsa-miR-615-3p,synovial sarcoma,0.86455237865448
hsa-miR-6858-5p,synovial sarcoma,0.86455237865448
hsa-miR-7706,synovial sarcoma,0.86455237865448
hsa-miR-6826-3p,synovial sarcoma,0.86455237865448
hsa-miR-4756-5p,miR-675-y,0.8644537925720215
hsa-miR-876-3p,miR-675-y,0.8644537925720215
hsa-miR-374a,miR-675-y,0.864345133304596
hsa-miR-323-3p,miR-675-y,0.864345133304596
hsa-miR-3934,"Luminal B,triple negative",0.8643068671226501
hsa-miR-377,synovial sarcoma,0.864274263381958
hsa-miRPlus-K1303*,synovial sarcoma,0.864274263381958
hsa-miR-30e*,synovial sarcoma,0.864274263381958
hsa-miR-376b-5p,synovial sarcoma,0.864274263381958
hsa-miR-512-5p-384,synovial sarcoma,0.864274263381958
hsa-miR-181c*,synovial sarcoma,0.864274263381958
hsa-miR-6757-5p,synovial sarcoma,0.864274263381958
hsa-miR-5585-5p,synovial sarcoma,0.864274263381958
hsa-miR-6500-5p,synovial sarcoma,0.864274263381958
hsa-miR-4694-5p,synovial sarcoma,0.864274263381958
hsa-miR-4271,brain cancer,0.8642100691795349
hsa-miR-617,miR-675-y,0.864111602306366
hsa-miR-552,miR-675-y,0.864111602306366
hsa-miR-3545-5p,miR-675-y,0.864111602306366
hsa-miR-449c,pilocytic astrocytoma,0.8640544414520264
hsa-miR-554,ovarian carcinoma,0.8640496730804443
hsa-miR-4314,ovarian carcinoma,0.8640496730804443
hsa-miR-6834-5p,ovarian carcinoma,0.8640496730804443
hsa-miR-6871-5p,miR-675-y,0.8639824986457825
hsa-miR-3176,miR-675-y,0.8639824986457825
hsa-miR-129-2-3p,miR-675-y,0.8638466000556946
hsa-miR-337-5p,miR-675-y,0.8638466000556946
hsa-miR-6887-3p,miR-675-y,0.8638466000556946
hsa-miR-7106-5p,miR-142-y,0.8638443946838379
hsa-miR-4777-5p,miR-142-y,0.8638443946838379
hsa-miR-3189-3p,miR-142-y,0.8638443946838379
hsa-miR-597,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-202*,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-569,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-525-3p,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-6827-5p,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-507,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-542-5p,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-4639-5p,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-6127,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-200b-3p,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-509-3-5p,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-6823-5p,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-8087,castration-resistant prostate cancer,0.8637457489967346
hsa-miR-1185-5p,miR-675-y,0.8637033104896545
hsa-miR-4723-3p,miR-675-y,0.8637033104896545
hsa-miR-1269,miR-675-y,0.8637033104896545
hsa-miR-675,miR-675-y,0.863643229007721
hsa-miR-3189,miR-675-y,0.863643229007721
hsa-miR-181a*,miR-675-y,0.863643229007721
hsa-miR-1912,miR-675-y,0.863643229007721
hsa-miR-584,miR-675-y,0.863643229007721
hsa-miR-26a-2,miR-675-y,0.863643229007721
hsa-miR-6735-5p,miR-675-y,0.863643229007721
hsa-miR-4448,sarcoma,0.8635620474815369
hsa-miR-3190,sarcoma,0.8635620474815369
hsa-miR-181d,sarcoma,0.8635620474815369
hsa-miR-665,miR-675-y,0.8635522723197937
hsa-miR-6759-3p,miR-675-y,0.8635522723197937
hsa-miR-600,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-6802-5p,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-2964a-3p,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-3173-5p,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-518e*,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-5004-3p,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-520b,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-203b-3p,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-4800-5p,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-4699-3p,castration-resistant prostate cancer,0.8635454177856445
hsa-miR-922,"squamous cell breast carcinoma, acantholytic variant",0.8634921908378601
hsa-miR-130b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8634921908378601
hsa-miR-3681,"squamous cell breast carcinoma, acantholytic variant",0.8634921908378601
hsa-miR-1236-5p,"squamous cell breast carcinoma, acantholytic variant",0.8634921908378601
hsa-miR-507,synovial sarcoma,0.8634364604949951
hsa-miR-339-5p,synovial sarcoma,0.8634364604949951
hsa-miR-4448,synovial sarcoma,0.8634364604949951
hsa-miR-6720-3p,synovial sarcoma,0.8634364604949951
hsa-miR-425*,synovial sarcoma,0.8634364604949951
hsa-miR-548m,Leptomeningeal metastasis,0.8634305596351624
hsa-miR-449b-5p,sarcoma,0.8633613586425781
hsa-miR-3123,sarcoma,0.8633613586425781
hsa-let-7a_c,sarcoma,0.8633613586425781
hsa-miR-196a-3p,sarcoma,0.8633613586425781
hsa-miR-219a-2-3p,sarcoma,0.8633613586425781
hsa-miR-19b-2-5p,papillary thyroid carcinoma,0.8633403182029724
hsa-miR-2964a-3p,synovial sarcoma,0.8632356524467468
hsa-miR-196-2,synovial sarcoma,0.8632356524467468
hsa-miR-6771-5p,synovial sarcoma,0.8632356524467468
hsa-miR-1273e,miR-675-y,0.8632275462150574
hsa-miR-191-5p,miR-675-y,0.8632275462150574
hsa-miR-6821-3p,miR-675-y,0.8632275462150574
hsa-miR-3926,rhabdomyosarcomas,0.8632014393806458
hsa-miR-374c,rhabdomyosarcomas,0.8632014393806458
hsa-miR-655-3p,miR-675-y,0.8631532788276672
hsa-miR-4753-5p,high grade serous papillary ovarian cancer,0.8631340265274048
hsa-miR-3682-5p,high grade serous papillary ovarian cancer,0.8631340265274048
hsa-miR-708*,high grade serous papillary ovarian cancer,0.8631340265274048
hsa-miR-4536-5p,high grade serous papillary ovarian cancer,0.8631340265274048
hsa-miR-3187-5p,high grade serous papillary ovarian cancer,0.8631340265274048
hsa-miR-6841-5p,high grade serous papillary ovarian cancer,0.8631340265274048
hsa-miR-7-1-3p,synovial sarcoma,0.8630947470664978
hsa-miR-4671-5p,synovial sarcoma,0.8630947470664978
hsa-miR-1287,synovial sarcoma,0.8630947470664978
hsa-miR-409-5p,synovial sarcoma,0.8630947470664978
hsa-miR-548c-5p,synovial sarcoma,0.8630947470664978
hsa-miR-544a,synovial sarcoma,0.8630947470664978
hsa-miR-431-5p,high grade serous papillary ovarian cancer,0.863034725189209
hsa-miR-548m,brain cancer,0.8630229234695435
hsa-miR-3927-3p,brain cancer,0.8630229234695435
hsa-miR-422b,solid pseudopapillary neoplasm of pancreas,0.8629374504089355
hsa-miR-6893-3p,solid pseudopapillary neoplasm of pancreas,0.8629374504089355
hsa-miR-30e-3p,solid pseudopapillary neoplasm of pancreas,0.8629374504089355
hsa-miR-101-5p,solid pseudopapillary neoplasm of pancreas,0.8629374504089355
hsa-miR-3143,breast cancer brain metastasis,0.8629334568977356
hsa-miR-941,breast cancer brain metastasis,0.8629334568977356
hsa-miR-6810-3p,ovarian carcinoma,0.8629287481307983
hsa-miR-6728-5p,ovarian carcinoma,0.8629287481307983
hsa-miR-1273h-3p,ovarian carcinoma,0.8629287481307983
hsa-miR-4436a,ovarian carcinoma,0.8629287481307983
hsa-miR-593*,brain cancer,0.8629249334335327
hsa-miR-616*,brain cancer,0.8629249334335327
hsa-miR-1468-5p,miR-675-y,0.8628782629966736
hsa-miR-4453,diffuse large B-cell lymphoma,0.8628696203231812
hsa-miR-99a*,diffuse large B-cell lymphoma,0.8628696203231812
hsa-miR-922,diffuse large B-cell lymphoma,0.8628696203231812
hsa-miR-302c,diffuse large B-cell lymphoma,0.8628309369087219
hsa-miR-3529-3p,"squamous cell breast carcinoma, acantholytic variant",0.8628204464912415
hsa-miR-128-1,"squamous cell breast carcinoma, acantholytic variant",0.8628204464912415
hsa-miR-676,"squamous cell breast carcinoma, acantholytic variant",0.8628204464912415
hsa-miR-6755-5p,miR-142-y,0.8627665042877197
hsa-miR-4794,miR-142-y,0.8627665042877197
hsa-miR-500a*,castration-resistant prostate cancer,0.8627603054046631
hsa-miR-1826,castration-resistant prostate cancer,0.8627603054046631
hsa-miR-4753-5p,castration-resistant prostate cancer,0.8627603054046631
hsa-miR-517-5p,castration-resistant prostate cancer,0.8627603054046631
hsa-miR-5187-5p,castration-resistant prostate cancer,0.8627603054046631
hsa-miR-4536-5p,castration-resistant prostate cancer,0.8627603054046631
hsa-miR-151-3p,brain cancer,0.8627009987831116
hsa-miR-138-1*,miR-675-y,0.8626965880393982
hsa-miR-6804-5p,miR-675-y,0.8626965880393982
hsa-miR-6835-5p,miR-675-y,0.8626965880393982
hsa-miR-338-3p,miR-675-y,0.8626944422721863
hsa-miR-133b,miR-675-y,0.8626944422721863
hsa-miR-1301,miR-675-y,0.8626944422721863
hsa-miR-411-5p,miR-675-y,0.8626944422721863
hsa-miR-520d-5p,miR-675-y,0.8626944422721863
hsa-miR-4315,miR-675-y,0.8625093102455139
hsa-miR-6733-3p,miR-142-y,0.8624740242958069
hsa-miR-4256,breast cancer brain metastasis,0.8624525666236877
hsa-miR-330-3p,breast cancer brain metastasis,0.8624525666236877
hsa-miR-454*,miR-142-y,0.8623421788215637
hsa-miR-10b-5p,miR-142-y,0.8622724413871765
hsa-miR-489,miR-142-y,0.8622002005577087
hsa-miR-1267,Leptomeningeal metastasis,0.8621944785118103
hsa-miR-6795-3p,Leptomeningeal metastasis,0.8621944785118103
hsa-miR-469,"Luminal B,triple negative",0.862153947353363
hsa-miR-548av-5p,miR-142-y,0.8621230125427246
hsa-miR-6499-5p,miR-675-y,0.8621047735214233
hsa-miR-5088-5p,miR-675-y,0.8621047735214233
hsa-miR-1285-3p,miR-675-y,0.8621047735214233
hsa-miR-153-3p,miR-675-y,0.8621047735214233
hsa-miR-548av-3p,miR-675-y,0.8619892001152039
hsa-miR-363,miR-675-y,0.8619892001152039
hsa-miR-6823-3p,miR-675-y,0.8619892001152039
hsa-miR-500*,miR-142-y,0.8619657158851624
hsa-miR-367-3p,miR-142-y,0.8619359731674194
hsa-miR-222-3p,miR-142-y,0.8619359731674194
hsa-miR-1182,miR-142-y,0.8619359731674194
hsa-miR-6073,miR-142-y,0.8619359731674194
hsa-miR-330-3p,miR-142-y,0.8619359731674194
hsa-miR-8073,miR-142-y,0.8619359731674194
hsa-miR-4454,papillary thyroid carcinoma,0.8618903160095215
hsa-miR-320e,miR-675-y,0.8618809580802917
hsa-miR-634,miR-675-y,0.8618809580802917
hsa-miR-4276,miR-675-y,0.8618809580802917
hsa-miR-6861-3p,miR-675-y,0.8618809580802917
hsa-miR-449b,miR-675-y,0.8618809580802917
hsa-miRPlus-A1087,miR-675-y,0.8618809580802917
hsa-miR-1252-5p,miR-675-y,0.8618809580802917
hsa-miR-7706,solid pseudopapillary neoplasm of pancreas,0.861815333366394
hsa-miR-1262,miR-142-y,0.8617983460426331
hsa-miR-541,papillary thyroid carcinoma,0.8617901802062988
hsa-miR-654-5p,Leptomeningeal metastasis,0.8617624640464783
hsa-miR-150*,Leptomeningeal metastasis,0.8617624640464783
hsa-miR-342-3p,"Luminal B,triple negative",0.8617309927940369
hsa-miR-616*,Leptomeningeal metastasis,0.8617113828659058
hsa-miR-548g,Leptomeningeal metastasis,0.8617113828659058
hsa-miR-149*,miR-142-y,0.861710786819458
hsa-let-7b*,miR-142-y,0.861710786819458
hsa-miR-519c,miR-142-y,0.861710786819458
hsa-miR-760,brain cancer,0.8616933226585388
hsa-miR-1255b-2-3p,miR-675-y,0.8616695404052734
hsa-miR-4295,miR-142-y,0.8616192936897278
hsa-miR-6860,miR-142-y,0.8616192936897278
hsa-miR-6730-3p,miR-675-y,0.8615267276763916
hsa-miR-3945,miR-675-y,0.8615267276763916
hsa-miR-532,miR-675-y,0.8615267276763916
hsa-miR-570,miR-675-y,0.8615267276763916
hsa-miR-562,miR-675-y,0.8615267276763916
hsa-miR-4758-5p,miR-675-y,0.8615267276763916
hsa-miR-10b-3p,miR-675-y,0.8615267276763916
hsa-miR-185*,miR-675-y,0.8615267276763916
hsa-miR-320a,miR-142-y,0.861522912979126
hsa-miR-590,brain cancer,0.8614872694015503
hsa-miR-6514-3p,miR-675-y,0.8614599704742432
hsa-miR-3074-5p,miR-675-y,0.8614599704742432
hsa-miR-450a-2-3p,miR-675-y,0.8614599704742432
hsa-miR-128a,miR-675-y,0.8614599704742432
hsa-miR-347,miR-675-y,0.8614599704742432
hsa-miR-7-1-3p,ovarian carcinoma,0.8614388704299927
hsa-miR-4671-5p,ovarian carcinoma,0.8614388704299927
hsa-miR-4484,ovarian carcinoma,0.8614388704299927
hsa-miR-6792-3p,miR-142-y,0.8614217042922974
hsa-miR-6809-5p,miR-142-y,0.8614217042922974
hsa-miR-513a-3p,synovial sarcoma,0.8614078760147095
hsa-miR-9-3,synovial sarcoma,0.8614078760147095
hsa-miR-136*,synovial sarcoma,0.8614078760147095
hsa-miR-124a-3,synovial sarcoma,0.8614078760147095
hsa-miR-921,synovial sarcoma,0.8614078760147095
hsa-miR-3909,synovial sarcoma,0.8614078760147095
hsa-miRPlus-G1065-5p,synovial sarcoma,0.8614078760147095
hsa-miR-7152-3p,synovial sarcoma,0.8614078760147095
hsa-miR-7976,synovial sarcoma,0.8614078760147095
hsa-miR-4423-5p,synovial sarcoma,0.8614078760147095
hsa-miR-1237-3p,synovial sarcoma,0.8614078760147095
hsa-miR-506,synovial sarcoma,0.8614078760147095
hsa-miR-550a-3-5p,synovial sarcoma,0.8614078760147095
hsa-miR-34c-3p,synovial sarcoma,0.8614078760147095
hsa-miR-2467-3p,synovial sarcoma,0.8614078760147095
hsa-miR-4765,synovial sarcoma,0.8614078760147095
hsa-miR-556,synovial sarcoma,0.8614078760147095
hsa-miR-124-3,synovial sarcoma,0.8614078760147095
hsa-miR-3143,"squamous cell breast carcinoma, acantholytic variant",0.8613284826278687
hsa-miR-4722-3p,"squamous cell breast carcinoma, acantholytic variant",0.8613284826278687
hsa-miR-651-5p,"squamous cell breast carcinoma, acantholytic variant",0.8613284826278687
hsa-miR-659-5p,"squamous cell breast carcinoma, acantholytic variant",0.8613284826278687
hsa-miR-4752,"squamous cell breast carcinoma, acantholytic variant",0.8613284826278687
hsa-miR-4756-5p,miR-142-y,0.861315906047821
hsa-miR-23c,miR-142-y,0.861315906047821
hsa-miR-6801-3p,miR-142-y,0.861315906047821
hsa-miR-3657,miR-675-y,0.8612908720970154
hsa-miR-30a-3p,miR-675-y,0.8612908720970154
hsa-miR-1296,miR-675-y,0.8612908720970154
hsa-let-7c*,miR-675-y,0.8612908720970154
hsa-miR-147a,miR-675-y,0.8612908720970154
hsa-miR-29a*,miR-675-y,0.8612908720970154
hsa-miR-936,miR-675-y,0.8612601161003113
hsa-miR-3928-3p,miR-675-y,0.8612601161003113
hsa-miR-646,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-497*,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-6762-3p,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-5088,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-3681,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-3606,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-1249-3p,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-5571-3p,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-1909-5p,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-4483,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-4266,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-548g-3p,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-6859-3p,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-889-5p,castration-resistant prostate cancer,0.8612415194511414
hsa-miR-26b-3p,miR-142-y,0.8612052202224731
hsa-miR-4683,miR-142-y,0.8612052202224731
hsa-miR-212-3p,miR-142-y,0.8612052202224731
hsa-miR-6851-5p,miR-675-y,0.8611812591552734
hsa-miR-376c,miR-675-y,0.8611812591552734
hsa-miR-32*,miR-675-y,0.8611812591552734
hsa-miR-486-5p,miR-675-y,0.8611812591552734
hsa-miR-3944-5p,miR-675-y,0.8611812591552734
hsa-miR-520g-5p,miR-675-y,0.8611812591552734
hsa-miR-519d-5p,miR-675-y,0.8611712455749512
hsa-miR-1260,miR-675-y,0.8611712455749512
hsa-miR-194,miR-675-y,0.861158013343811
hsa-miR-106b*,miR-675-y,0.861158013343811
hsa-miR-614,miR-675-y,0.861158013343811
hsa-miR-8079,miR-675-y,0.861158013343811
hsa-miR-548i,miR-675-y,0.861158013343811
hsa-miR-128b,miR-675-y,0.861158013343811
hsa-miR-568,miR-675-y,0.861158013343811
hsa-miR-1234-3p,miR-142-y,0.8610889315605164
hsa-miR-517,brain cancer,0.8610661625862122
hsa-miR-6867-3p,"Luminal B,triple negative",0.8610647916793823
hsa-miR-125b-1-3p,sarcoma,0.8610548973083496
hsa-miR-6081,sarcoma,0.8610548973083496
hsa-miR-4483,sarcoma,0.8610548973083496
hsa-miR-3922,sarcoma,0.8610548973083496
hsa-miR-554,high grade serous papillary ovarian cancer,0.8610420227050781
hsa-miR-337,"squamous cell breast carcinoma, acantholytic variant",0.8609815835952759
hsa-miR-4735-5p,"squamous cell breast carcinoma, acantholytic variant",0.8609815835952759
hsa-miR-548ax,"squamous cell breast carcinoma, acantholytic variant",0.8609815835952759
hsa-miR-617,miR-142-y,0.8609671592712402
hsa-miR-3180-5p,synovial sarcoma,0.860927402973175
hsa-miR-5088,synovial sarcoma,0.860927402973175
hsa-let-7a*,synovial sarcoma,0.860927402973175
hsa-miR-922,synovial sarcoma,0.860927402973175
hsa-miR-1294,synovial sarcoma,0.860927402973175
hsa-miR-3663-5p,synovial sarcoma,0.860927402973175
hsa-miR-7150,synovial sarcoma,0.860927402973175
hsa-miR-3124,synovial sarcoma,0.860927402973175
hsa-miR-6854-5p,synovial sarcoma,0.860927402973175
hsa-miR-6882-3p,miR-142-y,0.8608354926109314
hsa-miR-922,breast cancer brain metastasis,0.8608039021492004
hsa-miR-4322,breast cancer brain metastasis,0.8608039021492004
hsa-miR-558,breast cancer brain metastasis,0.860789954662323
hsa-miR-3616-5p,rhabdomyosarcomas,0.8607714772224426
hsa-miR-7158-3p,rhabdomyosarcomas,0.8607714772224426
hsa-miR-6836-3p,brain cancer,0.8607122302055359
hsa-miR-1251-3p,"Luminal B,triple negative",0.8607039451599121
hsa-miR-2276-3p,rhabdomyosarcomas,0.8607008457183838
hsa-miR-4524b-5p,miR-142-y,0.8606968522071838
hsa-miR-192-3p,miR-142-y,0.8606968522071838
hsa-miR-6887-3p,miR-142-y,0.8606968522071838
hsa-miR-6789-3p,solid pseudopapillary neoplasm of pancreas,0.8606805205345154
hsa-miR-5695,solid pseudopapillary neoplasm of pancreas,0.8606805205345154
hsa-miR-509-3-5p,solid pseudopapillary neoplasm of pancreas,0.8606805205345154
hsa-miR-4436a,high grade serous papillary ovarian cancer,0.8606324791908264
hsa-miR-6886-3p,high grade serous papillary ovarian cancer,0.8606324791908264
hsa-miR-6069,miR-675-y,0.860589325428009
hsa-miR-6877-5p,miR-675-y,0.860589325428009
hsa-miR-767,miR-142-y,0.8605509996414185
hsa-miR-29a,miR-142-y,0.8605509996414185
hsa-miR-1269,miR-142-y,0.8605509996414185
hsa-miR-520a-3p,miR-142-y,0.8605509996414185
hsa-miR-6829-3p,miR-142-y,0.8605509996414185
hsa-miR-15b,brain cancer,0.8605281114578247
hsa-miR-6727-5p,brain cancer,0.8605281114578247
hsa-miR-520d-3p,brain cancer,0.8605260252952576
hsa-miR-8069,miR-142-y,0.8604896664619446
hsa-miR-199a-3p,miR-142-y,0.8604896664619446
hsa-miR-181a*,miR-142-y,0.8604896664619446
hsa-miR-3607-3p,miR-142-y,0.8604896664619446
hsa-miR-8088,miR-142-y,0.8604896664619446
hsa-miR-6774-3p,miR-142-y,0.8604896664619446
hsa-miR-6753-5p,miR-142-y,0.8604896664619446
hsa-miR-3977,solid pseudopapillary neoplasm of pancreas,0.8604763150215149
hsa-miR-518e*,solid pseudopapillary neoplasm of pancreas,0.8604763150215149
hsa-miR-1225,solid pseudopapillary neoplasm of pancreas,0.8604763150215149
hsa-miR-573,"squamous cell breast carcinoma, acantholytic variant",0.8604392409324646
hsa-miR-544b,miR-142-y,0.8603969812393188
hsa-miR-6759-3p,miR-142-y,0.8603969812393188
hsa-miR-363*,miR-142-y,0.8603969812393188
hsa-miR-4761-5p,sarcoma,0.8603550791740417
hsa-let-7f-2*,sarcoma,0.8603550791740417
hsa-miR-493-3p,"Luminal B,triple negative",0.8603377342224121
hsa-miR-668-3p,ovarian carcinoma,0.8602915406227112
hsa-miR-5193,ovarian carcinoma,0.8602915406227112
hsa-miR-518e,ovarian carcinoma,0.8602915406227112
hsa-miR-3659,ovarian carcinoma,0.8602915406227112
hsa-miR-500a-5p,ovarian carcinoma,0.8602915406227112
hsa-miR-7975,ovarian carcinoma,0.8602915406227112
hsa-miR-4716-5p,ovarian carcinoma,0.8602915406227112
hsa-miR-1244,"squamous cell breast carcinoma, acantholytic variant",0.8602875471115112
hsa-miR-4662b,"squamous cell breast carcinoma, acantholytic variant",0.8602875471115112
hsa-miR-630,pilocytic astrocytoma,0.8602829575538635
hsa-miRPlus-A1083,ovarian carcinoma,0.8602361083030701
hsa-miR-6827-5p,ovarian carcinoma,0.8602361083030701
hsa-miR-6746-5p,ovarian carcinoma,0.8602361083030701
hsa-miR-425*,ovarian carcinoma,0.8602361083030701
hsa-miR-186,"squamous cell breast carcinoma, acantholytic variant",0.8602338433265686
hsa-miR-4794,"squamous cell breast carcinoma, acantholytic variant",0.8602338433265686
hsa-miR-4677-3p,miR-142-y,0.8602296710014343
hsa-miR-5587-3p,miR-142-y,0.8602296710014343
hsa-miR-367-3p,"Luminal B,triple negative",0.8602256178855896
hsa-miR-15b-3p,"Luminal B,triple negative",0.8602256178855896
hsa-miR-8052,"Luminal B,triple negative",0.8602256178855896
hsa-miR-6754-3p,"Luminal B,triple negative",0.8602256178855896
hsa-miR-552-3p,"Luminal B,triple negative",0.8602256178855896
hsa-miR-609,brain cancer,0.8601368069648743
hsa-miR-888-5p,"squamous cell breast carcinoma, acantholytic variant",0.860120952129364
hsa-miR-6800-5p,miR-142-y,0.8600658774375916
hsa-miR-593,Leptomeningeal metastasis,0.8600553274154663
hsa-miR-92-1,Leptomeningeal metastasis,0.8600413203239441
hsa-miR-558,Leptomeningeal metastasis,0.8600413203239441
hsa-miR-5691,"squamous cell breast carcinoma, acantholytic variant",0.8599368929862976
hsa-miR-630,solid pseudopapillary neoplasm of pancreas,0.8598986268043518
hsa-miR-4430,solid pseudopapillary neoplasm of pancreas,0.8598986268043518
hsa-miR-6516-3p,solid pseudopapillary neoplasm of pancreas,0.8598986268043518
hsa-miR-6847-3p,"Luminal B,triple negative",0.8598083257675171
hsa-miRPlus-K1303*,ovarian carcinoma,0.8597726821899414
hsa-miR-291-5p,miR-142-y,0.859769344329834
hsa-miR-5588-5p,miR-142-y,0.859769344329834
hsa-miR-337-3p,miR-142-y,0.859769344329834
hsa-miR-517c,miR-142-y,0.8597098588943481
hsa-miR-4707-3p,miR-142-y,0.8597098588943481
hsa-miR-3177-3p,miR-142-y,0.8597098588943481
hsa-miR-6826-5p,"Luminal B,triple negative",0.8597061038017273
hsa-miR-4768-5p,diffuse large B-cell lymphoma,0.8597051501274109
hsa-miR-1915*,brain cancer,0.8597017526626587
hsa-miR-4419b,"squamous cell breast carcinoma, acantholytic variant",0.8596587777137756
hsa-miR-323a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8595824837684631
hsa-miR-4695-5p,miR-142-y,0.8595246076583862
hsa-miR-383,miR-142-y,0.8595246076583862
hsa-miR-345-3p,miR-142-y,0.8595246076583862
hsa-miR-3936,miR-142-y,0.8595246076583862
hsa-miR-6751-5p,miR-142-y,0.8595246076583862
hsa-miR-331,miR-142-y,0.8595246076583862
hsa-miR-1250-5p,miR-142-y,0.8595246076583862
hsa-miR-3685,miR-142-y,0.8595246076583862
hsa-miR-6835-5p,miR-142-y,0.8595246076583862
hsa-miR-8085,miR-142-y,0.8595246076583862
hsa-miR-520g-3p,miR-142-y,0.8595246076583862
hsa-miR-3676-3p,miR-142-y,0.8595225214958191
hsa-miR-3156-5p,miR-142-y,0.8595225214958191
hsa-miR-135b-5p,miR-142-y,0.8595225214958191
hsa-miR-141-5p,miR-142-y,0.8595225214958191
hsa-miR-489-3p,miR-142-y,0.8595225214958191
hsa-miR-5010-5p,"squamous cell breast carcinoma, acantholytic variant",0.8595032095909119
hsa-miR-671,brain cancer,0.8594874739646912
hsa-miR-1236-3p,brain cancer,0.8594874739646912
hsa-miR-450b-5p,aryngeal squamous cell carcinoma,0.8594328761100769
hsa-miR-1915-5p,"squamous cell breast carcinoma, acantholytic variant",0.859420657157898
hsa-miR-1343,"squamous cell breast carcinoma, acantholytic variant",0.8593904376029968
hsa-miR-4256,"squamous cell breast carcinoma, acantholytic variant",0.8593904376029968
hsa-miR-933,"squamous cell breast carcinoma, acantholytic variant",0.8593904376029968
hsa-miR-208b,"squamous cell breast carcinoma, acantholytic variant",0.8593904376029968
hsa-miR-3200-3p,"squamous cell breast carcinoma, acantholytic variant",0.8593904376029968
hsa-miR-6824-3p,"Luminal B,triple negative",0.8593699336051941
hsa-miR-588,"Luminal B,triple negative",0.8593699336051941
hsa-miR-553,papillary thyroid carcinoma,0.8593696355819702
hsa-miR-221*,diffuse large B-cell lymphoma,0.8593443036079407
hsa-miR-6723-5p,diffuse large B-cell lymphoma,0.8593443036079407
hsa-miR-295,Leptomeningeal metastasis,0.8593415021896362
hsa-miR-138-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.8593360185623169
hsa-miR-129-5p,"squamous cell breast carcinoma, acantholytic variant",0.8593360185623169
hsa-miR-4709-3p,miR-142-y,0.8593338131904602
hsa-miR-373-3p,miR-142-y,0.8593338131904602
hsa-miR-125b-1*,aryngeal squamous cell carcinoma,0.8593122363090515
hsa-miR-4505,diffuse large B-cell lymphoma,0.8593007922172546
hsa-miR-3679-5p,brain cancer,0.859275221824646
hsa-miR-662,brain cancer,0.859275221824646
hsa-miR-1272,brain cancer,0.859275221824646
hsa-miR-299-5p,castration-resistant prostate cancer,0.8592723608016968
hsa-miR-519a,castration-resistant prostate cancer,0.8592723608016968
hsa-miR-221*,castration-resistant prostate cancer,0.8592723608016968
hsa-miR-6829-5p,castration-resistant prostate cancer,0.8592723608016968
hsa-miR-125b-1*,castration-resistant prostate cancer,0.8592723608016968
hsa-miR-676,castration-resistant prostate cancer,0.8592723608016968
hsa-miR-6819-3p,castration-resistant prostate cancer,0.8592723608016968
hsa-miR-3670,castration-resistant prostate cancer,0.8592723608016968
hsa-miR-6822-5p,"squamous cell breast carcinoma, acantholytic variant",0.8592506647109985
hsa-miR-4642,"squamous cell breast carcinoma, acantholytic variant",0.8592506647109985
hsa-miR-4318,"Luminal B,triple negative",0.8592467904090881
hsa-miR-542-5p,high grade serous papillary ovarian cancer,0.859220564365387
hsa-miR-6824-5p,high grade serous papillary ovarian cancer,0.859220564365387
hsa-miR-6720-3p,high grade serous papillary ovarian cancer,0.859220564365387
hsa-miR-509-3-5p,high grade serous papillary ovarian cancer,0.859220564365387
hsa-miR-425*,high grade serous papillary ovarian cancer,0.859220564365387
hsa-miR-194-1,rhabdomyosarcomas,0.8591907024383545
hsa-miR-7-3,rhabdomyosarcomas,0.8591907024383545
hsa-miR-454*,diffuse large B-cell lymphoma,0.8591663241386414
hsa-miR-942-3p,"squamous cell breast carcinoma, acantholytic variant",0.8591617345809937
hsa-miR-6720-5p,"squamous cell breast carcinoma, acantholytic variant",0.8591617345809937
hsa-miR-5686,"squamous cell breast carcinoma, acantholytic variant",0.8591617345809937
hsa-miR-361-5p,miR-142-y,0.8591309785842896
hsa-miR-4742-3p,miR-142-y,0.8591309785842896
hsa-miR-26a-5p,miR-142-y,0.8591309785842896
hsa-miR-4433b-5p,high grade serous papillary ovarian cancer,0.8591216206550598
hsa-miR-4538,high grade serous papillary ovarian cancer,0.8591216206550598
hsa-miR-4649-3p,high grade serous papillary ovarian cancer,0.8591216206550598
hsa-miR-7158-3p,high grade serous papillary ovarian cancer,0.8591216206550598
hsa-miR-544a,high grade serous papillary ovarian cancer,0.8591216206550598
hsa-miR-6882-3p,"Luminal B,triple negative",0.8591136932373047
hsa-miR-1295,brain cancer,0.8591038584709167
hsa-miR-196b-5p,diffuse large B-cell lymphoma,0.8590953350067139
hsa-miR-4454,synovial sarcoma,0.8590505719184875
hsa-miR-1247,synovial sarcoma,0.8590505719184875
hsa-miR-3158-3p,synovial sarcoma,0.8590505719184875
hsa-miR-188-3p,synovial sarcoma,0.8590505719184875
hsa-miR-651,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-216b,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-214-3p,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-19a*,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-4798-5p,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-302d-5p,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-4777-5p,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-4719,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-6780b-3p,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-3200-5p,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-6845-5p,castration-resistant prostate cancer,0.8590480089187622
hsa-miR-489,diffuse large B-cell lymphoma,0.8590217232704163
hsa-miR-4419b,diffuse large B-cell lymphoma,0.8590217232704163
hsa-miR-4454,diffuse large B-cell lymphoma,0.8589925169944763
hsa-miR-455-3p,diffuse large B-cell lymphoma,0.8589925169944763
hsa-miR-181d-5p,diffuse large B-cell lymphoma,0.8589925169944763
hsa-miR-5700,brain cancer,0.8589826226234436
hsa-miR-449b-3p,brain cancer,0.8589826226234436
hsa-miR-4782-5p,"Luminal B,triple negative",0.8589737415313721
hsa-miR-6858-3p,"squamous cell breast carcinoma, acantholytic variant",0.8589710593223572
hsa-miR-769-3p,miR-142-y,0.8589214086532593
hsa-let-7b_c,miR-142-y,0.8589214086532593
hsa-miR-514b-5p,miR-142-y,0.8589214086532593
hsa-miR-5088-5p,miR-142-y,0.8589214086532593
hsa-miR-153-3p,miR-142-y,0.8589214086532593
hsa-miR-5702,castration-resistant prostate cancer,0.8588919043540955
hsa-miR-19a-3p,breast cancer brain metastasis,0.8588804602622986
hsa-miR-122-3p,"squamous cell breast carcinoma, acantholytic variant",0.8588683009147644
hsa-miR-758-3p,"squamous cell breast carcinoma, acantholytic variant",0.8588683009147644
hsa-miR-4798-5p,sarcoma,0.8588588833808899
hsa-miR-324-5p,sarcoma,0.8588588833808899
hsa-miR-503-5p,sarcoma,0.8588588833808899
hsa-miR-1306-3p,sarcoma,0.8588588833808899
hsa-miR-219b-3p,castration-resistant prostate cancer,0.858833372592926
hsa-miR-29a,"Luminal B,triple negative",0.8588262796401978
hsa-miR-520a-3p,"Luminal B,triple negative",0.8588262796401978
hsa-miR-604,miR-142-y,0.8588035702705383
hsa-miR-320c,miR-142-y,0.8588035702705383
hsa-miR-1205,miR-142-y,0.8588035702705383
hsa-miR-4745-3p,miR-142-y,0.8588035702705383
hsa-miR-6777-5p,diffuse large B-cell lymphoma,0.8587825894355774
hsa-miR-2681,"Luminal B,triple negative",0.8587644100189209
hsa-miR-450a,"squamous cell breast carcinoma, acantholytic variant",0.8587608933448792
hsa-miR-3151-5p,high grade serous papillary ovarian cancer,0.8587544560432434
hsa-miR-548aj-5p,high grade serous papillary ovarian cancer,0.8587544560432434
hsa-miR-4694-5p,high grade serous papillary ovarian cancer,0.8587544560432434
hsa-miR-516b,diffuse large B-cell lymphoma,0.8587522506713867
hsa-miR-3918,diffuse large B-cell lymphoma,0.8587522506713867
hsa-miR-15b-3p,diffuse large B-cell lymphoma,0.8587522506713867
hsa-miR-376a-2-5p,diffuse large B-cell lymphoma,0.8587522506713867
hsa-miR-3143,synovial sarcoma,0.8587297201156616
hsa-miR-6798-3p,synovial sarcoma,0.8587297201156616
hsa-miR-1267,synovial sarcoma,0.8587297201156616
hsa-miR-4798-5p,synovial sarcoma,0.8587297201156616
hsa-miR-4777-5p,synovial sarcoma,0.8587297201156616
hsa-miR-3545-3p,synovial sarcoma,0.8587297201156616
hsa-miR-4722-3p,synovial sarcoma,0.8587297201156616
hsa-miR-5583-3p,synovial sarcoma,0.8587297201156616
hsa-miR-4719,synovial sarcoma,0.8587297201156616
hsa-miR-1306-3p,synovial sarcoma,0.8587297201156616
hsa-miR-4752,synovial sarcoma,0.8587297201156616
hsa-miR-4772-3p,diffuse large B-cell lymphoma,0.8586976528167725
hsa-miR-4680-5p,diffuse large B-cell lymphoma,0.8586976528167725
hsa-miR-1233-3p,miR-142-y,0.8586933612823486
hsa-miR-5701,miR-142-y,0.8586933612823486
hsa-miR-4251,miR-142-y,0.8586933612823486
hsa-miR-150-5p,miR-142-y,0.8586933612823486
hsa-miR-449b,miR-142-y,0.8586933612823486
hsa-let-7a-3,miR-142-y,0.8586933612823486
hsa-miR-93-5p,miR-142-y,0.8586933612823486
hsa-miR-143-3p,miR-142-y,0.8586933612823486
hsa-miR-4528,miR-142-y,0.8586933612823486
hsa-miR-495-5p,miR-142-y,0.8586933612823486
hsa-miR-4637,miR-142-y,0.8586933612823486
hsa-miR-766-5p,miR-142-y,0.8586933612823486
hsa-miR-6891-3p,miR-142-y,0.8586933612823486
hsa-miR-520f-520c,miR-142-y,0.8586933612823486
hsa-miR-548al,"Luminal B,triple negative",0.8586707711219788
hsa-miR-28-5p,"Luminal B,triple negative",0.8586707711219788
hsa-miR-1266,"Luminal B,triple negative",0.8586707711219788
hsa-miR-212-3p,"squamous cell breast carcinoma, acantholytic variant",0.858648419380188
hsa-miR-6757-3p,"squamous cell breast carcinoma, acantholytic variant",0.858648419380188
hsa-miR-6782-3p,diffuse large B-cell lymphoma,0.858612060546875
hsa-miR-8053,"squamous cell breast carcinoma, acantholytic variant",0.8586114645004272
hsa-miR-6783-3p,"squamous cell breast carcinoma, acantholytic variant",0.8586114645004272
hsa-miR-194-1,ovarian carcinoma,0.8585603833198547
hsa-miR-4538,ovarian carcinoma,0.8585603833198547
hsa-miR-409-5p,ovarian carcinoma,0.8585603833198547
hsa-miR-203a,ovarian carcinoma,0.8585603833198547
hsa-miR-544a,ovarian carcinoma,0.8585603833198547
hsa-miR-4724-5p,"squamous cell breast carcinoma, acantholytic variant",0.8585304021835327
hsa-miR-216b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8585304021835327
hsa-miR-362-5p,diffuse large B-cell lymphoma,0.8585227131843567
hsa-miR-3690,diffuse large B-cell lymphoma,0.8585227131843567
hsa-miR-4431,"Luminal B,triple negative",0.8585017919540405
hsa-miR-136,"Luminal B,triple negative",0.8585017919540405
hsa-miR-524-3p,miR-142-y,0.8584778904914856
hsa-miR-25-5p,miR-142-y,0.8584778904914856
hsa-miR-30b*,miR-142-y,0.8584778904914856
hsa-miR-2113,miR-142-y,0.8584778904914856
hsa-miR-520a,miR-142-y,0.8584778904914856
hsa-miR-1247-3p,miR-142-y,0.8584778904914856
hsa-miR-4288,diffuse large B-cell lymphoma,0.8584295511245728
hsa-miR-6860,diffuse large B-cell lymphoma,0.8584295511245728
hsa-miR-4417,castration-resistant prostate cancer,0.858414351940155
hsa-miR-374c-3p,"squamous cell breast carcinoma, acantholytic variant",0.8584067225456238
hsa-miR-6811-3p,"squamous cell breast carcinoma, acantholytic variant",0.8584067225456238
hsa-miR-25-3p,"squamous cell breast carcinoma, acantholytic variant",0.8584067225456238
hsa-miR-652-3p,"squamous cell breast carcinoma, acantholytic variant",0.8584067225456238
hsa-miRPlus-A1083,rhabdomyosarcomas,0.8583976030349731
hsa-miR-4520a-3p,rhabdomyosarcomas,0.8583976030349731
hsa-miR-507,rhabdomyosarcomas,0.8583976030349731
hsa-miR-4720-5p,"Luminal B,triple negative",0.8583362102508545
hsa-miR-643,"Luminal B,triple negative",0.8583362102508545
hsa-miR-5589-5p,"Luminal B,triple negative",0.8583362102508545
hsa-miR-1203,miR-142-y,0.8583321571350098
hsa-miR-6730-3p,miR-142-y,0.8583321571350098
hsa-miR-1-1,miR-142-y,0.8583321571350098
hsa-miR-4305,miR-142-y,0.8583321571350098
hsa-miR-4489,castration-resistant prostate cancer,0.8583306670188904
hsa-miR-4290,castration-resistant prostate cancer,0.8583306670188904
hsa-miR-127-3p,"squamous cell breast carcinoma, acantholytic variant",0.8582730293273926
hsa-miR-6780a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8582730293273926
hsa-miR-6882-3p,"squamous cell breast carcinoma, acantholytic variant",0.8582730293273926
hsa-miR-6816-5p,"squamous cell breast carcinoma, acantholytic variant",0.8582730293273926
hsa-miR-3162,miR-142-y,0.8582642674446106
hsa-miR-6746-3p,miR-142-y,0.8582642674446106
hsa-miR-450a-2-3p,miR-142-y,0.8582642674446106
hsa-miR-1234-5p,miR-142-y,0.8582642674446106
hsa-miR-3620-5p,miR-142-y,0.8582642674446106
hsa-miR-6080,miR-142-y,0.8582642674446106
hsa-miR-516,miR-142-y,0.8582642674446106
hsa-miR-6854-3p,miR-142-y,0.8582642674446106
hsa-miR-302c,miR-675-y,0.8581414222717285
hsa-miR-658,miR-675-y,0.8581414222717285
hsa-miR-199a-2,"squamous cell breast carcinoma, acantholytic variant",0.8581324219703674
hsa-miR-1226-3p,"squamous cell breast carcinoma, acantholytic variant",0.8581324219703674
hsa-miR-292-3p,"squamous cell breast carcinoma, acantholytic variant",0.8581324219703674
hsa-miR-4313,"squamous cell breast carcinoma, acantholytic variant",0.8581324219703674
hsa-miR-99a*,solid pseudopapillary neoplasm of pancreas,0.8581291437149048
hsa-miR-1470,solid pseudopapillary neoplasm of pancreas,0.8581291437149048
hsa-miR-6081,solid pseudopapillary neoplasm of pancreas,0.8581291437149048
hsa-miR-4417,synovial sarcoma,0.8580949306488037
hsa-miR-3657,miR-142-y,0.8580919504165649
hsa-miR-6785-5p,miR-142-y,0.8580919504165649
hsa-miR-379,miR-142-y,0.8580919504165649
hsa-miR-223*,miR-142-y,0.8580919504165649
hsa-miR-4749-5p,miR-142-y,0.8580919504165649
hsa-miR-4469,miR-142-y,0.8580919504165649
hsa-miR-1296,miR-142-y,0.8580919504165649
hsa-miR-147a,miR-142-y,0.8580919504165649
hsa-miR-376c-3p,miR-142-y,0.8580919504165649
hsa-miR-6504-5p,miR-142-y,0.8580919504165649
hsa-miR-7973,miR-142-y,0.8580919504165649
hsa-miR-6795-5p,miR-142-y,0.8580919504165649
hsa-miR-553,brain cancer,0.8580793142318726
hsa-miR-505,brain cancer,0.8580793142318726
hsa-miR-363-3p,miR-142-y,0.8580604791641235
hsa-miR-6800-3p,miR-142-y,0.8580604791641235
hsa-miR-4800-3p,miR-142-y,0.8580604791641235
hsa-miR-1180-5p,synovial sarcoma,0.8580535650253296
hsa-miR-15b-5p,sarcoma,0.8580514788627625
hsa-miR-4768-5p,castration-resistant prostate cancer,0.8580455780029297
hsa-miR-566,rhabdomyosarcomas,0.8580279350280762
hsa-miR-3194,rhabdomyosarcomas,0.8580279350280762
hsa-miR-518e,rhabdomyosarcomas,0.8580279350280762
hsa-miR-6743-5p,rhabdomyosarcomas,0.8580279350280762
hsa-miR-374a,diffuse large B-cell lymphoma,0.8580074906349182
hsa-miR-1244,castration-resistant prostate cancer,0.8579928278923035
hsa-miR-1292-5p,"squamous cell breast carcinoma, acantholytic variant",0.8579841256141663
hsa-miR-767,"squamous cell breast carcinoma, acantholytic variant",0.8579841256141663
hsa-miR-210-3p,"squamous cell breast carcinoma, acantholytic variant",0.8579841256141663
hsa-miR-26b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8579841256141663
hsa-miR-3613-5p,miR-142-y,0.8579801321029663
hsa-miR-4309,miR-142-y,0.8579801321029663
hsa-miR-4437,miR-142-y,0.8579801321029663
hsa-miR-1184,miR-142-y,0.8579801321029663
hsa-miR-6833-5p,miR-142-y,0.8579801321029663
hsa-miR-4532,miR-142-y,0.8579801321029663
hsa-miR-6715b-5p,miR-142-y,0.8579801321029663
hsa-miR-4799-3p,miR-142-y,0.8579801321029663
hsa-miR-3617-5p,miR-142-y,0.8579801321029663
hsa-miR-619-5p,"Luminal B,triple negative",0.857976496219635
hsa-miR-6076,"Luminal B,triple negative",0.857976496219635
hsa-miR-3664-5p,"Luminal B,triple negative",0.857976496219635
hsa-miR-3606-3p,miR-142-y,0.8579699397087097
hsa-miR-4520b-3p,miR-142-y,0.8579699397087097
hsa-miR-103a-3p,miR-142-y,0.8579699397087097
hsa-miR-135a-5p,miR-142-y,0.8579699397087097
hsa-miR-6727-3p,synovial sarcoma,0.8579670190811157
hsa-miR-195,synovial sarcoma,0.8579670190811157
hsa-miR-3617-3p,high grade serous papillary ovarian cancer,0.8579583764076233
hsa-miR-3160-3p,high grade serous papillary ovarian cancer,0.8579583764076233
hsa-miR-4677-5p,high grade serous papillary ovarian cancer,0.8579583764076233
hsa-miR-341,high grade serous papillary ovarian cancer,0.8579583764076233
hsa-miR-7702,high grade serous papillary ovarian cancer,0.8579583764076233
hsa-miR-1185-2-3p,miR-142-y,0.8579564094543457
hsa-miR-520d,miR-142-y,0.8579564094543457
hsa-miR-106b*,miR-142-y,0.8579564094543457
hsa-miR-548au-5p,miR-142-y,0.8579564094543457
hsa-miR-4699-5p,miR-142-y,0.8579564094543457
hsa-miR-1307-3p,miR-142-y,0.8579564094543457
hsa-miR-412-3p,miR-142-y,0.8579564094543457
hsa-miR-6758-3p,miR-142-y,0.8579564094543457
hsa-miR-1911-3p,miR-142-y,0.8579564094543457
hsa-miR-548az-5p,miR-142-y,0.8579564094543457
hsa-miR-5087,miR-142-y,0.8579564094543457
hsa-miR-4716-3p,castration-resistant prostate cancer,0.8579382300376892
hsa-miR-6777-3p,rhabdomyosarcomas,0.8579291105270386
hsa-miR-675,"squamous cell breast carcinoma, acantholytic variant",0.8579219579696655
hsa-miR-2681,"squamous cell breast carcinoma, acantholytic variant",0.8579219579696655
hsa-miR-499a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8579219579696655
hsa-miR-3189,"squamous cell breast carcinoma, acantholytic variant",0.8579219579696655
hsa-miR-129-3p,"squamous cell breast carcinoma, acantholytic variant",0.8579219579696655
hsa-miR-6766-5p,"squamous cell breast carcinoma, acantholytic variant",0.8579219579696655
hsa-miR-1912,"squamous cell breast carcinoma, acantholytic variant",0.8579219579696655
hsa-miR-452-3p,"squamous cell breast carcinoma, acantholytic variant",0.8579219579696655
hsa-miR-371b-3p,sarcoma,0.857906699180603
hsa-miR-6741-3p,castration-resistant prostate cancer,0.8578820824623108
hsa-miR-6884-5p,castration-resistant prostate cancer,0.8578820824623108
hsa-miR-548al,"squamous cell breast carcinoma, acantholytic variant",0.8578277826309204
hsa-miR-937-5p,"squamous cell breast carcinoma, acantholytic variant",0.8578277826309204
hsa-miR-1295a,"squamous cell breast carcinoma, acantholytic variant",0.8578277826309204
hsa-miR-518a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8578277826309204
hsa-miR-1266,"squamous cell breast carcinoma, acantholytic variant",0.8578277826309204
hsa-miR-502-3p,"squamous cell breast carcinoma, acantholytic variant",0.8578277826309204
hsa-miR-6759-3p,"squamous cell breast carcinoma, acantholytic variant",0.8578277826309204
hsa-miR-2114-5p,"squamous cell breast carcinoma, acantholytic variant",0.8578277826309204
hsa-miR-573,synovial sarcoma,0.8578265905380249
hsa-miR-548q,synovial sarcoma,0.8578265905380249
hsa-miR-1247,aryngeal squamous cell carcinoma,0.8578264713287354
hsa-miR-3158-3p,aryngeal squamous cell carcinoma,0.8578264713287354
hsa-miR-142,castration-resistant prostate cancer,0.8578238487243652
hsa-miR-2114*,castration-resistant prostate cancer,0.8578238487243652
hsa-miR-1185-1,"Luminal B,triple negative",0.8577894568443298
hsa-miR-644b-5p,"Luminal B,triple negative",0.8577894568443298
hsa-miR-21*,"Luminal B,triple negative",0.8577894568443298
hsa-miR-4697-3p,"Luminal B,triple negative",0.8577894568443298
hsa-miR-7849-3p,"Luminal B,triple negative",0.8577894568443298
hsa-miR-338-3p,"Luminal B,triple negative",0.8577872514724731
hsa-miR-639,"Luminal B,triple negative",0.8577872514724731
hsa-miR-124*,"Luminal B,triple negative",0.8577872514724731
hsa-miR-6747-3p,synovial sarcoma,0.8577767610549927
hsa-miR-208a,diffuse large B-cell lymphoma,0.8577648401260376
hsa-miR-130a-3p,synovial sarcoma,0.8577255010604858
hsa-miR-708-3p,aryngeal squamous cell carcinoma,0.8577239513397217
hsa-miR-150*,aryngeal squamous cell carcinoma,0.8577239513397217
hsa-miR-30b-5p,aryngeal squamous cell carcinoma,0.8577239513397217
hsa-miR-33b*,ovarian carcinoma,0.8576928377151489
hsa-miR-6893-3p,ovarian carcinoma,0.8576928377151489
hsa-miR-1227-5p,ovarian carcinoma,0.8576928377151489
hsa-miR-5088-3p,ovarian carcinoma,0.8576928377151489
hsa-miR-671-5p,ovarian carcinoma,0.8576928377151489
hsa-miR-563,ovarian carcinoma,0.8576928377151489
hsa-miR-30e-3p,ovarian carcinoma,0.8576928377151489
hsa-miR-4760-3p,ovarian carcinoma,0.8576928377151489
hsa-miR-4804-5p,ovarian carcinoma,0.8576928377151489
hsa-miR-561-3p,ovarian carcinoma,0.8576928377151489
hsa-miR-146a,"squamous cell breast carcinoma, acantholytic variant",0.8576580286026001
hsa-miR-1229,castration-resistant prostate cancer,0.8576372861862183
hsa-miR-6867-3p,synovial sarcoma,0.8576180338859558
hsa-miR-186,synovial sarcoma,0.8576180338859558
hsa-miR-6503-5p,synovial sarcoma,0.8576180338859558
hsa-miR-4315,"Luminal B,triple negative",0.8575965166091919
hsa-miR-4502,synovial sarcoma,0.8575616478919983
hsa-miR-4421,high grade serous papillary ovarian cancer,0.8575348258018494
hsa-miR-4484,high grade serous papillary ovarian cancer,0.8575348258018494
hsa-miR-203a,high grade serous papillary ovarian cancer,0.8575348258018494
hsa-miR-2114*,synovial sarcoma,0.8575032353401184
hsa-miR-5007-3p,castration-resistant prostate cancer,0.8575015068054199
hsa-miR-145-3p,"squamous cell breast carcinoma, acantholytic variant",0.8574916124343872
hsa-miR-4713-5p,"squamous cell breast carcinoma, acantholytic variant",0.8574916124343872
hsa-miR-2277,"squamous cell breast carcinoma, acantholytic variant",0.8574916124343872
hsa-miR-6842-3p,"squamous cell breast carcinoma, acantholytic variant",0.8574916124343872
hsa-miR-3656,diffuse large B-cell lymphoma,0.8574894070625305
hsa-miR-4735-5p,diffuse large B-cell lymphoma,0.8574666380882263
hsa-miR-548av-5p,diffuse large B-cell lymphoma,0.8574666380882263
hsa-miR-6873-5p,miR-675-y,0.8574314117431641
hsa-miR-1587,miR-675-y,0.8574314117431641
hsa-miR-1229-3p,miR-675-y,0.8574314117431641
hsa-miR-10b-5p,castration-resistant prostate cancer,0.8574297428131104
hsa-miR-548m,castration-resistant prostate cancer,0.8573936820030212
hsa-miR-3677-3p,castration-resistant prostate cancer,0.8573936820030212
hsa-miR-1185-1-3p,castration-resistant prostate cancer,0.8573936820030212
hsa-miR-103-2,castration-resistant prostate cancer,0.8573936820030212
hsa-miR-24-3p,castration-resistant prostate cancer,0.8573936820030212
hsa-miR-1255a,"Luminal B,triple negative",0.8573917150497437
hsa-miR-4770,"Luminal B,triple negative",0.8573917150497437
hsa-miR-22*,"Luminal B,triple negative",0.8573917150497437
hsa-miR-219a-1-3p,diffuse large B-cell lymphoma,0.8573406338691711
hsa-miR-520a-3p,diffuse large B-cell lymphoma,0.8573406338691711
hsa-miR-520g-520h,diffuse large B-cell lymphoma,0.8573406338691711
hsa-miR-4505,synovial sarcoma,0.8573164343833923
hsa-miR-1270,"squamous cell breast carcinoma, acantholytic variant",0.8573151230812073
hsa-miR-3131,diffuse large B-cell lymphoma,0.8572781085968018
hsa-miR-675,diffuse large B-cell lymphoma,0.8572781085968018
hsa-miR-100*,diffuse large B-cell lymphoma,0.8572781085968018
hsa-miR-193a,castration-resistant prostate cancer,0.857278048992157
hsa-miR-1254,castration-resistant prostate cancer,0.857278048992157
hsa-miR-559,breast cancer brain metastasis,0.8572711944580078
hsa-miR-3928,synovial sarcoma,0.8572496771812439
hsa-miR-374b-3p,ovarian carcinoma,0.8572337031364441
hsa-miR-1197,ovarian carcinoma,0.8572337031364441
hsa-miR-615,ovarian carcinoma,0.8572337031364441
hsa-miR-513c,ovarian carcinoma,0.8572337031364441
hsa-miR-3121,ovarian carcinoma,0.8572337031364441
hsa-miR-941,primary central nervous system lymphomas,0.8572112917900085
hsa-miR-3200,primary central nervous system lymphomas,0.8572112917900085
hsa-miR-6873-3p,primary central nervous system lymphomas,0.8572112917900085
hsa-miR-92a-1-5p,primary central nervous system lymphomas,0.8572112917900085
hsa-miR-1193,castration-resistant prostate cancer,0.857197642326355
hsa-miR-3196,diffuse large B-cell lymphoma,0.8571836948394775
hsa-miR-518a-5p,diffuse large B-cell lymphoma,0.8571836948394775
hsa-miR-1266,diffuse large B-cell lymphoma,0.8571836948394775
hsa-miR-196a-1,synovial sarcoma,0.8571803569793701
hsa-miR-4804-3p,"Luminal B,triple negative",0.8571799397468567
hsa-miR-153-3p,"Luminal B,triple negative",0.8571799397468567
hsa-miR-199b-5p,miR-142-y,0.8571523427963257
hsa-miR-886,miR-142-y,0.8571523427963257
hsa-miR-6877-5p,miR-142-y,0.8571523427963257
hsa-miRPlus-A1083,papillary thyroid carcinoma,0.8571434020996094
hsa-miR-4538,breast cancer brain metastasis,0.8571314811706543
hsa-miR-374b*,"squamous cell breast carcinoma, acantholytic variant",0.8571301102638245
hsa-miR-935,"squamous cell breast carcinoma, acantholytic variant",0.8571301102638245
hsa-miR-148a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8571301102638245
hsa-miR-6780a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8571301102638245
hsa-miR-6786-3p,"squamous cell breast carcinoma, acantholytic variant",0.8571301102638245
hsa-miR-3135b,castration-resistant prostate cancer,0.8571139574050903
hsa-miR-6764-3p,synovial sarcoma,0.857108473777771
hsa-miR-100-5p,synovial sarcoma,0.857108473777771
hsa-miR-6883-5p,synovial sarcoma,0.857108473777771
hsa-miR-545-3p,sarcoma,0.8570870757102966
hsa-miR-187,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-516-3p,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-937,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-2116,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-3179,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-3150a-3p,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-548at-5p,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-483-3p-1106,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-933,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-519a-5p,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-208b,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-323b-3p,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-3200-3p,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-3126-3p,castration-resistant prostate cancer,0.8570833206176758
hsa-miR-26a-1*,"Luminal B,triple negative",0.8570609092712402
hsa-miR-3911,synovial sarcoma,0.8570340275764465
hsa-miR-489,synovial sarcoma,0.8570340275764465
hsa-miR-129-5p,castration-resistant prostate cancer,0.8570281863212585
hsa-miR-349,diffuse large B-cell lymphoma,0.8570132255554199
hsa-miR-5587-3p,diffuse large B-cell lymphoma,0.8570132255554199
hsa-miR-596,synovial sarcoma,0.8569564819335938
hsa-miR-545-3p,synovial sarcoma,0.8569564819335938
hsa-miR-3074,"Luminal B,triple negative",0.8569495677947998
hsa-miR-1233-3p,"Luminal B,triple negative",0.8569495677947998
hsa-miR-190b,"Luminal B,triple negative",0.8569495677947998
hsa-miR-1252-5p,"Luminal B,triple negative",0.8569495677947998
hsa-miR-425-3p,"squamous cell breast carcinoma, acantholytic variant",0.8569421172142029
hsa-miR-3141,castration-resistant prostate cancer,0.8569417595863342
hsa-miR-579-3p,castration-resistant prostate cancer,0.8569417595863342
hsa-miR-4639-3p,castration-resistant prostate cancer,0.8569417595863342
hsa-miR-4642,castration-resistant prostate cancer,0.8569417595863342
hsa-miR-4739,castration-resistant prostate cancer,0.8569417595863342
hsa-miR-3676-3p,"squamous cell breast carcinoma, acantholytic variant",0.8569399118423462
hsa-miR-516b*,"squamous cell breast carcinoma, acantholytic variant",0.8569399118423462
hsa-miR-133b,"squamous cell breast carcinoma, acantholytic variant",0.8569399118423462
hsa-miR-204-5p,"squamous cell breast carcinoma, acantholytic variant",0.8569399118423462
hsa-miR-519c-5p,"squamous cell breast carcinoma, acantholytic variant",0.8569399118423462
hsa-miR-635,"squamous cell breast carcinoma, acantholytic variant",0.8569399118423462
hsa-miR-1301,"squamous cell breast carcinoma, acantholytic variant",0.8569399118423462
hsa-miR-135b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8569399118423462
hsa-miR-489-3p,"squamous cell breast carcinoma, acantholytic variant",0.8569399118423462
hsa-miR-7160-3p,sarcoma,0.8568921089172363
hsa-miR-6773-5p,sarcoma,0.8568921089172363
hsa-miR-3175,synovial sarcoma,0.8568759560585022
hsa-miR-519c,castration-resistant prostate cancer,0.8568515181541443
hsa-miR-942-3p,castration-resistant prostate cancer,0.8568515181541443
hsa-miR-3690,castration-resistant prostate cancer,0.8568515181541443
hsa-miR-181c-3p,castration-resistant prostate cancer,0.8568515181541443
hsa-miR-500a*,synovial sarcoma,0.8568497896194458
hsa-miR-34b-3p,synovial sarcoma,0.8568497896194458
hsa-miR-5187-5p,synovial sarcoma,0.8568497896194458
hsa-miR-6740-3p,synovial sarcoma,0.8568497896194458
hsa-miR-643,diffuse large B-cell lymphoma,0.856846272945404
hsa-miR-3180-3p,diffuse large B-cell lymphoma,0.856846272945404
hsa-miR128b,ovarian carcinoma,0.8568270802497864
hsa-miR-615-5p,ovarian carcinoma,0.8568270802497864
hsa-miR-129-1-3p,ovarian carcinoma,0.8568270802497864
hsa-miR-1234,ovarian carcinoma,0.8568270802497864
hsa-miR-320e-1095,ovarian carcinoma,0.8568270802497864
hsa-miR-3649,ovarian carcinoma,0.8568270802497864
hsa-miR-652-5p,ovarian carcinoma,0.8568270802497864
hsa-miRPlus-G1065-5p,ovarian carcinoma,0.8568270802497864
hsa-miR-6852-3p,ovarian carcinoma,0.8568270802497864
hsa-miR-1237-3p,ovarian carcinoma,0.8568270802497864
hsa-miR-1915-3p,ovarian carcinoma,0.8568270802497864
hsa-miR-6724-5p,ovarian carcinoma,0.8568270802497864
hsa-miR-455-3p,"squamous cell breast carcinoma, acantholytic variant",0.856794536113739
hsa-miR-302c,"squamous cell breast carcinoma, acantholytic variant",0.856794536113739
hsa-miR-708*,"squamous cell breast carcinoma, acantholytic variant",0.856794536113739
hsa-miR-658,"squamous cell breast carcinoma, acantholytic variant",0.856794536113739
hsa-miR-188-3p,"squamous cell breast carcinoma, acantholytic variant",0.856794536113739
hsa-miR-5196-5p,"squamous cell breast carcinoma, acantholytic variant",0.856794536113739
hsa-miR-761,"squamous cell breast carcinoma, acantholytic variant",0.856794536113739
hsa-miR-6740-3p,"squamous cell breast carcinoma, acantholytic variant",0.856794536113739
hsa-miR-6790-5p,"squamous cell breast carcinoma, acantholytic variant",0.856794536113739
hsa-miR-6777-5p,synovial sarcoma,0.8567920923233032
hsa-miR-4473,synovial sarcoma,0.8567920923233032
hsa-miR-1275,synovial sarcoma,0.8567614555358887
hsa-miR-593*,synovial sarcoma,0.8567614555358887
hsa-miR-616*,synovial sarcoma,0.8567614555358887
hsa-miR-518f-3p,synovial sarcoma,0.8567614555358887
hsa-miR-1182,synovial sarcoma,0.8567614555358887
hsa-miR-3121-3p,synovial sarcoma,0.8567614555358887
hsa-miR-15b-3p,synovial sarcoma,0.8567614555358887
hsa-miR-3689f,synovial sarcoma,0.8567614555358887
hsa-miR-1295b-3p,synovial sarcoma,0.8567614555358887
hsa-miR-323b-3p,synovial sarcoma,0.8567614555358887
hsa-miR-4701-5p,synovial sarcoma,0.8567614555358887
hsa-miR-6501-5p,synovial sarcoma,0.8567614555358887
hsa-miR-15a*,synovial sarcoma,0.8567614555358887
hsa-miR-5591-3p,synovial sarcoma,0.8567614555358887
hsa-miR-5572,synovial sarcoma,0.8567614555358887
hsa-miR-552-3p,synovial sarcoma,0.8567614555358887
hsa-miR-513c-3p,synovial sarcoma,0.8567614555358887
hsa-miR-5197-3p,synovial sarcoma,0.8567614555358887
hsa-miR-4288,castration-resistant prostate cancer,0.8567574620246887
hsa-miR-103b,castration-resistant prostate cancer,0.8567574620246887
hsa-miR-3149,castration-resistant prostate cancer,0.8567574620246887
hsa-miR-4298,"squamous cell breast carcinoma, acantholytic variant",0.8567483425140381
hsa-miR-4315,"squamous cell breast carcinoma, acantholytic variant",0.8567483425140381
hsa-miR-4296,"squamous cell breast carcinoma, acantholytic variant",0.8567483425140381
hsa-miR-4652-3p,"squamous cell breast carcinoma, acantholytic variant",0.8567483425140381
hsa-miR-3140-5p,"squamous cell breast carcinoma, acantholytic variant",0.8567483425140381
hsa-miR-4436a,"Luminal B,triple negative",0.8567481637001038
hsa-miR-30b*,"Luminal B,triple negative",0.8567317724227905
hsa-miR-148b,synovial sarcoma,0.8567315936088562
hsa-miR-892a,synovial sarcoma,0.8567315936088562
hsa-miR-4518,synovial sarcoma,0.8567315936088562
hsa-miR-294,synovial sarcoma,0.8567315936088562
hsa-miR-326,synovial sarcoma,0.8567315936088562
hsa-miR-1269a,synovial sarcoma,0.8567315936088562
hsa-miR-499a-3p,synovial sarcoma,0.8567315936088562
hsa-miR-3687,synovial sarcoma,0.8567315936088562
hsa-miR-324-5p,synovial sarcoma,0.8567315936088562
hsa-miR-503-5p,synovial sarcoma,0.8567315936088562
hsa-miR-3200,synovial sarcoma,0.8567315936088562
hsa-let-7e-3p,synovial sarcoma,0.8567315936088562
hsa-miR-92a-1-5p,synovial sarcoma,0.8567315936088562
hsa-miR-4704-5p,synovial sarcoma,0.8567315936088562
hsa-miR-7112-3p,synovial sarcoma,0.8567315936088562
hsa-miR-469,synovial sarcoma,0.8567315936088562
hsa-miR-15a*,primary central nervous system lymphomas,0.856713593006134
hsa-miR-4429,synovial sarcoma,0.8567061424255371
hsa-miR-4668-5p,synovial sarcoma,0.8567061424255371
hsa-miR-6858-3p,castration-resistant prostate cancer,0.8566582202911377
hsa-miR-6825-3p,castration-resistant prostate cancer,0.8566582202911377
hsa-miR-6878-3p,Leptomeningeal metastasis,0.8566467761993408
hsa-miR-3606-5p,synovial sarcoma,0.8566195368766785
hsa-miR-579-3p,synovial sarcoma,0.8566195368766785
hsa-miR-548e,"Luminal B,triple negative",0.8565846681594849
hsa-miR-30a,"Luminal B,triple negative",0.8565846681594849
hsa-miR-6846-5p,"Luminal B,triple negative",0.8565846681594849
hsa-miR-4289,"Luminal B,triple negative",0.8565846681594849
hsa-miR-122-3p,castration-resistant prostate cancer,0.8565541505813599
hsa-miR-3064-5p,castration-resistant prostate cancer,0.8565541505813599
hsa-miR-6809-5p,castration-resistant prostate cancer,0.8565541505813599
hsa-miR-7854-3p,castration-resistant prostate cancer,0.8565541505813599
hsa-miR-492,"squamous cell breast carcinoma, acantholytic variant",0.8565424084663391
hsa-miR-3156-3p,"squamous cell breast carcinoma, acantholytic variant",0.8565424084663391
hsa-miR-5195-3p,"squamous cell breast carcinoma, acantholytic variant",0.8565424084663391
hsa-miR-362-3p,ovarian carcinoma,0.8565347790718079
hsa-miR-151*,ovarian carcinoma,0.8565347790718079
hsa-miR-5192,ovarian carcinoma,0.8565347790718079
hsa-miR-3157-5p,ovarian carcinoma,0.8565347790718079
hsa-miR-6861-5p,ovarian carcinoma,0.8565347790718079
hsa-miR-4795-5p,ovarian carcinoma,0.8565347790718079
hsa-miR-4636,ovarian carcinoma,0.8565347790718079
hsa-miR-106b-5p,ovarian carcinoma,0.8565347790718079
hsa-miR-136*,ovarian carcinoma,0.8565347790718079
hsa-miR-4307,ovarian carcinoma,0.8565347790718079
hsa-miR-4284,ovarian carcinoma,0.8565347790718079
hsa-miR-4686,ovarian carcinoma,0.8565347790718079
hsa-miR-548b,ovarian carcinoma,0.8565347790718079
hsa-miR-3909,ovarian carcinoma,0.8565347790718079
hsa-miR-4674,ovarian carcinoma,0.8565347790718079
hsa-miR-1277-3p,ovarian carcinoma,0.8565347790718079
hsa-miR-6796-5p,ovarian carcinoma,0.8565347790718079
hsa-miR-151-3p,synovial sarcoma,0.8565291166305542
hsa-miR-6769a-3p,synovial sarcoma,0.8565291166305542
hsa-miR-942-3p,synovial sarcoma,0.8565291166305542
hsa-miR-6720-5p,synovial sarcoma,0.8565291166305542
hsa-miR-544,"Luminal B,triple negative",0.8565160632133484
hsa-miR-526a,"Luminal B,triple negative",0.8565160632133484
hsa-miR-6846-3p,"Luminal B,triple negative",0.8565160632133484
hsa-miR-517a-3p,Leptomeningeal metastasis,0.8565067052841187
hsa-miR-874,Leptomeningeal metastasis,0.8565067052841187
hsa-miR-4707-3p,diffuse large B-cell lymphoma,0.8564833998680115
hsa-miR-602,solid pseudopapillary neoplasm of pancreas,0.856482744216919
hsa-miRPlus-G1065-5p,solid pseudopapillary neoplasm of pancreas,0.856482744216919
hsa-miR-4756-5p,castration-resistant prostate cancer,0.8564452528953552
hsa-miR-767-5p,castration-resistant prostate cancer,0.8564452528953552
hsa-miR-23c,castration-resistant prostate cancer,0.8564452528953552
hsa-miR-302f,castration-resistant prostate cancer,0.8564452528953552
hsa-miR-4775,castration-resistant prostate cancer,0.8564452528953552
hsa-miR-6728-3p,synovial sarcoma,0.8564348220825195
hsa-miR-6817-5p,synovial sarcoma,0.8564348220825195
hsa-miR-4295,synovial sarcoma,0.8564348220825195
hsa-miR-518d-3p,synovial sarcoma,0.8564348220825195
hsa-miR-105-5p,sarcoma,0.8563622832298279
hsa-miR-377*,"Luminal B,triple negative",0.8563418984413147
hsa-miR-7107-5p,"Luminal B,triple negative",0.8563418984413147
hsa-miR-485-3p,synovial sarcoma,0.8563355207443237
hsa-miR-3919,synovial sarcoma,0.8563355207443237
hsa-miR-412,"squamous cell breast carcinoma, acantholytic variant",0.8563295602798462
hsa-miR-4657,"squamous cell breast carcinoma, acantholytic variant",0.8563295602798462
hsa-miR-466,"Luminal B,triple negative",0.8563101887702942
hsa-miR-5579-5p,"Luminal B,triple negative",0.8563101887702942
hsa-miR-1913,"Luminal B,triple negative",0.8563101887702942
hsa-miR-1224,diffuse large B-cell lymphoma,0.8562946915626526
hsa-miR-138-1*,diffuse large B-cell lymphoma,0.8562946915626526
hsa-miR-378g,diffuse large B-cell lymphoma,0.8562946915626526
hsa-miR-6835-5p,diffuse large B-cell lymphoma,0.8562946915626526
hsa-miR-520d-3p,diffuse large B-cell lymphoma,0.8562925457954407
hsa-miR-516b*,diffuse large B-cell lymphoma,0.8562925457954407
hsa-miR-133b,diffuse large B-cell lymphoma,0.8562925457954407
hsa-miR-6739-5p,diffuse large B-cell lymphoma,0.8562925457954407
hsa-miR-943,synovial sarcoma,0.8562325835227966
hsa-miR-96*,synovial sarcoma,0.8562325835227966
hsa-miR-2116,synovial sarcoma,0.8562325835227966
hsa-let-7a-1,synovial sarcoma,0.8562325835227966
hsa-miR-1538,synovial sarcoma,0.8562325835227966
hsa-miR-5189,synovial sarcoma,0.8562325835227966
hsa-miR-126-3p,synovial sarcoma,0.8562325835227966
hsa-miR-193b-3p,synovial sarcoma,0.8562325835227966
hsa-miR-3150a-3p,synovial sarcoma,0.8562325835227966
hsa-miR-103a,synovial sarcoma,0.8562325835227966
hsa-miR-7162-5p,synovial sarcoma,0.8562325835227966
hsa-miR-7703,synovial sarcoma,0.8562325835227966
hsa-miR-18a,synovial sarcoma,0.8562325835227966
hsa-miR-5000-3p,synovial sarcoma,0.8562325835227966
hsa-miR-3126-3p,synovial sarcoma,0.8562325835227966
hsa-miR-4427,synovial sarcoma,0.8562325835227966
hsa-miR-4712-5p,synovial sarcoma,0.8562325835227966
hsa-miR-6826-5p,synovial sarcoma,0.856231153011322
hsa-miR-376c,"Luminal B,triple negative",0.8562289476394653
hsa-miR-6838-5p,"Luminal B,triple negative",0.8562289476394653
hsa-miR-1286,"Luminal B,triple negative",0.8562289476394653
hsa-miR-103a-3p,"Luminal B,triple negative",0.8562186360359192
hsa-miR-1249-5p,"Luminal B,triple negative",0.8562186360359192
hsa-miR-4783-5p,castration-resistant prostate cancer,0.8562116026878357
hsa-miR-1234-3p,castration-resistant prostate cancer,0.8562116026878357
hsa-miR-560,castration-resistant prostate cancer,0.8562116026878357
hsa-miR-4687-3p,castration-resistant prostate cancer,0.8562116026878357
hsa-miR-4724-5p,castration-resistant prostate cancer,0.8562116026878357
hsa-miR-145-5p,castration-resistant prostate cancer,0.8562116026878357
hsa-miR-6722-5p,"squamous cell breast carcinoma, acantholytic variant",0.8562099933624268
hsa-miR-604,"squamous cell breast carcinoma, acantholytic variant",0.8562099933624268
hsa-miR-1976,"squamous cell breast carcinoma, acantholytic variant",0.8562099933624268
hsa-miR-378e,"squamous cell breast carcinoma, acantholytic variant",0.8562099933624268
hsa-miR-195-3p,"squamous cell breast carcinoma, acantholytic variant",0.8562099933624268
hsa-miR-26a-1*,"squamous cell breast carcinoma, acantholytic variant",0.8562099933624268
hsa-miR-589*,"squamous cell breast carcinoma, acantholytic variant",0.8562099933624268
hsa-miR-23b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8562099933624268
hsa-miR-194,"Luminal B,triple negative",0.8562050461769104
hsa-miR-106b*,"Luminal B,triple negative",0.8562050461769104
hsa-miR-578,"Luminal B,triple negative",0.8562050461769104
hsa-miR-8079,"Luminal B,triple negative",0.8562050461769104
hsa-miR-4302,"Luminal B,triple negative",0.8562050461769104
hsa-miR-568,"Luminal B,triple negative",0.8562050461769104
hsa-miR-4454,solid pseudopapillary neoplasm of pancreas,0.8561843037605286
hsa-miR-367-5p,sarcoma,0.8561391234397888
hsa-miR-3926,castration-resistant prostate cancer,0.8561362624168396
hsa-miR-5582-3p,castration-resistant prostate cancer,0.8561362624168396
hsa-miR-3158-3p,castration-resistant prostate cancer,0.8561362624168396
hsa-miR-5196-5p,castration-resistant prostate cancer,0.8561362624168396
hsa-miR-761,castration-resistant prostate cancer,0.8561362624168396
hsa-miR-181d-5p,castration-resistant prostate cancer,0.8561362624168396
hsa-miR-6790-5p,castration-resistant prostate cancer,0.8561362624168396
hsa-miR-6769b-5p,synovial sarcoma,0.8561220765113831
hsa-miR-627,synovial sarcoma,0.8561220765113831
hsa-miR-4267,synovial sarcoma,0.8561220765113831
hsa-miR-320e,"squamous cell breast carcinoma, acantholytic variant",0.8560980558395386
hsa-miR-1304,"squamous cell breast carcinoma, acantholytic variant",0.8560980558395386
hsa-miR-150-5p,"squamous cell breast carcinoma, acantholytic variant",0.8560980558395386
hsa-miR-27b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8560980558395386
hsa-miR-4440,"squamous cell breast carcinoma, acantholytic variant",0.8560980558395386
hsa-miR-6716-3p,"squamous cell breast carcinoma, acantholytic variant",0.8560980558395386
hsa-miR-4528,"squamous cell breast carcinoma, acantholytic variant",0.8560980558395386
hsa-miR-6765-5p,"squamous cell breast carcinoma, acantholytic variant",0.8560980558395386
hsa-miR-6812-5p,castration-resistant prostate cancer,0.8560861945152283
hsa-miR-27a-5p,castration-resistant prostate cancer,0.8560861945152283
hsa-miR-6811-3p,castration-resistant prostate cancer,0.8560861945152283
hsa-miR-7851-3p,castration-resistant prostate cancer,0.8560861945152283
hsa-miR-25-3p,castration-resistant prostate cancer,0.8560861945152283
hsa-miR-652-3p,castration-resistant prostate cancer,0.8560861945152283
hsa-miR-330,castration-resistant prostate cancer,0.8560861945152283
hsa-miR-154-5p,castration-resistant prostate cancer,0.8560861945152283
hsa-miR-664*,sarcoma,0.8560830354690552
hsa-miR-150*,sarcoma,0.8560830354690552
hsa-miR-8053,sarcoma,0.8560830354690552
hsa-miR-4714-5p,sarcoma,0.8560830354690552
hsa-miR-367-5p,synovial sarcoma,0.8560079336166382
hsa-miR-4458,synovial sarcoma,0.8560079336166382
hsa-miR-6728-5p,"squamous cell breast carcinoma, acantholytic variant",0.8559766411781311
hsa-miR-4738-5p,"squamous cell breast carcinoma, acantholytic variant",0.8559766411781311
hsa-miR-518a,"squamous cell breast carcinoma, acantholytic variant",0.8559766411781311
hsa-miR-3170,"squamous cell breast carcinoma, acantholytic variant",0.8559766411781311
hsa-miR-497,castration-resistant prostate cancer,0.8559507131576538
hsa-miR-34,castration-resistant prostate cancer,0.8559507131576538
hsa-miR-147,castration-resistant prostate cancer,0.8559507131576538
hsa-miR-598-3p,castration-resistant prostate cancer,0.8559507131576538
hsa-miR-6780a-5p,castration-resistant prostate cancer,0.8559507131576538
hsa-miR-2115-3p,castration-resistant prostate cancer,0.8559507131576538
hsa-miR-194*,pilocytic astrocytoma,0.8559284210205078
hsa-miR-493*,pilocytic astrocytoma,0.8559284210205078
hsa-miR-4269,breast cancer brain metastasis,0.8559282422065735
hsa-miR-532,breast cancer brain metastasis,0.8559282422065735
hsa-miR-570,breast cancer brain metastasis,0.8559282422065735
hsa-miR-562,breast cancer brain metastasis,0.8559282422065735
hsa-miR-185*,breast cancer brain metastasis,0.8559282422065735
hsa-miR-892a,solid pseudopapillary neoplasm of pancreas,0.8558946251869202
hsa-miR-1267,solid pseudopapillary neoplasm of pancreas,0.8558946251869202
hsa-miR-7851-3p,sarcoma,0.8558938503265381
hsa-miR-7161-3p,diffuse large B-cell lymphoma,0.8558934330940247
hsa-miR-4790-5p,diffuse large B-cell lymphoma,0.8558934330940247
hsa-miR-4740-5p,diffuse large B-cell lymphoma,0.8558934330940247
hsa-miR-4999-3p,diffuse large B-cell lymphoma,0.8558934330940247
hsa-miR-588,synovial sarcoma,0.8558880686759949
hsa-miR-5095,synovial sarcoma,0.8558880686759949
hsa-let-7f-1-3p,synovial sarcoma,0.8558880686759949
hsa-miR-548e-5p,synovial sarcoma,0.8558880686759949
hsa-miR-5586-5p,"squamous cell breast carcinoma, acantholytic variant",0.8558792471885681
hsa-miR-654-3p,"squamous cell breast carcinoma, acantholytic variant",0.8558792471885681
hsa-miR-138-5p,"squamous cell breast carcinoma, acantholytic variant",0.8558792471885681
hsa-miR-519a,brain cancer,0.8558192253112793
hsa-miR-6834-3p,castration-resistant prostate cancer,0.8558080196380615
hsa-miR-668-5p,castration-resistant prostate cancer,0.8558080196380615
hsa-miR-642,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-6861-5p,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-4278,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-136*,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-615-5p,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-4284,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-6796-5p,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-7976,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-4729,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-219a-5p,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-4765,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-556,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-4510,high grade serous papillary ovarian cancer,0.8557908535003662
hsa-miR-512-5p,synovial sarcoma,0.8557624220848083
hsa-miR-374c-3p,synovial sarcoma,0.8557624220848083
hsa-miR-4768-3p,synovial sarcoma,0.8557624220848083
hsa-miR-6811-3p,synovial sarcoma,0.8557624220848083
hsa-miR-34,sarcoma,0.8557581901550293
hsa-miR-4646-5p,sarcoma,0.8557581901550293
hsa-miR-3158-3p,sarcoma,0.8557433485984802
hsa-miR-181d-5p,sarcoma,0.8557433485984802
hsa-miR-1203,"squamous cell breast carcinoma, acantholytic variant",0.8557313680648804
hsa-miR-1-1,"squamous cell breast carcinoma, acantholytic variant",0.8557313680648804
hsa-miR-5047,"squamous cell breast carcinoma, acantholytic variant",0.8557313680648804
hsa-miR-149,"squamous cell breast carcinoma, acantholytic variant",0.8557313680648804
hsa-miR-1179,"squamous cell breast carcinoma, acantholytic variant",0.8557313680648804
hsa-miR-4485-3p,"squamous cell breast carcinoma, acantholytic variant",0.8557313680648804
hsa-miR-6865-3p,"squamous cell breast carcinoma, acantholytic variant",0.8557313680648804
hsa-miR-1247,miR-142-y,0.8556967973709106
hsa-miR-658,miR-142-y,0.8556967973709106
hsa-miR-1199-3p,miR-142-y,0.8556967973709106
hsa-miR-514b-5p,diffuse large B-cell lymphoma,0.8556798696517944
hsa-miR-519e-3p,"squamous cell breast carcinoma, acantholytic variant",0.8556624054908752
hsa-miR-548p,"squamous cell breast carcinoma, acantholytic variant",0.8556624054908752
hsa-miR-4707-5p,"squamous cell breast carcinoma, acantholytic variant",0.8556624054908752
hsa-miR-183,"squamous cell breast carcinoma, acantholytic variant",0.8556624054908752
hsa-miR-526a,"squamous cell breast carcinoma, acantholytic variant",0.8556624054908752
hsa-miR-4698,"squamous cell breast carcinoma, acantholytic variant",0.8556624054908752
hsa-miR-181b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8556624054908752
hsa-miR-6815-3p,"squamous cell breast carcinoma, acantholytic variant",0.8556624054908752
hsa-miR-516,"squamous cell breast carcinoma, acantholytic variant",0.8556624054908752
hsa-miR-1266-3p,castration-resistant prostate cancer,0.8556578755378723
hsa-miR-767,castration-resistant prostate cancer,0.8556578755378723
hsa-miR-151-5p,castration-resistant prostate cancer,0.8556578755378723
hsa-miR-486,castration-resistant prostate cancer,0.8556578755378723
hsa-miR-155-3p,castration-resistant prostate cancer,0.8556578755378723
hsa-miR-629,castration-resistant prostate cancer,0.8556578755378723
hsa-miR-215,castration-resistant prostate cancer,0.8556578755378723
hsa-miR-4650-3p,castration-resistant prostate cancer,0.8556578755378723
hsa-miR-4733-5p,synovial sarcoma,0.8556267023086548
hsa-miR-147,synovial sarcoma,0.8556267023086548
hsa-miR-519c-3p,synovial sarcoma,0.8556267023086548
hsa-miR-4647,sarcoma,0.8556153774261475
hsa-miR-499a-5p,castration-resistant prostate cancer,0.8555947542190552
hsa-miR-199a-3p,castration-resistant prostate cancer,0.8555947542190552
hsa-miR-558,castration-resistant prostate cancer,0.8555947542190552
hsa-miR-488-5p,castration-resistant prostate cancer,0.8555947542190552
hsa-miR-18b,castration-resistant prostate cancer,0.8555947542190552
hsa-miR-3167,castration-resistant prostate cancer,0.8555947542190552
hsa-miR-6827-3p,castration-resistant prostate cancer,0.8555947542190552
hsa-miR-6771-3p,castration-resistant prostate cancer,0.8555947542190552
hsa-miR-5692c,castration-resistant prostate cancer,0.8555947542190552
hsa-miR-363,diffuse large B-cell lymphoma,0.8555598855018616
hsa-miR-23b-3p,diffuse large B-cell lymphoma,0.8555598855018616
hsa-miR-6788-5p,diffuse large B-cell lymphoma,0.8555598855018616
hsa-miR-665,castration-resistant prostate cancer,0.8554993867874146
hsa-miR-6884-3p,castration-resistant prostate cancer,0.8554993867874146
hsa-miR-4306,castration-resistant prostate cancer,0.8554993867874146
hsa-miR-548al,castration-resistant prostate cancer,0.8554993867874146
hsa-miR-3681-3p,castration-resistant prostate cancer,0.8554993867874146
hsa-miR-1910-5p,castration-resistant prostate cancer,0.8554993867874146
hsa-miR-548ah-3p,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-291-3p,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-223*,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-4436b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-4304,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-4766-5p,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-293,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-410-3p,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-375,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-29a*,"squamous cell breast carcinoma, acantholytic variant",0.8554873466491699
hsa-miR-542-3p,synovial sarcoma,0.855484127998352
hsa-miR-525-5p,synovial sarcoma,0.855484127998352
hsa-miR-181a-1,synovial sarcoma,0.855484127998352
hsa-miR-6760-5p,synovial sarcoma,0.855484127998352
hsa-let-7f-2*,synovial sarcoma,0.855484127998352
hsa-miR-337-5p,synovial sarcoma,0.8554837703704834
hsa-miR-4451,synovial sarcoma,0.8554837703704834
hsa-miR-205-3p,synovial sarcoma,0.8554837703704834
hsa-miR-27b*,synovial sarcoma,0.8554837703704834
hsa-miR-4723-3p,sarcoma,0.8554650545120239
hsa-miR-512-5p-1105,sarcoma,0.8554650545120239
hsa-miR-4433a-3p,sarcoma,0.8554650545120239
hsa-miR-3192-3p,"squamous cell breast carcinoma, acantholytic variant",0.8554555177688599
hsa-miR-1-5p,"squamous cell breast carcinoma, acantholytic variant",0.8554555177688599
hsa-miR-24-2-5p,"squamous cell breast carcinoma, acantholytic variant",0.8554555177688599
hsa-miR-1233-3p,diffuse large B-cell lymphoma,0.8554474115371704
hsa-miR-6511b-3p,diffuse large B-cell lymphoma,0.8554474115371704
hsa-miR-4251,diffuse large B-cell lymphoma,0.8554474115371704
hsa-miR-124-5p,diffuse large B-cell lymphoma,0.8554474115371704
hsa-miR-766-5p,diffuse large B-cell lymphoma,0.8554474115371704
hsa-miR-6891-3p,diffuse large B-cell lymphoma,0.8554474115371704
hsa-miR-675,sarcoma,0.855401873588562
hsa-miR-8089,sarcoma,0.855401873588562
hsa-miR-1912,sarcoma,0.855401873588562
hsa-miR-584,sarcoma,0.855401873588562
hsa-miR-6774-3p,sarcoma,0.855401873588562
hsa-miR-6847-5p,sarcoma,0.855401873588562
hsa-miR-4661-5p,rhabdomyosarcomas,0.8553941249847412
hsa-miR-4679,rhabdomyosarcomas,0.8553941249847412
hsa-miR-6828-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-6799-3p,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-550b,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-32*,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-017,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-486-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-597-3p,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-5683,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-6833-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-1286,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-3944-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-627-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-1282,"squamous cell breast carcinoma, acantholytic variant",0.8553738594055176
hsa-miR-196-2,breast cancer brain metastasis,0.8553706407546997
hsa-miR-525-3p,ovarian carcinoma,0.8553639054298401
hsa-miR-29b-1,ovarian carcinoma,0.8553639054298401
hsa-miR-21-3p,ovarian carcinoma,0.8553639054298401
hsa-miR-513b,ovarian carcinoma,0.8553639054298401
hsa-miR-6824-5p,ovarian carcinoma,0.8553639054298401
hsa-miR-1283,ovarian carcinoma,0.8553639054298401
hsa-miR-6515-5p,ovarian carcinoma,0.8553639054298401
hsa-miR-4274,ovarian carcinoma,0.8553639054298401
hsa-miR-96-5p,ovarian carcinoma,0.8553639054298401
hsa-miR-6769a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-548as-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-550a,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-34a*,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-6753-3p,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-7109-3p,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-200c,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-4520-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-4539,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-3681-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-6844,"squamous cell breast carcinoma, acantholytic variant",0.8553636074066162
hsa-miR-651-3p,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-1295b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-29b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-122a,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-let-7f-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-2116-3p,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-6880-3p,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-548az-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-4277,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-30c-1*,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-2681-5p,"squamous cell breast carcinoma, acantholytic variant",0.8553497791290283
hsa-miR-3677-3p,primary central nervous system lymphomas,0.8553414344787598
hsa-miR-1266-3p,synovial sarcoma,0.8553332090377808
hsa-miR-29a,synovial sarcoma,0.8553332090377808
hsa-miR-629,synovial sarcoma,0.8553332090377808
hsa-miR-6126,synovial sarcoma,0.8553332090377808
hsa-miR-1269,synovial sarcoma,0.8553332090377808
hsa-let-7a-3p,synovial sarcoma,0.8553332090377808
hsa-miR-381-5p,synovial sarcoma,0.8553332090377808
hsa-miR-4650-3p,synovial sarcoma,0.8553332090377808
hsa-miR-6829-3p,synovial sarcoma,0.8553332090377808
hsa-miR-26b-5p,synovial sarcoma,0.8553332090377808
hsa-miR-7641,castration-resistant prostate cancer,0.8553271889686584
hsa-miR-4486,castration-resistant prostate cancer,0.8553271889686584
hsa-miR-6780b-5p,high grade serous papillary ovarian cancer,0.8553235530853271
hsa-miR-30e-3p,high grade serous papillary ovarian cancer,0.8553235530853271
hsa-miR-4760-3p,high grade serous papillary ovarian cancer,0.8553235530853271
hsa-miR-548t-5p,high grade serous papillary ovarian cancer,0.8553235530853271
hsa-miR-518a-5p,sarcoma,0.8553063869476318
hsa-miR-663b,synovial sarcoma,0.8552700281143188
hsa-miR-3134,synovial sarcoma,0.8552700281143188
hsa-miR-484,synovial sarcoma,0.8552700281143188
hsa-miR-3189,synovial sarcoma,0.8552700281143188
hsa-miR-5008-5p,synovial sarcoma,0.8552700281143188
hsa-miR-6766-5p,synovial sarcoma,0.8552700281143188
hsa-miR-488-5p,synovial sarcoma,0.8552700281143188
hsa-miR-125b-5p,synovial sarcoma,0.8552700281143188
hsa-miR-5579-3p,synovial sarcoma,0.8552700281143188
hsa-miR-3190-5p,synovial sarcoma,0.8552700281143188
hsa-miR-18b,synovial sarcoma,0.8552700281143188
hsa-miR-6774-3p,synovial sarcoma,0.8552700281143188
hsa-miR-4708-3p,synovial sarcoma,0.8552700281143188
hsa-miR-3167,synovial sarcoma,0.8552700281143188
hsa-miR-6847-5p,synovial sarcoma,0.8552700281143188
hsa-miR-5692c,synovial sarcoma,0.8552700281143188
hsa-let-7f-2*,breast cancer brain metastasis,0.8552539944648743
hsa-miR-524-3p,diffuse large B-cell lymphoma,0.8552278280258179
hsa-miR-7155-5p,diffuse large B-cell lymphoma,0.8552278280258179
hsa-miR-4717-3p,diffuse large B-cell lymphoma,0.8552278280258179
hsa-miR-548b-3p,pilocytic astrocytoma,0.8552242517471313
hsa-miR-151*,pilocytic astrocytoma,0.8552242517471313
hsa-miR-221*,primary central nervous system lymphomas,0.8552178740501404
hsa-miR-3196,synovial sarcoma,0.8551744222640991
hsa-miR-665,synovial sarcoma,0.8551744222640991
hsa-miR-525*,synovial sarcoma,0.8551744222640991
hsa-miR-28-5p,synovial sarcoma,0.8551744222640991
hsa-miR-6759-3p,synovial sarcoma,0.8551744222640991
hsa-miR-463,follicular thyroid carcinoma,0.8551662564277649
hsa-miR-517,castration-resistant prostate cancer,0.8551586866378784
hsa-miR-633,castration-resistant prostate cancer,0.8551586866378784
hsa-miR-643,castration-resistant prostate cancer,0.8551586866378784
hsa-miR-4667-3p,castration-resistant prostate cancer,0.8551586866378784
hsa-miR-3915,castration-resistant prostate cancer,0.8551586866378784
hsa-miR-1283-1,castration-resistant prostate cancer,0.8551586866378784
hsa-miR-488*,Leptomeningeal metastasis,0.8551579117774963
hsa-miR-3945,Leptomeningeal metastasis,0.8551579117774963
hsa-let-7a-2-3p,Leptomeningeal metastasis,0.8551579117774963
hsa-miR-2276,Leptomeningeal metastasis,0.8551579117774963
hsa-miR-548y,Leptomeningeal metastasis,0.8551579117774963
hsa-miR-3977,ovarian carcinoma,0.8551532626152039
hsa-miR-7162-3p,ovarian carcinoma,0.8551532626152039
hsa-miR-877,ovarian carcinoma,0.8551532626152039
hsa-miR-3945,diffuse large B-cell lymphoma,0.8550794124603271
hsa-miR-6772-3p,diffuse large B-cell lymphoma,0.8550794124603271
hsa-miR-1-1,diffuse large B-cell lymphoma,0.8550794124603271
hsa-miR-6879-5p,diffuse large B-cell lymphoma,0.8550794124603271
hsa-miR-1974,diffuse large B-cell lymphoma,0.8550794124603271
hsa-miR-562,diffuse large B-cell lymphoma,0.8550794124603271
hsa-miR-4643,diffuse large B-cell lymphoma,0.8550794124603271
hsa-miRPlus-C1114,diffuse large B-cell lymphoma,0.8550465703010559
hsa-miR-150*,diffuse large B-cell lymphoma,0.8550465703010559
hsa-miR-370,diffuse large B-cell lymphoma,0.8550101518630981
hsa-miR-92a-1*,diffuse large B-cell lymphoma,0.8550101518630981
hsa-miR-582-3p,diffuse large B-cell lymphoma,0.8550101518630981
hsa-miR-5696,diffuse large B-cell lymphoma,0.8550101518630981
hsa-miR-349,synovial sarcoma,0.8550020456314087
hsa-miR-516a-3p,synovial sarcoma,0.8550020456314087
hsa-miR-4659b-3p,synovial sarcoma,0.8550020456314087
hsa-miR-136,synovial sarcoma,0.8550020456314087
hsa-miR-3929,synovial sarcoma,0.8550020456314087
hsa-miR-98-3p,synovial sarcoma,0.8550020456314087
hsa-miR-5587-3p,synovial sarcoma,0.8550020456314087
hsa-miR-8069,primary central nervous system lymphomas,0.8549933433532715
hsa-miR-592,castration-resistant prostate cancer,0.8549797534942627
hsa-miR-6814-5p,castration-resistant prostate cancer,0.8549797534942627
hsa-miR-3908,castration-resistant prostate cancer,0.8549797534942627
hsa-miR-654-5p,castration-resistant prostate cancer,0.8549726009368896
hsa-miR-572,castration-resistant prostate cancer,0.8549726009368896
hsa-miR-183*,castration-resistant prostate cancer,0.8549726009368896
hsa-miR-1260a,castration-resistant prostate cancer,0.8549726009368896
hsa-miRPlus-C1114,castration-resistant prostate cancer,0.8549726009368896
hsa-miR-6783-3p,castration-resistant prostate cancer,0.8549726009368896
hsa-miR-337-3p,castration-resistant prostate cancer,0.8549726009368896
hsa-miR-643,sarcoma,0.8549652695655823
hsa-miR-4769-3p,sarcoma,0.8549652695655823
hsa-miR-602,rhabdomyosarcomas,0.8549512624740601
hsa-miR-3065-3p,rhabdomyosarcomas,0.8549512624740601
hsa-miR-4748,rhabdomyosarcomas,0.8549512624740601
hsa-miR-4795-5p,rhabdomyosarcomas,0.8549512624740601
hsa-miR128b,rhabdomyosarcomas,0.8549512624740601
hsa-miR-652-5p,rhabdomyosarcomas,0.8549512624740601
hsa-miR-548c-3p,rhabdomyosarcomas,0.8549288511276245
hsa-miR-1271-3p,rhabdomyosarcomas,0.8549288511276245
hsa-miR-181c*,rhabdomyosarcomas,0.8549288511276245
hsa-miR-4520-2-3p,brain cancer,0.8548741340637207
hsa-miR-423-5p_2,high grade serous papillary ovarian cancer,0.8548580408096313
hsa-miR-181c*,high grade serous papillary ovarian cancer,0.8548580408096313
hsa-miRPlus-C1099,diffuse large B-cell lymphoma,0.8548344969749451
hsa-miR-30a-5p,diffuse large B-cell lymphoma,0.8548344969749451
hsa-miR-30a-3p,diffuse large B-cell lymphoma,0.8548344969749451
hsa-miR-29a*,diffuse large B-cell lymphoma,0.8548344969749451
hsa-miR-6772-5p,diffuse large B-cell lymphoma,0.8548344969749451
hsa-miR-3193,synovial sarcoma,0.8548331260681152
hsa-miR-7850-5p,synovial sarcoma,0.8548331260681152
hsa-miR-4769-3p,synovial sarcoma,0.8548331260681152
hsa-miR-191-5p,synovial sarcoma,0.8548331260681152
hsa-miR-548an,synovial sarcoma,0.8548331260681152
hsa-miR-6514-5p,synovial sarcoma,0.8548331260681152
hsa-miR-302b-5p,synovial sarcoma,0.8548331260681152
hsa-miR-1306,breast cancer brain metastasis,0.8548235297203064
hsa-miR-293,breast cancer brain metastasis,0.8548235297203064
hsa-miR-488-3p,breast cancer brain metastasis,0.8548235297203064
hsa-miR-542-3p,miR-675-y,0.8548187017440796
hsa-let-7f-2*,miR-675-y,0.8548187017440796
hsa-miR-3658,diffuse large B-cell lymphoma,0.8548025488853455
hsa-miR-374b*,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-935,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-382-5p,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-4676-5p,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-526b,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-4764-3p,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-6786-3p,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-6797-3p,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-4714-3p,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-4632-5p,castration-resistant prostate cancer,0.8547922372817993
hsa-miR-4320,sarcoma,0.8547861576080322
hsa-miR-5582-3p,Luminal B Her2+,0.854771077632904
hsa-miR-4693-5p,diffuse large B-cell lymphoma,0.8547205924987793
hsa-miR-6799-3p,diffuse large B-cell lymphoma,0.8547205924987793
hsa-miR-433,diffuse large B-cell lymphoma,0.8547205924987793
hsa-miR-3192,diffuse large B-cell lymphoma,0.8547205924987793
hsa-miR-218-1*,diffuse large B-cell lymphoma,0.8547102212905884
hsa-miR-3157-3p,diffuse large B-cell lymphoma,0.8547102212905884
hsa-miR-1260,diffuse large B-cell lymphoma,0.8547102212905884
hsa-miR-34a*,diffuse large B-cell lymphoma,0.8547102212905884
hsa-miR-3680-5p,diffuse large B-cell lymphoma,0.8547102212905884
hsa-miR-1245a,diffuse large B-cell lymphoma,0.8547102212905884
hsa-miR-135a-5p,diffuse large B-cell lymphoma,0.8547102212905884
hsa-miR-603,diffuse large B-cell lymphoma,0.8546964526176453
hsa-miR-378f,diffuse large B-cell lymphoma,0.8546964526176453
hsa-miR-6506-3p,diffuse large B-cell lymphoma,0.8546964526176453
hsa-miR-128b,diffuse large B-cell lymphoma,0.8546964526176453
hsa-miR-548aq-5p,synovial sarcoma,0.8546537756919861
hsa-miR-4293,synovial sarcoma,0.8546537756919861
hsa-miR-297,synovial sarcoma,0.8546537756919861
hsa-miR-1278,synovial sarcoma,0.8546537756919861
hsa-miR-548u,synovial sarcoma,0.8546537756919861
hsa-miR-5002-3p,synovial sarcoma,0.8546537756919861
hsa-miR-645,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-5704,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-548am-5p,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-450,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-1224,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-193,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-383,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-4529-5p,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-4498,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-425-3p,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-4786-3p,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-19a-3p,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-1264,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-4447,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-6818-5p,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-4697-3p,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-203a-3p,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-3620,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-520g-3p,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-3120,castration-resistant prostate cancer,0.8546016812324524
hsa-miR-873,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-8059,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-6078,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-133b,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-1207-5p,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-30c-1-3p,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-371a-3p,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-519c-5p,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-4690-3p,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-892c-3p,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-489-3p,castration-resistant prostate cancer,0.8545994162559509
hsa-miR-374b*,sarcoma,0.8545984029769897
hsa-miR-18b-3p,sarcoma,0.8545984029769897
hsa-miR-1468-5p,sarcoma,0.8545984029769897
hsa-miR-1908-3p,sarcoma,0.8545984029769897
hsa-miR-193a-3p,Leptomeningeal metastasis,0.854597806930542
hsa-miR-1908,Leptomeningeal metastasis,0.854597806930542
hsa-miR-3189-5p,Leptomeningeal metastasis,0.854597806930542
hsa-miR-151b,synovial sarcoma,0.854522168636322
hsa-miR-3681,synovial sarcoma,0.854522168636322
hsa-miR-1236-5p,synovial sarcoma,0.854522168636322
hsa-miR-5571-3p,synovial sarcoma,0.854522168636322
hsa-miR-1909-5p,synovial sarcoma,0.854522168636322
hsa-miR-7978,synovial sarcoma,0.854522168636322
hsa-miR-6830-3p,synovial sarcoma,0.854522168636322
hsa-miR-6859-3p,synovial sarcoma,0.854522168636322
hsa-miR-499a-5p,synovial sarcoma,0.8545076251029968
hsa-miR-590,synovial sarcoma,0.8545076251029968
hsa-miR-4495,synovial sarcoma,0.8545076251029968
hsa-miR-8089,synovial sarcoma,0.8545076251029968
hsa-miR-4670-3p,synovial sarcoma,0.8545076251029968
hsa-miR-3607-3p,synovial sarcoma,0.8545076251029968
hsa-miR-100*,synovial sarcoma,0.8545076251029968
hsa-miR-6781-3p,synovial sarcoma,0.8545076251029968
hsa-miR-146b,synovial sarcoma,0.8544660210609436
hsa-miR-9-1*,synovial sarcoma,0.8544660210609436
hsa-miR-6743-3p,synovial sarcoma,0.8544660210609436
hsa-miR-6780a-3p,synovial sarcoma,0.8544660210609436
hsa-miR-374c,pilocytic astrocytoma,0.8544532060623169
hsa-miR-505*,pilocytic astrocytoma,0.8544532060623169
hsa-miR-1183,pilocytic astrocytoma,0.8544532060623169
hsa-miR-3677-3p,diffuse large B-cell lymphoma,0.8544450402259827
hsa-miR-342-3p,diffuse large B-cell lymphoma,0.8544450402259827
hsa-miR-6505-3p,sarcoma,0.8544076681137085
hsa-miR-4327,sarcoma,0.8544076681137085
hsa-miR-4754,sarcoma,0.8544076681137085
hsa-miR-7843-5p,sarcoma,0.854405403137207
hsa-miR-133b,sarcoma,0.854405403137207
hsa-miR-548ae,sarcoma,0.854405403137207
hsa-miR-548f-3p,sarcoma,0.854405403137207
hsa-miR-1273g-5p,sarcoma,0.854405403137207
hsa-miR-489-3p,sarcoma,0.854405403137207
hsa-miR-6074,castration-resistant prostate cancer,0.8544052243232727
hsa-miR-4782-3p,castration-resistant prostate cancer,0.8544052243232727
hsa-miR-6890-3p,castration-resistant prostate cancer,0.8544052243232727
hsa-miR-219-5p,castration-resistant prostate cancer,0.8544052243232727
hsa-miR-1539,castration-resistant prostate cancer,0.8544052243232727
hsa-miR-4709-3p,castration-resistant prostate cancer,0.8544052243232727
hsa-miR-383-5p,castration-resistant prostate cancer,0.8544052243232727
hsa-let-7g-3p,castration-resistant prostate cancer,0.8544052243232727
hsa-miR-525,castration-resistant prostate cancer,0.8544052243232727
hsa-miR-1826,ovarian carcinoma,0.8544048070907593
hsa-miR-455-3p,ovarian carcinoma,0.8544048070907593
hsa-miR-302c,ovarian carcinoma,0.8544048070907593
hsa-miR-708*,ovarian carcinoma,0.8544048070907593
hsa-miR-4777-3p,ovarian carcinoma,0.8544048070907593
hsa-miR-632,solid pseudopapillary neoplasm of pancreas,0.8543898463249207
hsa-miR-454*,solid pseudopapillary neoplasm of pancreas,0.8543194532394409
hsa-miR-6893-3p,miR-675-y,0.8542984127998352
hsa-miR-561-3p,miR-675-y,0.8542984127998352
hsa-miR-4695-5p,synovial sarcoma,0.854275107383728
hsa-miR-138-1*,synovial sarcoma,0.854275107383728
hsa-miR-335-3p,synovial sarcoma,0.854275107383728
hsa-miR-4327,synovial sarcoma,0.854275107383728
hsa-miR-6818-5p,synovial sarcoma,0.854275107383728
hsa-miR-4697-3p,synovial sarcoma,0.854275107383728
hsa-miR-1250-5p,synovial sarcoma,0.854275107383728
hsa-let-7b-5p,synovial sarcoma,0.854275107383728
hsa-miR-154-3p,synovial sarcoma,0.854275107383728
hsa-miR-3620,synovial sarcoma,0.854275107383728
hsa-miR-411,synovial sarcoma,0.854275107383728
hsa-miR-520g-3p,synovial sarcoma,0.854275107383728
hsa-miR-6756-5p,synovial sarcoma,0.854275107383728
hsa-miR-520d-3p,synovial sarcoma,0.8542729020118713
hsa-miR-625*,synovial sarcoma,0.8542729020118713
hsa-miR-8059,synovial sarcoma,0.8542729020118713
hsa-miR-133b,synovial sarcoma,0.8542729020118713
hsa-miR-30c-1-3p,synovial sarcoma,0.8542729020118713
hsa-miR-635,synovial sarcoma,0.8542729020118713
hsa-miR-135b-5p,synovial sarcoma,0.8542729020118713
hsa-miR-548ae,synovial sarcoma,0.8542729020118713
hsa-miR-141-5p,synovial sarcoma,0.8542729020118713
hsa-miR-4690-3p,synovial sarcoma,0.8542729020118713
hsa-miR-548f-3p,synovial sarcoma,0.8542729020118713
hsa-miR-130a-5p,breast cancer brain metastasis,0.8542371392250061
hsa-miR-6839-3p,breast cancer brain metastasis,0.8542371392250061
hsa-miR-218-2*,breast cancer brain metastasis,0.8542371392250061
hsa-miR-624-5p,breast cancer brain metastasis,0.8542371392250061
hsa-miR-4792,breast cancer brain metastasis,0.8542371392250061
hsa-miR-99,rhabdomyosarcomas,0.8542205691337585
hsa-miR-362-3p,rhabdomyosarcomas,0.8542205691337585
hsa-miR-4634,rhabdomyosarcomas,0.8542205691337585
hsa-miR-5587-5p,rhabdomyosarcomas,0.8542205691337585
hsa-miR-4480,rhabdomyosarcomas,0.8542205691337585
hsa-miR-302b*,rhabdomyosarcomas,0.8542205691337585
hsa-miR-374a-3p,sarcoma,0.8542109727859497
hsa-miR-1287-5p,sarcoma,0.8542109727859497
hsa-miR-4672,sarcoma,0.8542109727859497
hsa-miR-1266-5p,castration-resistant prostate cancer,0.8541965484619141
hsa-miR-4783-3p,castration-resistant prostate cancer,0.8541965484619141
hsa-miR-4790-5p,castration-resistant prostate cancer,0.8541965484619141
hsa-miR-4640-5p,castration-resistant prostate cancer,0.8541965484619141
hsa-miR-6843-3p,castration-resistant prostate cancer,0.8541965484619141
hsa-miR-3142,castration-resistant prostate cancer,0.8541965484619141
hsa-miR-6812-3p,castration-resistant prostate cancer,0.8541965484619141
hsa-miR-5192,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-1234,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-124a-3,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-4684-3p,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-652-5p,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-4441,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-937-3p,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-342-5p,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-4511,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-410-5p,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-152-5p,high grade serous papillary ovarian cancer,0.8541494607925415
hsa-miR-224-5p,synovial sarcoma,0.8540782332420349
hsa-miR-1243,synovial sarcoma,0.8540782332420349
hsa-miR-3671,synovial sarcoma,0.8540782332420349
hsa-miR-5195-5p,synovial sarcoma,0.8540782332420349
hsa-miR-092,solid pseudopapillary neoplasm of pancreas,0.8540558218955994
hsa-miR-190a,Leptomeningeal metastasis,0.8540482521057129
hsa-miR-1306,Leptomeningeal metastasis,0.8540482521057129
hsa-miR-292-5p,Leptomeningeal metastasis,0.8540482521057129
hsa-miR-3195,Leptomeningeal metastasis,0.8540482521057129
hsa-miR-599,Leptomeningeal metastasis,0.8540482521057129
hsa-miR-7-1,Leptomeningeal metastasis,0.8540482521057129
hsa-miR-6841-3p,Leptomeningeal metastasis,0.8540482521057129
hsa-miR-597,pilocytic astrocytoma,0.854044497013092
hsa-miR-422b,papillary thyroid carcinoma,0.8540207743644714
hsa-miR-92a,papillary thyroid carcinoma,0.8540207743644714
hsa-miR-664a-5p,sarcoma,0.854002058506012
hsa-miR-585-3p,sarcoma,0.854002058506012
hsa-miR-6843-3p,sarcoma,0.854002058506012
hsa-miR-340,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-509-3p,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-548ay-3p,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-4275,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-3191-3p,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-3688-5p,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-4797-3p,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-520e,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-5088-5p,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-1285-3p,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-3664-3p,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-6502-5p,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-4710,castration-resistant prostate cancer,0.8539807796478271
hsa-miR-1185-2-3p,breast cancer brain metastasis,0.8539515137672424
hsa-miR-106b*,breast cancer brain metastasis,0.8539515137672424
hsa-miR-425-5p,breast cancer brain metastasis,0.8539515137672424
hsa-miR-614,breast cancer brain metastasis,0.8539515137672424
hsa-miR-8079,breast cancer brain metastasis,0.8539515137672424
hsa-miR-3617-3p,miR-142-y,0.8539299964904785
hsa-miR-6873-5p,miR-142-y,0.8539299964904785
hsa-miR-1229-3p,miR-142-y,0.8539299964904785
hsa-miR-200a-3p,solid pseudopapillary neoplasm of pancreas,0.8538935780525208
hsa-miR-6073,solid pseudopapillary neoplasm of pancreas,0.8538935780525208
hsa-miR-7703,solid pseudopapillary neoplasm of pancreas,0.8538935780525208
hsa-miR-26b*,synovial sarcoma,0.8538692593574524
hsa-miR-4534,synovial sarcoma,0.8538692593574524
hsa-miR-4640-5p,synovial sarcoma,0.8538692593574524
hsa-miR-196b,synovial sarcoma,0.8538692593574524
hsa-miR-585-3p,synovial sarcoma,0.8538692593574524
hsa-miR-539-5p,synovial sarcoma,0.8538692593574524
hsa-miR-3142,synovial sarcoma,0.8538692593574524
hsa-miR-22*,synovial sarcoma,0.8538692593574524
hsa-miR-6866-5p,synovial sarcoma,0.8538692593574524
hsa-miR-5195-3p,synovial sarcoma,0.8538692593574524
hsa-miR-1b-2,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-1201,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-213,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-508-3p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-6787-5p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-5687,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-4428,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-559,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-6864-5p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-509-5p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-1205,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-378e,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-4711-5p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-3622a-3p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-454-3p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-4745-3p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-487a-5p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-653-3p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-7107-3p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-3913-5p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-4743-3p,castration-resistant prostate cancer,0.8538596034049988
hsa-miR-1260,breast cancer brain metastasis,0.853800356388092
hsa-miR-627-3p,breast cancer brain metastasis,0.853800356388092
hsa-miR-514b-5p,sarcoma,0.8537861108779907
hsa-miR-4433a-5p,sarcoma,0.8537861108779907
hsa-miR-548ab,solid pseudopapillary neoplasm of pancreas,0.8537492752075195
hsa-miR-3609,solid pseudopapillary neoplasm of pancreas,0.8537492752075195
hsa-miR-5681b,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-548h,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-4730,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-5701,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-4651,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-634,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-4276,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-138-1-3p,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-18a*,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-4680-3p,castration-resistant prostate cancer,0.8537461161613464
hsa-miRPlus-A1087,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-190b,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-525*-524,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-93-5p,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-892c-5p,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-143-3p,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-4528,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-605-5p,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-6782-5p,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-4637,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-3168,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-520f-520c,castration-resistant prostate cancer,0.8537461161613464
hsa-miR-302c,breast cancer brain metastasis,0.8537326455116272
hsa-miR-362-3p,papillary thyroid carcinoma,0.8536718487739563
hsa-miR-509-5p,sarcoma,0.8536648154258728
hsa-miR-1255b-2,sarcoma,0.8536648154258728
hsa-miR-454-3p,sarcoma,0.8536648154258728
hsa-miR-4745-3p,sarcoma,0.8536648154258728
hsa-miR-4772-5p,sarcoma,0.8536648154258728
hsa-miR-215-3p,sarcoma,0.8536648154258728
hsa-miR-3186-3p,sarcoma,0.8536648154258728
hsa-miR-598,breast cancer brain metastasis,0.85366290807724
hsa-miR-5692b,breast cancer brain metastasis,0.85366290807724
hsa-miR-139-5p,breast cancer brain metastasis,0.85366290807724
hsa-miR-6516-5p,solid pseudopapillary neoplasm of pancreas,0.8536574244499207
hsa-miR-769-3p,synovial sarcoma,0.8536531329154968
hsa-miR-3653,synovial sarcoma,0.8536531329154968
hsa-miR-187-3p,synovial sarcoma,0.8536531329154968
hsa-miR-514b-5p,synovial sarcoma,0.8536531329154968
hsa-miR-4433a-5p,synovial sarcoma,0.8536531329154968
hsa-miR-768-5p,synovial sarcoma,0.8536531329154968
hsa-miR-5088-5p,synovial sarcoma,0.8536531329154968
hsa-miR-3664-3p,synovial sarcoma,0.8536531329154968
hsa-miR-7154-3p,synovial sarcoma,0.8536531329154968
hsa-miR-664a-3p,primary central nervous system lymphomas,0.8535912036895752
hsa-miR-450b-5p,miR-675-y,0.8535712361335754
hsa-miR-337,synovial sarcoma,0.8535634279251099
hsa-miR-7113-5p,synovial sarcoma,0.8535634279251099
hsa-miR-340-5p,solid pseudopapillary neoplasm of pancreas,0.8535615801811218
hsa-miR-551b-3p,solid pseudopapillary neoplasm of pancreas,0.8535615801811218
hsa-miR-18a*,sarcoma,0.8535512089729309
hsa-miR-4751,sarcoma,0.8535512089729309
hsa-miR-6739-3p,sarcoma,0.8535512089729309
hsa-miR-4470,breast cancer brain metastasis,0.8535361886024475
hsa-miR-885-5p,breast cancer brain metastasis,0.8535361886024475
hsa-miR-548h-3p,breast cancer brain metastasis,0.8535361886024475
hsa-miR-548av-3p,synovial sarcoma,0.8535316586494446
hsa-miR-26a-1,synovial sarcoma,0.8535316586494446
hsa-miR-6885-5p,synovial sarcoma,0.8535316586494446
hsa-miR-6864-5p,synovial sarcoma,0.8535316586494446
hsa-miR-2054,synovial sarcoma,0.8535316586494446
hsa-miR-15a-3p,synovial sarcoma,0.8535316586494446
hsa-miR-195-5p,synovial sarcoma,0.8535316586494446
hsa-miR-370-5p,synovial sarcoma,0.8535316586494446
hsa-miR-2117,synovial sarcoma,0.8535316586494446
hsa-miR-23b-5p,synovial sarcoma,0.8535316586494446
hsa-miR-6788-5p,synovial sarcoma,0.8535316586494446
hsa-miR-3661,synovial sarcoma,0.8535316586494446
hsa-miR-192-2/3,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-3619-3p,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-585,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-586,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-520f,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-708,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-132-3p,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-644b-3p,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-3616-3p,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-4697-5p,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-30b*,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-7-2,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-373-5p,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-146b-3p,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-597-5p,castration-resistant prostate cancer,0.8535244464874268
hsa-let-7d-v2,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-497-3p,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-1247-3p,castration-resistant prostate cancer,0.8535244464874268
hsa-miR-374b-3p,Leptomeningeal metastasis,0.8535227179527283
hsa-miR-6777-3p,Leptomeningeal metastasis,0.8535227179527283
hsa-miR-1292-3p,Leptomeningeal metastasis,0.8535227179527283
hsa-miR-4299,"Luminal B,triple negative",0.8535181879997253
hsa-miR-3617-3p,"Luminal B,triple negative",0.8535181879997253
hsa-miR-30c-2-3p,"Luminal B,triple negative",0.8535181879997253
hsa-miR-215-5p,"Luminal B,triple negative",0.8535181879997253
hsa-miR-1587,"Luminal B,triple negative",0.8535181879997253
hsa-miR-1229-3p,"Luminal B,triple negative",0.8535181879997253
hsa-miR-6831-5p,"Luminal B,triple negative",0.8535181879997253
hsa-miR-518d,synovial sarcoma,0.8535020351409912
hsa-miR-519a,synovial sarcoma,0.8535020351409912
hsa-miR-221*,synovial sarcoma,0.8535020351409912
hsa-miR-33a*,synovial sarcoma,0.8535020351409912
hsa-miR-6829-5p,synovial sarcoma,0.8535020351409912
hsa-miR-519e-5p,synovial sarcoma,0.8535020351409912
hsa-miR-6888-5p,synovial sarcoma,0.8535020351409912
hsa-miR-125b-1*,synovial sarcoma,0.8535020351409912
hsa-miR-676,synovial sarcoma,0.8535020351409912
hsa-miR-1250-3p,synovial sarcoma,0.8535020351409912
hsa-miR-1255b-2-3p,breast cancer brain metastasis,0.8534780740737915
hsa-let-7d-v2,breast cancer brain metastasis,0.8534780740737915
hsa-miR-451,solid pseudopapillary neoplasm of pancreas,0.8534605503082275
hsa-miR-6814-3p,Leptomeningeal metastasis,0.8534592986106873
hsa-miR-550b-2-5p,Leptomeningeal metastasis,0.8534592986106873
hsa-miR-138-1,Leptomeningeal metastasis,0.8534592986106873
hsa-miR-580,Leptomeningeal metastasis,0.8534592986106873
hsa-miR-1184,Leptomeningeal metastasis,0.8534592986106873
hsa-miR-32*,Leptomeningeal metastasis,0.8534592986106873
hsa-miR-017,Leptomeningeal metastasis,0.8534592986106873
hsa-miR-6760-5p,"squamous cell breast carcinoma, acantholytic variant",0.8534456491470337
hsa-let-7f-2*,"squamous cell breast carcinoma, acantholytic variant",0.8534456491470337
hsa-miR-4485-5p,"squamous cell breast carcinoma, acantholytic variant",0.8534456491470337
hsa-miR-1250-3p,"squamous cell breast carcinoma, acantholytic variant",0.8534456491470337
hsa-miRPlus-A1087,breast cancer brain metastasis,0.8534294366836548
hsa-miR-4528,breast cancer brain metastasis,0.8534294366836548
hsa-miR-1233-3p,synovial sarcoma,0.8534179925918579
hsa-miR-7151-3p,synovial sarcoma,0.8534179925918579
hsa-miR-4251,synovial sarcoma,0.8534179925918579
hsa-miR-634,synovial sarcoma,0.8534179925918579
hsa-miR-150-5p,synovial sarcoma,0.8534179925918579
hsa-miR-4751,synovial sarcoma,0.8534179925918579
hsa-miR-6739-3p,synovial sarcoma,0.8534179925918579
hsa-miR-548v,synovial sarcoma,0.8534179925918579
hsa-miR-495-5p,synovial sarcoma,0.8534179925918579
hsa-miR-4637,synovial sarcoma,0.8534179925918579
hsa-miR-516-5p,sarcoma,0.853408932685852
hsa-miR-4645-3p,sarcoma,0.853408932685852
hsa-miR-488*,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-4269,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-6772-3p,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-4681,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-6513-3p,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-6879-5p,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-1273c,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-550,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-4758-5p,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-1179,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-886-3p,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-4755-3p,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-8061,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-185*,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-465,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-5093,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-16-1*,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-6128,castration-resistant prostate cancer,0.8533744812011719
hsa-miR-021,solid pseudopapillary neoplasm of pancreas,0.8533545136451721
hsa-miR-4655-5p,high grade serous papillary ovarian cancer,0.8533543348312378
hsa-let-7f-2*,"Luminal B,triple negative",0.8533520102500916
hsa-miR-412,breast cancer brain metastasis,0.853342592716217
hsa-miR-185-3p,sarcoma,0.8533291816711426
hsa-miR-133a-5p,sarcoma,0.8533291816711426
hsa-miR-190a-5p,sarcoma,0.8533291816711426
hsa-miR-6881-5p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-519e-3p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-1914*,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-301a-3p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-593-5p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-6514-3p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-3620-3p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-3074-5p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-1272,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-4756-3p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-4698,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-181b-5p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-5696,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-1178-3p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-5001-5p,castration-resistant prostate cancer,0.8533046245574951
hsa-miR-3155b,solid pseudopapillary neoplasm of pancreas,0.8532435894012451
hsa-miR-5187-3p,synovial sarcoma,0.8531957864761353
hsa-miR-520f,synovial sarcoma,0.8531957864761353
hsa-miR-4785,synovial sarcoma,0.8531957864761353
hsa-miR-29c-5p,synovial sarcoma,0.8531957864761353
hsa-miR-25-5p,synovial sarcoma,0.8531957864761353
hsa-miR-146a*,synovial sarcoma,0.8531957864761353
hsa-miR-185-3p,synovial sarcoma,0.8531957864761353
hsa-miR-373-5p,synovial sarcoma,0.8531957864761353
hsa-miR-520a,synovial sarcoma,0.8531957864761353
hsa-miR-497-3p,synovial sarcoma,0.8531957864761353
hsa-miR-6766-3p,synovial sarcoma,0.8531957864761353
hsa-miR-138-5p,synovial sarcoma,0.8531957864761353
hsa-miR-103a-2-5p,sarcoma,0.8531790971755981
hsa-miR-2909,sarcoma,0.8531790971755981
hsa-miR-3140-3p,sarcoma,0.8531790971755981
hsa-miR-10b-3p,sarcoma,0.8531790971755981
hsa-miR-203a-5p,sarcoma,0.8531790971755981
hsa-miR-340*,sarcoma,0.8531790971755981
hsa-miR-520d,Leptomeningeal metastasis,0.853172242641449
hsa-miR-3941,Leptomeningeal metastasis,0.853172242641449
hsa-miR-574-5p,Leptomeningeal metastasis,0.853172242641449
hsa-miRPlus-C1099,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-3657,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-548ah-3p,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-130b*,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-379,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-377-5p,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-200b*,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-16-1-3p,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-30a-5p,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-4263,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-4749-5p,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-374a*,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-4469,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-224*,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-1248,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-92a-1,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-190a-3p,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-4508,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-376c-3p,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-29a*,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-6818-3p,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-885,castration-resistant prostate cancer,0.8531272411346436
hsa-miR-139-3p,breast cancer brain metastasis,0.8531267642974854
hsa-miR-450a-2-3p,sarcoma,0.8531091809272766
hsa-miR-483-3p,sarcoma,0.8531091809272766
hsa-miR-744-3p,sarcoma,0.8531091809272766
hsa-miR-208b-3p,sarcoma,0.8531091809272766
hsa-miR-4698,sarcoma,0.8531091809272766
hsa-miR-5696,sarcoma,0.8531091809272766
hsa-miR-34b-5p,sarcoma,0.8531091809272766
hsa-miR-626,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-1307,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-514a-3p,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-936,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-4319,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-3591-5p,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-93-3p,castration-resistant prostate cancer,0.8530948758125305
hsa-let-7i-3p,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-4655-3p,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-1-5p,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-577,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-30d-3p,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-1913,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-6798-5p,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-3613-3p,castration-resistant prostate cancer,0.8530948758125305
hsa-miR-488*,synovial sarcoma,0.853045642375946
hsa-miR-4269,synovial sarcoma,0.853045642375946
hsa-miR-1203,synovial sarcoma,0.853045642375946
hsa-miR-3945,synovial sarcoma,0.853045642375946
hsa-miR-455,synovial sarcoma,0.853045642375946
hsa-miR-103a-2-5p,synovial sarcoma,0.853045642375946
hsa-miR-3618,synovial sarcoma,0.853045642375946
hsa-miR-1185,synovial sarcoma,0.853045642375946
hsa-miR-550,synovial sarcoma,0.853045642375946
hsa-miR-29b-2-5p,synovial sarcoma,0.853045642375946
hsa-miR-520f-5p,synovial sarcoma,0.853045642375946
hsa-miR-620,synovial sarcoma,0.853045642375946
hsa-miR-1238,synovial sarcoma,0.853045642375946
hsa-miR-203a-5p,synovial sarcoma,0.853045642375946
hsa-miR-886-3p,synovial sarcoma,0.853045642375946
hsa-miR-4643,synovial sarcoma,0.853045642375946
hsa-miR-4717-5p,synovial sarcoma,0.853045642375946
hsa-miR-376a,synovial sarcoma,0.853045642375946
hsa-miR-519b,synovial sarcoma,0.853045642375946
hsa-miR-6848-3p,synovial sarcoma,0.853045642375946
hsa-miR-5093,synovial sarcoma,0.853045642375946
hsa-miR-6128,synovial sarcoma,0.853045642375946
hsa-miR-6789-3p,rhabdomyosarcomas,0.8530340194702148
hsa-miR-6827-5p,rhabdomyosarcomas,0.8530340194702148
hsa-miRPlus-A1031,rhabdomyosarcomas,0.8530340194702148
hsa-miR-1301,breast cancer brain metastasis,0.8530299067497253
hsa-miR-487b,Leptomeningeal metastasis,0.8530204892158508
hsa-miR-1226*,Leptomeningeal metastasis,0.8530204892158508
hsa-miR-5011-3p,Leptomeningeal metastasis,0.8530204892158508
hsa-miR-5002-5p,primary central nervous system lymphomas,0.8530178070068359
hsa-miR-376c-5p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-6814-3p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-4693-5p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-4452,castration-resistant prostate cancer,0.853012204170227
hsa-miR-6799-3p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-433,castration-resistant prostate cancer,0.853012204170227
hsa-miR-323a-5p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-1293,castration-resistant prostate cancer,0.853012204170227
hsa-miR-4755-5p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-125b-2-3p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-495,castration-resistant prostate cancer,0.853012204170227
hsa-miR-597-3p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-4481,castration-resistant prostate cancer,0.853012204170227
hsa-miR-4693-3p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-6839-3p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-624-5p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-3689a-5p,castration-resistant prostate cancer,0.853012204170227
hsa-miR-148b-3p,solid pseudopapillary neoplasm of pancreas,0.8530057072639465
hsa-miR-10a*,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-3197,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-3151-3p,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-3689d,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-550a,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-4703-3p,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-141*,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-3155a,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-6511a-3p,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-6504-3p,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-3146,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-3681-5p,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-4708-5p,castration-resistant prostate cancer,0.8530017137527466
hsa-miR-605,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-3917,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-106,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-302d*,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-6786-5p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-1246,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-6506-3p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-520d,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-432-3p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-548au-5p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-122a,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-614,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-578,castration-resistant prostate cancer,0.8529878258705139
hsa-let-7d-5p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-875-5p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-132-5p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-7151-5p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-5681a,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-499b-3p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-6828-3p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-2682-5p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-5010-3p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-3162-3p,castration-resistant prostate cancer,0.8529878258705139
hsa-miR-6514-3p,synovial sarcoma,0.8529756665229797
hsa-miR-6511b-5p,synovial sarcoma,0.8529756665229797
hsa-miR-6796-3p,synovial sarcoma,0.8529756665229797
hsa-miR-10b*,synovial sarcoma,0.8529756665229797
hsa-miR-4535,synovial sarcoma,0.8529756665229797
hsa-miR-3678-5p,synovial sarcoma,0.8529756665229797
hsa-miR-2052,synovial sarcoma,0.8529756665229797
hsa-miR-4746-3p,synovial sarcoma,0.8529756665229797
hsa-miR-208b-3p,synovial sarcoma,0.8529756665229797
hsa-miR-6815-3p,synovial sarcoma,0.8529756665229797
hsa-miR-3184-5p,synovial sarcoma,0.8529756665229797
hsa-miR-6846-3p,synovial sarcoma,0.8529756665229797
hsa-miR-513b,high grade serous papillary ovarian cancer,0.8529624938964844
hsa-miR-551a,high grade serous papillary ovarian cancer,0.8529624938964844
hsa-miR-519b-3p,sarcoma,0.8529316186904907
hsa-miR-3657,sarcoma,0.8529316186904907
hsa-miR-3692-5p,sarcoma,0.8529316186904907
hsa-miR-29a-2,sarcoma,0.8529316186904907
hsa-miR-374b,sarcoma,0.8529316186904907
hsa-miR-325,sarcoma,0.8528992533683777
hsa-miR-1260b,sarcoma,0.8528992533683777
hsa-miR-510,sarcoma,0.8528992533683777
hsa-miR-218-2-3p,sarcoma,0.8528992533683777
hsa-miR-577,sarcoma,0.8528992533683777
hsa-miR-6800-3p,sarcoma,0.8528992533683777
hsa-miR-527,sarcoma,0.8528992533683777
hsa-miR-500a-3p,Leptomeningeal metastasis,0.852882444858551
hsa-miR-936,Leptomeningeal metastasis,0.852882444858551
hsa-miR-5006-5p,breast cancer brain metastasis,0.8528496026992798
hsa-miR-3185,breast cancer brain metastasis,0.8528496026992798
hsa-miR-3157-5p,papillary thyroid carcinoma,0.8528380393981934
hsa-miR-382-3p,solid pseudopapillary neoplasm of pancreas,0.8528235554695129
hsa-miR-600,rhabdomyosarcomas,0.8528205156326294
hsa-miR-220a,rhabdomyosarcomas,0.8528205156326294
hsa-miR-744*,rhabdomyosarcomas,0.8528205156326294
hsa-let-7a_c,rhabdomyosarcomas,0.8528205156326294
hsa-miR-3974,sarcoma,0.8528164625167847
hsa-miR-6833-5p,sarcoma,0.8528164625167847
hsa-miR-1914-3p,sarcoma,0.8528164625167847
hsa-miR-105-1,Leptomeningeal metastasis,0.8528088331222534
hsa-miR-4520b-3p,sarcoma,0.8528058528900146
hsa-miR-29b-1-5p,sarcoma,0.8528058528900146
hsa-miR-4520-5p,sarcoma,0.8528058528900146
hsa-let-7e*,synovial sarcoma,0.8527979254722595
hsa-miR-571,synovial sarcoma,0.8527979254722595
hsa-miR-5089,synovial sarcoma,0.8527979254722595
hsa-miR-3195,synovial sarcoma,0.8527979254722595
hsa-miR-4779,synovial sarcoma,0.8527979254722595
hsa-miR-4436b-5p,synovial sarcoma,0.8527979254722595
hsa-miR-377*,synovial sarcoma,0.8527979254722595
hsa-miR-516a-5p,synovial sarcoma,0.8527979254722595
hsa-miR-7-1,synovial sarcoma,0.8527979254722595
hsa-let-7c*,synovial sarcoma,0.8527979254722595
hsa-miR-514a-5p,synovial sarcoma,0.8527979254722595
hsa-miR-379-5p,synovial sarcoma,0.8527979254722595
hsa-miR-5000-5p,synovial sarcoma,0.8527979254722595
hsa-miR-517a,synovial sarcoma,0.8527979254722595
hsa-miR-376c-3p,synovial sarcoma,0.8527979254722595
hsa-miR-520f-3p,synovial sarcoma,0.8527979254722595
hsa-miR-3119,synovial sarcoma,0.8527979254722595
hsa-miR-7107-5p,synovial sarcoma,0.8527979254722595
hsa-miR-548ba,synovial sarcoma,0.8527979254722595
hsa-miR-8086,synovial sarcoma,0.8527979254722595
hsa-miR-4252,synovial sarcoma,0.8527979254722595
hsa-miR-6885-3p,synovial sarcoma,0.8527979254722595
hsa-miR-378j,sarcoma,0.8527920246124268
hsa-miR-565,sarcoma,0.8527920246124268
hsa-miR-4476,sarcoma,0.8527920246124268
hsa-miR-7151-5p,sarcoma,0.8527920246124268
hsa-miR-499b-3p,sarcoma,0.8527920246124268
hsa-miR-548aj-3p,sarcoma,0.8527920246124268
hsa-miR-412-3p,sarcoma,0.8527920246124268
hsa-miR-19b-2-5p,castration-resistant prostate cancer,0.8527746796607971
hsa-miR-3691-5p,castration-resistant prostate cancer,0.8527746796607971
hsa-miR-33a*,castration-resistant prostate cancer,0.8527746796607971
hsa-miR-519e-5p,castration-resistant prostate cancer,0.8527746796607971
hsa-miR-4485-5p,castration-resistant prostate cancer,0.8527746796607971
hsa-miR-8063,castration-resistant prostate cancer,0.8527746796607971
hsa-miR-1260b,synovial sarcoma,0.8527655601501465
hsa-miR-4747-3p,synovial sarcoma,0.8527655601501465
hsa-miR-362,synovial sarcoma,0.8527655601501465
hsa-miR-500a-3p,synovial sarcoma,0.8527655601501465
hsa-miR-518b,synovial sarcoma,0.8527655601501465
hsa-miR-510,synovial sarcoma,0.8527655601501465
hsa-miR-4635,synovial sarcoma,0.8527655601501465
hsa-miR-345,synovial sarcoma,0.8527655601501465
hsa-miR-5579-5p,synovial sarcoma,0.8527655601501465
hsa-miR-5692b,synovial sarcoma,0.8527655601501465
hsa-miR-4523,synovial sarcoma,0.8527655601501465
hsa-miR-527,synovial sarcoma,0.8527655601501465
hsa-miR-504-5p,synovial sarcoma,0.8527655601501465
hsa-miR-6746-3p,Leptomeningeal metastasis,0.852755069732666
hsa-miR-3977,high grade serous papillary ovarian cancer,0.8527489304542542
hsa-miR-487a-3p,high grade serous papillary ovarian cancer,0.8527489304542542
hsa-miR-6780a-5p,solid pseudopapillary neoplasm of pancreas,0.8527399897575378
hsa-miR-3160-3p,"squamous cell breast carcinoma, acantholytic variant",0.8527321815490723
hsa-miR-301b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8527321815490723
hsa-miR-301a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8527321815490723
hsa-let-7a*,ovarian carcinoma,0.8527319431304932
hsa-miR-16-2*,ovarian carcinoma,0.8527319431304932
hsa-miR-1294,ovarian carcinoma,0.8527319431304932
hsa-miR-3681,ovarian carcinoma,0.8527319431304932
hsa-miR-4483,ovarian carcinoma,0.8527319431304932
hsa-miR-349,breast cancer brain metastasis,0.8526983857154846
hsa-miR-4659b-3p,breast cancer brain metastasis,0.8526983857154846
hsa-miR-4527,breast cancer brain metastasis,0.8526983857154846
hsa-miR-518d-5p,Leptomeningeal metastasis,0.8526968359947205
hsa-miR-1237,Leptomeningeal metastasis,0.8526968359947205
hsa-miR-21-3p,aryngeal squamous cell carcinoma,0.8526895642280579
hsa-miR-551a,aryngeal squamous cell carcinoma,0.8526895642280579
hsa-miR-4726-5p,aryngeal squamous cell carcinoma,0.8526895642280579
hsa-miR-130a-5p,synovial sarcoma,0.8526827692985535
hsa-miR-6734-3p,synovial sarcoma,0.8526827692985535
hsa-miR-4693-5p,synovial sarcoma,0.8526827692985535
hsa-miR-1226-5p,synovial sarcoma,0.8526827692985535
hsa-miR-4452,synovial sarcoma,0.8526827692985535
hsa-miR-892b,synovial sarcoma,0.8526827692985535
hsa-miR-6828-5p,synovial sarcoma,0.8526827692985535
hsa-miR-3121-5p,synovial sarcoma,0.8526827692985535
hsa-miR-376c,synovial sarcoma,0.8526827692985535
hsa-miR-1288,synovial sarcoma,0.8526827692985535
hsa-miR-32*,synovial sarcoma,0.8526827692985535
hsa-miR-495,synovial sarcoma,0.8526827692985535
hsa-miR-891a-3p,synovial sarcoma,0.8526827692985535
hsa-miR-1268,synovial sarcoma,0.8526827692985535
hsa-miR-3190-3p,synovial sarcoma,0.8526827692985535
hsa-miR-624-5p,synovial sarcoma,0.8526827692985535
hsa-miR-1282,synovial sarcoma,0.8526827692985535
hsa-miR-4792,synovial sarcoma,0.8526827692985535
hsa-miR-1257,synovial sarcoma,0.8526722192764282
hsa-miR-143*,synovial sarcoma,0.8526722192764282
hsa-miR-3940,synovial sarcoma,0.8526722192764282
hsa-let-7f-1,synovial sarcoma,0.8526722192764282
hsa-miR-1b-1,synovial sarcoma,0.8526722192764282
hsa-miR-4478,synovial sarcoma,0.8526722192764282
hsa-miR-9-5p,synovial sarcoma,0.8526722192764282
hsa-miR-34a*,synovial sarcoma,0.8526722192764282
hsa-miR-3174,synovial sarcoma,0.8526722192764282
hsa-miR-3680-5p,synovial sarcoma,0.8526722192764282
hsa-miR-200c,synovial sarcoma,0.8526722192764282
hsa-miR-29b-1-5p,synovial sarcoma,0.8526722192764282
hsa-miR-520c,synovial sarcoma,0.8526722192764282
hsa-miR-4282,synovial sarcoma,0.8526722192764282
hsa-miR-6840-5p,synovial sarcoma,0.8526722192764282
hsa-miR-6511a-3p,synovial sarcoma,0.8526722192764282
hsa-miR-6504-3p,synovial sarcoma,0.8526722192764282
hsa-miR-6868-5p,synovial sarcoma,0.8526722192764282
hsa-miR-508-5p,synovial sarcoma,0.8526582717895508
hsa-miR-138-2,synovial sarcoma,0.8526582717895508
hsa-miR-3927-5p,synovial sarcoma,0.8526582717895508
hsa-miR-3150a-5p,synovial sarcoma,0.8526582717895508
hsa-miR-1225-5p,synovial sarcoma,0.8526582717895508
hsa-miR-3605-5p,synovial sarcoma,0.8526582717895508
hsa-miR-3148,synovial sarcoma,0.8526582717895508
hsa-miR-565,synovial sarcoma,0.8526582717895508
hsa-miR-4476,synovial sarcoma,0.8526582717895508
hsa-let-7f-5p,synovial sarcoma,0.8526582717895508
hsa-miR-578,synovial sarcoma,0.8526582717895508
hsa-miR-5589-3p,synovial sarcoma,0.8526582717895508
hsa-miR-8079,synovial sarcoma,0.8526582717895508
hsa-miR-490,synovial sarcoma,0.8526582717895508
hsa-miR-1251-5p,synovial sarcoma,0.8526582717895508
hsa-miR-889-3p,synovial sarcoma,0.8526582717895508
hsa-miR-128b,synovial sarcoma,0.8526582717895508
hsa-miR-6758-3p,synovial sarcoma,0.8526582717895508
hsa-miR-29b-2,synovial sarcoma,0.8526582717895508
hsa-miR-300,synovial sarcoma,0.8526582717895508
hsa-miR-6833-3p,synovial sarcoma,0.8526582717895508
hsa-miR-30c-1*,synovial sarcoma,0.8526582717895508
hsa-miR-32-5p,synovial sarcoma,0.8526582717895508
hsa-miR-519a-1,synovial sarcoma,0.8526582717895508
hsa-miR-5089-3p,synovial sarcoma,0.8526582717895508
hsa-miR-365,breast cancer brain metastasis,0.8526573181152344
hsa-miR-6759-3p,breast cancer brain metastasis,0.8526573181152344
hsa-miR-449b,Leptomeningeal metastasis,0.8526480197906494
hsa-miR-199a-2,solid pseudopapillary neoplasm of pancreas,0.8525947332382202
hsa-miR-151a-3p,breast cancer brain metastasis,0.8525828719139099
hsa-miR-524,Leptomeningeal metastasis,0.8525606989860535
hsa-miR-765,breast cancer brain metastasis,0.8525503873825073
hsa-miR-676-5p,synovial sarcoma,0.8525266051292419
hsa-miR-129-2,synovial sarcoma,0.8525266051292419
hsa-miR-4498,synovial sarcoma,0.8525266051292419
hsa-miR-6779-5p,synovial sarcoma,0.8525266051292419
hsa-miR-223-3p,synovial sarcoma,0.8525266051292419
hsa-miR-1185-1,synovial sarcoma,0.8525266051292419
hsa-miR-5582-5p,synovial sarcoma,0.8525266051292419
hsa-miR-5002-5p,synovial sarcoma,0.8525266051292419
hsa-miR-4477b,synovial sarcoma,0.8525266051292419
hsa-miR-20a-3p,synovial sarcoma,0.8525266051292419
hsa-miR-8074,synovial sarcoma,0.8525266051292419
hsa-miR-6804-5p,synovial sarcoma,0.8525266051292419
hsa-miR-891a-5p,synovial sarcoma,0.8525266051292419
hsa-miR-3120-3p,synovial sarcoma,0.8525266051292419
hsa-miR-148a-3p,synovial sarcoma,0.8525266051292419
hsa-miR-4768-3p,breast cancer brain metastasis,0.8525175452232361
hsa-miR-092,rhabdomyosarcomas,0.8525028228759766
hsa-miRPlus-C1087,rhabdomyosarcomas,0.8525028228759766
hsa-miR-4454,rhabdomyosarcomas,0.8525028228759766
hsa-miR-188-3p,rhabdomyosarcomas,0.8525028228759766
hsa-miR-4497,aryngeal squamous cell carcinoma,0.8524843454360962
hsa-miR-660,aryngeal squamous cell carcinoma,0.8524843454360962
hsa-miR-5707,aryngeal squamous cell carcinoma,0.8524843454360962
hsa-miR-520c-3p,Leptomeningeal metastasis,0.8524482250213623
hsa-miR-4475,Leptomeningeal metastasis,0.8524482250213623
hsa-miR-122-3p,breast cancer brain metastasis,0.8524281978607178
hsa-miR-876-5p,breast cancer brain metastasis,0.8524143695831299
hsa-miR-4502,breast cancer brain metastasis,0.852406919002533
hsa-miR-186,breast cancer brain metastasis,0.8524065017700195
hsa-miR-640,breast cancer brain metastasis,0.8524045944213867
hsa-miR-6088,Leptomeningeal metastasis,0.8523966073989868
hsa-miR-1271-3p,Leptomeningeal metastasis,0.8523966073989868
hsa-miR-26a-2*,solid pseudopapillary neoplasm of pancreas,0.8523774743080139
hsa-miR-542-3p,sarcoma,0.8523740768432617
hsa-miR-3691-5p,sarcoma,0.8523740768432617
hsa-miR-219-5p,Leptomeningeal metastasis,0.8523439168930054
hsa-miR-221*,miR-142-y,0.8523266911506653
hsa-miR-4530,miR-142-y,0.8523266911506653
hsa-miR-1468,miR-142-y,0.8523266911506653
hsa-miR-6829-5p,miR-142-y,0.8523266911506653
hsa-miR-4485-5p,miR-142-y,0.8523266911506653
hsa-miR-8063,miR-142-y,0.8523266911506653
hsa-miR-4738-5p,castration-resistant prostate cancer,0.8522816896438599
hsa-let-7d*,castration-resistant prostate cancer,0.8522816896438599
hsa-miR-4436a,castration-resistant prostate cancer,0.8522816896438599
hsa-miR-381-3p,castration-resistant prostate cancer,0.8522816896438599
hsa-miR-516-5p,castration-resistant prostate cancer,0.8522816896438599
hsa-miR-350,castration-resistant prostate cancer,0.8522816896438599
hsa-miR-513a-5p,solid pseudopapillary neoplasm of pancreas,0.85228031873703
hsa-miR-3196,solid pseudopapillary neoplasm of pancreas,0.85228031873703
hsa-miR-6732-5p,solid pseudopapillary neoplasm of pancreas,0.85228031873703
hsa-miR-519c-5p,Leptomeningeal metastasis,0.8522465229034424
hsa-miR-450b-5p,synovial sarcoma,0.8522451519966125
hsa-miR-24-3p,synovial sarcoma,0.8522451519966125
hsa-miR-4432,synovial sarcoma,0.8522451519966125
hsa-miR-449b*,aryngeal squamous cell carcinoma,0.8522055149078369
hsa-miR-3677-3p,"squamous cell breast carcinoma, acantholytic variant",0.8521885275840759
hsa-miR-7154-5p,Leptomeningeal metastasis,0.8521550297737122
hsa-miR-6803-3p,solid pseudopapillary neoplasm of pancreas,0.8521049618721008
hsa-miR-513-3p,"Luminal B,triple negative",0.8520939946174622
hsa-miR-587,Leptomeningeal metastasis,0.8520654439926147
hsa-miR-517,Leptomeningeal metastasis,0.851972758769989
hsa-miR-621,Leptomeningeal metastasis,0.851972758769989
hsa-miR-6815-5p,solid pseudopapillary neoplasm of pancreas,0.8519333004951477
hsa-miR-516a-3p,Leptomeningeal metastasis,0.8519137501716614
hsa-let-7f-2,Leptomeningeal metastasis,0.8518333435058594
hsa-miR-324-3p,Leptomeningeal metastasis,0.851732075214386
hsa-miR-4318,Leptomeningeal metastasis,0.851732075214386
hsa-miR-367-5p,Leptomeningeal metastasis,0.8516817688941956
hsa-miR-106a*,Leptomeningeal metastasis,0.8516340255737305
hsa-miR-4772-3p,Leptomeningeal metastasis,0.8516284227371216
hsa-miR-6764-3p,Leptomeningeal metastasis,0.8516248464584351
hsa-miR-4502,Leptomeningeal metastasis,0.8516209721565247
hsa-miR-511-2,Leptomeningeal metastasis,0.8516127467155457
hsa-miR-23a-3p,Leptomeningeal metastasis,0.8516127467155457
hsa-miR-548J,solid pseudopapillary neoplasm of pancreas,0.8515620231628418
hsa-miR-105*,solid pseudopapillary neoplasm of pancreas,0.851560115814209
hsa-miR-128-2-5p,solid pseudopapillary neoplasm of pancreas,0.851560115814209
hsa-miR-146b,solid pseudopapillary neoplasm of pancreas,0.851560115814209
hsa-miR-744*,miR-675-y,0.8515501618385315
hsa-miR-548e-3p,miR-675-y,0.8515501618385315
hsa-miR-320B,miR-675-y,0.8515501618385315
hsa-miR-3927-3p,castration-resistant prostate cancer,0.8515127301216125
hsa-miR-199a*,castration-resistant prostate cancer,0.8515127301216125
hsa-miR-2964a-5p,castration-resistant prostate cancer,0.8515127301216125
hsa-miR-7113-5p,castration-resistant prostate cancer,0.8515127301216125
hsa-miR-6506-5p,papillary thyroid carcinoma,0.8514270186424255
hsa-miR-1296-3p,Leptomeningeal metastasis,0.8513975143432617
hsa-miR-4453,pilocytic astrocytoma,0.8513926267623901
hsa-miR-4695-5p,solid pseudopapillary neoplasm of pancreas,0.8513661026954651
hsa-miR-887-3p,solid pseudopapillary neoplasm of pancreas,0.8513661026954651
hsa-miR-222-5p,solid pseudopapillary neoplasm of pancreas,0.8513661026954651
hsa-miRPlus-G1246-3p,solid pseudopapillary neoplasm of pancreas,0.8513661026954651
hsa-miR-372-5p,solid pseudopapillary neoplasm of pancreas,0.8513637781143188
hsa-miR-8059,solid pseudopapillary neoplasm of pancreas,0.8513637781143188
hsa-miR-639,solid pseudopapillary neoplasm of pancreas,0.8513637781143188
hsa-miR-548ae,solid pseudopapillary neoplasm of pancreas,0.8513637781143188
hsa-miR-1201,primary central nervous system lymphomas,0.8513534069061279
hsa-miR-500b-5p,primary central nervous system lymphomas,0.8513534069061279
hsa-miRPlus-C1066,papillary thyroid carcinoma,0.8512054085731506
hsa-miR-5190,sarcoma,0.8511092662811279
hsa-miR-655-3p,synovial sarcoma,0.85108882188797
hsa-miR-4690-5p,synovial sarcoma,0.85108882188797
hsa-miR-4471,synovial sarcoma,0.85108882188797
hsa-miR-1260a,synovial sarcoma,0.85108882188797
hsa-miR-6783-3p,synovial sarcoma,0.85108882188797
hsa-miR-1269b,synovial sarcoma,0.85108882188797
hsa-miR-450b-5p,miR-142-y,0.8510616421699524
hsa-miR-548ax,miR-142-y,0.8510616421699524
hsa-miR-342-3p,miR-142-y,0.8510616421699524
hsa-miR-6850-3p,miR-142-y,0.8510616421699524
hsa-miR-95-5p,primary central nervous system lymphomas,0.851051926612854
hsa-miR-361-5p,solid pseudopapillary neoplasm of pancreas,0.8509535193443298
hsa-miR-4790-5p,solid pseudopapillary neoplasm of pancreas,0.8509535193443298
hsa-miR-554,aryngeal squamous cell carcinoma,0.8509390950202942
hsa-miR-6722-5p,synovial sarcoma,0.8508575558662415
hsa-miR-1281,synovial sarcoma,0.8508575558662415
hsa-miR-559,synovial sarcoma,0.8508575558662415
hsa-miR-320c,synovial sarcoma,0.8508575558662415
hsa-miR-1205,synovial sarcoma,0.8508575558662415
hsa-miR-6823-3p,synovial sarcoma,0.8508575558662415
hsa-miR-3622a-3p,synovial sarcoma,0.8508575558662415
hsa-miR-208b-5p,synovial sarcoma,0.8508575558662415
hsa-miR-6862-5p,synovial sarcoma,0.8508575558662415
hsa-miR-3118,synovial sarcoma,0.8508575558662415
hsa-miR-2276-5p,synovial sarcoma,0.8508575558662415
hsa-miR-4493,synovial sarcoma,0.8508575558662415
hsa-miR-1204,synovial sarcoma,0.8508575558662415
hsa-miR-23b-3p,synovial sarcoma,0.8508575558662415
hsa-miR-653-3p,synovial sarcoma,0.8508575558662415
hsa-miR-7107-3p,synovial sarcoma,0.8508575558662415
hsa-miR-181a-1,ovarian carcinoma,0.8507413864135742
hsa-miR-3691-5p,ovarian carcinoma,0.8507413864135742
hsa-miR-1468,ovarian carcinoma,0.8507413864135742
hsa-miR-769-3p,solid pseudopapillary neoplasm of pancreas,0.8507338166236877
hsa-miR-30e-3p,miR-142-y,0.8507332801818848
hsa-miR-6507-3p,miR-142-y,0.8507332801818848
hsa-miR-4740-3p,miR-142-y,0.8507332801818848
hsa-miR-4461,solid pseudopapillary neoplasm of pancreas,0.8506104350090027
hsa-miR-208b-5p,solid pseudopapillary neoplasm of pancreas,0.8506104350090027
hsa-miR-320e,solid pseudopapillary neoplasm of pancreas,0.8504948616027832
hsa-miR-1915*,solid pseudopapillary neoplasm of pancreas,0.8504948616027832
hsa-miR-548h,solid pseudopapillary neoplasm of pancreas,0.8504948616027832
hsa-miRPlus-A1087,solid pseudopapillary neoplasm of pancreas,0.8504948616027832
hsa-miR-148b,ovarian carcinoma,0.8504272103309631
hsa-miR-3687,ovarian carcinoma,0.8504272103309631
hsa-miR-718,ovarian carcinoma,0.8504272103309631
hsa-miR-132,rhabdomyosarcomas,0.85036700963974
hsa-miR-99a*,rhabdomyosarcomas,0.85036700963974
hsa-miR-6513-5p,rhabdomyosarcomas,0.85036700963974
hsa-miR-5088,rhabdomyosarcomas,0.85036700963974
hsa-miR-4279,rhabdomyosarcomas,0.85036700963974
hsa-miR-518e-3p,diffuse large B-cell lymphoma,0.8503246307373047
hsa-miR-328-3p,diffuse large B-cell lymphoma,0.8503246307373047
hsa-miR-3198,diffuse large B-cell lymphoma,0.8503246307373047
hsa-miR-607,"Luminal B,triple negative",0.8503140807151794
hsa-miR-2355,"Luminal B,triple negative",0.8503140807151794
hsa-miR-759,high grade serous papillary ovarian cancer,0.8502943515777588
hsa-miR-1249-3p,high grade serous papillary ovarian cancer,0.8502943515777588
hsa-miR-6794-3p,solid pseudopapillary neoplasm of pancreas,0.8502690196037292
hsa-miR-4524a-3p,solid pseudopapillary neoplasm of pancreas,0.8502690196037292
hsa-miR-3607-5p,sarcoma,0.8501168489456177
hsa-miR-488*,solid pseudopapillary neoplasm of pancreas,0.8501163125038147
hsa-miR-548s,solid pseudopapillary neoplasm of pancreas,0.8501163125038147
hsa-miR-344,follicular thyroid carcinoma,0.8500788807868958
hsa-miR-1973,follicular thyroid carcinoma,0.8500788807868958
hsa-miR-6511b-5p,solid pseudopapillary neoplasm of pancreas,0.8500452041625977
hsa-miR-1272,solid pseudopapillary neoplasm of pancreas,0.8500452041625977
hsa-miR-885-5p,solid pseudopapillary neoplasm of pancreas,0.8500452041625977
hsa-miR-589-3p,primary central nervous system lymphomas,0.8499644994735718
hsa-miR-620,primary central nervous system lymphomas,0.8499644994735718
hsa-miR-664a-3p,diffuse large B-cell lymphoma,0.8498842120170593
hsa-miR-1295,solid pseudopapillary neoplasm of pancreas,0.8498644828796387
hsa-miR-292-5p,solid pseudopapillary neoplasm of pancreas,0.8498644828796387
hsa-miR-561,solid pseudopapillary neoplasm of pancreas,0.8498644828796387
hsa-miR-374b,solid pseudopapillary neoplasm of pancreas,0.8498644828796387
hsa-miR-92a-1,solid pseudopapillary neoplasm of pancreas,0.8498644828796387
hsa-miR-363-3p,solid pseudopapillary neoplasm of pancreas,0.8498317003250122
hsa-miR-92a,aryngeal squamous cell carcinoma,0.8497657775878906
hsa-miR-548w,aryngeal squamous cell carcinoma,0.8497657775878906
hsa-miR-4271,ovarian carcinoma,0.8497615456581116
hsa-miR-130a-5p,solid pseudopapillary neoplasm of pancreas,0.8497474193572998
hsa-miR-6734-3p,solid pseudopapillary neoplasm of pancreas,0.8497474193572998
hsa-miR-1238-5p,solid pseudopapillary neoplasm of pancreas,0.8497474193572998
hsa-miRPlus-C1110,solid pseudopapillary neoplasm of pancreas,0.849736750125885
hsa-miR-10a*,solid pseudopapillary neoplasm of pancreas,0.849736750125885
hsa-miR-143*,solid pseudopapillary neoplasm of pancreas,0.849736750125885
hsa-miR-1296-5p,solid pseudopapillary neoplasm of pancreas,0.849736750125885
hsa-miR-501-5p,diffuse large B-cell lymphoma,0.8497359156608582
hsa-miR-545-5p,diffuse large B-cell lymphoma,0.8497359156608582
hsa-miR-138-2,solid pseudopapillary neoplasm of pancreas,0.8497226238250732
hsa-miR-3927-5p,solid pseudopapillary neoplasm of pancreas,0.8497226238250732
hsa-miR-5693,solid pseudopapillary neoplasm of pancreas,0.8497226238250732
hsa-miR-106b*,solid pseudopapillary neoplasm of pancreas,0.8497226238250732
hsa-miR-506-3p,solid pseudopapillary neoplasm of pancreas,0.8497226238250732
hsa-miR-518d,high grade serous papillary ovarian cancer,0.8496689200401306
hsa-miR-8063,high grade serous papillary ovarian cancer,0.8496689200401306
hsa-miR-6727-3p,ovarian carcinoma,0.8496275544166565
hsa-miR-433-3p,ovarian carcinoma,0.8496275544166565
hsa-miR-421,Luminal B Her2+,0.8496254086494446
hsa-miR-607,"squamous cell breast carcinoma, acantholytic variant",0.8495140671730042
hsa-miR-548w,"squamous cell breast carcinoma, acantholytic variant",0.8495140671730042
hsa-let-7c-3p,"squamous cell breast carcinoma, acantholytic variant",0.8495140671730042
hsa-miR-561-3p,"squamous cell breast carcinoma, acantholytic variant",0.8495140671730042
hsa-miR-3064-3p,"squamous cell breast carcinoma, acantholytic variant",0.8495140671730042
hsa-miR-6874-3p,"squamous cell breast carcinoma, acantholytic variant",0.8495140671730042
hsa-miR-409-5p,breast cancer brain metastasis,0.849492609500885
hsa-miR-4314,breast cancer brain metastasis,0.849492609500885
hsa-miR-532,synovial sarcoma,0.8494648337364197
hsa-miR-4776-3p,synovial sarcoma,0.8494648337364197
hsa-miR-548e,synovial sarcoma,0.8494648337364197
hsa-miR-3181,synovial sarcoma,0.8494648337364197
hsa-miR-3122,synovial sarcoma,0.8494648337364197
hsa-miR-3940-5p,synovial sarcoma,0.8494648337364197
hsa-miR-548s,synovial sarcoma,0.8494648337364197
hsa-miR-5571-5p,synovial sarcoma,0.8494648337364197
hsa-miR-340*,synovial sarcoma,0.8494648337364197
hsa-miR-6779-3p,synovial sarcoma,0.8494648337364197
hsa-miR-6846-5p,synovial sarcoma,0.8494648337364197
hsa-miR-4289,synovial sarcoma,0.8494648337364197
hsa-miR-602,Leptomeningeal metastasis,0.8493229150772095
hsa-miRPlus-G1065-5p,Leptomeningeal metastasis,0.8493229150772095
hsa-miR-1260a,diffuse large B-cell lymphoma,0.8492885231971741
hsa-miR-4716-3p,ovarian carcinoma,0.8492615222930908
hsa-miR-6867-3p,ovarian carcinoma,0.8492615222930908
hsa-miR-186,ovarian carcinoma,0.8492615222930908
hsa-miR-4502,ovarian carcinoma,0.8492024540901184
hsa-miR-646,miR-675-y,0.8491821885108948
hsa-let-7a*,miR-675-y,0.8491821885108948
hsa-miR-4279,miR-675-y,0.8491821885108948
hsa-miR-6747-5p,ovarian carcinoma,0.8491413593292236
hsa-miR-5192,aryngeal squamous cell carcinoma,0.8491286039352417
hsa-miR-487b-5p,aryngeal squamous cell carcinoma,0.8491286039352417
hsa-miR-557,aryngeal squamous cell carcinoma,0.8491286039352417
hsa-miR-4307,aryngeal squamous cell carcinoma,0.8491286039352417
hsa-miR-921,aryngeal squamous cell carcinoma,0.8491286039352417
hsa-miRPlus-G1065-5p,aryngeal squamous cell carcinoma,0.8491286039352417
hsa-miR-3614-3p,aryngeal squamous cell carcinoma,0.8491286039352417
hsa-miR-506,aryngeal squamous cell carcinoma,0.8491286039352417
hsa-miR-205-5p,ovarian carcinoma,0.8490782976150513
hsa-miR-7-2*,pilocytic astrocytoma,0.8490707278251648
hsa-miR-3607-5p,diffuse large B-cell lymphoma,0.8490450978279114
hsa-miR-4471,miR-675-y,0.848987877368927
hsa-miR-4258,castration-resistant prostate cancer,0.8489686250686646
hsa-miR-215-5p,castration-resistant prostate cancer,0.8489686250686646
hsa-miR-7702,castration-resistant prostate cancer,0.8489686250686646
hsa-miR-4716-5p,castration-resistant prostate cancer,0.8489686250686646
hsa-miR-646,Leptomeningeal metastasis,0.848924458026886
hsa-miR-922,Leptomeningeal metastasis,0.848924458026886
hsa-miR-6081,Leptomeningeal metastasis,0.848924458026886
hsa-miR-6515-3p,Leptomeningeal metastasis,0.848924458026886
hsa-miR-1227-3p,Luminal B Her2+,0.8488971590995789
hsa-miR-193a-3p,synovial sarcoma,0.8488866686820984
hsa-miR-490-3p,synovial sarcoma,0.8488866686820984
hsa-miR-1908,synovial sarcoma,0.8488866686820984
hsa-miR-212-5p,synovial sarcoma,0.8488866686820984
hsa-miR-3977,synovial sarcoma,0.8488866686820984
hsa-miR-1261,synovial sarcoma,0.8488866686820984
hsa-miR-548au-3p,synovial sarcoma,0.8488866686820984
hsa-miR-144-3p,synovial sarcoma,0.8488866686820984
hsa-miR-764,synovial sarcoma,0.8488866686820984
hsa-miR-570-5p,synovial sarcoma,0.8488866686820984
hsa-miR-220a,synovial sarcoma,0.8488866686820984
hsa-miR-487a-3p,synovial sarcoma,0.8488866686820984
hsa-miR-4784,synovial sarcoma,0.8488866686820984
hsa-miR-219a-2-3p,synovial sarcoma,0.8488866686820984
hsa-miR-203b-3p,synovial sarcoma,0.8488866686820984
hsa-miR-4778-3p,synovial sarcoma,0.8488866686820984
hsa-miR-3116,synovial sarcoma,0.8488866686820984
hsa-miR-632,ovarian carcinoma,0.8488754034042358
hsa-miR-516a-5p,primary central nervous system lymphomas,0.8488221764564514
hsa-miR-525-5p,rhabdomyosarcomas,0.8487998843193054
hsa-miR-610,ovarian carcinoma,0.8487687110900879
hsa-miR-513-3p,ovarian carcinoma,0.8487687110900879
hsa-miR-24-3p,ovarian carcinoma,0.8487687110900879
hsa-miR-342-3p,ovarian carcinoma,0.8487687110900879
hsa-miR-1247,ovarian carcinoma,0.8487517237663269
hsa-miR-4667,ovarian carcinoma,0.8487275242805481
hsa-miR-6799-5p,ovarian carcinoma,0.8486493825912476
hsa-miR-596,ovarian carcinoma,0.8485680818557739
hsa-miR-642,aryngeal squamous cell carcinoma,0.8485546708106995
hsa-miR-106b-5p,aryngeal squamous cell carcinoma,0.8485546708106995
hsa-miR-7-1*,aryngeal squamous cell carcinoma,0.8485546708106995
hsa-miR-649,aryngeal squamous cell carcinoma,0.8485546708106995
hsa-miR-6796-5p,aryngeal squamous cell carcinoma,0.8485546708106995
hsa-miR-4435,aryngeal squamous cell carcinoma,0.8485546708106995
hsa-miRPlus-A1086,ovarian carcinoma,0.8484836220741272
hsa-miR-1909*,ovarian carcinoma,0.8484836220741272
hsa-miR-548m,solid pseudopapillary neoplasm of pancreas,0.8484086394309998
hsa-miR-24-3p,solid pseudopapillary neoplasm of pancreas,0.8484086394309998
hsa-miR-581,ovarian carcinoma,0.8483957648277283
hsa-miR-1915-5p,ovarian carcinoma,0.8483957648277283
hsa-miR-943,ovarian carcinoma,0.8483636379241943
hsa-miR-4668-3p,ovarian carcinoma,0.8483636379241943
hsa-miR-367-3p,ovarian carcinoma,0.8483636379241943
hsa-let-7a-1,ovarian carcinoma,0.8483636379241943
hsa-miR-2115,ovarian carcinoma,0.8483636379241943
hsa-miR-1538,ovarian carcinoma,0.8483636379241943
hsa-miR-22-3p,ovarian carcinoma,0.8483636379241943
hsa-miR-6741-5p,ovarian carcinoma,0.8483636379241943
hsa-miR-3179,ovarian carcinoma,0.8483636379241943
hsa-miR-6877-3p,ovarian carcinoma,0.8483636379241943
hsa-miR-15b-3p,ovarian carcinoma,0.8483636379241943
hsa-miR-330-3p,ovarian carcinoma,0.8483636379241943
hsa-miR-376a-2-5p,ovarian carcinoma,0.8483636379241943
hsa-miR-208b,ovarian carcinoma,0.8483636379241943
hsa-miR-4491,ovarian carcinoma,0.8483636379241943
hsa-miR-3126-3p,ovarian carcinoma,0.8483636379241943
hsa-miR-9500,ovarian carcinoma,0.8483636379241943
hsa-miR-509-2,ovarian carcinoma,0.8483636379241943
hsa-miR-376a-3p,synovial sarcoma,0.8483383655548096
hsa-miR-350,synovial sarcoma,0.8483383655548096
hsa-miR-6886-3p,synovial sarcoma,0.8483383655548096
hsa-miR-3136-3p,synovial sarcoma,0.8483383655548096
hsa-miR-1-3p,synovial sarcoma,0.8483383655548096
hsa-miR-6893-3p,diffuse large B-cell lymphoma,0.8483250737190247
hsa-miRPlus-C1099,synovial sarcoma,0.8483192920684814
hsa-miR-292-5p,synovial sarcoma,0.8483192920684814
hsa-miR-379,synovial sarcoma,0.8483192920684814
hsa-miR-200b*,synovial sarcoma,0.8483192920684814
hsa-miR-1289,synovial sarcoma,0.8483192920684814
hsa-miR-3692-5p,synovial sarcoma,0.8483192920684814
hsa-miR-561,synovial sarcoma,0.8483192920684814
hsa-miR-4766-5p,synovial sarcoma,0.8483192920684814
hsa-miR-4469,synovial sarcoma,0.8483192920684814
hsa-miR-106a:9.1,synovial sarcoma,0.8483192920684814
hsa-miR-365a-3p,synovial sarcoma,0.8483192920684814
hsa-miR-1248,synovial sarcoma,0.8483192920684814
hsa-miR-1296,synovial sarcoma,0.8483192920684814
hsa-miR-3907,synovial sarcoma,0.8483192920684814
hsa-miR-374b,synovial sarcoma,0.8483192920684814
hsa-miR-293,synovial sarcoma,0.8483192920684814
hsa-miR-1285-2,synovial sarcoma,0.8483192920684814
hsa-miR-6734-5p,synovial sarcoma,0.8483192920684814
hsa-miR-152-3p,synovial sarcoma,0.8483192920684814
hsa-miR-7973,synovial sarcoma,0.8483192920684814
hsa-miR-215-5p,breast cancer brain metastasis,0.8482639193534851
hsa-miR-3137,ovarian carcinoma,0.8482149243354797
hsa-miR-29b-2*,ovarian carcinoma,0.8482149243354797
hsa-miR-579-3p,ovarian carcinoma,0.8482149243354797
hsa-miR-3157-5p,solid pseudopapillary neoplasm of pancreas,0.8481250405311584
hsa-miR-4265,solid pseudopapillary neoplasm of pancreas,0.8481250405311584
hsa-miR-100-3p,solid pseudopapillary neoplasm of pancreas,0.8481250405311584
hsa-miR-4757-5p,solid pseudopapillary neoplasm of pancreas,0.8481250405311584
hsa-miR-6888-3p,solid pseudopapillary neoplasm of pancreas,0.8481250405311584
hsa-miR-519c,ovarian carcinoma,0.8481201529502869
hsa-miR-1207-3p,ovarian carcinoma,0.8481201529502869
hsa-miR-216b,rhabdomyosarcomas,0.8480319380760193
hsa-miR-3143,rhabdomyosarcomas,0.8480319380760193
hsa-miR-1267,rhabdomyosarcomas,0.8480319380760193
hsa-miR-6768-3p,rhabdomyosarcomas,0.8480319380760193
hsa-miR-6768-5p,rhabdomyosarcomas,0.8480319380760193
hsa-miR-324-5p,rhabdomyosarcomas,0.8480319380760193
hsa-miR-3189-3p,rhabdomyosarcomas,0.8480319380760193
hsa-miR-6768-3p,high grade serous papillary ovarian cancer,0.8479583859443665
hsa-miR-19a*,high grade serous papillary ovarian cancer,0.8479583859443665
hsa-miR-143-5p,high grade serous papillary ovarian cancer,0.8479583859443665
hsa-miR-3972,high grade serous papillary ovarian cancer,0.8479583859443665
hsa-miR-503-5p,high grade serous papillary ovarian cancer,0.8479583859443665
hsa-let-7e-3p,high grade serous papillary ovarian cancer,0.8479583859443665
hsa-miR-1306-3p,high grade serous papillary ovarian cancer,0.8479583859443665
hsa-miR-3200-5p,high grade serous papillary ovarian cancer,0.8479583859443665
hsa-miR-7112-3p,high grade serous papillary ovarian cancer,0.8479583859443665
hsa-miR-490-3p,miR-142-y,0.8479296565055847
hsa-miR-34b*,miR-142-y,0.8479296565055847
hsa-miR-1225,miR-142-y,0.8479296565055847
hsa-miR-520b,miR-142-y,0.8479296565055847
hsa-miR-219a-2-3p,miR-142-y,0.8479296565055847
hsa-miR-122a,primary central nervous system lymphomas,0.847920298576355
hsa-miR-512-3p,ovarian carcinoma,0.8479171395301819
hsa-miR-4419a,ovarian carcinoma,0.8478078842163086
hsa-miR-105-5p,ovarian carcinoma,0.8478078842163086
hsa-miR-6814-3p,synovial sarcoma,0.8477113246917725
hsa-miR-6894-3p,synovial sarcoma,0.8477113246917725
hsa-miR-3613-5p,synovial sarcoma,0.8477113246917725
hsa-miR-4781-3p,synovial sarcoma,0.8477113246917725
hsa-miR-5092,synovial sarcoma,0.8477113246917725
hsa-miR-1286,synovial sarcoma,0.8477113246917725
hsa-miR-218-2*,synovial sarcoma,0.8477113246917725
hsa-miR-4532,synovial sarcoma,0.8477113246917725
hsa-miR-4660,synovial sarcoma,0.8477113246917725
hsa-miR-3689a-5p,synovial sarcoma,0.8477113246917725
hsa-miR-4457,synovial sarcoma,0.8477113246917725
hsa-miR-516b-3p,synovial sarcoma,0.8477113246917725
hsa-miR-4267,ovarian carcinoma,0.8476934432983398
hsa-miR-493-5p,ovarian carcinoma,0.8476934432983398
hsa-miR-876-3p,ovarian carcinoma,0.8476934432983398
hsa-miR-19a-5p,high grade serous papillary ovarian cancer,0.8476846814155579
hsa-miRPlus-C1114,synovial sarcoma,0.8476276397705078
hsa-miR-4727-5p,synovial sarcoma,0.8476276397705078
hsa-miR-6839-5p,synovial sarcoma,0.8476276397705078
hsa-miR-5588-5p,synovial sarcoma,0.8476276397705078
hsa-miR-378,synovial sarcoma,0.8476276397705078
hsa-miR-22,primary central nervous system lymphomas,0.8476219177246094
hsa-miR-3591-5p,primary central nervous system lymphomas,0.8476219177246094
hsa-miR-3143,diffuse large B-cell lymphoma,0.8475766181945801
hsa-miR-1267,diffuse large B-cell lymphoma,0.8475766181945801
hsa-miR-294,diffuse large B-cell lymphoma,0.8475766181945801
hsa-miR-202-5p,diffuse large B-cell lymphoma,0.8475766181945801
hsa-miR-323-3p,ovarian carcinoma,0.8475737571716309
hsa-miR-4683,ovarian carcinoma,0.8475737571716309
hsa-miR-655-3p,"squamous cell breast carcinoma, acantholytic variant",0.847569465637207
hsa-miR-4471,"squamous cell breast carcinoma, acantholytic variant",0.847569465637207
hsa-miR-183*,"squamous cell breast carcinoma, acantholytic variant",0.847569465637207
hsa-miR-150*,"squamous cell breast carcinoma, acantholytic variant",0.847569465637207
hsa-miR-4727-5p,"squamous cell breast carcinoma, acantholytic variant",0.847569465637207
hsa-miR-3151,"squamous cell breast carcinoma, acantholytic variant",0.847569465637207
hsa-miR-410,"squamous cell breast carcinoma, acantholytic variant",0.847569465637207
hsa-miR-337-3p,"squamous cell breast carcinoma, acantholytic variant",0.847569465637207
hsa-miR-6089,"Luminal B,triple negative",0.8475041389465332
hsa-miR-548e-3p,"Luminal B,triple negative",0.8475041389465332
hsa-miR-320B,"Luminal B,triple negative",0.8475041389465332
hsa-miR-6810-3p,synovial sarcoma,0.8474987745285034
hsa-miR-6728-5p,synovial sarcoma,0.8474987745285034
hsa-let-7d*,synovial sarcoma,0.8474987745285034
hsa-miR-2355-3p,synovial sarcoma,0.8474987745285034
hsa-miR-516-5p,synovial sarcoma,0.8474987745285034
hsa-miR-519e-3p,primary central nervous system lymphomas,0.8474909663200378
hsa-miR-3679-5p,primary central nervous system lymphomas,0.8474909663200378
hsa-miR-181b-5p,primary central nervous system lymphomas,0.8474909663200378
hsa-miR-2467-5p,"Luminal B,triple negative",0.8474725484848022
hsa-miR-192-5p,ovarian carcinoma,0.8474481701850891
hsa-miR-588,ovarian carcinoma,0.8474481701850891
hsa-miR-30b*,primary central nervous system lymphomas,0.8474308848381042
hsa-miR-605,synovial sarcoma,0.8474152088165283
hsa-miR-3202,synovial sarcoma,0.8474152088165283
hsa-miR-6506-3p,synovial sarcoma,0.8474152088165283
hsa-miR-125b-1,synovial sarcoma,0.8474152088165283
hsa-miR-1295b-5p,synovial sarcoma,0.8474152088165283
hsa-miR-432-3p,synovial sarcoma,0.8474152088165283
hsa-miR-122a,synovial sarcoma,0.8474152088165283
hsa-miR-548h-5p,synovial sarcoma,0.8474152088165283
hsa-miR-614,synovial sarcoma,0.8474152088165283
hsa-miR-491-5p,synovial sarcoma,0.8474152088165283
hsa-miR-548i,synovial sarcoma,0.8474152088165283
hsa-miR-1307-3p,synovial sarcoma,0.8474152088165283
hsa-miR-4302,synovial sarcoma,0.8474152088165283
hsa-miR-548aj-3p,synovial sarcoma,0.8474152088165283
hsa-miR-412-3p,synovial sarcoma,0.8474152088165283
hsa-miR-506-3p,synovial sarcoma,0.8474152088165283
hsa-miR-3125,synovial sarcoma,0.8474152088165283
hsa-miR-644a,synovial sarcoma,0.8474152088165283
hsa-miR-6820-3p,synovial sarcoma,0.8474152088165283
hsa-miR-4277,synovial sarcoma,0.8474152088165283
hsa-miR-4500,synovial sarcoma,0.8474152088165283
hsa-miR-4774-5p,synovial sarcoma,0.8474152088165283
hsa-miR-4694-3p,synovial sarcoma,0.8474152088165283
hsa-miR-4638-3p,synovial sarcoma,0.8474152088165283
hsa-miR-3162-3p,synovial sarcoma,0.8474152088165283
hsa-miR-6869-3p,synovial sarcoma,0.8474152088165283
hsa-miR-649,follicular thyroid carcinoma,0.847414493560791
hsa-miR-190b,primary central nervous system lymphomas,0.8473806381225586
hsa-miR-4757-3p,primary central nervous system lymphomas,0.8473806381225586
hsa-miR-343,ovarian carcinoma,0.8473164439201355
hsa-miR-324-3p,ovarian carcinoma,0.8473164439201355
hsa-miR-4318,ovarian carcinoma,0.8473164439201355
hsa-miR-617,ovarian carcinoma,0.8473164439201355
hsa-miR-221-3p,ovarian carcinoma,0.8473164439201355
hsa-miR-4768-3p,ovarian carcinoma,0.8473164439201355
hsa-miR-6812-5p,ovarian carcinoma,0.8473164439201355
hsa-miR-154-5p,ovarian carcinoma,0.8473164439201355
hsa-miR-3143,miR-675-y,0.8473091721534729
hsa-miR-1267,miR-675-y,0.8473091721534729
hsa-miR-324-5p,miR-675-y,0.8473091721534729
hsa-miR-3972,miR-675-y,0.8473091721534729
hsa-miR-92a-1-5p,miR-675-y,0.8473091721534729
hsa-miR-181a-2*,pilocytic astrocytoma,0.8472796082496643
hsa-miR-3144-3p,synovial sarcoma,0.8472585082054138
hsa-miR-3606-3p,synovial sarcoma,0.8472585082054138
hsa-miR-146a-3p,synovial sarcoma,0.8472585082054138
hsa-miR-7855-5p,synovial sarcoma,0.8472585082054138
hsa-miR-4520b-3p,synovial sarcoma,0.8472585082054138
hsa-miR-4741,synovial sarcoma,0.8472585082054138
hsa-miR-4482-5p,synovial sarcoma,0.8472585082054138
hsa-miR-7161-5p,synovial sarcoma,0.8472585082054138
hsa-miR-548l,synovial sarcoma,0.8472585082054138
hsa-miR-7704,synovial sarcoma,0.8472585082054138
hsa-miR-642b-5p,synovial sarcoma,0.8472585082054138
hsa-miR-3679-3p,synovial sarcoma,0.8472585082054138
hsa-miR-1180-5p,high grade serous papillary ovarian cancer,0.8472398519515991
hsa-miR-596,pilocytic astrocytoma,0.8471977114677429
hsa-miR-4733-5p,ovarian carcinoma,0.8471742272377014
hsa-miR-147,ovarian carcinoma,0.8471742272377014
hsa-miR-6727-3p,high grade serous papillary ovarian cancer,0.8471478819847107
hsa-miR-34c-5p,synovial sarcoma,0.8471160531044006
hsa-miR-22,synovial sarcoma,0.8471160531044006
hsa-miR-466,synovial sarcoma,0.8471160531044006
hsa-miR-936,synovial sarcoma,0.8471160531044006
hsa-miR-222*,synovial sarcoma,0.8471160531044006
hsa-let-7i-3p,synovial sarcoma,0.8471160531044006
hsa-miR-106a-3p,synovial sarcoma,0.8471160531044006
hsa-miR-4646-3p,synovial sarcoma,0.8471160531044006
hsa-miR-4655-3p,synovial sarcoma,0.8471160531044006
hsa-miR-577,synovial sarcoma,0.8471160531044006
hsa-miR-30d-3p,synovial sarcoma,0.8471160531044006
hsa-miR-33a-3p,synovial sarcoma,0.8471160531044006
hsa-miR-1913,synovial sarcoma,0.8471160531044006
hsa-miR-4715-5p,synovial sarcoma,0.8471160531044006
hsa-miR-4800-3p,synovial sarcoma,0.8471160531044006
hsa-miR-24-2-5p,synovial sarcoma,0.8471160531044006
hsa-miR-526c,synovial sarcoma,0.8471160531044006
hsa-miR-5705,synovial sarcoma,0.8471160531044006
hsa-miR-548aa,synovial sarcoma,0.8471160531044006
hsa-miR-600,aryngeal squamous cell carcinoma,0.8471099734306335
hsa-miR-6893-3p,breast cancer brain metastasis,0.8470767736434937
hsa-miR-606,breast cancer brain metastasis,0.8470767736434937
hsa-miR-4298,primary central nervous system lymphomas,0.8470675945281982
hsa-miR-187,diffuse large B-cell lymphoma,0.8470513820648193
hsa-miR-367-3p,diffuse large B-cell lymphoma,0.8470513820648193
hsa-miR-1343,diffuse large B-cell lymphoma,0.8470513820648193
hsa-miR-193b-3p,diffuse large B-cell lymphoma,0.8470513820648193
hsa-miR-330-3p,diffuse large B-cell lymphoma,0.8470513820648193
hsa-miR-208b,diffuse large B-cell lymphoma,0.8470513820648193
hsa-miR-129-2-3p,ovarian carcinoma,0.8470244407653809
hsa-miR-3162,synovial sarcoma,0.8469845652580261
hsa-miR-4470,synovial sarcoma,0.8469845652580261
hsa-miR-593-5p,synovial sarcoma,0.8469845652580261
hsa-miR-582-3p,synovial sarcoma,0.8469845652580261
hsa-miR-1238-3p,synovial sarcoma,0.8469845652580261
hsa-miR-4796-5p,synovial sarcoma,0.8469845652580261
hsa-miR-6807-3p,synovial sarcoma,0.8469845652580261
hsa-miR-483-3p,synovial sarcoma,0.8469845652580261
hsa-miR-4283,synovial sarcoma,0.8469845652580261
hsa-miR-374a-5p,synovial sarcoma,0.8469845652580261
hsa-miR-888*,synovial sarcoma,0.8469845652580261
hsa-miR-4423-3p,synovial sarcoma,0.8469845652580261
hsa-miR-4418,synovial sarcoma,0.8469845652580261
hsa-miR-181b-5p,synovial sarcoma,0.8469845652580261
hsa-miR-5001-5p,synovial sarcoma,0.8469845652580261
hsa-miR-128a,synovial sarcoma,0.8469845652580261
hsa-miR-347,synovial sarcoma,0.8469845652580261
hsa-miR-24-1-5p,synovial sarcoma,0.8469845652580261
hsa-miR-6854-3p,synovial sarcoma,0.8469845652580261
hsa-miR-6801-5p,synovial sarcoma,0.8469845652580261
hsa-miR-3619-3p,synovial sarcoma,0.8469243049621582
hsa-miR-494-5p,synovial sarcoma,0.8469243049621582
hsa-miR-524-3p,synovial sarcoma,0.8469243049621582
hsa-miR-219-1-3p,synovial sarcoma,0.8469243049621582
hsa-miR-4467,synovial sarcoma,0.8469243049621582
hsa-miR-3616-3p,synovial sarcoma,0.8469243049621582
hsa-miR-518d-5p,synovial sarcoma,0.8469243049621582
hsa-miR-548x,synovial sarcoma,0.8469243049621582
hsa-miR-3126-5p,synovial sarcoma,0.8469243049621582
hsa-miR-2113,synovial sarcoma,0.8469243049621582
hsa-miR-3928-5p,synovial sarcoma,0.8469243049621582
hsa-miR-4761-3p,synovial sarcoma,0.8469243049621582
hsa-miR-597-5p,synovial sarcoma,0.8469243049621582
hsa-miR-122-5p,synovial sarcoma,0.8469243049621582
hsa-miR-4717-3p,synovial sarcoma,0.8469243049621582
hsa-miR-2964a-5p,diffuse large B-cell lymphoma,0.8469030857086182
hsa-miR-518e,synovial sarcoma,0.8469008803367615
hsa-miR-4520-2-3p,synovial sarcoma,0.8469008803367615
hsa-miR-3659,synovial sarcoma,0.8469008803367615
hsa-miR-4444,synovial sarcoma,0.8469008803367615
hsa-miR-3160-3p,synovial sarcoma,0.8469008803367615
hsa-miR-301b-5p,synovial sarcoma,0.8469008803367615
hsa-miR-4677-5p,synovial sarcoma,0.8469008803367615
hsa-miR-215-5p,synovial sarcoma,0.8469008803367615
hsa-miR-6873-5p,synovial sarcoma,0.8469008803367615
hsa-miR-708-3p,castration-resistant prostate cancer,0.846876323223114
hsa-miR-4727-5p,castration-resistant prostate cancer,0.846876323223114
hsa-miR-5588-5p,castration-resistant prostate cancer,0.846876323223114
hsa-miR-4714-5p,castration-resistant prostate cancer,0.846876323223114
hsa-miR-320e,synovial sarcoma,0.8468739986419678
hsa-miR-5196-3p,synovial sarcoma,0.8468739986419678
hsa-miR-424-5p,synovial sarcoma,0.8468739986419678
hsa-miR-449b,synovial sarcoma,0.8468739986419678
hsa-miR-4680-3p,synovial sarcoma,0.8468739986419678
hsa-let-7a-3,synovial sarcoma,0.8468739986419678
hsa-miR-944,synovial sarcoma,0.8468739986419678
hsa-miR-452-5p,synovial sarcoma,0.8468739986419678
hsa-miR-351,synovial sarcoma,0.8468739986419678
hsa-miR-4528,synovial sarcoma,0.8468739986419678
hsa-miR-6891-3p,synovial sarcoma,0.8468739986419678
hsa-miR-4757-3p,synovial sarcoma,0.8468739986419678
hsa-miR-6842-5p,primary central nervous system lymphomas,0.8468733429908752
hsa-miR-1266-3p,ovarian carcinoma,0.8468667268753052
hsa-miR-18b*,ovarian carcinoma,0.8468667268753052
hsa-miR-29a,ovarian carcinoma,0.8468667268753052
hsa-miR-629,ovarian carcinoma,0.8468667268753052
hsa-let-7a-3p,ovarian carcinoma,0.8468667268753052
hsa-miR-7108-5p,ovarian carcinoma,0.8468667268753052
hsa-miR-26b-5p,ovarian carcinoma,0.8468667268753052
hsa-miR-1284,sarcoma,0.8468518853187561
hsa-let-7c-3p,sarcoma,0.8468518853187561
hsa-miR-4679,sarcoma,0.8468518853187561
hsa-miR-154*,rhabdomyosarcomas,0.8468062877655029
hsa-miR-1200,rhabdomyosarcomas,0.8468062877655029
hsa-miR-1181,ovarian carcinoma,0.8468003869056702
hsa-miR-2681,ovarian carcinoma,0.8468003869056702
hsa-miR-484,ovarian carcinoma,0.8468003869056702
hsa-miR-3189,ovarian carcinoma,0.8468003869056702
hsa-miR-5008-5p,ovarian carcinoma,0.8468003869056702
hsa-miR-106a.1,ovarian carcinoma,0.8468003869056702
hsa-miR-99a-5p,ovarian carcinoma,0.8468003869056702
hsa-miR-1912,ovarian carcinoma,0.8468003869056702
hsa-miR-19b-3p,ovarian carcinoma,0.8468003869056702
hsa-miR-4723-5p,ovarian carcinoma,0.8468003869056702
hsa-miR-5692c,ovarian carcinoma,0.8468003869056702
hsa-miRPlus-C1087,papillary thyroid carcinoma,0.8467884063720703
hsa-miR-514,synovial sarcoma,0.8467839956283569
hsa-miR-3611,synovial sarcoma,0.8467839956283569
hsa-miR-4659a-5p,synovial sarcoma,0.8467839956283569
hsa-miR-3191-3p,synovial sarcoma,0.8467839956283569
hsa-miR-3688-5p,synovial sarcoma,0.8467839956283569
hsa-miR-520e,synovial sarcoma,0.8467839956283569
hsa-miR-6499-5p,synovial sarcoma,0.8467839956283569
hsa-miR-613,synovial sarcoma,0.8467839956283569
hsa-miR-3185,primary central nervous system lymphomas,0.8467810750007629
hsa-miR-151-3p,pilocytic astrocytoma,0.846746563911438
hsa-miR-937-5p,ovarian carcinoma,0.8467003107070923
hsa-miR-1295a,ovarian carcinoma,0.8467003107070923
hsa-miR-28-5p,ovarian carcinoma,0.8467003107070923
hsa-miR-2114-5p,ovarian carcinoma,0.8467003107070923
hsa-miR-212-5p,"squamous cell breast carcinoma, acantholytic variant",0.8466916084289551
hsa-miR-6089,"squamous cell breast carcinoma, acantholytic variant",0.8466916084289551
hsa-miR-3147,"squamous cell breast carcinoma, acantholytic variant",0.8466916084289551
hsa-miR-144-3p,"squamous cell breast carcinoma, acantholytic variant",0.8466916084289551
hsa-miR-764,"squamous cell breast carcinoma, acantholytic variant",0.8466916084289551
hsa-miR-3123,"squamous cell breast carcinoma, acantholytic variant",0.8466916084289551
hsa-miR-548e-3p,"squamous cell breast carcinoma, acantholytic variant",0.8466916084289551
hsa-miR-4800-5p,"squamous cell breast carcinoma, acantholytic variant",0.8466916084289551
hsa-miR-4699-3p,"squamous cell breast carcinoma, acantholytic variant",0.8466916084289551
hsa-miR-609,synovial sarcoma,0.8466677665710449
hsa-miR-520c-3p,synovial sarcoma,0.8466677665710449
hsa-miR-6736-3p,synovial sarcoma,0.8466677665710449
hsa-miR-6879-3p,synovial sarcoma,0.8466677665710449
hsa-miR-7846-3p,synovial sarcoma,0.8466677665710449
hsa-miR-589-5p,synovial sarcoma,0.8466677665710449
hsa-miR-4254,synovial sarcoma,0.8466677665710449
hsa-miR-26a-5p,synovial sarcoma,0.8466677665710449
hsa-miR-136,primary central nervous system lymphomas,0.8466248512268066
hsa-miR-801,papillary thyroid carcinoma,0.8466011881828308
hsa-miR-302c,aryngeal squamous cell carcinoma,0.8465997576713562
hsa-miR-188-3p,aryngeal squamous cell carcinoma,0.8465997576713562
hsa-miR-5186,diffuse large B-cell lymphoma,0.8465944528579712
hsa-miR-219a-2-3p,diffuse large B-cell lymphoma,0.8465944528579712
hsa-miR-8065,high grade serous papillary ovarian cancer,0.8465911746025085
hsa-miR-6759-3p,primary central nervous system lymphomas,0.846582293510437
hsa-miR-3143,Leptomeningeal metastasis,0.8465709686279297
hsa-miR-4705,Leptomeningeal metastasis,0.8465709686279297
hsa-miR-196-1,synovial sarcoma,0.8465601205825806
hsa-miRPlus-J1002,synovial sarcoma,0.8465601205825806
hsa-miR-4449,synovial sarcoma,0.8465601205825806
hsa-miR-548bb-3p,synovial sarcoma,0.8465601205825806
hsa-miR-4652-3p,synovial sarcoma,0.8465601205825806
hsa-let-7g-3p,synovial sarcoma,0.8465601205825806
hsa-miR-1287-5p,synovial sarcoma,0.8465601205825806
hsa-miR-6083,synovial sarcoma,0.8465601205825806
hsa-miR-874-5p,synovial sarcoma,0.8465601205825806
hsa-miR-301b-3p,synovial sarcoma,0.8465601205825806
hsa-miR-4672,synovial sarcoma,0.8465601205825806
hsa-miR-373-3p,synovial sarcoma,0.8465601205825806
hsa-miR-4673,high grade serous papillary ovarian cancer,0.8465250730514526
hsa-miR-575,ovarian carcinoma,0.8465195298194885
hsa-miR-6803-3p,ovarian carcinoma,0.8465195298194885
hsa-miR-6887-5p,ovarian carcinoma,0.8465195298194885
hsa-miR-98-3p,ovarian carcinoma,0.8465195298194885
hsa-miR-6808-5p,ovarian carcinoma,0.8465195298194885
hsa-miR-1226-3p,primary central nervous system lymphomas,0.8465054035186768
hsa-miR-151a-3p,primary central nervous system lymphomas,0.8465054035186768
hsa-miR-092,Leptomeningeal metastasis,0.8464856147766113
hsa-miR-519c-3p,primary central nervous system lymphomas,0.8464717864990234
hsa-miR-3151,sarcoma,0.846462607383728
hsa-miR-664a-3p,sarcoma,0.846462607383728
hsa-miR-2467-5p,sarcoma,0.846462607383728
hsa-miR-183-5p,synovial sarcoma,0.8464597463607788
hsa-miR-639,synovial sarcoma,0.8464597463607788
hsa-miR-5708,synovial sarcoma,0.8464597463607788
hsa-miR-204-5p,synovial sarcoma,0.8464597463607788
hsa-miR-519c-5p,synovial sarcoma,0.8464597463607788
hsa-miR-1301,synovial sarcoma,0.8464597463607788
hsa-let-7d-3p,synovial sarcoma,0.8464597463607788
hsa-miR-3591-3p,synovial sarcoma,0.8464597463607788
hsa-miR-521,castration-resistant prostate cancer,0.8464580774307251
hsa-miR-518a,castration-resistant prostate cancer,0.8464580774307251
hsa-miR-4526,castration-resistant prostate cancer,0.8464580774307251
hsa-miR-4652-5p,castration-resistant prostate cancer,0.8464580774307251
hsa-miR-376a-3p,castration-resistant prostate cancer,0.8464580774307251
hsa-miR-4691-3p,castration-resistant prostate cancer,0.8464580774307251
hsa-miR-1-3p,castration-resistant prostate cancer,0.8464580774307251
hsa-miR-6877-5p,castration-resistant prostate cancer,0.8464580774307251
hsa-miR-664b-3p,castration-resistant prostate cancer,0.8464580774307251
hsa-miR-22-5p,synovial sarcoma,0.8464466333389282
hsa-miR-431-5p,synovial sarcoma,0.8464466333389282
hsa-miR-150*,synovial sarcoma,0.8464466333389282
hsa-miR-3151,synovial sarcoma,0.8464466333389282
hsa-miR-6811-3p,primary central nervous system lymphomas,0.846437931060791
hsa-miR-4290,miR-675-y,0.8464372754096985
hsa-miR-195,miR-675-y,0.8464218974113464
hsa-miR-4471,miR-142-y,0.846413791179657
hsa-miR-664*,miR-142-y,0.846413791179657
hsa-miR-4727-5p,miR-142-y,0.846413791179657
hsa-miR-6783-3p,miR-142-y,0.846413791179657
hsa-miR-640,miR-675-y,0.8463731408119202
hsa-miR-4707-3p,synovial sarcoma,0.8463651537895203
hsa-miR-148a-5p,synovial sarcoma,0.8463651537895203
hsa-miR-135-2,synovial sarcoma,0.8463651537895203
hsa-miR-182-3p,synovial sarcoma,0.8463651537895203
hsa-miR-1908-3p,synovial sarcoma,0.8463651537895203
hsa-miR-1978,synovial sarcoma,0.8463651537895203
hsa-miR-220c,primary central nervous system lymphomas,0.8463456034660339
hsa-miR-4725-5p,ovarian carcinoma,0.8463425636291504
hsa-miR-2277,ovarian carcinoma,0.8463425636291504
hsa-miR-320a,primary central nervous system lymphomas,0.8463369011878967
hsa-miR-486-3p,primary central nervous system lymphomas,0.8463297486305237
hsa-miR-6820-5p,primary central nervous system lymphomas,0.8463239669799805
hsa-miR-195,primary central nervous system lymphomas,0.8463199138641357
hsa-miR-654-5p,pilocytic astrocytoma,0.8462784886360168
hsa-miR-625-5p,synovial sarcoma,0.8462727665901184
hsa-miR-331-5p,synovial sarcoma,0.8462727665901184
hsa-miR-4439,synovial sarcoma,0.8462727665901184
hsa-miR-4767,synovial sarcoma,0.8462727665901184
hsa-miR-6764-3p,high grade serous papillary ovarian cancer,0.8462356328964233
hsa-miR-3651,high grade serous papillary ovarian cancer,0.8462356328964233
hsa-miR-489,rhabdomyosarcomas,0.8462308049201965
hsa-miR-628-3p,ovarian carcinoma,0.8462274670600891
hsa-miR-664*,ovarian carcinoma,0.8462274670600891
hsa-miR-632,miR-675-y,0.8461819887161255
hsa-miR-4667-3p,synovial sarcoma,0.8461770415306091
hsa-miR-5589-5p,synovial sarcoma,0.8461770415306091
hsa-miR-1283-1,synovial sarcoma,0.8461770415306091
hsa-miR-24-2,synovial sarcoma,0.8461770415306091
hsa-miR-1277-5p,synovial sarcoma,0.8461770415306091
hsa-miR-660-3p,synovial sarcoma,0.8461770415306091
hsa-miR-4713-5p,synovial sarcoma,0.8461770415306091
hsa-miR-519e*,synovial sarcoma,0.8461770415306091
hsa-miR-6797-5p,high grade serous papillary ovarian cancer,0.8461565375328064
hsa-miR-1278,ovarian carcinoma,0.8461546301841736
hsa-miR-4713-3p,ovarian carcinoma,0.8461546301841736
hsa-miR-1270,ovarian carcinoma,0.8461546301841736
hsa-miR-197-5p,ovarian carcinoma,0.8461546301841736
hsa-miR-3651,miR-675-y,0.8461353778839111
hsa-miR-3682-3p,synovial sarcoma,0.8461160659790039
hsa-miR-6758-5p,synovial sarcoma,0.8461160659790039
hsa-miR-674,high grade serous papillary ovarian cancer,0.846074104309082
hsa-miR-6884-3p,synovial sarcoma,0.846073567867279
hsa-miR-106b-3p,synovial sarcoma,0.846073567867279
hsa-miR-1295a,synovial sarcoma,0.846073567867279
hsa-miR-618,synovial sarcoma,0.846073567867279
hsa-miR-3128,synovial sarcoma,0.846073567867279
hsa-miR-544b,synovial sarcoma,0.846073567867279
hsa-miR-3681-3p,synovial sarcoma,0.846073567867279
hsa-miR-1193,rhabdomyosarcomas,0.8460628986358643
hsa-miR-1247-5p,miR-675-y,0.8460621237754822
hsa-miR-374b-5p,Leptomeningeal metastasis,0.8460568785667419
hsa-miR-215,synovial sarcoma,0.8460331559181213
hsa-miR-520a-3p,synovial sarcoma,0.8460331559181213
hsa-miR-7108-5p,synovial sarcoma,0.8460331559181213
hsa-miR-210-3p,synovial sarcoma,0.8460331559181213
hsa-miR-4715-3p,synovial sarcoma,0.8460331559181213
hsa-miR-222-3p,miR-675-y,0.84602952003479
hsa-miR-1182,miR-675-y,0.84602952003479
hsa-miR-885-3p,miR-675-y,0.84602952003479
hsa-miR-208b,miR-675-y,0.84602952003479
hsa-miR-138-2-3p,miR-675-y,0.8460100293159485
hsa-miR-1199-5p,miR-675-y,0.8460100293159485
hsa-miR-129-2-3p,synovial sarcoma,0.8459963798522949
hsa-miR-1226-3p,synovial sarcoma,0.8459963798522949
hsa-miR-4728-3p,synovial sarcoma,0.8459963798522949
hsa-miR-4731-3p,synovial sarcoma,0.8459963798522949
hsa-miR-6887-3p,synovial sarcoma,0.8459963798522949
hsa-miR-1247-5p,high grade serous papillary ovarian cancer,0.8459885716438293
hsa-miR-6740-5p,high grade serous papillary ovarian cancer,0.8459885716438293
hsa-miR-1909,miR-675-y,0.8459821939468384
hsa-miR-3129-3p,rhabdomyosarcomas,0.8459738492965698
hsa-miR-6777-5p,rhabdomyosarcomas,0.8459738492965698
hsa-miR-4499,synovial sarcoma,0.8459625840187073
hsa-miR-765,synovial sarcoma,0.8459625840187073
hsa-miR-6780a-5p,synovial sarcoma,0.8459625840187073
hsa-miR-145,ovarian carcinoma,0.8459578156471252
hsa-miR-6857-5p,ovarian carcinoma,0.8459578156471252
hsa-miR-6743-3p,ovarian carcinoma,0.8459578156471252
hsa-miR-6780a-3p,ovarian carcinoma,0.8459578156471252
hsa-miR-3664-5p,ovarian carcinoma,0.8459578156471252
hsa-miR-1978,ovarian carcinoma,0.8459578156471252
hsa-let-7b*,miR-675-y,0.8459533452987671
hsa-miR-5686,miR-675-y,0.8459533452987671
hsa-miR-593*,rhabdomyosarcomas,0.8459413051605225
hsa-miR-550b-3p,rhabdomyosarcomas,0.8459413051605225
hsa-miR-2116,rhabdomyosarcomas,0.8459413051605225
hsa-miR-5189,rhabdomyosarcomas,0.8459413051605225
hsa-miR-1182,rhabdomyosarcomas,0.8459413051605225
hsa-miR-885-3p,rhabdomyosarcomas,0.8459413051605225
hsa-miR-376a-2-5p,rhabdomyosarcomas,0.8459413051605225
hsa-miR-302e,synovial sarcoma,0.8459287285804749
hsa-miR-617,synovial sarcoma,0.8459287285804749
hsa-miR-4669,synovial sarcoma,0.8459287285804749
hsa-miR-27a-5p,synovial sarcoma,0.8459287285804749
hsa-miR-6732-3p,synovial sarcoma,0.8459287285804749
hsa-miR-5689,synovial sarcoma,0.8459287285804749
hsa-miR-7851-3p,synovial sarcoma,0.8459287285804749
hsa-miR-652-3p,synovial sarcoma,0.8459287285804749
hsa-miR-548d-2,synovial sarcoma,0.8459287285804749
hsa-miR-4292,synovial sarcoma,0.8459287285804749
hsa-miR-4662a-3p,synovial sarcoma,0.8459287285804749
hsa-miR-1256,synovial sarcoma,0.8458986878395081
hsa-miR-1911*,synovial sarcoma,0.8458986878395081
hsa-miR-216b-3p,synovial sarcoma,0.8458986878395081
hsa-miR-216a-5p,synovial sarcoma,0.8458986878395081
hsa-miR-6729-3p,miR-675-y,0.8458918333053589
hsa-miR-6847-3p,miR-675-y,0.8458918333053589
hsa-miR-4429,rhabdomyosarcomas,0.8458826541900635
hsa-miR-200a-3p,high grade serous papillary ovarian cancer,0.845866858959198
hsa-miR-222-3p,high grade serous papillary ovarian cancer,0.845866858959198
hsa-miR-516b,high grade serous papillary ovarian cancer,0.845866858959198
hsa-miR-193b-3p,high grade serous papillary ovarian cancer,0.845866858959198
hsa-miR-3689f,high grade serous papillary ovarian cancer,0.845866858959198
hsa-miR-7160-3p,high grade serous papillary ovarian cancer,0.845866858959198
hsa-miR-7110-3p,high grade serous papillary ovarian cancer,0.845866858959198
hsa-miR-1237-5p,high grade serous papillary ovarian cancer,0.845866858959198
hsa-miR-5197-3p,high grade serous papillary ovarian cancer,0.845866858959198
hsa-miR-6863,miR-675-y,0.845859169960022
hsa-miR-211-3p,miR-675-y,0.845859169960022
hsa-miR-501-5p,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-4520-2-3p,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-4330,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-196a-2,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-191-3p,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-30c-2-3p,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-3160-3p,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-5094,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-6873-5p,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-1587,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-1229-3p,castration-resistant prostate cancer,0.8458569049835205
hsa-miR-451b,synovial sarcoma,0.8458555340766907
hsa-miR-4271,synovial sarcoma,0.8458470702171326
hsa-miR-220c,synovial sarcoma,0.8458361625671387
hsa-miR-582,synovial sarcoma,0.8458361625671387
hsa-miR-6863,synovial sarcoma,0.8458361625671387
hsa-miR-6837-3p,synovial sarcoma,0.8458361625671387
hsa-miR-451,synovial sarcoma,0.8458274006843567
hsa-miR-4665-3p,synovial sarcoma,0.8458274006843567
hsa-miR-149-3p,synovial sarcoma,0.8458232879638672
hsa-miR-3137,synovial sarcoma,0.8458225727081299
hsa-miR-593-3p,synovial sarcoma,0.8458225727081299
hsa-miR-4645-5p,synovial sarcoma,0.8458225727081299
hsa-miR-5090,synovial sarcoma,0.8458225727081299
hsa-miR-4680-5p,synovial sarcoma,0.8458216786384583
hsa-miR-504-3p,synovial sarcoma,0.8458209037780762
hsa-miR-3135b,synovial sarcoma,0.8458209037780762
hsa-miR-6875-3p,synovial sarcoma,0.8458209037780762
hsa-miR-1909*,synovial sarcoma,0.8458201885223389
hsa-miR-493-3p,synovial sarcoma,0.8458201885223389
hsa-miR-6799-5p,synovial sarcoma,0.8458189368247986
hsa-miR-4419b,synovial sarcoma,0.8458189368247986
hsa-miR-5007-3p,synovial sarcoma,0.8458173274993896
hsa-miR-6077,synovial sarcoma,0.8458161950111389
hsa-miR-5691,synovial sarcoma,0.8458161950111389
hsa-miR-95-3p,synovial sarcoma,0.8458150625228882
hsa-miR-142,synovial sarcoma,0.8458144068717957
hsa-miR-1245b-5p,synovial sarcoma,0.8458144068717957
hsa-miR-888-5p,synovial sarcoma,0.8458144068717957
hsa-miR-6741-3p,synovial sarcoma,0.8458139896392822
hsa-miR-6884-5p,synovial sarcoma,0.8458139896392822
hsa-miR-6755-5p,synovial sarcoma,0.8458134531974792
hsa-miR-4799-5p,synovial sarcoma,0.8458134531974792
hsa-miR-1244,synovial sarcoma,0.8458128571510315
hsa-miR-371b-3p,synovial sarcoma,0.845812201499939
hsa-miR-433-3p,synovial sarcoma,0.8458104133605957
hsa-miR-876-5p,high grade serous papillary ovarian cancer,0.8458082675933838
hsa-miR-3609,rhabdomyosarcomas,0.8457906246185303
hsa-miR-4666a-3p,rhabdomyosarcomas,0.8457906246185303
hsa-miR-6822-5p,rhabdomyosarcomas,0.8457906246185303
hsa-miR-1262,rhabdomyosarcomas,0.8457906246185303
hsa-miR-33b*,diffuse large B-cell lymphoma,0.8457610011100769
hsa-miR-6071,diffuse large B-cell lymphoma,0.8457610011100769
hsa-miR-1914-5p,ovarian carcinoma,0.845757782459259
hsa-miR-425-3p,ovarian carcinoma,0.845757782459259
hsa-miRPlus-G1246-3p,ovarian carcinoma,0.845757782459259
hsa-let-7b-5p,ovarian carcinoma,0.845757782459259
hsa-miR-3924,ovarian carcinoma,0.845757782459259
hsa-miR-7843-5p,ovarian carcinoma,0.845755398273468
hsa-miR-6811-5p,ovarian carcinoma,0.845755398273468
hsa-miR-6840-3p,ovarian carcinoma,0.845755398273468
hsa-miR-639,ovarian carcinoma,0.845755398273468
hsa-miR-204-5p,ovarian carcinoma,0.845755398273468
hsa-miR-4728-5p,ovarian carcinoma,0.845755398273468
hsa-miR-451a,ovarian carcinoma,0.845755398273468
hsa-miR-1343-5p,ovarian carcinoma,0.845755398273468
hsa-miR-124*,ovarian carcinoma,0.845755398273468
hsa-miR-371a-3p,ovarian carcinoma,0.845755398273468
hsa-let-7d-3p,ovarian carcinoma,0.845755398273468
hsa-miR-135b-5p,ovarian carcinoma,0.845755398273468
hsa-miR-582-5p,ovarian carcinoma,0.845755398273468
hsa-miR-6810-3p,solid pseudopapillary neoplasm of pancreas,0.8457508087158203
hsa-miR-145-5p,miR-675-y,0.8457498550415039
hsa-miR-6782-3p,high grade serous papillary ovarian cancer,0.8457161784172058
hsa-miR-711,miR-675-y,0.8457096219062805
hsa-miR-4656,miR-675-y,0.8457096219062805
hsa-miR-218-1-3p,castration-resistant prostate cancer,0.8456830978393555
hsa-miR-1227-5p,castration-resistant prostate cancer,0.8456830978393555
hsa-miR-5088-3p,castration-resistant prostate cancer,0.8456830978393555
hsa-miR-607,castration-resistant prostate cancer,0.8456830978393555
hsa-miR-101-5p,castration-resistant prostate cancer,0.8456830978393555
hsa-miR-1284,castration-resistant prostate cancer,0.8456830978393555
hsa-miR-27a-3p,castration-resistant prostate cancer,0.8456830978393555
hsa-miR-127-3p,miR-675-y,0.8456652164459229
hsa-miR-519c-3p,miR-675-y,0.8456652164459229
hsa-miR-4787-3p,miR-675-y,0.8456171751022339
hsa-miR-340-5p,rhabdomyosarcomas,0.8455945253372192
hsa-miR-767,miR-675-y,0.8455675840377808
hsa-miR-4462,miR-675-y,0.8455675840377808
hsa-miR-4650-3p,miR-675-y,0.8455675840377808
hsa-miRPlus-J1002,ovarian carcinoma,0.8455515503883362
hsa-miR-302b-3p,ovarian carcinoma,0.8455515503883362
hsa-miR-654,Leptomeningeal metastasis,0.8455506563186646
hsa-miR-551b-3p,high grade serous papillary ovarian cancer,0.84552001953125
hsa-miR-3149,high grade serous papillary ovarian cancer,0.84552001953125
hsa-miR-378a-5p,high grade serous papillary ovarian cancer,0.84552001953125
hsa-miR-186*,miR-675-y,0.8455171585083008
hsa-miR-28-5p,miR-675-y,0.8455171585083008
hsa-miR-646,miR-142-y,0.8455142974853516
hsa-miR-922,miR-142-y,0.8455142974853516
hsa-miR-130b-3p,miR-142-y,0.8455142974853516
hsa-miR-1224-3p,miR-142-y,0.8455142974853516
hsa-miR-3934,miR-142-y,0.8455142974853516
hsa-miR-6081,miR-142-y,0.8455142974853516
hsa-miR-6830-3p,miR-142-y,0.8455142974853516
hsa-miR-518c*,miR-142-y,0.8455142974853516
hsa-miR-4280,miR-142-y,0.8455142974853516
hsa-miR-4266,miR-142-y,0.8455142974853516
hsa-miR-28-3p,pilocytic astrocytoma,0.8454838395118713
hsa-miR-20b,papillary thyroid carcinoma,0.8454696536064148
hsa-miR-3605-3p,synovial sarcoma,0.845468282699585
hsa-miR-140,synovial sarcoma,0.845468282699585
hsa-miR-30e-3p,synovial sarcoma,0.845468282699585
hsa-miR-4679,synovial sarcoma,0.845468282699585
hsa-miR-154*,papillary thyroid carcinoma,0.8454679846763611
hsa-miR-092,high grade serous papillary ovarian cancer,0.8454660177230835
hsa-miR-181d-5p,high grade serous papillary ovarian cancer,0.8454660177230835
hsa-miR-6790-5p,high grade serous papillary ovarian cancer,0.8454660177230835
hsa-miR-349,miR-675-y,0.8454644680023193
hsa-miR-101-5p,primary central nervous system lymphomas,0.845443606376648
hsa-miR-663b,pilocytic astrocytoma,0.8454170227050781
hsa-miR-3919,high grade serous papillary ovarian cancer,0.8454144597053528
hsa-miR-6825-3p,high grade serous papillary ovarian cancer,0.8454144597053528
hsa-miR-4713-5p,miR-675-y,0.8454124331474304
hsa-miR-33a-5p,castration-resistant prostate cancer,0.8454001545906067
hsa-miR-19b-2*,castration-resistant prostate cancer,0.8454001545906067
hsa-miR-431-5p,castration-resistant prostate cancer,0.8454001545906067
hsa-miR-150*,castration-resistant prostate cancer,0.8454001545906067
hsa-miR-378,castration-resistant prostate cancer,0.8454001545906067
hsa-miR-616-5p,castration-resistant prostate cancer,0.8454001545906067
hsa-miR-122-3p,rhabdomyosarcomas,0.8453782200813293
hsa-miR-3185,miR-675-y,0.8453572988510132
hsa-miR-766,ovarian carcinoma,0.8453323841094971
hsa-miR-548am-3p,ovarian carcinoma,0.8453323841094971
hsa-miR-7161-3p,ovarian carcinoma,0.8453323841094971
hsa-miR-6736-3p,ovarian carcinoma,0.8453323841094971
hsa-miR-335*,ovarian carcinoma,0.8453323841094971
hsa-miR-200a*,ovarian carcinoma,0.8453323841094971
hsa-miR-4661-3p,ovarian carcinoma,0.8453323841094971
hsa-miR-92a-3p,ovarian carcinoma,0.8453323841094971
hsa-miR-199b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8453295826911926
hsa-miR-6836-3p,miR-675-y,0.8452987670898438
hsa-miR-148a-5p,miR-675-y,0.8452987670898438
hsa-miR-3664-5p,miR-675-y,0.8452987670898438
hsa-miR-3607-3p,miR-675-y,0.8452705144882202
hsa-miR-125b-5p,miR-675-y,0.8452705144882202
hsa-miR-6729-5p,miR-675-y,0.8452705144882202
hsa-miR-297-1,miR-675-y,0.8452705144882202
hsa-miR-202-3p,miR-675-y,0.8452705144882202
hsa-miR-450a,rhabdomyosarcomas,0.8452622890472412
hsa-miR-3180-5p,diffuse large B-cell lymphoma,0.8452513217926025
hsa-miR-1224-3p,diffuse large B-cell lymphoma,0.8452513217926025
hsa-miR-196a-5p,diffuse large B-cell lymphoma,0.8452513217926025
hsa-miR-4490,ovarian carcinoma,0.8452486991882324
hsa-miR-519a,ovarian carcinoma,0.8452486991882324
hsa-miR-542-3p,ovarian carcinoma,0.8452486991882324
hsa-miR-616-3p,ovarian carcinoma,0.8452486991882324
hsa-miR-6760-5p,ovarian carcinoma,0.8452486991882324
hsa-miR-516-1,miR-675-y,0.8452374339103699
hsa-miR-516b*,miR-675-y,0.8452374339103699
hsa-miR-1207-5p,miR-675-y,0.8452374339103699
hsa-miR-181a*,diffuse large B-cell lymphoma,0.84523606300354
hsa-miR-558,diffuse large B-cell lymphoma,0.84523606300354
hsa-miR-99a-5p,diffuse large B-cell lymphoma,0.84523606300354
hsa-miR-8088,diffuse large B-cell lymphoma,0.84523606300354
hsa-miR-139-3p,miR-675-y,0.845173716545105
hsa-miRPlus-J1002,miR-675-y,0.845173716545105
hsa-miR-4721,miR-675-y,0.845173716545105
hsa-miRPlus-C1066,rhabdomyosarcomas,0.8451707363128662
hsa-miR-3678-3p,rhabdomyosarcomas,0.8451707363128662
hsa-miR-1247,rhabdomyosarcomas,0.8451707363128662
hsa-miR-5588-5p,high grade serous papillary ovarian cancer,0.8451287150382996
hsa-miR-664a-3p,high grade serous papillary ovarian cancer,0.8451287150382996
hsa-miR-6783-3p,high grade serous papillary ovarian cancer,0.8451287150382996
hsa-miR-514,ovarian carcinoma,0.8451060652732849
hsa-miR-548ac,ovarian carcinoma,0.8451060652732849
hsa-miR-412,ovarian carcinoma,0.8451060652732849
hsa-miR-646,"Luminal B,triple negative",0.8450832366943359
hsa-miR-3180-5p,"Luminal B,triple negative",0.8450832366943359
hsa-miR-3663-5p,"Luminal B,triple negative",0.8450832366943359
hsa-miR-518c*,"Luminal B,triple negative",0.8450832366943359
hsa-miR-521,diffuse large B-cell lymphoma,0.845032811164856
hsa-miR-6738-5p,diffuse large B-cell lymphoma,0.845032811164856
hsa-miR-518a,diffuse large B-cell lymphoma,0.845032811164856
hsa-miR-4436a,diffuse large B-cell lymphoma,0.845032811164856
hsa-let-7b_c,miR-675-y,0.8450321555137634
hsa-miR-3653,miR-675-y,0.8450321555137634
hsa-miR-4783-5p,rhabdomyosarcomas,0.8450138568878174
hsa-miR-148b-3p,rhabdomyosarcomas,0.8450138568878174
hsa-miR-5687,ovarian carcinoma,0.8449788093566895
hsa-miR-1914,ovarian carcinoma,0.8449788093566895
hsa-miR-517a-3p,ovarian carcinoma,0.8449788093566895
hsa-miR-655,ovarian carcinoma,0.8449788093566895
hsa-miR-5100,ovarian carcinoma,0.8449788093566895
hsa-miR-187-5p,ovarian carcinoma,0.8449788093566895
hsa-miR-509-5p,ovarian carcinoma,0.8449788093566895
hsa-miR-320c,ovarian carcinoma,0.8449788093566895
hsa-miR-1255b-2,ovarian carcinoma,0.8449788093566895
hsa-miR-1205,ovarian carcinoma,0.8449788093566895
hsa-miR-23b-3p,ovarian carcinoma,0.8449788093566895
hsa-miR-4299,synovial sarcoma,0.8449528813362122
hsa-miR-545-5p,synovial sarcoma,0.8449528813362122
hsa-miR-3173,synovial sarcoma,0.8449528813362122
hsa-miR-7157-3p,synovial sarcoma,0.8449528813362122
hsa-miR-4716-5p,synovial sarcoma,0.8449528813362122
hsa-miR-615,primary central nervous system lymphomas,0.8449520468711853
hsa-miR-3121,primary central nervous system lymphomas,0.8449520468711853
hsa-miR-1304,miR-675-y,0.8449475765228271
hsa-miR-18a*,miR-675-y,0.8449475765228271
hsa-miR-4687-3p,high grade serous papillary ovarian cancer,0.8449392318725586
hsa-miR-4724-5p,high grade serous papillary ovarian cancer,0.8449392318725586
hsa-miR-5007-3p,Leptomeningeal metastasis,0.8449122905731201
hsa-miR-343,rhabdomyosarcomas,0.8448804616928101
hsa-miR-324-3p,rhabdomyosarcomas,0.8448804616928101
hsa-miR-320e,ovarian carcinoma,0.8448596596717834
hsa-miR-1915*,ovarian carcinoma,0.8448596596717834
hsa-miR-7151-3p,ovarian carcinoma,0.8448596596717834
hsa-miR-4730,ovarian carcinoma,0.8448596596717834
hsa-miR-634,ovarian carcinoma,0.8448596596717834
hsa-miR-150-5p,ovarian carcinoma,0.8448596596717834
hsa-miR-4680-3p,ovarian carcinoma,0.8448596596717834
hsa-miR-182-5p,ovarian carcinoma,0.8448596596717834
hsa-miR-944,ovarian carcinoma,0.8448596596717834
hsa-miR-124-5p,ovarian carcinoma,0.8448596596717834
hsa-miR-4540,ovarian carcinoma,0.8448596596717834
hsa-miR-6867-5p,ovarian carcinoma,0.8448596596717834
hsa-miR-548v,ovarian carcinoma,0.8448596596717834
hsa-miR-143-3p,ovarian carcinoma,0.8448596596717834
hsa-miR-524-3p,miR-675-y,0.8448517918586731
hsa-miR-25-5p,miR-675-y,0.8448517918586731
hsa-miR-30b*,miR-675-y,0.8448517918586731
hsa-miR-3136-5p,high grade serous papillary ovarian cancer,0.8448057174682617
hsa-miR-33b-3p,high grade serous papillary ovarian cancer,0.8448057174682617
hsa-miR-8074,miR-675-y,0.8447774648666382
hsa-miR-4324,pilocytic astrocytoma,0.8447664976119995
hsa-miR-6746-3p,miR-675-y,0.8447485566139221
hsa-miR-885-5p,miR-675-y,0.8447485566139221
hsa-miR-548h-3p,miR-675-y,0.8447485566139221
hsa-miR-6133,miR-675-y,0.8447485566139221
hsa-miR-4466,rhabdomyosarcomas,0.8447363376617432
hsa-miR-3607-5p,"squamous cell breast carcinoma, acantholytic variant",0.8447247743606567
hsa-miR-668-3p,"squamous cell breast carcinoma, acantholytic variant",0.8447247743606567
hsa-miR-660,"squamous cell breast carcinoma, acantholytic variant",0.8447247743606567
hsa-miR-191-3p,"squamous cell breast carcinoma, acantholytic variant",0.8447247743606567
hsa-miR-6873-5p,"squamous cell breast carcinoma, acantholytic variant",0.8447247743606567
hsa-miR-1229-3p,"squamous cell breast carcinoma, acantholytic variant",0.8447247743606567
hsa-miR-584-5p,diffuse large B-cell lymphoma,0.8446648120880127
hsa-miR-4279,diffuse large B-cell lymphoma,0.8446648120880127
hsa-miR-196b-3p,high grade serous papillary ovarian cancer,0.8446614146232605
hsa-miR-513-5p,high grade serous papillary ovarian cancer,0.8446614146232605
hsa-miR-6882-3p,high grade serous papillary ovarian cancer,0.8446614146232605
hsa-miR-4802-5p,high grade serous papillary ovarian cancer,0.8446614146232605
hsa-miR-211-5p,high grade serous papillary ovarian cancer,0.8446614146232605
hsa-miR-1260b,miR-675-y,0.8446345329284668
hsa-miR-5692b,miR-675-y,0.8446345329284668
hsa-miR-1913,miR-675-y,0.8446345329284668
hsa-miR-187*,ovarian carcinoma,0.8446269035339355
hsa-miR-8076,ovarian carcinoma,0.8446269035339355
hsa-miR-1236-3p,ovarian carcinoma,0.8446269035339355
hsa-miR-6793-3p,ovarian carcinoma,0.8446269035339355
hsa-miR-4467,ovarian carcinoma,0.8446269035339355
hsa-miR-30b*,ovarian carcinoma,0.8446269035339355
hsa-miR-6730-5p,ovarian carcinoma,0.8446269035339355
hsa-miR-4483,aryngeal squamous cell carcinoma,0.8445786237716675
hsa-miR-374b*,pilocytic astrocytoma,0.844568133354187
hsa-miR-105*,pilocytic astrocytoma,0.844568133354187
hsa-miR-6769a-5p,miR-675-y,0.8445308208465576
hsa-miR-3174,miR-675-y,0.8445308208465576
hsa-miR-103a-3p,miR-675-y,0.8445308208465576
hsa-miR-199a-2,high grade serous papillary ovarian cancer,0.8445097208023071
hsa-miR-4726-3p,high grade serous papillary ovarian cancer,0.8445097208023071
hsa-miR-3129-3p,Leptomeningeal metastasis,0.8444967269897461
hsa-miR-937,papillary thyroid carcinoma,0.8444945216178894
hsa-miR-26a-1,miR-675-y,0.8444851636886597
hsa-miR-559,miR-675-y,0.8444851636886597
hsa-miR-6862-5p,miR-675-y,0.8444851636886597
hsa-miR-26a-1*,miR-675-y,0.8444851636886597
hsa-miR-488*,ovarian carcinoma,0.844469428062439
hsa-miR-1203,ovarian carcinoma,0.844469428062439
hsa-miR-6730-3p,ovarian carcinoma,0.844469428062439
hsa-miR-513a-1,ovarian carcinoma,0.844469428062439
hsa-miR-493,ovarian carcinoma,0.844469428062439
hsa-miR-505-3p,ovarian carcinoma,0.844469428062439
hsa-miR-103a-2-5p,ovarian carcinoma,0.844469428062439
hsa-miR-3618,ovarian carcinoma,0.844469428062439
hsa-miR-5047,ovarian carcinoma,0.844469428062439
hsa-miR-4802-3p,ovarian carcinoma,0.844469428062439
hsa-miR-149,ovarian carcinoma,0.844469428062439
hsa-miR-1273c,ovarian carcinoma,0.844469428062439
hsa-miR-2909,ovarian carcinoma,0.844469428062439
hsa-miR-3140-3p,ovarian carcinoma,0.844469428062439
hsa-miR-10b-3p,ovarian carcinoma,0.844469428062439
hsa-miR-324,ovarian carcinoma,0.844469428062439
hsa-miR-125b-2,ovarian carcinoma,0.844469428062439
hsa-miR-1238,ovarian carcinoma,0.844469428062439
hsa-miR-3122,ovarian carcinoma,0.844469428062439
hsa-miR-3157,ovarian carcinoma,0.844469428062439
hsa-miR-3667-3p,Leptomeningeal metastasis,0.8444640040397644
hsa-miR-3605-5p,miR-675-y,0.8444463014602661
hsa-miR-1295b-5p,miR-675-y,0.8444463014602661
hsa-miR-1185-2-3p,miR-675-y,0.8444463014602661
hsa-miR-29b-3p,miR-675-y,0.8444463014602661
hsa-miR-578,miR-675-y,0.8444463014602661
hsa-miR-490,miR-675-y,0.8444463014602661
hsa-miR-5681a,miR-675-y,0.8444463014602661
hsa-miR-548az-5p,miR-675-y,0.8444463014602661
hsa-miR-4277,miR-675-y,0.8444463014602661
hsa-miR-9-3p,rhabdomyosarcomas,0.8444249033927917
hsa-miR-532-5p,castration-resistant prostate cancer,0.8444163799285889
hsa-miR-33b*,castration-resistant prostate cancer,0.8444163799285889
hsa-miR-4661-5p,castration-resistant prostate cancer,0.8444163799285889
hsa-miR-30e-3p,castration-resistant prostate cancer,0.8444163799285889
hsa-miR-30b-3p,castration-resistant prostate cancer,0.8444163799285889
hsa-miR-548w,castration-resistant prostate cancer,0.8444163799285889
hsa-miR-520g,castration-resistant prostate cancer,0.8444163799285889
hsa-miR-4679,castration-resistant prostate cancer,0.8444163799285889
hsa-miR-580-5p,castration-resistant prostate cancer,0.8444163799285889
hsa-miR-6881-5p,ovarian carcinoma,0.8443962335586548
hsa-miR-4465,ovarian carcinoma,0.8443962335586548
hsa-miR-3679-5p,ovarian carcinoma,0.8443962335586548
hsa-miR-6807-3p,ovarian carcinoma,0.8443962335586548
hsa-miR-548p,ovarian carcinoma,0.8443962335586548
hsa-miR-5096,ovarian carcinoma,0.8443962335586548
hsa-miR-3184-5p,ovarian carcinoma,0.8443962335586548
hsa-miR-124-3p,ovarian carcinoma,0.8443962335586548
hsa-let-7g*,ovarian carcinoma,0.8443962335586548
hsa-miR-1226-5p,miR-675-y,0.8443766236305237
hsa-miR-3187-3p,miR-675-y,0.8443766236305237
hsa-miR-4755-5p,miR-675-y,0.8443766236305237
hsa-miR-1184,miR-675-y,0.8443766236305237
hsa-miR-1286,miR-675-y,0.8443766236305237
hsa-miR-1268,miR-675-y,0.8443766236305237
hsa-miR-145*,miR-675-y,0.8443671464920044
hsa-miR-5047,miR-675-y,0.8443671464920044
hsa-miR-589-3p,miR-675-y,0.8443671464920044
hsa-miR-376a,miR-675-y,0.8443671464920044
hsa-miR-333,rhabdomyosarcomas,0.8443577289581299
hsa-miR-595,rhabdomyosarcomas,0.8443577289581299
hsa-miR-9-3p,high grade serous papillary ovarian cancer,0.8443498611450195
hsa-miR-4433a-3p,high grade serous papillary ovarian cancer,0.8443498611450195
hsa-miR-3195,miR-675-y,0.8443470001220703
hsa-miR-223*,miR-675-y,0.8443470001220703
hsa-miR-212,miR-675-y,0.8443470001220703
hsa-miR-561,miR-675-y,0.8443470001220703
hsa-miR-6817-3p,miR-675-y,0.8443470001220703
hsa-miR-1471,miR-675-y,0.8443470001220703
hsa-miR-1262,Leptomeningeal metastasis,0.8443120718002319
hsa-miR-921,follicular thyroid carcinoma,0.8442976474761963
hsa-miR-4495,high grade serous papillary ovarian cancer,0.8442826867103577
hsa-miR-106a.1,high grade serous papillary ovarian cancer,0.8442826867103577
hsa-miR-4723-5p,high grade serous papillary ovarian cancer,0.8442826867103577
hsa-miR-106a-5p,high grade serous papillary ovarian cancer,0.8442826867103577
hsa-miR-452-3p,high grade serous papillary ovarian cancer,0.8442826867103577
hsa-miR-30b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8442652821540833
hsa-miR-759,"squamous cell breast carcinoma, acantholytic variant",0.8442599177360535
hsa-miR-550a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8442599177360535
hsa-miR-134-5p,"squamous cell breast carcinoma, acantholytic variant",0.8442599177360535
hsa-miR-7844-5p,"squamous cell breast carcinoma, acantholytic variant",0.8442599177360535
hsa-miR-3124,"squamous cell breast carcinoma, acantholytic variant",0.8442599177360535
hsa-miR-4325,"squamous cell breast carcinoma, acantholytic variant",0.8442599177360535
hsa-miR-513a-5p,rhabdomyosarcomas,0.8442562818527222
hsa-miR-296-3p,rhabdomyosarcomas,0.8442562818527222
hsa-miR-495-3p,rhabdomyosarcomas,0.8442562818527222
hsa-miR-365,rhabdomyosarcomas,0.8442562818527222
hsa-miR-7-1*,breast cancer brain metastasis,0.8442423343658447
hsa-miRPlus-G1065-5p,breast cancer brain metastasis,0.8442423343658447
hsa-miR-550a-3-5p,breast cancer brain metastasis,0.8442423343658447
hsa-miR-181a-3p,breast cancer brain metastasis,0.8442423343658447
hsa-miR-4687-5p,breast cancer brain metastasis,0.8442423343658447
hsa-miR-654-5p,rhabdomyosarcomas,0.8442381024360657
hsa-miR-628-3p,rhabdomyosarcomas,0.8442381024360657
hsa-miR-150*,rhabdomyosarcomas,0.8442381024360657
hsa-let-7c_c,ovarian carcinoma,0.8442099690437317
hsa-miR-30a*,ovarian carcinoma,0.8442099690437317
hsa-miR-1324,ovarian carcinoma,0.8442099690437317
hsa-miR-517b,ovarian carcinoma,0.8442099690437317
hsa-miR-6785-5p,ovarian carcinoma,0.8442099690437317
hsa-miR-1249,ovarian carcinoma,0.8442099690437317
hsa-miR-200b*,ovarian carcinoma,0.8442099690437317
hsa-miR-16-1-3p,ovarian carcinoma,0.8442099690437317
hsa-miR-4779,ovarian carcinoma,0.8442099690437317
hsa-miR-4304,ovarian carcinoma,0.8442099690437317
hsa-miR-526b-3p,ovarian carcinoma,0.8442099690437317
hsa-miR-365a-3p,ovarian carcinoma,0.8442099690437317
hsa-miR-499b-5p,ovarian carcinoma,0.8442099690437317
hsa-miR-769-5p,ovarian carcinoma,0.8442099690437317
hsa-miR-1471,ovarian carcinoma,0.8442099690437317
hsa-miR-6884-3p,high grade serous papillary ovarian cancer,0.8441811800003052
hsa-miR-106b-3p,high grade serous papillary ovarian cancer,0.8441811800003052
hsa-miR-518a-3p,high grade serous papillary ovarian cancer,0.8441811800003052
hsa-miR-365,high grade serous papillary ovarian cancer,0.8441811800003052
hsa-miR-518a-5p,high grade serous papillary ovarian cancer,0.8441811800003052
hsa-miR-6759-3p,high grade serous papillary ovarian cancer,0.8441811800003052
hsa-miR-2114-5p,high grade serous papillary ovarian cancer,0.8441811800003052
hsa-miR-325,ovarian carcinoma,0.8441760540008545
hsa-miR-2115*,ovarian carcinoma,0.8441760540008545
hsa-miR-526b-5p,ovarian carcinoma,0.8441760540008545
hsa-miR-3658,ovarian carcinoma,0.8441760540008545
hsa-miR-1260b,ovarian carcinoma,0.8441760540008545
hsa-miR-3192-3p,ovarian carcinoma,0.8441760540008545
hsa-miR-1909-3p,ovarian carcinoma,0.8441760540008545
hsa-miR-193b*,ovarian carcinoma,0.8441760540008545
hsa-miR-500a-3p,ovarian carcinoma,0.8441760540008545
hsa-miR-936,ovarian carcinoma,0.8441760540008545
hsa-miR-6776-5p,ovarian carcinoma,0.8441760540008545
hsa-miR-4635,ovarian carcinoma,0.8441760540008545
hsa-miR-363-3p,ovarian carcinoma,0.8441760540008545
hsa-miR-4655-3p,ovarian carcinoma,0.8441760540008545
hsa-miR-7158-5p,ovarian carcinoma,0.8441760540008545
hsa-let-7d*,miR-675-y,0.8441129326820374
hsa-miR-6880-5p,ovarian carcinoma,0.8440892696380615
hsa-miR-455-5p,ovarian carcinoma,0.8440892696380615
hsa-miR-376c-5p,ovarian carcinoma,0.8440892696380615
hsa-miR-6512-5p,ovarian carcinoma,0.8440892696380615
hsa-miR-1238-5p,ovarian carcinoma,0.8440892696380615
hsa-miR-6851-5p,ovarian carcinoma,0.8440892696380615
hsa-miR-4437,ovarian carcinoma,0.8440892696380615
hsa-miR-376c,ovarian carcinoma,0.8440892696380615
hsa-miR-4755-5p,ovarian carcinoma,0.8440892696380615
hsa-miR-3132,ovarian carcinoma,0.8440892696380615
hsa-miR-517*,ovarian carcinoma,0.8440892696380615
hsa-miR-6134,ovarian carcinoma,0.8440892696380615
hsa-miR-6806-5p,ovarian carcinoma,0.8440783023834229
hsa-miR-29b-1-5p,ovarian carcinoma,0.8440783023834229
hsa-miR-548l,ovarian carcinoma,0.8440783023834229
hsa-miR-4708-5p,ovarian carcinoma,0.8440783023834229
hsa-miRPlus-A1073,ovarian carcinoma,0.8440636992454529
hsa-miR-508-5p,ovarian carcinoma,0.8440636992454529
hsa-miR-3202,ovarian carcinoma,0.8440636992454529
hsa-miR-1225-5p,ovarian carcinoma,0.8440636992454529
hsa-miR-3605-5p,ovarian carcinoma,0.8440636992454529
hsa-miR-663,ovarian carcinoma,0.8440636992454529
hsa-miR-194,ovarian carcinoma,0.8440636992454529
hsa-miR-1185-2-3p,ovarian carcinoma,0.8440636992454529
hsa-miR-500,ovarian carcinoma,0.8440636992454529
hsa-miR-3689a-3p,ovarian carcinoma,0.8440636992454529
hsa-miR-302c-5p,ovarian carcinoma,0.8440636992454529
hsa-miR-875-5p,ovarian carcinoma,0.8440636992454529
hsa-miR-1307-3p,ovarian carcinoma,0.8440636992454529
hsa-miR-568,ovarian carcinoma,0.8440636992454529
hsa-miR-2682-5p,ovarian carcinoma,0.8440636992454529
hsa-miR-941-1,ovarian carcinoma,0.8440636992454529
hsa-miR-6820-3p,ovarian carcinoma,0.8440636992454529
hsa-miR-3677-3p,synovial sarcoma,0.8440244793891907
hsa-miR-4735-5p,synovial sarcoma,0.8440244793891907
hsa-miR-5190,synovial sarcoma,0.8440244793891907
hsa-miR-516a-3p,high grade serous papillary ovarian cancer,0.8439981341362
hsa-miR-10a-3p,sarcoma,0.8439888954162598
hsa-miR-5004-3p,sarcoma,0.8439888954162598
hsa-miR-503-3p,sarcoma,0.8439888954162598
hsa-miR-471,pilocytic astrocytoma,0.8439381718635559
hsa-miR-3677-3p,ovarian carcinoma,0.8439339995384216
hsa-miR-1200,ovarian carcinoma,0.8439339995384216
hsa-miR-633,rhabdomyosarcomas,0.8438938856124878
hsa-miR-3193,rhabdomyosarcomas,0.8438938856124878
hsa-miR-3145-5p,high grade serous papillary ovarian cancer,0.8438186645507812
hsa-miR-6769b-5p,Leptomeningeal metastasis,0.8437796831130981
hsa-miR-5580-5p,synovial sarcoma,0.8437111377716064
hsa-miR-519d,synovial sarcoma,0.8437111377716064
hsa-miR-449b-5p,synovial sarcoma,0.8437111377716064
hsa-miR-3123,synovial sarcoma,0.8437111377716064
hsa-miR-5004-3p,synovial sarcoma,0.8437111377716064
hsa-miR-1225,synovial sarcoma,0.8437111377716064
hsa-miR-5590-5p,synovial sarcoma,0.8437111377716064
hsa-miR-4786-5p,synovial sarcoma,0.8437111377716064
hsa-miR-340,pilocytic astrocytoma,0.8437101244926453
hsa-miR-548aq-5p,rhabdomyosarcomas,0.8437035083770752
hsa-miR-7,papillary thyroid carcinoma,0.8436881899833679
hsa-miR-6069,solid pseudopapillary neoplasm of pancreas,0.843632698059082
hsa-miR-516-5p,solid pseudopapillary neoplasm of pancreas,0.843632698059082
hsa-miR-377-3p,high grade serous papillary ovarian cancer,0.8436282873153687
hsa-miR-6814-5p,high grade serous papillary ovarian cancer,0.8436282873153687
hsa-miR-1270,high grade serous papillary ovarian cancer,0.8436282873153687
hsa-miR-202-5p,miR-142-y,0.843604326248169
hsa-miR-24-1*,miR-142-y,0.843604326248169
hsa-miR-588,Leptomeningeal metastasis,0.843529224395752
hsa-miR-145,rhabdomyosarcomas,0.8435041308403015
hsa-miR-105*,rhabdomyosarcomas,0.8435041308403015
hsa-miR-935,rhabdomyosarcomas,0.8435041308403015
hsa-miR-517c,rhabdomyosarcomas,0.8435041308403015
hsa-miR-502-5p,brain cancer,0.8435035943984985
hsa-miR-590-3p,pilocytic astrocytoma,0.8434619903564453
hsa-miR-935,high grade serous papillary ovarian cancer,0.8434287905693054
hsa-miR-4707-3p,high grade serous papillary ovarian cancer,0.8434287905693054
hsa-miR-767-3p,high grade serous papillary ovarian cancer,0.8434287905693054
hsa-miR-6776-3p,high grade serous papillary ovarian cancer,0.8434287905693054
hsa-miR-6786-3p,high grade serous papillary ovarian cancer,0.8434287905693054
hsa-miR-2277-5p,high grade serous papillary ovarian cancer,0.8434287905693054
hsa-miR-500b-3p,high grade serous papillary ovarian cancer,0.8434287905693054
hsa-miR-448,papillary thyroid carcinoma,0.8434255719184875
hsa-miR-4738-5p,ovarian carcinoma,0.8434041142463684
hsa-miR-3170,ovarian carcinoma,0.8434041142463684
hsa-miR-6812-5p,Leptomeningeal metastasis,0.8433948159217834
hsa-miR-516-3p,brain cancer,0.8433049917221069
hsa-miR-4662a-5p,rhabdomyosarcomas,0.8433014750480652
hsa-miR-6507-5p,rhabdomyosarcomas,0.8433014750480652
hsa-miR-645,rhabdomyosarcomas,0.8433014750480652
hsa-miR-676-5p,rhabdomyosarcomas,0.8433014750480652
hsa-miRPlus-G1246-3p,rhabdomyosarcomas,0.8433014750480652
hsa-miR-520d-3p,rhabdomyosarcomas,0.8432990908622742
hsa-miR-516b*,rhabdomyosarcomas,0.8432990908622742
hsa-miR-4466,papillary thyroid carcinoma,0.8432803750038147
hsa-miR-606,"squamous cell breast carcinoma, acantholytic variant",0.8432756066322327
hsa-miR-6507-3p,"squamous cell breast carcinoma, acantholytic variant",0.8432756066322327
hsa-miR-30b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8432756066322327
hsa-miR-29b-2*,brain cancer,0.843256950378418
hsa-miR-518d,papillary thyroid carcinoma,0.8432483673095703
hsa-miR-4257,pilocytic astrocytoma,0.8432274460792542
hsa-miR-138-1*,high grade serous papillary ovarian cancer,0.8432260751724243
hsa-miR-5002-5p,high grade serous papillary ovarian cancer,0.8432260751724243
hsa-miR-4447,high grade serous papillary ovarian cancer,0.8432260751724243
hsa-miR-548ar-3p,high grade serous papillary ovarian cancer,0.8432260751724243
hsa-miR-6804-5p,high grade serous papillary ovarian cancer,0.8432260751724243
hsa-miR-411,high grade serous papillary ovarian cancer,0.8432260751724243
hsa-miR-136-5p,high grade serous papillary ovarian cancer,0.8432260751724243
hsa-miR-365*,high grade serous papillary ovarian cancer,0.8432260751724243
hsa-miR-7843-5p,high grade serous papillary ovarian cancer,0.8432237505912781
hsa-miR-639,high grade serous papillary ovarian cancer,0.8432237505912781
hsa-miR-194-5p,high grade serous papillary ovarian cancer,0.8432237505912781
hsa-miR-371a-3p,high grade serous papillary ovarian cancer,0.8432237505912781
hsa-miR-520d-5p,high grade serous papillary ovarian cancer,0.8432237505912781
hsa-miR-19a*,"Luminal B,triple negative",0.8431689143180847
hsa-miR-143-5p,"Luminal B,triple negative",0.8431689143180847
hsa-miR-3169,"Luminal B,triple negative",0.8431689143180847
hsa-miR-4455,"Luminal B,triple negative",0.8431689143180847
hsa-miR-4737,diffuse large B-cell lymphoma,0.8431520462036133
hsa-miR-518c,diffuse large B-cell lymphoma,0.8431520462036133
hsa-miR-1226-3p,papillary thyroid carcinoma,0.8431275486946106
hsa-miR-4264,rhabdomyosarcomas,0.8430926203727722
hsa-miR-4298,rhabdomyosarcomas,0.8430926203727722
hsa-miR-642a-5p,rhabdomyosarcomas,0.8430926203727722
hsa-miR-4315,rhabdomyosarcomas,0.8430926203727722
hsa-miR-3120-5p,rhabdomyosarcomas,0.8430926203727722
hsa-miR-3170,sarcoma,0.8430651426315308
hsa-miR-566,solid pseudopapillary neoplasm of pancreas,0.8430225253105164
hsa-miR-483,brain cancer,0.8430212140083313
hsa-miR-4449,high grade serous papillary ovarian cancer,0.843017041683197
hsa-miR-224-5p,high grade serous papillary ovarian cancer,0.843017041683197
hsa-miR-5581-5p,high grade serous papillary ovarian cancer,0.843017041683197
hsa-miR-676-3p,high grade serous papillary ovarian cancer,0.843017041683197
hsa-let-7g-3p,high grade serous papillary ovarian cancer,0.843017041683197
hsa-miR-373-3p,high grade serous papillary ovarian cancer,0.843017041683197
hsa-miR-4490,diffuse large B-cell lymphoma,0.8429977893829346
hsa-miR-519a,diffuse large B-cell lymphoma,0.8429977893829346
hsa-miR-525-5p,diffuse large B-cell lymphoma,0.8429977893829346
hsa-miR-181a-1,diffuse large B-cell lymphoma,0.8429977893829346
hsa-miR-1468,diffuse large B-cell lymphoma,0.8429977893829346
hsa-miR-154*,castration-resistant prostate cancer,0.8429645299911499
hsa-miR-629-3p,castration-resistant prostate cancer,0.8429645299911499
hsa-miR-708-5p,castration-resistant prostate cancer,0.8429645299911499
hsa-miR-4432,castration-resistant prostate cancer,0.8429645299911499
hsa-miR-18b*,Leptomeningeal metastasis,0.8429356217384338
hsa-miR-520a-3p,Leptomeningeal metastasis,0.8429356217384338
hsa-miR-199a-2,brain cancer,0.8428866863250732
hsa-miR-212-5p,diffuse large B-cell lymphoma,0.8428813219070435
hsa-miR-34b*,diffuse large B-cell lymphoma,0.8428813219070435
hsa-miR-335*,rhabdomyosarcomas,0.8428706526756287
hsa-miR-6879-3p,rhabdomyosarcomas,0.8428706526756287
hsa-let-7i,Leptomeningeal metastasis,0.8428679704666138
hsa-miR-423-5p_1,brain cancer,0.8428365588188171
hsa-miR-216b,diffuse large B-cell lymphoma,0.8428288102149963
hsa-miR-941,diffuse large B-cell lymphoma,0.8428288102149963
hsa-miR-3200,diffuse large B-cell lymphoma,0.8428288102149963
hsa-miR-4301,diffuse large B-cell lymphoma,0.8428288102149963
hsa-miR-24-1*,diffuse large B-cell lymphoma,0.8428288102149963
hsa-miR-6756-3p,diffuse large B-cell lymphoma,0.8428288102149963
hsa-miR-519b-3p,pilocytic astrocytoma,0.8428075909614563
hsa-miR-642b,pilocytic astrocytoma,0.8428075909614563
hsa-miR-1908,castration-resistant prostate cancer,0.8428023457527161
hsa-miR-3189-5p,castration-resistant prostate cancer,0.8428023457527161
hsa-miR-1296-3p,castration-resistant prostate cancer,0.8428023457527161
hsa-miR-502,castration-resistant prostate cancer,0.8428023457527161
hsa-miR-548au-3p,castration-resistant prostate cancer,0.8428023457527161
hsa-miR-10a-3p,castration-resistant prostate cancer,0.8428023457527161
hsa-miR-519d,castration-resistant prostate cancer,0.8428023457527161
hsa-miR-449b-5p,castration-resistant prostate cancer,0.8428023457527161
hsa-miR-219a-2-3p,castration-resistant prostate cancer,0.8428023457527161
hsa-let-7f-2-3p,high grade serous papillary ovarian cancer,0.8427951335906982
hsa-miR-4443,high grade serous papillary ovarian cancer,0.8427951335906982
hsa-miR-4742-3p,high grade serous papillary ovarian cancer,0.8427951335906982
hsa-miR-519a,aryngeal squamous cell carcinoma,0.842775821685791
hsa-miR-626,pilocytic astrocytoma,0.8427733778953552
hsa-miR-744*,breast cancer brain metastasis,0.8427640795707703
hsa-miR-2964a-3p,primary central nervous system lymphomas,0.8427254557609558
hsa-miR-1261,primary central nervous system lymphomas,0.8427254557609558
hsa-miR-34b*,primary central nervous system lymphomas,0.8427254557609558
hsa-miR-5584-3p,synovial sarcoma,0.8427169919013977
hsa-miR-6082,synovial sarcoma,0.8427169919013977
hsa-miR-886,synovial sarcoma,0.8427169919013977
hsa-miR-6069,synovial sarcoma,0.8427169919013977
hsa-miR-6877-5p,synovial sarcoma,0.8427169919013977
hsa-miR-195,miR-142-y,0.8426994681358337
hsa-miR-4310,pilocytic astrocytoma,0.8426859378814697
hsa-miRPlus-C1110,pilocytic astrocytoma,0.8426748514175415
hsa-miR-10a*,pilocytic astrocytoma,0.8426748514175415
hsa-miR-500b,pilocytic astrocytoma,0.8426748514175415
hsa-miR-769,pilocytic astrocytoma,0.8426748514175415
hsa-miR-378j,pilocytic astrocytoma,0.842660129070282
hsa-miR-138-2,pilocytic astrocytoma,0.842660129070282
hsa-miR-125b-2*,pilocytic astrocytoma,0.842660129070282
hsa-miR-1273h-3p,"squamous cell breast carcinoma, acantholytic variant",0.842657208442688
hsa-miR-4436a,"squamous cell breast carcinoma, acantholytic variant",0.842657208442688
hsa-miR-376a-3p,"squamous cell breast carcinoma, acantholytic variant",0.842657208442688
hsa-miR-4633-5p,"squamous cell breast carcinoma, acantholytic variant",0.842657208442688
hsa-miR-3136-3p,"squamous cell breast carcinoma, acantholytic variant",0.842657208442688
hsa-miR-193a-3p,castration-resistant prostate cancer,0.8426494598388672
hsa-miR-1250,castration-resistant prostate cancer,0.8426494598388672
hsa-miR-877,castration-resistant prostate cancer,0.8426494598388672
hsa-miR-487a,castration-resistant prostate cancer,0.8426494598388672
hsa-miR-6089,castration-resistant prostate cancer,0.8426494598388672
hsa-miR-764,castration-resistant prostate cancer,0.8426494598388672
hsa-miR-744*,castration-resistant prostate cancer,0.8426494598388672
hsa-miR-487a-3p,castration-resistant prostate cancer,0.8426494598388672
hsa-miR-323-5p,rhabdomyosarcomas,0.842641294002533
hsa-miR-1291,papillary thyroid carcinoma,0.842612087726593
hsa-miR-349,Leptomeningeal metastasis,0.8425812125205994
hsa-miR-656,miR-142-y,0.842579185962677
hsa-miR-3615,high grade serous papillary ovarian cancer,0.842565655708313
hsa-miR-4275,high grade serous papillary ovarian cancer,0.842565655708313
hsa-miR-412,high grade serous papillary ovarian cancer,0.842565655708313
hsa-miR-5191,high grade serous papillary ovarian cancer,0.842565655708313
hsa-miR-1285-3p,high grade serous papillary ovarian cancer,0.842565655708313
hsa-miR-4787-5p,miR-142-y,0.8425602912902832
hsa-miR-1201,rhabdomyosarcomas,0.8425124287605286
hsa-miR-213,rhabdomyosarcomas,0.8425124287605286
hsa-miR-548av-3p,rhabdomyosarcomas,0.8425124287605286
hsa-miR-655,rhabdomyosarcomas,0.8425124287605286
hsa-miR-625*,brain cancer,0.8425015211105347
hsa-miR-559,high grade serous papillary ovarian cancer,0.842436671257019
hsa-miR-3647-5p,high grade serous papillary ovarian cancer,0.842436671257019
hsa-miR-4509,high grade serous papillary ovarian cancer,0.842436671257019
hsa-miR-1205,high grade serous papillary ovarian cancer,0.842436671257019
hsa-miR-363,high grade serous papillary ovarian cancer,0.842436671257019
hsa-miR-2054,high grade serous papillary ovarian cancer,0.842436671257019
hsa-miR-4745-3p,high grade serous papillary ovarian cancer,0.842436671257019
hsa-miR-3186-3p,high grade serous papillary ovarian cancer,0.842436671257019
hsa-miR-589*,high grade serous papillary ovarian cancer,0.842436671257019
hsa-miR-4516,miR-142-y,0.842431366443634
hsa-miR-6850-5p,Leptomeningeal metastasis,0.8424004912376404
hsa-miR-4651,rhabdomyosarcomas,0.8423917889595032
hsa-miR-208a-3p,rhabdomyosarcomas,0.8423917889595032
hsa-miR-6799-5p,miR-142-y,0.84238201379776
hsa-miR-1269a,"squamous cell breast carcinoma, acantholytic variant",0.8423375487327576
hsa-miR-4777-5p,"squamous cell breast carcinoma, acantholytic variant",0.8423375487327576
hsa-miR-4719,"squamous cell breast carcinoma, acantholytic variant",0.8423375487327576
hsa-miR-1306-3p,"squamous cell breast carcinoma, acantholytic variant",0.8423375487327576
hsa-miR-4455,"squamous cell breast carcinoma, acantholytic variant",0.8423375487327576
hsa-miR-486-3p,miR-142-y,0.8423324823379517
hsa-miR-493-3p,miR-142-y,0.8423324823379517
hsa-miR-320e,high grade serous papillary ovarian cancer,0.8423159718513489
hsa-miR-449b,high grade serous papillary ovarian cancer,0.8423159718513489
hsa-miRPlus-A1087,high grade serous papillary ovarian cancer,0.8423159718513489
hsa-miR-371a-5p,high grade serous papillary ovarian cancer,0.8423159718513489
hsa-miR-4637,high grade serous papillary ovarian cancer,0.8423159718513489
hsa-miR-4796-3p,miR-142-y,0.8422995805740356
hsa-miR-516b,miR-142-y,0.8422995805740356
hsa-miR-8052,miR-142-y,0.8422995805740356
hsa-miR-7160-5p,miR-142-y,0.8422995805740356
hsa-miR-5000-3p,miR-142-y,0.8422995805740356
hsa-miR-19b-1-5p,miR-142-y,0.8422995805740356
hsa-miR-1268b,miR-142-y,0.8422995805740356
hsa-miR-4526,high grade serous papillary ovarian cancer,0.8422887325286865
hsa-miR-6877-5p,high grade serous papillary ovarian cancer,0.8422887325286865
hsa-miR-664b-3p,high grade serous papillary ovarian cancer,0.8422887325286865
hsa-miR-6822-5p,miR-142-y,0.842251181602478
hsa-miR-3141,miR-142-y,0.842251181602478
hsa-miR-548h,brain cancer,0.842207133769989
hsa-miR-340-5p,miR-142-y,0.8421911001205444
hsa-miR-341,"Luminal B,triple negative",0.8421856760978699
hsa-miR-302d-5p,aryngeal squamous cell carcinoma,0.8421698808670044
hsa-miR-4727-3p,aryngeal squamous cell carcinoma,0.8421698808670044
hsa-miR-485-3p,miR-142-y,0.8421590328216553
hsa-miR-4665-3p,miR-142-y,0.8421590328216553
hsa-miR-6847-3p,miR-142-y,0.8421590328216553
hsa-miR-192-2/3,rhabdomyosarcomas,0.8421559929847717
hsa-miR-671-3p,rhabdomyosarcomas,0.8421559929847717
hsa-miR-431,rhabdomyosarcomas,0.8421559929847717
hsa-miR-29c-5p,rhabdomyosarcomas,0.8421559929847717
hsa-miR-220c,miR-142-y,0.8421255350112915
hsa-miR-3910,"Luminal B,triple negative",0.8420822620391846
hsa-miR-494-5p,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-6793-3p,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-4785,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-29c-5p,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-132-3p,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-7-2,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-190a-5p,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-3686,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-1237,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-1233-1-5p,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-654-3p,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-4760-5p,high grade serous papillary ovarian cancer,0.8420800566673279
hsa-miR-3155,miR-142-y,0.8420531749725342
hsa-miR-4458,miR-142-y,0.8420531749725342
hsa-miR-520d*,miR-142-y,0.8420531749725342
hsa-miR-6733-3p,"Luminal B,triple negative",0.8420394062995911
hsa-miR-526b,papillary thyroid carcinoma,0.8420387506484985
hsa-miR-4737,brain cancer,0.8420349955558777
hsa-miR-1199-3p,primary central nervous system lymphomas,0.8420179486274719
hsa-miR-6824-3p,miR-142-y,0.8420143127441406
hsa-miR-192-5p,miR-142-y,0.8420143127441406
hsa-miR-91,miR-142-y,0.8420143127441406
hsa-miR-1273h-3p,solid pseudopapillary neoplasm of pancreas,0.8419979214668274
hsa-miR-381-3p,solid pseudopapillary neoplasm of pancreas,0.8419979214668274
hsa-miR-95-5p,solid pseudopapillary neoplasm of pancreas,0.8419979214668274
hsa-miR-5007-3p,"Luminal B,triple negative",0.8419933319091797
hsa-miR-3136-5p,miR-142-y,0.8419732451438904
hsa-miR-25-3p,miR-142-y,0.8419732451438904
hsa-miR-3545-5p,miR-142-y,0.8419732451438904
hsa-miR-4656,miR-142-y,0.8419732451438904
hsa-miR-1298,castration-resistant prostate cancer,0.841946005821228
hsa-miR-6810-3p,castration-resistant prostate cancer,0.841946005821228
hsa-miR-553,castration-resistant prostate cancer,0.841946005821228
hsa-miR-125a-3p,castration-resistant prostate cancer,0.841946005821228
hsa-miR-4645-3p,castration-resistant prostate cancer,0.841946005821228
hsa-miR-4633-5p,castration-resistant prostate cancer,0.841946005821228
hsa-miR-3198,castration-resistant prostate cancer,0.841946005821228
hsa-miR-6799-5p,"Luminal B,triple negative",0.8419439792633057
hsa-miR-765,miR-142-y,0.8419278860092163
hsa-miR-3162,rhabdomyosarcomas,0.8419222831726074
hsa-miR-4465,rhabdomyosarcomas,0.8419222831726074
hsa-miR-6807-3p,rhabdomyosarcomas,0.8419222831726074
hsa-miR-6803-5p,rhabdomyosarcomas,0.8419222831726074
hsa-miR-548p,rhabdomyosarcomas,0.8419222831726074
hsa-miR-488*,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-4269,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-6730-3p,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-6513-3p,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-145*,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-4758-5p,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-324,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-3122,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-548s,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-185*,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-4717-5p,high grade serous papillary ovarian cancer,0.8419206142425537
hsa-miR-4490,high grade serous papillary ovarian cancer,0.8419010043144226
hsa-miR-221*,high grade serous papillary ovarian cancer,0.8419010043144226
hsa-miR-4530,high grade serous papillary ovarian cancer,0.8419010043144226
hsa-miR-144*,brain cancer,0.8418819904327393
hsa-miR-129-2-3p,miR-142-y,0.8418787717819214
hsa-miR-4647,miR-142-y,0.8418787717819214
hsa-miR-151a-3p,miR-142-y,0.8418787717819214
hsa-miR-511-3p,miR-142-y,0.8418787717819214
hsa-miR-516b,"Luminal B,triple negative",0.8418610095977783
hsa-miR-513b-3p,"Luminal B,triple negative",0.8418610095977783
hsa-miR-15a*,"Luminal B,triple negative",0.8418610095977783
hsa-miR-3162,high grade serous papillary ovarian cancer,0.8418463468551636
hsa-miR-1914*,high grade serous papillary ovarian cancer,0.8418463468551636
hsa-miR-6511b-5p,high grade serous papillary ovarian cancer,0.8418463468551636
hsa-miR-3074-5p,high grade serous papillary ovarian cancer,0.8418463468551636
hsa-miR-4675,high grade serous papillary ovarian cancer,0.8418463468551636
hsa-miR-6749-3p,papillary thyroid carcinoma,0.8418344855308533
hsa-miR-4650-3p,miR-142-y,0.8418283462524414
hsa-miR-103-2,"squamous cell breast carcinoma, acantholytic variant",0.8418150544166565
hsa-miR-2964a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8418150544166565
hsa-miR-520d-3p,Leptomeningeal metastasis,0.8418012261390686
hsa-miR-1257,brain cancer,0.8417848348617554
hsa-miR-518a-5p,miR-142-y,0.8417769074440002
hsa-miR-28-5p,miR-142-y,0.8417769074440002
hsa-miR-1266,miR-142-y,0.8417769074440002
hsa-miR-4515,miR-142-y,0.8417769074440002
hsa-miR-4288,"Luminal B,triple negative",0.8417525291442871
hsa-miR-516b-5p,"Luminal B,triple negative",0.8417525291442871
hsa-miR-4695-3p,synovial sarcoma,0.8417520523071289
hsa-miR-20a-5p,synovial sarcoma,0.8417520523071289
hsa-miR-181a-5p,synovial sarcoma,0.8417520523071289
hsa-miR-125b-1-3p,synovial sarcoma,0.8417520523071289
hsa-miR-6081,synovial sarcoma,0.8417520523071289
hsa-miR-7844-5p,synovial sarcoma,0.8417520523071289
hsa-miR-4734,synovial sarcoma,0.8417520523071289
hsa-miR-889-5p,synovial sarcoma,0.8417520523071289
hsa-miR-138-2*,rhabdomyosarcomas,0.8417336344718933
hsa-miR-1259,rhabdomyosarcomas,0.8417336344718933
hsa-miR-4431,miR-142-y,0.8417230844497681
hsa-miR-4659b-3p,miR-142-y,0.8417230844497681
hsa-miR-2115*,rhabdomyosarcomas,0.8416993618011475
hsa-miR-4268,rhabdomyosarcomas,0.8416993618011475
hsa-miR-4291,rhabdomyosarcomas,0.8416993618011475
hsa-miR-4676-3p,rhabdomyosarcomas,0.8416993618011475
hsa-miR-34c-5p,rhabdomyosarcomas,0.8416993618011475
hsa-miR-4747-5p,brain cancer,0.8416990041732788
hsa-miR-643,miR-142-y,0.8416699767112732
hsa-miR-1283-1,miR-142-y,0.8416699767112732
hsa-miR-1277-5p,miR-142-y,0.8416699767112732
hsa-miR-128,miR-142-y,0.8416699767112732
hsa-miR-5089,high grade serous papillary ovarian cancer,0.8416576385498047
hsa-miR-1277,high grade serous papillary ovarian cancer,0.8416576385498047
hsa-miR-561,high grade serous papillary ovarian cancer,0.8416576385498047
hsa-miR-4263,high grade serous papillary ovarian cancer,0.8416576385498047
hsa-miR-514a-5p,high grade serous papillary ovarian cancer,0.8416576385498047
hsa-miR-3935,high grade serous papillary ovarian cancer,0.8416576385498047
hsa-miR-7107-5p,high grade serous papillary ovarian cancer,0.8416576385498047
hsa-miR-6772-5p,high grade serous papillary ovarian cancer,0.8416576385498047
hsa-miR-876-3p,"Luminal B,triple negative",0.8416515588760376
hsa-miR-6750-5p,brain cancer,0.8416280746459961
hsa-miR-376c-5p,brain cancer,0.8416280746459961
hsa-miR-4693-5p,brain cancer,0.8416280746459961
hsa-miR-433,brain cancer,0.8416280746459961
hsa-miR-379*,brain cancer,0.8416280746459961
hsa-miR-483-5p,papillary thyroid carcinoma,0.8416240215301514
hsa-miR-500a-3p,high grade serous papillary ovarian cancer,0.8416232466697693
hsa-miR-22,high grade serous papillary ovarian cancer,0.8416232466697693
hsa-miR-466,high grade serous papillary ovarian cancer,0.8416232466697693
hsa-miR-4655-3p,high grade serous papillary ovarian cancer,0.8416232466697693
hsa-miR-1-5p,high grade serous papillary ovarian cancer,0.8416232466697693
hsa-miR-30d-3p,high grade serous papillary ovarian cancer,0.8416232466697693
hsa-miR-6800-3p,high grade serous papillary ovarian cancer,0.8416232466697693
hsa-miR-139-5p,high grade serous papillary ovarian cancer,0.8416232466697693
hsa-miR-6751-3p,high grade serous papillary ovarian cancer,0.8416232466697693
hsa-miR-6781-5p,brain cancer,0.8416187167167664
hsa-miR-6513-3p,brain cancer,0.8416187167167664
hsa-miR-548e,brain cancer,0.8416187167167664
hsa-miRPlus-D1058,rhabdomyosarcomas,0.8416113257408142
hsa-miR-452*,rhabdomyosarcomas,0.8416113257408142
hsa-miR-32*,rhabdomyosarcomas,0.8416113257408142
hsa-miR-1182,follicular thyroid carcinoma,0.8416079878807068
hsa-miR-3668,"squamous cell breast carcinoma, acantholytic variant",0.841600775718689
hsa-let-7f-2*,rhabdomyosarcomas,0.8416002988815308
hsa-miR-6769a-5p,rhabdomyosarcomas,0.8416002988815308
hsa-miR-3689d,rhabdomyosarcomas,0.8416002988815308
hsa-miR-550a,rhabdomyosarcomas,0.8416002988815308
hsa-miR-4520b-3p,rhabdomyosarcomas,0.8416002988815308
hsa-miR-200c,rhabdomyosarcomas,0.8416002988815308
hsa-miR-422b,synovial sarcoma,0.8415964245796204
hsa-miR-6071,synovial sarcoma,0.8415964245796204
hsa-miR-4661-5p,synovial sarcoma,0.8415964245796204
hsa-miR-607,synovial sarcoma,0.8415964245796204
hsa-miR-606,synovial sarcoma,0.8415964245796204
hsa-miR-2355,synovial sarcoma,0.8415964245796204
hsa-miR-30b-3p,synovial sarcoma,0.8415964245796204
hsa-miR-520g,synovial sarcoma,0.8415964245796204
hsa-miR-5008-3p,synovial sarcoma,0.8415964245796204
hsa-miR-4804-5p,synovial sarcoma,0.8415964245796204
hsa-miR-1284,synovial sarcoma,0.8415964245796204
hsa-miR-27a-3p,synovial sarcoma,0.8415964245796204
hsa-miR-580-5p,synovial sarcoma,0.8415964245796204
hsa-miR-4298,Leptomeningeal metastasis,0.8415930271148682
hsa-miR-642a-5p,Leptomeningeal metastasis,0.8415930271148682
hsa-miRPlus-A1073,rhabdomyosarcomas,0.8415854573249817
hsa-miR-3917,rhabdomyosarcomas,0.8415854573249817
hsa-miR-6786-5p,rhabdomyosarcomas,0.8415854573249817
hsa-miR-651-3p,rhabdomyosarcomas,0.8415854573249817
hsa-miR-548h-5p,rhabdomyosarcomas,0.8415854573249817
hsa-miR-5739,rhabdomyosarcomas,0.8415854573249817
hsa-miR-374b*,miR-142-y,0.8415541648864746
hsa-miR-619-5p,miR-142-y,0.8415541648864746
hsa-miR-135-2,miR-142-y,0.8415541648864746
hsa-miR-1908-3p,miR-142-y,0.8415541648864746
hsa-miR-376c-5p,high grade serous papillary ovarian cancer,0.8415353894233704
hsa-miR-6894-3p,high grade serous papillary ovarian cancer,0.8415353894233704
hsa-miR-4452,high grade serous papillary ovarian cancer,0.8415353894233704
hsa-miR-3937,high grade serous papillary ovarian cancer,0.8415353894233704
hsa-miR-3187-3p,high grade serous papillary ovarian cancer,0.8415353894233704
hsa-miR-486-5p,high grade serous papillary ovarian cancer,0.8415353894233704
hsa-miR-627-5p,high grade serous papillary ovarian cancer,0.8415353894233704
hsa-miR-520g-5p,high grade serous papillary ovarian cancer,0.8415353894233704
hsa-miR-484,miR-142-y,0.8415255546569824
hsa-miR-6859-5p,miR-142-y,0.8415255546569824
hsa-miR-106a.1,miR-142-y,0.8415255546569824
hsa-miR-4433-5p,miR-142-y,0.8415255546569824
hsa-miR-100*,miR-142-y,0.8415255546569824
hsa-miR-26a-2,miR-142-y,0.8415255546569824
hsa-miR-202-3p,miR-142-y,0.8415255546569824
hsa-miR-3606-3p,high grade serous papillary ovarian cancer,0.8415242433547974
hsa-miR-5700,high grade serous papillary ovarian cancer,0.8415242433547974
hsa-miR-6806-5p,high grade serous papillary ovarian cancer,0.8415242433547974
hsa-miR-6784-5p,high grade serous papillary ovarian cancer,0.8415242433547974
hsa-miR-6753-3p,high grade serous papillary ovarian cancer,0.8415242433547974
hsa-miR-1-2,high grade serous papillary ovarian cancer,0.8415242433547974
hsa-miR-3679-3p,high grade serous papillary ovarian cancer,0.8415242433547974
hsa-miR-922,sarcoma,0.8415225148200989
hsa-miR-4279,sarcoma,0.8415225148200989
hsa-let-7d*,sarcoma,0.8415213823318481
hsa-miR-6886-3p,sarcoma,0.8415213823318481
hsa-miR-6506-3p,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-372,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-548h-5p,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-let-7f-5p,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-1307-3p,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-128b,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-5590-3p,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-29b-2,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-300,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-644a,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-8056,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-4774-5p,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-874-3p,high grade serous papillary ovarian cancer,0.8415093421936035
hsa-miR-2964a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8414981365203857
hsa-miR-3189-5p,"squamous cell breast carcinoma, acantholytic variant",0.8414981365203857
hsa-miR-34b*,"squamous cell breast carcinoma, acantholytic variant",0.8414981365203857
hsa-miR-4786-5p,"squamous cell breast carcinoma, acantholytic variant",0.8414981365203857
hsa-miR-520d-5p,miR-142-y,0.8414916396141052
hsa-miR-598-3p,"Luminal B,triple negative",0.8414885997772217
hsa-miR-4738-5p,miR-142-y,0.8414711952209473
hsa-miR-4524b-5p,"Luminal B,triple negative",0.8414394855499268
hsa-miR-511-3p,"Luminal B,triple negative",0.8414394855499268
hsa-miR-4313,"Luminal B,triple negative",0.8414394855499268
hsa-miR-4298,miR-142-y,0.8414267897605896
hsa-miR-139-3p,miR-142-y,0.8414267897605896
hsa-miRPlus-J1002,miR-142-y,0.8414267897605896
hsa-miR-224-5p,miR-142-y,0.8414267897605896
hsa-miR-374a-3p,miR-142-y,0.8414267897605896
hsa-miR-7106-3p,diffuse large B-cell lymphoma,0.8413966298103333
hsa-miR-517a-3p,diffuse large B-cell lymphoma,0.8413966298103333
hsa-miR-3129-5p,diffuse large B-cell lymphoma,0.8413966298103333
hsa-miR-4711-5p,diffuse large B-cell lymphoma,0.8413966298103333
hsa-miR-1204,diffuse large B-cell lymphoma,0.8413966298103333
hsa-miR-423-5p_1,"Luminal B,triple negative",0.8413891196250916
hsa-miR-125a-3p,rhabdomyosarcomas,0.8413848876953125
hsa-miR-640,"squamous cell breast carcinoma, acantholytic variant",0.8413766622543335
hsa-miR-26b*,miR-142-y,0.8413567543029785
hsa-miR-589-5p,miR-142-y,0.8413567543029785
hsa-miR-4740-5p,miR-142-y,0.8413567543029785
hsa-miR-6727-3p,aryngeal squamous cell carcinoma,0.841334342956543
hsa-miR-942-5p,"squamous cell breast carcinoma, acantholytic variant",0.8413242101669312
hsa-miR-4787-5p,"squamous cell breast carcinoma, acantholytic variant",0.841286301612854
hsa-miR-3682-3p,"Luminal B,triple negative",0.8412836790084839
hsa-miR-514,miR-142-y,0.8412824273109436
hsa-miR-6737-3p,miR-142-y,0.8412824273109436
hsa-miR-6502-5p,miR-142-y,0.8412824273109436
hsa-miR-2114*,"squamous cell breast carcinoma, acantholytic variant",0.8412665724754333
hsa-miR-95-3p,"squamous cell breast carcinoma, acantholytic variant",0.8412460684776306
hsa-miR-191-5p,"Luminal B,triple negative",0.8412303924560547
hsa-miR-4713-5p,"Luminal B,triple negative",0.8412303924560547
hsa-miR-6733-3p,"squamous cell breast carcinoma, acantholytic variant",0.8412028551101685
hsa-miR-548ay-5p,miR-142-y,0.8411958813667297
hsa-miR-5196-3p,miR-142-y,0.8411958813667297
hsa-miR-634,miR-142-y,0.8411958813667297
hsa-miR-491,miR-142-y,0.8411958813667297
hsa-miR-944,miR-142-y,0.8411958813667297
hsa-miR-124-5p,miR-142-y,0.8411958813667297
hsa-miR-2116-5p,miR-142-y,0.8411958813667297
hsa-miR-561-5p,miR-142-y,0.8411958813667297
hsa-miR-4425,miR-142-y,0.8411958813667297
hsa-miR-133a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8411804437637329
hsa-miR-133a-3p,diffuse large B-cell lymphoma,0.8411483764648438
hsa-miR-196b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8411325216293335
hsa-miR-3651,"squamous cell breast carcinoma, acantholytic variant",0.8411325216293335
hsa-miR-18b-3p,"Luminal B,triple negative",0.8411142230033875
hsa-miR-135-2,"Luminal B,triple negative",0.8411142230033875
hsa-miR-3177-3p,"Luminal B,triple negative",0.8411142230033875
hsa-miR-4714-3p,"Luminal B,triple negative",0.8411142230033875
hsa-miR-1978,"Luminal B,triple negative",0.8411142230033875
hsa-miR-6797-5p,"squamous cell breast carcinoma, acantholytic variant",0.8411072492599487
hsa-miR-103a,diffuse large B-cell lymphoma,0.841105043888092
hsa-miR-15a*,diffuse large B-cell lymphoma,0.841105043888092
hsa-miR-2110,miR-142-y,0.8410984873771667
hsa-let-7d-v2,miR-142-y,0.8410984873771667
hsa-miR-654-3p,miR-142-y,0.8410984873771667
hsa-miR-497-3p,miR-142-y,0.8410984873771667
hsa-miR-8069,"Luminal B,triple negative",0.8410853743553162
hsa-miR-6729-5p,"Luminal B,triple negative",0.8410853743553162
hsa-miR-6827-3p,"Luminal B,triple negative",0.8410853743553162
hsa-miR-123,"squamous cell breast carcinoma, acantholytic variant",0.841082751750946
hsa-miR-6740-5p,"squamous cell breast carcinoma, acantholytic variant",0.841057300567627
hsa-miR-1343-5p,"Luminal B,triple negative",0.8410513401031494
hsa-miR-6882-5p,papillary thyroid carcinoma,0.8410394191741943
hsa-let-7f-1*,papillary thyroid carcinoma,0.8410394191741943
hsa-miR-6875-3p,"squamous cell breast carcinoma, acantholytic variant",0.8410310745239258
hsa-miR-1182,"squamous cell breast carcinoma, acantholytic variant",0.8410239815711975
hsa-miR-3179,"squamous cell breast carcinoma, acantholytic variant",0.8410239815711975
hsa-miR-15b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8410239815711975
hsa-miR-323b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8410239815711975
hsa-miR-552-3p,"squamous cell breast carcinoma, acantholytic variant",0.8410239815711975
hsa-miR-1224,miR-142-y,0.8410227298736572
hsa-miR-425-3p,miR-142-y,0.8410227298736572
hsa-miR-138-1*,miR-142-y,0.8410227298736572
hsa-miR-92a-2*,miR-142-y,0.8410227298736572
hsa-miR-21*,miR-142-y,0.8410227298736572
hsa-miR-149-5p,miR-142-y,0.8410227298736572
hsa-miR-3150b-3p,miR-142-y,0.8410227298736572
hsa-miR-4472,miR-142-y,0.8410227298736572
hsa-miR-4680-5p,"squamous cell breast carcinoma, acantholytic variant",0.8410038352012634
hsa-miR-6514-3p,miR-142-y,0.8409931659698486
hsa-miR-544,miR-142-y,0.8409931659698486
hsa-miR-6831-3p,miR-142-y,0.8409931659698486
hsa-miR-183,miR-142-y,0.8409931659698486
hsa-miR-4746-3p,miR-142-y,0.8409931659698486
hsa-miR-4418,miR-142-y,0.8409931659698486
hsa-miR-548h-3p,miR-142-y,0.8409931659698486
hsa-miR-3184-5p,miR-142-y,0.8409931659698486
hsa-miR-124-3p,miR-142-y,0.8409931659698486
hsa-miR-3606-5p,"squamous cell breast carcinoma, acantholytic variant",0.8409755229949951
hsa-miR-1262,"squamous cell breast carcinoma, acantholytic variant",0.8409755229949951
hsa-miR-4639-3p,"squamous cell breast carcinoma, acantholytic variant",0.8409755229949951
hsa-miR-149*,"squamous cell breast carcinoma, acantholytic variant",0.8409456610679626
hsa-miR-3690,"squamous cell breast carcinoma, acantholytic variant",0.8409456610679626
hsa-miR-548ay-5p,papillary thyroid carcinoma,0.8409179449081421
hsa-miR-4254,"Luminal B,triple negative",0.8409162759780884
hsa-miR-4288,"squamous cell breast carcinoma, acantholytic variant",0.8409148454666138
hsa-miR-103b,"squamous cell breast carcinoma, acantholytic variant",0.8409148454666138
hsa-miR-6860,"squamous cell breast carcinoma, acantholytic variant",0.8409148454666138
hsa-miR-8071,"squamous cell breast carcinoma, acantholytic variant",0.8409148454666138
hsa-miR-302f,follicular thyroid carcinoma,0.8409135341644287
hsa-miR-5681b,Leptomeningeal metastasis,0.8408867716789246
hsa-miR-4251,Leptomeningeal metastasis,0.8408867716789246
hsa-miR-6861-3p,Leptomeningeal metastasis,0.8408867716789246
hsa-miR-320a,"squamous cell breast carcinoma, acantholytic variant",0.8408827185630798
hsa-miR-1298-5p,"squamous cell breast carcinoma, acantholytic variant",0.8408827185630798
hsa-miR-218-1,miR-142-y,0.8408770561218262
hsa-miR-936,miR-142-y,0.8408770561218262
hsa-miR-194-2,miR-142-y,0.8408770561218262
hsa-miR-1-5p,miR-142-y,0.8408770561218262
hsa-miR-518e-5p,miR-142-y,0.8408770561218262
hsa-miR-021,"squamous cell breast carcinoma, acantholytic variant",0.8408491611480713
hsa-miR-1206,"Luminal B,triple negative",0.8408416509628296
hsa-miR-4433a-5p,"Luminal B,triple negative",0.8408416509628296
hsa-miR-2355,primary central nervous system lymphomas,0.8408147096633911
hsa-miR-23c,"squamous cell breast carcinoma, acantholytic variant",0.8408135771751404
hsa-miR-493-5p,"squamous cell breast carcinoma, acantholytic variant",0.8408135771751404
hsa-miR-367-5p,follicular thyroid carcinoma,0.8407894968986511
hsa-miR-6806-5p,miR-142-y,0.8407710194587708
hsa-miR-1b-1,miR-142-y,0.8407710194587708
hsa-miR-548as-5p,miR-142-y,0.8407710194587708
hsa-miR-627-3p,miR-142-y,0.8407710194587708
hsa-miR-7855-5p,miR-142-y,0.8407710194587708
hsa-miR-6753-3p,miR-142-y,0.8407710194587708
hsa-miR-7109-3p,miR-142-y,0.8407710194587708
hsa-miR-8077,miR-142-y,0.8407710194587708
hsa-miR-4539,miR-142-y,0.8407710194587708
hsa-miR-3146,miR-142-y,0.8407710194587708
hsa-miR-7151-3p,"Luminal B,triple negative",0.8407551050186157
hsa-miR-1304,"Luminal B,triple negative",0.8407551050186157
hsa-miR-548v,"Luminal B,triple negative",0.8407551050186157
hsa-miR-3960,"Luminal B,triple negative",0.8407551050186157
hsa-miR-378b,"Luminal B,triple negative",0.8407551050186157
hsa-miR-548av-3p,miR-142-y,0.8407244086265564
hsa-miR-874,miR-142-y,0.8407244086265564
hsa-miR-559,miR-142-y,0.8407244086265564
hsa-miR-4509,miR-142-y,0.8407244086265564
hsa-miR-2117,miR-142-y,0.8407244086265564
hsa-miR-589*,miR-142-y,0.8407244086265564
hsa-miR-3680-3p,miR-142-y,0.8407244086265564
hsa-miR-3192-5p,aryngeal squamous cell carcinoma,0.8407176733016968
hsa-miR-3677-3p,aryngeal squamous cell carcinoma,0.8407176733016968
hsa-miR-1200,aryngeal squamous cell carcinoma,0.8407176733016968
hsa-miR-561-3p,"Luminal B,triple negative",0.8407172560691833
hsa-miR-3545-5p,"squamous cell breast carcinoma, acantholytic variant",0.8406954407691956
hsa-miR-4691-5p,"squamous cell breast carcinoma, acantholytic variant",0.8406954407691956
hsa-miR-603,miR-142-y,0.8406848907470703
hsa-miR-372,miR-142-y,0.8406848907470703
hsa-miR-122a,miR-142-y,0.8406848907470703
hsa-miR-16-5p,miR-142-y,0.8406848907470703
hsa-miR-302c-5p,miR-142-y,0.8406848907470703
hsa-miR-491-5p,miR-142-y,0.8406848907470703
hsa-miR-132-5p,miR-142-y,0.8406848907470703
hsa-miR-490,miR-142-y,0.8406848907470703
hsa-miR-5739,miR-142-y,0.8406848907470703
hsa-miR-4678,miR-142-y,0.8406848907470703
hsa-miR-5590-3p,miR-142-y,0.8406848907470703
hsa-miR-6833-3p,miR-142-y,0.8406848907470703
hsa-miR-548t,miR-142-y,0.8406848907470703
hsa-miR-642a-3p,miR-142-y,0.8406848907470703
hsa-miR-4454,aryngeal squamous cell carcinoma,0.8406829833984375
hsa-miR-5187-5p,aryngeal squamous cell carcinoma,0.8406829833984375
hsa-miR-187*,papillary thyroid carcinoma,0.8406803607940674
hsa-miR-524-3p,papillary thyroid carcinoma,0.8406803607940674
hsa-miR-1202,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-642a,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-16-2*,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-3663-5p,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-125b-1-3p,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-146b-5p,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-4279,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-3922,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-6830-3p,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-186-5p,castration-resistant prostate cancer,0.8406795859336853
hsa-miR-4771,diffuse large B-cell lymphoma,0.8406789302825928
hsa-miR-3175,diffuse large B-cell lymphoma,0.8406789302825928
hsa-miR-2115-3p,"squamous cell breast carcinoma, acantholytic variant",0.8406501412391663
hsa-miR-585,Leptomeningeal metastasis,0.8406491279602051
hsa-miR-708,Leptomeningeal metastasis,0.8406491279602051
hsa-miR-501-5p,brain cancer,0.8406243324279785
hsa-miR-4497,brain cancer,0.8406243324279785
hsa-miR-323a-5p,miR-142-y,0.8406137228012085
hsa-miR-32*,miR-142-y,0.8406137228012085
hsa-miR-3192,miR-142-y,0.8406137228012085
hsa-miR-5683,miR-142-y,0.8406137228012085
hsa-miR-891a-3p,miR-142-y,0.8406137228012085
hsa-miR-3944-5p,miR-142-y,0.8406137228012085
hsa-miR-4731-5p,miR-142-y,0.8406137228012085
hsa-miR-4792,miR-142-y,0.8406137228012085
hsa-miR-548e,miR-142-y,0.8406041860580444
hsa-let-7a-2-3p,miR-142-y,0.8406041860580444
hsa-miR-16-2-3p,miR-142-y,0.8406041860580444
hsa-miR-6511a-5p,miR-142-y,0.8406041860580444
hsa-miR-1178,miR-142-y,0.8406041860580444
hsa-miR-3157,miR-142-y,0.8406041860580444
hsa-miR-151a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8406006693840027
hsa-miR-511-3p,"squamous cell breast carcinoma, acantholytic variant",0.8406006693840027
hsa-miR-6887-3p,"squamous cell breast carcinoma, acantholytic variant",0.8406006693840027
hsa-miR-4436a,miR-675-y,0.8405904173851013
hsa-miR-561,miR-142-y,0.8405836820602417
hsa-miR-224*,miR-142-y,0.8405836820602417
hsa-miR-379-5p,miR-142-y,0.8405836820602417
hsa-miR-6734-5p,miR-142-y,0.8405836820602417
hsa-miR-6130,miR-142-y,0.8405836820602417
hsa-miR-3127-5p,miR-142-y,0.8405836820602417
hsa-miR-6818-3p,miR-142-y,0.8405836820602417
hsa-miR-138-1*,"Luminal B,triple negative",0.8405815362930298
hsa-miR-19a-3p,"Luminal B,triple negative",0.8405815362930298
hsa-miR-3150b-3p,"Luminal B,triple negative",0.8405815362930298
hsa-miR-4472,"Luminal B,triple negative",0.8405815362930298
hsa-miR-3620,"Luminal B,triple negative",0.8405815362930298
hsa-miR-2682-3p,"Luminal B,triple negative",0.8405815362930298
hsa-miR-3135b,diffuse large B-cell lymphoma,0.8405739068984985
hsa-miR-548ax,high grade serous papillary ovarian cancer,0.8405633568763733
hsa-miR-3162,"Luminal B,triple negative",0.8405517935752869
hsa-miR-6815-3p,"Luminal B,triple negative",0.8405517935752869
hsa-let-7g*,"Luminal B,triple negative",0.8405517935752869
hsa-miR-4723-3p,"squamous cell breast carcinoma, acantholytic variant",0.840549886226654
hsa-miR-2278,"squamous cell breast carcinoma, acantholytic variant",0.840549886226654
hsa-miR-4462,"squamous cell breast carcinoma, acantholytic variant",0.840549886226654
hsa-miR-4663,"squamous cell breast carcinoma, acantholytic variant",0.840549886226654
hsa-miR-3928,aryngeal squamous cell carcinoma,0.8405485153198242
hsa-miR-374c-3p,follicular thyroid carcinoma,0.8405229449272156
hsa-miR-488*,papillary thyroid carcinoma,0.8405197262763977
hsa-miR-6730-3p,papillary thyroid carcinoma,0.8405197262763977
hsa-miR-3945,papillary thyroid carcinoma,0.8405197262763977
hsa-miR-376a*,papillary thyroid carcinoma,0.8405197262763977
hsa-miR-3196,"squamous cell breast carcinoma, acantholytic variant",0.8404980301856995
hsa-miR-186*,"squamous cell breast carcinoma, acantholytic variant",0.8404980301856995
hsa-miR-3128,"squamous cell breast carcinoma, acantholytic variant",0.8404980301856995
hsa-miR-4515,"squamous cell breast carcinoma, acantholytic variant",0.8404980301856995
hsa-miR-363*,"squamous cell breast carcinoma, acantholytic variant",0.8404980301856995
hsa-miR-16-2-3p,Leptomeningeal metastasis,0.8404884934425354
hsa-miR-877*,Leptomeningeal metastasis,0.8404884934425354
hsa-miR-768,Leptomeningeal metastasis,0.8404884934425354
hsa-miR-30c-2-3p,diffuse large B-cell lymphoma,0.8404800891876221
hsa-miR-129-5p,diffuse large B-cell lymphoma,0.8404644727706909
hsa-miR-349,"squamous cell breast carcinoma, acantholytic variant",0.840444028377533
hsa-miR-516a-3p,"squamous cell breast carcinoma, acantholytic variant",0.840444028377533
hsa-miR-768-5p:11.0,"squamous cell breast carcinoma, acantholytic variant",0.840444028377533
hsa-miR-6894-5p,"squamous cell breast carcinoma, acantholytic variant",0.840444028377533
hsa-miR-5587-3p,"squamous cell breast carcinoma, acantholytic variant",0.840444028377533
hsa-miR-3192-3p,"Luminal B,triple negative",0.8404353260993958
hsa-miR-598,"Luminal B,triple negative",0.8404353260993958
hsa-miR-1-5p,"Luminal B,triple negative",0.8404353260993958
hsa-miR-6751-3p,"Luminal B,triple negative",0.8404353260993958
hsa-miR-3127-3p,"Luminal B,triple negative",0.8404353260993958
hsa-miR-4470,Leptomeningeal metastasis,0.8404136300086975
hsa-miR-1236-5p,diffuse large B-cell lymphoma,0.8404005765914917
hsa-miR-3188,"squamous cell breast carcinoma, acantholytic variant",0.8403906226158142
hsa-miR-24-2,"squamous cell breast carcinoma, acantholytic variant",0.8403906226158142
hsa-miR-3180-3p,"squamous cell breast carcinoma, acantholytic variant",0.8403906226158142
hsa-miR-302b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8403906226158142
hsa-miR-548aq-5p,"squamous cell breast carcinoma, acantholytic variant",0.840333878993988
hsa-miR-5006-5p,"squamous cell breast carcinoma, acantholytic variant",0.840333878993988
hsa-miR-4439,"squamous cell breast carcinoma, acantholytic variant",0.840333878993988
hsa-miR-5692a,"squamous cell breast carcinoma, acantholytic variant",0.840333878993988
hsa-miR-6784-5p,"Luminal B,triple negative",0.8403295278549194
hsa-miR-103-2*,"Luminal B,triple negative",0.8403295278549194
hsa-miR-4520-5p,"Luminal B,triple negative",0.8403295278549194
hsa-miR-6844,"Luminal B,triple negative",0.8403295278549194
hsa-miR-151b,castration-resistant prostate cancer,0.8403207063674927
hsa-let-7a*,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-1294,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-181a-5p,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-4322,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-1236-5p,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-1224-3p,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-3934,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-4769-5p,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-103-as,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-6081,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-7150,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-518c*,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-6854-5p,castration-resistant prostate cancer,0.8403207063674927
hsa-miR-1227-5p,synovial sarcoma,0.8402903079986572
hsa-miR-101-5p,synovial sarcoma,0.8402903079986572
hsa-miR-7856-5p,synovial sarcoma,0.8402903079986572
hsa-miR-561-3p,synovial sarcoma,0.8402903079986572
hsa-miR-4742-5p,synovial sarcoma,0.8402903079986572
hsa-miR-23b-3p,"Luminal B,triple negative",0.8402827978134155
hsa-miR-6892-3p,"squamous cell breast carcinoma, acantholytic variant",0.8402740359306335
hsa-miR-3664-5p,"squamous cell breast carcinoma, acantholytic variant",0.8402740359306335
hsa-miR-2277-5p,"squamous cell breast carcinoma, acantholytic variant",0.8402740359306335
hsa-miR-24-3p,rhabdomyosarcomas,0.8402605056762695
hsa-miR-519b-3p,papillary thyroid carcinoma,0.8402548432350159
hsa-miR-380,papillary thyroid carcinoma,0.8402548432350159
hsa-miR-191*,papillary thyroid carcinoma,0.8402548432350159
hsa-miR-8089,"squamous cell breast carcinoma, acantholytic variant",0.8402450084686279
hsa-miR-5008-5p,"squamous cell breast carcinoma, acantholytic variant",0.8402450084686279
hsa-miR-100*,"squamous cell breast carcinoma, acantholytic variant",0.8402450084686279
hsa-miR-8088,"squamous cell breast carcinoma, acantholytic variant",0.8402450084686279
hsa-miR-4658,"squamous cell breast carcinoma, acantholytic variant",0.8402450084686279
hsa-miR-548ap-3p,"squamous cell breast carcinoma, acantholytic variant",0.8402450084686279
hsa-miR-26a-2,"squamous cell breast carcinoma, acantholytic variant",0.8402450084686279
hsa-miR-6735-5p,"squamous cell breast carcinoma, acantholytic variant",0.8402450084686279
hsa-miR-520d,"Luminal B,triple negative",0.8402431011199951
hsa-miR-548h-5p,"Luminal B,triple negative",0.8402431011199951
hsa-miR-548i,"Luminal B,triple negative",0.8402431011199951
hsa-miR-642a-3p,"Luminal B,triple negative",0.8402431011199951
hsa-miR-193a,aryngeal squamous cell carcinoma,0.840227484703064
hsa-miR-373,aryngeal squamous cell carcinoma,0.840227484703064
hsa-miR-539,Leptomeningeal metastasis,0.8402235507965088
hsa-miR-1324,Leptomeningeal metastasis,0.8402235507965088
hsa-miR-130a*,Leptomeningeal metastasis,0.8402235507965088
hsa-miR-92a-1,Leptomeningeal metastasis,0.8402235507965088
hsa-miR-574,Leptomeningeal metastasis,0.8402235507965088
hsa-miR-325,papillary thyroid carcinoma,0.8402202725410461
hsa-miR-626,papillary thyroid carcinoma,0.8402202725410461
hsa-miR-338-3p,"squamous cell breast carcinoma, acantholytic variant",0.8402107954025269
hsa-miR-1207-5p,"squamous cell breast carcinoma, acantholytic variant",0.8402107954025269
hsa-miR-371a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8402107954025269
hsa-miR-1302,"squamous cell breast carcinoma, acantholytic variant",0.8402107954025269
hsa-miR-6895-5p,Leptomeningeal metastasis,0.8401889801025391
hsa-miR-6734-3p,"Luminal B,triple negative",0.8401715755462646
hsa-miR-550b,"Luminal B,triple negative",0.8401715755462646
hsa-miR-570,"Luminal B,triple negative",0.8401622176170349
hsa-miR-494-3p,"Luminal B,triple negative",0.8401622176170349
hsa-miR-219-5p,"squamous cell breast carcinoma, acantholytic variant",0.8401454091072083
hsa-miR-5195-5p,"squamous cell breast carcinoma, acantholytic variant",0.8401454091072083
hsa-miR-4474-5p,"squamous cell breast carcinoma, acantholytic variant",0.8401454091072083
hsa-miR-212,"Luminal B,triple negative",0.8401415348052979
hsa-miR-106a:9.1,"Luminal B,triple negative",0.8401415348052979
hsa-miR-224*,"Luminal B,triple negative",0.8401415348052979
hsa-miR-3907,"Luminal B,triple negative",0.8401415348052979
hsa-let-7c*,"Luminal B,triple negative",0.8401415348052979
hsa-miR-3115,"Luminal B,triple negative",0.8401415348052979
hsa-miR-7973,"Luminal B,triple negative",0.8401415348052979
hsa-let-7a*,primary central nervous system lymphomas,0.8401352167129517
hsa-miR-4279,primary central nervous system lymphomas,0.8401352167129517
hsa-miR-637,papillary thyroid carcinoma,0.8401316404342651
hsa-miR-3130-3p,papillary thyroid carcinoma,0.8401316404342651
hsa-miR-6880-5p,papillary thyroid carcinoma,0.8401316404342651
hsa-miR-130a-5p,papillary thyroid carcinoma,0.8401316404342651
hsa-miR-4452,papillary thyroid carcinoma,0.8401316404342651
hsa-miR-23b,papillary thyroid carcinoma,0.8401316404342651
hsa-miR-3202,papillary thyroid carcinoma,0.8401054739952087
hsa-miR-378*,papillary thyroid carcinoma,0.8401054739952087
hsa-miR-382,papillary thyroid carcinoma,0.8401054739952087
hsa-miR-623,Leptomeningeal metastasis,0.8401003479957581
hsa-miR-376c-5p,Leptomeningeal metastasis,0.8401003479957581
hsa-miRPlus-C1110,Leptomeningeal metastasis,0.8400890827178955
hsa-miR-143*,Leptomeningeal metastasis,0.8400890827178955
hsa-miR-384,Leptomeningeal metastasis,0.8400890827178955
hsa-miR-4475,"squamous cell breast carcinoma, acantholytic variant",0.8400751352310181
hsa-miR-7161-3p,"squamous cell breast carcinoma, acantholytic variant",0.8400751352310181
hsa-miR-6736-3p,"squamous cell breast carcinoma, acantholytic variant",0.8400751352310181
hsa-miR-3684,"squamous cell breast carcinoma, acantholytic variant",0.8400751352310181
hsa-miR-549,"squamous cell breast carcinoma, acantholytic variant",0.8400751352310181
hsa-miR-585-3p,"squamous cell breast carcinoma, acantholytic variant",0.8400751352310181
hsa-miR-3142,"squamous cell breast carcinoma, acantholytic variant",0.8400751352310181
hsa-miRPlus-A1073,Leptomeningeal metastasis,0.8400741815567017
hsa-miR-29b-2,Leptomeningeal metastasis,0.8400741815567017
hsa-miR-4490,synovial sarcoma,0.8400596380233765
hsa-miR-4433-3p,synovial sarcoma,0.8400596380233765
hsa-miR-146a-5p,synovial sarcoma,0.8400596380233765
hsa-miR-3529-3p,synovial sarcoma,0.8400596380233765
hsa-miR-4485-5p,synovial sarcoma,0.8400596380233765
hsa-miR-511-2,solid pseudopapillary neoplasm of pancreas,0.8400510549545288
hsa-miR-4781-5p,solid pseudopapillary neoplasm of pancreas,0.8400510549545288
hsa-miRPlus-G1065-5p,primary central nervous system lymphomas,0.8400498628616333
hsa-miR-491-3p,aryngeal squamous cell carcinoma,0.8400138020515442
hsa-miR-3150a-3p,aryngeal squamous cell carcinoma,0.8400138020515442
hsa-miR-4491,aryngeal squamous cell carcinoma,0.8400138020515442
hsa-miR-518e-3p,papillary thyroid carcinoma,0.8400082588195801
hsa-miR-2276-3p,papillary thyroid carcinoma,0.8400082588195801
hsa-miR-3653,"squamous cell breast carcinoma, acantholytic variant",0.8400001525878906
hsa-miR-187-3p,"squamous cell breast carcinoma, acantholytic variant",0.8400001525878906
hsa-miR-3191-3p,"squamous cell breast carcinoma, acantholytic variant",0.8400001525878906
hsa-miR-4797-3p,"squamous cell breast carcinoma, acantholytic variant",0.8400001525878906
hsa-miR-499a-5p,follicular thyroid carcinoma,0.8399882316589355
hsa-miR-333,follicular thyroid carcinoma,0.8399882316589355
hsa-miR-144*,pilocytic astrocytoma,0.839981734752655
hsa-miR-1977,diffuse large B-cell lymphoma,0.8399788737297058
hsa-miR-4299,miR-675-y,0.839970588684082
hsa-miR-3659,miR-675-y,0.839970588684082
hsa-miR-3173,miR-675-y,0.839970588684082
hsa-miR-1199-5p,aryngeal squamous cell carcinoma,0.8399533033370972
hsa-miR-1185,diffuse large B-cell lymphoma,0.8399321436882019
hsa-miR-520f-5p,diffuse large B-cell lymphoma,0.8399321436882019
hsa-miR-4497,ovarian carcinoma,0.839929461479187
hsa-miR-3617-3p,ovarian carcinoma,0.839929461479187
hsa-miR-5707,ovarian carcinoma,0.839929461479187
hsa-miR-3173,ovarian carcinoma,0.839929461479187
hsa-miR-6873-5p,ovarian carcinoma,0.839929461479187
hsa-miR-548ay-5p,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-4651,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-124-5p,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-351,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-143-3p,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-6876-3p,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-6782-5p,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-1252-5p,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-378b,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-664b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8399131894111633
hsa-miR-6768-3p,synovial sarcoma,0.8398881554603577
hsa-miR-202-5p,synovial sarcoma,0.8398881554603577
hsa-miR-675-3p,synovial sarcoma,0.8398881554603577
hsa-miR-718,synovial sarcoma,0.8398881554603577
hsa-miR-3972,synovial sarcoma,0.8398881554603577
hsa-miR-4727-3p,synovial sarcoma,0.8398881554603577
hsa-miR-5699-3p,synovial sarcoma,0.8398881554603577
hsa-miR-24-1*,synovial sarcoma,0.8398881554603577
hsa-miR-655-5p,synovial sarcoma,0.8398881554603577
hsa-miR-6756-3p,synovial sarcoma,0.8398881554603577
hsa-miR-6857-3p,synovial sarcoma,0.8398881554603577
hsa-miR-146b-5p,testicular cancer,0.8398838043212891
hsa-miR-7150,testicular cancer,0.8398838043212891
hsa-miR-5702,synovial sarcoma,0.8398838043212891
hsa-miR-3137,aryngeal squamous cell carcinoma,0.8398584723472595
hsa-miR-220c,diffuse large B-cell lymphoma,0.8398424983024597
hsa-miR-021,diffuse large B-cell lymphoma,0.8398424983024597
hsa-miR-524-3p,"squamous cell breast carcinoma, acantholytic variant",0.8398151397705078
hsa-miR-4445-3p,"squamous cell breast carcinoma, acantholytic variant",0.8398151397705078
hsa-miR-132-3p,"squamous cell breast carcinoma, acantholytic variant",0.8398151397705078
hsa-miR-3616-3p,"squamous cell breast carcinoma, acantholytic variant",0.8398151397705078
hsa-miR-518d-5p,"squamous cell breast carcinoma, acantholytic variant",0.8398151397705078
hsa-miR-30b*,"squamous cell breast carcinoma, acantholytic variant",0.8398151397705078
hsa-miR-6761-3p,"squamous cell breast carcinoma, acantholytic variant",0.8398151397705078
hsa-miR-3653-3p,"squamous cell breast carcinoma, acantholytic variant",0.8398151397705078
hsa-miR-497-3p,"squamous cell breast carcinoma, acantholytic variant",0.8398151397705078
hsa-miR-487a-3p,solid pseudopapillary neoplasm of pancreas,0.8397672176361084
hsa-miR-1224,"squamous cell breast carcinoma, acantholytic variant",0.8397390246391296
hsa-miR-3673,"squamous cell breast carcinoma, acantholytic variant",0.8397390246391296
hsa-miR-644b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8397390246391296
hsa-miR-6835-5p,"squamous cell breast carcinoma, acantholytic variant",0.8397390246391296
hsa-miR-200c*,"squamous cell breast carcinoma, acantholytic variant",0.8397390246391296
hsa-miR-3924,"squamous cell breast carcinoma, acantholytic variant",0.8397390246391296
hsa-miR-518c,"squamous cell breast carcinoma, acantholytic variant",0.8397390246391296
hsa-miR-450a-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.8397092223167419
hsa-miR-4283,"squamous cell breast carcinoma, acantholytic variant",0.8397092223167419
hsa-miR-4746-3p,"squamous cell breast carcinoma, acantholytic variant",0.8397092223167419
hsa-miR-4775,diffuse large B-cell lymphoma,0.8396993279457092
hsa-miR-1260b,"squamous cell breast carcinoma, acantholytic variant",0.8395923972129822
hsa-miR-3124-5p,"squamous cell breast carcinoma, acantholytic variant",0.8395923972129822
hsa-miR-500a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8395923972129822
hsa-miR-4635,"squamous cell breast carcinoma, acantholytic variant",0.8395923972129822
hsa-miR-514b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8395923972129822
hsa-miR-5692b,"squamous cell breast carcinoma, acantholytic variant",0.8395923972129822
hsa-miR-200c-3p,"squamous cell breast carcinoma, acantholytic variant",0.8395923972129822
hsa-miR-139-5p,"squamous cell breast carcinoma, acantholytic variant",0.8395923972129822
hsa-miR-6759-5p,"squamous cell breast carcinoma, acantholytic variant",0.8395923972129822
hsa-miR-7106-5p,sarcoma,0.8395722508430481
hsa-miR-499a-3p,sarcoma,0.8395722508430481
hsa-miR-5583-3p,sarcoma,0.8395722508430481
hsa-miR-4719,sarcoma,0.8395722508430481
hsa-miR-4704-5p,sarcoma,0.8395722508430481
hsa-miR-7975,solid pseudopapillary neoplasm of pancreas,0.8395522832870483
hsa-miR-520d*,diffuse large B-cell lymphoma,0.8395492434501648
hsa-miR-485-3p,aryngeal squamous cell carcinoma,0.8395473957061768
hsa-miR-6858-3p,aryngeal squamous cell carcinoma,0.8395473957061768
hsa-miR-500a-5p,miR-675-y,0.8395382165908813
hsa-miR-545-5p,miR-675-y,0.8395382165908813
hsa-miR-4258,miR-675-y,0.8395382165908813
hsa-miR-3180-5p,"squamous cell breast carcinoma, acantholytic variant",0.8395166397094727
hsa-miR-584-5p,"squamous cell breast carcinoma, acantholytic variant",0.8395166397094727
hsa-miR-4322,"squamous cell breast carcinoma, acantholytic variant",0.8395166397094727
hsa-miR-4514,"squamous cell breast carcinoma, acantholytic variant",0.8395166397094727
hsa-miR-3922,"squamous cell breast carcinoma, acantholytic variant",0.8395166397094727
hsa-miR-196a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8395166397094727
hsa-miR-199a-3p,diffuse large B-cell lymphoma,0.8394877910614014
hsa-miR-6766-5p,diffuse large B-cell lymphoma,0.8394877910614014
hsa-miR-3675-3p,diffuse large B-cell lymphoma,0.8394877910614014
hsa-miR-548o-3p,diffuse large B-cell lymphoma,0.8394877910614014
hsa-miR-3144-3p,"squamous cell breast carcinoma, acantholytic variant",0.8394858837127686
hsa-miR-627-3p,"squamous cell breast carcinoma, acantholytic variant",0.8394858837127686
hsa-let-7i-5p,"squamous cell breast carcinoma, acantholytic variant",0.8394858837127686
hsa-miR-9-5p,"squamous cell breast carcinoma, acantholytic variant",0.8394858837127686
hsa-miR-6508-5p,"squamous cell breast carcinoma, acantholytic variant",0.8394858837127686
hsa-miR-4708-5p,"squamous cell breast carcinoma, acantholytic variant",0.8394858837127686
hsa-miR-1201,"squamous cell breast carcinoma, acantholytic variant",0.8394389152526855
hsa-miR-3647-5p,"squamous cell breast carcinoma, acantholytic variant",0.8394389152526855
hsa-miR-1255b-2,"squamous cell breast carcinoma, acantholytic variant",0.8394389152526855
hsa-miR-1205,"squamous cell breast carcinoma, acantholytic variant",0.8394389152526855
hsa-miR-363,"squamous cell breast carcinoma, acantholytic variant",0.8394389152526855
hsa-miR-429,"squamous cell breast carcinoma, acantholytic variant",0.8394389152526855
hsa-miR-1288-5p,"squamous cell breast carcinoma, acantholytic variant",0.8394389152526855
hsa-miR-7107-3p,"squamous cell breast carcinoma, acantholytic variant",0.8394389152526855
hsa-miR-5188,"squamous cell breast carcinoma, acantholytic variant",0.8394389152526855
hsa-miR-220c,aryngeal squamous cell carcinoma,0.8394331932067871
hsa-miR-603,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-194,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-3648,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-372,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-432-3p,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-614,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-302c-5p,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-1307-3p,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-5681a,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-7108-3p,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-5739,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-128b,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-506-3p,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-1911-3p,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-644a,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-32-5p,"squamous cell breast carcinoma, acantholytic variant",0.8393990993499756
hsa-miR-6824-3p,diffuse large B-cell lymphoma,0.8393919467926025
hsa-miR-216a-5p,diffuse large B-cell lymphoma,0.8393919467926025
hsa-miR-4693-3p,"squamous cell breast carcinoma, acantholytic variant",0.8393270373344421
hsa-miR-6838-5p,"squamous cell breast carcinoma, acantholytic variant",0.8393270373344421
hsa-miR-1268,"squamous cell breast carcinoma, acantholytic variant",0.8393270373344421
hsa-miR-6715b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8393270373344421
hsa-miR-1250,diffuse large B-cell lymphoma,0.8393242955207825
hsa-miR-2964a-3p,diffuse large B-cell lymphoma,0.8393242955207825
hsa-miR-1296-3p,diffuse large B-cell lymphoma,0.8393242955207825
hsa-miR-513a-1,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-145*,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-1974,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-562,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-620,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-125b-2,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-548s,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-203a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-4643,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-185*,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-376a,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-465,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-519b,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-768,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-3157,"squamous cell breast carcinoma, acantholytic variant",0.8393179178237915
hsa-miR-493-5p,aryngeal squamous cell carcinoma,0.839313805103302
hsa-miR-4779,"squamous cell breast carcinoma, acantholytic variant",0.8392969965934753
hsa-let-7c*,"squamous cell breast carcinoma, acantholytic variant",0.8392969965934753
hsa-miR-450a-1-3p,"squamous cell breast carcinoma, acantholytic variant",0.8392969965934753
hsa-miR-4424,"squamous cell breast carcinoma, acantholytic variant",0.8392969965934753
hsa-miR-545*,"squamous cell breast carcinoma, acantholytic variant",0.8392969965934753
hsa-miR-3127-5p,"squamous cell breast carcinoma, acantholytic variant",0.8392969965934753
hsa-miR-7973,"squamous cell breast carcinoma, acantholytic variant",0.8392969965934753
hsa-miR-885,"squamous cell breast carcinoma, acantholytic variant",0.8392969965934753
hsa-miR-548au-3p,sarcoma,0.8391883969306946
hsa-miR-6771-5p,sarcoma,0.8391883969306946
hsa-miR-203b-3p,sarcoma,0.8391883969306946
hsa-miR-4290,synovial sarcoma,0.8391558527946472
hsa-miR-148a-5p,follicular thyroid carcinoma,0.8391152024269104
hsa-miR-4471,ovarian carcinoma,0.8391059041023254
hsa-miR-431-5p,ovarian carcinoma,0.8391059041023254
hsa-let-7f-1-3p,aryngeal squamous cell carcinoma,0.8390575647354126
hsa-miR-127-3p,diffuse large B-cell lymphoma,0.8390489816665649
hsa-miR-765,diffuse large B-cell lymphoma,0.8390489816665649
hsa-miR-15b-5p,synovial sarcoma,0.8390411734580994
hsa-miR-4490,castration-resistant prostate cancer,0.8389778137207031
hsa-miR-518d,castration-resistant prostate cancer,0.8389778137207031
hsa-miR-6760-5p,castration-resistant prostate cancer,0.8389778137207031
hsa-let-7f-2*,castration-resistant prostate cancer,0.8389778137207031
hsa-miR-15a-5p,castration-resistant prostate cancer,0.8389778137207031
hsa-miR-4691-5p,aryngeal squamous cell carcinoma,0.8389200568199158
hsa-miR-490-3p,"Luminal B,triple negative",0.8389163613319397
hsa-miR-212-5p,"Luminal B,triple negative",0.8389163613319397
hsa-miR-3147,"Luminal B,triple negative",0.8389163613319397
hsa-miR-1226-3p,diffuse large B-cell lymphoma,0.8388635516166687
hsa-miR-892a,castration-resistant prostate cancer,0.8388054370880127
hsa-miR-6798-3p,castration-resistant prostate cancer,0.8388054370880127
hsa-miR-324-5p,castration-resistant prostate cancer,0.8388054370880127
hsa-miR-5583-3p,castration-resistant prostate cancer,0.8388054370880127
hsa-let-7e-3p,castration-resistant prostate cancer,0.8388054370880127
hsa-miR-92a-1-5p,castration-resistant prostate cancer,0.8388054370880127
hsa-miR-4301,castration-resistant prostate cancer,0.8388054370880127
hsa-miR-4258,high grade serous papillary ovarian cancer,0.838793933391571
hsa-miR-4768-5p,synovial sarcoma,0.8387905359268188
hsa-miR-6780a-5p,aryngeal squamous cell carcinoma,0.838771402835846
hsa-miR-1306,diffuse large B-cell lymphoma,0.8387277722358704
hsa-miR-379,diffuse large B-cell lymphoma,0.8387277722358704
hsa-miR-16-1-3p,diffuse large B-cell lymphoma,0.8387277722358704
hsa-miR-130a*,diffuse large B-cell lymphoma,0.8387277722358704
hsa-miR-106a:9.1,diffuse large B-cell lymphoma,0.8387277722358704
hsa-miR-7-1,diffuse large B-cell lymphoma,0.8387277722358704
hsa-miR-6130,diffuse large B-cell lymphoma,0.8387277722358704
hsa-miR-6504-5p,diffuse large B-cell lymphoma,0.8387277722358704
hsa-miR-942-5p,synovial sarcoma,0.838722825050354
hsa-miR-1180-5p,sarcoma,0.8386801481246948
hsa-miR-1292-5p,diffuse large B-cell lymphoma,0.838667631149292
hsa-miR-1269,diffuse large B-cell lymphoma,0.838667631149292
hsa-miR-93*,diffuse large B-cell lymphoma,0.838667631149292
hsa-miR-4489,sarcoma,0.8386648297309875
hsa-miR-600,synovial sarcoma,0.8386539220809937
hsa-miR-3189-5p,synovial sarcoma,0.8386539220809937
hsa-miR-877,synovial sarcoma,0.8386539220809937
hsa-miR-6089,synovial sarcoma,0.8386539220809937
hsa-miR-199a*-2,synovial sarcoma,0.8386539220809937
hsa-miR-5186,synovial sarcoma,0.8386539220809937
hsa-let-7a_c,synovial sarcoma,0.8386539220809937
hsa-miR-153-5p,synovial sarcoma,0.8386539220809937
hsa-miR-4699-3p,synovial sarcoma,0.8386539220809937
hsa-miR-4716-3p,synovial sarcoma,0.8386530876159668
hsa-miR-151a-3p,aryngeal squamous cell carcinoma,0.8386149406433105
hsa-miR-551b,brain cancer,0.8386076092720032
hsa-miR-7162-3p,brain cancer,0.8386076092720032
hsa-miR-365b-3p,synovial sarcoma,0.8385809659957886
hsa-miR-186,sarcoma,0.8385258913040161
hsa-miR-142,sarcoma,0.8384863138198853
hsa-miR-2114*,sarcoma,0.8384863138198853
hsa-miR-607,miR-675-y,0.838485598564148
hsa-miR-606,miR-675-y,0.838485598564148
hsa-miR-302c-3p,sarcoma,0.8384656310081482
hsa-miR-548al,diffuse large B-cell lymphoma,0.8384606242179871
hsa-miR-3545-3p,diffuse large B-cell lymphoma,0.8384393453598022
hsa-miR-6864-3p,diffuse large B-cell lymphoma,0.8384393453598022
hsa-miR-4450,synovial sarcoma,0.8384295701980591
hsa-miR-3182,synovial sarcoma,0.8384295701980591
hsa-miR-205-5p,synovial sarcoma,0.8384295701980591
hsa-miR-302c-3p,synovial sarcoma,0.8384295701980591
hsa-miR-5008-5p,aryngeal squamous cell carcinoma,0.8383809924125671
hsa-miR-129-3p,aryngeal squamous cell carcinoma,0.8383809924125671
hsa-miR-558,aryngeal squamous cell carcinoma,0.8383809924125671
hsa-miR-6752-5p,aryngeal squamous cell carcinoma,0.8383809924125671
hsa-miR-6847-5p,aryngeal squamous cell carcinoma,0.8383809924125671
hsa-miR-801,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-624-3p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-1267,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-30c-2,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-4468,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-941,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-3972,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-4722-3p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-302a-5p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-214-5p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-6864-3p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-3200,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-6873-3p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-6505-5p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-4704-5p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-6868-3p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-655-5p,castration-resistant prostate cancer,0.8383588194847107
hsa-miR-130a-3p,diffuse large B-cell lymphoma,0.838356614112854
hsa-miR-365,aryngeal squamous cell carcinoma,0.8382763266563416
hsa-miR-3681-3p,aryngeal squamous cell carcinoma,0.8382763266563416
hsa-miR-1909*,sarcoma,0.8382742404937744
hsa-miR-3622b-5p,diffuse large B-cell lymphoma,0.8382417559623718
hsa-miR-6803-3p,diffuse large B-cell lymphoma,0.8382417559623718
hsa-miR-136,diffuse large B-cell lymphoma,0.8382417559623718
hsa-miR-4749-3p,sarcoma,0.8382404446601868
hsa-miR-4256,sarcoma,0.8382404446601868
hsa-miR-3200-3p,sarcoma,0.8382404446601868
hsa-miR-4642,sarcoma,0.8381911516189575
hsa-miR-5089-5p,synovial sarcoma,0.8381822109222412
hsa-miR-1251-3p,synovial sarcoma,0.8381822109222412
hsa-miR-149*,sarcoma,0.8381607532501221
hsa-let-7b*,sarcoma,0.8381607532501221
hsa-miR-362-5p,sarcoma,0.8381607532501221
hsa-miR-218-5p,sarcoma,0.8381607532501221
hsa-miR-6720-5p,sarcoma,0.8381607532501221
hsa-miR-6500-3p,synovial sarcoma,0.838138222694397
hsa-miR-612,synovial sarcoma,0.838138222694397
hsa-miR-222-3p,synovial sarcoma,0.838138222694397
hsa-miR-516b,synovial sarcoma,0.838138222694397
hsa-miR-6741-5p,synovial sarcoma,0.838138222694397
hsa-miR-6877-3p,synovial sarcoma,0.838138222694397
hsa-miR-330-3p,synovial sarcoma,0.838138222694397
hsa-miR-4491,synovial sarcoma,0.838138222694397
hsa-miR-3200-3p,synovial sarcoma,0.838138222694397
hsa-miR-8073,synovial sarcoma,0.838138222694397
hsa-miR-1237-5p,synovial sarcoma,0.838138222694397
hsa-miR-3672,synovial sarcoma,0.838138222694397
hsa-miR-551b-3p,sarcoma,0.8381296992301941
hsa-miR-4653-3p,castration-resistant prostate cancer,0.8381243944168091
hsa-miR-566,synovial sarcoma,0.8381091952323914
hsa-miR-4330,synovial sarcoma,0.8381091952323914
hsa-miR-196a-2,synovial sarcoma,0.8381091952323914
hsa-miR-7975,synovial sarcoma,0.8381091952323914
hsa-miR-4258,synovial sarcoma,0.8381091952323914
hsa-miR-341,synovial sarcoma,0.8381091952323914
hsa-miR-1229-3p,synovial sarcoma,0.8381091952323914
hsa-miR-485-3p,sarcoma,0.8380971550941467
hsa-miR-4516,synovial sarcoma,0.8380937576293945
hsa-miR-129*,diffuse large B-cell lymphoma,0.8380889296531677
hsa-miR-6814-3p,diffuse large B-cell lymphoma,0.8380889296531677
hsa-miR-1226-5p,diffuse large B-cell lymphoma,0.8380889296531677
hsa-miR-4763-5p,diffuse large B-cell lymphoma,0.8380889296531677
hsa-miR-3187-3p,diffuse large B-cell lymphoma,0.8380889296531677
hsa-miR-1184,diffuse large B-cell lymphoma,0.8380889296531677
hsa-miR-3677-5p,diffuse large B-cell lymphoma,0.8380889296531677
hsa-miR-3944-5p,diffuse large B-cell lymphoma,0.8380889296531677
hsa-miR-4659b-3p,aryngeal squamous cell carcinoma,0.8380875587463379
hsa-miR-4471,aryngeal squamous cell carcinoma,0.8380670547485352
hsa-miR-6084,sarcoma,0.8380628228187561
hsa-miR-30c-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.838047981262207
hsa-miR-6512-3p,"squamous cell breast carcinoma, acantholytic variant",0.838047981262207
hsa-miR-6852-5p,sarcoma,0.8380269408226013
hsa-miR-676-5p,diffuse large B-cell lymphoma,0.8380062580108643
hsa-miR-3150b-3p,diffuse large B-cell lymphoma,0.8380062580108643
hsa-miR-1323,diffuse large B-cell lymphoma,0.8380062580108643
hsa-miR-4683,sarcoma,0.8379891514778137
hsa-miR-203b-5p,sarcoma,0.8379891514778137
hsa-miR-6861-3p,follicular thyroid carcinoma,0.8379777669906616
hsa-miR-219b-3p,synovial sarcoma,0.8379685878753662
hsa-miR-15b-5p,castration-resistant prostate cancer,0.8379538655281067
hsa-let-7f-1-3p,sarcoma,0.8379490971565247
hsa-miR-374c-3p,sarcoma,0.8379072546958923
hsa-miR-6878-5p,sarcoma,0.8379072546958923
hsa-miR-135b-3p,sarcoma,0.8379072546958923
hsa-miR-6797-5p,synovial sarcoma,0.8379070162773132
hsa-miR-7850-5p,aryngeal squamous cell carcinoma,0.8379027247428894
hsa-miR-1283-1,aryngeal squamous cell carcinoma,0.8379027247428894
hsa-miR-4299,rhabdomyosarcomas,0.8378741145133972
hsa-miR-4497,rhabdomyosarcomas,0.8378741145133972
hsa-miR-422a,rhabdomyosarcomas,0.8378741145133972
hsa-miR-4706,sarcoma,0.8378610610961914
hsa-miR-2115-3p,sarcoma,0.8378610610961914
hsa-miR-548aq-5p,diffuse large B-cell lymphoma,0.837812602519989
hsa-miR-5006-5p,diffuse large B-cell lymphoma,0.837812602519989
hsa-miR-331-5p,diffuse large B-cell lymphoma,0.837812602519989
hsa-miR-1270,diffuse large B-cell lymphoma,0.837812602519989
hsa-miR-199a-2,sarcoma,0.8378109335899353
hsa-miR-193a,synovial sarcoma,0.83780837059021
hsa-miR-373,synovial sarcoma,0.83780837059021
hsa-miR-631,synovial sarcoma,0.83780837059021
hsa-miR-674,synovial sarcoma,0.83780837059021
hsa-miR-616-3p,"squamous cell breast carcinoma, acantholytic variant",0.837804913520813
hsa-miR-6723-5p,"squamous cell breast carcinoma, acantholytic variant",0.837804913520813
hsa-miR-142,diffuse large B-cell lymphoma,0.8377962708473206
hsa-miR-330-5p,diffuse large B-cell lymphoma,0.8377773761749268
hsa-miR-3202,diffuse large B-cell lymphoma,0.8377773761749268
hsa-miR-651-3p,diffuse large B-cell lymphoma,0.8377773761749268
hsa-miR-1185-2-3p,diffuse large B-cell lymphoma,0.8377773761749268
hsa-miR-106b*,diffuse large B-cell lymphoma,0.8377773761749268
hsa-miR-132-5p,diffuse large B-cell lymphoma,0.8377773761749268
hsa-miR-767,sarcoma,0.8377594947814941
hsa-miR-092,diffuse large B-cell lymphoma,0.837713360786438
hsa-miR-34b-3p,diffuse large B-cell lymphoma,0.837713360786438
hsa-miR-202-5p,breast cancer brain metastasis,0.837710440158844
hsa-miR-3196,sarcoma,0.8377069234848022
hsa-miR-548al,sarcoma,0.8377069234848022
hsa-miR-1266,sarcoma,0.8377069234848022
hsa-miR-587,aryngeal squamous cell carcinoma,0.8377065062522888
hsa-miR-1247-5p,synovial sarcoma,0.837705671787262
hsa-miR-6740-5p,synovial sarcoma,0.837705671787262
hsa-miR-3143,primary central nervous system lymphomas,0.8376708626747131
hsa-miR-4677-3p,sarcoma,0.8376520872116089
hsa-miR-19a*,"squamous cell breast carcinoma, acantholytic variant",0.8376314043998718
hsa-miR-326,"squamous cell breast carcinoma, acantholytic variant",0.8376314043998718
hsa-miR-503-5p,"squamous cell breast carcinoma, acantholytic variant",0.8376314043998718
hsa-miR-655-5p,"squamous cell breast carcinoma, acantholytic variant",0.8376314043998718
hsa-miR-500b,diffuse large B-cell lymphoma,0.8376128673553467
hsa-miR-6806-5p,diffuse large B-cell lymphoma,0.8376128673553467
hsa-miR-3146,diffuse large B-cell lymphoma,0.8376128673553467
hsa-miR-6844,diffuse large B-cell lymphoma,0.8376128673553467
hsa-miR-3668,castration-resistant prostate cancer,0.8376071453094482
hsa-let-7a-2*,synovial sarcoma,0.8375990986824036
hsa-miR-500*,synovial sarcoma,0.8375990986824036
hsa-miR-191-5p,sarcoma,0.8375979661941528
hsa-miR-1287-3p,sarcoma,0.8375979661941528
hsa-miR-145,diffuse large B-cell lymphoma,0.8375948667526245
hsa-miR-935,diffuse large B-cell lymphoma,0.8375948667526245
hsa-miR-548aq-3p,diffuse large B-cell lymphoma,0.8375948667526245
hsa-miR-6503-5p,castration-resistant prostate cancer,0.8375635743141174
hsa-miR-221*,breast cancer brain metastasis,0.8375537991523743
hsa-miR-1468,breast cancer brain metastasis,0.8375537991523743
hsa-miR-219b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8375500440597534
hsa-miR-4767,sarcoma,0.8375406861305237
hsa-miR-6747-3p,miR-675-y,0.8375336527824402
hsa-miR-4290,diffuse large B-cell lymphoma,0.8375266194343567
hsa-miR-4764-3p,aryngeal squamous cell carcinoma,0.8375009298324585
hsa-miR-519e-3p,follicular thyroid carcinoma,0.8374975919723511
hsa-miR-3655,synovial sarcoma,0.837488055229187
hsa-miR-30c-2*,synovial sarcoma,0.837488055229187
hsa-miR-1300,diffuse large B-cell lymphoma,0.8374629616737366
hsa-miR-500a-3p,diffuse large B-cell lymphoma,0.8374629616737366
hsa-miR-518b,diffuse large B-cell lymphoma,0.8374629616737366
hsa-miR-139-5p,diffuse large B-cell lymphoma,0.8374629616737366
hsa-miR-4800-3p,diffuse large B-cell lymphoma,0.8374629616737366
hsa-miR-24-2-5p,diffuse large B-cell lymphoma,0.8374629616737366
hsa-miR-2681,sarcoma,0.837450385093689
hsa-miR-558,sarcoma,0.837450385093689
hsa-miR-433-3p,castration-resistant prostate cancer,0.8374294638633728
hsa-miR-193b,sarcoma,0.8374156951904297
hsa-miR-1247,breast cancer brain metastasis,0.8374084830284119
hsa-miR-1244,diffuse large B-cell lymphoma,0.8374059200286865
hsa-miR-6867-3p,diffuse large B-cell lymphoma,0.8373870849609375
hsa-miR-640,castration-resistant prostate cancer,0.8373783230781555
hsa-miR-3609,synovial sarcoma,0.8373724818229675
hsa-miR-1909,synovial sarcoma,0.8373724818229675
hsa-miR-4739,synovial sarcoma,0.8373724818229675
hsa-miR-7843-5p,diffuse large B-cell lymphoma,0.837369441986084
hsa-miR-140-5p,diffuse large B-cell lymphoma,0.837369441986084
hsa-miR-411-5p,diffuse large B-cell lymphoma,0.837369441986084
hsa-miR-4787-5p,diffuse large B-cell lymphoma,0.8373673558235168
hsa-miR-4298,sarcoma,0.8373492956161499
hsa-miR-676-3p,sarcoma,0.8373492956161499
hsa-miR-6083,sarcoma,0.8373492956161499
hsa-miR-3140-5p,sarcoma,0.8373492956161499
hsa-miR-130a-3p,castration-resistant prostate cancer,0.8373432755470276
hsa-miR-8065,castration-resistant prostate cancer,0.837338924407959
hsa-miR-4450,castration-resistant prostate cancer,0.837338924407959
hsa-miR-942-5p,castration-resistant prostate cancer,0.8373249769210815
hsa-miR-6881-5p,diffuse large B-cell lymphoma,0.8373247981071472
hsa-miR-6831-3p,diffuse large B-cell lymphoma,0.8373247981071472
hsa-miR-4418,diffuse large B-cell lymphoma,0.8373247981071472
hsa-miR-566,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-3194,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-4497,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-422a,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-3617-3p,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-5707,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-7975,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-3173,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-301b-5p,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-3683,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-4677-5p,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-6512-3p,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-6831-5p,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-7157-3p,castration-resistant prostate cancer,0.8373199701309204
hsa-miR-6755-5p,castration-resistant prostate cancer,0.837306022644043
hsa-miR-656,castration-resistant prostate cancer,0.837306022644043
hsa-miR-186,castration-resistant prostate cancer,0.837306022644043
hsa-miR-887-3p,aryngeal squamous cell carcinoma,0.8372920751571655
hsa-miR-1224,aryngeal squamous cell carcinoma,0.8372920751571655
hsa-miRPlus-G1246-3p,aryngeal squamous cell carcinoma,0.8372920751571655
hsa-miR-4724-3p,aryngeal squamous cell carcinoma,0.8372920751571655
hsa-miR-3187,aryngeal squamous cell carcinoma,0.8372920751571655
hsa-let-7b-5p,aryngeal squamous cell carcinoma,0.8372920751571655
hsa-miR-4438,aryngeal squamous cell carcinoma,0.8372920751571655
hsa-miR-133b,aryngeal squamous cell carcinoma,0.837289571762085
hsa-miR-204-5p,aryngeal squamous cell carcinoma,0.837289571762085
hsa-miR-6813-5p,aryngeal squamous cell carcinoma,0.837289571762085
hsa-miR-4446-3p,castration-resistant prostate cancer,0.8372862935066223
hsa-miR-424*,castration-resistant prostate cancer,0.8372862935066223
hsa-miR-365b-3p,castration-resistant prostate cancer,0.8372862935066223
hsa-miR-6077,diffuse large B-cell lymphoma,0.8372823596000671
hsa-miR-4640-5p,sarcoma,0.8372781872749329
hsa-miR-4443,sarcoma,0.8372781872749329
hsa-miR-6747-5p,castration-resistant prostate cancer,0.8372661471366882
hsa-miR-92b,castration-resistant prostate cancer,0.8372661471366882
hsa-miR-6794-3p,diffuse large B-cell lymphoma,0.8372615575790405
hsa-miR-25-5p,diffuse large B-cell lymphoma,0.8372615575790405
hsa-miR-502-5p,castration-resistant prostate cancer,0.8372588753700256
hsa-let-7b*,synovial sarcoma,0.8372520208358765
hsa-miR-218-5p,synovial sarcoma,0.8372520208358765
hsa-miR-6808-3p,synovial sarcoma,0.8372520208358765
hsa-miR-3690,synovial sarcoma,0.8372520208358765
hsa-miR-6715b-3p,synovial sarcoma,0.8372520208358765
hsa-miR-3182,castration-resistant prostate cancer,0.8372453451156616
hsa-miR-302c-3p,castration-resistant prostate cancer,0.8372453451156616
hsa-miR-3646,diffuse large B-cell lymphoma,0.8372353315353394
hsa-miR-185,diffuse large B-cell lymphoma,0.83720862865448
hsa-miR-320e,diffuse large B-cell lymphoma,0.83720862865448
hsa-miR-548h,diffuse large B-cell lymphoma,0.83720862865448
hsa-miR-449b,diffuse large B-cell lymphoma,0.83720862865448
hsa-miR-351,diffuse large B-cell lymphoma,0.83720862865448
hsa-miR-323-5p,sarcoma,0.8372021913528442
hsa-miR-3191-3p,sarcoma,0.8372021913528442
hsa-miR-3688-5p,sarcoma,0.8372021913528442
hsa-miR-4505,castration-resistant prostate cancer,0.8372011184692383
hsa-miR-6733-3p,castration-resistant prostate cancer,0.8372011184692383
hsa-miR-103-as,sarcoma,0.8371835947036743
hsa-miR-4310,follicular thyroid carcinoma,0.8371797204017639
hsa-miR-1288,follicular thyroid carcinoma,0.8371797204017639
hsa-miR-7113-3p,castration-resistant prostate cancer,0.8371781706809998
hsa-miR-4670-5p,castration-resistant prostate cancer,0.8371781706809998
hsa-miR-1251-3p,castration-resistant prostate cancer,0.8371781706809998
hsa-miR-4670-5p,diffuse large B-cell lymphoma,0.8371616005897522
hsa-miR-3668,solid pseudopapillary neoplasm of pancreas,0.8371544480323792
hsa-miR-372,follicular thyroid carcinoma,0.8371531963348389
hsa-miR-486-3p,diffuse large B-cell lymphoma,0.8371338844299316
hsa-miR-642a-5p,diffuse large B-cell lymphoma,0.8371333479881287
hsa-miR-454-5p,synovial sarcoma,0.8371263742446899
hsa-miR-103b,synovial sarcoma,0.8371263742446899
hsa-miR-6802-3p,diffuse large B-cell lymphoma,0.8371139168739319
hsa-miR-769-3p,diffuse large B-cell lymphoma,0.8371139168739319
hsa-miR-3688-5p,diffuse large B-cell lymphoma,0.8371139168739319
hsa-miR-548h,sarcoma,0.8371139168739319
hsa-miR-6773-3p,sarcoma,0.8371139168739319
hsa-miR-351,sarcoma,0.8371139168739319
hsa-miR-3960,sarcoma,0.8371139168739319
hsa-miR-6782-5p,sarcoma,0.8371139168739319
hsa-miR-1182,diffuse large B-cell lymphoma,0.8370999693870544
hsa-miR-6773-5p,diffuse large B-cell lymphoma,0.8370999693870544
hsa-miR-1268b,diffuse large B-cell lymphoma,0.8370999693870544
hsa-miR-5089-5p,castration-resistant prostate cancer,0.837090253829956
hsa-miR-133a-3p,castration-resistant prostate cancer,0.837090253829956
hsa-miR-138-2-3p,diffuse large B-cell lymphoma,0.8370791673660278
hsa-miR-596,castration-resistant prostate cancer,0.8370783925056458
hsa-miR-3666,castration-resistant prostate cancer,0.8370783925056458
hsa-miR-123,castration-resistant prostate cancer,0.8370783925056458
hsa-miR-373,castration-resistant prostate cancer,0.8370783925056458
hsa-miR-674,castration-resistant prostate cancer,0.8370783925056458
hsa-miR-642a-5p,aryngeal squamous cell carcinoma,0.8370766639709473
hsa-miR-3184-3p,aryngeal squamous cell carcinoma,0.8370766639709473
hsa-miR-302b-3p,aryngeal squamous cell carcinoma,0.8370766639709473
hsa-miRPlus-A1086,castration-resistant prostate cancer,0.837052583694458
hsa-miR-485-5p,castration-resistant prostate cancer,0.837052583694458
hsa-miR-3137,diffuse large B-cell lymphoma,0.8370502591133118
hsa-miR-593*,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-96*,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-1538,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-1182,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-4256,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-3689f,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-376a-2-5p,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-8052,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-7162-5p,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-7160-3p,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-4491,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-3065-5p,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-8073,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-3186-5p,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-4712-5p,castration-resistant prostate cancer,0.8370460271835327
hsa-miR-146a-5p,aryngeal squamous cell carcinoma,0.837028980255127
hsa-miR-676,aryngeal squamous cell carcinoma,0.837028980255127
hsa-miR-6875-3p,castration-resistant prostate cancer,0.8370259404182434
hsa-miR-616*,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-518f-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-200a-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-1343,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-6500-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-let-7a-1,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-612,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-491-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-4796-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-516b,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-193b-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-6877-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-6073,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-3121-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-7703,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-4701-5p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-513b-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-552-5p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-5000-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-15a*,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-6754-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-513c-3p,castration-resistant prostate cancer,0.8370186686515808
hsa-miR-520f,sarcoma,0.8370144963264465
hsa-miR-29c-5p,sarcoma,0.8370144963264465
hsa-miR-132-3p,sarcoma,0.8370144963264465
hsa-miR-1301-3p,sarcoma,0.8370144963264465
hsa-miR-3686,sarcoma,0.8370144963264465
hsa-miR-122-5p,sarcoma,0.8370144963264465
hsa-miR-4429,castration-resistant prostate cancer,0.8369978666305542
hsa-miR-3655,castration-resistant prostate cancer,0.8369978666305542
hsa-miR-924,castration-resistant prostate cancer,0.8369978666305542
hsa-miR-30c-2*,castration-resistant prostate cancer,0.8369978666305542
hsa-miR-106a*,synovial sarcoma,0.8369951248168945
hsa-miR-24-1,synovial sarcoma,0.8369951248168945
hsa-miR-1977,synovial sarcoma,0.8369951248168945
hsa-miR-6858-3p,synovial sarcoma,0.8369951248168945
hsa-miR-6847-3p,synovial sarcoma,0.8369951248168945
hsa-miR-1298-5p,synovial sarcoma,0.8369951248168945
hsa-miR-548x-3p,diffuse large B-cell lymphoma,0.8369919657707214
hsa-miR-1307-5p,diffuse large B-cell lymphoma,0.8369919657707214
hsa-miR-6741-3p,miR-675-y,0.8369909524917603
hsa-miR-424*,miR-675-y,0.8369909524917603
hsa-miR-3137,castration-resistant prostate cancer,0.8369690179824829
hsa-miR-4666a-3p,castration-resistant prostate cancer,0.8369690179824829
hsa-miR-5090,castration-resistant prostate cancer,0.8369690179824829
hsa-miR-6782-3p,castration-resistant prostate cancer,0.8369690179824829
hsa-miR-4271,primary central nervous system lymphomas,0.8369594216346741
hsa-miR-151-3p,castration-resistant prostate cancer,0.8369387984275818
hsa-let-7b*,castration-resistant prostate cancer,0.8369387984275818
hsa-miR-149-3p,castration-resistant prostate cancer,0.8369387984275818
hsa-miR-6720-5p,castration-resistant prostate cancer,0.8369387984275818
hsa-miR-6715b-3p,castration-resistant prostate cancer,0.8369387984275818
hsa-miR-1258,sarcoma,0.8369371891021729
hsa-miR-2114-3p,sarcoma,0.8369371891021729
hsa-miR-331,sarcoma,0.8369371891021729
hsa-miR-6818-5p,sarcoma,0.8369371891021729
hsa-miR-4697-3p,sarcoma,0.8369371891021729
hsa-miR-891a-5p,sarcoma,0.8369371891021729
hsa-let-7a*,"Luminal B,triple negative",0.8369088172912598
hsa-miR-4322,"Luminal B,triple negative",0.8369088172912598
hsa-miR-3922,"Luminal B,triple negative",0.8369088172912598
hsa-miR-196a-5p,"Luminal B,triple negative",0.8369088172912598
hsa-miR-6728-3p,castration-resistant prostate cancer,0.8369070291519165
hsa-miR-4295,castration-resistant prostate cancer,0.8369070291519165
hsa-miR-2052,sarcoma,0.8369070291519165
hsa-miR-7156-5p,castration-resistant prostate cancer,0.8369070291519165
hsa-miR-4290,breast cancer brain metastasis,0.836905300617218
hsa-miR-5702,sarcoma,0.836894154548645
hsa-miR-4475,diffuse large B-cell lymphoma,0.8368907570838928
hsa-miR-26b*,diffuse large B-cell lymphoma,0.8368907570838928
hsa-miR-549,diffuse large B-cell lymphoma,0.8368907570838928
hsa-miR-22*,diffuse large B-cell lymphoma,0.8368907570838928
hsa-miR-5195-3p,diffuse large B-cell lymphoma,0.8368907570838928
hsa-miR-147b,diffuse large B-cell lymphoma,0.836885392665863
hsa-miR-3155b,diffuse large B-cell lymphoma,0.836885392665863
hsa-miR-3683,sarcoma,0.8368853330612183
hsa-miR-483-5p,diffuse large B-cell lymphoma,0.8368787169456482
hsa-miR-219-5p,diffuse large B-cell lymphoma,0.8368787169456482
hsa-miR-369-3p,diffuse large B-cell lymphoma,0.8368787169456482
hsa-miR-1977,castration-resistant prostate cancer,0.8368744850158691
hsa-miR-320a,castration-resistant prostate cancer,0.8368744850158691
hsa-miR-6847-3p,castration-resistant prostate cancer,0.8368744850158691
hsa-miR-122-3p,synovial sarcoma,0.8368567228317261
hsa-miR-4419a,synovial sarcoma,0.8368567228317261
hsa-miR-105-5p,synovial sarcoma,0.8368567228317261
hsa-miR-3064-5p,synovial sarcoma,0.8368567228317261
hsa-miR-3156-3p,aryngeal squamous cell carcinoma,0.8368478417396545
hsa-miR-4458,diffuse large B-cell lymphoma,0.8368470668792725
hsa-miR-1245b-5p,miR-675-y,0.8368416428565979
hsa-miR-220c,castration-resistant prostate cancer,0.8368399739265442
hsa-miR-4271,"squamous cell breast carcinoma, acantholytic variant",0.836836576461792
hsa-miR-4330,miR-142-y,0.8368338942527771
hsa-miR-489,castration-resistant prostate cancer,0.8368135094642639
hsa-miR-3934-3p,castration-resistant prostate cancer,0.8368135094642639
hsa-miR-6797-5p,castration-resistant prostate cancer,0.8368135094642639
hsa-miR-19b-1,castration-resistant prostate cancer,0.8368040323257446
hsa-miR-627,castration-resistant prostate cancer,0.8368040323257446
hsa-miR-31-5p,castration-resistant prostate cancer,0.8368040323257446
hsa-miR-6755-3p,castration-resistant prostate cancer,0.8368040323257446
hsa-miR-3155b,castration-resistant prostate cancer,0.8368040323257446
hsa-miR-604,diffuse large B-cell lymphoma,0.836793065071106
hsa-miR-4509,diffuse large B-cell lymphoma,0.836793065071106
hsa-miR-363-3p,sarcoma,0.8367884755134583
hsa-miR-5692b,sarcoma,0.8367884755134583
hsa-miR-124*,diffuse large B-cell lymphoma,0.8367732167243958
hsa-miR-519c-5p,diffuse large B-cell lymphoma,0.8367732167243958
hsa-miR-7,castration-resistant prostate cancer,0.836765706539154
hsa-miR-4644,castration-resistant prostate cancer,0.836765706539154
hsa-miR-367-5p,castration-resistant prostate cancer,0.836765706539154
hsa-miR-203b-5p,castration-resistant prostate cancer,0.836765706539154
hsa-miR-4318,diffuse large B-cell lymphoma,0.8367648720741272
hsa-miR-330,diffuse large B-cell lymphoma,0.8367648720741272
hsa-miR-4271,"Luminal B,triple negative",0.8367342948913574
hsa-miR-4299,breast cancer brain metastasis,0.8367300033569336
hsa-miR-1587,breast cancer brain metastasis,0.8367300033569336
hsa-miR-483,castration-resistant prostate cancer,0.8367254734039307
hsa-miR-588,castration-resistant prostate cancer,0.8367254734039307
hsa-miR-1911*,castration-resistant prostate cancer,0.8367254734039307
hsa-miR-216a-5p,castration-resistant prostate cancer,0.8367254734039307
hsa-miRPlus-C1114,Leptomeningeal metastasis,0.8367229104042053
hsa-miR-513-5p,diffuse large B-cell lymphoma,0.8367183804512024
hsa-miR-517c-3p,castration-resistant prostate cancer,0.8367142677307129
hsa-miR-4756-5p,synovial sarcoma,0.8367113471031189
hsa-miR-6791-5p,synovial sarcoma,0.8367113471031189
hsa-miR-767-5p,synovial sarcoma,0.8367113471031189
hsa-miR-4775,synovial sarcoma,0.8367113471031189
hsa-miR-3938,synovial sarcoma,0.8367113471031189
hsa-miR-552,castration-resistant prostate cancer,0.8366835713386536
hsa-miR-3136-5p,castration-resistant prostate cancer,0.8366835713386536
hsa-miR-548d-2,castration-resistant prostate cancer,0.8366835713386536
hsa-miR-3152-5p,castration-resistant prostate cancer,0.8366835713386536
hsa-miR-5584-5p,sarcoma,0.8366805911064148
hsa-miR-1305,sarcoma,0.8366805911064148
hsa-miR-200c,sarcoma,0.8366805911064148
hsa-miR-4539,sarcoma,0.8366805911064148
hsa-miR-6511a-3p,sarcoma,0.8366805911064148
hsa-miR-517c,diffuse large B-cell lymphoma,0.8366739749908447
hsa-miR-6836-3p,diffuse large B-cell lymphoma,0.8366739749908447
hsa-miR-7154-5p,diffuse large B-cell lymphoma,0.8366739749908447
hsa-miR-3177-3p,diffuse large B-cell lymphoma,0.8366739749908447
hsa-miR-6834-3p,diffuse large B-cell lymphoma,0.8366683125495911
hsa-miR-1261,miR-675-y,0.8366643190383911
hsa-miR-3123,miR-675-y,0.8366643190383911
hsa-miR-220a,miR-675-y,0.8366643190383911
hsa-miR-640,primary central nervous system lymphomas,0.8366587162017822
hsa-miR-548q,"squamous cell breast carcinoma, acantholytic variant",0.8366519808769226
hsa-miR-4260,castration-resistant prostate cancer,0.8366368412971497
hsa-miR-4499,castration-resistant prostate cancer,0.8366368412971497
hsa-miR-4706,castration-resistant prostate cancer,0.8366368412971497
hsa-miR-127-3p,castration-resistant prostate cancer,0.8366368412971497
hsa-miR-765,castration-resistant prostate cancer,0.8366368412971497
hsa-miR-519c-3p,castration-resistant prostate cancer,0.8366368412971497
hsa-miR-513-5p,castration-resistant prostate cancer,0.8366368412971497
hsa-miR-6722-5p,sarcoma,0.836633026599884
hsa-miR-320c,sarcoma,0.836633026599884
hsa-miR-4323,sarcoma,0.836633026599884
hsa-miR-208b-5p,sarcoma,0.836633026599884
hsa-miR-487a-5p,sarcoma,0.836633026599884
hsa-miR-4446-5p,diffuse large B-cell lymphoma,0.8366295099258423
hsa-miR-153-3p,diffuse large B-cell lymphoma,0.8366295099258423
hsa-miR-1185-5p,diffuse large B-cell lymphoma,0.8366161584854126
hsa-miR-4650-3p,diffuse large B-cell lymphoma,0.8366161584854126
hsa-miR-548ay-3p,aryngeal squamous cell carcinoma,0.8366113901138306
hsa-miR-1206,aryngeal squamous cell carcinoma,0.8366113901138306
hsa-miR-5010-5p,castration-resistant prostate cancer,0.8366111516952515
hsa-miR-132,brain cancer,0.8365969657897949
hsa-miR-3202,sarcoma,0.836592435836792
hsa-miR-578,sarcoma,0.836592435836792
hsa-miR-490,sarcoma,0.836592435836792
hsa-miR-7108-3p,sarcoma,0.836592435836792
hsa-miR-4735-3p,sarcoma,0.836592435836792
hsa-miR-4678,sarcoma,0.836592435836792
hsa-miR-6828-3p,sarcoma,0.836592435836792
hsa-miR-300,sarcoma,0.836592435836792
hsa-miR-644a,sarcoma,0.836592435836792
hsa-miR-6747-3p,"squamous cell breast carcinoma, acantholytic variant",0.8365876078605652
hsa-miR-760,castration-resistant prostate cancer,0.836586594581604
hsa-miR-3654,castration-resistant prostate cancer,0.836586594581604
hsa-miR-23a*,castration-resistant prostate cancer,0.836586594581604
hsa-miR-199a-2,castration-resistant prostate cancer,0.836586594581604
hsa-miR-205-3p,castration-resistant prostate cancer,0.836586594581604
hsa-miR-768-3p:11.0,castration-resistant prostate cancer,0.836586594581604
hsa-miR-511-3p,castration-resistant prostate cancer,0.836586594581604
hsa-miR-665,diffuse large B-cell lymphoma,0.8365635275840759
hsa-miR-186*,diffuse large B-cell lymphoma,0.8365635275840759
hsa-miR-1910-5p,diffuse large B-cell lymphoma,0.8365635275840759
hsa-miR-4700-3p,synovial sarcoma,0.8365591168403625
hsa-miR-4683,synovial sarcoma,0.8365591168403625
hsa-miR-212-3p,synovial sarcoma,0.8365591168403625
hsa-miR-923,pilocytic astrocytoma,0.8365383148193359
hsa-miR-219a-1-3p,castration-resistant prostate cancer,0.8365347385406494
hsa-miR-520a-3p,castration-resistant prostate cancer,0.8365347385406494
hsa-miR-210-3p,castration-resistant prostate cancer,0.8365347385406494
hsa-miR-4663,castration-resistant prostate cancer,0.8365347385406494
hsa-miR-26b-5p,castration-resistant prostate cancer,0.8365347385406494
hsa-miR-1299,castration-resistant prostate cancer,0.8365347385406494
hsa-miR-4768-5p,"squamous cell breast carcinoma, acantholytic variant",0.8365213871002197
hsa-miR-4763-5p,sarcoma,0.836519718170166
hsa-miR-670,sarcoma,0.836519718170166
hsa-miR-1184,sarcoma,0.836519718170166
hsa-miR-4445-5p,sarcoma,0.836519718170166
hsa-miR-4481,sarcoma,0.836519718170166
hsa-miR-5092,sarcoma,0.836519718170166
hsa-miR-195,"squamous cell breast carcinoma, acantholytic variant",0.8365103602409363
hsa-miR-4426,sarcoma,0.8365099430084229
hsa-miR-675-5p,sarcoma,0.8365099430084229
hsa-miR-4431,diffuse large B-cell lymphoma,0.8365083932876587
hsa-miR-3129-3p,castration-resistant prostate cancer,0.8365039229393005
hsa-let-7a-2*,castration-resistant prostate cancer,0.8365039229393005
hsa-miR-500*,castration-resistant prostate cancer,0.8365039229393005
hsa-miR-6790-3p,synovial sarcoma,0.8364967107772827
hsa-miR-371-3p,synovial sarcoma,0.8364967107772827
hsa-let-7i*,synovial sarcoma,0.8364967107772827
hsa-miR-558,synovial sarcoma,0.8364967107772827
hsa-miR-6859-5p,synovial sarcoma,0.8364967107772827
hsa-miR-106a.1,synovial sarcoma,0.8364967107772827
hsa-miR-584,synovial sarcoma,0.8364967107772827
hsa-miR-580-3p,synovial sarcoma,0.8364967107772827
hsa-miR-4422,synovial sarcoma,0.8364967107772827
hsa-miR-4723-5p,synovial sarcoma,0.8364967107772827
hsa-miR-4648,synovial sarcoma,0.8364967107772827
hsa-miR-548o-3p,synovial sarcoma,0.8364967107772827
hsa-miR-200b*,sarcoma,0.8364890217781067
hsa-miR-517a,sarcoma,0.8364890217781067
hsa-miR-4508,sarcoma,0.8364890217781067
hsa-miR-375,sarcoma,0.8364890217781067
hsa-miR-574,sarcoma,0.8364890217781067
hsa-miR-6892-5p,ovarian carcinoma,0.8364852070808411
hsa-miR-6507-3p,ovarian carcinoma,0.8364852070808411
hsa-miR-27a-3p,ovarian carcinoma,0.8364852070808411
hsa-miR-5682,ovarian carcinoma,0.8364852070808411
hsa-miR-606,diffuse large B-cell lymphoma,0.8364843726158142
hsa-miR-140,diffuse large B-cell lymphoma,0.8364843726158142
hsa-miR-520g,diffuse large B-cell lymphoma,0.8364843726158142
hsa-miR-106b-3p,castration-resistant prostate cancer,0.8364818692207336
hsa-miR-518a-3p,castration-resistant prostate cancer,0.8364818692207336
hsa-miR-365,castration-resistant prostate cancer,0.8364818692207336
hsa-miR-525*,castration-resistant prostate cancer,0.8364818692207336
hsa-miR-518a-5p,castration-resistant prostate cancer,0.8364818692207336
hsa-miR-1266,castration-resistant prostate cancer,0.8364818692207336
hsa-miR-539-3p,castration-resistant prostate cancer,0.8364818692207336
hsa-miR-4515,castration-resistant prostate cancer,0.8364818692207336
hsa-miR-6855-5p,castration-resistant prostate cancer,0.8364818692207336
hsa-miR-874,aryngeal squamous cell carcinoma,0.8364785313606262
hsa-miR-548aw,aryngeal squamous cell carcinoma,0.8364785313606262
hsa-miR-1205,aryngeal squamous cell carcinoma,0.8364785313606262
hsa-miR-15a-3p,aryngeal squamous cell carcinoma,0.8364785313606262
hsa-miR-3680-3p,aryngeal squamous cell carcinoma,0.8364785313606262
hsa-miR-517,diffuse large B-cell lymphoma,0.8364760875701904
hsa-miR-4720-5p,diffuse large B-cell lymphoma,0.8364760875701904
hsa-miR-6800-5p,diffuse large B-cell lymphoma,0.8364760875701904
hsa-miR-4713-5p,diffuse large B-cell lymphoma,0.8364760875701904
hsa-miR-3194,papillary thyroid carcinoma,0.836472749710083
hsa-miR-323a-3p,diffuse large B-cell lymphoma,0.8364285230636597
hsa-miR-1291,castration-resistant prostate cancer,0.8364267945289612
hsa-miR-6803-3p,castration-resistant prostate cancer,0.8364267945289612
hsa-miR-146a,castration-resistant prostate cancer,0.8364267945289612
hsa-miR-4659b-3p,castration-resistant prostate cancer,0.8364267945289612
hsa-miR-136,castration-resistant prostate cancer,0.8364267945289612
hsa-miR-768-5p:11.0,castration-resistant prostate cancer,0.8364267945289612
hsa-miR-6894-5p,castration-resistant prostate cancer,0.8364267945289612
hsa-miR-6808-5p,castration-resistant prostate cancer,0.8364267945289612
hsa-miR-193b-5p,diffuse large B-cell lymphoma,0.8364121913909912
hsa-miR-3929,diffuse large B-cell lymphoma,0.8364121913909912
hsa-miR-4783-5p,synovial sarcoma,0.8363994359970093
hsa-miR-91,synovial sarcoma,0.8363994359970093
hsa-let-7b-3p,diffuse large B-cell lymphoma,0.8363962173461914
hsa-miR-8081,castration-resistant prostate cancer,0.8363922834396362
hsa-miR-4725-5p,castration-resistant prostate cancer,0.8363720774650574
hsa-miR-101-1,castration-resistant prostate cancer,0.8363720774650574
hsa-miR-302d,castration-resistant prostate cancer,0.8363720774650574
hsa-miR-3193,castration-resistant prostate cancer,0.8363720774650574
hsa-miR-6821-3p,castration-resistant prostate cancer,0.8363720774650574
hsa-miR-621,castration-resistant prostate cancer,0.8363720774650574
hsa-miR-24-2,castration-resistant prostate cancer,0.8363720774650574
hsa-miR-3162-5p,castration-resistant prostate cancer,0.8363720774650574
hsa-miR-3145-5p,castration-resistant prostate cancer,0.8363720774650574
hsa-miR-591,diffuse large B-cell lymphoma,0.8363674283027649
hsa-miR-365,diffuse large B-cell lymphoma,0.8363674283027649
hsa-miR-363*,diffuse large B-cell lymphoma,0.8363674283027649
hsa-miR-18a*,aryngeal squamous cell carcinoma,0.8363540768623352
hsa-miR-664-5p,aryngeal squamous cell carcinoma,0.8363540768623352
hsa-miR-2116-5p,aryngeal squamous cell carcinoma,0.8363540768623352
hsa-miR-5699,aryngeal squamous cell carcinoma,0.8363540768623352
hsa-miR-1304,diffuse large B-cell lymphoma,0.8363445997238159
hsa-miR-93-5p,diffuse large B-cell lymphoma,0.8363445997238159
hsa-miR-4540,diffuse large B-cell lymphoma,0.8363445997238159
hsa-miR-374b*,diffuse large B-cell lymphoma,0.8363348245620728
hsa-miR-6780a-3p,diffuse large B-cell lymphoma,0.8363348245620728
hsa-miR-4436a,miR-142-y,0.8363283276557922
hsa-miR-4633-5p,miR-142-y,0.8363283276557922
hsa-miR-328-3p,miR-142-y,0.8363283276557922
hsa-miR-29a,diffuse large B-cell lymphoma,0.8363248705863953
hsa-miR-4462,diffuse large B-cell lymphoma,0.8363248705863953
hsa-miR-4725-3p,castration-resistant prostate cancer,0.8363145589828491
hsa-miR-207,castration-resistant prostate cancer,0.8363145589828491
hsa-miR-934,castration-resistant prostate cancer,0.8363145589828491
hsa-miR-450a-1,castration-resistant prostate cancer,0.8363145589828491
hsa-miR-4320,castration-resistant prostate cancer,0.8363145589828491
hsa-miR-6876-5p,castration-resistant prostate cancer,0.8363145589828491
hsa-miR-4713-3p,castration-resistant prostate cancer,0.8363145589828491
hsa-miR-5692a,castration-resistant prostate cancer,0.8363145589828491
hsa-miR-1270,castration-resistant prostate cancer,0.8363145589828491
hsa-miR-4502,"squamous cell breast carcinoma, acantholytic variant",0.8363094925880432
hsa-miR-6859-5p,diffuse large B-cell lymphoma,0.8363053202629089
hsa-miR-202-3p,diffuse large B-cell lymphoma,0.8363053202629089
hsa-miR-129-2-3p,diffuse large B-cell lymphoma,0.8362863063812256
hsa-miR-292-3p,diffuse large B-cell lymphoma,0.8362863063812256
hsa-miR-3606-5p,castration-resistant prostate cancer,0.836276113986969
hsa-miR-873,diffuse large B-cell lymphoma,0.8362705111503601
hsa-miR-126-5p,castration-resistant prostate cancer,0.8362531661987305
hsa-miR-6076,castration-resistant prostate cancer,0.8362531661987305
hsa-miR-24-3p-186,castration-resistant prostate cancer,0.8362531661987305
hsa-miR-4707-3p,castration-resistant prostate cancer,0.8362531661987305
hsa-miR-182-3p,castration-resistant prostate cancer,0.8362531661987305
hsa-miR-4688,castration-resistant prostate cancer,0.8362531661987305
hsa-miR-1978,castration-resistant prostate cancer,0.8362531661987305
hsa-miR-4471,follicular thyroid carcinoma,0.8362515568733215
hsa-miR-4706,diffuse large B-cell lymphoma,0.8362508416175842
hsa-miR-343,synovial sarcoma,0.8362301588058472
hsa-miR-4318,synovial sarcoma,0.8362301588058472
hsa-miR-711,synovial sarcoma,0.8362301588058472
hsa-miRPlus-J1011,synovial sarcoma,0.8362301588058472
hsa-miR-520b-520c,synovial sarcoma,0.8362301588058472
hsa-miR-4691-5p,synovial sarcoma,0.8362301588058472
hsa-miR-4656,synovial sarcoma,0.8362301588058472
hsa-miR-154-5p,synovial sarcoma,0.8362301588058472
hsa-miR-3131,castration-resistant prostate cancer,0.836223840713501
hsa-miR-92-1,castration-resistant prostate cancer,0.836223840713501
hsa-miR-26a-2*,castration-resistant prostate cancer,0.836223840713501
hsa-miR-590,castration-resistant prostate cancer,0.836223840713501
hsa-miR-331-3p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-333,castration-resistant prostate cancer,0.836223840713501
hsa-miR-181a*,castration-resistant prostate cancer,0.836223840713501
hsa-miR-129-3p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-105-3p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-5706,castration-resistant prostate cancer,0.836223840713501
hsa-miR-106a.1,castration-resistant prostate cancer,0.836223840713501
hsa-miR-1910-3p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-3675-3p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-4658,castration-resistant prostate cancer,0.836223840713501
hsa-miR-6774-3p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-6729-5p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-4708-3p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-4422,castration-resistant prostate cancer,0.836223840713501
hsa-miR-5583-5p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-202-3p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-452-3p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-6735-5p,castration-resistant prostate cancer,0.836223840713501
hsa-miR-3135a,castration-resistant prostate cancer,0.836223840713501
hsa-miR-617,diffuse large B-cell lymphoma,0.8362151980400085
hsa-miR-4298,diffuse large B-cell lymphoma,0.8362037539482117
hsa-miR-6889-3p,diffuse large B-cell lymphoma,0.8362037539482117
hsa-miR-4315,diffuse large B-cell lymphoma,0.8362037539482117
hsa-miR-139-3p,diffuse large B-cell lymphoma,0.8362037539482117
hsa-miR-374a-3p,diffuse large B-cell lymphoma,0.8362037539482117
hsa-miR-183-5p,castration-resistant prostate cancer,0.8361890316009521
hsa-miR-338-3p,castration-resistant prostate cancer,0.8361890316009521
hsa-miR-5694,castration-resistant prostate cancer,0.8361890316009521
hsa-miR-660-5p,castration-resistant prostate cancer,0.8361890316009521
hsa-miR-204-5p,castration-resistant prostate cancer,0.8361890316009521
hsa-miR-140-5p,castration-resistant prostate cancer,0.8361890316009521
hsa-miR-4520-3p,castration-resistant prostate cancer,0.8361890316009521
hsa-miR-1302,castration-resistant prostate cancer,0.8361890316009521
hsa-miR-582-5p,castration-resistant prostate cancer,0.8361890316009521
hsa-miR-3677-3p,breast cancer brain metastasis,0.836186408996582
hsa-miR-337,breast cancer brain metastasis,0.836186408996582
hsa-miR-6850-3p,breast cancer brain metastasis,0.836186408996582
hsa-miR-192-5p,diffuse large B-cell lymphoma,0.8361837863922119
hsa-miR-323-3p,diffuse large B-cell lymphoma,0.8361606597900391
hsa-miR-1207-3p,castration-resistant prostate cancer,0.8361549973487854
hsa-miR-6808-3p,castration-resistant prostate cancer,0.8361549973487854
hsa-miR-3684,diffuse large B-cell lymphoma,0.8361321687698364
hsa-miR-4640-5p,diffuse large B-cell lymphoma,0.8361321687698364
hsa-miR-6843-3p,diffuse large B-cell lymphoma,0.8361321687698364
hsa-miR-26a-5p,diffuse large B-cell lymphoma,0.8361321687698364
hsa-miR-214,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-642a-5p,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-196-1,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-886-5p,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-4296,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-374a-3p,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-5195-5p,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-4652-3p,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-6083,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-302b-3p,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-541*,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-8075,castration-resistant prostate cancer,0.8361222743988037
hsa-miR-642a,synovial sarcoma,0.8361194133758545
hsa-miR-16-2*,synovial sarcoma,0.8361194133758545
hsa-miR-146b-5p,synovial sarcoma,0.8361194133758545
hsa-miR-3606,synovial sarcoma,0.8361194133758545
hsa-miR-134-5p,synovial sarcoma,0.8361194133758545
hsa-miR-3922,synovial sarcoma,0.8361194133758545
hsa-miR-518c*,synovial sarcoma,0.8361194133758545
hsa-miR-29c-5p,aryngeal squamous cell carcinoma,0.8361110687255859
hsa-miR-518d-3p,diffuse large B-cell lymphoma,0.8361054062843323
hsa-miR-151-3p,diffuse large B-cell lymphoma,0.8361043334007263
hsa-miR-1262,diffuse large B-cell lymphoma,0.8361036777496338
hsa-miR-924,diffuse large B-cell lymphoma,0.8361027240753174
hsa-miR-30c-2*,diffuse large B-cell lymphoma,0.8361027240753174
hsa-miR-657,solid pseudopapillary neoplasm of pancreas,0.8361014127731323
hsa-miR-3619,solid pseudopapillary neoplasm of pancreas,0.8361014127731323
hsa-miR-631,diffuse large B-cell lymphoma,0.8361003994941711
hsa-miR-6733-3p,diffuse large B-cell lymphoma,0.836097002029419
hsa-miR-6820-5p,diffuse large B-cell lymphoma,0.8360950946807861
hsa-miR-6755-5p,diffuse large B-cell lymphoma,0.8360941410064697
hsa-miR-640,diffuse large B-cell lymphoma,0.8360921740531921
hsa-miR-573,diffuse large B-cell lymphoma,0.8360921740531921
hsa-miR-5584-3p,ovarian carcinoma,0.8360843062400818
hsa-miR-2276-3p,ovarian carcinoma,0.8360843062400818
hsa-miR-505,ovarian carcinoma,0.8360843062400818
hsa-miR-6082,ovarian carcinoma,0.8360843062400818
hsa-miR-295,ovarian carcinoma,0.8360843062400818
hsa-miR-744-5p,ovarian carcinoma,0.8360843062400818
hsa-miR-23a-3p,follicular thyroid carcinoma,0.8360595107078552
hsa-miR-181d,follicular thyroid carcinoma,0.8360595107078552
hsa-miR-323-5p,diffuse large B-cell lymphoma,0.8360557556152344
hsa-miR-187-3p,diffuse large B-cell lymphoma,0.8360557556152344
hsa-miR-3978,diffuse large B-cell lymphoma,0.8360557556152344
hsa-miR-548q,"Luminal B,triple negative",0.8360519409179688
hsa-miR-4706,synovial sarcoma,0.836051344871521
hsa-miR-369-5p,synovial sarcoma,0.836051344871521
hsa-miR-2115-3p,synovial sarcoma,0.836051344871521
hsa-miR-6882-3p,synovial sarcoma,0.836051344871521
hsa-miR-766,castration-resistant prostate cancer,0.8360505104064941
hsa-miR-520c-3p,castration-resistant prostate cancer,0.8360505104064941
hsa-miR-6870-3p,castration-resistant prostate cancer,0.8360505104064941
hsa-miR-6849-3p,castration-resistant prostate cancer,0.8360505104064941
hsa-miR-3684,castration-resistant prostate cancer,0.8360505104064941
hsa-miR-4460,castration-resistant prostate cancer,0.8360505104064941
hsa-miR-3529-5p,castration-resistant prostate cancer,0.8360505104064941
hsa-miR-3156-3p,castration-resistant prostate cancer,0.8360505104064941
hsa-miR-4740-5p,castration-resistant prostate cancer,0.8360505104064941
hsa-miR-3619-3p,diffuse large B-cell lymphoma,0.8360461592674255
hsa-miR-4445-3p,diffuse large B-cell lymphoma,0.8360461592674255
hsa-miR-654-3p,diffuse large B-cell lymphoma,0.8360461592674255
hsa-miR-454-5p,castration-resistant prostate cancer,0.8360285758972168
hsa-miR-340-5p,castration-resistant prostate cancer,0.8360285758972168
hsa-miR-378a-5p,castration-resistant prostate cancer,0.8360285758972168
hsa-miR-371b-3p,"squamous cell breast carcinoma, acantholytic variant",0.836028516292572
hsa-miR-500*,diffuse large B-cell lymphoma,0.8360161781311035
hsa-miR-1180-5p,castration-resistant prostate cancer,0.8359982371330261
hsa-miR-23b*,castration-resistant prostate cancer,0.8359742760658264
hsa-miR-802,castration-resistant prostate cancer,0.8359742760658264
hsa-miR-769-3p,castration-resistant prostate cancer,0.8359742760658264
hsa-miR-3653,castration-resistant prostate cancer,0.8359742760658264
hsa-miR-187-3p,castration-resistant prostate cancer,0.8359742760658264
hsa-miR-768-5p,castration-resistant prostate cancer,0.8359742760658264
hsa-miR-4750-3p,castration-resistant prostate cancer,0.8359742760658264
hsa-miR-6718-5p,castration-resistant prostate cancer,0.8359742760658264
hsa-miR-2116-5p,diffuse large B-cell lymphoma,0.8359670042991638
hsa-miR-1227,aryngeal squamous cell carcinoma,0.835946798324585
hsa-miR-145*,aryngeal squamous cell carcinoma,0.835946798324585
hsa-miR-4426,aryngeal squamous cell carcinoma,0.835946798324585
hsa-miR-520f-5p,aryngeal squamous cell carcinoma,0.835946798324585
hsa-miR-3122,aryngeal squamous cell carcinoma,0.835946798324585
hsa-miR-16-1*,aryngeal squamous cell carcinoma,0.835946798324585
hsa-miR-4797-5p,aryngeal squamous cell carcinoma,0.835946798324585
hsa-miR-5089-5p,"squamous cell breast carcinoma, acantholytic variant",0.8359062075614929
hsa-miR-512-3p,castration-resistant prostate cancer,0.8358967304229736
hsa-miR-485-3p,castration-resistant prostate cancer,0.8358967304229736
hsa-miR-24-1,castration-resistant prostate cancer,0.8358967304229736
hsa-miR-758-5p,castration-resistant prostate cancer,0.8358967304229736
hsa-miR-579-5p,castration-resistant prostate cancer,0.8358967304229736
hsa-miR-4251,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-381,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-6861-3p,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-4273,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-4751,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-4533,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-2116-5p,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-5699,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-6739-3p,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-548v,castration-resistant prostate cancer,0.8358854651451111
hsa-miR-181b-5p,aryngeal squamous cell carcinoma,0.8358702063560486
hsa-miR-548h-3p,aryngeal squamous cell carcinoma,0.8358702063560486
hsa-miR-302a*,diffuse large B-cell lymphoma,0.8358670473098755
hsa-miR-1236-3p,diffuse large B-cell lymphoma,0.8358670473098755
hsa-miR-132-3p,diffuse large B-cell lymphoma,0.8358670473098755
hsa-miR-6730-5p,diffuse large B-cell lymphoma,0.8358670473098755
hsa-miR-651,solid pseudopapillary neoplasm of pancreas,0.8358665704727173
hsa-miR-4704-5p,solid pseudopapillary neoplasm of pancreas,0.8358665704727173
hsa-miR-6834-3p,synovial sarcoma,0.8358630537986755
hsa-miR-292-3p,synovial sarcoma,0.8358630537986755
hsa-miR-4726-3p,synovial sarcoma,0.8358630537986755
hsa-miR-768-3p:11.0,synovial sarcoma,0.8358630537986755
hsa-miR-151a-3p,synovial sarcoma,0.8358630537986755
hsa-miR-511-3p,synovial sarcoma,0.8358630537986755
hsa-miR-4313,synovial sarcoma,0.8358630537986755
hsa-miR-2116,"squamous cell breast carcinoma, acantholytic variant",0.8358617424964905
hsa-miR-4796-3p,"squamous cell breast carcinoma, acantholytic variant",0.8358617424964905
hsa-miR-1295b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8358617424964905
hsa-miR-519a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8358617424964905
hsa-miR-7110-3p,"squamous cell breast carcinoma, acantholytic variant",0.8358617424964905
hsa-miR-8073,"squamous cell breast carcinoma, acantholytic variant",0.8358617424964905
hsa-miR-15a-5p,breast cancer brain metastasis,0.8358575701713562
hsa-miR-4720-3p,diffuse large B-cell lymphoma,0.8358563780784607
hsa-miR-4269,diffuse large B-cell lymphoma,0.8358563780784607
hsa-miR-1203,diffuse large B-cell lymphoma,0.8358563780784607
hsa-miR-6730-3p,diffuse large B-cell lymphoma,0.8358563780784607
hsa-miR-149,diffuse large B-cell lymphoma,0.8358563780784607
hsa-miR-4758-5p,diffuse large B-cell lymphoma,0.8358563780784607
hsa-miR-185*,diffuse large B-cell lymphoma,0.8358563780784607
hsa-miR-16-2-3p,diffuse large B-cell lymphoma,0.8358563780784607
hsa-miR-4662b,synovial sarcoma,0.8358263373374939
hsa-miR-642b-3p,"Luminal B,triple negative",0.8357958793640137
hsa-miR-130a-3p,"Luminal B,triple negative",0.8357958793640137
hsa-miRPlus-G1246-3p,diffuse large B-cell lymphoma,0.8357892036437988
hsa-miR-376a-5p,diffuse large B-cell lymphoma,0.8357892036437988
hsa-miR-5002-5p,diffuse large B-cell lymphoma,0.8357892036437988
hsa-miR-302a*,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-513,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-5187-3p,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-671,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-524-3p,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-219-1-3p,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-4445-3p,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-4785,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-4467,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-29c-5p,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-518d-5p,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-6730-5p,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-3652,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-122-5p,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-138-5p,castration-resistant prostate cancer,0.8357852101325989
hsa-miR-6727-3p,castration-resistant prostate cancer,0.8357769250869751
hsa-miR-195,castration-resistant prostate cancer,0.8357769250869751
hsa-miR-3162,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-4470,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-6807-3p,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-3074-5p,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-6509-3p,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-6796-3p,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-4791,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-885-5p,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-888*,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-744-3p,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-128a,diffuse large B-cell lymphoma,0.8357732892036438
hsa-miR-450a-2-3p,diffuse large B-cell lymphoma,0.8357588052749634
hsa-miR-4283,diffuse large B-cell lymphoma,0.8357588052749634
hsa-miR-183,diffuse large B-cell lymphoma,0.8357588052749634
hsa-miR-181b-5p,diffuse large B-cell lymphoma,0.8357588052749634
hsa-miR-021,castration-resistant prostate cancer,0.8357575535774231
hsa-miR-6792-3p,castration-resistant prostate cancer,0.8357575535774231
hsa-miR-6863,castration-resistant prostate cancer,0.8357575535774231
hsa-miR-467,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-222-5p,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-1258,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-6779-5p,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-3673,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-4703-5p,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-3936,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-138-1*,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-4472,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-4327,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-6751-5p,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-383-3p,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-4754,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-7152-5p,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-3685,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-3139,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-5690,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-6856-5p,castration-resistant prostate cancer,0.8357073664665222
hsa-miR-668-3p,miR-142-y,0.835695207118988
hsa-miR-4258,miR-142-y,0.835695207118988
hsa-miR-215-5p,miR-142-y,0.835695207118988
hsa-miR-4794,synovial sarcoma,0.8356877565383911
hsa-miR-373,primary central nervous system lymphomas,0.8356838822364807
hsa-miR-3679-5p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-6511b-5p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-3622b-3p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-450a-2-3p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-1234-5p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-3620-5p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-374a-5p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-888*,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-4423-3p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-183,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-2052,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-3184-5p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-124-3p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-34b-5p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-6854-3p,castration-resistant prostate cancer,0.8356769680976868
hsa-miR-1324,aryngeal squamous cell carcinoma,0.8356757760047913
hsa-miR-889,aryngeal squamous cell carcinoma,0.8356757760047913
hsa-miR-223*,aryngeal squamous cell carcinoma,0.8356757760047913
hsa-miR-4779,aryngeal squamous cell carcinoma,0.8356757760047913
hsa-miR-365a-3p,aryngeal squamous cell carcinoma,0.8356757760047913
hsa-miR-599,aryngeal squamous cell carcinoma,0.8356757760047913
hsa-miR-499b-5p,aryngeal squamous cell carcinoma,0.8356757760047913
hsa-miR-3115,aryngeal squamous cell carcinoma,0.8356757760047913
hsa-miR-1471,aryngeal squamous cell carcinoma,0.8356757760047913
hsa-miR-5007-5p,synovial sarcoma,0.8356642127037048
hsa-miR-512-5p-1105,synovial sarcoma,0.8356642127037048
hsa-miR-9-3p,synovial sarcoma,0.8356642127037048
hsa-miR-200b-5p,synovial sarcoma,0.8356642127037048
hsa-miR-2278,synovial sarcoma,0.8356642127037048
hsa-miR-489,miR-675-y,0.8356620669364929
hsa-miR-4690-5p,high grade serous papillary ovarian cancer,0.835651159286499
hsa-miR-33a-5p,high grade serous papillary ovarian cancer,0.835651159286499
hsa-miR-500a-3p,aryngeal squamous cell carcinoma,0.8356403112411499
hsa-miR-363-3p,aryngeal squamous cell carcinoma,0.8356403112411499
hsa-miR-325,diffuse large B-cell lymphoma,0.8356398344039917
hsa-miR-3124-5p,diffuse large B-cell lymphoma,0.8356398344039917
hsa-miR-218-1,diffuse large B-cell lymphoma,0.8356398344039917
hsa-miR-6799-5p,"squamous cell breast carcinoma, acantholytic variant",0.8356279134750366
hsa-miR-6867-3p,"squamous cell breast carcinoma, acantholytic variant",0.835625946521759
hsa-miR-6769b-5p,castration-resistant prostate cancer,0.8356114625930786
hsa-miR-451b,castration-resistant prostate cancer,0.8356114625930786
hsa-miR-493-5p,castration-resistant prostate cancer,0.8356114625930786
hsa-miR-369,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-1260b,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-4676-3p,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-1253,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-362,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-222*,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-514b-3p,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-598,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-345,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-4646-3p,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-380-5p,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-4523,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-6895-5p,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-6751-3p,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-548aa,castration-resistant prostate cancer,0.8355578184127808
hsa-miR-455-5p,aryngeal squamous cell carcinoma,0.8355497717857361
hsa-miR-6851-5p,aryngeal squamous cell carcinoma,0.8355497717857361
hsa-miR-3192,aryngeal squamous cell carcinoma,0.8355497717857361
hsa-miR-3944-5p,aryngeal squamous cell carcinoma,0.8355497717857361
hsa-miR-424*,synovial sarcoma,0.8355436325073242
hsa-miR-8077,aryngeal squamous cell carcinoma,0.8355382084846497
hsa-miR-7704,aryngeal squamous cell carcinoma,0.8355382084846497
hsa-miR-6769a-5p,diffuse large B-cell lymphoma,0.8355310559272766
hsa-miR-8077,diffuse large B-cell lymphoma,0.8355310559272766
hsa-miR-4326,diffuse large B-cell lymphoma,0.8355310559272766
hsa-miR-4747-3p,diffuse large B-cell lymphoma,0.835530698299408
hsa-miR-466,diffuse large B-cell lymphoma,0.835530698299408
hsa-miR-140,miR-675-y,0.8355234861373901
hsa-miR-2355,miR-675-y,0.8355234861373901
hsa-miR-6507-3p,miR-675-y,0.8355234861373901
hsa-miR-520g,miR-675-y,0.8355234861373901
hsa-miR-27a-3p,miR-675-y,0.8355234861373901
hsa-miR-186,"Luminal B,triple negative",0.8355230689048767
hsa-miR-300,aryngeal squamous cell carcinoma,0.8355230689048767
hsa-miR-940,breast cancer brain metastasis,0.8355054259300232
hsa-miR-6774-5p,diffuse large B-cell lymphoma,0.8354832530021667
hsa-miR-1281,diffuse large B-cell lymphoma,0.8354832530021667
hsa-miR-15a-3p,diffuse large B-cell lymphoma,0.8354832530021667
hsa-miR-26a-1*,diffuse large B-cell lymphoma,0.8354832530021667
hsa-miR-424*,"squamous cell breast carcinoma, acantholytic variant",0.8354817628860474
hsa-miR-365b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8354817628860474
hsa-miR-573,solid pseudopapillary neoplasm of pancreas,0.8354732990264893
hsa-miR-4796-3p,primary central nervous system lymphomas,0.8354653716087341
hsa-miR-940,primary central nervous system lymphomas,0.8354653716087341
hsa-miR-330-3p,primary central nervous system lymphomas,0.8354653716087341
hsa-miR-3621,castration-resistant prostate cancer,0.8354583382606506
hsa-miR-323-3p,castration-resistant prostate cancer,0.8354583382606506
hsa-miR-3155,castration-resistant prostate cancer,0.8354583382606506
hsa-miR-212-3p,castration-resistant prostate cancer,0.8354583382606506
hsa-miR-520d*,castration-resistant prostate cancer,0.8354583382606506
hsa-miR-513a-5p,synovial sarcoma,0.8354540467262268
hsa-miR-365,synovial sarcoma,0.8354540467262268
hsa-miR-502-3p,synovial sarcoma,0.8354540467262268
hsa-miR-4515,synovial sarcoma,0.8354540467262268
hsa-miR-6855-5p,synovial sarcoma,0.8354540467262268
hsa-miR-363*,synovial sarcoma,0.8354540467262268
hsa-miR-2114-5p,synovial sarcoma,0.8354540467262268
hsa-miR-525-5p,sarcoma,0.8354518413543701
hsa-miR-519e-5p,sarcoma,0.8354518413543701
hsa-miR-15a-5p,sarcoma,0.8354518413543701
hsa-miR-3529-3p,sarcoma,0.8354518413543701
hsa-miR-382-3p,sarcoma,0.8354518413543701
hsa-miR-566,ovarian carcinoma,0.8354504108428955
hsa-miR-3194,ovarian carcinoma,0.8354504108428955
hsa-miR-4299,ovarian carcinoma,0.8354504108428955
hsa-miR-1229-3p,ovarian carcinoma,0.8354504108428955
hsa-miR-1257,castration-resistant prostate cancer,0.83544921875
hsa-miR-122,castration-resistant prostate cancer,0.83544921875
hsa-miR-518c-5p,castration-resistant prostate cancer,0.83544921875
hsa-miR-519d-5p,castration-resistant prostate cancer,0.83544921875
hsa-miR-3157-3p,castration-resistant prostate cancer,0.83544921875
hsa-miR-6851-3p,castration-resistant prostate cancer,0.83544921875
hsa-miR-352,castration-resistant prostate cancer,0.83544921875
hsa-miR-146a-3p,castration-resistant prostate cancer,0.83544921875
hsa-miR-4501,castration-resistant prostate cancer,0.83544921875
hsa-miR-4520b-3p,castration-resistant prostate cancer,0.83544921875
hsa-miR-181b-3p,castration-resistant prostate cancer,0.83544921875
hsa-miRPlus-J1003,castration-resistant prostate cancer,0.83544921875
hsa-miR-4282,castration-resistant prostate cancer,0.83544921875
hsa-miR-4520-5p,castration-resistant prostate cancer,0.83544921875
hsa-miR-548l,castration-resistant prostate cancer,0.83544921875
hsa-miR-4326,castration-resistant prostate cancer,0.83544921875
hsa-miR-135a-5p,castration-resistant prostate cancer,0.83544921875
hsa-miR-642b-5p,castration-resistant prostate cancer,0.83544921875
hsa-miR-550-1,castration-resistant prostate cancer,0.83544921875
hsa-miRPlus-A1073,diffuse large B-cell lymphoma,0.8354424238204956
hsa-miR-605,diffuse large B-cell lymphoma,0.8354424238204956
hsa-miR-194,diffuse large B-cell lymphoma,0.8354424238204956
hsa-miR-1295b-5p,diffuse large B-cell lymphoma,0.8354424238204956
hsa-miR-372,diffuse large B-cell lymphoma,0.8354424238204956
hsa-miR-888-3p,diffuse large B-cell lymphoma,0.8354424238204956
hsa-miR-491-5p,diffuse large B-cell lymphoma,0.8354424238204956
hsa-miR-4774-5p,diffuse large B-cell lymphoma,0.8354424238204956
hsa-miR-573,castration-resistant prostate cancer,0.8354195952415466
hsa-miR-668,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-6509-5p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-99b-3p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-5003-5p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-1976,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-3129-5p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-3180,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-429,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-15a-3p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-195-3p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-6862-5p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-215-3p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-2276-5p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-365b-5p,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-3661,castration-resistant prostate cancer,0.8354012966156006
hsa-miR-1181,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-518f,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-484,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-8089,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-4670-3p,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-3927,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-99a-5p,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-1912,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-100*,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-584,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-8088,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-548n,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-548ap-3p,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-6847-5p,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-619-3p,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-6735-3p,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-4648,castration-resistant prostate cancer,0.8353955745697021
hsa-miR-92b,synovial sarcoma,0.8353932499885559
hsa-miR-365b-3p,"Luminal B,triple negative",0.8353787660598755
hsa-miR-3130-3p,diffuse large B-cell lymphoma,0.8353692889213562
hsa-miR-6512-5p,diffuse large B-cell lymphoma,0.8353692889213562
hsa-miR-132*,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-101b,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-330-5p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-378f,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-3927-5p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-651-3p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-372,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-1307-3p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-4494,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-4302,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-128b,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-548aj-3p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-6775-5p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-412-3p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-3165,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-4766-3p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-6820-3p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-5087,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-2681-5p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-202,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-4718,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-4638-3p,castration-resistant prostate cancer,0.8353606462478638
hsa-miR-548e,diffuse large B-cell lymphoma,0.8353597521781921
hsa-miR-570,diffuse large B-cell lymphoma,0.8353597521781921
hsa-miR-620,diffuse large B-cell lymphoma,0.8353597521781921
hsa-miR-4305,diffuse large B-cell lymphoma,0.8353597521781921
hsa-miR-4717-5p,diffuse large B-cell lymphoma,0.8353597521781921
hsa-miR-465,diffuse large B-cell lymphoma,0.8353597521781921
hsa-miR-3137,breast cancer brain metastasis,0.835346519947052
hsa-miR-4252,diffuse large B-cell lymphoma,0.8353385925292969
hsa-miR-6071,high grade serous papillary ovarian cancer,0.8353298902511597
hsa-miR-607,high grade serous papillary ovarian cancer,0.8353298902511597
hsa-miR-20a*,high grade serous papillary ovarian cancer,0.8353298902511597
hsa-let-7b*,diffuse large B-cell lymphoma,0.8353213667869568
hsa-miR-500*,"squamous cell breast carcinoma, acantholytic variant",0.8353164792060852
hsa-miR-6767-5p,diffuse large B-cell lymphoma,0.8352994322776794
hsa-miR-627-3p,diffuse large B-cell lymphoma,0.8352994322776794
hsa-miR-9-5p,diffuse large B-cell lymphoma,0.8352994322776794
hsa-miR-148b-3p,castration-resistant prostate cancer,0.8352977633476257
hsa-miR-1256,castration-resistant prostate cancer,0.8352977633476257
hsa-miR-5095,castration-resistant prostate cancer,0.8352977633476257
hsa-miR-4744,castration-resistant prostate cancer,0.8352977633476257
hsa-miR-654,castration-resistant prostate cancer,0.8352931141853333
hsa-miR-623,castration-resistant prostate cancer,0.83528733253479
hsa-miR-6734-3p,castration-resistant prostate cancer,0.83528733253479
hsa-miRPlus-D1058,castration-resistant prostate cancer,0.83528733253479
hsa-miR-6828-5p,castration-resistant prostate cancer,0.83528733253479
hsa-miR-23b,castration-resistant prostate cancer,0.83528733253479
hsa-miR-4763-5p,castration-resistant prostate cancer,0.83528733253479
hsa-miR-4309,castration-resistant prostate cancer,0.83528733253479
hsa-miR-1288,castration-resistant prostate cancer,0.83528733253479
hsa-miR-017,castration-resistant prostate cancer,0.83528733253479
hsa-miR-486-5p,castration-resistant prostate cancer,0.83528733253479
hsa-miR-3158-5p,castration-resistant prostate cancer,0.83528733253479
hsa-miR-891a-3p,castration-resistant prostate cancer,0.83528733253479
hsa-miR-218-2*,castration-resistant prostate cancer,0.83528733253479
hsa-miR-550a*,castration-resistant prostate cancer,0.83528733253479
hsa-miR-3942-5p,castration-resistant prostate cancer,0.83528733253479
hsa-miR-6134,castration-resistant prostate cancer,0.83528733253479
hsa-miR-516b-3p,castration-resistant prostate cancer,0.83528733253479
hsa-miR-1203,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-3945,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-522,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-5047,castration-resistant prostate cancer,0.8352776169776917
hsa-let-7a-2-3p,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-203a-5p,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-513b-5p,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-4666a-5p,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-519b,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-768,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-374c-5p,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-3157,castration-resistant prostate cancer,0.8352776169776917
hsa-miR-4518,sarcoma,0.8352763652801514
hsa-miR-92a-1-5p,sarcoma,0.8352763652801514
hsa-let-7c_c,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-519b-3p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-30a*,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-138-2*,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-1295,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-6805-3p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-7111-3p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-6785-5p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-292-5p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-1259,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-889,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-4779,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-3692-5p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-4766-5p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-4764-5p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-3907,castration-resistant prostate cancer,0.8352566957473755
hsa-let-7c*,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-379-5p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-293,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-522-3p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-574,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-3935,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-7973,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-6885-3p,castration-resistant prostate cancer,0.8352566957473755
hsa-miR-29a-3p,diffuse large B-cell lymphoma,0.8352410197257996
hsa-miR-1295,diffuse large B-cell lymphoma,0.8352410197257996
hsa-miR-292-5p,diffuse large B-cell lymphoma,0.8352410197257996
hsa-miR-4304,diffuse large B-cell lymphoma,0.8352410197257996
hsa-let-7c*,diffuse large B-cell lymphoma,0.8352410197257996
hsa-miR-3115,diffuse large B-cell lymphoma,0.8352410197257996
hsa-miR-6841-3p,diffuse large B-cell lymphoma,0.8352410197257996
hsa-miR-3153,diffuse large B-cell lymphoma,0.8352410197257996
hsa-miR-7641,synovial sarcoma,0.8352319598197937
hsa-miR-4486,synovial sarcoma,0.8352319598197937
hsa-miR-6887-5p,synovial sarcoma,0.8352319598197937
hsa-miR-4653-5p,synovial sarcoma,0.8352319598197937
hsa-miR-888-5p,"Luminal B,triple negative",0.8352283239364624
hsa-miR-5686,primary central nervous system lymphomas,0.8352052569389343
hsa-miR-924,"squamous cell breast carcinoma, acantholytic variant",0.8352041840553284
hsa-miR-3910,"squamous cell breast carcinoma, acantholytic variant",0.8351789116859436
hsa-miR-4485-5p,"Luminal B,triple negative",0.8351746797561646
hsa-miR-642b-3p,castration-resistant prostate cancer,0.8351627588272095
hsa-miR-343,castration-resistant prostate cancer,0.8351277112960815
hsa-miR-340-3p,castration-resistant prostate cancer,0.8351277112960815
hsa-miR-448,castration-resistant prostate cancer,0.8351277112960815
hsa-miR-374c-3p,castration-resistant prostate cancer,0.8351277112960815
hsa-miR-1236,castration-resistant prostate cancer,0.8351277112960815
hsa-miR-135b-3p,castration-resistant prostate cancer,0.8351277112960815
hsa-miR-520b-520c,castration-resistant prostate cancer,0.8351277112960815
hsa-miR-6069,aryngeal squamous cell carcinoma,0.8351228833198547
hsa-miR-6817-5p,primary central nervous system lymphomas,0.8350995779037476
hsa-miR-518d-3p,primary central nervous system lymphomas,0.8350995779037476
hsa-miR-3201,diffuse large B-cell lymphoma,0.8350978493690491
hsa-miR-425-5p,diffuse large B-cell lymphoma,0.8350978493690491
hsa-miR-302c-5p,diffuse large B-cell lymphoma,0.8350978493690491
hsa-miR-1307-3p,diffuse large B-cell lymphoma,0.8350978493690491
hsa-miR-5087,diffuse large B-cell lymphoma,0.8350978493690491
hsa-miR-3137,"squamous cell breast carcinoma, acantholytic variant",0.8350872993469238
hsa-miR-6817-5p,diffuse large B-cell lymphoma,0.8350696563720703
hsa-miR-500*,miR-675-y,0.8350531458854675
hsa-miR-337,primary central nervous system lymphomas,0.8350420594215393
hsa-miR-1977,breast cancer brain metastasis,0.8350284099578857
hsa-miR-4662b,castration-resistant prostate cancer,0.8350282907485962
hsa-miR-4310,diffuse large B-cell lymphoma,0.8350256681442261
hsa-miR-6839-3p,diffuse large B-cell lymphoma,0.8350256681442261
hsa-miR-643,synovial sarcoma,0.835009753704071
hsa-miR-335-5p,synovial sarcoma,0.835009753704071
hsa-miR-3188,synovial sarcoma,0.835009753704071
hsa-miR-145-3p,synovial sarcoma,0.835009753704071
hsa-miR-6807-5p,synovial sarcoma,0.835009753704071
hsa-miR-3074-3p,synovial sarcoma,0.835009753704071
hsa-miR-1287-3p,synovial sarcoma,0.835009753704071
hsa-miR-3180-3p,synovial sarcoma,0.835009753704071
hsa-miR-3189-3p,"Luminal B,triple negative",0.8349990248680115
hsa-miR-24-1*,"Luminal B,triple negative",0.8349990248680115
hsa-miR-1224,synovial sarcoma,0.8349929451942444
hsa-miR-425-3p,synovial sarcoma,0.8349929451942444
hsa-miRPlus-G1246-3p,synovial sarcoma,0.8349929451942444
hsa-miR-4447,synovial sarcoma,0.8349929451942444
hsa-miR-6505-3p,synovial sarcoma,0.8349929451942444
hsa-miR-6751-5p,synovial sarcoma,0.8349929451942444
hsa-miR-6855-3p,synovial sarcoma,0.8349929451942444
hsa-miR-7152-5p,synovial sarcoma,0.8349929451942444
hsa-miR-3924,synovial sarcoma,0.8349929451942444
hsa-miR-5690,synovial sarcoma,0.8349929451942444
hsa-miR-518c,synovial sarcoma,0.8349929451942444
hsa-miR-654-5p,ovarian carcinoma,0.8349688649177551
hsa-miR-655-3p,ovarian carcinoma,0.8349688649177551
hsa-miR-291-5p,ovarian carcinoma,0.8349688649177551
hsa-miR-6808-3p,"squamous cell breast carcinoma, acantholytic variant",0.8349655270576477
hsa-miR-6871-5p,castration-resistant prostate cancer,0.8349477052688599
hsa-miR-204-3p,castration-resistant prostate cancer,0.8349477052688599
hsa-miR-548ak,castration-resistant prostate cancer,0.8349477052688599
hsa-miR-3176,castration-resistant prostate cancer,0.8349477052688599
hsa-miR-4802-5p,castration-resistant prostate cancer,0.8349477052688599
hsa-miR-6733-3p,synovial sarcoma,0.8349199891090393
hsa-miR-3064-5p,breast cancer brain metastasis,0.8349116444587708
hsa-miR-4799-5p,castration-resistant prostate cancer,0.8348892331123352
hsa-miR-548b-5p,brain cancer,0.8348602056503296
hsa-miR-6817-5p,"squamous cell breast carcinoma, acantholytic variant",0.8348383903503418
hsa-miR-516b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8348383903503418
hsa-miR-924,miR-675-y,0.8348299264907837
hsa-miR-512-3p,diffuse large B-cell lymphoma,0.8348066210746765
hsa-miR-320a,diffuse large B-cell lymphoma,0.8348066210746765
hsa-miR-371b-3p,miR-142-y,0.8348022699356079
hsa-miR-934,synovial sarcoma,0.8347964286804199
hsa-miR-450a-1,synovial sarcoma,0.8347964286804199
hsa-miR-517b-3p,synovial sarcoma,0.8347964286804199
hsa-miR-433-5p,synovial sarcoma,0.8347964286804199
hsa-miR-4312,synovial sarcoma,0.8347964286804199
hsa-miR-6876-5p,synovial sarcoma,0.8347964286804199
hsa-miR-7114-5p,castration-resistant prostate cancer,0.8347585201263428
hsa-miR-1226-3p,castration-resistant prostate cancer,0.8347585201263428
hsa-miR-4524b-5p,castration-resistant prostate cancer,0.8347585201263428
hsa-miR-6887-3p,castration-resistant prostate cancer,0.8347585201263428
hsa-miR-1972,"Luminal B,triple negative",0.8347545862197876
hsa-miR-4670-5p,synovial sarcoma,0.8347510099411011
hsa-miR-450a,primary central nervous system lymphomas,0.8347493410110474
hsa-miR-876-3p,primary central nervous system lymphomas,0.8347493410110474
hsa-miR-4502,castration-resistant prostate cancer,0.8347445130348206
hsa-miR-664a-3p,solid pseudopapillary neoplasm of pancreas,0.8347297310829163
hsa-miR-455-3p,synovial sarcoma,0.8346957564353943
hsa-miR-4655-5p,synovial sarcoma,0.8346957564353943
hsa-miR-517-5p,synovial sarcoma,0.8346957564353943
hsa-miR-4536-5p,synovial sarcoma,0.8346957564353943
hsa-miR-487b-3p,synovial sarcoma,0.8346957564353943
hsa-miR-653-5p,synovial sarcoma,0.8346957564353943
hsa-miR-4670-5p,"squamous cell breast carcinoma, acantholytic variant",0.8346888422966003
hsa-miR-3143,brain cancer,0.8346841931343079
hsa-miR-214-3p,brain cancer,0.8346841931343079
hsa-miR-6809-3p,brain cancer,0.8346841931343079
hsa-miR-642a,miR-675-y,0.8346341848373413
hsa-miR-922,miR-675-y,0.8346341848373413
hsa-miR-1224-3p,miR-675-y,0.8346341848373413
hsa-miR-3934,miR-675-y,0.8346341848373413
hsa-miR-7844-5p,miR-675-y,0.8346341848373413
hsa-miR-4716-3p,solid pseudopapillary neoplasm of pancreas,0.8346066474914551
hsa-miR-6822-5p,miR-675-y,0.8345975279808044
hsa-miR-454*,synovial sarcoma,0.8345755934715271
hsa-miR-935,synovial sarcoma,0.8345754146575928
hsa-miR-619-5p,synovial sarcoma,0.8345754146575928
hsa-miR-6836-3p,synovial sarcoma,0.8345754146575928
hsa-miR-6076,synovial sarcoma,0.8345754146575928
hsa-miR-526b,synovial sarcoma,0.8345754146575928
hsa-miR-4733-3p,synovial sarcoma,0.8345754146575928
hsa-miR-767-3p,synovial sarcoma,0.8345754146575928
hsa-miR-6786-3p,synovial sarcoma,0.8345754146575928
hsa-miR-4696,synovial sarcoma,0.8345754146575928
hsa-miR-3177-3p,synovial sarcoma,0.8345754146575928
hsa-miR-1292-5p,castration-resistant prostate cancer,0.8345586657524109
hsa-miR-5007-5p,castration-resistant prostate cancer,0.8345586657524109
hsa-miR-4715-3p,castration-resistant prostate cancer,0.8345586657524109
hsa-miR-1244,miR-142-y,0.8345367312431335
hsa-miR-1234-3p,breast cancer brain metastasis,0.8345274925231934
hsa-miR-6824-3p,breast cancer brain metastasis,0.8345274925231934
hsa-miR-454*,"squamous cell breast carcinoma, acantholytic variant",0.8345134854316711
hsa-miR-6747-5p,solid pseudopapillary neoplasm of pancreas,0.8344572186470032
hsa-miR-95-3p,castration-resistant prostate cancer,0.8344405889511108
hsa-miR-451b,"squamous cell breast carcinoma, acantholytic variant",0.834418773651123
hsa-miR-186,miR-142-y,0.8343972563743591
hsa-miR-422b,rhabdomyosarcomas,0.8343943953514099
hsa-miR-923,rhabdomyosarcomas,0.8343943953514099
hsa-miR-5088-3p,rhabdomyosarcomas,0.8343943953514099
hsa-miR-92a,rhabdomyosarcomas,0.8343943953514099
hsa-miR-6507-3p,rhabdomyosarcomas,0.8343943953514099
hsa-miR-552,breast cancer brain metastasis,0.8343868255615234
hsa-miR-3545-5p,breast cancer brain metastasis,0.8343868255615234
hsa-miR-9-1,miR-675-y,0.8343550562858582
hsa-miR-362-5p,miR-675-y,0.8343550562858582
hsa-miR-149-3p,miR-675-y,0.8343550562858582
hsa-miR-6720-5p,miR-675-y,0.8343550562858582
hsa-miR-591,castration-resistant prostate cancer,0.8343473076820374
hsa-miR-513a-5p,castration-resistant prostate cancer,0.8343473076820374
hsa-miR-3196,castration-resistant prostate cancer,0.8343473076820374
hsa-miR-6732-5p,castration-resistant prostate cancer,0.8343473076820374
hsa-miR-10a,castration-resistant prostate cancer,0.8343473076820374
hsa-miR-618,castration-resistant prostate cancer,0.8343473076820374
hsa-miR-3128,castration-resistant prostate cancer,0.8343473076820374
hsa-miR-6760-3p,synovial sarcoma,0.8343466520309448
hsa-miR-3676-3p,synovial sarcoma,0.8343466520309448
hsa-miR-140-5p,synovial sarcoma,0.8343466520309448
hsa-miR-124*,synovial sarcoma,0.8343466520309448
hsa-miR-4520-3p,synovial sarcoma,0.8343466520309448
hsa-miR-1302,synovial sarcoma,0.8343466520309448
hsa-miR-489-3p,synovial sarcoma,0.8343466520309448
hsa-miR-10b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8343318104743958
hsa-miR-6875-5p,castration-resistant prostate cancer,0.8342821598052979
hsa-miR-4683,"squamous cell breast carcinoma, acantholytic variant",0.8342647552490234
hsa-miR-367-5p,"squamous cell breast carcinoma, acantholytic variant",0.8342647552490234
hsa-miR-4502,miR-142-y,0.8342524170875549
hsa-miR-484,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-199a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-106a.1,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-1910-3p,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-101-3p,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-488-5p,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-4433-5p,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-6729-5p,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-4708-3p,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-6827-3p,"squamous cell breast carcinoma, acantholytic variant",0.8342016339302063
hsa-miR-6893-3p,miR-142-y,0.8341783285140991
hsa-miR-218-1-3p,miR-142-y,0.8341783285140991
hsa-miR-140,miR-142-y,0.8341783285140991
hsa-miR-642b-3p,sarcoma,0.8341533541679382
hsa-miR-3934-3p,"squamous cell breast carcinoma, acantholytic variant",0.8341430425643921
hsa-miR-575,castration-resistant prostate cancer,0.8341240882873535
hsa-miR-6758-5p,castration-resistant prostate cancer,0.8341240882873535
hsa-miR-193b-5p,castration-resistant prostate cancer,0.8341240882873535
hsa-miR-98-3p,castration-resistant prostate cancer,0.8341240882873535
hsa-miR-4653-5p,castration-resistant prostate cancer,0.8341240882873535
hsa-miR-7-2*,synovial sarcoma,0.8341159224510193
hsa-miR-216b,synovial sarcoma,0.8341159224510193
hsa-miR-6795-3p,synovial sarcoma,0.8341159224510193
hsa-miR-19a*,synovial sarcoma,0.8341159224510193
hsa-miR-941,synovial sarcoma,0.8341159224510193
hsa-miR-6864-3p,synovial sarcoma,0.8341159224510193
hsa-miR-6873-3p,synovial sarcoma,0.8341159224510193
hsa-miR-3200-5p,synovial sarcoma,0.8341159224510193
hsa-miR-412-5p,synovial sarcoma,0.8341159224510193
hsa-miR-483-5p,synovial sarcoma,0.8341070413589478
hsa-miR-4298,synovial sarcoma,0.8341070413589478
hsa-miR-6890-3p,synovial sarcoma,0.8341070413589478
hsa-miR-1539,synovial sarcoma,0.8341070413589478
hsa-miR-3120-5p,synovial sarcoma,0.8341070413589478
hsa-miR-10a-5p,synovial sarcoma,0.8341070413589478
hsa-miR-510-5p,synovial sarcoma,0.8341070413589478
hsa-miR-302b-3p,synovial sarcoma,0.8341070413589478
hsa-miR-4261,synovial sarcoma,0.8341070413589478
hsa-miR-3133,synovial sarcoma,0.8341070413589478
hsa-miR-588,"squamous cell breast carcinoma, acantholytic variant",0.8341033458709717
hsa-miR-142,miR-142-y,0.8341010212898254
hsa-miR-1245b-5p,miR-142-y,0.8341010212898254
hsa-miR-4668-3p,solid pseudopapillary neoplasm of pancreas,0.8340813517570496
hsa-miR-937,solid pseudopapillary neoplasm of pancreas,0.8340813517570496
hsa-miR-1182,solid pseudopapillary neoplasm of pancreas,0.8340813517570496
hsa-miR-1226-3p,breast cancer brain metastasis,0.834074854850769
hsa-miR-4731-3p,breast cancer brain metastasis,0.834074854850769
hsa-miR-923,synovial sarcoma,0.8340657353401184
hsa-miR-3614-5p,synovial sarcoma,0.8340657353401184
hsa-miR-6780b-5p,synovial sarcoma,0.8340657353401184
hsa-miR-6893-3p,synovial sarcoma,0.8340657353401184
hsa-miR-92a,synovial sarcoma,0.8340657353401184
hsa-miR-6892-5p,synovial sarcoma,0.8340657353401184
hsa-miR-6507-3p,synovial sarcoma,0.8340657353401184
hsa-miR-1274b,synovial sarcoma,0.8340657353401184
hsa-miR-4419b,"Luminal B,triple negative",0.8340392112731934
hsa-miR-4731-3p,primary central nervous system lymphomas,0.8340345621109009
hsa-miR-323a-3p,synovial sarcoma,0.8340092301368713
hsa-miR-123,synovial sarcoma,0.8340092301368713
hsa-miR-5001-3p,synovial sarcoma,0.8340092301368713
hsa-miR-640,"Luminal B,triple negative",0.8340067267417908
hsa-miR-4661-5p,"squamous cell breast carcinoma, acantholytic variant",0.8340033888816833
hsa-miR-218-1-3p,"squamous cell breast carcinoma, acantholytic variant",0.8340033888816833
hsa-miR-7856-5p,"squamous cell breast carcinoma, acantholytic variant",0.8340033888816833
hsa-miR-1298,ovarian carcinoma,0.833974301815033
hsa-miR-518a,ovarian carcinoma,0.833974301815033
hsa-let-7d*,ovarian carcinoma,0.833974301815033
hsa-miR-4652-5p,ovarian carcinoma,0.833974301815033
hsa-miR-886,ovarian carcinoma,0.833974301815033
hsa-miR-6069,ovarian carcinoma,0.833974301815033
hsa-miR-367-5p,diffuse large B-cell lymphoma,0.8339493274688721
hsa-miR-632,castration-resistant prostate cancer,0.8339487314224243
hsa-miR-373,"squamous cell breast carcinoma, acantholytic variant",0.833946943283081
hsa-miR-631,"squamous cell breast carcinoma, acantholytic variant",0.833946943283081
hsa-miR-5001-3p,"squamous cell breast carcinoma, acantholytic variant",0.833946943283081
hsa-miR-340-3p,"squamous cell breast carcinoma, acantholytic variant",0.8339321613311768
hsa-miR-711,"squamous cell breast carcinoma, acantholytic variant",0.8339321613311768
hsa-miR-1279,"squamous cell breast carcinoma, acantholytic variant",0.8339321613311768
hsa-miR-27a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8339321613311768
hsa-miR-135b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8339321613311768
hsa-miR-422b,ovarian carcinoma,0.8339316844940186
hsa-miR-3605-3p,ovarian carcinoma,0.8339316844940186
hsa-miR-606,ovarian carcinoma,0.8339316844940186
hsa-miR-140,ovarian carcinoma,0.8339316844940186
hsa-miR-548w,ovarian carcinoma,0.8339316844940186
hsa-miR-101-5p,ovarian carcinoma,0.8339316844940186
hsa-miR-5008-3p,ovarian carcinoma,0.8339316844940186
hsa-miR-3676,castration-resistant prostate cancer,0.8339005708694458
hsa-miR-1273e,castration-resistant prostate cancer,0.8339005708694458
hsa-miR-548an,castration-resistant prostate cancer,0.8339005708694458
hsa-miR-3188,castration-resistant prostate cancer,0.8339005708694458
hsa-miR-6807-5p,castration-resistant prostate cancer,0.8339005708694458
hsa-miR-4713-5p,castration-resistant prostate cancer,0.8339005708694458
hsa-miR-548j,castration-resistant prostate cancer,0.8339005708694458
hsa-miR-3614-5p,"Luminal B,triple negative",0.833899736404419
hsa-miR-218-1-3p,"Luminal B,triple negative",0.833899736404419
hsa-miR-15b,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-676-5p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-6727-5p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-3610,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-223-3p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-4329,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-6068,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-1185-1,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-5582-5p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-1273g-3p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-21*,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-335-3p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-3150b-3p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-500a,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-20a-3p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-4763-3p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-378g,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-510-3p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-1250-5p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-6804-5p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-200c*,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-1323,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-518c,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-4438,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-136-5p,castration-resistant prostate cancer,0.8338837623596191
hsa-miR-6870-3p,synovial sarcoma,0.8338608741760254
hsa-miR-6749-5p,synovial sarcoma,0.8338608741760254
hsa-miR-4790-5p,synovial sarcoma,0.8338608741760254
hsa-miR-4460,synovial sarcoma,0.8338608741760254
hsa-miR-548x-3p,synovial sarcoma,0.8338608741760254
hsa-miR-3156-3p,synovial sarcoma,0.8338608741760254
hsa-miR-6812-3p,synovial sarcoma,0.8338608741760254
hsa-miR-5001-3p,"Luminal B,triple negative",0.8338430523872375
hsa-miR-517c-3p,"Luminal B,triple negative",0.8338430523872375
hsa-miR-485-3p,miR-675-y,0.8338378667831421
hsa-miR-320a,miR-675-y,0.8338378667831421
hsa-miR-1273a,breast cancer brain metastasis,0.8338356018066406
hsa-miR-100*,breast cancer brain metastasis,0.8338356018066406
hsa-miR-486-3p,synovial sarcoma,0.8338056206703186
hsa-miR-548ah-5p,synovial sarcoma,0.8338056206703186
hsa-miR-199a-3p,primary central nervous system lymphomas,0.8337953090667725
hsa-miR-454*,castration-resistant prostate cancer,0.8337727189064026
hsa-miR-4272,synovial sarcoma,0.8337617516517639
hsa-miR-515-3p,synovial sarcoma,0.8337617516517639
hsa-miRPlus-J1004,synovial sarcoma,0.8337617516517639
hsa-miR-874,synovial sarcoma,0.8337617516517639
hsa-miR-187-5p,synovial sarcoma,0.8337617516517639
hsa-miR-5585-3p,synovial sarcoma,0.8337617516517639
hsa-miR-625-3p,synovial sarcoma,0.8337617516517639
hsa-miR-3647-5p,synovial sarcoma,0.8337617516517639
hsa-miR-1255b-2,synovial sarcoma,0.8337617516517639
hsa-miR-363,synovial sarcoma,0.8337617516517639
hsa-miR-378e,synovial sarcoma,0.8337617516517639
hsa-miR-4745-3p,synovial sarcoma,0.8337617516517639
hsa-miR-4772-5p,synovial sarcoma,0.8337617516517639
hsa-miR-3186-3p,synovial sarcoma,0.8337617516517639
hsa-miR-3680-3p,synovial sarcoma,0.8337617516517639
hsa-miR-7-5p,synovial sarcoma,0.8337617516517639
hsa-miR-6750-3p,"squamous cell breast carcinoma, acantholytic variant",0.8337512612342834
hsa-miR-659-3p,solid pseudopapillary neoplasm of pancreas,0.8337448835372925
hsa-miR-3175,"squamous cell breast carcinoma, acantholytic variant",0.8337432146072388
hsa-miR-1247-5p,"squamous cell breast carcinoma, acantholytic variant",0.8337432146072388
hsa-miR-6503-3p,"squamous cell breast carcinoma, acantholytic variant",0.8337432146072388
hsa-miR-485-5p,"squamous cell breast carcinoma, acantholytic variant",0.8337432146072388
hsa-miR-518a-3p,breast cancer brain metastasis,0.8337286710739136
hsa-miR-342-3p,breast cancer brain metastasis,0.8337268233299255
hsa-miR-4324,castration-resistant prostate cancer,0.833686113357544
hsa-miR-587,castration-resistant prostate cancer,0.833686113357544
hsa-miR-4293,castration-resistant prostate cancer,0.833686113357544
hsa-miR-5006-5p,castration-resistant prostate cancer,0.833686113357544
hsa-miR-1278,castration-resistant prostate cancer,0.833686113357544
hsa-miR-517b-3p,castration-resistant prostate cancer,0.833686113357544
hsa-miR-197-5p,castration-resistant prostate cancer,0.833686113357544
hsa-miR-4502,"Luminal B,triple negative",0.833659827709198
hsa-miR-91,diffuse large B-cell lymphoma,0.8336406946182251
hsa-miR-6503-3p,"Luminal B,triple negative",0.8336393237113953
hsa-miR-5010-5p,"Luminal B,triple negative",0.8336393237113953
hsa-miR-23b*,synovial sarcoma,0.8335957527160645
hsa-let-7b_c,synovial sarcoma,0.8335957527160645
hsa-miR-3615,synovial sarcoma,0.8335957527160645
hsa-miR-1206,synovial sarcoma,0.8335957527160645
hsa-miR-323-5p,synovial sarcoma,0.8335957527160645
hsa-miR-412,synovial sarcoma,0.8335957527160645
hsa-miR-5191,synovial sarcoma,0.8335957527160645
hsa-miR-4750-3p,synovial sarcoma,0.8335957527160645
hsa-miR-4657,synovial sarcoma,0.8335957527160645
hsa-miR-153-3p,synovial sarcoma,0.8335957527160645
hsa-miR-581,synovial sarcoma,0.8335919976234436
hsa-miR-6891-5p,synovial sarcoma,0.8335919976234436
hsa-miR-4454,castration-resistant prostate cancer,0.8335848450660706
hsa-miR-487b-3p,castration-resistant prostate cancer,0.8335848450660706
hsa-miR-220c,miR-675-y,0.8335611820220947
hsa-miR-021,miR-675-y,0.8335611820220947
hsa-miR-3682-3p,breast cancer brain metastasis,0.8335356712341309
hsa-miR-3135b,"squamous cell breast carcinoma, acantholytic variant",0.8335296511650085
hsa-miR-1250,pilocytic astrocytoma,0.8335202932357788
hsa-miR-6808-5p,primary central nervous system lymphomas,0.8334952592849731
hsa-miR-1538,sarcoma,0.8334860801696777
hsa-miR-483-3p-1106,sarcoma,0.8334860801696777
hsa-miR-548g,sarcoma,0.8334860801696777
hsa-miR-4491,sarcoma,0.8334860801696777
hsa-miR-552-5p,sarcoma,0.8334860801696777
hsa-miR-193a-3p,ovarian carcinoma,0.8334663510322571
hsa-miR-490-3p,ovarian carcinoma,0.8334663510322571
hsa-miR-6802-5p,ovarian carcinoma,0.8334663510322571
hsa-miR-1296-3p,ovarian carcinoma,0.8334663510322571
hsa-miR-6089,ovarian carcinoma,0.8334663510322571
hsa-miR-3147,ovarian carcinoma,0.8334663510322571
hsa-miR-3123,ovarian carcinoma,0.8334663510322571
hsa-miR-570-5p,ovarian carcinoma,0.8334663510322571
hsa-miR-3163,ovarian carcinoma,0.8334663510322571
hsa-miR-4800-5p,ovarian carcinoma,0.8334663510322571
hsa-miR-145,castration-resistant prostate cancer,0.8334638476371765
hsa-miR-517c,castration-resistant prostate cancer,0.8334638476371765
hsa-miR-6836-3p,castration-resistant prostate cancer,0.8334638476371765
hsa-miR-6842-5p,castration-resistant prostate cancer,0.8334638476371765
hsa-miR-9-1*,castration-resistant prostate cancer,0.8334638476371765
hsa-miR-6743-3p,castration-resistant prostate cancer,0.8334638476371765
hsa-miR-3177-3p,castration-resistant prostate cancer,0.8334638476371765
hsa-miR-584-3p,castration-resistant prostate cancer,0.8334638476371765
hsa-miR-6755-5p,brain cancer,0.8334169387817383
hsa-miR-1199-5p,synovial sarcoma,0.8333673477172852
hsa-miR-876-5p,synovial sarcoma,0.8333673477172852
hsa-miR-924,synovial sarcoma,0.8333673477172852
hsa-miR-423-5p_1,"squamous cell breast carcinoma, acantholytic variant",0.8333598971366882
hsa-miR-3668,synovial sarcoma,0.8333483934402466
hsa-miR-643,breast cancer brain metastasis,0.8333466053009033
hsa-miR-923,solid pseudopapillary neoplasm of pancreas,0.8333150148391724
hsa-miR-4651,synovial sarcoma,0.8333065509796143
hsa-miR-4276,synovial sarcoma,0.8333065509796143
hsa-miR-138-1-3p,synovial sarcoma,0.8333065509796143
hsa-miR-18a*,synovial sarcoma,0.8333065509796143
hsa-miR-134-3p,synovial sarcoma,0.8333065509796143
hsa-miR-3171,synovial sarcoma,0.8333065509796143
hsa-miR-525*-524,synovial sarcoma,0.8333065509796143
hsa-miR-93-5p,synovial sarcoma,0.8333065509796143
hsa-miR-4540,synovial sarcoma,0.8333065509796143
hsa-miR-6773-3p,synovial sarcoma,0.8333065509796143
hsa-miR-605-5p,synovial sarcoma,0.8333065509796143
hsa-miR-1252-5p,synovial sarcoma,0.8333065509796143
hsa-miR-378b,synovial sarcoma,0.8333065509796143
hsa-miR-519d-3p,synovial sarcoma,0.8333065509796143
hsa-miR-29b-2*,solid pseudopapillary neoplasm of pancreas,0.8333002924919128
hsa-miR-450a,miR-675-y,0.8332735300064087
hsa-miR-3605-3p,castration-resistant prostate cancer,0.8332608938217163
hsa-miR-140,castration-resistant prostate cancer,0.8332608938217163
hsa-miR-2355,castration-resistant prostate cancer,0.8332608938217163
hsa-miR-4788,castration-resistant prostate cancer,0.8332608938217163
hsa-miR-1274b,castration-resistant prostate cancer,0.8332608938217163
hsa-miR-6072,castration-resistant prostate cancer,0.8332608938217163
hsa-miR-5089-5p,"Luminal B,triple negative",0.8332513570785522
hsa-miR-625*,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-6840-3p,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-639,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-3676-3p,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-516b*,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-1343-5p,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-124*,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-1301,castration-resistant prostate cancer,0.8332339525222778
hsa-let-7d-3p,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-141-5p,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-1273g-5p,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-2861,castration-resistant prostate cancer,0.8332339525222778
hsa-miR-1182,"Luminal B,triple negative",0.8332063555717468
hsa-miR-885-3p,"Luminal B,triple negative",0.8332063555717468
hsa-miR-4256,"Luminal B,triple negative",0.8332063555717468
hsa-miR-103a,"Luminal B,triple negative",0.8332063555717468
hsa-miR-210-5p,castration-resistant prostate cancer,0.8332040309906006
hsa-miR-323a-3p,castration-resistant prostate cancer,0.8332040309906006
hsa-miR-631,castration-resistant prostate cancer,0.8332040309906006
hsa-miR-876-5p,"Luminal B,triple negative",0.8332006335258484
hsa-miR-4680-5p,"Luminal B,triple negative",0.8332006335258484
hsa-miR-4653-3p,synovial sarcoma,0.8331995606422424
hsa-miR-7155-3p,synovial sarcoma,0.833183765411377
hsa-miR-151-3p,solid pseudopapillary neoplasm of pancreas,0.8331774473190308
hsa-let-7b*,solid pseudopapillary neoplasm of pancreas,0.8331774473190308
hsa-miR-3646,"Luminal B,triple negative",0.8331608176231384
hsa-miR-28-5p,"squamous cell breast carcinoma, acantholytic variant",0.8331472277641296
hsa-miR-934,breast cancer brain metastasis,0.8331459760665894
hsa-miR-6822-5p,synovial sarcoma,0.8331331610679626
hsa-miR-1262,synovial sarcoma,0.8331331610679626
hsa-miR-640,synovial sarcoma,0.8331149816513062
hsa-miR-548k,primary central nervous system lymphomas,0.8331054449081421
hsa-miR-196b-5p,miR-142-y,0.8330954313278198
hsa-miR-642b-3p,synovial sarcoma,0.8330792188644409
hsa-miR-5186,solid pseudopapillary neoplasm of pancreas,0.8330770134925842
hsa-miR-4739,"squamous cell breast carcinoma, acantholytic variant",0.8330705165863037
hsa-miRPlus-A1086,solid pseudopapillary neoplasm of pancreas,0.8330538868904114
hsa-miR-6503-3p,sarcoma,0.8330435752868652
hsa-miR-302a*,synovial sarcoma,0.8330036401748657
hsa-miR-192-2/3,synovial sarcoma,0.8330036401748657
hsa-miR-6793-3p,synovial sarcoma,0.8330036401748657
hsa-miR-7-2,synovial sarcoma,0.8330036401748657
hsa-miR-146b-3p,synovial sarcoma,0.8330036401748657
hsa-miR-3652,synovial sarcoma,0.8330036401748657
hsa-miR-190a-5p,synovial sarcoma,0.8330036401748657
hsa-miR-3686,synovial sarcoma,0.8330036401748657
hsa-miR-1237,synovial sarcoma,0.8330036401748657
hsa-let-7d-v2,synovial sarcoma,0.8330036401748657
hsa-miR-1909*,castration-resistant prostate cancer,0.8329996466636658
hsa-miR-6503-3p,castration-resistant prostate cancer,0.8329996466636658
hsa-miR-483-5p,castration-resistant prostate cancer,0.8329930305480957
hsa-miR-4298,castration-resistant prostate cancer,0.8329930305480957
hsa-miR-6889-3p,castration-resistant prostate cancer,0.8329930305480957
hsa-miRPlus-A1025,castration-resistant prostate cancer,0.8329930305480957
hsa-miR-431-3p,castration-resistant prostate cancer,0.8329930305480957
hsa-miR-224-5p,castration-resistant prostate cancer,0.8329930305480957
hsa-miR-5581-5p,castration-resistant prostate cancer,0.8329930305480957
hsa-miR-3671,castration-resistant prostate cancer,0.8329930305480957
hsa-miR-548bb-3p,castration-resistant prostate cancer,0.8329930305480957
hsa-miR-519c-3p,diffuse large B-cell lymphoma,0.8329836130142212
hsa-miR-8065,synovial sarcoma,0.8329792022705078
hsa-miR-4682,synovial sarcoma,0.8329792022705078
hsa-miR-367-5p,miR-675-y,0.8329763412475586
hsa-miR-1262,"Luminal B,triple negative",0.8329663872718811
hsa-miR-6875-5p,synovial sarcoma,0.8329570293426514
hsa-miR-6777-5p,sarcoma,0.8329344987869263
hsa-miR-4659b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8329227566719055
hsa-miR-3682-3p,"squamous cell breast carcinoma, acantholytic variant",0.8329227566719055
hsa-miR-6758-5p,"squamous cell breast carcinoma, acantholytic variant",0.8329227566719055
hsa-miR-3150b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8329227566719055
hsa-miR-632,synovial sarcoma,0.8329104781150818
hsa-miR-4419b,miR-142-y,0.8329055309295654
hsa-miR-3664-5p,primary central nervous system lymphomas,0.8328952789306641
hsa-miR-548aq-3p,primary central nervous system lymphomas,0.8328952789306641
hsa-miR-9-1,synovial sarcoma,0.8328890800476074
hsa-miR-362-5p,synovial sarcoma,0.8328890800476074
hsa-miR-519c,synovial sarcoma,0.8328890800476074
hsa-miR-3144-5p,synovial sarcoma,0.8328890800476074
hsa-miR-3646,synovial sarcoma,0.8328863382339478
hsa-miR-1301-5p,synovial sarcoma,0.8328863382339478
hsa-miR-629-5p,synovial sarcoma,0.8328863382339478
hsa-miR-519a,miR-675-y,0.8328807353973389
hsa-miR-631,"Luminal B,triple negative",0.8328683376312256
hsa-miR-196b-5p,synovial sarcoma,0.8328607678413391
hsa-miR-3651,synovial sarcoma,0.8328607678413391
hsa-miR-3688-3p,synovial sarcoma,0.8328346014022827
hsa-miR-3934-3p,synovial sarcoma,0.8328346014022827
hsa-miR-5009-3p,synovial sarcoma,0.8328346014022827
hsa-miR-6769a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8328263759613037
hsa-let-7b*,"squamous cell breast carcinoma, acantholytic variant",0.8328263759613037
hsa-miR-3614-5p,sarcoma,0.8328176140785217
hsa-miR-6874-5p,sarcoma,0.8328176140785217
hsa-miR-4720-3p,synovial sarcoma,0.8328111171722412
hsa-miR-7977,synovial sarcoma,0.8328111171722412
hsa-miR-4664-3p,synovial sarcoma,0.8328111171722412
hsa-miR-6879-5p,synovial sarcoma,0.8328111171722412
hsa-miR-513a-1,synovial sarcoma,0.8328111171722412
hsa-miR-1227,synovial sarcoma,0.8328111171722412
hsa-miR-145*,synovial sarcoma,0.8328111171722412
hsa-miR-1974,synovial sarcoma,0.8328111171722412
hsa-miR-505-3p,synovial sarcoma,0.8328111171722412
hsa-miR-4426,synovial sarcoma,0.8328111171722412
hsa-miR-4802-3p,synovial sarcoma,0.8328111171722412
hsa-miR-3663-3p,synovial sarcoma,0.8328111171722412
hsa-miR-1273c,synovial sarcoma,0.8328111171722412
hsa-let-7a-2-3p,synovial sarcoma,0.8328111171722412
hsa-miR-3140-3p,synovial sarcoma,0.8328111171722412
hsa-miR-4758-5p,synovial sarcoma,0.8328111171722412
hsa-miR-10b-3p,synovial sarcoma,0.8328111171722412
hsa-miR-324,synovial sarcoma,0.8328111171722412
hsa-miR-675-5p,synovial sarcoma,0.8328111171722412
hsa-miR-4755-3p,synovial sarcoma,0.8328111171722412
hsa-miR-5680,synovial sarcoma,0.8328111171722412
hsa-miR-8061,synovial sarcoma,0.8328111171722412
hsa-miR-4666a-5p,synovial sarcoma,0.8328111171722412
hsa-miR-16-2-3p,synovial sarcoma,0.8328111171722412
hsa-miR-3674,synovial sarcoma,0.8328111171722412
hsa-miR-374c-5p,synovial sarcoma,0.8328111171722412
hsa-miR-3159,synovial sarcoma,0.8328111171722412
hsa-miR-16-1*,synovial sarcoma,0.8328111171722412
hsa-miR-1254,synovial sarcoma,0.8328089714050293
hsa-miR-504-3p,castration-resistant prostate cancer,0.8327851295471191
hsa-miR-1915-5p,castration-resistant prostate cancer,0.8327851295471191
hsa-miR-6503-3p,synovial sarcoma,0.8327827453613281
hsa-miR-485-5p,synovial sarcoma,0.8327827453613281
hsa-miR-3605-3p,miR-142-y,0.8327651023864746
hsa-miR-101-5p,miR-142-y,0.8327651023864746
hsa-miR-27a-3p,miR-142-y,0.8327651023864746
hsa-miR-1915-5p,synovial sarcoma,0.8327551484107971
hsa-miR-187,synovial sarcoma,0.8327475786209106
hsa-miR-1343,synovial sarcoma,0.8327475786209106
hsa-miR-2115,synovial sarcoma,0.8327475786209106
hsa-miR-4796-3p,synovial sarcoma,0.8327475786209106
hsa-miR-22-3p,synovial sarcoma,0.8327475786209106
hsa-miR-885-3p,synovial sarcoma,0.8327475786209106
hsa-miR-3179,synovial sarcoma,0.8327475786209106
hsa-miR-548at-5p,synovial sarcoma,0.8327475786209106
hsa-miR-940,synovial sarcoma,0.8327475786209106
hsa-miR-5586-3p,synovial sarcoma,0.8327475786209106
hsa-miR-4256,synovial sarcoma,0.8327475786209106
hsa-miR-376a-2-5p,synovial sarcoma,0.8327475786209106
hsa-miR-933,synovial sarcoma,0.8327475786209106
hsa-miR-513b-3p,synovial sarcoma,0.8327475786209106
hsa-miR-4773,synovial sarcoma,0.8327475786209106
hsa-miR-19b-1-5p,synovial sarcoma,0.8327475786209106
hsa-miR-6754-3p,synovial sarcoma,0.8327475786209106
hsa-miR-548am-3p,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-200a*,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-4534,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-549,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-3912,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-4661-3p,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-492,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-128-3p,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-4770,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-4254,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-548x-3p,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-4999-3p,castration-resistant prostate cancer,0.8327455520629883
hsa-miR-3173-5p,diffuse large B-cell lymphoma,0.8327357769012451
hsa-miR-3189-5p,diffuse large B-cell lymphoma,0.8327357769012451
hsa-miR-744*,diffuse large B-cell lymphoma,0.8327357769012451
hsa-let-7a_c,diffuse large B-cell lymphoma,0.8327357769012451
hsa-miR-4772-3p,synovial sarcoma,0.832726776599884
hsa-miR-138-2-3p,synovial sarcoma,0.832726776599884
hsa-miR-129-5p,synovial sarcoma,0.832726776599884
hsa-miR-6746-3p,synovial sarcoma,0.8327266573905945
hsa-miR-6509-3p,synovial sarcoma,0.8327266573905945
hsa-miR-450a-2-3p,synovial sarcoma,0.8327266573905945
hsa-miR-544,synovial sarcoma,0.8327266573905945
hsa-miR-548p,synovial sarcoma,0.8327266573905945
hsa-miR-885-5p,synovial sarcoma,0.8327266573905945
hsa-miR-6080,synovial sarcoma,0.8327266573905945
hsa-miR-183,synovial sarcoma,0.8327266573905945
hsa-miR-526a,synovial sarcoma,0.8327266573905945
hsa-miR-744-3p,synovial sarcoma,0.8327266573905945
hsa-miR-548h-3p,synovial sarcoma,0.8327266573905945
hsa-miR-124-3p,synovial sarcoma,0.8327266573905945
hsa-miR-585-5p,synovial sarcoma,0.8327266573905945
hsa-let-7g*,synovial sarcoma,0.8327266573905945
hsa-miR-516,synovial sarcoma,0.8327266573905945
hsa-miR-425-3p,breast cancer brain metastasis,0.8327221274375916
hsa-miR-6835-5p,breast cancer brain metastasis,0.8327221274375916
hsa-miR-218-5p,"Luminal B,triple negative",0.8327219486236572
hsa-miR-3690,"Luminal B,triple negative",0.8327219486236572
hsa-miR-6720-5p,"Luminal B,triple negative",0.8327219486236572
hsa-miR-873,breast cancer brain metastasis,0.8327196836471558
hsa-miR-133b,breast cancer brain metastasis,0.8327196836471558
hsa-miR-411-5p,breast cancer brain metastasis,0.8327196836471558
hsa-miR-674,miR-142-y,0.8327082395553589
hsa-miR-6768-3p,miR-675-y,0.8327030539512634
hsa-miR-3200,miR-675-y,0.8327030539512634
hsa-miR-4301,miR-675-y,0.8327030539512634
hsa-miR-24-1*,miR-675-y,0.8327030539512634
hsa-miR-593-3p,sarcoma,0.8327026963233948
hsa-miR-3606-5p,sarcoma,0.8327026963233948
hsa-miR-7850-5p,"squamous cell breast carcinoma, acantholytic variant",0.8326979875564575
hsa-miR-6821-3p,"squamous cell breast carcinoma, acantholytic variant",0.8326979875564575
hsa-miR-5589-5p,"squamous cell breast carcinoma, acantholytic variant",0.8326979875564575
hsa-miR-6800-5p,"squamous cell breast carcinoma, acantholytic variant",0.8326979875564575
hsa-miR-1277-5p,"squamous cell breast carcinoma, acantholytic variant",0.8326979875564575
hsa-miR-3141,synovial sarcoma,0.8326971530914307
hsa-miR-125a-5p,synovial sarcoma,0.8326971530914307
hsa-miR-4639-3p,synovial sarcoma,0.8326971530914307
hsa-miR-4642,synovial sarcoma,0.8326971530914307
hsa-miR-6782-3p,synovial sarcoma,0.8326971530914307
hsa-miR-6779-5p,"squamous cell breast carcinoma, acantholytic variant",0.8326810598373413
hsa-miRPlus-G1246-3p,"squamous cell breast carcinoma, acantholytic variant",0.8326810598373413
hsa-miR-345-3p,"squamous cell breast carcinoma, acantholytic variant",0.8326810598373413
hsa-miR-21*,"squamous cell breast carcinoma, acantholytic variant",0.8326810598373413
hsa-miR-378g,"squamous cell breast carcinoma, acantholytic variant",0.8326810598373413
hsa-miR-605-3p,"squamous cell breast carcinoma, acantholytic variant",0.8326810598373413
hsa-let-7b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8326810598373413
hsa-miR-1234-3p,miR-675-y,0.8326663374900818
hsa-miR-181c-3p,synovial sarcoma,0.8326660990715027
hsa-miR-500*,"Luminal B,triple negative",0.8326540589332581
hsa-miR-3927-3p,miR-142-y,0.832649827003479
hsa-miR-337,miR-142-y,0.832649827003479
hsa-miR-4272,castration-resistant prostate cancer,0.832645833492279
hsa-miR-6774-5p,castration-resistant prostate cancer,0.832645833492279
hsa-miR-664,castration-resistant prostate cancer,0.832645833492279
hsa-miR-5100,castration-resistant prostate cancer,0.832645833492279
hsa-miR-1281,castration-resistant prostate cancer,0.832645833492279
hsa-miR-187-5p,castration-resistant prostate cancer,0.832645833492279
hsa-miR-363,castration-resistant prostate cancer,0.832645833492279
hsa-miR-2054,castration-resistant prostate cancer,0.832645833492279
hsa-miR-195-5p,castration-resistant prostate cancer,0.832645833492279
hsa-miR-370-5p,castration-resistant prostate cancer,0.832645833492279
hsa-miR-551b-3p,synovial sarcoma,0.8326342701911926
hsa-miR-6860,synovial sarcoma,0.8326342701911926
hsa-miR-340-5p,synovial sarcoma,0.8326340913772583
hsa-miR-4288,synovial sarcoma,0.8326340913772583
hsa-miR-7156-5p,synovial sarcoma,0.8326340913772583
hsa-miR-3149,synovial sarcoma,0.8326340913772583
hsa-miR-378a-5p,synovial sarcoma,0.8326340913772583
hsa-miR-8071,synovial sarcoma,0.8326340913772583
hsa-miR-4731-3p,diffuse large B-cell lymphoma,0.8326340317726135
hsa-miR-450a,solid pseudopapillary neoplasm of pancreas,0.8326259255409241
hsa-miR-767-5p,solid pseudopapillary neoplasm of pancreas,0.8326259255409241
hsa-miR-3938,solid pseudopapillary neoplasm of pancreas,0.8326259255409241
hsa-miR-6729-3p,synovial sarcoma,0.8326005339622498
hsa-miR-6825-3p,synovial sarcoma,0.8326005339622498
hsa-miR-6808-3p,sarcoma,0.832579493522644
hsa-miR-181c-3p,sarcoma,0.832579493522644
hsa-miR-518d-3p,"squamous cell breast carcinoma, acantholytic variant",0.8325715661048889
hsa-miR-021,synovial sarcoma,0.8325655460357666
hsa-miR-6792-3p,synovial sarcoma,0.8325655460357666
hsa-miR-6084,synovial sarcoma,0.8325655460357666
hsa-miR-6809-5p,synovial sarcoma,0.8325655460357666
hsa-miR-1199-5p,castration-resistant prostate cancer,0.8325594663619995
hsa-miR-450a,synovial sarcoma,0.8325287699699402
hsa-miR-890,synovial sarcoma,0.8325287699699402
hsa-miR-147b,synovial sarcoma,0.8325287699699402
hsa-miR-6755-3p,synovial sarcoma,0.8325287699699402
hsa-miR-876-3p,synovial sarcoma,0.8325287699699402
hsa-miR-1226-5p,testicular cancer,0.8325221538543701
hsa-miR-323-3p,synovial sarcoma,0.8324896693229675
hsa-miR-6757-3p,synovial sarcoma,0.8324896693229675
hsa-miR-520d*,synovial sarcoma,0.8324896693229675
hsa-miR-625-5p,"squamous cell breast carcinoma, acantholytic variant",0.8324822187423706
hsa-miR-3185,"squamous cell breast carcinoma, acantholytic variant",0.8324822187423706
hsa-miR-3124-5p,synovial sarcoma,0.8324806094169617
hsa-miR-218-1,synovial sarcoma,0.8324806094169617
hsa-miR-548ag,synovial sarcoma,0.8324806094169617
hsa-miR-3591-5p,synovial sarcoma,0.8324806094169617
hsa-miR-363-3p,synovial sarcoma,0.8324806094169617
hsa-miR-598,synovial sarcoma,0.8324806094169617
hsa-miR-199b-3p,synovial sarcoma,0.8324806094169617
hsa-miR-514,castration-resistant prostate cancer,0.832478940486908
hsa-miR-3615,castration-resistant prostate cancer,0.832478940486908
hsa-miR-548ac,castration-resistant prostate cancer,0.832478940486908
hsa-miR-514b-5p,castration-resistant prostate cancer,0.832478940486908
hsa-miR-5191,castration-resistant prostate cancer,0.832478940486908
hsa-miR-4433a-5p,castration-resistant prostate cancer,0.832478940486908
hsa-miR-6737-3p,castration-resistant prostate cancer,0.832478940486908
hsa-miR-613,castration-resistant prostate cancer,0.832478940486908
hsa-miR-7154-3p,castration-resistant prostate cancer,0.832478940486908
hsa-miR-6832-5p,solid pseudopapillary neoplasm of pancreas,0.8324705958366394
hsa-miR-551b-3p,"Luminal B,triple negative",0.8324670195579529
hsa-miRPlus-J1002,primary central nervous system lymphomas,0.8324613571166992
hsa-miR-670-3p,primary central nervous system lymphomas,0.8324613571166992
hsa-miR-541*,primary central nervous system lymphomas,0.8324613571166992
hsa-miR-340-5p,sarcoma,0.8324509263038635
hsa-miR-148b-3p,synovial sarcoma,0.8324485421180725
hsa-miR-1234-3p,synovial sarcoma,0.8324485421180725
hsa-miR-6824-3p,synovial sarcoma,0.8324485421180725
hsa-miR-4744,synovial sarcoma,0.8324485421180725
hsa-miR-1909,"Luminal B,triple negative",0.8324219584465027
hsa-miR-552,synovial sarcoma,0.832405686378479
hsa-miR-1236,synovial sarcoma,0.832405686378479
hsa-miR-6812-5p,synovial sarcoma,0.832405686378479
hsa-miR-3136-5p,synovial sarcoma,0.832405686378479
hsa-miR-135b-3p,synovial sarcoma,0.832405686378479
hsa-miR-25-3p,synovial sarcoma,0.832405686378479
hsa-miR-33b-3p,synovial sarcoma,0.832405686378479
hsa-miR-3192-5p,ovarian carcinoma,0.8324014544487
hsa-miR-103-2,ovarian carcinoma,0.8324014544487
hsa-miR-337,ovarian carcinoma,0.8324014544487
hsa-miR-4735-5p,ovarian carcinoma,0.8324014544487
hsa-miR-2964a-5p,ovarian carcinoma,0.8324014544487
hsa-miR-548av-5p,ovarian carcinoma,0.8324014544487
hsa-miR-4300,ovarian carcinoma,0.8324014544487
hsa-miR-4655-5p,"squamous cell breast carcinoma, acantholytic variant",0.832380473613739
hsa-miR-3689e,"squamous cell breast carcinoma, acantholytic variant",0.832380473613739
hsa-miR-6822-5p,solid pseudopapillary neoplasm of pancreas,0.8323790431022644
hsa-miR-1227-3p,synovial sarcoma,0.8323682546615601
hsa-miR-320a,synovial sarcoma,0.8323682546615601
hsa-miR-3176,synovial sarcoma,0.8323582410812378
hsa-miR-513-5p,synovial sarcoma,0.8323582410812378
hsa-miR-3135b,sarcoma,0.8323410153388977
hsa-miR-6822-5p,castration-resistant prostate cancer,0.8323245644569397
hsa-miR-125a-5p,castration-resistant prostate cancer,0.8323245644569397
hsa-miR-4645-5p,castration-resistant prostate cancer,0.8323245644569397
hsa-miR-502,miR-142-y,0.8323181867599487
hsa-miR-1308,miR-142-y,0.8323181867599487
hsa-miR-320a,sarcoma,0.8323166966438293
hsa-miRPlus-C1114,primary central nervous system lymphomas,0.8323158621788025
hsa-miR-4687-3p,solid pseudopapillary neoplasm of pancreas,0.8323078155517578
hsa-miR-588,solid pseudopapillary neoplasm of pancreas,0.8323078155517578
hsa-miR-4787-3p,synovial sarcoma,0.8323067426681519
hsa-miR-199a-2,synovial sarcoma,0.8323067426681519
hsa-miR-4524b-5p,synovial sarcoma,0.8323067426681519
hsa-miR-192-3p,synovial sarcoma,0.8323067426681519
hsa-miR-579-5p,"squamous cell breast carcinoma, acantholytic variant",0.8323053121566772
hsa-miR-1977,"squamous cell breast carcinoma, acantholytic variant",0.8323053121566772
hsa-miR-490-3p,high grade serous papillary ovarian cancer,0.8322941064834595
hsa-miR-877,high grade serous papillary ovarian cancer,0.8322941064834595
hsa-miR-320B,high grade serous papillary ovarian cancer,0.8322941064834595
hsa-miR-1915-5p,miR-142-y,0.832288384437561
hsa-miR-4790-5p,breast cancer brain metastasis,0.8322680592536926
hsa-miR-4742-3p,breast cancer brain metastasis,0.8322680592536926
hsa-miR-22*,breast cancer brain metastasis,0.8322680592536926
hsa-miR-548ai,"squamous cell breast carcinoma, acantholytic variant",0.8322588205337524
hsa-miR-767-3p,"squamous cell breast carcinoma, acantholytic variant",0.8322588205337524
hsa-miR-18b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8322588205337524
hsa-miR-135-2,"squamous cell breast carcinoma, acantholytic variant",0.8322588205337524
hsa-miR-1468-5p,"squamous cell breast carcinoma, acantholytic variant",0.8322588205337524
hsa-miR-5189-3p,"squamous cell breast carcinoma, acantholytic variant",0.8322588205337524
hsa-miR-4641,"squamous cell breast carcinoma, acantholytic variant",0.8322588205337524
hsa-miR-423-5p_1,synovial sarcoma,0.8322538733482361
hsa-let-7f-2,synovial sarcoma,0.8322538733482361
hsa-miR-4723-3p,synovial sarcoma,0.8322538733482361
hsa-miR-1299,synovial sarcoma,0.8322538733482361
hsa-miR-4433b-5p,diffuse large B-cell lymphoma,0.8322514891624451
hsa-miR-554,diffuse large B-cell lymphoma,0.8322514891624451
hsa-miR-409-5p,diffuse large B-cell lymphoma,0.8322514891624451
hsa-miR-4314,diffuse large B-cell lymphoma,0.8322514891624451
hsa-miR-218-1*,synovial sarcoma,0.8322457671165466
hsa-miR-500b,synovial sarcoma,0.8322457671165466
hsa-miR-519d-5p,synovial sarcoma,0.8322457671165466
hsa-miR-3157-3p,synovial sarcoma,0.8322457671165466
hsa-miR-548as-5p,synovial sarcoma,0.8322457671165466
hsa-miR-5584-5p,synovial sarcoma,0.8322457671165466
hsa-miR-3173-3p,synovial sarcoma,0.8322457671165466
hsa-miR-7109-3p,synovial sarcoma,0.8322457671165466
hsa-miR-5011-3p,synovial sarcoma,0.8322457671165466
hsa-miR-3155a,synovial sarcoma,0.8322457671165466
hsa-miR-4539,synovial sarcoma,0.8322457671165466
hsa-miR-3912-3p,synovial sarcoma,0.8322457671165466
hsa-miR-3146,synovial sarcoma,0.8322457671165466
hsa-miR-4684-5p,synovial sarcoma,0.8322457671165466
hsa-miR-550-1,synovial sarcoma,0.8322457671165466
hsa-miR-551a,primary central nervous system lymphomas,0.8322440981864929
hsa-miR-3605-5p,testicular cancer,0.8322021961212158
hsa-miR-194,testicular cancer,0.8322021961212158
hsa-miR-372,testicular cancer,0.8322021961212158
hsa-miR-518a-5p,synovial sarcoma,0.8322000503540039
hsa-miR-1266,synovial sarcoma,0.8322000503540039
hsa-miR-320e,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-1233-3p,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-7151-3p,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-5196-3p,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-290,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-1304,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-4525,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-548i-1,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-182-5p,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-452-5p,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-3960,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-4425,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-470,castration-resistant prostate cancer,0.8321882486343384
hsa-miR-539,synovial sarcoma,0.8321865797042847
hsa-miR-138-2*,synovial sarcoma,0.8321865797042847
hsa-miR-1295,synovial sarcoma,0.8321865797042847
hsa-miR-6785-5p,synovial sarcoma,0.8321865797042847
hsa-miR-291-3p,synovial sarcoma,0.8321865797042847
hsa-miR-223*,synovial sarcoma,0.8321865797042847
hsa-miR-16-1-3p,synovial sarcoma,0.8321865797042847
hsa-miR-30a-5p,synovial sarcoma,0.8321865797042847
hsa-miR-526b-3p,synovial sarcoma,0.8321865797042847
hsa-miR-766-3p,synovial sarcoma,0.8321865797042847
hsa-miR-30a-3p,synovial sarcoma,0.8321865797042847
hsa-miR-4753-3p,synovial sarcoma,0.8321865797042847
hsa-miR-29a-2,synovial sarcoma,0.8321865797042847
hsa-miR-4487,synovial sarcoma,0.8321865797042847
hsa-miR-92a-1,synovial sarcoma,0.8321865797042847
hsa-miR-450a-1-3p,synovial sarcoma,0.8321865797042847
hsa-miR-7157-5p,synovial sarcoma,0.8321865797042847
hsa-miR-6818-3p,synovial sarcoma,0.8321865797042847
hsa-miR-6772-5p,synovial sarcoma,0.8321865797042847
hsa-miR-1471,synovial sarcoma,0.8321865797042847
hsa-miR-6809-5p,sarcoma,0.832175076007843
hsa-miR-4295,"Luminal B,triple negative",0.8321697115898132
hsa-miR-6803-3p,synovial sarcoma,0.8321435451507568
hsa-miR-4677-3p,synovial sarcoma,0.8321435451507568
hsa-miR-6894-5p,synovial sarcoma,0.8321435451507568
hsa-miR-4527,synovial sarcoma,0.8321435451507568
hsa-miR-6808-5p,synovial sarcoma,0.8321435451507568
hsa-miR-6769a-3p,solid pseudopapillary neoplasm of pancreas,0.8321340680122375
hsa-miR-520h,brain cancer,0.8321031332015991
hsa-miR-758-3p,synovial sarcoma,0.8320896029472351
hsa-miR-548ar-5p,synovial sarcoma,0.8320896029472351
hsa-miR-6821-3p,synovial sarcoma,0.8320881128311157
hsa-miR-6800-5p,synovial sarcoma,0.8320881128311157
hsa-miR-3162-5p,synovial sarcoma,0.8320881128311157
hsa-miR-3145-5p,synovial sarcoma,0.8320881128311157
hsa-miR-548j,synovial sarcoma,0.8320881128311157
hsa-miR-2277,synovial sarcoma,0.8320881128311157
hsa-miR-6842-3p,synovial sarcoma,0.8320881128311157
hsa-miR-218-5p,castration-resistant prostate cancer,0.8320795893669128
hsa-miR-1908,ovarian carcinoma,0.8320693373680115
hsa-miR-5580-5p,ovarian carcinoma,0.8320693373680115
hsa-miR-212-5p,ovarian carcinoma,0.8320693373680115
hsa-miR-487a,ovarian carcinoma,0.8320693373680115
hsa-miR-502,ovarian carcinoma,0.8320693373680115
hsa-miR-5186,ovarian carcinoma,0.8320693373680115
hsa-miR-744*,ovarian carcinoma,0.8320693373680115
hsa-miR-6082,papillary thyroid carcinoma,0.8320494890213013
hsa-miR-520d,synovial sarcoma,0.8320413827896118
hsa-miR-500,synovial sarcoma,0.8320413827896118
hsa-miR-106b*,synovial sarcoma,0.8320413827896118
hsa-miR-29b-3p,synovial sarcoma,0.8320413827896118
hsa-miR-5011-5p,synovial sarcoma,0.8320413827896118
hsa-miR-888-3p,synovial sarcoma,0.8320413827896118
hsa-miR-132-5p,synovial sarcoma,0.8320413827896118
hsa-miR-7151-5p,synovial sarcoma,0.8320413827896118
hsa-miR-5681a,synovial sarcoma,0.8320413827896118
hsa-miR-7108-3p,synovial sarcoma,0.8320413827896118
hsa-miR-499b-3p,synovial sarcoma,0.8320413827896118
hsa-miR-5739,synovial sarcoma,0.8320413827896118
hsa-miR-4735-3p,synovial sarcoma,0.8320413827896118
hsa-miR-5697,synovial sarcoma,0.8320413827896118
hsa-miR-6828-3p,synovial sarcoma,0.8320413827896118
hsa-miR-941-1,synovial sarcoma,0.8320413827896118
hsa-miR-2681-5p,synovial sarcoma,0.8320413827896118
hsa-miR-202,synovial sarcoma,0.8320413827896118
hsa-miR-33a,synovial sarcoma,0.8320289254188538
hsa-miR-592,synovial sarcoma,0.8320289254188538
hsa-miR-6814-5p,synovial sarcoma,0.8320289254188538
hsa-miR-3908,synovial sarcoma,0.8320289254188538
hsa-miR-99a-3p,synovial sarcoma,0.8320289254188538
hsa-miR-548k,synovial sarcoma,0.8320289254188538
hsa-miR-3185,synovial sarcoma,0.8320289254188538
hsa-miR-5692a,synovial sarcoma,0.8320289254188538
hsa-miR-873,"squamous cell breast carcinoma, acantholytic variant",0.8320274949073792
hsa-miR-3156-5p,"squamous cell breast carcinoma, acantholytic variant",0.8320274949073792
hsa-miR-124*,"squamous cell breast carcinoma, acantholytic variant",0.8320274949073792
hsa-miR-220c,"squamous cell breast carcinoma, acantholytic variant",0.8320266008377075
hsa-miR-663a,sarcoma,0.8320264220237732
hsa-miR-768-5p,breast cancer brain metastasis,0.8320263028144836
hsa-miR-3978,breast cancer brain metastasis,0.8320263028144836
hsa-miR-765,miR-675-y,0.8320062160491943
hsa-miR-513-5p,miR-675-y,0.8320062160491943
hsa-miR-6816-5p,miR-675-y,0.8320062160491943
hsa-miR-613,primary central nervous system lymphomas,0.831985592842102
hsa-miR-637,synovial sarcoma,0.8319680094718933
hsa-miR-920,synovial sarcoma,0.8319680094718933
hsa-miR-376c-5p,synovial sarcoma,0.8319680094718933
hsa-miR-6512-5p,synovial sarcoma,0.8319680094718933
hsa-miR-6799-3p,synovial sarcoma,0.8319680094718933
hsa-miR-4763-5p,synovial sarcoma,0.8319680094718933
hsa-miR-4309,synovial sarcoma,0.8319680094718933
hsa-miR-4437,synovial sarcoma,0.8319680094718933
hsa-miR-4692,synovial sarcoma,0.8319680094718933
hsa-miR-017,synovial sarcoma,0.8319680094718933
hsa-miR-3132,synovial sarcoma,0.8319680094718933
hsa-miR-4287,synovial sarcoma,0.8319680094718933
hsa-miR-4778-5p,synovial sarcoma,0.8319680094718933
hsa-miR-376b-3p,synovial sarcoma,0.8319680094718933
hsa-miR-3976,synovial sarcoma,0.8319680094718933
hsa-miR-8066,synovial sarcoma,0.8319680094718933
hsa-miR-4693-3p,synovial sarcoma,0.8319680094718933
hsa-miR-3677-5p,synovial sarcoma,0.8319680094718933
hsa-miR-548ad-3p,synovial sarcoma,0.8319680094718933
hsa-miR-3944-5p,synovial sarcoma,0.8319680094718933
hsa-miR-6165,synovial sarcoma,0.8319680094718933
hsa-miR-3152,synovial sarcoma,0.8319680094718933
hsa-miR-3942-5p,synovial sarcoma,0.8319680094718933
hsa-miR-4799-3p,synovial sarcoma,0.8319680094718933
hsa-miR-27b-5p,synovial sarcoma,0.8319680094718933
hsa-miR-374b*,synovial sarcoma,0.8319665193557739
hsa-miR-4676-5p,synovial sarcoma,0.8319665193557739
hsa-miR-4764-3p,synovial sarcoma,0.8319665193557739
hsa-miR-3664-5p,synovial sarcoma,0.8319665193557739
hsa-miR-1285-5p,synovial sarcoma,0.8319665193557739
hsa-miR-548aq-3p,synovial sarcoma,0.8319665193557739
hsa-miR-4688,synovial sarcoma,0.8319665193557739
hsa-miR-1468-5p,synovial sarcoma,0.8319665193557739
hsa-miR-4714-3p,synovial sarcoma,0.8319665193557739
hsa-miR-519c-3p,solid pseudopapillary neoplasm of pancreas,0.831952691078186
hsa-miR-675,synovial sarcoma,0.8319365382194519
hsa-miR-2681,synovial sarcoma,0.8319365382194519
hsa-miR-333,synovial sarcoma,0.8319365382194519
hsa-miR-129-3p,synovial sarcoma,0.8319365382194519
hsa-miR-1910-3p,synovial sarcoma,0.8319365382194519
hsa-miR-4433-5p,synovial sarcoma,0.8319365382194519
hsa-miR-185-5p,synovial sarcoma,0.8319365382194519
hsa-miR-8088,synovial sarcoma,0.8319365382194519
hsa-miR-19b-3p,synovial sarcoma,0.8319365382194519
hsa-miR-548ap-3p,synovial sarcoma,0.8319365382194519
hsa-miR-6771-3p,synovial sarcoma,0.8319365382194519
hsa-miR-452-3p,synovial sarcoma,0.8319365382194519
hsa-miR-513c-5p,synovial sarcoma,0.8319365382194519
hsa-miR-3135a,synovial sarcoma,0.8319365382194519
hsa-miR-362-3p,breast cancer brain metastasis,0.8319162130355835
hsa-miR-5192,breast cancer brain metastasis,0.8319162130355835
hsa-miR-20b-5p,breast cancer brain metastasis,0.8319162130355835
hsa-miR-7112-5p,synovial sarcoma,0.8319007754325867
hsa-miR-516-1,synovial sarcoma,0.8319007754325867
hsa-miR-5694,synovial sarcoma,0.8319007754325867
hsa-miR-194-5p,synovial sarcoma,0.8319007754325867
hsa-miR-193b,synovial sarcoma,0.8319007754325867
hsa-miR-3156-5p,synovial sarcoma,0.8319007754325867
hsa-miR-1343-5p,synovial sarcoma,0.8319007754325867
hsa-miR-6813-5p,synovial sarcoma,0.8319007754325867
hsa-miR-411-5p,synovial sarcoma,0.8319007754325867
hsa-miR-1273g-5p,synovial sarcoma,0.8319007754325867
hsa-miR-892c-3p,synovial sarcoma,0.8319007754325867
hsa-miR-2861,synovial sarcoma,0.8319007754325867
hsa-miR-6863,"Luminal B,triple negative",0.8318936228752136
hsa-miR-1201,breast cancer brain metastasis,0.8318904042243958
hsa-miR-874,breast cancer brain metastasis,0.8318904042243958
hsa-miR-4509,breast cancer brain metastasis,0.8318904042243958
hsa-miR-4321,breast cancer brain metastasis,0.8318904042243958
hsa-miR-6794-3p,castration-resistant prostate cancer,0.8318837285041809
hsa-miR-671-3p,castration-resistant prostate cancer,0.8318837285041809
hsa-miR-2113,castration-resistant prostate cancer,0.8318837285041809
hsa-miR-133a-5p,castration-resistant prostate cancer,0.8318837285041809
hsa-miR-1301-3p,castration-resistant prostate cancer,0.8318837285041809
hsa-miR-124,castration-resistant prostate cancer,0.8318837285041809
hsa-miR-7843-3p,castration-resistant prostate cancer,0.8318837285041809
hsa-miR-4639-3p,sarcoma,0.8318793177604675
hsa-miR-222*,testicular cancer,0.831879198551178
hsa-miR-139-5p,testicular cancer,0.831879198551178
hsa-miR-6732-5p,diffuse large B-cell lymphoma,0.8318760395050049
hsa-miR-518a-3p,diffuse large B-cell lymphoma,0.8318760395050049
hsa-miR-4700-3p,sarcoma,0.8318706154823303
hsa-miR-5584-3p,papillary thyroid carcinoma,0.8318572044372559
hsa-miR-501-3p,diffuse large B-cell lymphoma,0.8318506479263306
hsa-miR-921,diffuse large B-cell lymphoma,0.8318506479263306
hsa-miR-3909,diffuse large B-cell lymphoma,0.8318506479263306
hsa-miR-342-5p,diffuse large B-cell lymphoma,0.8318506479263306
hsa-miR-4511,diffuse large B-cell lymphoma,0.8318506479263306
hsa-miR-1288-3p,diffuse large B-cell lymphoma,0.8318506479263306
hsa-miR-450a-3p,diffuse large B-cell lymphoma,0.8318506479263306
hsa-miR-4435,diffuse large B-cell lymphoma,0.8318506479263306
hsa-miR-3647-5p,primary central nervous system lymphomas,0.8318496346473694
hsa-miR-4509,primary central nervous system lymphomas,0.8318496346473694
hsa-miR-3118,primary central nervous system lymphomas,0.8318496346473694
hsa-miR-642a-5p,synovial sarcoma,0.8318325877189636
hsa-miR-431-3p,synovial sarcoma,0.8318325877189636
hsa-miR-4296,synovial sarcoma,0.8318325877189636
hsa-miR-4709-3p,synovial sarcoma,0.8318325877189636
hsa-miR-4721,synovial sarcoma,0.8318325877189636
hsa-miR-525,synovial sarcoma,0.8318325877189636
hsa-miR-8075,synovial sarcoma,0.8318325877189636
hsa-miR-1909,miR-142-y,0.8318266868591309
hsa-miR-551b-3p,castration-resistant prostate cancer,0.8318238258361816
hsa-miR-6771-3p,sarcoma,0.8318068385124207
hsa-miR-302f,synovial sarcoma,0.8317998051643372
hsa-miR-6852-5p,synovial sarcoma,0.8317998051643372
hsa-miR-493-5p,synovial sarcoma,0.8317998051643372
hsa-miR-3155b,synovial sarcoma,0.8317998051643372
hsa-miR-483-5p,"squamous cell breast carcinoma, acantholytic variant",0.8317852020263672
hsa-miR-6890-3p,"squamous cell breast carcinoma, acantholytic variant",0.8317852020263672
hsa-miR-139-3p,"squamous cell breast carcinoma, acantholytic variant",0.8317852020263672
hsa-miR-510-5p,"squamous cell breast carcinoma, acantholytic variant",0.8317852020263672
hsa-miR-6752-3p,"squamous cell breast carcinoma, acantholytic variant",0.8317852020263672
hsa-miR-548h,breast cancer brain metastasis,0.8317632675170898
hsa-miR-4425,breast cancer brain metastasis,0.8317632675170898
hsa-miR-361-5p,synovial sarcoma,0.8317595720291138
hsa-miR-4475,synovial sarcoma,0.8317595720291138
hsa-miR-7161-3p,synovial sarcoma,0.8317595720291138
hsa-miR-1266-5p,synovial sarcoma,0.8317595720291138
hsa-miR-6849-3p,synovial sarcoma,0.8317595720291138
hsa-miR-3684,synovial sarcoma,0.8317595720291138
hsa-miR-92a-3p,synovial sarcoma,0.8317595720291138
hsa-miR-4443,synovial sarcoma,0.8317595720291138
hsa-miR-6843-3p,synovial sarcoma,0.8317595720291138
hsa-miR-4740-5p,synovial sarcoma,0.8317595720291138
hsa-miR-2964a-3p,miR-675-y,0.8317574262619019
hsa-miR-3147,miR-675-y,0.8317574262619019
hsa-miR-5186,miR-675-y,0.8317574262619019
hsa-miR-493-5p,"Luminal B,triple negative",0.8317447304725647
hsa-miR-885-5p,testicular cancer,0.8317371606826782
hsa-miR-890,"squamous cell breast carcinoma, acantholytic variant",0.8317368626594543
hsa-miR-4775,"squamous cell breast carcinoma, acantholytic variant",0.8317368626594543
hsa-miR-1227-3p,brain cancer,0.831716001033783
hsa-miR-485-3p,brain cancer,0.831716001033783
hsa-miR-4783-5p,sarcoma,0.8317073583602905
hsa-miR-4687-3p,sarcoma,0.8317073583602905
hsa-miR-573,miR-675-y,0.8316998481750488
hsa-miR-7977,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-1-1,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-4664-3p,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-181a-2-3p,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-513a-1,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-338-5p,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-570,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-1974,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-3181,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-520f-5p,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-620,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-3912-5p,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-5680,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-16-2-3p,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-3674,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-4507,castration-resistant prostate cancer,0.8316901326179504
hsa-miR-340,synovial sarcoma,0.8316813707351685
hsa-miR-548ay-3p,synovial sarcoma,0.8316813707351685
hsa-miR-4797-3p,synovial sarcoma,0.8316813707351685
hsa-miR-221-5p,synovial sarcoma,0.8316813707351685
hsa-miR-1285-3p,synovial sarcoma,0.8316813707351685
hsa-miR-6131,synovial sarcoma,0.8316813707351685
hsa-miR-6502-5p,synovial sarcoma,0.8316813707351685
hsa-miR-6718-5p,synovial sarcoma,0.8316813707351685
hsa-miR-151a-3p,miR-675-y,0.8316550254821777
hsa-miR-6858-3p,solid pseudopapillary neoplasm of pancreas,0.8316113352775574
hsa-miR-370,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-3162,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-1238-3p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-4796-5p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-520a-5p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-6509-3p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-483-3p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-6816-3p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-548p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-4283,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-4707-5p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-4685-3p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-4418,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-372-3p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-1245b-3p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-516,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-24-1-5p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-6133,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-3943,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-6846-3p,castration-resistant prostate cancer,0.8316053152084351
hsa-miR-548h,synovial sarcoma,0.8315907716751099
hsa-miR-4730,synovial sarcoma,0.8315907716751099
hsa-miR-1304,synovial sarcoma,0.8315907716751099
hsa-miR-371a-5p,synovial sarcoma,0.8315907716751099
hsa-miR-27b-3p,synovial sarcoma,0.8315907716751099
hsa-miR-190b,synovial sarcoma,0.8315907716751099
hsa-miR-124-5p,synovial sarcoma,0.8315907716751099
hsa-miR-4533,synovial sarcoma,0.8315907716751099
hsa-miR-2116-5p,synovial sarcoma,0.8315907716751099
hsa-miR-6716-3p,synovial sarcoma,0.8315907716751099
hsa-miR-5699,synovial sarcoma,0.8315907716751099
hsa-miR-892c-5p,synovial sarcoma,0.8315907716751099
hsa-miR-6876-3p,synovial sarcoma,0.8315907716751099
hsa-miR-3960,synovial sarcoma,0.8315907716751099
hsa-miR-216b-5p,synovial sarcoma,0.8315907716751099
hsa-miR-4425,synovial sarcoma,0.8315907716751099
hsa-miR-3168,synovial sarcoma,0.8315907716751099
hsa-miR-4652-5p,Leptomeningeal metastasis,0.8315857648849487
hsa-miR-362-5p,miR-142-y,0.8315810561180115
hsa-miR-1911-5p,solid pseudopapillary neoplasm of pancreas,0.8315578699111938
hsa-miR-9-3p,solid pseudopapillary neoplasm of pancreas,0.8315578699111938
hsa-let-7a-3p,solid pseudopapillary neoplasm of pancreas,0.8315578699111938
hsa-miR-2278,solid pseudopapillary neoplasm of pancreas,0.8315578699111938
hsa-miR-451,castration-resistant prostate cancer,0.8315565586090088
hsa-miR-1227-3p,castration-resistant prostate cancer,0.8315565586090088
hsa-miR-3919,castration-resistant prostate cancer,0.8315565586090088
hsa-miR-4665-3p,castration-resistant prostate cancer,0.8315565586090088
hsa-miR-1298-5p,castration-resistant prostate cancer,0.8315565586090088
hsa-miR-4790-5p,"squamous cell breast carcinoma, acantholytic variant",0.8315362930297852
hsa-miR-1255a,"squamous cell breast carcinoma, acantholytic variant",0.8315362930297852
hsa-miR-4742-3p,"squamous cell breast carcinoma, acantholytic variant",0.8315362930297852
hsa-miR-548x-3p,"squamous cell breast carcinoma, acantholytic variant",0.8315362930297852
hsa-miR-648,"squamous cell breast carcinoma, acantholytic variant",0.8315362930297852
hsa-miR-18b,"Luminal B,triple negative",0.8315247297286987
hsa-miR-106a-5p,"Luminal B,triple negative",0.8315247297286987
hsa-miR-4445-3p,breast cancer brain metastasis,0.8315147757530212
hsa-miR-7,synovial sarcoma,0.8315005302429199
hsa-miR-26b-3p,synovial sarcoma,0.8315005302429199
hsa-miR-513,synovial sarcoma,0.8314886689186096
hsa-miR-1236-3p,synovial sarcoma,0.8314886689186096
hsa-miR-132-3p,synovial sarcoma,0.8314886689186096
hsa-miR-1255b-2-3p,synovial sarcoma,0.8314886689186096
hsa-miR-4697-5p,synovial sarcoma,0.8314886689186096
hsa-miR-2110,synovial sarcoma,0.8314886689186096
hsa-miR-6761-3p,synovial sarcoma,0.8314886689186096
hsa-miR-6730-5p,synovial sarcoma,0.8314886689186096
hsa-miR-124,synovial sarcoma,0.8314886689186096
hsa-miR-873-5p,synovial sarcoma,0.8314886689186096
hsa-miR-654-3p,primary central nervous system lymphomas,0.8314738869667053
hsa-miR-374a,"squamous cell breast carcinoma, acantholytic variant",0.8314375877380371
hsa-miR-559,"squamous cell breast carcinoma, acantholytic variant",0.8314359784126282
hsa-miR-4321,"squamous cell breast carcinoma, acantholytic variant",0.8314359784126282
hsa-miR-15a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8314359784126282
hsa-miR-195-5p,"squamous cell breast carcinoma, acantholytic variant",0.8314359784126282
hsa-miR-3186-3p,"squamous cell breast carcinoma, acantholytic variant",0.8314359784126282
hsa-miR-1204,"squamous cell breast carcinoma, acantholytic variant",0.8314359784126282
hsa-miR-3680-3p,"squamous cell breast carcinoma, acantholytic variant",0.8314359784126282
hsa-miR-7-5p,"squamous cell breast carcinoma, acantholytic variant",0.8314359784126282
hsa-miR-216b-3p,"Luminal B,triple negative",0.8314251899719238
hsa-miR-6755-5p,miR-675-y,0.831423819065094
hsa-miR-656,miR-675-y,0.831423819065094
hsa-miR-887-3p,synovial sarcoma,0.831409215927124
hsa-miR-467,synovial sarcoma,0.831409215927124
hsa-miR-383,synovial sarcoma,0.831409215927124
hsa-miR-222-5p,synovial sarcoma,0.831409215927124
hsa-miR-1273g-3p,synovial sarcoma,0.831409215927124
hsa-miR-3934-5p,synovial sarcoma,0.831409215927124
hsa-miR-19a-3p,synovial sarcoma,0.831409215927124
hsa-miR-149-5p,synovial sarcoma,0.831409215927124
hsa-miR-2114-3p,synovial sarcoma,0.831409215927124
hsa-miR-4754,synovial sarcoma,0.831409215927124
hsa-miR-203a-3p,synovial sarcoma,0.831409215927124
hsa-miR-3139,synovial sarcoma,0.831409215927124
hsa-miR-1323,synovial sarcoma,0.831409215927124
hsa-miR-7849-3p,synovial sarcoma,0.831409215927124
hsa-miR-6856-5p,synovial sarcoma,0.831409215927124
hsa-miR-566,papillary thyroid carcinoma,0.8314031958580017
hsa-miR-92a-1*,synovial sarcoma,0.8313782215118408
hsa-miR-6881-5p,synovial sarcoma,0.8313782215118408
hsa-miR-519e-3p,synovial sarcoma,0.8313782215118408
hsa-miR-1914*,synovial sarcoma,0.8313782215118408
hsa-miR-3074-5p,synovial sarcoma,0.8313782215118408
hsa-miR-1234-5p,synovial sarcoma,0.8313782215118408
hsa-miR-3620-5p,synovial sarcoma,0.8313782215118408
hsa-miR-6831-3p,synovial sarcoma,0.8313782215118408
hsa-miR-4685-3p,synovial sarcoma,0.8313782215118408
hsa-miR-372-3p,synovial sarcoma,0.8313782215118408
hsa-miR-325,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-526b-5p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-3124-5p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-33b,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-193b*,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-466,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-6776-5p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-128-1-5p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-3172,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-363-3p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-106a-3p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-3160-5p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-5579-5p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-4780,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-4715-5p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-3127-3p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-6893-5p,castration-resistant prostate cancer,0.8313577771186829
hsa-miR-4733-5p,sarcoma,0.8313512206077576
hsa-miR-765,sarcoma,0.8313512206077576
hsa-miR-6780a-5p,sarcoma,0.8313512206077576
hsa-miR-6730-3p,breast cancer brain metastasis,0.8313467502593994
hsa-miR-193a-3p,rhabdomyosarcomas,0.8313446044921875
hsa-miR-5580-5p,rhabdomyosarcomas,0.8313446044921875
hsa-miR-3173-5p,rhabdomyosarcomas,0.8313446044921875
hsa-miR-199a*-2,rhabdomyosarcomas,0.8313446044921875
hsa-miR-6884-3p,solid pseudopapillary neoplasm of pancreas,0.8313434720039368
hsa-miR-186*,solid pseudopapillary neoplasm of pancreas,0.8313434720039368
hsa-miR-323-3p,"Luminal B,triple negative",0.8313325047492981
hsa-miR-122-3p,solid pseudopapillary neoplasm of pancreas,0.8313317894935608
hsa-miR-1974,primary central nervous system lymphomas,0.8313059210777283
hsa-miR-29a,miR-675-y,0.8312845826148987
hsa-miR-215,miR-675-y,0.8312845826148987
hsa-miR-93*,miR-675-y,0.8312845826148987
hsa-miR-582,castration-resistant prostate cancer,0.831277072429657
hsa-miR-4463,castration-resistant prostate cancer,0.831277072429657
hsa-miR-105-5p,castration-resistant prostate cancer,0.831277072429657
hsa-miR-6084,castration-resistant prostate cancer,0.831277072429657
hsa-miR-450a-2-3p,breast cancer brain metastasis,0.8312684893608093
hsa-miR-347,breast cancer brain metastasis,0.8312684893608093
hsa-miR-4659a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8312681913375854
hsa-miR-3117-3p,"squamous cell breast carcinoma, acantholytic variant",0.8312681913375854
hsa-miR-1206,"squamous cell breast carcinoma, acantholytic variant",0.8312681913375854
hsa-miR-3664-3p,"squamous cell breast carcinoma, acantholytic variant",0.8312681913375854
hsa-miR-325,synovial sarcoma,0.8312564492225647
hsa-miR-453,synovial sarcoma,0.8312564492225647
hsa-miR-1307,synovial sarcoma,0.8312564492225647
hsa-miR-194-2,synovial sarcoma,0.8312564492225647
hsa-miR-1-5p,synovial sarcoma,0.8312564492225647
hsa-miR-3160-5p,synovial sarcoma,0.8312564492225647
hsa-miR-6800-3p,synovial sarcoma,0.8312564492225647
hsa-miR-6798-5p,synovial sarcoma,0.8312564492225647
hsa-miR-6751-3p,synovial sarcoma,0.8312564492225647
hsa-miR-330,"Luminal B,triple negative",0.831251859664917
hsa-miR-3545-5p,"Luminal B,triple negative",0.831251859664917
hsa-miR-4691-5p,"Luminal B,triple negative",0.831251859664917
hsa-miR-128a,primary central nervous system lymphomas,0.8312276601791382
hsa-miR-516,primary central nervous system lymphomas,0.8312276601791382
hsa-miR-331-3p,brain cancer,0.8312046527862549
hsa-miR-192-5p,synovial sarcoma,0.831188440322876
hsa-miR-4724-5p,synovial sarcoma,0.831188440322876
hsa-miRPlus-C1110,synovial sarcoma,0.831145703792572
hsa-miR-10a*,synovial sarcoma,0.831145703792572
hsa-miR-550a,synovial sarcoma,0.831145703792572
hsa-miR-1260,synovial sarcoma,0.831145703792572
hsa-let-7i-5p,synovial sarcoma,0.831145703792572
hsa-miR-4703-3p,synovial sarcoma,0.831145703792572
hsa-miR-1305,synovial sarcoma,0.831145703792572
hsa-miR-99b*,synovial sarcoma,0.831145703792572
hsa-miR-3178,synovial sarcoma,0.831145703792572
hsa-miRPlus-J1003,synovial sarcoma,0.831145703792572
hsa-miR-6508-5p,synovial sarcoma,0.831145703792572
hsa-miR-4520-5p,synovial sarcoma,0.831145703792572
hsa-miR-7-2-3p,synovial sarcoma,0.831145703792572
hsa-miR-1252,synovial sarcoma,0.831145703792572
hsa-miR-4704-3p,synovial sarcoma,0.831145703792572
hsa-miR-4708-5p,synovial sarcoma,0.831145703792572
hsa-miR-1234-3p,"squamous cell breast carcinoma, acantholytic variant",0.8311250805854797
hsa-miR-91,"squamous cell breast carcinoma, acantholytic variant",0.8311250805854797
hsa-miR-218-1*,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-3940,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-3144-3p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-6769a-5p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-543,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-5584-5p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-328-5p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-7855-5p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-7109-3p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-4640-3p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-1226*,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-29b-1-5p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-4482-5p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-520c,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-7161-5p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-4704-3p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-3679-3p,castration-resistant prostate cancer,0.8311218619346619
hsa-miR-7641,solid pseudopapillary neoplasm of pancreas,0.8311170339584351
hsa-miR-4665-3p,sarcoma,0.8311097025871277
hsa-miR-1201,synovial sarcoma,0.8310969471931458
hsa-miR-7106-3p,synovial sarcoma,0.8310969471931458
hsa-miR-664,synovial sarcoma,0.8310969471931458
hsa-miR-1914,synovial sarcoma,0.8310969471931458
hsa-miR-655,synovial sarcoma,0.8310969471931458
hsa-miR-5003-5p,synovial sarcoma,0.8310969471931458
hsa-miR-604,synovial sarcoma,0.8310969471931458
hsa-miR-509-5p,synovial sarcoma,0.8310969471931458
hsa-miR-223-5p,synovial sarcoma,0.8310969471931458
hsa-miR-4509,synovial sarcoma,0.8310969471931458
hsa-miR-26a-1*,synovial sarcoma,0.8310969471931458
hsa-miR-151a-5p,synovial sarcoma,0.8310969471931458
hsa-miR-5188,synovial sarcoma,0.8310969471931458
hsa-miR-3913-5p,synovial sarcoma,0.8310969471931458
hsa-miR-7159-3p,synovial sarcoma,0.8310969471931458
hsa-miR-4304,breast cancer brain metastasis,0.8310697078704834
hsa-miR-574,breast cancer brain metastasis,0.8310697078704834
hsa-miR-3935,breast cancer brain metastasis,0.8310697078704834
hsa-miR-127-3p,"Luminal B,triple negative",0.8310686349868774
hsa-miR-765,"Luminal B,triple negative",0.8310686349868774
hsa-miR-2115-3p,"Luminal B,triple negative",0.8310686349868774
hsa-miR-4646-5p,"Luminal B,triple negative",0.8310686349868774
hsa-miR-513-5p,"Luminal B,triple negative",0.8310686349868774
hsa-miR-6816-5p,"Luminal B,triple negative",0.8310686349868774
hsa-miR-135-2,testicular cancer,0.8310684561729431
hsa-miR-539,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-29a-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-4743,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-4732-5p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-1304-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-380,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-5089,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-191*,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-561,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-766-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-106a:9.1,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-377*,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-365a-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-4487,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-374b,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-450a-1-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-410-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-147a,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-6130,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-152-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-6841-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-520f-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-3127-5p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-6817-3p,castration-resistant prostate cancer,0.8310622572898865
hsa-miR-6858-3p,miR-142-y,0.8310569524765015
hsa-miR-1298-5p,miR-142-y,0.8310569524765015
hsa-miR-4420,synovial sarcoma,0.8310552835464478
hsa-miR-4503,synovial sarcoma,0.8310552835464478
hsa-miR-4747-5p,synovial sarcoma,0.8310552835464478
hsa-miR-651-3p,synovial sarcoma,0.8310552835464478
hsa-miR-372,synovial sarcoma,0.8310552835464478
hsa-miR-425-5p,synovial sarcoma,0.8310552835464478
hsa-miR-548au-5p,synovial sarcoma,0.8310552835464478
hsa-miR-23a-5p,synovial sarcoma,0.8310552835464478
hsa-miR-875-5p,synovial sarcoma,0.8310552835464478
hsa-miR-4678,synovial sarcoma,0.8310552835464478
hsa-miR-5590-3p,synovial sarcoma,0.8310552835464478
hsa-miR-568,synovial sarcoma,0.8310552835464478
hsa-miR-6775-5p,synovial sarcoma,0.8310552835464478
hsa-miR-6862-3p,synovial sarcoma,0.8310552835464478
hsa-miR-1911-3p,synovial sarcoma,0.8310552835464478
hsa-miR-548az-5p,synovial sarcoma,0.8310552835464478
hsa-miR-874-3p,synovial sarcoma,0.8310552835464478
hsa-miR-1587,follicular thyroid carcinoma,0.8310492038726807
hsa-miR-663a,solid pseudopapillary neoplasm of pancreas,0.8310410380363464
hsa-miR-345,breast cancer brain metastasis,0.8310335278511047
hsa-miR-24-2-5p,breast cancer brain metastasis,0.8310335278511047
hsa-miR-200b*,primary central nervous system lymphomas,0.8310287594795227
hsa-miR-30a-3p,primary central nervous system lymphomas,0.8310287594795227
hsa-miR-3935,primary central nervous system lymphomas,0.8310287594795227
hsa-miR-7107-5p,primary central nervous system lymphomas,0.8310287594795227
hsa-miR-633,diffuse large B-cell lymphoma,0.8310273885726929
hsa-miR-101-1,diffuse large B-cell lymphoma,0.8310273885726929
hsa-miR-548an,diffuse large B-cell lymphoma,0.8310273885726929
hsa-miR-1277-5p,diffuse large B-cell lymphoma,0.8310273885726929
hsa-miR-6784-3p,diffuse large B-cell lymphoma,0.8310273885726929
hsa-miR-139-5p,primary central nervous system lymphomas,0.8309926390647888
hsa-miR-450a,castration-resistant prostate cancer,0.8309862017631531
hsa-miR-4700-5p,castration-resistant prostate cancer,0.8309862017631531
hsa-miR-6791-5p,castration-resistant prostate cancer,0.8309862017631531
hsa-miR-4267,castration-resistant prostate cancer,0.8309862017631531
hsa-miR-147b,castration-resistant prostate cancer,0.8309862017631531
hsa-miR-140-3p,castration-resistant prostate cancer,0.8309862017631531
hsa-miR-3938,castration-resistant prostate cancer,0.8309862017631531
hsa-miR-455-5p,synovial sarcoma,0.8309804201126099
hsa-miR-6750-5p,synovial sarcoma,0.8309804201126099
hsa-miR-4801,synovial sarcoma,0.8309804201126099
hsa-miR-6851-5p,synovial sarcoma,0.8309804201126099
hsa-miR-670,synovial sarcoma,0.8309804201126099
hsa-miR-3619-5p,synovial sarcoma,0.8309804201126099
hsa-miR-2116*,synovial sarcoma,0.8309804201126099
hsa-miR-125b-2-3p,synovial sarcoma,0.8309804201126099
hsa-miR-4445-5p,synovial sarcoma,0.8309804201126099
hsa-miR-4659b-5p,synovial sarcoma,0.8309804201126099
hsa-miR-6833-5p,synovial sarcoma,0.8309804201126099
hsa-miR-7111-5p,synovial sarcoma,0.8309804201126099
hsa-miR-6839-3p,synovial sarcoma,0.8309804201126099
hsa-miR-7848-3p,synovial sarcoma,0.8309804201126099
hsa-miR-7151-3p,"squamous cell breast carcinoma, acantholytic variant",0.8309757709503174
hsa-miR-4251,"squamous cell breast carcinoma, acantholytic variant",0.8309757709503174
hsa-miR-138-1-3p,"squamous cell breast carcinoma, acantholytic variant",0.8309757709503174
hsa-miR-491,"squamous cell breast carcinoma, acantholytic variant",0.8309757709503174
hsa-miR-182-5p,"squamous cell breast carcinoma, acantholytic variant",0.8309757709503174
hsa-miR-93-5p,"squamous cell breast carcinoma, acantholytic variant",0.8309757709503174
hsa-miR-2116-5p,"squamous cell breast carcinoma, acantholytic variant",0.8309757709503174
hsa-miR-6739-3p,"squamous cell breast carcinoma, acantholytic variant",0.8309757709503174
hsa-miR-561-5p,"squamous cell breast carcinoma, acantholytic variant",0.8309757709503174
hsa-miR-616,synovial sarcoma,0.8309707045555115
hsa-miR-6513-3p,synovial sarcoma,0.8309707045555115
hsa-miR-338-5p,synovial sarcoma,0.8309707045555115
hsa-miR-4746-5p,synovial sarcoma,0.8309707045555115
hsa-miR-562,synovial sarcoma,0.8309707045555115
hsa-miR-589-3p,synovial sarcoma,0.8309707045555115
hsa-miR-513b-5p,synovial sarcoma,0.8309707045555115
hsa-miR-1298-3p,synovial sarcoma,0.8309707045555115
hsa-miR-1178,synovial sarcoma,0.8309707045555115
hsa-miR-20b-3p,synovial sarcoma,0.8309707045555115
hsa-miR-542,synovial sarcoma,0.8309707045555115
hsa-miR-768,synovial sarcoma,0.8309707045555115
hsa-miR-4507,synovial sarcoma,0.8309707045555115
hsa-let-7a-3p,sarcoma,0.8309553265571594
hsa-miR-199a*-1,synovial sarcoma,0.8309489488601685
hsa-miR-191*,synovial sarcoma,0.8309489488601685
hsa-miR-370-3p,synovial sarcoma,0.8309489488601685
hsa-miR-374a*,synovial sarcoma,0.8309489488601685
hsa-miR-4667-5p,synovial sarcoma,0.8309489488601685
hsa-miR-5698,synovial sarcoma,0.8309489488601685
hsa-miR-769-5p,synovial sarcoma,0.8309489488601685
hsa-miR-147a,synovial sarcoma,0.8309489488601685
hsa-miR-29a*,synovial sarcoma,0.8309489488601685
hsa-miR-3935,synovial sarcoma,0.8309489488601685
hsa-miR-3127-5p,synovial sarcoma,0.8309489488601685
hsa-miR-6817-3p,synovial sarcoma,0.8309489488601685
hsa-miR-6825-5p,synovial sarcoma,0.8309489488601685
hsa-miR-32*,breast cancer brain metastasis,0.830940842628479
hsa-miR-3607-5p,Leptomeningeal metastasis,0.8309379816055298
hsa-miR-34a*,breast cancer brain metastasis,0.8309291005134583
hsa-miR-1245a,breast cancer brain metastasis,0.8309291005134583
hsa-miR-646,pilocytic astrocytoma,0.8309215903282166
hsa-miR-497*,pilocytic astrocytoma,0.8309215903282166
hsa-miRPlus-A1073,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-508-5p,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-361,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-3202,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-3201,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-4747-5p,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-194,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-888-3p,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-7108-3p,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-889-3p,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-5697,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-568,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-3166,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-29b-2,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-506-3p,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-644a,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-4277,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-30c-1*,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-574-5p,castration-resistant prostate cancer,0.8309163451194763
hsa-miR-520d,breast cancer brain metastasis,0.8309135437011719
hsa-miR-654-5p,papillary thyroid carcinoma,0.8309121131896973
hsa-miR-433,primary central nervous system lymphomas,0.8308999538421631
hsa-miR-3128,miR-675-y,0.8308935165405273
hsa-miR-1910-5p,miR-675-y,0.8308935165405273
hsa-miR-1268a,miR-675-y,0.8308904767036438
hsa-miR-15a*,miR-675-y,0.8308904767036438
hsa-miR-505-5p,miR-675-y,0.8308904767036438
hsa-miR-4671-3p,solid pseudopapillary neoplasm of pancreas,0.8308902978897095
hsa-miR-129-2,solid pseudopapillary neoplasm of pancreas,0.8308731913566589
hsa-miR-651-3p,primary central nervous system lymphomas,0.8308725357055664
hsa-miR-491-5p,primary central nervous system lymphomas,0.8308725357055664
hsa-miR-584-5p,ovarian carcinoma,0.8308668732643127
hsa-miR-3663-5p,ovarian carcinoma,0.8308668732643127
hsa-miR-3606,ovarian carcinoma,0.8308668732643127
hsa-miR-103-as,ovarian carcinoma,0.8308668732643127
hsa-miR-6081,ovarian carcinoma,0.8308668732643127
hsa-miR-340-3p,synovial sarcoma,0.8308625817298889
hsa-miR-221-3p,synovial sarcoma,0.8308625817298889
hsa-miR-1279,synovial sarcoma,0.8308625817298889
hsa-miR-6878-5p,synovial sarcoma,0.8308625817298889
hsa-miR-3152-5p,synovial sarcoma,0.8308625817298889
hsa-miR-129*,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-637,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-1226-5p,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-6894-3p,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-138-1,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-1238-5p,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-670,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-3692-3p,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-4287,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-4445-5p,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-5683,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-4659b-5p,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-7111-5p,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-5703,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-1282,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-4660,castration-resistant prostate cancer,0.8308426141738892
hsa-miR-4318,"squamous cell breast carcinoma, acantholytic variant",0.8307992815971375
hsa-miRPlus-J1011,"squamous cell breast carcinoma, acantholytic variant",0.8307992815971375
hsa-miR-617,"squamous cell breast carcinoma, acantholytic variant",0.8307992815971375
hsa-miR-4662a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8307992815971375
hsa-miR-6084,miR-142-y,0.830776572227478
hsa-miR-196b-5p,miR-675-y,0.83074951171875
hsa-miR-711,"Luminal B,triple negative",0.8306940197944641
hsa-miR-4700-3p,castration-resistant prostate cancer,0.8306858539581299
hsa-miR-4324,solid pseudopapillary neoplasm of pancreas,0.8306726813316345
hsa-miR-367*,solid pseudopapillary neoplasm of pancreas,0.8306726813316345
hsa-miR-767,"Luminal B,triple negative",0.8306722044944763
hsa-miR-4462,"Luminal B,triple negative",0.8306722044944763
hsa-miR-185-3p,"squamous cell breast carcinoma, acantholytic variant",0.8306694626808167
hsa-miR-373-5p,"squamous cell breast carcinoma, acantholytic variant",0.8306694626808167
hsa-miR-1247-3p,"squamous cell breast carcinoma, acantholytic variant",0.8306694626808167
hsa-miR-519c-3p,testicular cancer,0.8306337594985962
hsa-miR-4318,testicular cancer,0.8305971622467041
hsa-miR-658,solid pseudopapillary neoplasm of pancreas,0.8305700421333313
hsa-miR-587,diffuse large B-cell lymphoma,0.830565333366394
hsa-miR-4293,diffuse large B-cell lymphoma,0.830565333366394
hsa-miR-123,miR-675-y,0.8305488228797913
hsa-miR-373,miR-675-y,0.8305488228797913
hsa-miR-631,miR-675-y,0.8305488228797913
hsa-miR-6791-5p,sarcoma,0.8305382132530212
hsa-miR-6871-5p,synovial sarcoma,0.8305237293243408
hsa-miR-6750-3p,synovial sarcoma,0.8305237293243408
hsa-miR-4802-5p,synovial sarcoma,0.8305237293243408
hsa-miR-211-5p,synovial sarcoma,0.8305237293243408
hsa-miR-450a,testicular cancer,0.8305181860923767
hsa-miR-4486,sarcoma,0.8305131196975708
hsa-miR-3682-3p,sarcoma,0.8305131196975708
hsa-miR-147b,miR-142-y,0.8304851651191711
hsa-miR-663a,miR-142-y,0.8304851651191711
hsa-miR-4677-3p,miR-675-y,0.8304795026779175
hsa-miR-488*,"squamous cell breast carcinoma, acantholytic variant",0.8304747343063354
hsa-miR-103a-2-5p,"squamous cell breast carcinoma, acantholytic variant",0.8304747343063354
hsa-miR-4789-3p,"squamous cell breast carcinoma, acantholytic variant",0.8304747343063354
hsa-miR-29b-2-5p,"squamous cell breast carcinoma, acantholytic variant",0.8304747343063354
hsa-miR-340*,"squamous cell breast carcinoma, acantholytic variant",0.8304747343063354
hsa-miR-548y,"squamous cell breast carcinoma, acantholytic variant",0.8304747343063354
hsa-miR-4305,"squamous cell breast carcinoma, acantholytic variant",0.8304747343063354
hsa-miR-3159,"squamous cell breast carcinoma, acantholytic variant",0.8304747343063354
hsa-miR-646,solid pseudopapillary neoplasm of pancreas,0.8304725289344788
hsa-miR-3180-5p,solid pseudopapillary neoplasm of pancreas,0.8304725289344788
hsa-miR-6871-5p,"squamous cell breast carcinoma, acantholytic variant",0.830460250377655
hsa-miR-4646-5p,"squamous cell breast carcinoma, acantholytic variant",0.830460250377655
hsa-miR-513-5p,"squamous cell breast carcinoma, acantholytic variant",0.830460250377655
hsa-miR-4802-5p,"squamous cell breast carcinoma, acantholytic variant",0.830460250377655
hsa-miR-3196,"Luminal B,triple negative",0.8304569125175476
hsa-miR-518a-3p,"Luminal B,triple negative",0.8304569125175476
hsa-miR-518a-5p,"Luminal B,triple negative",0.8304569125175476
hsa-miR-539-3p,"Luminal B,triple negative",0.8304569125175476
hsa-miR-486-3p,miR-675-y,0.8304426074028015
hsa-miR-4652-5p,high grade serous papillary ovarian cancer,0.8304316401481628
hsa-miR-95-5p,high grade serous papillary ovarian cancer,0.8304316401481628
hsa-miR-3136-3p,high grade serous papillary ovarian cancer,0.8304316401481628
hsa-miR-1-3p,high grade serous papillary ovarian cancer,0.8304316401481628
hsa-miR-4470,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-miR-1914*,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-miR-3679-5p,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-miR-4791,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-miR-3620-5p,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-miR-888*,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-miR-4685-3p,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-miR-3194-5p,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-let-7g*,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-miR-3612,"squamous cell breast carcinoma, acantholytic variant",0.8303894996643066
hsa-miR-6824-3p,castration-resistant prostate cancer,0.8303723335266113
hsa-miR-91,castration-resistant prostate cancer,0.8303723335266113
hsa-miR-548e-5p,castration-resistant prostate cancer,0.8303723335266113
hsa-miR-6780a-5p,"Luminal B,triple negative",0.8303547501564026
hsa-miR-422b,diffuse large B-cell lymphoma,0.8302927017211914
hsa-miR-3614-5p,diffuse large B-cell lymphoma,0.8302927017211914
hsa-miR-6780b-5p,diffuse large B-cell lymphoma,0.8302927017211914
hsa-miR-3605-3p,diffuse large B-cell lymphoma,0.8302927017211914
hsa-miR-607,diffuse large B-cell lymphoma,0.8302927017211914
hsa-miR-6507-3p,diffuse large B-cell lymphoma,0.8302927017211914
hsa-miR-6800-5p,sarcoma,0.8302858471870422
hsa-miR-3162-5p,sarcoma,0.8302858471870422
hsa-miR-744*,synovial sarcoma,0.8302730321884155
hsa-miR-4800-5p,synovial sarcoma,0.8302730321884155
hsa-miR-1914-5p,sarcoma,0.8302686810493469
hsa-miR-4329,sarcoma,0.8302686810493469
hsa-miR-378g,sarcoma,0.8302686810493469
hsa-miR-1250-5p,sarcoma,0.8302686810493469
hsa-miR-16-2*,miR-142-y,0.8302450776100159
hsa-miR-3681,miR-142-y,0.8302450776100159
hsa-miR-6757-3p,sarcoma,0.8302372097969055
hsa-miR-6076,brain cancer,0.8302367329597473
hsa-miR-4486,"Luminal B,triple negative",0.8302294015884399
hsa-miR-548d-5p,solid pseudopapillary neoplasm of pancreas,0.8302140235900879
hsa-miR-6821-5p,solid pseudopapillary neoplasm of pancreas,0.8302140235900879
hsa-miR-490-3p,"squamous cell breast carcinoma, acantholytic variant",0.8302096128463745
hsa-miR-3977,"squamous cell breast carcinoma, acantholytic variant",0.8302096128463745
hsa-miR-548au-3p,"squamous cell breast carcinoma, acantholytic variant",0.8302096128463745
hsa-miR-5186,"squamous cell breast carcinoma, acantholytic variant",0.8302096128463745
hsa-miR-196-2,"squamous cell breast carcinoma, acantholytic variant",0.8302096128463745
hsa-miR-744*,"squamous cell breast carcinoma, acantholytic variant",0.8302096128463745
hsa-miR-1308,"squamous cell breast carcinoma, acantholytic variant",0.8302096128463745
hsa-miR-3163,"squamous cell breast carcinoma, acantholytic variant",0.8302096128463745
hsa-miR-5006-3p,miR-142-y,0.8301840424537659
hsa-miR-668-5p,synovial sarcoma,0.8301699161529541
hsa-miR-4747-3p,"squamous cell breast carcinoma, acantholytic variant",0.8301406502723694
hsa-miR-4676-3p,"squamous cell breast carcinoma, acantholytic variant",0.8301406502723694
hsa-let-7i-3p,"squamous cell breast carcinoma, acantholytic variant",0.8301406502723694
hsa-miR-363-3p,"squamous cell breast carcinoma, acantholytic variant",0.8301406502723694
hsa-miR-4523,"squamous cell breast carcinoma, acantholytic variant",0.8301406502723694
hsa-miR-1913,"squamous cell breast carcinoma, acantholytic variant",0.8301406502723694
hsa-miR-199b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8301406502723694
hsa-miR-6751-3p,"squamous cell breast carcinoma, acantholytic variant",0.8301406502723694
hsa-miR-526c,"squamous cell breast carcinoma, acantholytic variant",0.8301406502723694
hsa-miR-545-5p,primary central nervous system lymphomas,0.8301291465759277
hsa-miR-521,rhabdomyosarcomas,0.8301134705543518
hsa-miR-4787-3p,"squamous cell breast carcinoma, acantholytic variant",0.8301064968109131
hsa-miR-205-3p,"squamous cell breast carcinoma, acantholytic variant",0.8301064968109131
hsa-miR-764,"Luminal B,triple negative",0.8301040530204773
hsa-miR-135b-3p,solid pseudopapillary neoplasm of pancreas,0.8301002383232117
hsa-miR-1262,miR-675-y,0.8300974369049072
hsa-miR-105*,diffuse large B-cell lymphoma,0.8300849795341492
hsa-miR-6776-3p,diffuse large B-cell lymphoma,0.8300849795341492
hsa-miR-500b-3p,diffuse large B-cell lymphoma,0.8300849795341492
hsa-miR-4318,castration-resistant prostate cancer,0.830045223236084
hsa-miRPlus-J1011,castration-resistant prostate cancer,0.830045223236084
hsa-miR-221-3p,castration-resistant prostate cancer,0.830045223236084
hsa-miR-6721-5p,castration-resistant prostate cancer,0.830045223236084
hsa-miR-1279,castration-resistant prostate cancer,0.830045223236084
hsa-miR-6732-3p,castration-resistant prostate cancer,0.830045223236084
hsa-miR-6878-5p,castration-resistant prostate cancer,0.830045223236084
hsa-miR-5689,castration-resistant prostate cancer,0.830045223236084
hsa-miR-4691-5p,castration-resistant prostate cancer,0.830045223236084
hsa-miR-33b-3p,castration-resistant prostate cancer,0.830045223236084
hsa-miR-145-3p,"Luminal B,triple negative",0.8300018310546875
hsa-miR-1226-3p,"Luminal B,triple negative",0.8300006985664368
hsa-miR-6887-3p,"Luminal B,triple negative",0.8300006985664368
hsa-miR-511,ovarian carcinoma,0.8299937844276428
hsa-miR-3180-5p,ovarian carcinoma,0.8299937844276428
hsa-miR-593,ovarian carcinoma,0.8299937844276428
hsa-miR-151b,ovarian carcinoma,0.8299937844276428
hsa-miR-6124,ovarian carcinoma,0.8299937844276428
hsa-miR-3934,ovarian carcinoma,0.8299937844276428
hsa-miR-4279,ovarian carcinoma,0.8299937844276428
hsa-miR-548g-3p,ovarian carcinoma,0.8299937844276428
hsa-miR-383,"Luminal B,triple negative",0.8299846053123474
hsa-miR-1264,"Luminal B,triple negative",0.8299846053123474
hsa-miR-1250-5p,"Luminal B,triple negative",0.8299846053123474
hsa-miR-548ap-5p,"Luminal B,triple negative",0.8299846053123474
hsa-let-7b-5p,"Luminal B,triple negative",0.8299846053123474
hsa-miR-887,pilocytic astrocytoma,0.829979658126831
hsa-miR-3690,miR-675-y,0.8299726247787476
hsa-miR-3682-5p,sarcoma,0.8299647569656372
hsa-miR-188-3p,sarcoma,0.8299647569656372
hsa-miR-141-3p,sarcoma,0.8299647569656372
hsa-miR-653-5p,sarcoma,0.8299647569656372
hsa-miR-588,sarcoma,0.8299230337142944
hsa-miR-5095,sarcoma,0.8299230337142944
hsa-miR-3157-3p,"squamous cell breast carcinoma, acantholytic variant",0.829903244972229
hsa-miR-1260,"squamous cell breast carcinoma, acantholytic variant",0.829903244972229
hsa-miR-99b*,"squamous cell breast carcinoma, acantholytic variant",0.829903244972229
hsa-miR-548l,"squamous cell breast carcinoma, acantholytic variant",0.829903244972229
hsa-miR-135a-5p,"squamous cell breast carcinoma, acantholytic variant",0.829903244972229
hsa-miR-4684-5p,"squamous cell breast carcinoma, acantholytic variant",0.829903244972229
hsa-miR-642b-5p,"squamous cell breast carcinoma, acantholytic variant",0.829903244972229
hsa-miR-5580-5p,papillary thyroid carcinoma,0.8298984169960022
hsa-miR-3189-5p,papillary thyroid carcinoma,0.8298984169960022
hsa-miR-4454,distal cholangiocarcinoma,0.829893946647644
hsa-miR-588,miR-142-y,0.82986980676651
hsa-miR-145-5p,miR-142-y,0.82986980676651
hsa-miR-532-5p,papillary thyroid carcinoma,0.8298547267913818
hsa-miR-766-3p,"squamous cell breast carcinoma, acantholytic variant",0.8298434019088745
hsa-miR-4469,"squamous cell breast carcinoma, acantholytic variant",0.8298434019088745
hsa-miR-377*,"squamous cell breast carcinoma, acantholytic variant",0.8298434019088745
hsa-miR-92a-1,"squamous cell breast carcinoma, acantholytic variant",0.8298434019088745
hsa-miR-6772-5p,"squamous cell breast carcinoma, acantholytic variant",0.8298434019088745
hsa-miR-6510-3p,"squamous cell breast carcinoma, acantholytic variant",0.8298434019088745
hsa-miR-105*,sarcoma,0.8298415541648865
hsa-miR-935,sarcoma,0.8298415541648865
hsa-miR-148a-5p,sarcoma,0.8298415541648865
hsa-miR-328,synovial sarcoma,0.8297969102859497
hsa-miR-1911-5p,synovial sarcoma,0.8297969102859497
hsa-miR-1185-5p,synovial sarcoma,0.8297969102859497
hsa-miR-1292-5p,synovial sarcoma,0.8297969102859497
hsa-miR-767,synovial sarcoma,0.8297969102859497
hsa-miR-155-3p,synovial sarcoma,0.8297969102859497
hsa-miR-93*,synovial sarcoma,0.8297969102859497
hsa-miR-4433a-3p,synovial sarcoma,0.8297969102859497
hsa-miR-4663,synovial sarcoma,0.8297969102859497
hsa-miR-99a-3p,"Luminal B,triple negative",0.8297833204269409
hsa-miR-4439,"Luminal B,triple negative",0.8297833204269409
hsa-miR-4767,"Luminal B,triple negative",0.8297833204269409
hsa-miR-512-5p-1105,"squamous cell breast carcinoma, acantholytic variant",0.8297333717346191
hsa-miR-200b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8297333717346191
hsa-miR-4650-3p,"squamous cell breast carcinoma, acantholytic variant",0.8297333717346191
hsa-miR-7843-5p,brain cancer,0.8297287225723267
hsa-miR-7161-3p,solid pseudopapillary neoplasm of pancreas,0.8297186493873596
hsa-miR-579-5p,miR-675-y,0.8297066688537598
hsa-miR-4733-5p,castration-resistant prostate cancer,0.8297050595283508
hsa-miR-369-5p,castration-resistant prostate cancer,0.8297050595283508
hsa-miR-211-5p,castration-resistant prostate cancer,0.8297050595283508
hsa-miR-6506-3p,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-500,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-548h-5p,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-578,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-4302,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-3166,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-6758-3p,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-29b-2,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-3125,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-300,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-548t,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-8056,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-4701-3p,"squamous cell breast carcinoma, acantholytic variant",0.829696536064148
hsa-miR-1294,high grade serous papillary ovarian cancer,0.829680323600769
hsa-miR-146b-5p,high grade serous papillary ovarian cancer,0.829680323600769
hsa-miR-1909-5p,high grade serous papillary ovarian cancer,0.829680323600769
hsa-miR-1247,"Luminal B,triple negative",0.8296802043914795
hsa-miR-302c,"Luminal B,triple negative",0.8296802043914795
hsa-miR-658,"Luminal B,triple negative",0.8296802043914795
hsa-miR-761,"Luminal B,triple negative",0.8296802043914795
hsa-miR-298,brain cancer,0.8296794295310974
hsa-miR-6749-3p,brain cancer,0.8296622633934021
hsa-miR-3610,brain cancer,0.8296622633934021
hsa-miR-4650-3p,"Luminal B,triple negative",0.8296274542808533
hsa-miR-6829-3p,"Luminal B,triple negative",0.8296274542808533
hsa-miR-455-5p,"squamous cell breast carcinoma, acantholytic variant",0.8296223878860474
hsa-miR-376c-5p,"squamous cell breast carcinoma, acantholytic variant",0.8296223878860474
hsa-miR-4693-5p,"squamous cell breast carcinoma, acantholytic variant",0.8296223878860474
hsa-miR-376c,"squamous cell breast carcinoma, acantholytic variant",0.8296223878860474
hsa-miR-1184,"squamous cell breast carcinoma, acantholytic variant",0.8296223878860474
hsa-miR-3132,"squamous cell breast carcinoma, acantholytic variant",0.8296223878860474
hsa-miR-8066,"squamous cell breast carcinoma, acantholytic variant",0.8296223878860474
hsa-miR-4731-5p,"squamous cell breast carcinoma, acantholytic variant",0.8296223878860474
hsa-miR-5687,solid pseudopapillary neoplasm of pancreas,0.8296175599098206
hsa-miR-187-5p,solid pseudopapillary neoplasm of pancreas,0.8296175599098206
hsa-miR-215-3p,solid pseudopapillary neoplasm of pancreas,0.8296175599098206
hsa-miR-548d-5p,sarcoma,0.8296076655387878
hsa-miR-873,sarcoma,0.8296076655387878
hsa-miR-3676-3p,sarcoma,0.8296076655387878
hsa-miR-4690-3p,sarcoma,0.8296076655387878
hsa-miR-3194,synovial sarcoma,0.8295767307281494
hsa-miR-3607-5p,synovial sarcoma,0.8295767307281494
hsa-miR-668-3p,synovial sarcoma,0.8295767307281494
hsa-miR-191-3p,synovial sarcoma,0.8295767307281494
hsa-miR-411-3p,synovial sarcoma,0.8295767307281494
hsa-miR-3683,synovial sarcoma,0.8295767307281494
hsa-miR-301a-5p,synovial sarcoma,0.8295767307281494
hsa-miR-7702,synovial sarcoma,0.8295767307281494
hsa-miR-523-5p,synovial sarcoma,0.8295767307281494
hsa-miR-1278,miR-675-y,0.8295767307281494
hsa-miR-6760-3p,diffuse large B-cell lymphoma,0.8295764923095703
hsa-miR-1301,diffuse large B-cell lymphoma,0.8295764923095703
hsa-miR-6780a-3p,"Luminal B,triple negative",0.8295570015907288
hsa-miR-552,miR-142-y,0.8295419812202454
hsa-miR-1236,miR-142-y,0.8295419812202454
hsa-miR-132,diffuse large B-cell lymphoma,0.829512357711792
hsa-miR-5088,diffuse large B-cell lymphoma,0.829512357711792
hsa-miR-642a,diffuse large B-cell lymphoma,0.829512357711792
hsa-miR-6848-5p,diffuse large B-cell lymphoma,0.829512357711792
hsa-miR-125b-1-3p,diffuse large B-cell lymphoma,0.829512357711792
hsa-miR-600,solid pseudopapillary neoplasm of pancreas,0.8295086026191711
hsa-miR-490-3p,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-212-5p,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-551b,castration-resistant prostate cancer,0.8294534683227539
hsa-miRPlus-C1100,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-6506-5p,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-5186,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-570-5p,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-220a,castration-resistant prostate cancer,0.8294534683227539
hsa-let-7a_c,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-548e-3p,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-196a-3p,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-153-5p,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-4778-3p,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-3163,castration-resistant prostate cancer,0.8294534683227539
hsa-miR-30e,solid pseudopapillary neoplasm of pancreas,0.8294482231140137
hsa-miR-4524a-5p,solid pseudopapillary neoplasm of pancreas,0.8294482231140137
hsa-miR-3688-5p,solid pseudopapillary neoplasm of pancreas,0.8294482231140137
hsa-miR-302f,miR-675-y,0.8294126987457275
hsa-miR-147b,miR-675-y,0.8294126987457275
hsa-miR-7114-5p,solid pseudopapillary neoplasm of pancreas,0.8294051885604858
hsa-miR-548al,synovial sarcoma,0.8294031023979187
hsa-miR-937-5p,synovial sarcoma,0.8294031023979187
hsa-miR-1910-5p,synovial sarcoma,0.8294031023979187
hsa-miR-6856-3p,synovial sarcoma,0.8294031023979187
hsa-miR-539-3p,synovial sarcoma,0.8294031023979187
hsa-miR-422b,Leptomeningeal metastasis,0.8293861150741577
hsa-miR-92a,Leptomeningeal metastasis,0.8293861150741577
hsa-miR-642a-5p,sarcoma,0.8293626308441162
hsa-miR-5195-5p,sarcoma,0.8293626308441162
hsa-miR-301b-3p,sarcoma,0.8293626308441162
hsa-miR-129-2-3p,castration-resistant prostate cancer,0.8293499946594238
hsa-miR-4787-3p,castration-resistant prostate cancer,0.8293499946594238
hsa-miR-4728-3p,castration-resistant prostate cancer,0.8293499946594238
hsa-miR-292-3p,castration-resistant prostate cancer,0.8293499946594238
hsa-miR-2681-3p,castration-resistant prostate cancer,0.8293499946594238
hsa-miR-151a-3p,castration-resistant prostate cancer,0.8293499946594238
hsa-miR-4313,castration-resistant prostate cancer,0.8293499946594238
hsa-miR-665,"squamous cell breast carcinoma, acantholytic variant",0.8293395042419434
hsa-miR-195,follicular thyroid carcinoma,0.8293310403823853
hsa-miR-635,"Luminal B,triple negative",0.8293227553367615
hsa-miR-135b-5p,"Luminal B,triple negative",0.8293227553367615
hsa-miR-489-3p,"Luminal B,triple negative",0.8293227553367615
hsa-miR-520d*,miR-675-y,0.8292550444602966
hsa-miR-136-3p,sarcoma,0.8292543292045593
hsa-miR-4515,"Luminal B,triple negative",0.8292334079742432
hsa-miR-363*,"Luminal B,triple negative",0.8292334079742432
hsa-miR-6795-3p,Luminal B Her2+,0.829230010509491
hsa-miR-6871-5p,miR-142-y,0.8292009234428406
hsa-miR-6780a-5p,miR-142-y,0.8292009234428406
hsa-miR-4646-5p,miR-142-y,0.8292009234428406
hsa-miR-6816-5p,miR-142-y,0.8292009234428406
hsa-miR-199a-3p,miR-675-y,0.8291903734207153
hsa-miR-1273a,miR-675-y,0.8291903734207153
hsa-miR-4433-5p,miR-675-y,0.8291903734207153
hsa-miR-8088,miR-675-y,0.8291903734207153
hsa-miR-615,diffuse large B-cell lymphoma,0.8291804790496826
hsa-miR-1298,rhabdomyosarcomas,0.8291663527488708
hsa-miR-6738-5p,rhabdomyosarcomas,0.8291663527488708
hsa-miR-3607-5p,ovarian carcinoma,0.8291622400283813
hsa-miR-4330,ovarian carcinoma,0.8291622400283813
hsa-miR-196a-2,ovarian carcinoma,0.8291622400283813
hsa-miR-545-5p,ovarian carcinoma,0.8291622400283813
hsa-miR-4258,ovarian carcinoma,0.8291622400283813
hsa-miR-4651,solid pseudopapillary neoplasm of pancreas,0.829153299331665
hsa-miR-1304,solid pseudopapillary neoplasm of pancreas,0.829153299331665
hsa-miR-463,synovial sarcoma,0.8291528820991516
hsa-miR-877-5p,synovial sarcoma,0.8291528820991516
hsa-miR-4314,synovial sarcoma,0.8291528820991516
hsa-miR-548at-3p,synovial sarcoma,0.8291528820991516
hsa-miR-7158-3p,synovial sarcoma,0.8291528820991516
hsa-miR-7110-5p,synovial sarcoma,0.8291528820991516
hsa-miR-489-5p,sarcoma,0.829110860824585
hsa-miR-539-5p,sarcoma,0.829110860824585
hsa-miR-619-5p,miR-675-y,0.8290941715240479
hsa-miR-6076,miR-675-y,0.8290941715240479
hsa-miR-4707-3p,miR-675-y,0.8290941715240479
hsa-miR-670-3p,diffuse large B-cell lymphoma,0.8290501236915588
hsa-miR-219a-1-3p,solid pseudopapillary neoplasm of pancreas,0.8290309906005859
hsa-miR-523-3p,solid pseudopapillary neoplasm of pancreas,0.8290309906005859
hsa-miR-767,solid pseudopapillary neoplasm of pancreas,0.8290309906005859
hsa-miR-213,sarcoma,0.8290094137191772
hsa-miR-187-5p,sarcoma,0.8290094137191772
hsa-miR-429,sarcoma,0.8290094137191772
hsa-miR-2276-5p,sarcoma,0.8290094137191772
hsa-miR-487a-3p,sarcoma,0.8290022015571594
hsa-miR-548d-5p,brain cancer,0.8289993405342102
hsa-miR-219-2-3p,brain cancer,0.8289993405342102
hsa-miR-4255,synovial sarcoma,0.8289862275123596
hsa-miR-768-5p:11.0,synovial sarcoma,0.8289862275123596
hsa-miR-193b-5p,synovial sarcoma,0.8289862275123596
hsa-miR-661,castration-resistant prostate cancer,0.8289754986763
hsa-miR-1185-5p,castration-resistant prostate cancer,0.8289754986763
hsa-miR-24-2*,castration-resistant prostate cancer,0.8289754986763
hsa-miR-1269,castration-resistant prostate cancer,0.8289754986763
hsa-let-7a-3p,castration-resistant prostate cancer,0.8289754986763
hsa-miR-200b-5p,castration-resistant prostate cancer,0.8289754986763
hsa-miR-2278,castration-resistant prostate cancer,0.8289754986763
hsa-miR-600,miR-142-y,0.8289487957954407
hsa-miR-2964a-3p,miR-142-y,0.8289487957954407
hsa-miR-212-5p,miR-142-y,0.8289487957954407
hsa-miR-1261,miR-142-y,0.8289487957954407
hsa-let-7a_c,miR-142-y,0.8289487957954407
hsa-miR-5590-5p,miR-142-y,0.8289487957954407
hsa-miR-193b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8289223313331604
hsa-miR-3929,"squamous cell breast carcinoma, acantholytic variant",0.8289223313331604
hsa-miR-4316,"squamous cell breast carcinoma, acantholytic variant",0.8289223313331604
hsa-miR-1236,miR-675-y,0.82891446352005
hsa-miR-4728-3p,sarcoma,0.8288984894752502
hsa-miR-758,pilocytic astrocytoma,0.8288676142692566
hsa-miR-1245,pilocytic astrocytoma,0.8288676142692566
hsa-miR-92a-1-5p,pilocytic astrocytoma,0.8288676142692566
hsa-miR-205-3p,miR-142-y,0.8288450241088867
hsa-miR-4313,miR-142-y,0.8288450241088867
hsa-miR-302a*,solid pseudopapillary neoplasm of pancreas,0.8288443684577942
hsa-miR-3662,solid pseudopapillary neoplasm of pancreas,0.8288443684577942
hsa-miR-192-2/3,solid pseudopapillary neoplasm of pancreas,0.8288443684577942
hsa-miR-4750-3p,sarcoma,0.8288397192955017
hsa-miR-4657,sarcoma,0.8288397192955017
hsa-miR-3929,"Luminal B,triple negative",0.8288161158561707
hsa-miR-6808-5p,"Luminal B,triple negative",0.8288161158561707
hsa-miR-4653-5p,"Luminal B,triple negative",0.8288161158561707
hsa-miR-4518,ovarian carcinoma,0.8288124203681946
hsa-miR-3143,ovarian carcinoma,0.8288124203681946
hsa-miR-1267,ovarian carcinoma,0.8288124203681946
hsa-miR-326,ovarian carcinoma,0.8288124203681946
hsa-miR-499a-3p,ovarian carcinoma,0.8288124203681946
hsa-miR-3169,ovarian carcinoma,0.8288124203681946
hsa-miR-92a-1-5p,ovarian carcinoma,0.8288124203681946
hsa-miR-24-1*,ovarian carcinoma,0.8288124203681946
hsa-miR-4455,ovarian carcinoma,0.8288124203681946
hsa-miR-196-1,brain cancer,0.8287535905838013
hsa-miR-4748,synovial sarcoma,0.8287462592124939
hsa-miR-3157-5p,synovial sarcoma,0.8287462592124939
hsa-miR-6861-5p,synovial sarcoma,0.8287462592124939
hsa-miR-487b-5p,synovial sarcoma,0.8287462592124939
hsa-miR-5587-5p,synovial sarcoma,0.8287462592124939
hsa-miR-4281,synovial sarcoma,0.8287462592124939
hsa-miR-4278,synovial sarcoma,0.8287462592124939
hsa-miR-7-1*,synovial sarcoma,0.8287462592124939
hsa-miR-615-5p,synovial sarcoma,0.8287462592124939
hsa-miR-4684-3p,synovial sarcoma,0.8287462592124939
hsa-miR-135a-3p,synovial sarcoma,0.8287462592124939
hsa-miR-548o,synovial sarcoma,0.8287462592124939
hsa-miR-6796-5p,synovial sarcoma,0.8287462592124939
hsa-miR-101-2,synovial sarcoma,0.8287462592124939
hsa-miR-4757-5p,synovial sarcoma,0.8287462592124939
hsa-miR-1537-3p,synovial sarcoma,0.8287462592124939
hsa-miR-3614-3p,synovial sarcoma,0.8287462592124939
hsa-miR-4729,synovial sarcoma,0.8287462592124939
hsa-miR-4511,synovial sarcoma,0.8287462592124939
hsa-miR-98-5p,synovial sarcoma,0.8287462592124939
hsa-let-7g-5p,synovial sarcoma,0.8287462592124939
hsa-miR-4510,synovial sarcoma,0.8287462592124939
hsa-miR-5003-3p,synovial sarcoma,0.8287462592124939
hsa-miR-6788-3p,synovial sarcoma,0.8287462592124939
hsa-miR-3177-5p,synovial sarcoma,0.8287462592124939
hsa-miR-548az-3p,synovial sarcoma,0.8287462592124939
hsa-miR-1281,"Luminal B,triple negative",0.828723669052124
hsa-miR-604,"Luminal B,triple negative",0.828723669052124
hsa-miR-320c,"Luminal B,triple negative",0.828723669052124
hsa-miR-1255b-2,"Luminal B,triple negative",0.828723669052124
hsa-miR-7-5p,"Luminal B,triple negative",0.828723669052124
hsa-miR-20a-5p,rhabdomyosarcomas,0.8287190198898315
hsa-miR-493,solid pseudopapillary neoplasm of pancreas,0.828648030757904
hsa-miR-505-3p,solid pseudopapillary neoplasm of pancreas,0.828648030757904
hsa-miR-675-5p,solid pseudopapillary neoplasm of pancreas,0.828648030757904
hsa-miR-518a-5p,solid pseudopapillary neoplasm of pancreas,0.828635573387146
hsa-miR-2114-5p,solid pseudopapillary neoplasm of pancreas,0.828635573387146
hsa-miR-4728-5p,miR-675-y,0.8285835385322571
hsa-miR-544b,castration-resistant prostate cancer,0.8285800814628601
hsa-miR-502-3p,castration-resistant prostate cancer,0.8285800814628601
hsa-miR-370,solid pseudopapillary neoplasm of pancreas,0.8285619616508484
hsa-miR-6881-5p,solid pseudopapillary neoplasm of pancreas,0.8285619616508484
hsa-miR-4796-5p,solid pseudopapillary neoplasm of pancreas,0.8285619616508484
hsa-miR-4685-3p,solid pseudopapillary neoplasm of pancreas,0.8285619616508484
hsa-miR-4662b,follicular thyroid carcinoma,0.8285589814186096
hsa-miR-3978,"Luminal B,triple negative",0.8285536766052246
hsa-miR-633,synovial sarcoma,0.8285447359085083
hsa-miR-4720-5p,synovial sarcoma,0.8285447359085083
hsa-miR-1273e,synovial sarcoma,0.8285447359085083
hsa-miR-4671-3p,synovial sarcoma,0.8285447359085083
hsa-miR-296-5p,synovial sarcoma,0.8285447359085083
hsa-miR-3915,synovial sarcoma,0.8285447359085083
hsa-miR-6784-3p,synovial sarcoma,0.8285447359085083
hsa-miRPlus-A1087,sarcoma,0.8285439610481262
hsa-miR-6876-3p,sarcoma,0.8285439610481262
hsa-miR-4451,miR-675-y,0.8285343050956726
hsa-miR-292-3p,miR-675-y,0.8285343050956726
hsa-miR-4731-3p,miR-675-y,0.8285343050956726
hsa-miR-1266-3p,sarcoma,0.8285233378410339
hsa-miR-3920,sarcoma,0.8285233378410339
hsa-miR-215,sarcoma,0.8285233378410339
hsa-miR-4322,miR-675-y,0.8285188674926758
hsa-miR-518c*,miR-675-y,0.8285188674926758
hsa-miR-196a-5p,miR-675-y,0.8285188674926758
hsa-miR-3607-5p,rhabdomyosarcomas,0.8285111784934998
hsa-miR-668-3p,rhabdomyosarcomas,0.8285111784934998
hsa-miR-660,rhabdomyosarcomas,0.8285111784934998
hsa-miR-3659,rhabdomyosarcomas,0.8285111784934998
hsa-miR-766,brain cancer,0.8285010457038879
hsa-miR-335*,brain cancer,0.8285010457038879
hsa-miR-567,diffuse large B-cell lymphoma,0.8285001516342163
hsa-miR-511-2,diffuse large B-cell lymphoma,0.8285001516342163
hsa-miR-636,diffuse large B-cell lymphoma,0.8285001516342163
hsa-miR-509-3-5p,diffuse large B-cell lymphoma,0.8285001516342163
hsa-miR-96-5p,diffuse large B-cell lymphoma,0.8285001516342163
hsa-miR-766,diffuse large B-cell lymphoma,0.8284993171691895
hsa-miR-609,diffuse large B-cell lymphoma,0.8284993171691895
hsa-miR-1273e,"squamous cell breast carcinoma, acantholytic variant",0.8284806609153748
hsa-miR-643,"squamous cell breast carcinoma, acantholytic variant",0.8284806609153748
hsa-miR-548an,"squamous cell breast carcinoma, acantholytic variant",0.8284806609153748
hsa-miR-6126,miR-142-y,0.8284698128700256
hsa-miR-7-2*,solid pseudopapillary neoplasm of pancreas,0.8284141421318054
hsa-miR-941,solid pseudopapillary neoplasm of pancreas,0.8284141421318054
hsa-miR-4719,solid pseudopapillary neoplasm of pancreas,0.8284141421318054
hsa-miR-1306-3p,solid pseudopapillary neoplasm of pancreas,0.8284141421318054
hsa-miR-26a-1,brain cancer,0.8283993601799011
hsa-miR-7850-5p,"Luminal B,triple negative",0.8283743262290955
hsa-miR-520a-3p,miR-675-y,0.8283284306526184
hsa-miR-1307,solid pseudopapillary neoplasm of pancreas,0.828311026096344
hsa-miR-374b-5p,ovarian carcinoma,0.8283098936080933
hsa-miR-3143,miR-142-y,0.8282732367515564
hsa-miR-941,miR-142-y,0.8282732367515564
hsa-miR-324-5p,miR-142-y,0.8282732367515564
hsa-miR-92a-1-5p,miR-142-y,0.8282732367515564
hsa-miR-4787-5p,follicular thyroid carcinoma,0.828266441822052
hsa-miR-4651,"Luminal B,triple negative",0.8282575011253357
hsa-miR-944,"Luminal B,triple negative",0.8282575011253357
hsa-miR-4637,"Luminal B,triple negative",0.8282575011253357
hsa-miR-146a*,sarcoma,0.8282341361045837
hsa-miR-7-2,sarcoma,0.8282341361045837
hsa-miR-373-5p,sarcoma,0.8282341361045837
hsa-miR-146b-3p,sarcoma,0.8282341361045837
hsa-miR-3652,sarcoma,0.8282341361045837
hsa-miR-299-5p,ovarian carcinoma,0.8282012939453125
hsa-miR-6132,ovarian carcinoma,0.8282012939453125
hsa-miR-4433-3p,ovarian carcinoma,0.8282012939453125
hsa-miR-33a*,ovarian carcinoma,0.8282012939453125
hsa-miR-4761-5p,ovarian carcinoma,0.8282012939453125
hsa-miR-219b-3p,miR-142-y,0.8281881809234619
hsa-miR-3622b-5p,castration-resistant prostate cancer,0.8281617164611816
hsa-miR-4677-3p,castration-resistant prostate cancer,0.8281617164611816
hsa-miR-4255,castration-resistant prostate cancer,0.8281617164611816
hsa-miR-5587-3p,castration-resistant prostate cancer,0.8281617164611816
hsa-miR-3614-5p,Leptomeningeal metastasis,0.8281285762786865
hsa-miR-6071,Leptomeningeal metastasis,0.8281285762786865
hsa-miR-106b-3p,sarcoma,0.8281270265579224
hsa-miR-365,sarcoma,0.8281270265579224
hsa-miR-186*,sarcoma,0.8281270265579224
hsa-miR-3681-3p,sarcoma,0.8281270265579224
hsa-miR-3196,miR-675-y,0.8281107544898987
hsa-miR-518a-3p,miR-675-y,0.8281107544898987
hsa-miR-518a-5p,miR-675-y,0.8281107544898987
hsa-miR-6856-3p,miR-675-y,0.8281107544898987
hsa-miR-363*,miR-675-y,0.8281107544898987
hsa-miR-193a-3p,pilocytic astrocytoma,0.8280822038650513
hsa-miR-600,pilocytic astrocytoma,0.8280822038650513
hsa-miR-490-3p,pilocytic astrocytoma,0.8280822038650513
hsa-miR-587,synovial sarcoma,0.8280771374702454
hsa-miR-207,synovial sarcoma,0.8280771374702454
hsa-miR-377-3p,synovial sarcoma,0.8280771374702454
hsa-miR-5006-5p,synovial sarcoma,0.8280771374702454
hsa-let-7b-3p,synovial sarcoma,0.8280771374702454
hsa-miR-4713-3p,synovial sarcoma,0.8280771374702454
hsa-miR-1270,synovial sarcoma,0.8280771374702454
hsa-miR-549a,synovial sarcoma,0.8280771374702454
hsa-miR-518a-3p,miR-142-y,0.8280735015869141
hsa-miR-3940,solid pseudopapillary neoplasm of pancreas,0.8280715942382812
hsa-miR-6769a-5p,solid pseudopapillary neoplasm of pancreas,0.8280715942382812
hsa-miR-6787-3p,solid pseudopapillary neoplasm of pancreas,0.8280715942382812
hsa-let-7f-1,solid pseudopapillary neoplasm of pancreas,0.8280715942382812
hsa-miR-6511a-3p,solid pseudopapillary neoplasm of pancreas,0.8280715942382812
hsa-miR-670-3p,miR-675-y,0.8280546069145203
hsa-miR-6752-3p,miR-675-y,0.8280546069145203
hsa-miR-548e,sarcoma,0.8280372023582458
hsa-miR-550,sarcoma,0.8280372023582458
hsa-miR-589-3p,sarcoma,0.8280372023582458
hsa-miR-125b-2,sarcoma,0.8280372023582458
hsa-miR-30a,sarcoma,0.8280372023582458
hsa-miR-3940-5p,sarcoma,0.8280372023582458
hsa-miR-548s,sarcoma,0.8280372023582458
hsa-miR-15b*,ovarian carcinoma,0.8280196189880371
hsa-miR-214-3p,ovarian carcinoma,0.8280196189880371
hsa-miR-294,ovarian carcinoma,0.8280196189880371
hsa-miR-625,ovarian carcinoma,0.8280196189880371
hsa-miR-4468,ovarian carcinoma,0.8280196189880371
hsa-miR-4798-5p,ovarian carcinoma,0.8280196189880371
hsa-miR-143-5p,ovarian carcinoma,0.8280196189880371
hsa-miR-3972,ovarian carcinoma,0.8280196189880371
hsa-miR-3545-3p,ovarian carcinoma,0.8280196189880371
hsa-miR-5583-3p,ovarian carcinoma,0.8280196189880371
hsa-miR-3200,ovarian carcinoma,0.8280196189880371
hsa-miR-1306-3p,ovarian carcinoma,0.8280196189880371
hsa-miR-587,"squamous cell breast carcinoma, acantholytic variant",0.828013002872467
hsa-miR-377-3p,"squamous cell breast carcinoma, acantholytic variant",0.828013002872467
hsa-let-7b-3p,"squamous cell breast carcinoma, acantholytic variant",0.828013002872467
hsa-miR-548u,"squamous cell breast carcinoma, acantholytic variant",0.828013002872467
hsa-miR-6731-3p,castration-resistant prostate cancer,0.8280125260353088
hsa-miR-4538,castration-resistant prostate cancer,0.8280125260353088
hsa-miR-4649-3p,castration-resistant prostate cancer,0.8280125260353088
hsa-miR-4484,castration-resistant prostate cancer,0.8280125260353088
hsa-miR-498,castration-resistant prostate cancer,0.8280125260353088
hsa-miR-548c-5p,castration-resistant prostate cancer,0.8280125260353088
hsa-miR-544a,castration-resistant prostate cancer,0.8280125260353088
hsa-miR-020,solid pseudopapillary neoplasm of pancreas,0.8280112147331238
hsa-miR-1306,solid pseudopapillary neoplasm of pancreas,0.8280112147331238
hsa-miR-1249,solid pseudopapillary neoplasm of pancreas,0.8280112147331238
hsa-miR-4459,solid pseudopapillary neoplasm of pancreas,0.8280112147331238
hsa-miR-6885-3p,solid pseudopapillary neoplasm of pancreas,0.8280112147331238
hsa-miR-3173-5p,papillary thyroid carcinoma,0.8279561400413513
hsa-miR-6509-3p,sarcoma,0.8279509544372559
hsa-miR-3620-5p,sarcoma,0.8279509544372559
hsa-miR-885-5p,sarcoma,0.8279509544372559
hsa-miR-183,sarcoma,0.8279509544372559
hsa-miR-4685-3p,sarcoma,0.8279509544372559
hsa-miR-497-5p,sarcoma,0.8279509544372559
hsa-miR-181b-5p,sarcoma,0.8279509544372559
hsa-miR-1178-3p,sarcoma,0.8279509544372559
hsa-miR-520a,"Luminal B,triple negative",0.8279473781585693
hsa-miR-4651,brain cancer,0.827932596206665
hsa-miR-218-1-3p,aryngeal squamous cell carcinoma,0.8279127478599548
hsa-miR-768-5p,diffuse large B-cell lymphoma,0.8279001712799072
hsa-miR-5088-5p,diffuse large B-cell lymphoma,0.8279001712799072
hsa-miR-376b,ovarian carcinoma,0.8278980255126953
hsa-miR-4417,ovarian carcinoma,0.8278980255126953
hsa-miR-516a-3p,miR-675-y,0.8278807997703552
hsa-miR-136,miR-675-y,0.8278807997703552
hsa-miR-4527,miR-675-y,0.8278807997703552
hsa-miR-4653-3p,ovarian carcinoma,0.8278725147247314
hsa-miR-603,solid pseudopapillary neoplasm of pancreas,0.8278631567955017
hsa-miR-508-5p,solid pseudopapillary neoplasm of pancreas,0.8278631567955017
hsa-miR-148a*,solid pseudopapillary neoplasm of pancreas,0.8278631567955017
hsa-miR-302d*,solid pseudopapillary neoplasm of pancreas,0.8278631567955017
hsa-miR-300,solid pseudopapillary neoplasm of pancreas,0.8278631567955017
hsa-miR-4489,ovarian carcinoma,0.8278565406799316
hsa-miR-554,breast cancer brain metastasis,0.8278462290763855
hsa-miR-376c-5p,solid pseudopapillary neoplasm of pancreas,0.8277882933616638
hsa-miR-6814-3p,solid pseudopapillary neoplasm of pancreas,0.8277882933616638
hsa-miR-550b-2-5p,solid pseudopapillary neoplasm of pancreas,0.8277882933616638
hsa-miR-433,solid pseudopapillary neoplasm of pancreas,0.8277882933616638
hsa-miR-4763-5p,solid pseudopapillary neoplasm of pancreas,0.8277882933616638
hsa-miR-3162-5p,solid pseudopapillary neoplasm of pancreas,0.8277739882469177
hsa-miR-1974,"Luminal B,triple negative",0.8277501463890076
hsa-miR-3618,"Luminal B,triple negative",0.8277501463890076
hsa-miR-1273c,"Luminal B,triple negative",0.8277501463890076
hsa-miR-340*,"Luminal B,triple negative",0.8277501463890076
hsa-miR-376a,"Luminal B,triple negative",0.8277501463890076
hsa-miR-6865-3p,"Luminal B,triple negative",0.8277501463890076
hsa-miR-519b,"Luminal B,triple negative",0.8277501463890076
hsa-miR-642b-3p,ovarian carcinoma,0.8277493119239807
hsa-miR-4720-5p,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-7850-5p,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-298,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-4769-3p,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-191-5p,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-5589-5p,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-6800-5p,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-1287-3p,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-3180-3p,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-660-3p,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-519e*,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-8083,castration-resistant prostate cancer,0.8277184963226318
hsa-miR-656,ovarian carcinoma,0.8277100324630737
hsa-miR-218-1,sarcoma,0.8276993036270142
hsa-miR-6741-3p,ovarian carcinoma,0.8276897072792053
hsa-miR-1914*,"Luminal B,triple negative",0.827663779258728
hsa-miR-3679-5p,"Luminal B,triple negative",0.827663779258728
hsa-miR-770-5p,"Luminal B,triple negative",0.827663779258728
hsa-miR-3620-5p,"Luminal B,triple negative",0.827663779258728
hsa-miR-3612,"Luminal B,triple negative",0.827663779258728
hsa-miR-6887-5p,miR-142-y,0.8276540040969849
hsa-miR-3150b-5p,miR-142-y,0.8276540040969849
hsa-miR-621,miR-675-y,0.8276506662368774
hsa-miR-302c-3p,ovarian carcinoma,0.8276468515396118
hsa-miRPlus-G1246-3p,miR-675-y,0.8276333212852478
hsa-miR-644b-5p,miR-675-y,0.8276333212852478
hsa-miR-5002-5p,miR-675-y,0.8276333212852478
hsa-miR-378g,miR-675-y,0.8276333212852478
hsa-miR-3925-3p,brain cancer,0.8276218771934509
hsa-miR-499a-3p,high grade serous papillary ovarian cancer,0.8276143670082092
hsa-miR-6780b-3p,high grade serous papillary ovarian cancer,0.8276143670082092
hsa-miR-3065-3p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-642,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-3157-5p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-615-5p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-6090,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-20b-5p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-3909,castration-resistant prostate cancer,0.8276036381721497
hsa-miRPlus-G1065-5p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-6852-3p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-4423-5p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-152-5p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-656-5p,castration-resistant prostate cancer,0.8276036381721497
hsa-let-7g-5p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-4633-3p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-5003-3p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-3177-5p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-548az-3p,castration-resistant prostate cancer,0.8276036381721497
hsa-miR-4505,ovarian carcinoma,0.8276006579399109
hsa-miR-1972,ovarian carcinoma,0.8276006579399109
hsa-miR-7154-5p,synovial sarcoma,0.8275913000106812
hsa-miR-6892-3p,synovial sarcoma,0.8275913000106812
hsa-miR-6776-3p,synovial sarcoma,0.8275913000106812
hsa-miR-6822-3p,synovial sarcoma,0.8275913000106812
hsa-miR-2277-5p,synovial sarcoma,0.8275913000106812
hsa-miR-584-3p,synovial sarcoma,0.8275913000106812
hsa-miR-5189-3p,synovial sarcoma,0.8275913000106812
hsa-miR-6797-3p,synovial sarcoma,0.8275913000106812
hsa-miR-4632-5p,synovial sarcoma,0.8275913000106812
hsa-miR-3928,ovarian carcinoma,0.8275762796401978
hsa-miR-4670-5p,ovarian carcinoma,0.8275762796401978
hsa-miR-195,ovarian carcinoma,0.8275577425956726
hsa-miR-3646,ovarian carcinoma,0.8275512456893921
hsa-miR-4516,ovarian carcinoma,0.8275512456893921
hsa-miR-3177-3p,"squamous cell breast carcinoma, acantholytic variant",0.8275269269943237
hsa-miR-584-3p,"squamous cell breast carcinoma, acantholytic variant",0.8275269269943237
hsa-miR-10b-5p,ovarian carcinoma,0.8275253772735596
hsa-miR-3156-3p,miR-675-y,0.8275011777877808
hsa-miR-6812-3p,miR-675-y,0.8275011777877808
hsa-miR-181a-2*,ovarian carcinoma,0.8274984359741211
hsa-miR-1228-3p,ovarian carcinoma,0.8274984359741211
hsa-miR-2964a-3p,Leptomeningeal metastasis,0.8274834156036377
hsa-miR-570-5p,Leptomeningeal metastasis,0.8274834156036377
hsa-miR-302e,Luminal B Her2+,0.8274797201156616
hsa-miR-323a-3p,ovarian carcinoma,0.8274721503257751
hsa-miR-545-3p,ovarian carcinoma,0.8274721503257751
hsa-miR-631,ovarian carcinoma,0.8274721503257751
hsa-miR-593*,pilocytic astrocytoma,0.8274649381637573
hsa-miR-181b-3p,sarcoma,0.8274591565132141
hsa-miR-3912-3p,sarcoma,0.8274591565132141
hsa-miR-1247-5p,ovarian carcinoma,0.827444851398468
hsa-miR-486-3p,ovarian carcinoma,0.827444851398468
hsa-miR-33a,miR-675-y,0.8274298310279846
hsa-miR-6814-5p,miR-675-y,0.8274298310279846
hsa-miR-4293,miR-675-y,0.8274298310279846
hsa-miR-99a-3p,miR-675-y,0.8274298310279846
hsa-miR-548k,miR-675-y,0.8274298310279846
hsa-miR-1227,brain cancer,0.8274244070053101
hsa-miR-517c,"Luminal B,triple negative",0.8274199962615967
hsa-miR-148a-5p,"Luminal B,triple negative",0.8274199962615967
hsa-miR-1307,"Luminal B,triple negative",0.8274117112159729
hsa-miR-510,"Luminal B,triple negative",0.8274117112159729
hsa-miR-6805-5p,"Luminal B,triple negative",0.8274117112159729
hsa-miR-1275,ovarian carcinoma,0.8274092674255371
hsa-miR-550b-3p,ovarian carcinoma,0.8274092674255371
hsa-miR-483-3p-1106,ovarian carcinoma,0.8274092674255371
hsa-miR-3689f,ovarian carcinoma,0.8274092674255371
hsa-miR-3922-3p,ovarian carcinoma,0.8274092674255371
hsa-miR-190a,sarcoma,0.8273985981941223
hsa-miR-377-5p,sarcoma,0.8273985981941223
hsa-miR-6130,sarcoma,0.8273985981941223
hsa-miR-152-3p,sarcoma,0.8273985981941223
hsa-miR-4459,sarcoma,0.8273985981941223
hsa-miR-138-2-3p,ovarian carcinoma,0.8273879289627075
hsa-miR-3655,ovarian carcinoma,0.8273879289627075
hsa-miR-4691-3p,high grade serous papillary ovarian cancer,0.827384889125824
hsa-miR-4666a-3p,ovarian carcinoma,0.8273574113845825
hsa-miR-593-3p,ovarian carcinoma,0.8273574113845825
hsa-miR-3606-5p,ovarian carcinoma,0.8273574113845825
hsa-miR-770-5p,brain cancer,0.8273378610610962
hsa-miR-649,breast cancer brain metastasis,0.8273347616195679
hsa-miR-100-3p,breast cancer brain metastasis,0.8273347616195679
hsa-miR-1244,solid pseudopapillary neoplasm of pancreas,0.8273299932479858
hsa-miR-151-3p,ovarian carcinoma,0.8273258805274963
hsa-miR-6769a-3p,ovarian carcinoma,0.8273258805274963
hsa-miR-3690,ovarian carcinoma,0.8273258805274963
hsa-miR-4454,miR-675-y,0.8273255825042725
hsa-miR-3187-5p,miR-675-y,0.8273255825042725
hsa-miR-106a*,pilocytic astrocytoma,0.8273139595985413
hsa-miR-4276,diffuse large B-cell lymphoma,0.8273004293441772
hsa-miRPlus-A1087,diffuse large B-cell lymphoma,0.8273004293441772
hsa-let-7a-3,diffuse large B-cell lymphoma,0.8273004293441772
hsa-miR-944,diffuse large B-cell lymphoma,0.8273004293441772
hsa-miR-190b,diffuse large B-cell lymphoma,0.8273004293441772
hsa-miR-6716-3p,diffuse large B-cell lymphoma,0.8273004293441772
hsa-miR-143-3p,diffuse large B-cell lymphoma,0.8273004293441772
hsa-miR-1252-5p,diffuse large B-cell lymphoma,0.8273004293441772
hsa-miR-3168,diffuse large B-cell lymphoma,0.8273004293441772
hsa-miR-4665-3p,ovarian carcinoma,0.8272585272789001
hsa-miR-500,sarcoma,0.8272501230239868
hsa-miR-16-5p,sarcoma,0.8272501230239868
hsa-miR-5681a,sarcoma,0.8272501230239868
hsa-miR-3166,sarcoma,0.8272501230239868
hsa-miR-506-3p,sarcoma,0.8272501230239868
hsa-miR-548aq-5p,castration-resistant prostate cancer,0.8272492289543152
hsa-miR-625-5p,castration-resistant prostate cancer,0.8272492289543152
hsa-miR-3185,castration-resistant prostate cancer,0.8272492289543152
hsa-miR-331-5p,castration-resistant prostate cancer,0.8272492289543152
hsa-miR-4439,castration-resistant prostate cancer,0.8272492289543152
hsa-miR-4767,castration-resistant prostate cancer,0.8272492289543152
hsa-miR-549a,castration-resistant prostate cancer,0.8272492289543152
hsa-miR-640,miR-142-y,0.8272489309310913
hsa-miR-573,miR-142-y,0.8272489309310913
hsa-miR-95-3p,solid pseudopapillary neoplasm of pancreas,0.8272464275360107
hsa-miR-4290,ovarian carcinoma,0.8272442817687988
hsa-miR-6792-3p,ovarian carcinoma,0.827222466468811
hsa-miR-4463,ovarian carcinoma,0.827222466468811
hsa-miR-1273e,miR-142-y,0.8272097706794739
hsa-miR-191-5p,miR-142-y,0.8272097706794739
hsa-miR-335-5p,miR-142-y,0.8272097706794739
hsa-miR-3188,miR-142-y,0.8272097706794739
hsa-miR-145-3p,miR-142-y,0.8272097706794739
hsa-miR-374b*,miR-675-y,0.8272010087966919
hsa-miR-935,miR-675-y,0.8272010087966919
hsa-miR-6842-5p,miR-675-y,0.8272010087966919
hsa-miR-6780a-3p,miR-675-y,0.8272010087966919
hsa-miR-135-2,miR-675-y,0.8272010087966919
hsa-miR-6747-3p,miR-142-y,0.8271816372871399
hsa-miR-138-1,sarcoma,0.8271751403808594
hsa-miR-433,sarcoma,0.8271751403808594
hsa-miR-3613-5p,sarcoma,0.8271751403808594
hsa-miR-4287,sarcoma,0.8271751403808594
hsa-miR-376b-3p,sarcoma,0.8271751403808594
hsa-miR-891a-3p,sarcoma,0.8271751403808594
hsa-miR-3190-3p,sarcoma,0.8271751403808594
hsa-miR-4326,"Luminal B,triple negative",0.8271713852882385
hsa-miR-4708-5p,"Luminal B,triple negative",0.8271713852882385
hsa-miR-34a-5p,pilocytic astrocytoma,0.827158510684967
hsa-miR-6832-5p,ovarian carcinoma,0.8271446228027344
hsa-miR-7,ovarian carcinoma,0.8271446228027344
hsa-miR-4458,ovarian carcinoma,0.8271446228027344
hsa-miR-512-5p,pilocytic astrocytoma,0.8271145224571228
hsa-miR-292-5p,"Luminal B,triple negative",0.8271107077598572
hsa-miR-5699-5p,ovarian carcinoma,0.8271026015281677
hsa-miR-145-5p,ovarian carcinoma,0.8271026015281677
hsa-miR-4744,ovarian carcinoma,0.8271026015281677
hsa-miR-873,synovial sarcoma,0.8270769119262695
hsa-miR-5091,synovial sarcoma,0.8270769119262695
hsa-miR-516b*,synovial sarcoma,0.8270769119262695
hsa-miR-1207-5p,synovial sarcoma,0.8270769119262695
hsa-miR-451a,synovial sarcoma,0.8270769119262695
hsa-miR-371a-3p,synovial sarcoma,0.8270769119262695
hsa-miR-6739-5p,synovial sarcoma,0.8270769119262695
hsa-miR-374c-3p,ovarian carcinoma,0.8270586729049683
hsa-miR-1236,ovarian carcinoma,0.8270586729049683
hsa-miR-520b-520c,ovarian carcinoma,0.8270586729049683
hsa-miR-548d-2,ovarian carcinoma,0.8270586729049683
hsa-miR-4656,ovarian carcinoma,0.8270586729049683
hsa-miR-942-5p,miR-142-y,0.8270409107208252
hsa-miR-3129-3p,solid pseudopapillary neoplasm of pancreas,0.8270163536071777
hsa-miR-639,"squamous cell breast carcinoma, acantholytic variant",0.8270125389099121
hsa-miR-4520-3p,"squamous cell breast carcinoma, acantholytic variant",0.8270125389099121
hsa-miR-411-5p,"squamous cell breast carcinoma, acantholytic variant",0.8270125389099121
hsa-miR-3591-3p,"squamous cell breast carcinoma, acantholytic variant",0.8270125389099121
hsa-miR-892c-3p,"squamous cell breast carcinoma, acantholytic variant",0.8270125389099121
hsa-miR-520d-5p,"squamous cell breast carcinoma, acantholytic variant",0.8270125389099121
hsa-miR-2861,"squamous cell breast carcinoma, acantholytic variant",0.8270125389099121
hsa-miR-646,synovial sarcoma,0.8270119428634644
hsa-miR-99a*,synovial sarcoma,0.8270119428634644
hsa-miR-130b-3p,synovial sarcoma,0.8270119428634644
hsa-miR-584-5p,synovial sarcoma,0.8270119428634644
hsa-miR-4322,synovial sarcoma,0.8270119428634644
hsa-miR-1224-3p,synovial sarcoma,0.8270119428634644
hsa-miR-3934,synovial sarcoma,0.8270119428634644
hsa-miR-6848-5p,synovial sarcoma,0.8270119428634644
hsa-miR-1249-3p,synovial sarcoma,0.8270119428634644
hsa-miR-4483,synovial sarcoma,0.8270119428634644
hsa-miR-4650-5p,synovial sarcoma,0.8270119428634644
hsa-miR-4266,synovial sarcoma,0.8270119428634644
hsa-miR-204-3p,ovarian carcinoma,0.8270099759101868
hsa-miR-497,ovarian carcinoma,0.8270099759101868
hsa-miR-34,ovarian carcinoma,0.8270099759101868
hsa-miR-127-3p,ovarian carcinoma,0.8270099759101868
hsa-miR-519c-3p,ovarian carcinoma,0.8270099759101868
hsa-miR-187,solid pseudopapillary neoplasm of pancreas,0.8270086646080017
hsa-miR-593*,solid pseudopapillary neoplasm of pancreas,0.8270086646080017
hsa-miR-6881-3p,solid pseudopapillary neoplasm of pancreas,0.8270086646080017
hsa-miR-4701-5p,solid pseudopapillary neoplasm of pancreas,0.8270086646080017
hsa-miR-6790-3p,Luminal B Her2+,0.8269992470741272
hsa-miR-640,ovarian carcinoma,0.8269941806793213
hsa-miR-4772-3p,solid pseudopapillary neoplasm of pancreas,0.8269871473312378
hsa-miR-639,miR-675-y,0.8269641995429993
hsa-miR-635,miR-675-y,0.8269641995429993
hsa-miR-565,"Luminal B,triple negative",0.8269620537757874
hsa-miR-16-5p,"Luminal B,triple negative",0.8269620537757874
hsa-miR-4476,"Luminal B,triple negative",0.8269620537757874
hsa-miR-412-3p,"Luminal B,triple negative",0.8269620537757874
hsa-miR-3166,"Luminal B,triple negative",0.8269620537757874
hsa-miR-300,"Luminal B,triple negative",0.8269620537757874
hsa-miR-4766-3p,"Luminal B,triple negative",0.8269620537757874
hsa-miR-328,pilocytic astrocytoma,0.8269587755203247
hsa-miR-215,pilocytic astrocytoma,0.8269587755203247
hsa-miR-760,ovarian carcinoma,0.8269571661949158
hsa-miR-3654,ovarian carcinoma,0.8269571661949158
hsa-miR-4451,ovarian carcinoma,0.8269571661949158
hsa-miR-4731-3p,ovarian carcinoma,0.8269571661949158
hsa-miR-2681-3p,ovarian carcinoma,0.8269571661949158
hsa-miR-646,"squamous cell breast carcinoma, acantholytic variant",0.8269473910331726
hsa-miR-1294,"squamous cell breast carcinoma, acantholytic variant",0.8269473910331726
hsa-miR-302d-5p,diffuse large B-cell lymphoma,0.8269473910331726
hsa-miR-6848-5p,"squamous cell breast carcinoma, acantholytic variant",0.8269473910331726
hsa-miR-125b-1-3p,"squamous cell breast carcinoma, acantholytic variant",0.8269473910331726
hsa-miR-103-as,"squamous cell breast carcinoma, acantholytic variant",0.8269473910331726
hsa-miR-1909-5p,"squamous cell breast carcinoma, acantholytic variant",0.8269473910331726
hsa-miR-659-5p,diffuse large B-cell lymphoma,0.8269473910331726
hsa-miR-532-5p,rhabdomyosarcomas,0.8269416689872742
hsa-miR-3605-3p,rhabdomyosarcomas,0.8269416689872742
hsa-miR-301a,rhabdomyosarcomas,0.8269416689872742
hsa-miR-654,ovarian carcinoma,0.8269268274307251
hsa-miR-130a-3p,ovarian carcinoma,0.8269192576408386
hsa-miR-329,brain cancer,0.8269180655479431
hsa-miR-4520-3p,"Luminal B,triple negative",0.8269053101539612
hsa-miR-520d-5p,"Luminal B,triple negative",0.8269053101539612
hsa-miR-591,pilocytic astrocytoma,0.8269035816192627
hsa-miR-523-3p,ovarian carcinoma,0.8269029855728149
hsa-miR-1292-5p,ovarian carcinoma,0.8269029855728149
hsa-miR-486,ovarian carcinoma,0.8269029855728149
hsa-miR-9-3p,ovarian carcinoma,0.8269029855728149
hsa-miR-520g-520h,ovarian carcinoma,0.8269029855728149
hsa-miR-1299,ovarian carcinoma,0.8269029855728149
hsa-miR-4715-3p,ovarian carcinoma,0.8269029855728149
hsa-miR-1206,miR-675-y,0.8268992900848389
hsa-miR-187-3p,miR-675-y,0.8268992900848389
hsa-miR-514b-5p,miR-675-y,0.8268992900848389
hsa-miR-6728-3p,solid pseudopapillary neoplasm of pancreas,0.8268920183181763
hsa-miR-6750-5p,"Luminal B,triple negative",0.8268869519233704
hsa-miR-4437,"Luminal B,triple negative",0.8268869519233704
hsa-miR-4659b-5p,"Luminal B,triple negative",0.8268869519233704
hsa-miR-3190-3p,"Luminal B,triple negative",0.8268869519233704
hsa-miR-106a*,solid pseudopapillary neoplasm of pancreas,0.8268575668334961
hsa-miR-512-3p,solid pseudopapillary neoplasm of pancreas,0.8268575668334961
hsa-miR-665,ovarian carcinoma,0.8268476128578186
hsa-miR-4306,ovarian carcinoma,0.8268476128578186
hsa-miR-544b,ovarian carcinoma,0.8268476128578186
hsa-miR-1236-5p,"Luminal B,triple negative",0.8268402218818665
hsa-miR-219b-3p,high grade serous papillary ovarian cancer,0.8268339037895203
hsa-miR-582,solid pseudopapillary neoplasm of pancreas,0.8268212676048279
hsa-miR-619-5p,solid pseudopapillary neoplasm of pancreas,0.8268172144889832
hsa-miR-148a-5p,solid pseudopapillary neoplasm of pancreas,0.8268172144889832
hsa-miR-7641,ovarian carcinoma,0.8267898559570312
hsa-miR-4486,ovarian carcinoma,0.8267898559570312
hsa-miR-3682-3p,ovarian carcinoma,0.8267898559570312
hsa-miR-4255,ovarian carcinoma,0.8267898559570312
hsa-miR-708-5p,solid pseudopapillary neoplasm of pancreas,0.8267831802368164
hsa-miR-20b,ovarian carcinoma,0.826779305934906
hsa-miR-4662b,ovarian carcinoma,0.826779305934906
hsa-miR-409-5p,"squamous cell breast carcinoma, acantholytic variant",0.8267762064933777
hsa-miR-4649-3p,"squamous cell breast carcinoma, acantholytic variant",0.8267762064933777
hsa-miR-3668,papillary thyroid carcinoma,0.826766848564148
hsa-miR-373-5p,diffuse large B-cell lymphoma,0.826763927936554
hsa-miR-1237,diffuse large B-cell lymphoma,0.826763927936554
hsa-let-7d-v2,diffuse large B-cell lymphoma,0.826763927936554
hsa-miR-105*,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-619-5p,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-6892-3p,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-6780a-3p,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-3664-5p,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-135-2,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-1285-5p,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-548aq-3p,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-1908-3p,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-4641,castration-resistant prostate cancer,0.8267614245414734
hsa-miR-587,miR-142-y,0.826739490032196
hsa-miR-6814-5p,miR-142-y,0.826739490032196
hsa-miR-548k,miR-142-y,0.826739490032196
hsa-miR-4767,miR-142-y,0.826739490032196
hsa-miR-517,ovarian carcinoma,0.8267328143119812
hsa-miR-621,ovarian carcinoma,0.8267328143119812
hsa-miR-3194,high grade serous papillary ovarian cancer,0.8267243504524231
hsa-miR-4299,high grade serous papillary ovarian cancer,0.8267243504524231
hsa-miR-545-5p,high grade serous papillary ovarian cancer,0.8267243504524231
hsa-miR-6877-5p,primary central nervous system lymphomas,0.8267168402671814
hsa-miR-196-1,miR-675-y,0.8267161846160889
hsa-miR-219-5p,miR-675-y,0.8267161846160889
hsa-miR-369-3p,miR-675-y,0.8267161846160889
hsa-miR-374a-3p,miR-675-y,0.8267161846160889
hsa-miR-541*,miR-675-y,0.8267161846160889
hsa-miR-33a,ovarian carcinoma,0.8266723155975342
hsa-miR-6814-5p,ovarian carcinoma,0.8266723155975342
hsa-miR-4293,ovarian carcinoma,0.8266723155975342
hsa-miR-3908,ovarian carcinoma,0.8266723155975342
hsa-miR-4312,ovarian carcinoma,0.8266723155975342
hsa-miR-145,pilocytic astrocytoma,0.8266644477844238
hsa-miR-566,Leptomeningeal metastasis,0.826662540435791
hsa-miR-4318,solid pseudopapillary neoplasm of pancreas,0.8266572952270508
hsa-miR-6811-3p,solid pseudopapillary neoplasm of pancreas,0.8266572952270508
hsa-miR-4290,high grade serous papillary ovarian cancer,0.8266530632972717
hsa-miR-801,rhabdomyosarcomas,0.8266438245773315
hsa-miR-294,rhabdomyosarcomas,0.8266438245773315
hsa-miR-31-3p,ovarian carcinoma,0.8266355991363525
hsa-miR-4787-5p,ovarian carcinoma,0.8266355991363525
hsa-miR-6755-5p,ovarian carcinoma,0.8266348838806152
hsa-miR-6836-3p,ovarian carcinoma,0.8266082406044006
hsa-miR-7154-5p,ovarian carcinoma,0.8266082406044006
hsa-miR-382-5p,ovarian carcinoma,0.8266082406044006
hsa-miR-18b-3p,ovarian carcinoma,0.8266082406044006
hsa-miR-6786-3p,ovarian carcinoma,0.8266082406044006
hsa-miR-2277-5p,ovarian carcinoma,0.8266082406044006
hsa-miR-584-3p,ovarian carcinoma,0.8266082406044006
hsa-miR-520d-3p,pilocytic astrocytoma,0.8265968561172485
hsa-miR-573,high grade serous papillary ovarian cancer,0.8265822529792786
hsa-miR-6790-3p,ovarian carcinoma,0.8265774250030518
hsa-miR-499a-5p,ovarian carcinoma,0.8265774250030518
hsa-miR-6859-5p,ovarian carcinoma,0.8265774250030518
hsa-miR-105-3p,ovarian carcinoma,0.8265774250030518
hsa-miR-1273a,ovarian carcinoma,0.8265774250030518
hsa-miR-4738-3p,ovarian carcinoma,0.8265774250030518
hsa-miR-185-5p,ovarian carcinoma,0.8265774250030518
hsa-miR-125b-5p,ovarian carcinoma,0.8265774250030518
hsa-miR-4492,ovarian carcinoma,0.8265774250030518
hsa-miR-4658,ovarian carcinoma,0.8265774250030518
hsa-miR-6753-5p,ovarian carcinoma,0.8265774250030518
hsa-miR-3654,solid pseudopapillary neoplasm of pancreas,0.8265557289123535
hsa-miR-4768-5p,high grade serous papillary ovarian cancer,0.8265452980995178
hsa-miR-6889-3p,synovial sarcoma,0.8265444040298462
hsa-miR-219-5p,synovial sarcoma,0.8265444040298462
hsa-miR-548f,synovial sarcoma,0.8265444040298462
hsa-miR-369-3p,synovial sarcoma,0.8265444040298462
hsa-miR-374a-3p,synovial sarcoma,0.8265444040298462
hsa-miR-383-5p,synovial sarcoma,0.8265444040298462
hsa-miR-4474-5p,synovial sarcoma,0.8265444040298462
hsa-miR-3140-5p,synovial sarcoma,0.8265444040298462
hsa-miR-541*,synovial sarcoma,0.8265444040298462
hsa-miR-3164,synovial sarcoma,0.8265444040298462
hsa-miR-3975,synovial sarcoma,0.8265444040298462
hsa-miR-873,ovarian carcinoma,0.8265409469604492
hsa-miR-6078,ovarian carcinoma,0.8265409469604492
hsa-miR-338-3p,ovarian carcinoma,0.8265409469604492
hsa-miR-1975,ovarian carcinoma,0.8265409469604492
hsa-miR-3676-3p,ovarian carcinoma,0.8265409469604492
hsa-miR-5708,ovarian carcinoma,0.8265409469604492
hsa-miR-141-5p,ovarian carcinoma,0.8265409469604492
hsa-miR-186,high grade serous papillary ovarian cancer,0.8265060186386108
hsa-miR-1185-5p,solid pseudopapillary neoplasm of pancreas,0.8265013694763184
hsa-miR-24-2*,solid pseudopapillary neoplasm of pancreas,0.8265013694763184
hsa-miR-6741-3p,high grade serous papillary ovarian cancer,0.8264855146408081
hsa-miR-196-1,"squamous cell breast carcinoma, acantholytic variant",0.8264797329902649
hsa-miR-5581-5p,"squamous cell breast carcinoma, acantholytic variant",0.8264797329902649
hsa-miR-670-3p,"squamous cell breast carcinoma, acantholytic variant",0.8264797329902649
hsa-miR-4450,ovarian carcinoma,0.8264753222465515
hsa-miR-214,ovarian carcinoma,0.8264710903167725
hsa-miR-4298,ovarian carcinoma,0.8264710903167725
hsa-miR-642a-5p,ovarian carcinoma,0.8264710903167725
hsa-miR-1539,ovarian carcinoma,0.8264710903167725
hsa-miR-374a-3p,ovarian carcinoma,0.8264710903167725
hsa-miR-26b*,miR-675-y,0.8264612555503845
hsa-miR-22*,miR-675-y,0.8264612555503845
hsa-miR-361-5p,pilocytic astrocytoma,0.8264520168304443
hsa-miR-665,solid pseudopapillary neoplasm of pancreas,0.826445996761322
hsa-miR-4758-3p,Leptomeningeal metastasis,0.8264424800872803
hsa-miR-6803-5p,Luminal B Her2+,0.8264281749725342
hsa-miR-4773,miR-142-y,0.8264226317405701
hsa-miR-15a*,miR-142-y,0.8264226317405701
hsa-miR-6754-3p,miR-142-y,0.8264226317405701
hsa-miR-4465,brain cancer,0.826398491859436
hsa-miR-6509-3p,brain cancer,0.826398491859436
hsa-miR-888,brain cancer,0.826398491859436
hsa-miR-609,ovarian carcinoma,0.826396107673645
hsa-miR-1266-5p,ovarian carcinoma,0.826396107673645
hsa-miR-6870-3p,ovarian carcinoma,0.826396107673645
hsa-miR-3684,ovarian carcinoma,0.826396107673645
hsa-miR-3912,ovarian carcinoma,0.826396107673645
hsa-miR-492,ovarian carcinoma,0.826396107673645
hsa-miR-4640-5p,ovarian carcinoma,0.826396107673645
hsa-miR-1255a,ovarian carcinoma,0.826396107673645
hsa-miR-6812-3p,ovarian carcinoma,0.826396107673645
hsa-miR-1291,solid pseudopapillary neoplasm of pancreas,0.8263881206512451
hsa-miR-5581-5p,"Luminal B,triple negative",0.8263723254203796
hsa-miR-383-5p,"Luminal B,triple negative",0.8263723254203796
hsa-miR-4652-3p,"Luminal B,triple negative",0.8263723254203796
hsa-miR-4474-5p,"Luminal B,triple negative",0.8263723254203796
hsa-miR-4721,"Luminal B,triple negative",0.8263723254203796
hsa-miR-6752-3p,"Luminal B,triple negative",0.8263723254203796
hsa-miR-4441,"squamous cell breast carcinoma, acantholytic variant",0.8263649940490723
hsa-miR-5004-5p,"squamous cell breast carcinoma, acantholytic variant",0.8263649940490723
hsa-miR-1288-3p,"squamous cell breast carcinoma, acantholytic variant",0.8263649940490723
hsa-miR-6722-5p,miR-675-y,0.8263586759567261
hsa-miR-7107-3p,miR-675-y,0.8263586759567261
hsa-miR-3646,high grade serous papillary ovarian cancer,0.826346218585968
hsa-miR-454*,high grade serous papillary ovarian cancer,0.826346218585968
hsa-miR-191-5p,solid pseudopapillary neoplasm of pancreas,0.8263309597969055
hsa-miR-100-5p,high grade serous papillary ovarian cancer,0.8263199925422668
hsa-miR-30c-5p,ovarian carcinoma,0.8263161778450012
hsa-miR-1206,ovarian carcinoma,0.8263161778450012
hsa-miR-5191,ovarian carcinoma,0.8263161778450012
hsa-miR-613,ovarian carcinoma,0.8263161778450012
hsa-miR-1285-3p,ovarian carcinoma,0.8263161778450012
hsa-miR-3664-3p,ovarian carcinoma,0.8263161778450012
hsa-miR-7153-3p,Luminal B Her2+,0.8263037204742432
hsa-miR-3916,solid pseudopapillary neoplasm of pancreas,0.8263012766838074
hsa-miR-873,solid pseudopapillary neoplasm of pancreas,0.8263012766838074
hsa-miR-519c-5p,solid pseudopapillary neoplasm of pancreas,0.8263012766838074
hsa-miR-1233-3p,miR-675-y,0.8262968063354492
hsa-miR-134-3p,miR-675-y,0.8262968063354492
hsa-miR-190b,miR-675-y,0.8262968063354492
hsa-miR-124-5p,miR-675-y,0.8262968063354492
hsa-miR-2116-5p,miR-675-y,0.8262968063354492
hsa-miR-4528,miR-675-y,0.8262968063354492
hsa-miR-548aq-5p,solid pseudopapillary neoplasm of pancreas,0.826270341873169
hsa-miR-631,high grade serous papillary ovarian cancer,0.8262665867805481
hsa-miR-6780a-3p,miR-142-y,0.8262503743171692
hsa-miR-6776-3p,miR-142-y,0.8262503743171692
hsa-miR-5189-3p,miR-142-y,0.8262503743171692
hsa-miR-5091,castration-resistant prostate cancer,0.8262451887130737
hsa-miR-4728-5p,castration-resistant prostate cancer,0.8262451887130737
hsa-miR-451a,castration-resistant prostate cancer,0.8262451887130737
hsa-miR-635,castration-resistant prostate cancer,0.8262451887130737
hsa-miR-411-5p,castration-resistant prostate cancer,0.8262451887130737
hsa-miR-1537-5p,castration-resistant prostate cancer,0.8262451887130737
hsa-miR-548f-3p,castration-resistant prostate cancer,0.8262451887130737
hsa-miR-1914*,diffuse large B-cell lymphoma,0.8262439966201782
hsa-miR-301a-3p,diffuse large B-cell lymphoma,0.8262439966201782
hsa-miR-3679-5p,diffuse large B-cell lymphoma,0.8262439966201782
hsa-miR-6514-3p,diffuse large B-cell lymphoma,0.8262439966201782
hsa-miR-4746-3p,diffuse large B-cell lymphoma,0.8262439966201782
hsa-miR-6133,diffuse large B-cell lymphoma,0.8262439966201782
hsa-miR-497*,solid pseudopapillary neoplasm of pancreas,0.8262358903884888
hsa-miR-5196-3p,ovarian carcinoma,0.8262231349945068
hsa-miR-138-1-3p,ovarian carcinoma,0.8262231349945068
hsa-let-7a-3,ovarian carcinoma,0.8262231349945068
hsa-miR-452-5p,ovarian carcinoma,0.8262231349945068
hsa-miR-190b,ovarian carcinoma,0.8262231349945068
hsa-miR-4533,ovarian carcinoma,0.8262231349945068
hsa-let-7a-5p,ovarian carcinoma,0.8262231349945068
hsa-miR-7113-3p,ovarian carcinoma,0.8262134790420532
hsa-miR-6842-5p,solid pseudopapillary neoplasm of pancreas,0.8262062072753906
hsa-miR-550b-3p,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-2116,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-126-3p,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-6073,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-3150a-3p,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-548at-5p,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-483-3p-1106,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-519a-5p,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-6501-5p,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-3186-5p,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-513c-3p,high grade serous papillary ovarian cancer,0.826203465461731
hsa-miR-412,miR-675-y,0.8261867761611938
hsa-miR-768-5p,miR-675-y,0.8261867761611938
hsa-miR-4680-5p,high grade serous papillary ovarian cancer,0.8261818885803223
hsa-miR-132,castration-resistant prostate cancer,0.8261798620223999
hsa-miR-511,castration-resistant prostate cancer,0.8261798620223999
hsa-miR-922,castration-resistant prostate cancer,0.8261798620223999
hsa-miR-130b-3p,castration-resistant prostate cancer,0.8261798620223999
hsa-miR-584-5p,castration-resistant prostate cancer,0.8261798620223999
hsa-miR-20a-5p,castration-resistant prostate cancer,0.8261798620223999
hsa-miR-6848-5p,castration-resistant prostate cancer,0.8261798620223999
hsa-miR-550a-3p,castration-resistant prostate cancer,0.8261798620223999
hsa-miR-3124,castration-resistant prostate cancer,0.8261798620223999
hsa-miR-6774-3p,solid pseudopapillary neoplasm of pancreas,0.8261754512786865
hsa-miR-1224-5p,pilocytic astrocytoma,0.8261744976043701
hsa-miR-616*,ovarian carcinoma,0.8261669278144836
hsa-miR-518f-3p,ovarian carcinoma,0.8261669278144836
hsa-miR-96*,ovarian carcinoma,0.8261669278144836
hsa-miR-6881-3p,ovarian carcinoma,0.8261669278144836
hsa-miR-6500-3p,ovarian carcinoma,0.8261669278144836
hsa-miR-672,ovarian carcinoma,0.8261669278144836
hsa-miR-2116,ovarian carcinoma,0.8261669278144836
hsa-miR-6883-3p,ovarian carcinoma,0.8261669278144836
hsa-miR-516b,ovarian carcinoma,0.8261669278144836
hsa-miR-4749-3p,ovarian carcinoma,0.8261669278144836
hsa-miR-548g,ovarian carcinoma,0.8261669278144836
hsa-miR-4256,ovarian carcinoma,0.8261669278144836
hsa-miR-933,ovarian carcinoma,0.8261669278144836
hsa-miR-3065-5p,ovarian carcinoma,0.8261669278144836
hsa-miR-19b-1-5p,ovarian carcinoma,0.8261669278144836
hsa-miR-5572,ovarian carcinoma,0.8261669278144836
hsa-miR-4427,ovarian carcinoma,0.8261669278144836
hsa-miR-4645-5p,high grade serous papillary ovarian cancer,0.8261513710021973
hsa-miR-4711-3p,Luminal B Her2+,0.8261401653289795
hsa-miR-520d-3p,solid pseudopapillary neoplasm of pancreas,0.8261387348175049
hsa-miR-625*,solid pseudopapillary neoplasm of pancreas,0.8261387348175049
hsa-miR-149*,high grade serous papillary ovarian cancer,0.8261196613311768
hsa-miR-192-2/3,ovarian carcinoma,0.8261183500289917
hsa-miR-585,ovarian carcinoma,0.8261183500289917
hsa-miR-6794-3p,ovarian carcinoma,0.8261183500289917
hsa-miR-329,ovarian carcinoma,0.8261183500289917
hsa-miR-671-3p,ovarian carcinoma,0.8261183500289917
hsa-miR-132-3p,ovarian carcinoma,0.8261183500289917
hsa-miR-25-5p,ovarian carcinoma,0.8261183500289917
hsa-miR-4697-5p,ovarian carcinoma,0.8261183500289917
hsa-miR-3652,ovarian carcinoma,0.8261183500289917
hsa-miR-873-5p,ovarian carcinoma,0.8261183500289917
hsa-miR-454-5p,high grade serous papillary ovarian cancer,0.8260864615440369
hsa-miR-6817-5p,high grade serous papillary ovarian cancer,0.8260864615440369
hsa-miR-6860,high grade serous papillary ovarian cancer,0.8260864615440369
hsa-miR-214,solid pseudopapillary neoplasm of pancreas,0.8260685205459595
hsa-miR-4298,solid pseudopapillary neoplasm of pancreas,0.8260685205459595
hsa-miR-219-5p,solid pseudopapillary neoplasm of pancreas,0.8260685205459595
hsa-miR-676-3p,solid pseudopapillary neoplasm of pancreas,0.8260685205459595
hsa-miR-4672,solid pseudopapillary neoplasm of pancreas,0.8260685205459595
hsa-miR-1977,high grade serous papillary ovarian cancer,0.8260517120361328
hsa-miR-1271-3p,synovial sarcoma,0.8260369896888733
hsa-miR-589,synovial sarcoma,0.8260369896888733
hsa-miR-615,synovial sarcoma,0.8260369896888733
hsa-miR-6819-5p,synovial sarcoma,0.8260369896888733
hsa-miR-6889-5p,synovial sarcoma,0.8260369896888733
hsa-miR-6749-3p,ovarian carcinoma,0.8260369896888733
hsa-miR-450,ovarian carcinoma,0.8260369896888733
hsa-miR-1224,ovarian carcinoma,0.8260369896888733
hsa-miR-4498,ovarian carcinoma,0.8260369896888733
hsa-miR-3124-3p,ovarian carcinoma,0.8260369896888733
hsa-miR-6779-5p,ovarian carcinoma,0.8260369896888733
hsa-miR-19a-3p,ovarian carcinoma,0.8260369896888733
hsa-miR-149-5p,ovarian carcinoma,0.8260369896888733
hsa-miR-378g,ovarian carcinoma,0.8260369896888733
hsa-miR-6751-5p,ovarian carcinoma,0.8260369896888733
hsa-miR-3120-3p,ovarian carcinoma,0.8260369896888733
hsa-miR-103a-2*,ovarian carcinoma,0.8260369896888733
hsa-miR-3651,ovarian carcinoma,0.8260228633880615
hsa-miR-6084,high grade serous papillary ovarian cancer,0.8260155916213989
hsa-miR-6809-5p,high grade serous papillary ovarian cancer,0.8260155916213989
hsa-miR-211-3p,high grade serous papillary ovarian cancer,0.8260155916213989
hsa-miR-6514-3p,ovarian carcinoma,0.8260052800178528
hsa-miR-520a-5p,ovarian carcinoma,0.8260052800178528
hsa-miR-3074-5p,ovarian carcinoma,0.8260052800178528
hsa-miR-4791,ovarian carcinoma,0.8260052800178528
hsa-miR-31*,ovarian carcinoma,0.8260052800178528
hsa-miR-526a,ovarian carcinoma,0.8260052800178528
hsa-miR-2052,ovarian carcinoma,0.8260052800178528
hsa-miR-4418,ovarian carcinoma,0.8260052800178528
hsa-miR-34b-5p,ovarian carcinoma,0.8260052800178528
hsa-miR-4675,ovarian carcinoma,0.8260052800178528
hsa-miR-4742-3p,solid pseudopapillary neoplasm of pancreas,0.8259936571121216
hsa-miR-766,synovial sarcoma,0.8259871006011963
hsa-miR-200a*,synovial sarcoma,0.8259871006011963
hsa-miR-4783-3p,synovial sarcoma,0.8259871006011963
hsa-miR-3912,synovial sarcoma,0.8259871006011963
hsa-miR-664a-5p,synovial sarcoma,0.8259871006011963
hsa-miR-548j-3p,synovial sarcoma,0.8259871006011963
hsa-miR-4770,synovial sarcoma,0.8259871006011963
hsa-miR-3529-5p,synovial sarcoma,0.8259871006011963
hsa-miR-4742-3p,synovial sarcoma,0.8259871006011963
hsa-miR-7853-5p,synovial sarcoma,0.8259871006011963
hsa-miR-4999-3p,synovial sarcoma,0.8259871006011963
hsa-miR-4267,high grade serous papillary ovarian cancer,0.8259778618812561
hsa-miR-3545-3p,miR-675-y,0.8259422183036804
hsa-miR-4700-3p,high grade serous papillary ovarian cancer,0.8259375095367432
hsa-miR-3161,pilocytic astrocytoma,0.8259365558624268
hsa-miR-494,pilocytic astrocytoma,0.8259233832359314
hsa-miR-361-5p,"squamous cell breast carcinoma, acantholytic variant",0.8259223103523254
hsa-miR-3912,"squamous cell breast carcinoma, acantholytic variant",0.8259223103523254
hsa-miR-340,solid pseudopapillary neoplasm of pancreas,0.8259133100509644
hsa-miR-214*,solid pseudopapillary neoplasm of pancreas,0.8259133100509644
hsa-miR-548ay-3p,solid pseudopapillary neoplasm of pancreas,0.8259133100509644
hsa-miR-4744,high grade serous papillary ovarian cancer,0.8258951306343079
hsa-miR-6891-3p,miR-675-y,0.8258874416351318
hsa-miR-4747-3p,ovarian carcinoma,0.8258804082870483
hsa-miR-452,ovarian carcinoma,0.8258804082870483
hsa-miR-222*,ovarian carcinoma,0.8258804082870483
hsa-miR-4319,ovarian carcinoma,0.8258804082870483
hsa-miR-6800-3p,ovarian carcinoma,0.8258804082870483
hsa-miR-6805-5p,ovarian carcinoma,0.8258804082870483
hsa-miR-4800-3p,ovarian carcinoma,0.8258804082870483
hsa-miR-29a-5p,ovarian carcinoma,0.8258804082870483
hsa-miR-556-3p,brain cancer,0.8258645534515381
hsa-miR-374c-3p,high grade serous papillary ovarian cancer,0.8258509039878845
hsa-miR-6721-5p,high grade serous papillary ovarian cancer,0.8258509039878845
hsa-miR-593,papillary thyroid carcinoma,0.8258403539657593
hsa-miR-6728-5p,breast cancer brain metastasis,0.8258342742919922
hsa-miR-143*,pilocytic astrocytoma,0.8258229494094849
hsa-miR-628-5p,solid pseudopapillary neoplasm of pancreas,0.8258200883865356
hsa-miR-4276,solid pseudopapillary neoplasm of pancreas,0.8258200883865356
hsa-miR-4740-5p,"Luminal B,triple negative",0.8258146643638611
hsa-miR-6816-5p,high grade serous papillary ovarian cancer,0.8258020877838135
hsa-miR-1537-5p,sarcoma,0.8257871866226196
hsa-miR-508-3p,pilocytic astrocytoma,0.8257729411125183
hsa-miR-1257,ovarian carcinoma,0.8257666230201721
hsa-miR-500b,ovarian carcinoma,0.8257666230201721
hsa-miR-3914,ovarian carcinoma,0.8257666230201721
hsa-miR-3940,ovarian carcinoma,0.8257666230201721
hsa-miR-3151-3p,ovarian carcinoma,0.8257666230201721
hsa-miR-424-3p,ovarian carcinoma,0.8257666230201721
hsa-miR-622,ovarian carcinoma,0.8257666230201721
hsa-miR-3174,ovarian carcinoma,0.8257666230201721
hsa-miR-4640-3p,ovarian carcinoma,0.8257666230201721
hsa-miR-4520b-3p,ovarian carcinoma,0.8257666230201721
hsa-miR-3681-5p,ovarian carcinoma,0.8257666230201721
hsa-miR-4684-5p,ovarian carcinoma,0.8257666230201721
hsa-miR-550-1,ovarian carcinoma,0.8257666230201721
hsa-miR-1207,solid pseudopapillary neoplasm of pancreas,0.8257665634155273
hsa-miR-369-3p,solid pseudopapillary neoplasm of pancreas,0.8257665634155273
hsa-miR-4445-3p,miR-675-y,0.8257579207420349
hsa-miR-518d-5p,miR-675-y,0.8257579207420349
hsa-miR-124,miR-675-y,0.8257579207420349
hsa-miR-1226-3p,high grade serous papillary ovarian cancer,0.8257489204406738
hsa-miR-3656,high grade serous papillary ovarian cancer,0.8257489204406738
hsa-miR-138-2-3p,miR-142-y,0.8257352709770203
hsa-miR-876-5p,miR-142-y,0.8257352709770203
hsa-miR-924,miR-142-y,0.8257352709770203
hsa-miR-129-5p,miR-142-y,0.8257352709770203
hsa-miR-1343-5p,miR-142-y,0.825732946395874
hsa-miR-2861,miR-142-y,0.825732946395874
hsa-miR-148a*,pilocytic astrocytoma,0.8257303833961487
hsa-miR-16-2*,sarcoma,0.8257217407226562
hsa-miR-130b-3p,sarcoma,0.8257217407226562
hsa-miR-584-5p,sarcoma,0.8257217407226562
hsa-miR-20a-5p,sarcoma,0.8257217407226562
hsa-miR-1909-5p,sarcoma,0.8257217407226562
hsa-miR-1b-2,ovarian carcinoma,0.8257165551185608
hsa-miR-4428,ovarian carcinoma,0.8257165551185608
hsa-miR-1281,ovarian carcinoma,0.8257165551185608
hsa-miR-4323,ovarian carcinoma,0.8257165551185608
hsa-miR-323b-5p,ovarian carcinoma,0.8257165551185608
hsa-miR-429,ovarian carcinoma,0.8257165551185608
hsa-miR-378e,ovarian carcinoma,0.8257165551185608
hsa-miR-2054,ovarian carcinoma,0.8257165551185608
hsa-miR-201,ovarian carcinoma,0.8257165551185608
hsa-miR-585,solid pseudopapillary neoplasm of pancreas,0.8257154822349548
hsa-miR-8076,solid pseudopapillary neoplasm of pancreas,0.8257154822349548
hsa-miR-524-3p,solid pseudopapillary neoplasm of pancreas,0.8257154822349548
hsa-miR-146b-3p,solid pseudopapillary neoplasm of pancreas,0.8257154822349548
hsa-miR-1228-5p,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-4449,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-10a-5p,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-3184-3p,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-1243,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-510-5p,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-676-3p,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-4474-5p,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-670-3p,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-874-5p,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-4721,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-373-3p,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-4261,castration-resistant prostate cancer,0.8257105350494385
hsa-miR-2115*,diffuse large B-cell lymphoma,0.8257096409797668
hsa-miR-4676-3p,diffuse large B-cell lymphoma,0.8257096409797668
hsa-miR-222*,diffuse large B-cell lymphoma,0.8257096409797668
hsa-miR-1913,diffuse large B-cell lymphoma,0.8257096409797668
hsa-miR-376b,rhabdomyosarcomas,0.8257094025611877
hsa-miR-548ah-5p,ovarian carcinoma,0.8257090449333191
hsa-miR-493-3p,ovarian carcinoma,0.8257090449333191
hsa-miR-155-3p,high grade serous papillary ovarian cancer,0.8256946206092834
hsa-miR-629,high grade serous papillary ovarian cancer,0.8256946206092834
hsa-miR-512-5p-1105,high grade serous papillary ovarian cancer,0.8256946206092834
hsa-miR-93*,high grade serous papillary ovarian cancer,0.8256946206092834
hsa-miR-520g-520h,high grade serous papillary ovarian cancer,0.8256946206092834
hsa-miR-3927-5p,ovarian carcinoma,0.8256739377975464
hsa-miR-3648,ovarian carcinoma,0.8256739377975464
hsa-miR-619,ovarian carcinoma,0.8256739377975464
hsa-miR-16-5p,ovarian carcinoma,0.8256739377975464
hsa-miR-5589-3p,ovarian carcinoma,0.8256739377975464
hsa-miR-30c-1*,ovarian carcinoma,0.8256739377975464
hsa-miR-3162-3p,ovarian carcinoma,0.8256739377975464
hsa-miR-3180-5p,miR-142-y,0.8256675601005554
hsa-miR-134-5p,miR-142-y,0.8256675601005554
hsa-miR-7844-5p,miR-142-y,0.8256675601005554
hsa-miR-433-3p,rhabdomyosarcomas,0.825661301612854
hsa-miR-618,high grade serous papillary ovarian cancer,0.8256385922431946
hsa-miR-363*,high grade serous papillary ovarian cancer,0.8256385922431946
hsa-miR-4737,solid pseudopapillary neoplasm of pancreas,0.8256340026855469
hsa-miR-645,solid pseudopapillary neoplasm of pancreas,0.8256340026855469
hsa-miR-2682-3p,solid pseudopapillary neoplasm of pancreas,0.8256340026855469
hsa-let-7c_c,pilocytic astrocytoma,0.825621485710144
hsa-miR-3137,miR-142-y,0.8256130218505859
hsa-miR-6782-3p,miR-142-y,0.8256130218505859
hsa-miR-1914*,solid pseudopapillary neoplasm of pancreas,0.8256020545959473
hsa-miR-548p,solid pseudopapillary neoplasm of pancreas,0.8256020545959473
hsa-miR-347,solid pseudopapillary neoplasm of pancreas,0.8256020545959473
hsa-miR-129*,ovarian carcinoma,0.82559734582901
hsa-miR-6750-5p,ovarian carcinoma,0.82559734582901
hsa-miR-6734-3p,ovarian carcinoma,0.82559734582901
hsa-miR-4452,ovarian carcinoma,0.82559734582901
hsa-miR-138-1,ovarian carcinoma,0.82559734582901
hsa-miR-23b,ovarian carcinoma,0.82559734582901
hsa-miR-4801,ovarian carcinoma,0.82559734582901
hsa-miR-3187-3p,ovarian carcinoma,0.82559734582901
hsa-miR-1293,ovarian carcinoma,0.82559734582901
hsa-miR-4692,ovarian carcinoma,0.82559734582901
hsa-miR-1288,ovarian carcinoma,0.82559734582901
hsa-miR-3192,ovarian carcinoma,0.82559734582901
hsa-miR-4481,ovarian carcinoma,0.82559734582901
hsa-miR-7111-5p,ovarian carcinoma,0.82559734582901
hsa-miR-1914-3p,ovarian carcinoma,0.82559734582901
hsa-miR-449c-3p,ovarian carcinoma,0.82559734582901
hsa-miR-3945,ovarian carcinoma,0.825587272644043
hsa-miR-4681,ovarian carcinoma,0.825587272644043
hsa-miR-4746-5p,ovarian carcinoma,0.825587272644043
hsa-miR-550,ovarian carcinoma,0.825587272644043
hsa-let-7a-2-3p,ovarian carcinoma,0.825587272644043
hsa-miR-29b-2-5p,ovarian carcinoma,0.825587272644043
hsa-miR-675-5p,ovarian carcinoma,0.825587272644043
hsa-miR-185*,ovarian carcinoma,0.825587272644043
hsa-miR-4717-5p,ovarian carcinoma,0.825587272644043
hsa-miR-3674,ovarian carcinoma,0.825587272644043
hsa-miR-3929,high grade serous papillary ovarian cancer,0.8255805969238281
hsa-miR-3619-3p,miR-675-y,0.8255738615989685
hsa-miR-4697-5p,miR-675-y,0.8255738615989685
hsa-miRPlus-C1099,ovarian carcinoma,0.8255652189254761
hsa-miR-548ah-3p,ovarian carcinoma,0.8255652189254761
hsa-miR-7111-3p,ovarian carcinoma,0.8255652189254761
hsa-miR-130b*,ovarian carcinoma,0.8255652189254761
hsa-miR-292-5p,ovarian carcinoma,0.8255652189254761
hsa-miR-4736,ovarian carcinoma,0.8255652189254761
hsa-miR-4436b-5p,ovarian carcinoma,0.8255652189254761
hsa-miR-130a*,ovarian carcinoma,0.8255652189254761
hsa-miR-516a-5p,ovarian carcinoma,0.8255652189254761
hsa-miR-1296,ovarian carcinoma,0.8255652189254761
hsa-miR-3907,ovarian carcinoma,0.8255652189254761
hsa-miR-1285-2,ovarian carcinoma,0.8255652189254761
hsa-miR-545*,ovarian carcinoma,0.8255652189254761
hsa-miR-425,ovarian carcinoma,0.8255652189254761
hsa-miR-6795-5p,ovarian carcinoma,0.8255652189254761
hsa-miR-3607-5p,primary central nervous system lymphomas,0.8255650997161865
hsa-miR-668-3p,high grade serous papillary ovarian cancer,0.8255385160446167
hsa-miR-4330,high grade serous papillary ovarian cancer,0.8255385160446167
hsa-miR-301b-5p,high grade serous papillary ovarian cancer,0.8255385160446167
hsa-miR-1587,high grade serous papillary ovarian cancer,0.8255385160446167
hsa-miR-4716-5p,high grade serous papillary ovarian cancer,0.8255385160446167
hsa-miR-621,high grade serous papillary ovarian cancer,0.8255231380462646
hsa-miR-145-3p,high grade serous papillary ovarian cancer,0.8255231380462646
hsa-miR-1287-3p,high grade serous papillary ovarian cancer,0.8255231380462646
hsa-miR-6784-3p,high grade serous papillary ovarian cancer,0.8255231380462646
hsa-miR-6514-5p,high grade serous papillary ovarian cancer,0.8255231380462646
hsa-miR-4713-5p,high grade serous papillary ovarian cancer,0.8255231380462646
hsa-miR-128,high grade serous papillary ovarian cancer,0.8255231380462646
hsa-miR-4446-3p,rhabdomyosarcomas,0.8255099654197693
hsa-miR-6741-3p,rhabdomyosarcomas,0.8255099654197693
hsa-miR-8065,Luminal B Her2+,0.8254901766777039
hsa-miR-5686,miR-142-y,0.8254856467247009
hsa-miR-1199-5p,ovarian carcinoma,0.825478732585907
hsa-miR-8081,ovarian carcinoma,0.825478732585907
hsa-miR-6124,follicular thyroid carcinoma,0.8254771828651428
hsa-miR-325,solid pseudopapillary neoplasm of pancreas,0.8254770040512085
hsa-miR-626,solid pseudopapillary neoplasm of pancreas,0.8254770040512085
hsa-miR-3160-5p,solid pseudopapillary neoplasm of pancreas,0.8254770040512085
hsa-miR-196a-1,ovarian carcinoma,0.8254741430282593
hsa-miR-1301-5p,ovarian carcinoma,0.8254741430282593
hsa-miR-548aq-5p,high grade serous papillary ovarian cancer,0.8254626989364624
hsa-miR-33a,high grade serous papillary ovarian cancer,0.8254626989364624
hsa-miR-99a-3p,high grade serous papillary ovarian cancer,0.8254626989364624
hsa-miR-517b-3p,high grade serous papillary ovarian cancer,0.8254626989364624
hsa-miR-517c,high grade serous papillary ovarian cancer,0.8253980875015259
hsa-miR-1229-5p,high grade serous papillary ovarian cancer,0.8253980875015259
hsa-miR-4524a-5p,synovial sarcoma,0.8253809809684753
hsa-miR-6802-3p,synovial sarcoma,0.8253809809684753
hsa-miR-30c-5p,synovial sarcoma,0.8253809809684753
hsa-miR-4275,synovial sarcoma,0.8253809809684753
hsa-miR-320b-1,synovial sarcoma,0.8253809809684753
hsa-miR-548ac,synovial sarcoma,0.8253809809684753
hsa-miR-6737-3p,synovial sarcoma,0.8253809809684753
hsa-miR-4710,synovial sarcoma,0.8253809809684753
hsa-miR-1203,miR-675-y,0.8253744840621948
hsa-miR-1-1,miR-675-y,0.8253744840621948
hsa-miR-1974,miR-675-y,0.8253744840621948
hsa-miR-762,miR-675-y,0.8253744840621948
hsa-miR-550,miR-675-y,0.8253744840621948
hsa-let-7a-2-3p,miR-675-y,0.8253744840621948
hsa-miR-620,miR-675-y,0.8253744840621948
hsa-miR-3940-5p,miR-675-y,0.8253744840621948
hsa-miR-6865-3p,miR-675-y,0.8253744840621948
hsa-miR-5007-3p,rhabdomyosarcomas,0.8253699541091919
hsa-miR-4433-5p,high grade serous papillary ovarian cancer,0.8253669738769531
hsa-miR-6752-5p,high grade serous papillary ovarian cancer,0.8253669738769531
hsa-miR-18b,high grade serous papillary ovarian cancer,0.8253669738769531
hsa-miR-4708-3p,high grade serous papillary ovarian cancer,0.8253669738769531
hsa-miR-6771-3p,high grade serous papillary ovarian cancer,0.8253669738769531
hsa-miR-26a-2,high grade serous papillary ovarian cancer,0.8253669738769531
hsa-miR-548o-3p,high grade serous papillary ovarian cancer,0.8253669738769531
hsa-miR-1257,solid pseudopapillary neoplasm of pancreas,0.8253631591796875
hsa-miR-122,solid pseudopapillary neoplasm of pancreas,0.8253631591796875
hsa-miR-3151-3p,solid pseudopapillary neoplasm of pancreas,0.8253631591796875
hsa-miR-1305,solid pseudopapillary neoplasm of pancreas,0.8253631591796875
hsa-miR-3155a,solid pseudopapillary neoplasm of pancreas,0.8253631591796875
hsa-miR-196a-5p,Leptomeningeal metastasis,0.825363039970398
hsa-miR-3927-3p,rhabdomyosarcomas,0.8253604769706726
hsa-miR-199a*,rhabdomyosarcomas,0.8253604769706726
hsa-miR-610,rhabdomyosarcomas,0.8253604769706726
hsa-miR-3609,ovarian carcinoma,0.8253563046455383
hsa-miR-125a-5p,ovarian carcinoma,0.8253563046455383
hsa-miR-6817-5p,miR-142-y,0.8253528475761414
hsa-miR-518d-3p,miR-142-y,0.8253528475761414
hsa-miR-551b-3p,miR-142-y,0.8253528475761414
hsa-miR-199a-5p,synovial sarcoma,0.8253468871116638
hsa-miR-522*,synovial sarcoma,0.8253468871116638
hsa-miR-6824-5p,synovial sarcoma,0.8253468871116638
hsa-miR-23a-3p,synovial sarcoma,0.8253468871116638
hsa-miR-6515-5p,synovial sarcoma,0.8253468871116638
hsa-miR-4793-3p,synovial sarcoma,0.8253468871116638
hsa-miR-548j-5p,synovial sarcoma,0.8253468871116638
hsa-miR-4274,synovial sarcoma,0.8253468871116638
hsa-miR-181d,synovial sarcoma,0.8253468871116638
hsa-miR-509-3-5p,synovial sarcoma,0.8253468871116638
hsa-miR-96-5p,synovial sarcoma,0.8253468871116638
hsa-miR-338-3p,high grade serous papillary ovarian cancer,0.8253303170204163
hsa-miR-30c-1-3p,high grade serous papillary ovarian cancer,0.8253303170204163
hsa-miR-140-5p,high grade serous papillary ovarian cancer,0.8253303170204163
hsa-miR-4728-5p,high grade serous papillary ovarian cancer,0.8253303170204163
hsa-miR-124*,high grade serous papillary ovarian cancer,0.8253303170204163
hsa-miR-519c-5p,high grade serous papillary ovarian cancer,0.8253303170204163
hsa-miR-892c-3p,high grade serous papillary ovarian cancer,0.8253303170204163
hsa-miR-6851-3p,brain cancer,0.8253192901611328
hsa-miR-3911,rhabdomyosarcomas,0.8253165483474731
hsa-miR-769-3p,"squamous cell breast carcinoma, acantholytic variant",0.8253161311149597
hsa-miR-4804-3p,"squamous cell breast carcinoma, acantholytic variant",0.8253161311149597
hsa-miR-514b-5p,"squamous cell breast carcinoma, acantholytic variant",0.8253161311149597
hsa-miR-4433a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8253161311149597
hsa-miR-3978,"squamous cell breast carcinoma, acantholytic variant",0.8253161311149597
hsa-miR-1b-2,solid pseudopapillary neoplasm of pancreas,0.8253127932548523
hsa-miR-4509,solid pseudopapillary neoplasm of pancreas,0.8253127932548523
hsa-miR-6873-5p,primary central nervous system lymphomas,0.8252919316291809
hsa-miR-596,rhabdomyosarcomas,0.8252901434898376
hsa-miR-4470,miR-675-y,0.8252871632575989
hsa-miR-519e-3p,miR-675-y,0.8252871632575989
hsa-miR-1914*,miR-675-y,0.8252871632575989
hsa-miR-4791,miR-675-y,0.8252871632575989
hsa-miR-1234-5p,miR-675-y,0.8252871632575989
hsa-miR-5096,miR-675-y,0.8252871632575989
hsa-miR-5001-5p,miR-675-y,0.8252871632575989
hsa-let-7g*,miR-675-y,0.8252871632575989
hsa-miR-181c-5p,ovarian carcinoma,0.8252845406532288
hsa-miR-6883-5p,ovarian carcinoma,0.8252845406532288
hsa-let-7d*,aryngeal squamous cell carcinoma,0.8252794146537781
hsa-miR-2355-3p,aryngeal squamous cell carcinoma,0.8252794146537781
hsa-miR-376a-3p,aryngeal squamous cell carcinoma,0.8252794146537781
hsa-miR-378j,solid pseudopapillary neoplasm of pancreas,0.8252701759338379
hsa-miR-3917,solid pseudopapillary neoplasm of pancreas,0.8252701759338379
hsa-miR-432,solid pseudopapillary neoplasm of pancreas,0.8252701759338379
hsa-miR-194,solid pseudopapillary neoplasm of pancreas,0.8252701759338379
hsa-miR-432-3p,solid pseudopapillary neoplasm of pancreas,0.8252701759338379
hsa-miR-132-5p,solid pseudopapillary neoplasm of pancreas,0.8252701759338379
hsa-miR-889-3p,solid pseudopapillary neoplasm of pancreas,0.8252701759338379
hsa-miR-6862-3p,solid pseudopapillary neoplasm of pancreas,0.8252701759338379
hsa-miR-642a-5p,high grade serous papillary ovarian cancer,0.8252601027488708
hsa-miR-4315,high grade serous papillary ovarian cancer,0.8252601027488708
hsa-miR-139-3p,high grade serous papillary ovarian cancer,0.8252601027488708
hsa-miR-1539,high grade serous papillary ovarian cancer,0.8252601027488708
hsa-miR-3671,high grade serous papillary ovarian cancer,0.8252601027488708
hsa-miR-541*,high grade serous papillary ovarian cancer,0.8252601027488708
hsa-miR-371b-5p,high grade serous papillary ovarian cancer,0.8252601027488708
hsa-miR-383-5p,sarcoma,0.8252514004707336
hsa-let-7g-3p,sarcoma,0.8252514004707336
hsa-miR-3679-5p,miR-675-y,0.8252356052398682
hsa-miR-6831-3p,miR-675-y,0.8252356052398682
hsa-miR-374a-5p,miR-675-y,0.8252356052398682
hsa-miR-4707-5p,miR-675-y,0.8252356052398682
hsa-miR-183,miR-675-y,0.8252356052398682
hsa-miR-124-3p,miR-675-y,0.8252356052398682
hsa-miR-516,miR-675-y,0.8252356052398682
hsa-miR-3612,miR-675-y,0.8252356052398682
hsa-let-7a-2*,rhabdomyosarcomas,0.8252347111701965
hsa-miR-149*,ovarian carcinoma,0.8252288699150085
hsa-miR-8052,rhabdomyosarcomas,0.8252267241477966
hsa-miR-144*,rhabdomyosarcomas,0.8252130746841431
hsa-miR-6881-3p,brain cancer,0.8252087831497192
hsa-miR-3615,"Luminal B,triple negative",0.8252080678939819
hsa-miR-520e,"Luminal B,triple negative",0.8252080678939819
hsa-miR-585-3p,solid pseudopapillary neoplasm of pancreas,0.8252074718475342
hsa-miR-4772-3p,rhabdomyosarcomas,0.8252049088478088
hsa-miR-138-2-3p,rhabdomyosarcomas,0.8252049088478088
hsa-miR-30c-2*,rhabdomyosarcomas,0.8252049088478088
hsa-miR-670-3p,miR-142-y,0.8251971006393433
hsa-miR-637,solid pseudopapillary neoplasm of pancreas,0.825193464756012
hsa-miR-6512-5p,solid pseudopapillary neoplasm of pancreas,0.825193464756012
hsa-miR-6736-3p,high grade serous papillary ovarian cancer,0.8251845836639404
hsa-miR-218-2,high grade serous papillary ovarian cancer,0.8251845836639404
hsa-miR-4534,high grade serous papillary ovarian cancer,0.8251845836639404
hsa-miR-4640-5p,high grade serous papillary ovarian cancer,0.8251845836639404
hsa-miR-128-3p,high grade serous papillary ovarian cancer,0.8251845836639404
hsa-miR-664a-5p,high grade serous papillary ovarian cancer,0.8251845836639404
hsa-miR-7846-3p,high grade serous papillary ovarian cancer,0.8251845836639404
hsa-miR-3529-5p,high grade serous papillary ovarian cancer,0.8251845836639404
hsa-miR-6513-3p,solid pseudopapillary neoplasm of pancreas,0.8251832127571106
hsa-miR-4746-5p,solid pseudopapillary neoplasm of pancreas,0.8251832127571106
hsa-miR-548ab,rhabdomyosarcomas,0.8251742124557495
hsa-miR-7845-5p,rhabdomyosarcomas,0.8251742124557495
hsa-miR-625,papillary thyroid carcinoma,0.8251657485961914
hsa-miR-1257,diffuse large B-cell lymphoma,0.825164258480072
hsa-miR-7109-3p,diffuse large B-cell lymphoma,0.825164258480072
hsa-miR-200c,diffuse large B-cell lymphoma,0.825164258480072
hsa-miR-4762-5p,solid pseudopapillary neoplasm of pancreas,0.8251611590385437
hsa-miR-377-5p,solid pseudopapillary neoplasm of pancreas,0.8251611590385437
hsa-miR-609,castration-resistant prostate cancer,0.825151264667511
hsa-miR-361-5p,castration-resistant prostate cancer,0.825151264667511
hsa-miR-7161-3p,castration-resistant prostate cancer,0.825151264667511
hsa-miR-6736-3p,castration-resistant prostate cancer,0.825151264667511
hsa-miR-6749-5p,castration-resistant prostate cancer,0.825151264667511
hsa-let-7f-2-3p,castration-resistant prostate cancer,0.825151264667511
hsa-miR-196b,castration-resistant prostate cancer,0.825151264667511
hsa-miR-585-3p,castration-resistant prostate cancer,0.825151264667511
hsa-miR-4443,castration-resistant prostate cancer,0.825151264667511
hsa-miR-7846-3p,castration-resistant prostate cancer,0.825151264667511
hsa-miR-539-5p,castration-resistant prostate cancer,0.825151264667511
hsa-miR-26a-5p,castration-resistant prostate cancer,0.825151264667511
hsa-miR-3614-5p,high grade serous papillary ovarian cancer,0.825141966342926
hsa-miR-4661-5p,high grade serous papillary ovarian cancer,0.825141966342926
hsa-miR-92a,high grade serous papillary ovarian cancer,0.825141966342926
hsa-miR-499-5p,high grade serous papillary ovarian cancer,0.825141966342926
hsa-miR-3064-3p,high grade serous papillary ovarian cancer,0.825141966342926
hsa-miR-5682,high grade serous papillary ovarian cancer,0.825141966342926
hsa-miR-3653,high grade serous papillary ovarian cancer,0.8251042366027832
hsa-miR-4659a-5p,high grade serous papillary ovarian cancer,0.8251042366027832
hsa-miR-548ac,high grade serous papillary ovarian cancer,0.8251042366027832
hsa-miR-3664-3p,high grade serous papillary ovarian cancer,0.8251042366027832
hsa-miR-454-5p,ovarian carcinoma,0.8250958323478699
hsa-miR-4295,ovarian carcinoma,0.8250958323478699
hsa-miR-340-5p,ovarian carcinoma,0.8250958323478699
hsa-miR-3688-3p,ovarian carcinoma,0.8250877857208252
hsa-miR-489,ovarian carcinoma,0.8250877857208252
hsa-miR-5009-3p,ovarian carcinoma,0.8250877857208252
hsa-miR-451,rhabdomyosarcomas,0.8250741958618164
hsa-miR-516-3p,diffuse large B-cell lymphoma,0.8250535130500793
hsa-miR-4796-3p,diffuse large B-cell lymphoma,0.8250535130500793
hsa-miR-940,diffuse large B-cell lymphoma,0.8250535130500793
hsa-miR-4747-3p,miR-675-y,0.8250324130058289
hsa-miR-466,miR-675-y,0.8250324130058289
hsa-miR-598,miR-675-y,0.8250324130058289
hsa-miR-199b-3p,miR-675-y,0.8250324130058289
hsa-miR-1252-3p,miR-675-y,0.8250324130058289
hsa-miR-212-5p,rhabdomyosarcomas,0.8250173926353455
hsa-miR-1225,rhabdomyosarcomas,0.8250173926353455
hsa-miR-290,high grade serous papillary ovarian cancer,0.8250107765197754
hsa-miR-4651,high grade serous papillary ovarian cancer,0.8250107765197754
hsa-miR-1304,high grade serous papillary ovarian cancer,0.8250107765197754
hsa-miR-944,high grade serous papillary ovarian cancer,0.8250107765197754
hsa-miR-190b,high grade serous papillary ovarian cancer,0.8250107765197754
hsa-miR-6876-3p,high grade serous papillary ovarian cancer,0.8250107765197754
hsa-let-7a-5p,high grade serous papillary ovarian cancer,0.8250107765197754
hsa-miR-519d-3p,high grade serous papillary ovarian cancer,0.8250107765197754
hsa-miR-4700-5p,rhabdomyosarcomas,0.8250000476837158
hsa-miR-627,rhabdomyosarcomas,0.8250000476837158
hsa-miR-5186,Leptomeningeal metastasis,0.8249878883361816
hsa-miR-106a*,ovarian carcinoma,0.8249568939208984
hsa-miR-657,ovarian carcinoma,0.8249420523643494
hsa-miR-6780b-5p,ovarian carcinoma,0.8249420523643494
hsa-miR-218-1-3p,ovarian carcinoma,0.8249420523643494
hsa-miR-30b-3p,ovarian carcinoma,0.8249420523643494
hsa-miR-4788,ovarian carcinoma,0.8249420523643494
hsa-miR-509-3,ovarian carcinoma,0.8249420523643494
hsa-miR-374b-3p,breast cancer brain metastasis,0.8249278664588928
hsa-miR-302f,miR-142-y,0.8249141573905945
hsa-miR-4445-3p,high grade serous papillary ovarian cancer,0.8249053955078125
hsa-miR-25-5p,high grade serous papillary ovarian cancer,0.8249053955078125
hsa-miR-146b-3p,high grade serous papillary ovarian cancer,0.8249053955078125
hsa-miR-3928-5p,high grade serous papillary ovarian cancer,0.8249053955078125
hsa-miR-1254,ovarian carcinoma,0.8248831629753113
hsa-miR-674,ovarian carcinoma,0.8248831629753113
hsa-miR-377,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-200a-5p,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-8055,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-423-5p_2,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-589,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-519b-5p,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-449b*,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-6744-3p,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-6889-5p,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-6757-5p,castration-resistant prostate cancer,0.8248802423477173
hsa-miR-676-5p,high grade serous papillary ovarian cancer,0.8248236179351807
hsa-miR-887-3p,high grade serous papillary ovarian cancer,0.8248236179351807
hsa-miR-4703-5p,high grade serous papillary ovarian cancer,0.8248236179351807
hsa-miR-3936,high grade serous papillary ovarian cancer,0.8248236179351807
hsa-miR-335-3p,high grade serous papillary ovarian cancer,0.8248236179351807
hsa-miR-8085,high grade serous papillary ovarian cancer,0.8248236179351807
hsa-miR-200c*,high grade serous papillary ovarian cancer,0.8248236179351807
hsa-miR-3667-5p,high grade serous papillary ovarian cancer,0.8248236179351807
hsa-miR-3120-3p,high grade serous papillary ovarian cancer,0.8248236179351807
hsa-miR-3064-5p,ovarian carcinoma,0.8248103857040405
hsa-miR-6514-3p,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-526a,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-3678-5p,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-2052,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-4746-3p,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-4418,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-372-3p,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-6815-3p,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-124-3p,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-1178-3p,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-516,high grade serous papillary ovarian cancer,0.8247914910316467
hsa-miR-3606-3p,miR-675-y,0.8247894048690796
hsa-miR-3157-3p,miR-675-y,0.8247894048690796
hsa-miR-99b*,miR-675-y,0.8247894048690796
hsa-miR-3680-5p,miR-675-y,0.8247894048690796
hsa-miR-200c,miR-675-y,0.8247894048690796
hsa-miR-3155a,miR-675-y,0.8247894048690796
hsa-miR-4704-3p,miR-675-y,0.8247894048690796
hsa-miR-291-5p,primary central nervous system lymphomas,0.8247867822647095
hsa-miR-548ay-5p,synovial sarcoma,0.8247743844985962
hsa-miR-3074,synovial sarcoma,0.8247743844985962
hsa-miR-5701,synovial sarcoma,0.8247743844985962
hsa-miR-290,synovial sarcoma,0.8247743844985962
hsa-miR-381,synovial sarcoma,0.8247743844985962
hsa-miR-4525,synovial sarcoma,0.8247743844985962
hsa-miR-548i-1,synovial sarcoma,0.8247743844985962
hsa-miRPlus-A1087,synovial sarcoma,0.8247743844985962
hsa-miR-6867-5p,synovial sarcoma,0.8247743844985962
hsa-let-7a-5p,synovial sarcoma,0.8247743844985962
hsa-miR-760,rhabdomyosarcomas,0.8247701525688171
hsa-miR-199a-2,rhabdomyosarcomas,0.8247701525688171
hsa-miR-199a*-2,aryngeal squamous cell carcinoma,0.8247687220573425
hsa-miR-34b*,aryngeal squamous cell carcinoma,0.8247687220573425
hsa-miR-220a,aryngeal squamous cell carcinoma,0.8247687220573425
hsa-miR-323-3p,miR-142-y,0.8247530460357666
hsa-miR-190a,miR-675-y,0.8247280716896057
hsa-miR-200b*,miR-675-y,0.8247280716896057
hsa-miR-16-1-3p,miR-675-y,0.8247280716896057
hsa-miR-30a-5p,miR-675-y,0.8247280716896057
hsa-miR-4304,miR-675-y,0.8247280716896057
hsa-miR-7-1,miR-675-y,0.8247280716896057
hsa-miR-5698,miR-675-y,0.8247280716896057
hsa-miR-3935,miR-675-y,0.8247280716896057
hsa-miR-1266-3p,rhabdomyosarcomas,0.8247154355049133
hsa-miR-661,rhabdomyosarcomas,0.8247154355049133
hsa-miR-486,rhabdomyosarcomas,0.8247154355049133
hsa-miR-4723-3p,rhabdomyosarcomas,0.8247154355049133
hsa-miR-215,rhabdomyosarcomas,0.8247154355049133
hsa-miR-5196-3p,"squamous cell breast carcinoma, acantholytic variant",0.8247092962265015
hsa-miR-381,"squamous cell breast carcinoma, acantholytic variant",0.8247092962265015
hsa-miR-4276,"squamous cell breast carcinoma, acantholytic variant",0.8247092962265015
hsa-miR-548i-1,"squamous cell breast carcinoma, acantholytic variant",0.8247092962265015
hsa-miR-190b,"squamous cell breast carcinoma, acantholytic variant",0.8247092962265015
hsa-miR-3960,"squamous cell breast carcinoma, acantholytic variant",0.8247092962265015
hsa-let-7a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8247092962265015
hsa-miR-766-5p,"squamous cell breast carcinoma, acantholytic variant",0.8247092962265015
hsa-miR-199b-5p,breast cancer brain metastasis,0.8247026205062866
hsa-miR-4676-3p,miR-675-y,0.824698805809021
hsa-miR-22,miR-675-y,0.824698805809021
hsa-miR-1307,miR-675-y,0.824698805809021
hsa-let-7i-3p,miR-675-y,0.824698805809021
hsa-miR-139-5p,miR-675-y,0.824698805809021
hsa-miR-4800-3p,miR-675-y,0.824698805809021
hsa-miR-1266-5p,sarcoma,0.8246909379959106
hsa-miR-128-3p,sarcoma,0.8246909379959106
hsa-miR-548j-3p,sarcoma,0.8246909379959106
hsa-miR-675,miR-142-y,0.824687123298645
hsa-miR-3189,miR-142-y,0.824687123298645
hsa-miR-1273a,miR-142-y,0.824687123298645
hsa-miR-1910-3p,miR-142-y,0.824687123298645
hsa-miR-3675-3p,miR-142-y,0.824687123298645
hsa-miR-3124-5p,high grade serous papillary ovarian cancer,0.8246662616729736
hsa-miR-218-1,high grade serous papillary ovarian cancer,0.8246662616729736
hsa-miR-222*,high grade serous papillary ovarian cancer,0.8246662616729736
hsa-miR-514b-3p,high grade serous papillary ovarian cancer,0.8246662616729736
hsa-miR-6732-5p,rhabdomyosarcomas,0.8246596455574036
hsa-miR-518a-5p,rhabdomyosarcomas,0.8246596455574036
hsa-miR-627,ovarian carcinoma,0.82465660572052
hsa-miR-890,ovarian carcinoma,0.82465660572052
hsa-miR-6791-5p,ovarian carcinoma,0.82465660572052
hsa-miR-549,miR-142-y,0.8246365785598755
hsa-miR-664a-5p,miR-142-y,0.8246365785598755
hsa-miR-4999-3p,miR-142-y,0.8246365785598755
hsa-miR-29b-3p,diffuse large B-cell lymphoma,0.8246357440948486
hsa-miR-4303,rhabdomyosarcomas,0.8246011137962341
hsa-miR-134-3p,"Luminal B,triple negative",0.824600875377655
hsa-miR-766-5p,"Luminal B,triple negative",0.824600875377655
hsa-miR-802,solid pseudopapillary neoplasm of pancreas,0.8245992660522461
hsa-miR-4724-5p,miR-142-y,0.8245843648910522
hsa-miR-651-3p,miR-675-y,0.824577808380127
hsa-miR-122a,miR-675-y,0.824577808380127
hsa-miR-4699-5p,miR-675-y,0.824577808380127
hsa-miR-491-5p,miR-675-y,0.824577808380127
hsa-miR-300,miR-675-y,0.824577808380127
hsa-miR-352,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-622,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-4703-3p,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-34a*,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-4640-3p,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-1305,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-3178,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-520c,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-3912-3p,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-4512,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-7704,high grade serous papillary ovarian cancer,0.8245518803596497
hsa-miR-517,rhabdomyosarcomas,0.8245434165000916
hsa-miR-4524a-5p,castration-resistant prostate cancer,0.8245429396629333
hsa-let-7b_c,castration-resistant prostate cancer,0.8245429396629333
hsa-miR-4659a-5p,castration-resistant prostate cancer,0.8245429396629333
hsa-miR-30c-5p,castration-resistant prostate cancer,0.8245429396629333
hsa-miR-4804-3p,castration-resistant prostate cancer,0.8245429396629333
hsa-miR-1206,castration-resistant prostate cancer,0.8245429396629333
hsa-miR-221-5p,castration-resistant prostate cancer,0.8245429396629333
hsa-miR-4657,castration-resistant prostate cancer,0.8245429396629333
hsa-miR-4649-5p,castration-resistant prostate cancer,0.8245429396629333
hsa-miR-4661-5p,testicular cancer,0.8245140910148621
hsa-miR-1231,solid pseudopapillary neoplasm of pancreas,0.8245033025741577
hsa-miR-99,solid pseudopapillary neoplasm of pancreas,0.8245033025741577
hsa-miR-4634,solid pseudopapillary neoplasm of pancreas,0.8245033025741577
hsa-miR-105-1,solid pseudopapillary neoplasm of pancreas,0.8245033025741577
hsa-miR-4480,solid pseudopapillary neoplasm of pancreas,0.8245033025741577
hsa-miR-455-5p,miR-675-y,0.8245017528533936
hsa-miR-6839-3p,miR-675-y,0.8245017528533936
hsa-miR-4428,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-5585-3p,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-223-5p,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-3622a-3p,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-215-3p,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-4493,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-5188,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-6788-5p,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-3913-5p,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-7159-3p,high grade serous papillary ovarian cancer,0.8245015144348145
hsa-miR-3155,ovarian carcinoma,0.8244954347610474
hsa-miR-200c-5p,rhabdomyosarcomas,0.8244826197624207
hsa-miR-603,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-1246,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-3202,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-3605-5p,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-194,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-4699-5p,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-578,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-491-5p,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-4735-3p,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-3166,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-6758-3p,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-548t,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-2681-5p,high grade serous papillary ovarian cancer,0.8244588375091553
hsa-miR-3129-3p,ovarian carcinoma,0.824447751045227
hsa-miR-4716-3p,papillary thyroid carcinoma,0.8244438171386719
hsa-miR-675,ovarian carcinoma,0.8244293332099915
hsa-miR-8069,ovarian carcinoma,0.8244293332099915
hsa-miR-220b,ovarian carcinoma,0.8244293332099915
hsa-miR-3134,ovarian carcinoma,0.8244293332099915
hsa-miR-518f,ovarian carcinoma,0.8244293332099915
hsa-miR-4774-3p,ovarian carcinoma,0.8244293332099915
hsa-miR-371-3p,ovarian carcinoma,0.8244293332099915
hsa-miR-129-3p,ovarian carcinoma,0.8244293332099915
hsa-let-7i*,ovarian carcinoma,0.8244293332099915
hsa-miR-3607-3p,ovarian carcinoma,0.8244293332099915
hsa-miR-6729-5p,ovarian carcinoma,0.8244293332099915
hsa-miR-106a-5p,ovarian carcinoma,0.8244293332099915
hsa-miR-126-5p,rhabdomyosarcomas,0.8244180083274841
hsa-miR-6836-3p,rhabdomyosarcomas,0.8244180083274841
hsa-miR-6076,rhabdomyosarcomas,0.8244180083274841
hsa-miR-551b*,rhabdomyosarcomas,0.8244180083274841
hsa-miR-4688,rhabdomyosarcomas,0.8244180083274841
hsa-miR-302d-5p,synovial sarcoma,0.8244174122810364
hsa-miR-3169,synovial sarcoma,0.8244174122810364
hsa-miR-6505-5p,synovial sarcoma,0.8244174122810364
hsa-miR-4301,synovial sarcoma,0.8244174122810364
hsa-miR-6868-3p,synovial sarcoma,0.8244174122810364
hsa-miR-6845-5p,synovial sarcoma,0.8244174122810364
hsa-miR-340-3p,miR-142-y,0.8244054913520813
hsa-miR-4318,miR-142-y,0.8244054913520813
hsa-miR-4768-3p,miR-142-y,0.8244054913520813
hsa-miR-1279,miR-142-y,0.8244054913520813
hsa-miR-520b-520c,miR-142-y,0.8244054913520813
hsa-miR-499a-5p,rhabdomyosarcomas,0.8243866562843323
hsa-miR-26a-2*,rhabdomyosarcomas,0.8243866562843323
hsa-miR-584,rhabdomyosarcomas,0.8243866562843323
hsa-miR-376c,high grade serous papillary ovarian cancer,0.8243815898895264
hsa-miR-3191-5p,high grade serous papillary ovarian cancer,0.8243815898895264
hsa-miR-4755-5p,high grade serous papillary ovarian cancer,0.8243815898895264
hsa-miR-5092,high grade serous papillary ovarian cancer,0.8243815898895264
hsa-miR-891a-3p,high grade serous papillary ovarian cancer,0.8243815898895264
hsa-miR-624-5p,high grade serous papillary ovarian cancer,0.8243815898895264
hsa-miR-4660,high grade serous papillary ovarian cancer,0.8243815898895264
hsa-miR-4457,high grade serous papillary ovarian cancer,0.8243815898895264
hsa-miR-27b-5p,high grade serous papillary ovarian cancer,0.8243815898895264
hsa-miR-6879-5p,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-3663-3p,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-3181,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-620,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-203a-5p,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-4485-3p,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-494-3p,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-542,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-877*,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-768,high grade serous papillary ovarian cancer,0.8243715763092041
hsa-miR-1267,"squamous cell breast carcinoma, acantholytic variant",0.8243522047996521
hsa-miR-294,"squamous cell breast carcinoma, acantholytic variant",0.8243522047996521
hsa-miR-941,"squamous cell breast carcinoma, acantholytic variant",0.8243522047996521
hsa-miR-202-5p,"squamous cell breast carcinoma, acantholytic variant",0.8243522047996521
hsa-miR-324-5p,"squamous cell breast carcinoma, acantholytic variant",0.8243522047996521
hsa-miR-412-5p,"squamous cell breast carcinoma, acantholytic variant",0.8243522047996521
hsa-miR-548d-5p,rhabdomyosarcomas,0.8243497610092163
hsa-miR-141-5p,rhabdomyosarcomas,0.8243497610092163
hsa-miR-6785-5p,high grade serous papillary ovarian cancer,0.8243492841720581
hsa-miR-379,high grade serous papillary ovarian cancer,0.8243492841720581
hsa-miR-4487,high grade serous papillary ovarian cancer,0.8243492841720581
hsa-let-7c*,high grade serous papillary ovarian cancer,0.8243492841720581
hsa-miR-190a-3p,high grade serous papillary ovarian cancer,0.8243492841720581
hsa-miR-517a,high grade serous papillary ovarian cancer,0.8243492841720581
hsa-miR-152-3p,high grade serous papillary ovarian cancer,0.8243492841720581
hsa-miR-1256,ovarian carcinoma,0.8243265151977539
hsa-miR-148a,sarcoma,0.8242967128753662
hsa-miR-7-1-3p,sarcoma,0.8242967128753662
hsa-miR-498,sarcoma,0.8242967128753662
hsa-miR-623,brain cancer,0.8242935538291931
hsa-miR-4477a,brain cancer,0.8242935538291931
hsa-miR-1539,rhabdomyosarcomas,0.8242791891098022
hsa-miR-3619,Luminal B Her2+,0.8242602944374084
hsa-miR-4752,"Luminal B,triple negative",0.8242437243461609
hsa-miR-3925-3p,synovial sarcoma,0.8242316842079163
hsa-miR-644b-3p,synovial sarcoma,0.8242316842079163
hsa-miR-5586-5p,synovial sarcoma,0.8242316842079163
hsa-miR-133a-5p,synovial sarcoma,0.8242316842079163
hsa-miR-3653-3p,synovial sarcoma,0.8242316842079163
hsa-miR-4524a-3p,synovial sarcoma,0.8242316842079163
hsa-miR-1233-1-5p,synovial sarcoma,0.8242316842079163
hsa-miR-654-3p,synovial sarcoma,0.8242316842079163
hsa-miR-7843-3p,synovial sarcoma,0.8242316842079163
hsa-miR-1247-3p,synovial sarcoma,0.8242316842079163
hsa-miR-4760-5p,synovial sarcoma,0.8242316842079163
hsa-miR-598-3p,miR-142-y,0.824216365814209
hsa-miR-136-3p,miR-142-y,0.824216365814209
hsa-miR-513-5p,miR-142-y,0.824216365814209
hsa-miR-211-5p,miR-142-y,0.824216365814209
hsa-miR-4429,ovarian carcinoma,0.8242133855819702
hsa-miR-4668-5p,ovarian carcinoma,0.8242133855819702
hsa-miR-148b,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-3143,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-6795-3p,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-294,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-202-5p,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-326,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-1269a,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-143-5p,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-6768-5p,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-499a-3p,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-3687,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-718,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-4705,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-3189-3p,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-503-5p,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-469,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-412-5p,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-548g-5p,castration-resistant prostate cancer,0.8242111802101135
hsa-miR-766,rhabdomyosarcomas,0.8242034316062927
hsa-miR-609,rhabdomyosarcomas,0.8242034316062927
hsa-miR-4475,rhabdomyosarcomas,0.8242034316062927
hsa-miR-7161-3p,rhabdomyosarcomas,0.8242034316062927
hsa-miR-1266-5p,rhabdomyosarcomas,0.8242034316062927
hsa-miR-511-2,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-4430,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-29b-1,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-363-5p,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-6720-3p,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-6516-3p,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-7156-3p,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-3177,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-4793-3p,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-551a,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-181d,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-361-3p,castration-resistant prostate cancer,0.8241865038871765
hsa-miR-6727-3p,papillary thyroid carcinoma,0.8241764307022095
hsa-miR-433-3p,papillary thyroid carcinoma,0.8241764307022095
hsa-miR-3652,"squamous cell breast carcinoma, acantholytic variant",0.8241665959358215
hsa-miR-1233-1-5p,"squamous cell breast carcinoma, acantholytic variant",0.8241665959358215
hsa-miR-520a,"squamous cell breast carcinoma, acantholytic variant",0.8241665959358215
hsa-miR-6767-5p,miR-675-y,0.824150800704956
hsa-miR-4478,miR-675-y,0.824150800704956
hsa-miR-103-2*,miR-675-y,0.824150800704956
hsa-miR-1245a,miR-675-y,0.824150800704956
hsa-miR-3146,miR-675-y,0.824150800704956
hsa-miR-6721-5p,ovarian carcinoma,0.8241474032402039
hsa-miR-455-5p,diffuse large B-cell lymphoma,0.8241375088691711
hsa-miR-6750-5p,diffuse large B-cell lymphoma,0.8241375088691711
hsa-miR-6734-3p,diffuse large B-cell lymphoma,0.8241375088691711
hsa-miR-6872-5p,diffuse large B-cell lymphoma,0.8241375088691711
hsa-miR-3976,diffuse large B-cell lymphoma,0.8241375088691711
hsa-miR-1286,diffuse large B-cell lymphoma,0.8241375088691711
hsa-miR-4731-5p,diffuse large B-cell lymphoma,0.8241375088691711
hsa-miR-509-3p,rhabdomyosarcomas,0.8241226077079773
hsa-miR-548ac,rhabdomyosarcomas,0.8241226077079773
hsa-miR-769-3p,sarcoma,0.8240814208984375
hsa-miR-768-5p,sarcoma,0.8240814208984375
hsa-miR-520f,"Luminal B,triple negative",0.8240578174591064
hsa-miR-3652,"Luminal B,triple negative",0.8240578174591064
hsa-miR-1233-1-5p,"Luminal B,triple negative",0.8240578174591064
hsa-miR-200a-3p,miR-675-y,0.82403963804245
hsa-miR-516b,miR-675-y,0.82403963804245
hsa-miR-4256,miR-675-y,0.82403963804245
hsa-miR-103a,miR-675-y,0.82403963804245
hsa-miR-18a,miR-675-y,0.82403963804245
hsa-miR-1237-5p,miR-675-y,0.82403963804245
hsa-miR-3074,rhabdomyosarcomas,0.8240287899971008
hsa-miR-7151-3p,rhabdomyosarcomas,0.8240287899971008
hsa-miR-5701,rhabdomyosarcomas,0.8240287899971008
hsa-miR-574-3p,rhabdomyosarcomas,0.8240287899971008
hsa-miR-3653,miR-142-y,0.8240267634391785
hsa-miR-1206,miR-142-y,0.8240267634391785
hsa-miR-323-5p,miR-142-y,0.8240267634391785
hsa-miR-4797-3p,miR-142-y,0.8240267634391785
hsa-miR-6499-5p,miR-142-y,0.8240267634391785
hsa-miR-4446-5p,miR-142-y,0.8240267634391785
hsa-miR-3664-3p,miR-142-y,0.8240267634391785
hsa-miR-1226-3p,miR-142-y,0.824017345905304
hsa-miR-4728-3p,miR-142-y,0.824017345905304
hsa-miR-4451,miR-142-y,0.824017345905304
hsa-miR-4782-5p,miR-142-y,0.824017345905304
hsa-miR-6798-3p,miR-142-y,0.8240078091621399
hsa-miR-4727-3p,miR-142-y,0.8240078091621399
hsa-miR-659-5p,miR-142-y,0.8240078091621399
hsa-miR-7112-3p,miR-142-y,0.8240078091621399
hsa-miR-4730,solid pseudopapillary neoplasm of pancreas,0.8239904642105103
hsa-miR-523,solid pseudopapillary neoplasm of pancreas,0.8239904642105103
hsa-miR-328-3p,breast cancer brain metastasis,0.8239822387695312
hsa-miR-520h,ovarian carcinoma,0.8239691257476807
hsa-miR-6822-5p,ovarian carcinoma,0.8239691257476807
hsa-miR-4739,ovarian carcinoma,0.8239691257476807
hsa-miR-4706,ovarian carcinoma,0.8239580392837524
hsa-miR-598-3p,ovarian carcinoma,0.8239580392837524
hsa-miR-136-3p,ovarian carcinoma,0.8239580392837524
hsa-miR-765,ovarian carcinoma,0.8239580392837524
hsa-miR-185,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-548ay-5p,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-3074,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-548c,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-424-5p,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-27b-3p,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-134-3p,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-124-5p,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-3676-5p,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-6867-5p,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-6773-3p,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-495-5p,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-378b,castration-resistant prostate cancer,0.8239338994026184
hsa-miR-663b,diffuse large B-cell lymphoma,0.823931097984314
hsa-miR-371-3p,diffuse large B-cell lymphoma,0.823931097984314
hsa-miR-1273a,diffuse large B-cell lymphoma,0.823931097984314
hsa-miR-4708-3p,diffuse large B-cell lymphoma,0.823931097984314
hsa-miR-5583-5p,diffuse large B-cell lymphoma,0.823931097984314
hsa-miR-26a-2,diffuse large B-cell lymphoma,0.823931097984314
hsa-miR-3619-3p,rhabdomyosarcomas,0.8239229321479797
hsa-miR-30e-5p,rhabdomyosarcomas,0.8239229321479797
hsa-miR-524-3p,rhabdomyosarcomas,0.8239229321479797
hsa-miR-518d-5p,rhabdomyosarcomas,0.8239229321479797
hsa-miR-6796-5p,sarcoma,0.8238808512687683
hsa-miR-30c-1,sarcoma,0.8238808512687683
hsa-miR-6770-3p,sarcoma,0.8238808512687683
hsa-miR-2467-3p,sarcoma,0.8238808512687683
hsa-miR-939,rhabdomyosarcomas,0.8238407969474792
hsa-miR-6749-3p,rhabdomyosarcomas,0.8238407969474792
hsa-miR-3150b-3p,rhabdomyosarcomas,0.8238407969474792
hsa-miR-4763-3p,rhabdomyosarcomas,0.8238407969474792
hsa-miR-27a*,papillary thyroid carcinoma,0.8238282203674316
hsa-miR-6514-3p,rhabdomyosarcomas,0.8238086700439453
hsa-miR-102,rhabdomyosarcomas,0.8238086700439453
hsa-miR-1272,rhabdomyosarcomas,0.8238086700439453
hsa-miR-544,rhabdomyosarcomas,0.8238086700439453
hsa-miR-1185-5p,miR-142-y,0.8238071799278259
hsa-miR-1292-5p,miR-142-y,0.8238071799278259
hsa-miR-596,papillary thyroid carcinoma,0.8238030076026917
hsa-miR-636,breast cancer brain metastasis,0.8237968683242798
hsa-miR-6127,breast cancer brain metastasis,0.8237968683242798
hsa-miR-1306,brain cancer,0.8237786293029785
hsa-miR-1249,brain cancer,0.8237786293029785
hsa-miR-1193,papillary thyroid carcinoma,0.8237754106521606
hsa-miR-6834-3p,ovarian carcinoma,0.8237588405609131
hsa-miR-4524b-5p,ovarian carcinoma,0.8237588405609131
hsa-miR-292-3p,ovarian carcinoma,0.8237588405609131
hsa-miR-668-5p,ovarian carcinoma,0.8237588405609131
hsa-miR-518f-3p,papillary thyroid carcinoma,0.823739230632782
hsa-miR-200a-3p,papillary thyroid carcinoma,0.823739230632782
hsa-miR-195*,papillary thyroid carcinoma,0.823739230632782
hsa-miR-9-1,ovarian carcinoma,0.8237143158912659
hsa-miR-4258,aryngeal squamous cell carcinoma,0.8237084150314331
hsa-miR-3679-5p,synovial sarcoma,0.8237059116363525
hsa-miR-4791,synovial sarcoma,0.8237059116363525
hsa-miR-5096,synovial sarcoma,0.8237059116363525
hsa-miR-4707-5p,synovial sarcoma,0.8237059116363525
hsa-miR-518c-3p,synovial sarcoma,0.8237059116363525
hsa-miR-4698,synovial sarcoma,0.8237059116363525
hsa-miR-497-5p,synovial sarcoma,0.8237059116363525
hsa-miR-5696,synovial sarcoma,0.8237059116363525
hsa-miR-877-3p,synovial sarcoma,0.8237059116363525
hsa-miR-34b-5p,synovial sarcoma,0.8237059116363525
hsa-miR-6133,synovial sarcoma,0.8237059116363525
hsa-miR-3943,synovial sarcoma,0.8237059116363525
hsa-miR-4804-5p,primary central nervous system lymphomas,0.8236992359161377
hsa-miR-369,rhabdomyosarcomas,0.8236824870109558
hsa-miR-936,rhabdomyosarcomas,0.8236824870109558
hsa-miR-200c-3p,rhabdomyosarcomas,0.8236824870109558
hsa-miR-19a*,ovarian carcinoma,0.8236767053604126
hsa-miR-941,ovarian carcinoma,0.8236767053604126
hsa-miR-202-5p,ovarian carcinoma,0.8236767053604126
hsa-miR-675-3p,ovarian carcinoma,0.8236767053604126
hsa-miR-3200-5p,ovarian carcinoma,0.8236767053604126
hsa-miR-6756-3p,ovarian carcinoma,0.8236767053604126
hsa-miR-194-1,brain cancer,0.82367342710495
hsa-miR-6516-5p,papillary thyroid carcinoma,0.8236544132232666
hsa-miR-6514-3p,"squamous cell breast carcinoma, acantholytic variant",0.8236405253410339
hsa-miR-6807-3p,"squamous cell breast carcinoma, acantholytic variant",0.8236405253410339
hsa-miR-770-5p,"squamous cell breast carcinoma, acantholytic variant",0.8236405253410339
hsa-miR-1234-5p,"squamous cell breast carcinoma, acantholytic variant",0.8236405253410339
hsa-miR-544,"squamous cell breast carcinoma, acantholytic variant",0.8236405253410339
hsa-miR-885-5p,"squamous cell breast carcinoma, acantholytic variant",0.8236405253410339
hsa-miR-6831-3p,"squamous cell breast carcinoma, acantholytic variant",0.8236405253410339
hsa-miR-374a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8236405253410339
hsa-miR-3183,"squamous cell breast carcinoma, acantholytic variant",0.8236405253410339
hsa-miR-324-5p,solid pseudopapillary neoplasm of pancreas,0.8236321806907654
hsa-miR-3545-3p,solid pseudopapillary neoplasm of pancreas,0.8236321806907654
hsa-miR-6757-5p,"squamous cell breast carcinoma, acantholytic variant",0.8236261010169983
hsa-miR-4536-3p,"squamous cell breast carcinoma, acantholytic variant",0.8236261010169983
hsa-miR-190a,diffuse large B-cell lymphoma,0.8236224055290222
hsa-miR-516a-5p,diffuse large B-cell lymphoma,0.8236224055290222
hsa-miR-365a-5p,diffuse large B-cell lymphoma,0.8236224055290222
hsa-miR-6785-3p,diffuse large B-cell lymphoma,0.8236224055290222
hsa-miR-6881-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-367-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-2115,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-1268a,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-126-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-22-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-885-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-4749-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-330-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-103a,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-1295b-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-6773-5p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-4504,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-18a,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-548bb-5p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-6501-5p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-19b-1-5p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-552-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-4427,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-1237-5p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-5197-3p,castration-resistant prostate cancer,0.8236222267150879
hsa-miR-372,miR-675-y,0.8236199617385864
hsa-miR-425-5p,miR-675-y,0.8236199617385864
hsa-let-7f-5p,miR-675-y,0.8236199617385864
hsa-miR-132-5p,miR-675-y,0.8236199617385864
hsa-miR-499b-3p,miR-675-y,0.8236199617385864
hsa-miR-644a,miR-675-y,0.8236199617385864
hsa-miR-602,"Luminal B,triple negative",0.8235883712768555
hsa-miR-3157-5p,"Luminal B,triple negative",0.8235883712768555
hsa-miR-501-3p,"Luminal B,triple negative",0.8235883712768555
hsa-miR128b,"Luminal B,triple negative",0.8235883712768555
hsa-miR-4441,"Luminal B,triple negative",0.8235883712768555
hsa-miR-550a-3-5p,"Luminal B,triple negative",0.8235883712768555
hsa-miR-106a*,papillary thyroid carcinoma,0.8235856890678406
hsa-miR-186*,miR-142-y,0.8235850930213928
hsa-miR-7-2*,castration-resistant prostate cancer,0.823575496673584
hsa-miR-4518,castration-resistant prostate cancer,0.823575496673584
hsa-miR-6768-3p,castration-resistant prostate cancer,0.823575496673584
hsa-miR-7106-5p,castration-resistant prostate cancer,0.823575496673584
hsa-miR-675-3p,castration-resistant prostate cancer,0.823575496673584
hsa-miR-3545-3p,castration-resistant prostate cancer,0.823575496673584
hsa-miR-1306-3p,castration-resistant prostate cancer,0.823575496673584
hsa-miR-7112-3p,castration-resistant prostate cancer,0.823575496673584
hsa-miR-4455,castration-resistant prostate cancer,0.823575496673584
hsa-miR-6756-3p,castration-resistant prostate cancer,0.823575496673584
hsa-miR-6857-3p,castration-resistant prostate cancer,0.823575496673584
hsa-miR-548as-5p,rhabdomyosarcomas,0.8235680460929871
hsa-miR-3173-3p,rhabdomyosarcomas,0.8235680460929871
hsa-miR-122-3p,papillary thyroid carcinoma,0.823549211025238
hsa-miR-1185-5p,ovarian carcinoma,0.8235484957695007
hsa-let-7f-2,ovarian carcinoma,0.8235484957695007
hsa-miR-4735-5p,high grade serous papillary ovarian cancer,0.8235478401184082
hsa-miR-2964a-5p,high grade serous papillary ovarian cancer,0.8235478401184082
hsa-miR-4470,"Luminal B,triple negative",0.8235315084457397
hsa-miR-519e-3p,"Luminal B,triple negative",0.8235315084457397
hsa-miR-6746-3p,"Luminal B,triple negative",0.8235315084457397
hsa-miR-5096,"Luminal B,triple negative",0.8235315084457397
hsa-miR-4685-3p,"Luminal B,triple negative",0.8235315084457397
hsa-miR-518c-3p,"Luminal B,triple negative",0.8235315084457397
hsa-miR-5001-5p,"Luminal B,triple negative",0.8235315084457397
hsa-miR-347,"Luminal B,triple negative",0.8235315084457397
hsa-miR-5100,rhabdomyosarcomas,0.823517382144928
hsa-miR-96-3p,brain cancer,0.8235049247741699
hsa-miR-582,distal cholangiocarcinoma,0.8234957456588745
hsa-miR-138-2,rhabdomyosarcomas,0.8234741687774658
hsa-miR-605,rhabdomyosarcomas,0.8234741687774658
hsa-miR-148a*,rhabdomyosarcomas,0.8234741687774658
hsa-miR-568,rhabdomyosarcomas,0.8234741687774658
hsa-miR-6861-3p,sarcoma,0.823471188545227
hsa-miR-4525,sarcoma,0.823471188545227
hsa-let-7a-3,sarcoma,0.823471188545227
hsa-miR-4528,sarcoma,0.823471188545227
hsa-miR-6764-5p,sarcoma,0.823471188545227
hsa-miR-518d-3p,ovarian carcinoma,0.8234487175941467
hsa-miR-329,solid pseudopapillary neoplasm of pancreas,0.8234459757804871
hsa-miR-1255b-2-3p,solid pseudopapillary neoplasm of pancreas,0.8234459757804871
hsa-miR-1290,pilocytic astrocytoma,0.8234406113624573
hsa-miR-560,papillary thyroid carcinoma,0.8234273791313171
hsa-miR-3918,miR-142-y,0.8234183192253113
hsa-miR-940,miR-142-y,0.8234183192253113
hsa-miR-376a-2-5p,miR-142-y,0.8234183192253113
hsa-miR-7703,miR-142-y,0.8234183192253113
hsa-miR-5572,miR-142-y,0.8234183192253113
hsa-miR-190b,miR-142-y,0.8234162926673889
hsa-miR-4533,miR-142-y,0.8234162926673889
hsa-miR-6765-5p,miR-142-y,0.8234162926673889
hsa-miR-470,miR-142-y,0.8234162926673889
hsa-miR-130a-5p,rhabdomyosarcomas,0.8233969211578369
hsa-miR-6814-3p,rhabdomyosarcomas,0.8233969211578369
hsa-miR-550b-2-5p,rhabdomyosarcomas,0.8233969211578369
hsa-miR-1226-5p,rhabdomyosarcomas,0.8233969211578369
hsa-miR-1236-3p,castration-resistant prostate cancer,0.8233892917633057
hsa-miR-431,castration-resistant prostate cancer,0.8233892917633057
hsa-miR-146a*,castration-resistant prostate cancer,0.8233892917633057
hsa-miR-5586-5p,castration-resistant prostate cancer,0.8233892917633057
hsa-miR-6761-3p,castration-resistant prostate cancer,0.8233892917633057
hsa-miR-3653-3p,castration-resistant prostate cancer,0.8233892917633057
hsa-miR-4524a-3p,castration-resistant prostate cancer,0.8233892917633057
hsa-miR-1237,castration-resistant prostate cancer,0.8233892917633057
hsa-miR-145*,rhabdomyosarcomas,0.8233867287635803
hsa-miR-675-5p,rhabdomyosarcomas,0.8233867287635803
hsa-miR-548y,rhabdomyosarcomas,0.8233867287635803
hsa-let-7c_c,rhabdomyosarcomas,0.8233643174171448
hsa-miR-539,rhabdomyosarcomas,0.8233643174171448
hsa-miR-4743,rhabdomyosarcomas,0.8233643174171448
hsa-miR-4762-5p,rhabdomyosarcomas,0.8233643174171448
hsa-miR-020,rhabdomyosarcomas,0.8233643174171448
hsa-miR-1249,rhabdomyosarcomas,0.8233643174171448
hsa-miR-223*,rhabdomyosarcomas,0.8233643174171448
hsa-miR-377*,rhabdomyosarcomas,0.8233643174171448
hsa-miR-92a-1,rhabdomyosarcomas,0.8233643174171448
hsa-miR-349,miR-142-y,0.8233503699302673
hsa-miR-516a-3p,miR-142-y,0.8233503699302673
hsa-miR-3682-3p,miR-142-y,0.8233503699302673
hsa-miR-136,miR-142-y,0.8233503699302673
hsa-miR-6894-5p,miR-142-y,0.8233503699302673
hsa-miR-193b-5p,miR-142-y,0.8233503699302673
hsa-miR-3929,miR-142-y,0.8233503699302673
hsa-miR-887-3p,diffuse large B-cell lymphoma,0.8233485221862793
hsa-miR-96-3p,diffuse large B-cell lymphoma,0.8233485221862793
hsa-miR-644b-5p,diffuse large B-cell lymphoma,0.8233485221862793
hsa-miR-8074,diffuse large B-cell lymphoma,0.8233485221862793
hsa-miR-4754,diffuse large B-cell lymphoma,0.8233485221862793
hsa-miR-548ap-5p,diffuse large B-cell lymphoma,0.8233485221862793
hsa-miR-892a,Leptomeningeal metastasis,0.8233465552330017
hsa-miR-7-2*,Leptomeningeal metastasis,0.8233465552330017
hsa-miR-6884-3p,ovarian carcinoma,0.823326051235199
hsa-miR-495-3p,ovarian carcinoma,0.823326051235199
hsa-miR-525*,ovarian carcinoma,0.823326051235199
hsa-miR-1266,ovarian carcinoma,0.823326051235199
hsa-miR-3654,papillary thyroid carcinoma,0.8232794404029846
hsa-miR-199a-2,papillary thyroid carcinoma,0.8232794404029846
hsa-miR-6774-5p,brain cancer,0.8232715129852295
hsa-miR-5100,brain cancer,0.8232715129852295
hsa-miR-130a-3p,high grade serous papillary ovarian cancer,0.8232579827308655
hsa-let-7f-2*,follicular thyroid carcinoma,0.8232393264770508
hsa-miR-532,diffuse large B-cell lymphoma,0.8232148885726929
hsa-miR-145*,diffuse large B-cell lymphoma,0.8232148885726929
hsa-miR-103a-2-5p,diffuse large B-cell lymphoma,0.8232148885726929
hsa-miR-1178,diffuse large B-cell lymphoma,0.8232148885726929
hsa-miR-519b,diffuse large B-cell lymphoma,0.8232148885726929
hsa-miR-34b*,high grade serous papillary ovarian cancer,0.8232019543647766
hsa-miR-5186,high grade serous papillary ovarian cancer,0.8232019543647766
hsa-miR-196-2,high grade serous papillary ovarian cancer,0.8232019543647766
hsa-miR-520b,high grade serous papillary ovarian cancer,0.8232019543647766
hsa-miR-6729-3p,ovarian carcinoma,0.8231710195541382
hsa-miR-1227-3p,ovarian carcinoma,0.8231710195541382
hsa-miR-485-3p,ovarian carcinoma,0.8231710195541382
hsa-miR-579-5p,ovarian carcinoma,0.8231710195541382
hsa-miR-6847-3p,ovarian carcinoma,0.8231710195541382
hsa-miR-4306,papillary thyroid carcinoma,0.8231679797172546
hsa-miR-626,synovial sarcoma,0.8231653571128845
hsa-miR-1300,synovial sarcoma,0.8231653571128845
hsa-miR-3192-3p,synovial sarcoma,0.8231653571128845
hsa-miR-4676-3p,synovial sarcoma,0.8231653571128845
hsa-miR-452,synovial sarcoma,0.8231653571128845
hsa-miR-514a-3p,synovial sarcoma,0.8231653571128845
hsa-miR-218-2-3p,synovial sarcoma,0.8231653571128845
hsa-miR-128-1-5p,synovial sarcoma,0.8231653571128845
hsa-miR-3172,synovial sarcoma,0.8231653571128845
hsa-miR-93-3p,synovial sarcoma,0.8231653571128845
hsa-miR-3928-3p,synovial sarcoma,0.8231653571128845
hsa-miR-380-5p,synovial sarcoma,0.8231653571128845
hsa-miR-139-5p,synovial sarcoma,0.8231653571128845
hsa-miR-3127-3p,synovial sarcoma,0.8231653571128845
hsa-miR-6893-5p,synovial sarcoma,0.8231653571128845
hsa-miR-29a-5p,synovial sarcoma,0.8231653571128845
hsa-miR-6750-5p,miR-675-y,0.8231194615364075
hsa-miR-4693-5p,miR-675-y,0.8231194615364075
hsa-miR-4801,miR-675-y,0.8231194615364075
hsa-miR-3619-5p,miR-675-y,0.8231194615364075
hsa-miR-017,miR-675-y,0.8231194615364075
hsa-miR-7850-5p,miR-142-y,0.8231155276298523
hsa-miR-4713-5p,miR-142-y,0.8231155276298523
hsa-miR-302b-5p,miR-142-y,0.8231155276298523
hsa-miR-1201,diffuse large B-cell lymphoma,0.8231147527694702
hsa-miRPlus-J1004,diffuse large B-cell lymphoma,0.8231147527694702
hsa-miR-589*,diffuse large B-cell lymphoma,0.8231147527694702
hsa-miR-23b-5p,diffuse large B-cell lymphoma,0.8231147527694702
hsa-miR-6798-3p,sarcoma,0.8231119513511658
hsa-miR-3200,sarcoma,0.8231119513511658
hsa-miR-3200-5p,sarcoma,0.8231119513511658
hsa-miR-325,"squamous cell breast carcinoma, acantholytic variant",0.8230998516082764
hsa-miR-22,"squamous cell breast carcinoma, acantholytic variant",0.8230998516082764
hsa-miR-1307,"squamous cell breast carcinoma, acantholytic variant",0.8230998516082764
hsa-miR-510,"squamous cell breast carcinoma, acantholytic variant",0.8230998516082764
hsa-miR-936,"squamous cell breast carcinoma, acantholytic variant",0.8230998516082764
hsa-miR-3591-5p,"squamous cell breast carcinoma, acantholytic variant",0.8230998516082764
hsa-miR-3928-3p,"squamous cell breast carcinoma, acantholytic variant",0.8230998516082764
hsa-miR-6800-3p,"squamous cell breast carcinoma, acantholytic variant",0.8230998516082764
hsa-miR-4800-3p,"squamous cell breast carcinoma, acantholytic variant",0.8230998516082764
hsa-miR-676-5p,miR-142-y,0.823097825050354
hsa-miR-376a-5p,miR-142-y,0.823097825050354
hsa-miR-5002-5p,miR-142-y,0.823097825050354
hsa-miR-2114-3p,miR-142-y,0.823097825050354
hsa-miR-4697-3p,miR-142-y,0.823097825050354
hsa-miR-203a-3p,miR-142-y,0.823097825050354
hsa-miR-3924,miR-142-y,0.823097825050354
hsa-miR-516a-3p,ovarian carcinoma,0.8230910301208496
hsa-miR-4659b-3p,ovarian carcinoma,0.8230910301208496
hsa-miR-4677-3p,ovarian carcinoma,0.8230910301208496
hsa-miR-200a-3p,ovarian carcinoma,0.8230863213539124
hsa-miR-195*,ovarian carcinoma,0.8230863213539124
hsa-miR-612,ovarian carcinoma,0.8230863213539124
hsa-miR-491-3p,ovarian carcinoma,0.8230863213539124
hsa-miR-222-3p,ovarian carcinoma,0.8230863213539124
hsa-miR-6073,ovarian carcinoma,0.8230863213539124
hsa-miR-3121-3p,ovarian carcinoma,0.8230863213539124
hsa-miR-3150a-3p,ovarian carcinoma,0.8230863213539124
hsa-miR-548at-5p,ovarian carcinoma,0.8230863213539124
hsa-miR-3918,ovarian carcinoma,0.8230863213539124
hsa-miR-5591-3p,ovarian carcinoma,0.8230863213539124
hsa-miR-1267,miR-142-y,0.8230571746826172
hsa-miR-6768-3p,miR-142-y,0.8230571746826172
hsa-miR-326,miR-142-y,0.8230571746826172
hsa-miR-675-3p,miR-142-y,0.8230571746826172
hsa-miR-4301,miR-142-y,0.8230571746826172
hsa-miR-378i,miR-142-y,0.8230571746826172
hsa-miR-633,papillary thyroid carcinoma,0.8230512738227844
hsa-miR-4676-3p,"Luminal B,triple negative",0.8229905962944031
hsa-miR-6755-5p,high grade serous papillary ovarian cancer,0.8229687809944153
hsa-miR-636,"squamous cell breast carcinoma, acantholytic variant",0.8229284882545471
hsa-miR-4639-5p,"squamous cell breast carcinoma, acantholytic variant",0.8229284882545471
hsa-miR-6823-5p,"squamous cell breast carcinoma, acantholytic variant",0.8229284882545471
hsa-miR-4697-5p,sarcoma,0.822925329208374
hsa-miR-2110,sarcoma,0.822925329208374
hsa-miR-6761-3p,sarcoma,0.822925329208374
hsa-miR-3928-5p,sarcoma,0.822925329208374
hsa-miR-4717-3p,sarcoma,0.822925329208374
hsa-miR-6857-5p,papillary thyroid carcinoma,0.8229246735572815
hsa-miR-6836-3p,papillary thyroid carcinoma,0.8229246735572815
hsa-miR-4470,solid pseudopapillary neoplasm of pancreas,0.8229180574417114
hsa-miR-582-3p,solid pseudopapillary neoplasm of pancreas,0.8229180574417114
hsa-miR-3679-5p,solid pseudopapillary neoplasm of pancreas,0.8229180574417114
hsa-miR-371-3p,miR-675-y,0.8229119181632996
hsa-let-7i*,miR-675-y,0.8229119181632996
hsa-miR-106a.1,miR-675-y,0.8229119181632996
hsa-miR-6735-3p,miR-675-y,0.8229119181632996
hsa-miR-489,papillary thyroid carcinoma,0.8228813409805298
hsa-miR-220c,ovarian carcinoma,0.822880208492279
hsa-miR-582,ovarian carcinoma,0.822880208492279
hsa-miR-1202,rhabdomyosarcomas,0.8228732943534851
hsa-miR-1224-3p,rhabdomyosarcomas,0.8228732943534851
hsa-miR-6081,rhabdomyosarcomas,0.8228732943534851
hsa-miR-4445-3p,miR-142-y,0.8228705525398254
hsa-miR-132-3p,miR-142-y,0.8228705525398254
hsa-miR-1255b-2-3p,miR-142-y,0.8228705525398254
hsa-miR-185-3p,miR-142-y,0.8228705525398254
hsa-miR-4697-5p,miR-142-y,0.8228705525398254
hsa-miR-5586-5p,miR-142-y,0.8228705525398254
hsa-miR-3653-3p,miR-142-y,0.8228705525398254
hsa-miR-3652,miR-142-y,0.8228705525398254
hsa-miR-4717-3p,miR-142-y,0.8228705525398254
hsa-miR-124,miR-142-y,0.8228705525398254
hsa-miR-92a-1*,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-6742-5p,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-6807-3p,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-4791,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-770-5p,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-544,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-885-5p,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-10b*,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-4535,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-3678-5p,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-4746-3p,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-518c-3p,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-6815-3p,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-347,castration-resistant prostate cancer,0.8228613138198853
hsa-let-7g*,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-6801-5p,castration-resistant prostate cancer,0.8228613138198853
hsa-miR-873,papillary thyroid carcinoma,0.8228563070297241
hsa-miR-296-5p,ovarian carcinoma,0.8228559494018555
hsa-miR-4769-3p,ovarian carcinoma,0.8228559494018555
hsa-miR-3188,ovarian carcinoma,0.8228559494018555
hsa-miR-939,ovarian carcinoma,0.8228382468223572
hsa-miR-503,ovarian carcinoma,0.8228382468223572
hsa-miR-3610,ovarian carcinoma,0.8228382468223572
hsa-miR-4329,ovarian carcinoma,0.8228382468223572
hsa-miR-4703-5p,ovarian carcinoma,0.8228382468223572
hsa-miR-92a-2*,ovarian carcinoma,0.8228382468223572
hsa-miR-4790-3p,ovarian carcinoma,0.8228382468223572
hsa-miR-3940-3p,ovarian carcinoma,0.8228382468223572
hsa-miR-1323,ovarian carcinoma,0.8228382468223572
hsa-miR-148a-3p,ovarian carcinoma,0.8228382468223572
hsa-miR-136-5p,ovarian carcinoma,0.8228382468223572
hsa-miR-923_v12.0,ovarian carcinoma,0.8228382468223572
hsa-miRPlus-C1114,breast cancer brain metastasis,0.822801947593689
hsa-miR-376b,follicular thyroid carcinoma,0.822787344455719
hsa-miR-4655-5p,miR-142-y,0.8227837085723877
hsa-miR-3187-5p,miR-142-y,0.8227837085723877
hsa-miR-5088-3p,papillary thyroid carcinoma,0.8227344751358032
hsa-miR-654,papillary thyroid carcinoma,0.8227144479751587
hsa-miR-335*,papillary thyroid carcinoma,0.8227089047431946
hsa-miR-142,high grade serous papillary ovarian cancer,0.8226564526557922
hsa-miR-888-5p,high grade serous papillary ovarian cancer,0.8226564526557922
hsa-miR-935,miR-142-y,0.8226564526557922
hsa-miR-6836-3p,miR-142-y,0.8226564526557922
hsa-miR-9-1*,miR-142-y,0.8226564526557922
hsa-miR-548ai,miR-142-y,0.8226564526557922
hsa-miR-18b-3p,miR-142-y,0.8226564526557922
hsa-miR-4688,miR-142-y,0.8226564526557922
hsa-miR-6755-5p,rhabdomyosarcomas,0.8226396441459656
hsa-miR-450a-1,ovarian carcinoma,0.8226302266120911
hsa-miR-5006-5p,ovarian carcinoma,0.8226302266120911
hsa-miR-331-5p,ovarian carcinoma,0.8226302266120911
hsa-miR-297,ovarian carcinoma,0.8226302266120911
hsa-miR-122,synovial sarcoma,0.822613537311554
hsa-miR-6767-5p,synovial sarcoma,0.822613537311554
hsa-miR-5700,synovial sarcoma,0.822613537311554
hsa-miR-6806-5p,synovial sarcoma,0.822613537311554
hsa-miR-6769a-5p,synovial sarcoma,0.822613537311554
hsa-miR-328-5p,synovial sarcoma,0.822613537311554
hsa-miR-1-2,synovial sarcoma,0.822613537311554
hsa-miR-1245a,synovial sarcoma,0.822613537311554
hsa-miR-4326,synovial sarcoma,0.822613537311554
hsa-miR-1249-5p,synovial sarcoma,0.822613537311554
hsa-miR-889,miR-675-y,0.8226019144058228
hsa-miR-4749-5p,miR-675-y,0.8226019144058228
hsa-miR-106a:9.1,miR-675-y,0.8226019144058228
hsa-miR-3907,miR-675-y,0.8226019144058228
hsa-miR-365a-5p,miR-675-y,0.8226019144058228
hsa-miR-7107-5p,miR-675-y,0.8226019144058228
hsa-miR-19b-1,ovarian carcinoma,0.8225781321525574
hsa-miR-6784-5p,"squamous cell breast carcinoma, acantholytic variant",0.8225478529930115
hsa-miR-328-5p,"squamous cell breast carcinoma, acantholytic variant",0.8225478529930115
hsa-miR-3173-3p,"squamous cell breast carcinoma, acantholytic variant",0.8225478529930115
hsa-miR-8077,"squamous cell breast carcinoma, acantholytic variant",0.8225478529930115
hsa-miR-103a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8225478529930115
hsa-miR-3146,"squamous cell breast carcinoma, acantholytic variant",0.8225478529930115
hsa-miR-1249-5p,"squamous cell breast carcinoma, acantholytic variant",0.8225478529930115
hsa-miR-550-1,"squamous cell breast carcinoma, acantholytic variant",0.8225478529930115
hsa-miR-634,papillary thyroid carcinoma,0.8225331902503967
hsa-miR-6792-5p,ovarian carcinoma,0.8225236535072327
hsa-miR-3682-5p,ovarian carcinoma,0.8225236535072327
hsa-miR-5187-5p,ovarian carcinoma,0.8225236535072327
hsa-miR-141-3p,ovarian carcinoma,0.8225236535072327
hsa-miR-200a-3p,synovial sarcoma,0.8225016593933105
hsa-miR-367-3p,synovial sarcoma,0.8225016593933105
hsa-miR-550b-3p,synovial sarcoma,0.8225016593933105
hsa-miR-672,synovial sarcoma,0.8225016593933105
hsa-miR-491-3p,synovial sarcoma,0.8225016593933105
hsa-miR-1268a,synovial sarcoma,0.8225016593933105
hsa-miR-6073,synovial sarcoma,0.8225016593933105
hsa-miR-3918,synovial sarcoma,0.8225016593933105
hsa-miR-8052,synovial sarcoma,0.8225016593933105
hsa-miR-519a-5p,synovial sarcoma,0.8225016593933105
hsa-miR-7160-3p,synovial sarcoma,0.8225016593933105
hsa-miR-6773-5p,synovial sarcoma,0.8225016593933105
hsa-miR-7160-5p,synovial sarcoma,0.8225016593933105
hsa-miR-552-5p,synovial sarcoma,0.8225016593933105
hsa-miR-4504,synovial sarcoma,0.8225016593933105
hsa-miR-7110-3p,synovial sarcoma,0.8225016593933105
hsa-miR-3186-5p,synovial sarcoma,0.8225016593933105
hsa-miR-34a*,"Luminal B,triple negative",0.8224385380744934
hsa-miR-1-2,"Luminal B,triple negative",0.8224385380744934
hsa-miR-4539,"Luminal B,triple negative",0.8224385380744934
hsa-miR-200a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-367-3p,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-516b,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-548g,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-330-3p,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-103a,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-18a,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-4773,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-15a*,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-513c-3p,"squamous cell breast carcinoma, acantholytic variant",0.8224360346794128
hsa-miR-660-5p,miR-142-y,0.8224148154258728
hsa-miR-1207-5p,miR-142-y,0.8224148154258728
hsa-miR-4520-3p,miR-142-y,0.8224148154258728
hsa-miR-3591-3p,miR-142-y,0.8224148154258728
hsa-miR-4423-3p,sarcoma,0.8223963379859924
hsa-miR-4707-5p,sarcoma,0.8223963379859924
hsa-miR-518c-3p,sarcoma,0.8223963379859924
hsa-miR-6815-3p,sarcoma,0.8223963379859924
hsa-miR-126-5p,ovarian carcinoma,0.8223963379859924
hsa-miR-619-5p,ovarian carcinoma,0.8223963379859924
hsa-miR-6892-3p,ovarian carcinoma,0.8223963379859924
hsa-miR-4707-3p,ovarian carcinoma,0.8223963379859924
hsa-miR-148a-5p,ovarian carcinoma,0.8223963379859924
hsa-miR-135-2,ovarian carcinoma,0.8223963379859924
hsa-miR-548aq-3p,ovarian carcinoma,0.8223963379859924
hsa-miR-4641,ovarian carcinoma,0.8223963379859924
hsa-miR-526b-5p,solid pseudopapillary neoplasm of pancreas,0.8223757743835449
hsa-miR-1914*,miR-142-y,0.82234126329422
hsa-miR-770-5p,miR-142-y,0.82234126329422
hsa-miR-5096,miR-142-y,0.82234126329422
hsa-miR-4283,miR-142-y,0.82234126329422
hsa-miR-4685-3p,miR-142-y,0.82234126329422
hsa-miR-6815-3p,miR-142-y,0.82234126329422
hsa-miR-877-3p,miR-142-y,0.82234126329422
hsa-miR-5001-5p,miR-142-y,0.82234126329422
hsa-miR-128a,miR-142-y,0.82234126329422
hsa-miR-1224,miR-675-y,0.82232666015625
hsa-miR-376a-5p,miR-675-y,0.82232666015625
hsa-miR-3150b-3p,miR-675-y,0.82232666015625
hsa-miR-548ap-5p,miR-675-y,0.82232666015625
hsa-miR-8085,miR-675-y,0.82232666015625
hsa-miR-2116,"Luminal B,triple negative",0.8223264217376709
hsa-miR-933,"Luminal B,triple negative",0.8223264217376709
hsa-miR-18a,"Luminal B,triple negative",0.8223264217376709
hsa-miR-4773,"Luminal B,triple negative",0.8223264217376709
hsa-miR-767,follicular thyroid carcinoma,0.822319507598877
hsa-miR-4747-3p,castration-resistant prostate cancer,0.8223187923431396
hsa-miR-34c-5p,castration-resistant prostate cancer,0.8223187923431396
hsa-miR-452,castration-resistant prostate cancer,0.8223187923431396
hsa-miR-4635,castration-resistant prostate cancer,0.8223187923431396
hsa-miR-527,castration-resistant prostate cancer,0.8223187923431396
hsa-miR-504-5p,castration-resistant prostate cancer,0.8223187923431396
hsa-miR-24-2-5p,castration-resistant prostate cancer,0.8223187923431396
hsa-miR-526c,castration-resistant prostate cancer,0.8223187923431396
hsa-miR-5705,castration-resistant prostate cancer,0.8223187923431396
hsa-miR-593-5p,papillary thyroid carcinoma,0.8223116397857666
hsa-miR-770-5p,papillary thyroid carcinoma,0.8223116397857666
hsa-miR-511,Leptomeningeal metastasis,0.8222842812538147
hsa-miR-642a,Leptomeningeal metastasis,0.8222842812538147
hsa-miR-374a,ovarian carcinoma,0.8222659826278687
hsa-miR-513a-5p,distal cholangiocarcinoma,0.8222483992576599
hsa-miR-4269,miR-675-y,0.8221926689147949
hsa-miR-548e,miR-675-y,0.8221926689147949
hsa-miR-1185,miR-675-y,0.8221926689147949
hsa-miR-20b-3p,miR-675-y,0.8221926689147949
hsa-miR-6794-5p,miR-675-y,0.8221926689147949
hsa-miR-4291,papillary thyroid carcinoma,0.822184681892395
hsa-miR-642a-5p,miR-142-y,0.8221616148948669
hsa-miR-196-1,miR-142-y,0.8221616148948669
hsa-miR-219-5p,miR-142-y,0.8221616148948669
hsa-miR-548d-5p,ovarian carcinoma,0.8221544623374939
hsa-miR-8059,ovarian carcinoma,0.8221544623374939
hsa-miR-1302,ovarian carcinoma,0.8221544623374939
hsa-miR-5691,high grade serous papillary ovarian cancer,0.8221542835235596
hsa-miR-4716-3p,follicular thyroid carcinoma,0.8221268057823181
hsa-miR-3614-5p,aryngeal squamous cell carcinoma,0.8221045136451721
hsa-miR-30e-3p,aryngeal squamous cell carcinoma,0.8221045136451721
hsa-miR-1201,miR-675-y,0.8220921754837036
hsa-miR-5003-5p,miR-675-y,0.8220921754837036
hsa-miR-6885-5p,miR-675-y,0.8220921754837036
hsa-miR-320c,miR-675-y,0.8220921754837036
hsa-miR-6748-3p,miR-675-y,0.8220921754837036
hsa-miR-603,synovial sarcoma,0.8220791816711426
hsa-miR-132*,synovial sarcoma,0.8220791816711426
hsa-miR-125b-2*,synovial sarcoma,0.8220791816711426
hsa-miR-1246,synovial sarcoma,0.8220791816711426
hsa-miR-194,synovial sarcoma,0.8220791816711426
hsa-miR-619,synovial sarcoma,0.8220791816711426
hsa-miR-302c-5p,synovial sarcoma,0.8220791816711426
hsa-miR-4494,synovial sarcoma,0.8220791816711426
hsa-miR-3166,synovial sarcoma,0.8220791816711426
hsa-miR-4766-3p,synovial sarcoma,0.8220791816711426
hsa-miR-5087,synovial sarcoma,0.8220791816711426
hsa-miR-6813-3p,synovial sarcoma,0.8220791816711426
hsa-miR-208a-5p,synovial sarcoma,0.8220791816711426
hsa-miR-8056,synovial sarcoma,0.8220791816711426
hsa-miR-642a-3p,synovial sarcoma,0.8220791816711426
hsa-miR-3197,papillary thyroid carcinoma,0.8220691084861755
hsa-miR-449b-3p,papillary thyroid carcinoma,0.8220691084861755
hsa-miR-584-5p,aryngeal squamous cell carcinoma,0.8220624327659607
hsa-miR-3681,aryngeal squamous cell carcinoma,0.8220624327659607
hsa-miR-4514,aryngeal squamous cell carcinoma,0.8220624327659607
hsa-miR-4272,papillary thyroid carcinoma,0.8220181465148926
hsa-miR-6722-5p,papillary thyroid carcinoma,0.8220181465148926
hsa-miR-5687,papillary thyroid carcinoma,0.8220181465148926
hsa-miR-3202,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-4747-5p,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-125b-1,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-106b*,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-425-5p,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-5011-5p,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-491-5p,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-548i,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-490,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-412-3p,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-4766-3p,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-5087,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-208a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-202,"squamous cell breast carcinoma, acantholytic variant",0.8220133185386658
hsa-miR-1251-3p,high grade serous papillary ovarian cancer,0.82197505235672
hsa-miR-125b-2*,papillary thyroid carcinoma,0.8219748139381409
hsa-miR-148b-3p,ovarian carcinoma,0.8219403624534607
hsa-miR-6824-3p,ovarian carcinoma,0.8219403624534607
hsa-miR-367-3p,papillary thyroid carcinoma,0.821940004825592
hsa-miR-3202,"Luminal B,triple negative",0.8219037055969238
hsa-miR-1295b-5p,"Luminal B,triple negative",0.8219037055969238
hsa-miR-425-5p,"Luminal B,triple negative",0.8219037055969238
hsa-miR-3689a-3p,"Luminal B,triple negative",0.8219037055969238
hsa-miR-490,"Luminal B,triple negative",0.8219037055969238
hsa-miR-548az-5p,"Luminal B,triple negative",0.8219037055969238
hsa-miR-196b,miR-142-y,0.8219014406204224
hsa-miR-3142,miR-142-y,0.8219014406204224
hsa-miR-22*,miR-142-y,0.8219014406204224
hsa-miR-6889-3p,ovarian carcinoma,0.8219009637832642
hsa-miR-3184-3p,ovarian carcinoma,0.8219009637832642
hsa-miR-4261,ovarian carcinoma,0.8219009637832642
hsa-miRPlus-D1058,papillary thyroid carcinoma,0.8218970894813538
hsa-miR-138-1,papillary thyroid carcinoma,0.8218970894813538
hsa-miR-433,papillary thyroid carcinoma,0.8218970894813538
hsa-miR-4269,papillary thyroid carcinoma,0.8218869566917419
hsa-miR-3169,aryngeal squamous cell carcinoma,0.8218783140182495
hsa-miR-1303,pilocytic astrocytoma,0.8218660950660706
hsa-miR-020,papillary thyroid carcinoma,0.8218643069267273
hsa-miR-7111-3p,papillary thyroid carcinoma,0.8218643069267273
hsa-miR-4747-3p,sarcoma,0.8218528032302856
hsa-miR-1-5p,sarcoma,0.8218528032302856
hsa-miR-33a-3p,sarcoma,0.8218528032302856
hsa-miR-6895-5p,sarcoma,0.8218528032302856
hsa-miR-6806-5p,solid pseudopapillary neoplasm of pancreas,0.8218221068382263
hsa-miR-7-2-3p,solid pseudopapillary neoplasm of pancreas,0.8218221068382263
hsa-miR-3192-3p,miR-142-y,0.8217975497245789
hsa-miR-4747-3p,miR-142-y,0.8217975497245789
hsa-miR-222*,miR-142-y,0.8217975497245789
hsa-miR-548ag,miR-142-y,0.8217975497245789
hsa-miR-5579-5p,miR-142-y,0.8217975497245789
hsa-miR-1252-3p,miR-142-y,0.8217975497245789
hsa-miR-1201,miR-142-y,0.8217967748641968
hsa-miR-3129-5p,miR-142-y,0.8217967748641968
hsa-miR-4321,miR-142-y,0.8217967748641968
hsa-miR-6862-5p,miR-142-y,0.8217967748641968
hsa-miR-195-5p,miR-142-y,0.8217967748641968
hsa-miR-3118,miR-142-y,0.8217967748641968
hsa-miR-26a-1*,miR-142-y,0.8217967748641968
hsa-miRPlus-C1110,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-143*,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-6767-5p,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-3606-3p,castration-resistant prostate cancer,0.8217650651931763
hsa-let-7f-1,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-384,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-1b-1,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-548as-5p,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-622,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-4478,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-1260,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-3173-3p,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-3174,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-1305,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-1-2,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-5011-3p,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-103-2*,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-6508-5p,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-8077,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-1252,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-3912-3p,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-1249-5p,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-7704,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-6868-5p,castration-resistant prostate cancer,0.8217650651931763
hsa-miR-490-3p,primary central nervous system lymphomas,0.8217465877532959
hsa-miR-6500-3p,solid pseudopapillary neoplasm of pancreas,0.8217098116874695
hsa-miR-4256,solid pseudopapillary neoplasm of pancreas,0.8217098116874695
hsa-miR-519a-5p,solid pseudopapillary neoplasm of pancreas,0.8217098116874695
hsa-miR-2355,breast cancer brain metastasis,0.8217045664787292
hsa-miR-30e-3p,breast cancer brain metastasis,0.8217045664787292
hsa-miR-101-5p,breast cancer brain metastasis,0.8217045664787292
hsa-miR-1275,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-943,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-195*,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-550b-3p,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-672,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-222-3p,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-15b-3p,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-5586-3p,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-7160-5p,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-4773,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-5572,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-7110-3p,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-1469,castration-resistant prostate cancer,0.8216527104377747
hsa-miR-1228*,ovarian carcinoma,0.8216405510902405
hsa-miR-6849-3p,ovarian carcinoma,0.8216405510902405
hsa-miR-4534,ovarian carcinoma,0.8216405510902405
hsa-let-7f-2-3p,ovarian carcinoma,0.8216405510902405
hsa-miR-30c-5p,miR-142-y,0.821621298789978
hsa-miR-768-5p,miR-142-y,0.821621298789978
hsa-miR-3978,miR-142-y,0.821621298789978
hsa-miR-4649-5p,miR-142-y,0.821621298789978
hsa-miR-4453,castration-resistant prostate cancer,0.8216045498847961
hsa-miR-4695-3p,castration-resistant prostate cancer,0.8216045498847961
hsa-miR-759,castration-resistant prostate cancer,0.8216045498847961
hsa-miR-134-5p,castration-resistant prostate cancer,0.8216045498847961
hsa-miR-7844-5p,castration-resistant prostate cancer,0.8216045498847961
hsa-miR-4771,pilocytic astrocytoma,0.8216032981872559
hsa-miR-340-3p,ovarian carcinoma,0.8216005563735962
hsa-miR-711,ovarian carcinoma,0.8216005563735962
hsa-miRPlus-J1011,ovarian carcinoma,0.8216005563735962
hsa-miR-302e,ovarian carcinoma,0.8216005563735962
hsa-miR-552,ovarian carcinoma,0.8216005563735962
hsa-miR-1279,ovarian carcinoma,0.8216005563735962
hsa-miR-330,ovarian carcinoma,0.8216005563735962
hsa-miR-10b-5p,high grade serous papillary ovarian cancer,0.8215962648391724
hsa-miR-4538,miR-675-y,0.8215885162353516
hsa-miR-1287,miR-675-y,0.8215885162353516
hsa-miR-4798-3p,miR-675-y,0.8215885162353516
hsa-miR-8069,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-3134,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-6859-5p,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-1273a,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-4738-3p,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-6766-5p,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-6752-5p,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-6890-5p,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-580-3p,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-216a-3p,castration-resistant prostate cancer,0.8215874433517456
hsa-miR-433,synovial sarcoma,0.8215752840042114
hsa-miR-3937,synovial sarcoma,0.8215752840042114
hsa-miR-3187-3p,synovial sarcoma,0.8215752840042114
hsa-miR-3974,synovial sarcoma,0.8215752840042114
hsa-miR-3191-5p,synovial sarcoma,0.8215752840042114
hsa-miR-1184,synovial sarcoma,0.8215752840042114
hsa-miR-6872-5p,synovial sarcoma,0.8215752840042114
hsa-miR-3158-5p,synovial sarcoma,0.8215752840042114
hsa-miR-597-3p,synovial sarcoma,0.8215752840042114
hsa-miR-5683,synovial sarcoma,0.8215752840042114
hsa-miR-627-5p,synovial sarcoma,0.8215752840042114
hsa-miR-612,follicular thyroid carcinoma,0.8215703368186951
hsa-miR-213,ovarian carcinoma,0.821535587310791
hsa-miR-5580-3p,ovarian carcinoma,0.821535587310791
hsa-miR-668,ovarian carcinoma,0.821535587310791
hsa-miR-99b-3p,ovarian carcinoma,0.821535587310791
hsa-miR-3180,ovarian carcinoma,0.821535587310791
hsa-miR-4509,ovarian carcinoma,0.821535587310791
hsa-miR-195-5p,ovarian carcinoma,0.821535587310791
hsa-miR-5588-3p,ovarian carcinoma,0.821535587310791
hsa-miR-23b-5p,ovarian carcinoma,0.821535587310791
hsa-miR-365b-5p,ovarian carcinoma,0.821535587310791
hsa-miR-3913-5p,ovarian carcinoma,0.821535587310791
hsa-miR-4743-3p,ovarian carcinoma,0.821535587310791
hsa-miR-5581-3p,ovarian carcinoma,0.821535587310791
hsa-miR-454*,follicular thyroid carcinoma,0.8215224146842957
hsa-miR-1226-5p,"squamous cell breast carcinoma, acantholytic variant",0.8215091824531555
hsa-miR-3613-5p,"squamous cell breast carcinoma, acantholytic variant",0.8215091824531555
hsa-miR-1288,"squamous cell breast carcinoma, acantholytic variant",0.8215091824531555
hsa-miR-376b-3p,"squamous cell breast carcinoma, acantholytic variant",0.8215091824531555
hsa-miR-4481,"squamous cell breast carcinoma, acantholytic variant",0.8215091824531555
hsa-miR-6839-3p,"squamous cell breast carcinoma, acantholytic variant",0.8215091824531555
hsa-miR-624-5p,"squamous cell breast carcinoma, acantholytic variant",0.8215091824531555
hsa-miR-550a*,"squamous cell breast carcinoma, acantholytic variant",0.8215091824531555
hsa-miR-6783-5p,"squamous cell breast carcinoma, acantholytic variant",0.8215091824531555
hsa-miR-1182,Leptomeningeal metastasis,0.8214542865753174
hsa-miR-15a*,Leptomeningeal metastasis,0.8214542865753174
hsa-miR-6828-5p,"Luminal B,triple negative",0.8213993310928345
hsa-miR-1184,"Luminal B,triple negative",0.8213993310928345
hsa-miR-017,"Luminal B,triple negative",0.8213993310928345
hsa-miR-6833-5p,"Luminal B,triple negative",0.8213993310928345
hsa-miR-5703,"Luminal B,triple negative",0.8213993310928345
hsa-miR-6799-5p,high grade serous papillary ovarian cancer,0.8213961720466614
hsa-miR-2681,miR-142-y,0.8213816285133362
hsa-miR-371-3p,miR-142-y,0.8213816285133362
hsa-miR-5583-5p,miR-142-y,0.8213816285133362
hsa-miR-4648,miR-142-y,0.8213816285133362
hsa-miR-199a-3p,synovial sarcoma,0.8213663697242737
hsa-miR-181a*,synovial sarcoma,0.8213663697242737
hsa-miR-105-3p,synovial sarcoma,0.8213663697242737
hsa-miR-4738-3p,synovial sarcoma,0.8213663697242737
hsa-miR-101-3p,synovial sarcoma,0.8213663697242737
hsa-miR-3927,synovial sarcoma,0.8213663697242737
hsa-miR-3675-3p,synovial sarcoma,0.8213663697242737
hsa-miR-4492,synovial sarcoma,0.8213663697242737
hsa-miR-548n,synovial sarcoma,0.8213663697242737
hsa-miR-6729-5p,synovial sarcoma,0.8213663697242737
hsa-miR-6890-5p,synovial sarcoma,0.8213663697242737
hsa-miR-6827-3p,synovial sarcoma,0.8213663697242737
hsa-miR-619-3p,synovial sarcoma,0.8213663697242737
hsa-miR-216a-3p,synovial sarcoma,0.8213663697242737
hsa-miR-202-3p,synovial sarcoma,0.8213663697242737
hsa-miR-4524a-5p,ovarian carcinoma,0.8213600516319275
hsa-miR-23b*,ovarian carcinoma,0.8213600516319275
hsa-miR-548ay-3p,ovarian carcinoma,0.8213600516319275
hsa-miR-187-3p,ovarian carcinoma,0.8213600516319275
hsa-miR-221-5p,ovarian carcinoma,0.8213600516319275
hsa-miR-4649-5p,ovarian carcinoma,0.8213600516319275
hsa-miR-4276,miR-142-y,0.8213157653808594
hsa-miR-1304,miR-142-y,0.8213157653808594
hsa-miR-6861-3p,miR-142-y,0.8213157653808594
hsa-miR-4273,miR-142-y,0.8213157653808594
hsa-miR-548i-1,miR-142-y,0.8213157653808594
hsa-miRPlus-A1087,miR-142-y,0.8213157653808594
hsa-miR-134-3p,miR-142-y,0.8213157653808594
hsa-miR-4751,miR-142-y,0.8213157653808594
hsa-miR-3676-5p,miR-142-y,0.8213157653808594
hsa-miR-6716-3p,miR-142-y,0.8213157653808594
hsa-miR-1252-5p,miR-142-y,0.8213157653808594
hsa-miR-519d-3p,miR-142-y,0.8213157653808594
hsa-miR-3134,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-let-7i*,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-miR-558,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-miR-185-5p,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-miR-3190-5p,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-miR-6771-3p,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-miR-106a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-miR-216a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-miR-5692c,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-miR-513c-5p,"squamous cell breast carcinoma, acantholytic variant",0.8213002681732178
hsa-miR-6769a-5p,sarcoma,0.821297824382782
hsa-miR-548as-5p,sarcoma,0.821297824382782
hsa-miR-1252,sarcoma,0.821297824382782
hsa-miR-3202,solid pseudopapillary neoplasm of pancreas,0.821285605430603
hsa-miR-520d,solid pseudopapillary neoplasm of pancreas,0.821285605430603
hsa-miR-888-3p,solid pseudopapillary neoplasm of pancreas,0.821285605430603
hsa-miR-3166,solid pseudopapillary neoplasm of pancreas,0.821285605430603
hsa-miR-1268a,aryngeal squamous cell carcinoma,0.821283221244812
hsa-miR-4796-3p,aryngeal squamous cell carcinoma,0.821283221244812
hsa-miR-376a-2-5p,aryngeal squamous cell carcinoma,0.821283221244812
hsa-miR-7162-5p,aryngeal squamous cell carcinoma,0.821283221244812
hsa-miR-6893-3p,high grade serous papillary ovarian cancer,0.8212481737136841
hsa-miR-218-1-3p,high grade serous papillary ovarian cancer,0.8212481737136841
hsa-miR-548w,high grade serous papillary ovarian cancer,0.8212481737136841
hsa-miR-520g,high grade serous papillary ovarian cancer,0.8212481737136841
hsa-miR-7856-5p,high grade serous papillary ovarian cancer,0.8212481737136841
hsa-miR-4788,high grade serous papillary ovarian cancer,0.8212481737136841
hsa-miR-4679,high grade serous papillary ovarian cancer,0.8212481737136841
hsa-miR-6874-3p,high grade serous papillary ovarian cancer,0.8212481737136841
hsa-miR-513-5p,ovarian carcinoma,0.8212470412254333
hsa-miR-6769a-5p,miR-142-y,0.8212425112724304
hsa-miR-4478,miR-142-y,0.8212425112724304
hsa-miR-3680-5p,miR-142-y,0.8212425112724304
hsa-miR-3155a,miR-142-y,0.8212425112724304
hsa-miR-4326,miR-142-y,0.8212425112724304
hsa-miR-1249-5p,miR-142-y,0.8212425112724304
hsa-miR-378j,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-125b-2*,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-4420,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-4503,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-3150a-5p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-5693,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-3605-5p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-663,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-1295b-5p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-500,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-106b*,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-425-5p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-3689a-3p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-619,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-5011-5p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-5589-3p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-302c-5p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-8079,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-5739,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-4735-3p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-4678,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-3125,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-941-1,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-6833-3p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-642a-3p,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-3156,castration-resistant prostate cancer,0.8212285041809082
hsa-miR-4495,"Luminal B,triple negative",0.8211902379989624
hsa-let-7i*,"Luminal B,triple negative",0.8211902379989624
hsa-miR-3190-5p,"Luminal B,triple negative",0.8211902379989624
hsa-miR-6774-3p,"Luminal B,triple negative",0.8211902379989624
hsa-miR-4708-3p,"Luminal B,triple negative",0.8211902379989624
hsa-miR-6781-3p,"Luminal B,triple negative",0.8211902379989624
hsa-miR-1254,high grade serous papillary ovarian cancer,0.8211882710456848
hsa-miR-550b-3p,sarcoma,0.8211851716041565
hsa-miR-6073,sarcoma,0.8211851716041565
hsa-miR-8052,sarcoma,0.8211851716041565
hsa-miR-4701-5p,sarcoma,0.8211851716041565
hsa-miR-18a,sarcoma,0.8211851716041565
hsa-miR-5192,miR-675-y,0.8211676478385925
hsa-miR-3157-5p,miR-675-y,0.8211676478385925
hsa-miR-649,miR-675-y,0.8211676478385925
hsa-miR-302b*,miR-675-y,0.8211676478385925
hsa-miR-101-2,miR-675-y,0.8211676478385925
hsa-miR-181a-3p,miR-675-y,0.8211676478385925
hsa-miR-4687-5p,miR-675-y,0.8211676478385925
hsa-miR-18a,miR-142-y,0.8211297988891602
hsa-miR-720,sarcoma,0.821111261844635
hsa-miR-642a,ovarian carcinoma,0.821063756942749
hsa-miR-4695-3p,ovarian carcinoma,0.821063756942749
hsa-miR-130b-3p,ovarian carcinoma,0.821063756942749
hsa-miR-181a-5p,ovarian carcinoma,0.821063756942749
hsa-miR-4322,ovarian carcinoma,0.821063756942749
hsa-miR-1224-3p,ovarian carcinoma,0.821063756942749
hsa-miR-125b-1-3p,ovarian carcinoma,0.821063756942749
hsa-miR-3657,synovial sarcoma,0.8210541009902954
hsa-miR-1324,synovial sarcoma,0.8210541009902954
hsa-miR-190a,synovial sarcoma,0.8210541009902954
hsa-miR-548ah-3p,synovial sarcoma,0.8210541009902954
hsa-miR-7111-3p,synovial sarcoma,0.8210541009902954
hsa-miR-1306,synovial sarcoma,0.8210541009902954
hsa-miR-1304-3p,synovial sarcoma,0.8210541009902954
hsa-miR-130a*,synovial sarcoma,0.8210541009902954
hsa-miR-4304,synovial sarcoma,0.8210541009902954
hsa-miR-4263,synovial sarcoma,0.8210541009902954
hsa-miR-224*,synovial sarcoma,0.8210541009902954
hsa-miR-499b-5p,synovial sarcoma,0.8210541009902954
hsa-miR-3115,synovial sarcoma,0.8210541009902954
hsa-miR-190a-3p,synovial sarcoma,0.8210541009902954
hsa-miR-4508,synovial sarcoma,0.8210541009902954
hsa-miR-6130,synovial sarcoma,0.8210541009902954
hsa-miR-545*,synovial sarcoma,0.8210541009902954
hsa-miR-522-3p,synovial sarcoma,0.8210541009902954
hsa-miR-6841-3p,synovial sarcoma,0.8210541009902954
hsa-miR-574,synovial sarcoma,0.8210541009902954
hsa-miR-365a-5p,synovial sarcoma,0.8210541009902954
hsa-miR-425,synovial sarcoma,0.8210541009902954
hsa-miR-6785-3p,synovial sarcoma,0.8210541009902954
hsa-miR-885,synovial sarcoma,0.8210541009902954
hsa-miR-5681b,ovarian carcinoma,0.8210541009902954
hsa-miR-628-5p,ovarian carcinoma,0.8210541009902954
hsa-miR-4251,ovarian carcinoma,0.8210541009902954
hsa-miR-523,ovarian carcinoma,0.8210541009902954
hsa-miR-381,ovarian carcinoma,0.8210541009902954
hsa-miR-1304,ovarian carcinoma,0.8210541009902954
hsa-miR-424-5p,ovarian carcinoma,0.8210541009902954
hsa-miRPlus-A1087,ovarian carcinoma,0.8210541009902954
hsa-miR-5699,ovarian carcinoma,0.8210541009902954
hsa-miR-4425,ovarian carcinoma,0.8210541009902954
hsa-miR-3168,ovarian carcinoma,0.8210541009902954
hsa-miR-520f-520c,ovarian carcinoma,0.8210541009902954
hsa-miR-4757-3p,ovarian carcinoma,0.8210541009902954
hsa-miR-3131,ovarian carcinoma,0.8210467100143433
hsa-miR-181a*,ovarian carcinoma,0.8210467100143433
hsa-miR-4670-3p,ovarian carcinoma,0.8210467100143433
hsa-miR-3927,ovarian carcinoma,0.8210467100143433
hsa-miR-4433-5p,ovarian carcinoma,0.8210467100143433
hsa-miR-8088,ovarian carcinoma,0.8210467100143433
hsa-miR-6847-5p,ovarian carcinoma,0.8210467100143433
hsa-miR-6735-3p,ovarian carcinoma,0.8210467100143433
hsa-miR-646,high grade serous papillary ovarian cancer,0.8210403919219971
hsa-miR-5088,high grade serous papillary ovarian cancer,0.8210403919219971
hsa-miR-151b,high grade serous papillary ovarian cancer,0.8210403919219971
hsa-miR-642a,high grade serous papillary ovarian cancer,0.8210403919219971
hsa-miR-1236-5p,high grade serous papillary ovarian cancer,0.8210403919219971
hsa-miR-6848-5p,high grade serous papillary ovarian cancer,0.8210403919219971
hsa-miR-3606,high grade serous papillary ovarian cancer,0.8210403919219971
hsa-miR-4514,high grade serous papillary ovarian cancer,0.8210403919219971
hsa-miR-199a-5p,solid pseudopapillary neoplasm of pancreas,0.8210378885269165
hsa-miR-4520a-3p,solid pseudopapillary neoplasm of pancreas,0.8210378885269165
hsa-miR-3619-3p,miR-142-y,0.8209958672523499
hsa-miR-518d-5p,miR-142-y,0.8209958672523499
hsa-miR-7-2,miR-142-y,0.8209958672523499
hsa-miR-1301-3p,miR-142-y,0.8209958672523499
hsa-miR-190a-5p,miR-142-y,0.8209958672523499
hsa-miR-3195,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-379,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-30a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-106a:9.1,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-7-1,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-190a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-147a,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-6841-3p,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-365a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-488-3p,"squamous cell breast carcinoma, acantholytic variant",0.8209880590438843
hsa-miR-3175,Leptomeningeal metastasis,0.8209867477416992
hsa-miR-2964a-3p,ovarian carcinoma,0.8209855556488037
hsa-miR-3189-5p,ovarian carcinoma,0.8209855556488037
hsa-miR-6506-5p,ovarian carcinoma,0.8209855556488037
hsa-miR-34b*,ovarian carcinoma,0.8209855556488037
hsa-miR-220a,ovarian carcinoma,0.8209855556488037
hsa-let-7a_c,ovarian carcinoma,0.8209855556488037
hsa-miR-1308,ovarian carcinoma,0.8209855556488037
hsa-miR-4699-3p,ovarian carcinoma,0.8209855556488037
hsa-miR-3665,pilocytic astrocytoma,0.8209786415100098
hsa-miR-657,rhabdomyosarcomas,0.8209164142608643
hsa-miR-4787-3p,ovarian carcinoma,0.8208780884742737
hsa-miR-4647,ovarian carcinoma,0.8208780884742737
hsa-miR-26a-2-3p,ovarian carcinoma,0.8208780884742737
hsa-miR-4304,"Luminal B,triple negative",0.8208779096603394
hsa-miR-1296,"Luminal B,triple negative",0.8208779096603394
hsa-miR-374b,"Luminal B,triple negative",0.8208779096603394
hsa-miR-520f-3p,"Luminal B,triple negative",0.8208779096603394
hsa-miR-29a*,"Luminal B,triple negative",0.8208779096603394
hsa-miR-365a-5p,"Luminal B,triple negative",0.8208779096603394
hsa-miR-488-3p,"Luminal B,triple negative",0.8208779096603394
hsa-miR-1471,"Luminal B,triple negative",0.8208779096603394
hsa-miR-3607-5p,breast cancer brain metastasis,0.8208370208740234
hsa-miR-1245,rhabdomyosarcomas,0.8208342790603638
hsa-miR-651,rhabdomyosarcomas,0.8208342790603638
hsa-miR-3545-3p,rhabdomyosarcomas,0.8208342790603638
hsa-miR-532,miR-142-y,0.8207923769950867
hsa-miR-513a-1,miR-142-y,0.8207923769950867
hsa-miR-302a-3p,miR-142-y,0.8207923769950867
hsa-miR-3921,miR-142-y,0.8207923769950867
hsa-miR-4717-5p,miR-142-y,0.8207923769950867
hsa-miR-6865-3p,miR-142-y,0.8207923769950867
hsa-miR-129*,solid pseudopapillary neoplasm of pancreas,0.8207800984382629
hsa-miR-379-3p,solid pseudopapillary neoplasm of pancreas,0.8207800984382629
hsa-miR-6763-3p,solid pseudopapillary neoplasm of pancreas,0.8207800984382629
hsa-miR-96-3p,synovial sarcoma,0.8207771182060242
hsa-miR-4529-5p,synovial sarcoma,0.8207771182060242
hsa-miR-1914-5p,synovial sarcoma,0.8207771182060242
hsa-miR-4724-3p,synovial sarcoma,0.8207771182060242
hsa-miR-644b-5p,synovial sarcoma,0.8207771182060242
hsa-miR-3936,synovial sarcoma,0.8207771182060242
hsa-miR-21*,synovial sarcoma,0.8207771182060242
hsa-miR-3150b-3p,synovial sarcoma,0.8207771182060242
hsa-miR-500a,synovial sarcoma,0.8207771182060242
hsa-miR-4763-3p,synovial sarcoma,0.8207771182060242
hsa-miR-4472,synovial sarcoma,0.8207771182060242
hsa-miR-378g,synovial sarcoma,0.8207771182060242
hsa-miR-383-3p,synovial sarcoma,0.8207771182060242
hsa-miR-548ar-3p,synovial sarcoma,0.8207771182060242
hsa-miR-200c*,synovial sarcoma,0.8207771182060242
hsa-miR-3667-5p,synovial sarcoma,0.8207771182060242
hsa-miR-136-5p,synovial sarcoma,0.8207771182060242
hsa-miR-603,sarcoma,0.820760190486908
hsa-miR-132*,sarcoma,0.820760190486908
hsa-miR-4503,sarcoma,0.820760190486908
hsa-miR-3689a-3p,sarcoma,0.820760190486908
hsa-miR-491-5p,sarcoma,0.820760190486908
hsa-miR-889-3p,sarcoma,0.820760190486908
hsa-miR-128b,sarcoma,0.820760190486908
hsa-miR-29b-2,sarcoma,0.820760190486908
hsa-miR-3125,sarcoma,0.820760190486908
hsa-miR-2682-5p,sarcoma,0.820760190486908
hsa-miR-6833-3p,sarcoma,0.820760190486908
hsa-miR-513,ovarian carcinoma,0.8207337260246277
hsa-miR-3619-3p,ovarian carcinoma,0.8207337260246277
hsa-miR-7155-5p,ovarian carcinoma,0.8207337260246277
hsa-miR-520f,ovarian carcinoma,0.8207337260246277
hsa-miR-1255b-2-3p,ovarian carcinoma,0.8207337260246277
hsa-miR-548x,ovarian carcinoma,0.8207337260246277
hsa-miR-2110,ovarian carcinoma,0.8207337260246277
hsa-miR-3126-5p,ovarian carcinoma,0.8207337260246277
hsa-miR-7-2,ovarian carcinoma,0.8207337260246277
hsa-miR-152,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-4310,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3130-3p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-6880-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-6750-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-130a-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-6512-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-6763-3p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-6851-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3613-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3937,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3187-3p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3974,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-4692,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-1184,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3132,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-675*,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3976,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3192,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-30d-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3944-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-1268,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-627-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-3190-3p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-1914-3p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-4792,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-517*,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-27b-5p,castration-resistant prostate cancer,0.8207226395606995
hsa-miR-138-1*,"squamous cell breast carcinoma, acantholytic variant",0.8207108378410339
hsa-miR-92a-2*,"squamous cell breast carcinoma, acantholytic variant",0.8207108378410339
hsa-miR-5002-5p,"squamous cell breast carcinoma, acantholytic variant",0.8207108378410339
hsa-miR-2114-3p,"squamous cell breast carcinoma, acantholytic variant",0.8207108378410339
hsa-miR-383-3p,"squamous cell breast carcinoma, acantholytic variant",0.8207108378410339
hsa-miR-331,"squamous cell breast carcinoma, acantholytic variant",0.8207108378410339
hsa-miR-3685,"squamous cell breast carcinoma, acantholytic variant",0.8207108378410339
hsa-miR-203a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8207108378410339
hsa-miR-2682-3p,"squamous cell breast carcinoma, acantholytic variant",0.8207108378410339
hsa-miR-609,distal cholangiocarcinoma,0.8207085132598877
hsa-miR-425-5p,miR-142-y,0.8207048177719116
hsa-miR-619,miR-142-y,0.8207048177719116
hsa-miR-578,miR-142-y,0.8207048177719116
hsa-miR-548i,miR-142-y,0.8207048177719116
hsa-miR-128b,miR-142-y,0.8207048177719116
hsa-miR-568,miR-142-y,0.8207048177719116
hsa-miR-6820-3p,miR-142-y,0.8207048177719116
hsa-miR-30c-1*,miR-142-y,0.8207048177719116
hsa-miR-4718,miR-142-y,0.8207048177719116
hsa-miR-3074-5p,miR-142-y,0.8207032084465027
hsa-miR-4791,miR-142-y,0.8207032084465027
hsa-miR-885-5p,miR-142-y,0.8207032084465027
hsa-miR-888*,miR-142-y,0.8207032084465027
hsa-miR-372-3p,miR-142-y,0.8207032084465027
hsa-miR-4698,miR-142-y,0.8207032084465027
hsa-miR-6133,miR-142-y,0.8207032084465027
hsa-miR-6730-3p,synovial sarcoma,0.8206420540809631
hsa-miR-1-1,synovial sarcoma,0.8206420540809631
hsa-miR-570,synovial sarcoma,0.8206420540809631
hsa-miR-5047,synovial sarcoma,0.8206420540809631
hsa-miR-149,synovial sarcoma,0.8206420540809631
hsa-miR-2392,synovial sarcoma,0.8206420540809631
hsa-miR-125b-2,synovial sarcoma,0.8206420540809631
hsa-miR-6761-5p,synovial sarcoma,0.8206420540809631
hsa-miR-4305,synovial sarcoma,0.8206420540809631
hsa-miR-6511a-5p,synovial sarcoma,0.8206420540809631
hsa-miR-494-3p,synovial sarcoma,0.8206420540809631
hsa-miR-877*,synovial sarcoma,0.8206420540809631
hsa-miR-3137,Leptomeningeal metastasis,0.8206265568733215
hsa-miR-92a-2*,"Luminal B,triple negative",0.8206005692481995
hsa-miR-3120-3p,"Luminal B,triple negative",0.8206005692481995
hsa-miR-324-3p,pilocytic astrocytoma,0.8205807209014893
hsa-miR-548e,"squamous cell breast carcinoma, acantholytic variant",0.8205757737159729
hsa-miR-570,"squamous cell breast carcinoma, acantholytic variant",0.8205757737159729
hsa-miR-3618,"squamous cell breast carcinoma, acantholytic variant",0.8205757737159729
hsa-miR-302a-3p,"squamous cell breast carcinoma, acantholytic variant",0.8205757737159729
hsa-miR-3122,"squamous cell breast carcinoma, acantholytic variant",0.8205757737159729
hsa-miR-6779-3p,"squamous cell breast carcinoma, acantholytic variant",0.8205757737159729
hsa-miR-4717-5p,"squamous cell breast carcinoma, acantholytic variant",0.8205757737159729
hsa-miR-582,papillary thyroid carcinoma,0.820557713508606
hsa-miR-213,synovial sarcoma,0.8205409646034241
hsa-miR-1976,synovial sarcoma,0.8205409646034241
hsa-miR-3129-5p,synovial sarcoma,0.8205409646034241
hsa-miR-3180,synovial sarcoma,0.8205409646034241
hsa-miR-4323,synovial sarcoma,0.8205409646034241
hsa-miR-429,synovial sarcoma,0.8205409646034241
hsa-miR-4321,synovial sarcoma,0.8205409646034241
hsa-miR-4711-5p,synovial sarcoma,0.8205409646034241
hsa-miR-500b-5p,synovial sarcoma,0.8205409646034241
hsa-miR-454-3p,synovial sarcoma,0.8205409646034241
hsa-miR-487a-5p,synovial sarcoma,0.8205409646034241
hsa-miR-215-3p,synovial sarcoma,0.8205409646034241
hsa-miR-589*,synovial sarcoma,0.8205409646034241
hsa-miR-4531,synovial sarcoma,0.8205409646034241
hsa-miR-1-1,ovarian carcinoma,0.8205301761627197
hsa-miR-183-3p,ovarian carcinoma,0.8205301761627197
hsa-miR-338-5p,ovarian carcinoma,0.8205301761627197
hsa-miR-589-3p,ovarian carcinoma,0.8205301761627197
hsa-miR-520f-5p,ovarian carcinoma,0.8205301761627197
hsa-miR-620,ovarian carcinoma,0.8205301761627197
hsa-miR-6848-3p,ovarian carcinoma,0.8205301761627197
hsa-miR-5093,ovarian carcinoma,0.8205301761627197
hsa-miR-663b,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-6790-3p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-675,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-2681,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-4495,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-595,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-5008-5p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-371-3p,castration-resistant prostate cancer,0.8205130696296692
hsa-let-7i*,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-101-3p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-3607-3p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-4433-5p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-185-5p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-125b-5p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-4492,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-5579-3p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-3190-5p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-6781-3p,castration-resistant prostate cancer,0.8205130696296692
hsa-miR-1199-5p,high grade serous papillary ovarian cancer,0.820507287979126
hsa-miR-129-5p,high grade serous papillary ovarian cancer,0.820507287979126
hsa-miR-1911-5p,ovarian carcinoma,0.8204891681671143
hsa-miR-155-3p,ovarian carcinoma,0.8204891681671143
hsa-miR-5007-5p,ovarian carcinoma,0.8204891681671143
hsa-miR-3927-3p,aryngeal squamous cell carcinoma,0.820488691329956
hsa-miR-548J,aryngeal squamous cell carcinoma,0.820488691329956
hsa-miR-3614-5p,breast cancer brain metastasis,0.8204795718193054
hsa-miR-520g,breast cancer brain metastasis,0.8204795718193054
hsa-miR-4433b-3p,brain cancer,0.8204790949821472
hsa-miR-874,"squamous cell breast carcinoma, acantholytic variant",0.8204746246337891
hsa-miR-187-5p,"squamous cell breast carcinoma, acantholytic variant",0.8204746246337891
hsa-miR-450a-5p,"squamous cell breast carcinoma, acantholytic variant",0.8204746246337891
hsa-miR-5585-3p,"squamous cell breast carcinoma, acantholytic variant",0.8204746246337891
hsa-miR-4323,"squamous cell breast carcinoma, acantholytic variant",0.8204746246337891
hsa-miR-201,"squamous cell breast carcinoma, acantholytic variant",0.8204746246337891
hsa-miR-2117,"squamous cell breast carcinoma, acantholytic variant",0.8204746246337891
hsa-miR-181b-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.8204746246337891
hsa-miR-6788-5p,"squamous cell breast carcinoma, acantholytic variant",0.8204746246337891
hsa-miR-4269,"Luminal B,triple negative",0.8204654455184937
hsa-miR-149,"Luminal B,triple negative",0.8204654455184937
hsa-let-7a-2-3p,"Luminal B,triple negative",0.8204654455184937
hsa-miR-6848-3p,"Luminal B,triple negative",0.8204654455184937
hsa-miR-4676-3p,miR-142-y,0.8204432725906372
hsa-miR-466,miR-142-y,0.8204432725906372
hsa-miR-199b-3p,miR-142-y,0.8204432725906372
hsa-miR-6895-5p,miR-142-y,0.8204432725906372
hsa-miR-6751-3p,miR-142-y,0.8204432725906372
hsa-miR-24-2-5p,miR-142-y,0.8204432725906372
hsa-miR-526c,miR-142-y,0.8204432725906372
hsa-miR-519e-3p,ovarian carcinoma,0.8204408884048462
hsa-miR-1238-3p,ovarian carcinoma,0.8204408884048462
hsa-miR-3620-5p,ovarian carcinoma,0.8204408884048462
hsa-miR-6831-3p,ovarian carcinoma,0.8204408884048462
hsa-miR-4283,ovarian carcinoma,0.8204408884048462
hsa-miR-4535,ovarian carcinoma,0.8204408884048462
hsa-miR-888*,ovarian carcinoma,0.8204408884048462
hsa-miR-6080,ovarian carcinoma,0.8204408884048462
hsa-miR-6087,ovarian carcinoma,0.8204408884048462
hsa-miR-4685-3p,ovarian carcinoma,0.8204408884048462
hsa-miR-181b-5p,ovarian carcinoma,0.8204408884048462
hsa-miR-877-3p,ovarian carcinoma,0.8204408884048462
hsa-miR-454,primary central nervous system lymphomas,0.820435643196106
hsa-miR-6733-5p,primary central nervous system lymphomas,0.820435643196106
hsa-miR-6720-3p,sarcoma,0.8204059600830078
hsa-miR-6516-3p,sarcoma,0.8204059600830078
hsa-miR-7156-3p,sarcoma,0.8204059600830078
hsa-miR-6885-5p,"Luminal B,triple negative",0.820364236831665
hsa-miR-4509,"Luminal B,triple negative",0.820364236831665
hsa-miR-7107-3p,"Luminal B,triple negative",0.820364236831665
hsa-miR-485-3p,follicular thyroid carcinoma,0.8203353881835938
hsa-miR-576-5p,rhabdomyosarcomas,0.8203178644180298
hsa-miR-122-3p,Leptomeningeal metastasis,0.8203086256980896
hsa-miR-1908,Luminal B Her2+,0.8202915191650391
hsa-miR-6506-5p,Luminal B Her2+,0.8202915191650391
hsa-miR-3617-3p,aryngeal squamous cell carcinoma,0.8202696442604065
hsa-miR-3141,high grade serous papillary ovarian cancer,0.8202590346336365
hsa-miR-4642,high grade serous papillary ovarian cancer,0.8202590346336365
hsa-miRPlus-C1099,solid pseudopapillary neoplasm of pancreas,0.8202571868896484
hsa-let-7c_c,solid pseudopapillary neoplasm of pancreas,0.8202571868896484
hsa-miR-30a*,solid pseudopapillary neoplasm of pancreas,0.8202571868896484
hsa-miR-539,solid pseudopapillary neoplasm of pancreas,0.8202571868896484
hsa-miR-190a,solid pseudopapillary neoplasm of pancreas,0.8202571868896484
hsa-miR-30a-5p,solid pseudopapillary neoplasm of pancreas,0.8202571868896484
hsa-miR-376c,sarcoma,0.8202533721923828
hsa-miR-486-5p,sarcoma,0.8202533721923828
hsa-miR-675*,sarcoma,0.8202533721923828
hsa-miR-6847-3p,Leptomeningeal metastasis,0.8202186822891235
hsa-let-7e*,castration-resistant prostate cancer,0.820199728012085
hsa-miR-432*,castration-resistant prostate cancer,0.820199728012085
hsa-miR-1324,castration-resistant prostate cancer,0.820199728012085
hsa-miR-020,castration-resistant prostate cancer,0.820199728012085
hsa-miR-1249,castration-resistant prostate cancer,0.820199728012085
hsa-miR-199a*-1,castration-resistant prostate cancer,0.820199728012085
hsa-miR-223*,castration-resistant prostate cancer,0.820199728012085
hsa-miR-4436b-5p,castration-resistant prostate cancer,0.820199728012085
hsa-miR-1289,castration-resistant prostate cancer,0.820199728012085
hsa-miR-130a*,castration-resistant prostate cancer,0.820199728012085
hsa-miR-4667-5p,castration-resistant prostate cancer,0.820199728012085
hsa-miR-624,castration-resistant prostate cancer,0.820199728012085
hsa-miR-4793-5p,castration-resistant prostate cancer,0.820199728012085
hsa-miR-516a-5p,castration-resistant prostate cancer,0.820199728012085
hsa-miR-7-1,castration-resistant prostate cancer,0.820199728012085
hsa-miR-659,castration-resistant prostate cancer,0.820199728012085
hsa-miR-3115,castration-resistant prostate cancer,0.820199728012085
hsa-miR-5000-5p,castration-resistant prostate cancer,0.820199728012085
hsa-miR-4424,castration-resistant prostate cancer,0.820199728012085
hsa-miR-4459,castration-resistant prostate cancer,0.820199728012085
hsa-miR-3119,castration-resistant prostate cancer,0.820199728012085
hsa-miR-8086,castration-resistant prostate cancer,0.820199728012085
hsa-miR-1471,castration-resistant prostate cancer,0.820199728012085
hsa-miR-6785-3p,castration-resistant prostate cancer,0.820199728012085
hsa-miR-4481,miR-142-y,0.8201977014541626
hsa-miR-6839-3p,miR-142-y,0.8201977014541626
hsa-miR-627-5p,miR-142-y,0.8201977014541626
hsa-miR-624-5p,miR-142-y,0.8201977014541626
hsa-miR-6783-5p,miR-142-y,0.8201977014541626
hsa-miR-6767-5p,miR-142-y,0.820195198059082
hsa-miR-3157-3p,miR-142-y,0.820195198059082
hsa-miR-550a,miR-142-y,0.820195198059082
hsa-miR-622,miR-142-y,0.820195198059082
hsa-miR-1260,miR-142-y,0.820195198059082
hsa-miR-99b*,miR-142-y,0.820195198059082
hsa-miR-1245a,miR-142-y,0.820195198059082
hsa-miR-6742-3p,Luminal B Her2+,0.8201838731765747
hsa-miR-4529-3p,ovarian carcinoma,0.8201805949211121
hsa-miR-33b,ovarian carcinoma,0.8201805949211121
hsa-miR-34c-5p,ovarian carcinoma,0.8201805949211121
hsa-miR-466,ovarian carcinoma,0.8201805949211121
hsa-miR-514a-3p,ovarian carcinoma,0.8201805949211121
hsa-miR-3591-5p,ovarian carcinoma,0.8201805949211121
hsa-miR-106a-3p,ovarian carcinoma,0.8201805949211121
hsa-miR-4646-3p,ovarian carcinoma,0.8201805949211121
hsa-miR-577,ovarian carcinoma,0.8201805949211121
hsa-miR-6895-5p,ovarian carcinoma,0.8201805949211121
hsa-miR-1263,papillary thyroid carcinoma,0.8201694488525391
hsa-miR-6798-3p,Leptomeningeal metastasis,0.8201480507850647
hsa-miR-629*,Leptomeningeal metastasis,0.8201480507850647
hsa-miR-3189-5p,aryngeal squamous cell carcinoma,0.8201380968093872
hsa-miR-16-1-3p,miR-142-y,0.8201326727867126
hsa-miR-30a-5p,miR-142-y,0.8201326727867126
hsa-miR-4304,miR-142-y,0.8201326727867126
hsa-miR-516a-5p,miR-142-y,0.8201326727867126
hsa-miR-488-3p,miR-142-y,0.8201326727867126
hsa-miR-885,miR-142-y,0.8201326727867126
hsa-miR-522*,"Luminal B,triple negative",0.8201088309288025
hsa-miR-450b-5p,breast cancer brain metastasis,0.8200859427452087
hsa-miR-513a-5p,ovarian carcinoma,0.820078432559967
hsa-miR-3196,ovarian carcinoma,0.820078432559967
hsa-miR-365,ovarian carcinoma,0.820078432559967
hsa-miR-186*,ovarian carcinoma,0.820078432559967
hsa-miR-6729-5p,sarcoma,0.8200432658195496
hsa-miR-450a,follicular thyroid carcinoma,0.8200289011001587
hsa-miR-450a,Leptomeningeal metastasis,0.8200030326843262
hsa-miR-147b,Leptomeningeal metastasis,0.8200030326843262
hsa-let-7b*,high grade serous papillary ovarian cancer,0.8200001120567322
hsa-miR-942-3p,high grade serous papillary ovarian cancer,0.8200001120567322
hsa-miR-558,miR-142-y,0.8199877142906189
hsa-miR-584,miR-142-y,0.8199877142906189
hsa-miR-18b,miR-142-y,0.8199877142906189
hsa-miR-548ap-3p,miR-142-y,0.8199877142906189
hsa-miR-106a-5p,miR-142-y,0.8199877142906189
hsa-miR-6735-5p,miR-142-y,0.8199877142906189
hsa-miR-651-3p,miR-142-y,0.8199793100357056
hsa-miR-500,miR-142-y,0.8199793100357056
hsa-miR-29b-3p,miR-142-y,0.8199793100357056
hsa-miR-565,miR-142-y,0.8199793100357056
hsa-miR-4302,miR-142-y,0.8199793100357056
hsa-miR-941-1,miR-142-y,0.8199793100357056
hsa-miR-3610,solid pseudopapillary neoplasm of pancreas,0.8199791312217712
hsa-miR-3150b-3p,solid pseudopapillary neoplasm of pancreas,0.8199791312217712
hsa-miR-624*,pilocytic astrocytoma,0.8199629783630371
hsa-miR-122,ovarian carcinoma,0.8199323415756226
hsa-miR-143*,ovarian carcinoma,0.8199323415756226
hsa-miR-6767-5p,ovarian carcinoma,0.8199323415756226
hsa-miR-3606-3p,ovarian carcinoma,0.8199323415756226
hsa-miR-6769a-5p,ovarian carcinoma,0.8199323415756226
hsa-miR-449b-3p,ovarian carcinoma,0.8199323415756226
hsa-miR-384,ovarian carcinoma,0.8199323415756226
hsa-miR-1b-1,ovarian carcinoma,0.8199323415756226
hsa-miR-4478,ovarian carcinoma,0.8199323415756226
hsa-miR-4703-3p,ovarian carcinoma,0.8199323415756226
hsa-miR-9-5p,ovarian carcinoma,0.8199323415756226
hsa-miR-3173-3p,ovarian carcinoma,0.8199323415756226
hsa-miR-520h,rhabdomyosarcomas,0.8199259042739868
hsa-miR-1267,aryngeal squamous cell carcinoma,0.8199244141578674
hsa-miR-19a*,aryngeal squamous cell carcinoma,0.8199244141578674
hsa-miR-326,aryngeal squamous cell carcinoma,0.8199244141578674
hsa-miR-4737,castration-resistant prostate cancer,0.819921612739563
hsa-miR-939,castration-resistant prostate cancer,0.819921612739563
hsa-miR-4695-5p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-96-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-503,castration-resistant prostate cancer,0.819921612739563
hsa-miR-1914-5p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-4724-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-376a-5p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-4477b,castration-resistant prostate cancer,0.819921612739563
hsa-miR-4790-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-2114-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-6505-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-3940-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-6855-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-8085,castration-resistant prostate cancer,0.819921612739563
hsa-miR-3667-5p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-3120-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-7849-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-3924,castration-resistant prostate cancer,0.819921612739563
hsa-miR-2682-3p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-6756-5p,castration-resistant prostate cancer,0.819921612739563
hsa-miR-15b-5p,rhabdomyosarcomas,0.8199081420898438
hsa-miR-455-5p,miR-142-y,0.8199018239974976
hsa-miR-130a-5p,miR-142-y,0.8199018239974976
hsa-miR-376c,miR-142-y,0.8199018239974976
hsa-miR-550b,miR-142-y,0.8199018239974976
hsa-miR-3132,miR-142-y,0.8199018239974976
hsa-miR-4445-5p,miR-142-y,0.8199018239974976
hsa-miR-486-5p,miR-142-y,0.8199018239974976
hsa-miR-8066,miR-142-y,0.8199018239974976
hsa-miR-218-2*,miR-142-y,0.8199018239974976
hsa-miR-4743,ovarian carcinoma,0.8198696374893188
hsa-miR-4762-5p,ovarian carcinoma,0.8198696374893188
hsa-miR-190a,ovarian carcinoma,0.8198696374893188
hsa-miR-5089,ovarian carcinoma,0.8198696374893188
hsa-miR-191*,ovarian carcinoma,0.8198696374893188
hsa-miR-379,ovarian carcinoma,0.8198696374893188
hsa-miR-291-3p,ovarian carcinoma,0.8198696374893188
hsa-miR-374a*,ovarian carcinoma,0.8198696374893188
hsa-miR-4753-3p,ovarian carcinoma,0.8198696374893188
hsa-miR-106a:9.1,ovarian carcinoma,0.8198696374893188
hsa-miR-29a-2,ovarian carcinoma,0.8198696374893188
hsa-miR-7-1,ovarian carcinoma,0.8198696374893188
hsa-miR-4508,ovarian carcinoma,0.8198696374893188
hsa-miR-3119,ovarian carcinoma,0.8198696374893188
hsa-miR-885,ovarian carcinoma,0.8198696374893188
hsa-miR-105-1,synovial sarcoma,0.8198585510253906
hsa-miR-344,synovial sarcoma,0.8198585510253906
hsa-miR-557,synovial sarcoma,0.8198585510253906
hsa-miR-431*,synovial sarcoma,0.8198585510253906
hsa-miR-6717-5p,synovial sarcoma,0.8198585510253906
hsa-miR-1234,synovial sarcoma,0.8198585510253906
hsa-miR-4265,synovial sarcoma,0.8198585510253906
hsa-miR-6510-5p,synovial sarcoma,0.8198585510253906
hsa-miR-6770-3p,synovial sarcoma,0.8198585510253906
hsa-miR-6888-3p,synovial sarcoma,0.8198585510253906
hsa-miR-6865-5p,synovial sarcoma,0.8198585510253906
hsa-miR-1288-3p,synovial sarcoma,0.8198585510253906
hsa-miR-3680*,synovial sarcoma,0.8198585510253906
hsa-miR-6832-3p,synovial sarcoma,0.8198585510253906
hsa-miR-4633-3p,synovial sarcoma,0.8198585510253906
hsa-miR-6845-3p,synovial sarcoma,0.8198585510253906
hsa-miR-4720-3p,solid pseudopapillary neoplasm of pancreas,0.8198437690734863
hsa-miR-3912-5p,solid pseudopapillary neoplasm of pancreas,0.8198437690734863
hsa-miR-20b-3p,solid pseudopapillary neoplasm of pancreas,0.8198437690734863
hsa-miR-616,castration-resistant prostate cancer,0.819786012172699
hsa-miR-548e,castration-resistant prostate cancer,0.819786012172699
hsa-miR-455,castration-resistant prostate cancer,0.819786012172699
hsa-miR-505-3p,castration-resistant prostate cancer,0.819786012172699
hsa-miR-4789-3p,castration-resistant prostate cancer,0.819786012172699
hsa-miR-3140-3p,castration-resistant prostate cancer,0.819786012172699
hsa-miR-324,castration-resistant prostate cancer,0.819786012172699
hsa-miR-30a,castration-resistant prostate cancer,0.819786012172699
hsa-miR-548s,castration-resistant prostate cancer,0.819786012172699
hsa-miR-675-5p,castration-resistant prostate cancer,0.819786012172699
hsa-miR-5571-5p,castration-resistant prostate cancer,0.819786012172699
hsa-miR-6846-5p,castration-resistant prostate cancer,0.819786012172699
hsa-miR-20b-3p,castration-resistant prostate cancer,0.819786012172699
hsa-miR-4781-5p,brain cancer,0.8197717666625977
hsa-miR-199a-5p,brain cancer,0.8197717666625977
hsa-miR-507,brain cancer,0.8197717666625977
hsa-miR-3925-5p,solid pseudopapillary neoplasm of pancreas,0.8197422623634338
hsa-miR-6787-5p,solid pseudopapillary neoplasm of pancreas,0.8197422623634338
hsa-miRPlus-J1004,solid pseudopapillary neoplasm of pancreas,0.8197422623634338
hsa-miR-3647-5p,solid pseudopapillary neoplasm of pancreas,0.8197422623634338
hsa-miR-429,solid pseudopapillary neoplasm of pancreas,0.8197422623634338
hsa-miR-3118,solid pseudopapillary neoplasm of pancreas,0.8197422623634338
hsa-miR-5186,breast cancer brain metastasis,0.8197348117828369
hsa-miR-4288,high grade serous papillary ovarian cancer,0.8197299242019653
hsa-miR-7156-5p,high grade serous papillary ovarian cancer,0.8197299242019653
hsa-miR-7111-3p,sarcoma,0.8197293877601624
hsa-miR-292-5p,sarcoma,0.8197293877601624
hsa-miR-223*,sarcoma,0.8197293877601624
hsa-miR-130a*,sarcoma,0.8197293877601624
hsa-miR-4469,sarcoma,0.8197293877601624
hsa-miR-624,sarcoma,0.8197293877601624
hsa-miR-4793-5p,sarcoma,0.8197293877601624
hsa-miR-514a-5p,sarcoma,0.8197293877601624
hsa-miR-378d,sarcoma,0.8197293877601624
hsa-miR-379-5p,sarcoma,0.8197293877601624
hsa-miR-5000-5p,sarcoma,0.8197293877601624
hsa-miR-1246,ovarian carcinoma,0.8197160959243774
hsa-miR-3150a-5p,ovarian carcinoma,0.8197160959243774
hsa-miR-6506-3p,ovarian carcinoma,0.8197160959243774
hsa-miR-520d,ovarian carcinoma,0.8197160959243774
hsa-miR-372,ovarian carcinoma,0.8197160959243774
hsa-miR-29b-3p,ovarian carcinoma,0.8197160959243774
hsa-miR-432-3p,ovarian carcinoma,0.8197160959243774
hsa-miR-150-3p,ovarian carcinoma,0.8197160959243774
hsa-miR-548h-5p,ovarian carcinoma,0.8197160959243774
hsa-miR-614,ovarian carcinoma,0.8197160959243774
hsa-miR-8079,ovarian carcinoma,0.8197160959243774
hsa-miR-4302,ovarian carcinoma,0.8197160959243774
hsa-miR-506-3p,ovarian carcinoma,0.8197160959243774
hsa-miR-3125,ovarian carcinoma,0.8197160959243774
hsa-miR-3925-5p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-6722-5p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-1914,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-655,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-515-3p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-874,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-604,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-6885-5p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-5585-3p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-625-3p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-320c,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-223-5p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-548aw,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-4509,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-201,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-194-3p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-500b-5p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-4772-5p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-3118,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-589*,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-3680-3p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-7-5p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-5188,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-6788-5p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-7159-3p,castration-resistant prostate cancer,0.8196845054626465
hsa-miR-2681,Leptomeningeal metastasis,0.8196799755096436
hsa-miR-100*,Leptomeningeal metastasis,0.8196799755096436
hsa-miR-292-5p,miR-142-y,0.8196736574172974
hsa-miR-212,miR-142-y,0.8196736574172974
hsa-miR-4766-5p,miR-142-y,0.8196736574172974
hsa-miR-4764-5p,miR-142-y,0.8196736574172974
hsa-miR-377*,miR-142-y,0.8196736574172974
hsa-miR-499b-5p,miR-142-y,0.8196736574172974
hsa-miR-92a-1,miR-142-y,0.8196736574172974
hsa-miR-517a,miR-142-y,0.8196736574172974
hsa-miR-29a*,miR-142-y,0.8196736574172974
hsa-miR-365a-5p,miR-142-y,0.8196736574172974
hsa-miR-7107-5p,miR-142-y,0.8196736574172974
hsa-miR-6769a-3p,rhabdomyosarcomas,0.8196666836738586
hsa-miR-662,distal cholangiocarcinoma,0.8196550607681274
hsa-miR-136,ovarian carcinoma,0.8196436166763306
hsa-miR-6814-3p,ovarian carcinoma,0.8196385502815247
hsa-miR-550b-2-5p,ovarian carcinoma,0.8196385502815247
hsa-miR-6894-3p,ovarian carcinoma,0.8196385502815247
hsa-miR-892b,ovarian carcinoma,0.8196385502815247
hsa-miR-6799-3p,ovarian carcinoma,0.8196385502815247
hsa-miR-3613-5p,ovarian carcinoma,0.8196385502815247
hsa-miR-323a-5p,ovarian carcinoma,0.8196385502815247
hsa-miR-3191-5p,ovarian carcinoma,0.8196385502815247
hsa-miR-125b-2-3p,ovarian carcinoma,0.8196385502815247
hsa-miR-3692-3p,ovarian carcinoma,0.8196385502815247
hsa-miR-1273h-5p,ovarian carcinoma,0.8196385502815247
hsa-miR-30d-5p,ovarian carcinoma,0.8196385502815247
hsa-miR-6798-3p,miR-675-y,0.8196231722831726
hsa-miR-19a*,miR-675-y,0.8196231722831726
hsa-miR-941,miR-675-y,0.8196231722831726
hsa-miR-1306-3p,miR-675-y,0.8196231722831726
hsa-miR-6824-3p,Leptomeningeal metastasis,0.8195748925209045
hsa-miR-1244,rhabdomyosarcomas,0.819560170173645
hsa-miR-129-2-3p,papillary thyroid carcinoma,0.8194862008094788
hsa-miR-4716-3p,rhabdomyosarcomas,0.8194838762283325
hsa-miR-4447,sarcoma,0.8194506168365479
hsa-miR-3940-3p,sarcoma,0.8194506168365479
hsa-miR-548ar-3p,sarcoma,0.8194506168365479
hsa-miR-510-3p,sarcoma,0.8194506168365479
hsa-miR-6804-5p,sarcoma,0.8194506168365479
hsa-miR-6729-3p,high grade serous papillary ovarian cancer,0.8194477558135986
hsa-miR-644b-5p,miR-142-y,0.8193949460983276
hsa-miR-19a-3p,miR-142-y,0.8193949460983276
hsa-miR-1264,miR-142-y,0.8193949460983276
hsa-miR-6505-3p,miR-142-y,0.8193949460983276
hsa-miR-4327,miR-142-y,0.8193949460983276
hsa-miR-548ap-5p,miR-142-y,0.8193949460983276
hsa-miR-7849-3p,miR-142-y,0.8193949460983276
hsa-miR-208a,Leptomeningeal metastasis,0.8193920254707336
hsa-miR-343,papillary thyroid carcinoma,0.8193598985671997
hsa-miR-3945,sarcoma,0.8193148374557495
hsa-miR-513a-1,sarcoma,0.8193148374557495
hsa-miR-6779-3p,sarcoma,0.8193148374557495
hsa-miR-6769a-5p,distal cholangiocarcinoma,0.8192973732948303
hsa-miR-3151-3p,distal cholangiocarcinoma,0.8192973732948303
hsa-miR-378j,distal cholangiocarcinoma,0.8192809820175171
hsa-miR-1292-5p,papillary thyroid carcinoma,0.8192717432975769
hsa-miR-338-5p,miR-142-y,0.819258987903595
hsa-miR-570,miR-142-y,0.819258987903595
hsa-miR-145*,miR-142-y,0.819258987903595
hsa-miR-3618,miR-142-y,0.819258987903595
hsa-miR-340*,miR-142-y,0.819258987903595
hsa-miR-465,miR-142-y,0.819258987903595
hsa-miR-4662a-5p,castration-resistant prostate cancer,0.819253146648407
hsa-miR-6749-3p,castration-resistant prostate cancer,0.819253146648407
hsa-miR-887-3p,castration-resistant prostate cancer,0.819253146648407
hsa-miR-129-2,castration-resistant prostate cancer,0.819253146648407
hsa-miR-92a-2*,castration-resistant prostate cancer,0.819253146648407
hsa-miR-5002-5p,castration-resistant prostate cancer,0.819253146648407
hsa-miR-149-5p,castration-resistant prostate cancer,0.819253146648407
hsa-miR-8074,castration-resistant prostate cancer,0.819253146648407
hsa-miR-548ar-3p,castration-resistant prostate cancer,0.819253146648407
hsa-miR-891a-5p,castration-resistant prostate cancer,0.819253146648407
hsa-let-7b-5p,castration-resistant prostate cancer,0.819253146648407
hsa-miR-148a-3p,castration-resistant prostate cancer,0.819253146648407
hsa-miR-103a-2*,castration-resistant prostate cancer,0.819253146648407
hsa-miR-1224-3p,aryngeal squamous cell carcinoma,0.8192446231842041
hsa-miR-4279,aryngeal squamous cell carcinoma,0.8192446231842041
hsa-miR-6859-5p,aryngeal squamous cell carcinoma,0.8192273378372192
hsa-miR-99a-5p,aryngeal squamous cell carcinoma,0.8192273378372192
hsa-miR-584,aryngeal squamous cell carcinoma,0.8192273378372192
hsa-miR-1281,sarcoma,0.8192130327224731
hsa-miR-625-3p,sarcoma,0.8192130327224731
hsa-miR-3647-5p,sarcoma,0.8192130327224731
hsa-miR-363,sarcoma,0.8192130327224731
hsa-miR-4711-5p,sarcoma,0.8192130327224731
hsa-miR-633,ovarian carcinoma,0.8191831707954407
hsa-miR-7850-5p,ovarian carcinoma,0.8191831707954407
hsa-miR-335-5p,ovarian carcinoma,0.8191831707954407
hsa-miR-1277-5p,ovarian carcinoma,0.8191831707954407
hsa-miR-3162-5p,ovarian carcinoma,0.8191831707954407
hsa-miR-4713-5p,ovarian carcinoma,0.8191831707954407
hsa-miR-302b-5p,ovarian carcinoma,0.8191831707954407
hsa-miR-513a-5p,pilocytic astrocytoma,0.8191763758659363
hsa-miR-616-3p,high grade serous papillary ovarian cancer,0.8191739916801453
hsa-miR-1468,high grade serous papillary ovarian cancer,0.8191739916801453
hsa-miR-382-3p,high grade serous papillary ovarian cancer,0.8191739916801453
hsa-miR-128-1,high grade serous papillary ovarian cancer,0.8191739916801453
hsa-miR-125b-1*,high grade serous papillary ovarian cancer,0.8191739916801453
hsa-miR-6819-3p,high grade serous papillary ovarian cancer,0.8191739916801453
hsa-miR-195,breast cancer brain metastasis,0.8191711902618408
hsa-miR-6722-5p,miR-142-y,0.8191571831703186
hsa-miR-5003-5p,miR-142-y,0.8191571831703186
hsa-miR-363,miR-142-y,0.8191571831703186
hsa-miR-500b-5p,miR-142-y,0.8191571831703186
hsa-miR-1204,miR-142-y,0.8191571831703186
hsa-miR-151a-5p,miR-142-y,0.8191571831703186
hsa-miR-6788-5p,miR-142-y,0.8191571831703186
hsa-miR-6863,high grade serous papillary ovarian cancer,0.8191524147987366
hsa-miR-186,primary central nervous system lymphomas,0.8191262483596802
hsa-miR-6729-3p,rhabdomyosarcomas,0.8191134333610535
hsa-miR-383-3p,miR-142-y,0.8190453052520752
hsa-miR-200c*,miR-142-y,0.8190453052520752
hsa-miR-10a,papillary thyroid carcinoma,0.8190452456474304
hsa-miR-1244,Leptomeningeal metastasis,0.8190228939056396
hsa-miR-4796-3p,miR-675-y,0.8190222978591919
hsa-miR-497,papillary thyroid carcinoma,0.8190029263496399
hsa-miR-129-2-3p,Leptomeningeal metastasis,0.8189952373504639
hsa-miR-4798-5p,high grade serous papillary ovarian cancer,0.8189849257469177
hsa-miR-326,high grade serous papillary ovarian cancer,0.8189849257469177
hsa-miR-3687,high grade serous papillary ovarian cancer,0.8189849257469177
hsa-miR-4722-3p,high grade serous papillary ovarian cancer,0.8189849257469177
hsa-miR-92a-1-5p,high grade serous papillary ovarian cancer,0.8189849257469177
hsa-miR-4301,high grade serous papillary ovarian cancer,0.8189849257469177
hsa-miR-6868-3p,high grade serous papillary ovarian cancer,0.8189849257469177
hsa-miR-412-5p,high grade serous papillary ovarian cancer,0.8189849257469177
hsa-miR-6741-3p,Leptomeningeal metastasis,0.8189809322357178
hsa-miR-642a-5p,follicular thyroid carcinoma,0.8189551830291748
hsa-miR-219-5p,follicular thyroid carcinoma,0.8189551830291748
hsa-miR-8065,Leptomeningeal metastasis,0.8189362287521362
hsa-miR-516-3p,rhabdomyosarcomas,0.8189209699630737
hsa-miR-96*,rhabdomyosarcomas,0.8189209699630737
hsa-miR-1538,rhabdomyosarcomas,0.8189209699630737
hsa-miR-1269,follicular thyroid carcinoma,0.8188979625701904
hsa-miR-4756-5p,high grade serous papillary ovarian cancer,0.818845272064209
hsa-miR-6852-5p,high grade serous papillary ovarian cancer,0.818845272064209
hsa-miR-3155b,high grade serous papillary ovarian cancer,0.818845272064209
hsa-miR-454*,Leptomeningeal metastasis,0.8188371062278748
hsa-miR-021,rhabdomyosarcomas,0.818817675113678
hsa-miR-1245b-5p,primary central nervous system lymphomas,0.8188084363937378
hsa-miR-6799-5p,Leptomeningeal metastasis,0.8187819719314575
hsa-miR-1266-3p,Leptomeningeal metastasis,0.8187804818153381
hsa-miR-486-3p,Leptomeningeal metastasis,0.818726658821106
hsa-miR-8065,aryngeal squamous cell carcinoma,0.8187111020088196
hsa-miR-15b,ovarian carcinoma,0.8187068700790405
hsa-miR-4662a-5p,ovarian carcinoma,0.8187068700790405
hsa-miR-887-3p,ovarian carcinoma,0.8187068700790405
hsa-miR-193,ovarian carcinoma,0.8187068700790405
hsa-miR-467,ovarian carcinoma,0.8187068700790405
hsa-miR-383,ovarian carcinoma,0.8187068700790405
hsa-miR-222-5p,ovarian carcinoma,0.8187068700790405
hsa-miR-223-3p,ovarian carcinoma,0.8187068700790405
hsa-miR-376a-5p,ovarian carcinoma,0.8187068700790405
hsa-miR-5582-5p,ovarian carcinoma,0.8187068700790405
hsa-miR-3936,ovarian carcinoma,0.8187068700790405
hsa-miR-1273g-3p,ovarian carcinoma,0.8187068700790405
hsa-miR-21*,ovarian carcinoma,0.8187068700790405
hsa-miR-335-3p,ovarian carcinoma,0.8187068700790405
hsa-miR-20a-3p,ovarian carcinoma,0.8187068700790405
hsa-miR-3685,ovarian carcinoma,0.8187068700790405
hsa-miR-6835-5p,ovarian carcinoma,0.8187068700790405
hsa-miR-4438,ovarian carcinoma,0.8187068700790405
hsa-miR-633,pilocytic astrocytoma,0.8186976909637451
hsa-miR-581,Leptomeningeal metastasis,0.8186975717544556
hsa-miR-99a-3p,ovarian carcinoma,0.8186958432197571
hsa-miR-3185,ovarian carcinoma,0.8186958432197571
hsa-miR-7153-5p,ovarian carcinoma,0.8186958432197571
hsa-miR-518f-3p,Leptomeningeal metastasis,0.8186895847320557
hsa-miR-2116,Leptomeningeal metastasis,0.8186895847320557
hsa-miR-376a-2-5p,Leptomeningeal metastasis,0.8186895847320557
hsa-miR-15b,pilocytic astrocytoma,0.8186796307563782
hsa-miR-196a*,pilocytic astrocytoma,0.8186796307563782
hsa-miR-1972,aryngeal squamous cell carcinoma,0.8186632990837097
hsa-miR-6871-5p,Leptomeningeal metastasis,0.818656861782074
hsa-miR-4706,Leptomeningeal metastasis,0.818656861782074
hsa-miR-519c-3p,Leptomeningeal metastasis,0.818656861782074
hsa-miR-520h,Leptomeningeal metastasis,0.8186357617378235
hsa-miR-3651,aryngeal squamous cell carcinoma,0.8185849189758301
hsa-miR-6817-5p,Leptomeningeal metastasis,0.8185684680938721
hsa-miR-296-5p,papillary thyroid carcinoma,0.8185661435127258
hsa-miR-4485,Leptomeningeal metastasis,0.8185533881187439
hsa-miR-193,papillary thyroid carcinoma,0.8185481429100037
hsa-miR-374a,high grade serous papillary ovarian cancer,0.8185279965400696
hsa-miR-19b-1,rhabdomyosarcomas,0.8185099959373474
hsa-miR-220c,Leptomeningeal metastasis,0.8184953331947327
hsa-miR-582,Leptomeningeal metastasis,0.8184953331947327
hsa-miR-2681,papillary thyroid carcinoma,0.8184923529624939
hsa-miR-19b-1*,pilocytic astrocytoma,0.8184677958488464
hsa-miR-5189,aryngeal squamous cell carcinoma,0.8184643387794495
hsa-miR-548at-5p,aryngeal squamous cell carcinoma,0.8184643387794495
hsa-miR-330-3p,aryngeal squamous cell carcinoma,0.8184643387794495
hsa-miR-3186-5p,aryngeal squamous cell carcinoma,0.8184643387794495
hsa-miR-4775,Leptomeningeal metastasis,0.8184561729431152
hsa-miR-4429,aryngeal squamous cell carcinoma,0.8184419870376587
hsa-miR-876-5p,aryngeal squamous cell carcinoma,0.8184419870376587
hsa-miR-34b*,Leptomeningeal metastasis,0.8183924555778503
hsa-miR-511-2,breast cancer brain metastasis,0.8183921575546265
hsa-miR-496,breast cancer brain metastasis,0.8183921575546265
hsa-miR-551a,breast cancer brain metastasis,0.8183921575546265
hsa-miR-509-3-5p,breast cancer brain metastasis,0.8183921575546265
hsa-let-7b*,aryngeal squamous cell carcinoma,0.8183774948120117
hsa-miR-362-5p,aryngeal squamous cell carcinoma,0.8183774948120117
hsa-miR-548c-3p,miR-675-y,0.8183648586273193
hsa-miR-615,miR-675-y,0.8183648586273193
hsa-miR-3926,pilocytic astrocytoma,0.8183593153953552
hsa-miR-343,Leptomeningeal metastasis,0.8183251023292542
hsa-miR-4271,high grade serous papillary ovarian cancer,0.8182971477508545
hsa-miR-765,Leptomeningeal metastasis,0.8182745575904846
hsa-miR-219a-1-3p,papillary thyroid carcinoma,0.8182376027107239
hsa-miR-450a,aryngeal squamous cell carcinoma,0.818230926990509
hsa-miR-6769b-5p,aryngeal squamous cell carcinoma,0.818230926990509
hsa-miR-6792-5p,papillary thyroid carcinoma,0.8182277083396912
hsa-miR-1234-3p,high grade serous papillary ovarian cancer,0.8181970715522766
hsa-miR-5699-5p,high grade serous papillary ovarian cancer,0.8181970715522766
hsa-miR-588,high grade serous papillary ovarian cancer,0.8181970715522766
hsa-miR-7,rhabdomyosarcomas,0.8181923031806946
hsa-miR-191-5p,follicular thyroid carcinoma,0.8181911706924438
hsa-miR-935,ovarian carcinoma,0.8181891441345215
hsa-miR-6076,ovarian carcinoma,0.8181891441345215
hsa-miR-9-1*,ovarian carcinoma,0.8181891441345215
hsa-miR-3942-3p,ovarian carcinoma,0.8181891441345215
hsa-miR-767-3p,ovarian carcinoma,0.8181891441345215
hsa-miR-1285-5p,ovarian carcinoma,0.8181891441345215
hsa-miR-182-3p,ovarian carcinoma,0.8181891441345215
hsa-miR-676-5p,follicular thyroid carcinoma,0.8181731104850769
hsa-miR-129-2,follicular thyroid carcinoma,0.8181731104850769
hsa-miR-1185-5p,Leptomeningeal metastasis,0.8181632161140442
hsa-miR-4725-5p,pilocytic astrocytoma,0.8181525468826294
hsa-miR-6086,aryngeal squamous cell carcinoma,0.8181453347206116
hsa-miR-28-5p,Leptomeningeal metastasis,0.8181057572364807
hsa-miR-1279,aryngeal squamous cell carcinoma,0.8180995583534241
hsa-miR-517c,papillary thyroid carcinoma,0.8180979490280151
hsa-miR-9-1*,papillary thyroid carcinoma,0.8180979490280151
hsa-miR-1273e,Leptomeningeal metastasis,0.8180733323097229
hsa-miR-6741-3p,breast cancer brain metastasis,0.818057119846344
hsa-miR-1915,Leptomeningeal metastasis,0.8180552124977112
hsa-miRPlus-G1246-3p,Leptomeningeal metastasis,0.8180552124977112
hsa-miR-644b-5p,Leptomeningeal metastasis,0.8180552124977112
hsa-miR-15b-5p,high grade serous papillary ovarian cancer,0.8180513978004456
hsa-miR-369-5p,aryngeal squamous cell carcinoma,0.8180488348007202
hsa-miR-7641,Leptomeningeal metastasis,0.8180457353591919
hsa-miR-548d-5p,pilocytic astrocytoma,0.8179833292961121
hsa-miR-294,follicular thyroid carcinoma,0.8179494142532349
hsa-miR-520a-3p,aryngeal squamous cell carcinoma,0.8179375529289246
hsa-miR-548aq-5p,Leptomeningeal metastasis,0.8179237246513367
hsa-miR-6855-5p,aryngeal squamous cell carcinoma,0.8178799748420715
hsa-miR-105*,Leptomeningeal metastasis,0.817857027053833
hsa-miR-6842-5p,Leptomeningeal metastasis,0.817857027053833
hsa-miR-520b-520c,high grade serous papillary ovarian cancer,0.8178516030311584
hsa-miR-219-2-3p,papillary thyroid carcinoma,0.8178514242172241
hsa-miR-548d-5p,Leptomeningeal metastasis,0.8177871108055115
hsa-miR-372-5p,Leptomeningeal metastasis,0.8177871108055115
hsa-miR-1207-5p,Leptomeningeal metastasis,0.8177871108055115
hsa-miR-642b-3p,high grade serous papillary ovarian cancer,0.8177750706672668
hsa-miR-621,aryngeal squamous cell carcinoma,0.8177605867385864
hsa-miR-4454,Leptomeningeal metastasis,0.8177341222763062
hsa-miR-1247,Leptomeningeal metastasis,0.8177341222763062
hsa-miR-658,Leptomeningeal metastasis,0.8177341222763062
hsa-miR-4298,pilocytic astrocytoma,0.8177252411842346
hsa-miR-6728-5p,primary central nervous system lymphomas,0.8177215456962585
hsa-miRPlus-A1025,Leptomeningeal metastasis,0.8177143931388855
hsa-miR-196-1,Leptomeningeal metastasis,0.8177143931388855
hsa-miR-4662b,high grade serous papillary ovarian cancer,0.8177005648612976
hsa-miR-33a,aryngeal squamous cell carcinoma,0.8176976442337036
hsa-miR-3908,aryngeal squamous cell carcinoma,0.8176976442337036
hsa-miR-4312,aryngeal squamous cell carcinoma,0.8176976442337036
hsa-miR-1468,primary central nervous system lymphomas,0.8176928758621216
hsa-miR-183-5p,ovarian carcinoma,0.8176530003547668
hsa-miR-7112-5p,ovarian carcinoma,0.8176530003547668
hsa-miR-6760-3p,ovarian carcinoma,0.8176530003547668
hsa-miR-224-3p,ovarian carcinoma,0.8176530003547668
hsa-miR-516b*,ovarian carcinoma,0.8176530003547668
hsa-miR-660-5p,ovarian carcinoma,0.8176530003547668
hsa-miR-6813-5p,ovarian carcinoma,0.8176530003547668
hsa-miR-4297,miR-675-y,0.8176510334014893
hsa-miR-551a,miR-675-y,0.8176510334014893
hsa-miR-186,aryngeal squamous cell carcinoma,0.8176395297050476
hsa-miR-609,Leptomeningeal metastasis,0.8176364898681641
hsa-miR-361-5p,Leptomeningeal metastasis,0.8176364898681641
hsa-miR-549,Leptomeningeal metastasis,0.8176364898681641
hsa-miR-92b-5p,high grade serous papillary ovarian cancer,0.8176236748695374
hsa-miR-935,Leptomeningeal metastasis,0.8176041841506958
hsa-miR-3190-5p,aryngeal squamous cell carcinoma,0.8175987601280212
hsa-miR-6735-3p,aryngeal squamous cell carcinoma,0.8175987601280212
hsa-miR-132,ovarian carcinoma,0.8175851702690125
hsa-miR-646,ovarian carcinoma,0.8175851702690125
hsa-miR-1236-5p,ovarian carcinoma,0.8175851702690125
hsa-miR-4514,ovarian carcinoma,0.8175851702690125
hsa-miR-1909-5p,ovarian carcinoma,0.8175851702690125
hsa-miR-4266,ovarian carcinoma,0.8175851702690125
hsa-miR-412,Leptomeningeal metastasis,0.8175534009933472
hsa-miR-4502,high grade serous papillary ovarian cancer,0.8175442218780518
hsa-miR-582,rhabdomyosarcomas,0.8175204992294312
hsa-miR-448,rhabdomyosarcomas,0.8175150156021118
hsa-miR-302e,rhabdomyosarcomas,0.8175150156021118
hsa-miR-214-5p,primary central nervous system lymphomas,0.8175026178359985
hsa-miR-519c-3p,high grade serous papillary ovarian cancer,0.8174923658370972
hsa-miR-2115-3p,high grade serous papillary ovarian cancer,0.8174923658370972
hsa-miR-4652-3p,aryngeal squamous cell carcinoma,0.8174881339073181
hsa-miR-6857-5p,Luminal B Her2+,0.8174867630004883
hsa-miR-639,follicular thyroid carcinoma,0.8174753189086914
hsa-miR-591,Leptomeningeal metastasis,0.8174750804901123
hsa-miR-665,Leptomeningeal metastasis,0.8174750804901123
hsa-miR-2114*,high grade serous papillary ovarian cancer,0.8174622654914856
hsa-miR-6820-5p,high grade serous papillary ovarian cancer,0.8174622654914856
hsa-miR-520c-3p,pilocytic astrocytoma,0.8174600005149841
hsa-miR-320e,Leptomeningeal metastasis,0.8174566626548767
hsa-miR-5196-3p,Leptomeningeal metastasis,0.8174566626548767
hsa-miR-1304,Leptomeningeal metastasis,0.8174566626548767
hsa-miR-4525,Leptomeningeal metastasis,0.8174566626548767
hsa-miR-92a-3p,aryngeal squamous cell carcinoma,0.8174102902412415
hsa-miR-7641,papillary thyroid carcinoma,0.817383885383606
hsa-miR-3182,high grade serous papillary ovarian cancer,0.8173773288726807
hsa-miR-3910,high grade serous papillary ovarian cancer,0.8173773288726807
hsa-miR-27a-3p,primary central nervous system lymphomas,0.8173763751983643
hsa-miR-451a,Leptomeningeal metastasis,0.8173571228981018
hsa-miR-213,pilocytic astrocytoma,0.8173531889915466
hsa-miR-2110,Leptomeningeal metastasis,0.8173478841781616
hsa-miR-609,papillary thyroid carcinoma,0.8173277974128723
hsa-miR-4475,papillary thyroid carcinoma,0.8173277974128723
hsa-miR-2114*,aryngeal squamous cell carcinoma,0.817319929599762
hsa-miR-548av-3p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-7106-3p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-6882-5p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-517a-3p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-545,castration-resistant prostate cancer,0.8172881007194519
hsa-miRPlus-J1004,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-3647-5p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-1255b-2,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-4323,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-4321,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-6823-3p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-208b-5p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-3186-3p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-26a-1*,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-5588-3p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-151a-5p,castration-resistant prostate cancer,0.8172881007194519
hsa-miR-4529-5p,Leptomeningeal metastasis,0.8172633647918701
hsa-miR-5582-3p,solid pseudopapillary neoplasm of pancreas,0.8172587156295776
hsa-miRPlus-C1087,solid pseudopapillary neoplasm of pancreas,0.8172587156295776
hsa-miR-3679-5p,Leptomeningeal metastasis,0.8172302842140198
hsa-miR-4796-5p,Leptomeningeal metastasis,0.8172302842140198
hsa-miR-4791,Leptomeningeal metastasis,0.8172302842140198
hsa-miR-544,Leptomeningeal metastasis,0.8172302842140198
hsa-miR-6511b-3p,aryngeal squamous cell carcinoma,0.8172301650047302
hsa-miR-4276,aryngeal squamous cell carcinoma,0.8172301650047302
hsa-miR-371a-5p,aryngeal squamous cell carcinoma,0.8172301650047302
hsa-miR-212-5p,breast cancer brain metastasis,0.8172298073768616
hsa-miR-600,high grade serous papillary ovarian cancer,0.8172265887260437
hsa-miR-212-5p,high grade serous papillary ovarian cancer,0.8172265887260437
hsa-miR-199a*-2,high grade serous papillary ovarian cancer,0.8172265887260437
hsa-miR-3147,high grade serous papillary ovarian cancer,0.8172265887260437
hsa-miR-519d,high grade serous papillary ovarian cancer,0.8172265887260437
hsa-miR-3123,high grade serous papillary ovarian cancer,0.8172265887260437
hsa-miR-4296,follicular thyroid carcinoma,0.8172166347503662
hsa-miR-6738-5p,synovial sarcoma,0.8171376585960388
hsa-miR-4738-5p,synovial sarcoma,0.8171376585960388
hsa-miR-505,synovial sarcoma,0.8171376585960388
hsa-miR-1273h-3p,synovial sarcoma,0.8171376585960388
hsa-miR-381-3p,synovial sarcoma,0.8171376585960388
hsa-miR-220b,rhabdomyosarcomas,0.8171271085739136
hsa-miR-590,rhabdomyosarcomas,0.8171271085739136
hsa-let-7i,rhabdomyosarcomas,0.8171271085739136
hsa-miR-4774-3p,rhabdomyosarcomas,0.8171271085739136
hsa-miR-100*,rhabdomyosarcomas,0.8171271085739136
hsa-miR-5692c,rhabdomyosarcomas,0.8171271085739136
hsa-miRPlus-A1087,follicular thyroid carcinoma,0.8171249628067017
hsa-miR-513,aryngeal squamous cell carcinoma,0.8171214461326599
hsa-miR-4467,aryngeal squamous cell carcinoma,0.8171214461326599
hsa-miR-518d-5p,aryngeal squamous cell carcinoma,0.8171214461326599
hsa-miR-337-5p,high grade serous papillary ovarian cancer,0.81711745262146
hsa-miR-768-3p:11.0,high grade serous papillary ovarian cancer,0.81711745262146
hsa-miR-27b*,high grade serous papillary ovarian cancer,0.81711745262146
hsa-miR-325,Leptomeningeal metastasis,0.8171006441116333
hsa-miR-1307,Leptomeningeal metastasis,0.8171006441116333
hsa-miR-5692b,Leptomeningeal metastasis,0.8171006441116333
hsa-miR-6893-5p,Leptomeningeal metastasis,0.8171006441116333
hsa-miR-1228-5p,ovarian carcinoma,0.8170979022979736
hsa-miR-196-1,ovarian carcinoma,0.8170979022979736
hsa-miR-139-3p,ovarian carcinoma,0.8170979022979736
hsa-miR-4449,ovarian carcinoma,0.8170979022979736
hsa-miR-224-5p,ovarian carcinoma,0.8170979022979736
hsa-miR-369-3p,ovarian carcinoma,0.8170979022979736
hsa-miR-1243,ovarian carcinoma,0.8170979022979736
hsa-miR-219-1,ovarian carcinoma,0.8170979022979736
hsa-miR-541*,ovarian carcinoma,0.8170979022979736
hsa-miR-3133,ovarian carcinoma,0.8170979022979736
hsa-miR-26a-1,miR-142-y,0.8170784711837769
hsa-miRPlus-J1004,miR-142-y,0.8170784711837769
hsa-miR-6885-5p,miR-142-y,0.8170784711837769
hsa-miR-4323,miR-142-y,0.8170784711837769
hsa-miR-487a-5p,miR-142-y,0.8170784711837769
hsa-miR-4493,miR-142-y,0.8170784711837769
hsa-miR-1182,high grade serous papillary ovarian cancer,0.8170563578605652
hsa-miR-3179,high grade serous papillary ovarian cancer,0.8170563578605652
hsa-miR-103a,high grade serous papillary ovarian cancer,0.8170563578605652
hsa-miR-5591-3p,high grade serous papillary ovarian cancer,0.8170563578605652
hsa-miR-340,papillary thyroid carcinoma,0.8170421123504639
hsa-miR-4498,aryngeal squamous cell carcinoma,0.8170366287231445
hsa-miR-223-3p,aryngeal squamous cell carcinoma,0.8170366287231445
hsa-miR-454*,breast cancer brain metastasis,0.8170088529586792
hsa-miR-196a-1,high grade serous papillary ovarian cancer,0.8170074224472046
hsa-miR-450a-2-3p,aryngeal squamous cell carcinoma,0.8170034885406494
hsa-miR-526a,aryngeal squamous cell carcinoma,0.8170034885406494
hsa-miR-4675,aryngeal squamous cell carcinoma,0.8170034885406494
hsa-miR-3144-3p,Leptomeningeal metastasis,0.8169823288917542
hsa-miR-548ad,Leptomeningeal metastasis,0.8169823288917542
hsa-miR-543,Leptomeningeal metastasis,0.8169823288917542
hsa-miR-141*,Leptomeningeal metastasis,0.8169823288917542
hsa-miR-7112-5p,Luminal B Her2+,0.8169489502906799
hsa-miR-558,miR-675-y,0.8169461488723755
hsa-miR-3675-3p,miR-675-y,0.8169461488723755
hsa-miR-4538,miR-142-y,0.8169291019439697
hsa-miR-4649-3p,miR-142-y,0.8169291019439697
hsa-miR-877-5p,miR-142-y,0.8169291019439697
hsa-miR-7158-3p,miR-142-y,0.8169291019439697
hsa-miR-181c-5p,high grade serous papillary ovarian cancer,0.8169064521789551
hsa-miR-4503,Leptomeningeal metastasis,0.8168860673904419
hsa-miR-568,Leptomeningeal metastasis,0.8168860673904419
hsa-miR-4747-3p,aryngeal squamous cell carcinoma,0.8168737292289734
hsa-miR-34c-5p,aryngeal squamous cell carcinoma,0.8168737292289734
hsa-miR-218-2-3p,aryngeal squamous cell carcinoma,0.8168737292289734
hsa-miR-4319,aryngeal squamous cell carcinoma,0.8168737292289734
hsa-miR-106a-3p,aryngeal squamous cell carcinoma,0.8168737292289734
hsa-miR-425-3p,aryngeal squamous cell carcinoma,0.8168689012527466
hsa-miR-92a-2*,aryngeal squamous cell carcinoma,0.8168689012527466
hsa-miR-500a,aryngeal squamous cell carcinoma,0.8168689012527466
hsa-miR-3620,aryngeal squamous cell carcinoma,0.8168689012527466
hsa-miR-6856-5p,aryngeal squamous cell carcinoma,0.8168689012527466
hsa-miR-185,pilocytic astrocytoma,0.8168630003929138
hsa-miR-1915*,pilocytic astrocytoma,0.8168630003929138
hsa-miR-5681b,pilocytic astrocytoma,0.8168630003929138
hsa-miRPlus-J1004,follicular thyroid carcinoma,0.8168438076972961
hsa-miR-559,follicular thyroid carcinoma,0.8168438076972961
hsa-miR-6736-3p,Leptomeningeal metastasis,0.8168324828147888
hsa-miR-3651,breast cancer brain metastasis,0.8168120980262756
hsa-miR-10b-5p,breast cancer brain metastasis,0.8168120980262756
hsa-miR-637,Leptomeningeal metastasis,0.8168063759803772
hsa-miR-6750-5p,Leptomeningeal metastasis,0.8168063759803772
hsa-miR-892b,Leptomeningeal metastasis,0.8168063759803772
hsa-miR-4269,Leptomeningeal metastasis,0.8167959451675415
hsa-miR-519b-3p,Leptomeningeal metastasis,0.8167730569839478
hsa-miR-29a-3p,Leptomeningeal metastasis,0.8167730569839478
hsa-miR-6741-3p,follicular thyroid carcinoma,0.8167712092399597
hsa-miR-4501,aryngeal squamous cell carcinoma,0.816755473613739
hsa-miR-508-3p,ovarian carcinoma,0.816737174987793
hsa-miR-7106-3p,ovarian carcinoma,0.816737174987793
hsa-miR-515-3p,ovarian carcinoma,0.816737174987793
hsa-miR-5003-5p,ovarian carcinoma,0.816737174987793
hsa-miR-604,ovarian carcinoma,0.816737174987793
hsa-miR-5585-3p,ovarian carcinoma,0.816737174987793
hsa-miR-16-1,ovarian carcinoma,0.816737174987793
hsa-miR-548aw,ovarian carcinoma,0.816737174987793
hsa-miR-4321,ovarian carcinoma,0.816737174987793
hsa-miR-195-3p,ovarian carcinoma,0.816737174987793
hsa-miR-589*,ovarian carcinoma,0.816737174987793
hsa-miR-5188,ovarian carcinoma,0.816737174987793
hsa-miR-548ae-3p,ovarian carcinoma,0.816737174987793
hsa-miR-1b-2,Leptomeningeal metastasis,0.8167253136634827
hsa-miR-767,high grade serous papillary ovarian cancer,0.8167221546173096
hsa-miR-6829-3p,high grade serous papillary ovarian cancer,0.8167221546173096
hsa-miR-1299,high grade serous papillary ovarian cancer,0.8167221546173096
hsa-miR-559,aryngeal squamous cell carcinoma,0.8167033791542053
hsa-miR-509-5p,aryngeal squamous cell carcinoma,0.8167033791542053
hsa-miR-6830-5p,aryngeal squamous cell carcinoma,0.8167033791542053
hsa-miR-123,high grade serous papillary ovarian cancer,0.8166928887367249
hsa-miR-5088-5p,follicular thyroid carcinoma,0.8166646957397461
hsa-miR-3616-5p,ovarian carcinoma,0.8166624307632446
hsa-miR-6731-3p,ovarian carcinoma,0.8166624307632446
hsa-miR-4433b-5p,ovarian carcinoma,0.8166624307632446
hsa-miR-4421,ovarian carcinoma,0.8166624307632446
hsa-miR-463,ovarian carcinoma,0.8166624307632446
hsa-miR-4649-3p,ovarian carcinoma,0.8166624307632446
hsa-miR-548at-3p,ovarian carcinoma,0.8166624307632446
hsa-miR-7158-3p,ovarian carcinoma,0.8166624307632446
hsa-miR-4503,aryngeal squamous cell carcinoma,0.8166589736938477
hsa-miR-500,aryngeal squamous cell carcinoma,0.8166589736938477
hsa-miR-548h-5p,aryngeal squamous cell carcinoma,0.8166589736938477
hsa-miR-614,aryngeal squamous cell carcinoma,0.8166589736938477
hsa-miR-4706,rhabdomyosarcomas,0.8166404962539673
hsa-miR-876-5p,primary central nervous system lymphomas,0.8166230916976929
hsa-miR-129-5p,primary central nervous system lymphomas,0.8166230916976929
hsa-miR-3916,pilocytic astrocytoma,0.8166155219078064
hsa-miR-486-3p,high grade serous papillary ovarian cancer,0.8165798187255859
hsa-miR-6503-3p,high grade serous papillary ovarian cancer,0.8165798187255859
hsa-miR-550b-2-5p,aryngeal squamous cell carcinoma,0.8165794610977173
hsa-miR-4763-5p,aryngeal squamous cell carcinoma,0.8165794610977173
hsa-miR-3187-3p,aryngeal squamous cell carcinoma,0.8165794610977173
hsa-miR-6872-5p,aryngeal squamous cell carcinoma,0.8165794610977173
hsa-miR-3976,aryngeal squamous cell carcinoma,0.8165794610977173
hsa-miR-6800-5p,Leptomeningeal metastasis,0.8165697455406189
hsa-miR-532,aryngeal squamous cell carcinoma,0.8165688514709473
hsa-miR-103a-2-5p,aryngeal squamous cell carcinoma,0.8165688514709473
hsa-miR-589-3p,aryngeal squamous cell carcinoma,0.8165688514709473
hsa-miR-99a*,pilocytic astrocytoma,0.8165475130081177
hsa-miR-1470,pilocytic astrocytoma,0.8165475130081177
hsa-miR-1202,pilocytic astrocytoma,0.8165475130081177
hsa-miR-323-5p,Leptomeningeal metastasis,0.8165460824966431
hsa-miR-1289,aryngeal squamous cell carcinoma,0.8165456652641296
hsa-miR-1304-5p,aryngeal squamous cell carcinoma,0.8165456652641296
hsa-miR-373,follicular thyroid carcinoma,0.8165428638458252
hsa-miR-122*,ovarian carcinoma,0.8165169954299927
hsa-miR-5195-3p,ovarian carcinoma,0.8165169954299927
hsa-miR-431*,miR-142-y,0.8164997100830078
hsa-miR-921,miR-142-y,0.8164997100830078
hsa-miR-6508-3p,miR-142-y,0.8164997100830078
hsa-miR-4511,miR-142-y,0.8164997100830078
hsa-miR-410-5p,miR-142-y,0.8164997100830078
hsa-miR-181a-3p,miR-142-y,0.8164997100830078
hsa-miR-615-3p,miR-142-y,0.8164997100830078
hsa-miR-607,breast cancer brain metastasis,0.81645667552948
hsa-miR-4804-5p,breast cancer brain metastasis,0.81645667552948
hsa-miR-302a*,papillary thyroid carcinoma,0.8164041638374329
hsa-miR-320,papillary thyroid carcinoma,0.8164041638374329
hsa-miR-6500-3p,"Luminal A,Luminal B",0.8163982629776001
hsa-let-7a-3p,rhabdomyosarcomas,0.8163837790489197
hsa-miR-4429,high grade serous papillary ovarian cancer,0.8163400292396545
hsa-miR-30c-2*,high grade serous papillary ovarian cancer,0.8163400292396545
hsa-miR-6835-3p,high grade serous papillary ovarian cancer,0.8163400292396545
hsa-miR-488*,pilocytic astrocytoma,0.8163294792175293
hsa-miR-1238,pilocytic astrocytoma,0.8163294792175293
hsa-miR-544b,high grade serous papillary ovarian cancer,0.8163046836853027
hsa-miR-1266,high grade serous papillary ovarian cancer,0.8163046836853027
hsa-miR-370,pilocytic astrocytoma,0.8162385821342468
hsa-miR-185,Leptomeningeal metastasis,0.8162338137626648
hsa-miR-513a-3p,ovarian carcinoma,0.8162325620651245
hsa-miR-602,ovarian carcinoma,0.8162325620651245
hsa-miR-105-1,ovarian carcinoma,0.8162325620651245
hsa-miR-344,ovarian carcinoma,0.8162325620651245
hsa-miR-501-3p,ovarian carcinoma,0.8162325620651245
hsa-miR-6717-5p,ovarian carcinoma,0.8162325620651245
hsa-miR-3660,ovarian carcinoma,0.8162325620651245
hsa-miR-345-5p,ovarian carcinoma,0.8162325620651245
hsa-miR-556,ovarian carcinoma,0.8162325620651245
hsa-miR-3680*,ovarian carcinoma,0.8162325620651245
hsa-miR-219a-1-3p,rhabdomyosarcomas,0.8162177205085754
hsa-miR-1185-5p,rhabdomyosarcomas,0.8162177205085754
hsa-miR-5090,high grade serous papillary ovarian cancer,0.8162127137184143
hsa-miR-6879-5p,papillary thyroid carcinoma,0.8161966800689697
hsa-miR-1915,papillary thyroid carcinoma,0.8161265850067139
hsa-miR-129-2,papillary thyroid carcinoma,0.8161265850067139
hsa-miR-467,papillary thyroid carcinoma,0.8161265850067139
hsa-miR-3620-3p,papillary thyroid carcinoma,0.8161057233810425
hsa-miR-662,papillary thyroid carcinoma,0.8161057233810425
hsa-miR-1272,papillary thyroid carcinoma,0.8161057233810425
hsa-miR-6769a-3p,high grade serous papillary ovarian cancer,0.8160800933837891
hsa-miR-9-1,high grade serous papillary ovarian cancer,0.8160800933837891
hsa-miR-3690,high grade serous papillary ovarian cancer,0.8160800933837891
hsa-miR-3185,Leptomeningeal metastasis,0.816076934337616
hsa-miR-1207,pilocytic astrocytoma,0.8160578608512878
hsa-let-7f-2*,aryngeal squamous cell carcinoma,0.816055953502655
hsa-miR-1914*,follicular thyroid carcinoma,0.8160202503204346
hsa-miR-4685-3p,follicular thyroid carcinoma,0.8160202503204346
hsa-miR-591,rhabdomyosarcomas,0.8159880638122559
hsa-miR-1300,pilocytic astrocytoma,0.8159735798835754
hsa-miR-20b*,pilocytic astrocytoma,0.8159735798835754
hsa-miR-3196,rhabdomyosarcomas,0.8159657120704651
hsa-miR-665,rhabdomyosarcomas,0.8159657120704651
hsa-miR-518d-3p,high grade serous papillary ovarian cancer,0.815941572189331
hsa-miR-6793-3p,Leptomeningeal metastasis,0.8159067034721375
hsa-miRPlus-A1015,Leptomeningeal metastasis,0.8159067034721375
hsa-miR-30e,ovarian carcinoma,0.8158852458000183
hsa-miR-340,ovarian carcinoma,0.8158852458000183
hsa-miR-3117-3p,ovarian carcinoma,0.8158852458000183
hsa-miR-514b-5p,ovarian carcinoma,0.8158852458000183
hsa-miR-4710,ovarian carcinoma,0.8158852458000183
hsa-miR-6893-3p,aryngeal squamous cell carcinoma,0.8158788084983826
hsa-miR-606,aryngeal squamous cell carcinoma,0.8158788084983826
hsa-miR-140,aryngeal squamous cell carcinoma,0.8158788084983826
hsa-miR-4760-3p,aryngeal squamous cell carcinoma,0.8158788084983826
hsa-miR-4804-5p,aryngeal squamous cell carcinoma,0.8158788084983826
hsa-miR-4679,aryngeal squamous cell carcinoma,0.8158788084983826
hsa-miR-27a-3p,aryngeal squamous cell carcinoma,0.8158788084983826
hsa-miR-1224-3p,primary central nervous system lymphomas,0.8158677816390991
hsa-miR-92a-1-5p,aryngeal squamous cell carcinoma,0.8158643841743469
hsa-miR-6803-3p,high grade serous papillary ovarian cancer,0.8158628344535828
hsa-miR-768-5p:11.0,high grade serous papillary ovarian cancer,0.8158628344535828
hsa-miR-6808-5p,high grade serous papillary ovarian cancer,0.8158628344535828
hsa-miR-500a-3p,papillary thyroid carcinoma,0.8158405423164368
hsa-miR-136,follicular thyroid carcinoma,0.8158273100852966
hsa-miR-545-3p,aryngeal squamous cell carcinoma,0.8158172965049744
hsa-miR-4769-3p,follicular thyroid carcinoma,0.8157674074172974
hsa-miR-3197,pilocytic astrocytoma,0.8157208561897278
hsa-miR-3692*,pilocytic astrocytoma,0.8157208561897278
hsa-miR-1321,pilocytic astrocytoma,0.8157208561897278
hsa-miR-129-5p,breast cancer brain metastasis,0.815700352191925
hsa-miR-1203,Leptomeningeal metastasis,0.8156988024711609
hsa-miR-548e,Leptomeningeal metastasis,0.8156988024711609
hsa-miR-145*,Leptomeningeal metastasis,0.8156988024711609
hsa-miR-185*,Leptomeningeal metastasis,0.8156988024711609
hsa-miR-571,pilocytic astrocytoma,0.8156570196151733
hsa-miR-539,pilocytic astrocytoma,0.8156570196151733
hsa-miR-1306,pilocytic astrocytoma,0.8156570196151733
hsa-miR-296-5p,Luminal B Her2+,0.8156545162200928
hsa-miR-4720-3p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-6730-3p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-4776-3p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-183-3p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-145*,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-103a-2-5p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-762,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-3618,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-1185,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-4802-3p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-149,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-2909,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-589-3p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-29b-2-5p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-3940-5p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-340*,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-6761-5p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-548y,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-1298-3p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-4305,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-4717-5p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-6511a-5p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-1178,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-6848-3p,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-542,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-3159,castration-resistant prostate cancer,0.8156498670578003
hsa-miR-021,high grade serous papillary ovarian cancer,0.8156446218490601
hsa-miR-3064-5p,high grade serous papillary ovarian cancer,0.8156446218490601
hsa-miR-758-3p,high grade serous papillary ovarian cancer,0.8156446218490601
hsa-miR-4670-5p,primary central nervous system lymphomas,0.8156105279922485
hsa-miR-3620-3p,Leptomeningeal metastasis,0.8156076669692993
hsa-miR-347,Leptomeningeal metastasis,0.8156076669692993
hsa-miR-486-3p,aryngeal squamous cell carcinoma,0.8155964016914368
hsa-let-7f-1,papillary thyroid carcinoma,0.8155876994132996
hsa-miR-6851-3p,papillary thyroid carcinoma,0.8155876994132996
hsa-miR-885-3p,primary central nervous system lymphomas,0.8155617713928223
hsa-miR-1298-5p,primary central nervous system lymphomas,0.815545916557312
hsa-let-7e*,papillary thyroid carcinoma,0.8155237436294556
hsa-miRPlus-C1099,papillary thyroid carcinoma,0.8155237436294556
hsa-miR-190a,papillary thyroid carcinoma,0.8155237436294556
hsa-miR-517b,papillary thyroid carcinoma,0.8155237436294556
hsa-miR-575,rhabdomyosarcomas,0.8155232667922974
hsa-miR-349,rhabdomyosarcomas,0.8155232667922974
hsa-miR-7641,rhabdomyosarcomas,0.8155232667922974
hsa-miR-1273e,rhabdomyosarcomas,0.8155028223991394
hsa-miR-361,pilocytic astrocytoma,0.8155006766319275
hsa-miR-576-3p,pilocytic astrocytoma,0.8155006766319275
hsa-miR-5591-5p,pilocytic astrocytoma,0.8155006766319275
hsa-miR-330-5p,pilocytic astrocytoma,0.8155006766319275
hsa-miR-3917,pilocytic astrocytoma,0.8155006766319275
hsa-miR-106,pilocytic astrocytoma,0.8155006766319275
hsa-miR-548a-3p,pilocytic astrocytoma,0.8155006766319275
hsa-miR-890,high grade serous papillary ovarian cancer,0.8154845833778381
hsa-miR-302f,high grade serous papillary ovarian cancer,0.8154845833778381
hsa-miR-147b,high grade serous papillary ovarian cancer,0.8154845833778381
hsa-miR-6801-3p,high grade serous papillary ovarian cancer,0.8154845833778381
hsa-miR-15b,rhabdomyosarcomas,0.8154845237731934
hsa-miR-4737,rhabdomyosarcomas,0.8154845237731934
hsa-miR-6727-5p,rhabdomyosarcomas,0.8154845237731934
hsa-miR-222-5p,rhabdomyosarcomas,0.8154845237731934
hsa-miR-33b-5p,pilocytic astrocytoma,0.8154744505882263
hsa-miR-466,follicular thyroid carcinoma,0.8154612183570862
hsa-miR-19a*,breast cancer brain metastasis,0.8154535889625549
hsa-miR-4426,miR-142-y,0.8154386878013611
hsa-miR-562,miR-142-y,0.8154386878013611
hsa-miR-620,miR-142-y,0.8154386878013611
hsa-miR-6761-5p,miR-142-y,0.8154386878013611
hsa-miR-768,miR-142-y,0.8154386878013611
hsa-miR-129*,pilocytic astrocytoma,0.8154216408729553
hsa-miR-379-3p,pilocytic astrocytoma,0.8154216408729553
hsa-miR-1184,pilocytic astrocytoma,0.8154216408729553
hsa-miR-5589-5p,high grade serous papillary ovarian cancer,0.8153948783874512
hsa-miR-3201,papillary thyroid carcinoma,0.8153674006462097
hsa-miR-3192-3p,Leptomeningeal metastasis,0.8153419494628906
hsa-miR-222*,Leptomeningeal metastasis,0.8153419494628906
hsa-miR-6754-5p,high grade serous papillary ovarian cancer,0.815316915512085
hsa-miR-6810-5p,papillary thyroid carcinoma,0.8152883648872375
hsa-miR-550b-2-5p,papillary thyroid carcinoma,0.8152883648872375
hsa-miR-4324,rhabdomyosarcomas,0.8152698278427124
hsa-miR-587,rhabdomyosarcomas,0.8152698278427124
hsa-miR-891a,rhabdomyosarcomas,0.8152698278427124
hsa-miR-207,rhabdomyosarcomas,0.8152698278427124
hsa-miR-3185,rhabdomyosarcomas,0.8152698278427124
hsa-miR-548ay-5p,ovarian carcinoma,0.815252959728241
hsa-miR-548h,ovarian carcinoma,0.815252959728241
hsa-miR-3074,ovarian carcinoma,0.815252959728241
hsa-miR-1233-3p,ovarian carcinoma,0.815252959728241
hsa-miR-5701,ovarian carcinoma,0.815252959728241
hsa-miR-290,ovarian carcinoma,0.815252959728241
hsa-miR-4651,ovarian carcinoma,0.815252959728241
hsa-miR-548i-1,ovarian carcinoma,0.815252959728241
hsa-miR-134-3p,ovarian carcinoma,0.815252959728241
hsa-miR-4440,ovarian carcinoma,0.815252959728241
hsa-miR-484,high grade serous papillary ovarian cancer,0.8152481317520142
hsa-miR-3189,high grade serous papillary ovarian cancer,0.8152481317520142
hsa-miR-6859-5p,high grade serous papillary ovarian cancer,0.8152481317520142
hsa-miR-6766-5p,high grade serous papillary ovarian cancer,0.8152481317520142
hsa-miR-3675-3p,high grade serous papillary ovarian cancer,0.8152481317520142
hsa-miR-6890-5p,high grade serous papillary ovarian cancer,0.8152481317520142
hsa-miR-297-1,high grade serous papillary ovarian cancer,0.8152481317520142
hsa-miR-6781-3p,high grade serous papillary ovarian cancer,0.8152481317520142
hsa-miR-123,primary central nervous system lymphomas,0.8151959776878357
hsa-miR-500a*,rhabdomyosarcomas,0.8151599168777466
hsa-miR-4779,follicular thyroid carcinoma,0.8151440024375916
hsa-miR-1256,high grade serous papillary ovarian cancer,0.8151410222053528
hsa-miR-2116,distal cholangiocarcinoma,0.8151330947875977
hsa-miR-3655,aryngeal squamous cell carcinoma,0.8151205778121948
hsa-miR-4269,ovarian carcinoma,0.8150950074195862
hsa-miR-6772-3p,ovarian carcinoma,0.8150950074195862
hsa-miR-532,ovarian carcinoma,0.8150950074195862
hsa-miR-6513-3p,ovarian carcinoma,0.8150950074195862
hsa-miR-4776-3p,ovarian carcinoma,0.8150950074195862
hsa-miR-1974,ovarian carcinoma,0.8150950074195862
hsa-miR-4426,ovarian carcinoma,0.8150950074195862
hsa-miR-302a-3p,ovarian carcinoma,0.8150950074195862
hsa-miR-3181,ovarian carcinoma,0.8150950074195862
hsa-miR-4643,ovarian carcinoma,0.8150950074195862
hsa-miR-494-3p,ovarian carcinoma,0.8150950074195862
hsa-miR-541-5p,ovarian carcinoma,0.8150950074195862
hsa-miR-5700,Leptomeningeal metastasis,0.8150885105133057
hsa-miR-99b*,Leptomeningeal metastasis,0.8150885105133057
hsa-miR-4520b-3p,Leptomeningeal metastasis,0.8150885105133057
hsa-miR-3676,rhabdomyosarcomas,0.8150548338890076
hsa-miR-296-5p,rhabdomyosarcomas,0.8150548338890076
hsa-miR-4290,aryngeal squamous cell carcinoma,0.8150464296340942
hsa-miR-1224,follicular thyroid carcinoma,0.8150372505187988
hsa-miR-619-5p,rhabdomyosarcomas,0.8150284886360168
hsa-miR-4764-3p,rhabdomyosarcomas,0.8150284886360168
hsa-miR-548aq-3p,rhabdomyosarcomas,0.8150284886360168
hsa-let-7c_c,Leptomeningeal metastasis,0.8150246143341064
hsa-miR-7111-3p,Leptomeningeal metastasis,0.8150246143341064
hsa-miR-8059,Leptomeningeal metastasis,0.8150224685668945
hsa-miR-6807-3p,follicular thyroid carcinoma,0.8150038719177246
hsa-miR-500,follicular thyroid carcinoma,0.814987301826477
hsa-miR-5580-5p,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-3977,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-7162-3p,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-1261,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-144-3p,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-34b*,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-3123,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-6771-5p,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-1225,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-4784,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-5590-5p,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-4786-5p,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-1308,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-3116,castration-resistant prostate cancer,0.8149700164794922
hsa-miR-6811-3p,high grade serous papillary ovarian cancer,0.8149546980857849
hsa-miR-497*,Leptomeningeal metastasis,0.8149538636207581
hsa-miR-5088,Leptomeningeal metastasis,0.8149538636207581
hsa-miR-1224-3p,Leptomeningeal metastasis,0.8149538636207581
hsa-miR-4775,primary central nervous system lymphomas,0.8149332404136658
hsa-miR-433,follicular thyroid carcinoma,0.8149081468582153
hsa-miR-376c,follicular thyroid carcinoma,0.8149081468582153
hsa-miR-518d-3p,breast cancer brain metastasis,0.8149070143699646
hsa-miR-207,high grade serous papillary ovarian cancer,0.8148996829986572
hsa-miR-592,high grade serous papillary ovarian cancer,0.8148996829986572
hsa-miR-3908,high grade serous papillary ovarian cancer,0.8148996829986572
hsa-miR-3185,high grade serous papillary ovarian cancer,0.8148996829986572
hsa-miR-1201,aryngeal squamous cell carcinoma,0.8148840069770813
hsa-miR-4509,aryngeal squamous cell carcinoma,0.8148840069770813
hsa-miR-429,aryngeal squamous cell carcinoma,0.8148840069770813
hsa-miR-3118,aryngeal squamous cell carcinoma,0.8148840069770813
hsa-miR-892a,ovarian carcinoma,0.814880907535553
hsa-miR-7-2*,ovarian carcinoma,0.814880907535553
hsa-miR-7106-5p,ovarian carcinoma,0.814880907535553
hsa-miR-1269a,ovarian carcinoma,0.814880907535553
hsa-miR-302d-5p,ovarian carcinoma,0.814880907535553
hsa-miR-324-5p,ovarian carcinoma,0.814880907535553
hsa-miR-4777-5p,ovarian carcinoma,0.814880907535553
hsa-miR-219b-5p,ovarian carcinoma,0.814880907535553
hsa-miR-4705,ovarian carcinoma,0.814880907535553
hsa-miR-4727-3p,ovarian carcinoma,0.814880907535553
hsa-miR-214-5p,ovarian carcinoma,0.814880907535553
hsa-miR-3189-3p,ovarian carcinoma,0.814880907535553
hsa-miR-4301,ovarian carcinoma,0.814880907535553
hsa-miR-659-5p,ovarian carcinoma,0.814880907535553
hsa-miR-132*,Leptomeningeal metastasis,0.8148678541183472
hsa-miR-6786-5p,Leptomeningeal metastasis,0.8148678541183472
hsa-miR-4420,Leptomeningeal metastasis,0.8148678541183472
hsa-miR-3605-5p,Leptomeningeal metastasis,0.8148678541183472
hsa-miR-651-3p,Leptomeningeal metastasis,0.8148678541183472
hsa-miR-4277,Leptomeningeal metastasis,0.8148678541183472
hsa-miR-4739,aryngeal squamous cell carcinoma,0.8148665428161621
hsa-miR-6074,papillary thyroid carcinoma,0.8148131966590881
hsa-miR-433,Leptomeningeal metastasis,0.8147886991500854
hsa-miR-376c,Leptomeningeal metastasis,0.8147886991500854
hsa-miR-3944-5p,Leptomeningeal metastasis,0.8147886991500854
hsa-miR-640,aryngeal squamous cell carcinoma,0.8147825598716736
hsa-miR-6811-5p,rhabdomyosarcomas,0.8147788047790527
hsa-miR-133b,rhabdomyosarcomas,0.8147788047790527
hsa-miR-635,rhabdomyosarcomas,0.8147788047790527
hsa-miR-5186,miR-142-y,0.8147583603858948
hsa-miR-548e-3p,miR-142-y,0.8147583603858948
hsa-miR-320B,miR-142-y,0.8147583603858948
hsa-miR-4271,breast cancer brain metastasis,0.8147554397583008
hsa-miR-302a*,ovarian carcinoma,0.8146876096725464
hsa-miR-3925-3p,ovarian carcinoma,0.8146876096725464
hsa-miR-494-5p,ovarian carcinoma,0.8146876096725464
hsa-miR-586,ovarian carcinoma,0.8146876096725464
hsa-miR-708,ovarian carcinoma,0.8146876096725464
hsa-miR-644b-3p,ovarian carcinoma,0.8146876096725464
hsa-miR-5586-5p,ovarian carcinoma,0.8146876096725464
hsa-miR-2113,ovarian carcinoma,0.8146876096725464
hsa-miR-6766-3p,ovarian carcinoma,0.8146876096725464
hsa-miR-491-5p,follicular thyroid carcinoma,0.8146566152572632
hsa-miR-323-3p,primary central nervous system lymphomas,0.8146106600761414
hsa-miR-212-3p,primary central nervous system lymphomas,0.8146106600761414
hsa-let-7b*,primary central nervous system lymphomas,0.8145793080329895
hsa-miR-4763-5p,follicular thyroid carcinoma,0.8145761489868164
hsa-miR-676-5p,miR-675-y,0.8145647644996643
hsa-miR-3934-5p,miR-675-y,0.8145647644996643
hsa-miR-4725-3p,rhabdomyosarcomas,0.814558744430542
hsa-miR-668-5p,high grade serous papillary ovarian cancer,0.8145503997802734
hsa-miR-6887-3p,high grade serous papillary ovarian cancer,0.8145503997802734
hsa-miR-190a,follicular thyroid carcinoma,0.8145424127578735
hsa-miR-196-1,rhabdomyosarcomas,0.8145171403884888
hsa-miR-642a,breast cancer brain metastasis,0.8144335150718689
hsa-miR-1224-3p,breast cancer brain metastasis,0.8144335150718689
hsa-miR-551b,ovarian carcinoma,0.8144137263298035
hsa-miR-199a*-2,ovarian carcinoma,0.8144137263298035
hsa-miR-619-5p,high grade serous papillary ovarian cancer,0.8143846988677979
hsa-miR-6892-3p,high grade serous papillary ovarian cancer,0.8143846988677979
hsa-miR-4733-3p,high grade serous papillary ovarian cancer,0.8143846988677979
hsa-miR-1468-5p,high grade serous papillary ovarian cancer,0.8143846988677979
hsa-miR-584-3p,high grade serous papillary ovarian cancer,0.8143846988677979
hsa-miR-423-5p_1,high grade serous papillary ovarian cancer,0.8143315315246582
hsa-miR-5007-5p,high grade serous papillary ovarian cancer,0.8143315315246582
hsa-miR-1269,high grade serous papillary ovarian cancer,0.8143315315246582
hsa-miR-200b-5p,high grade serous papillary ovarian cancer,0.8143315315246582
hsa-miR-210-3p,high grade serous papillary ovarian cancer,0.8143315315246582
hsa-miR-103b,aryngeal squamous cell carcinoma,0.8143252730369568
hsa-miR-6837-3p,breast cancer brain metastasis,0.814317524433136
hsa-miR-646,"Luminal A,Luminal B",0.8143165111541748
hsa-miR-571,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-190a,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-517b,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-1306,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-3195,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-4304,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-526b-3p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-4753-3p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-8084,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-29a-2,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-499b-5p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-514a-5p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-769-5p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-378d,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-1285-2,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-6734-5p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-7157-5p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-425,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-7107-5p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-548ba,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-4252,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-3153,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-6853-3p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-6825-5p,castration-resistant prostate cancer,0.8143032193183899
hsa-miR-371b-3p,breast cancer brain metastasis,0.8142988681793213
hsa-miR-663b,"Luminal A,Luminal B",0.8142988085746765
hsa-miR-3131,"Luminal A,Luminal B",0.8142988085746765
hsa-miR-6729-5p,"Luminal A,Luminal B",0.8142988085746765
hsa-miR-1234-3p,primary central nervous system lymphomas,0.8142741322517395
hsa-miR-361-5p,rhabdomyosarcomas,0.8142483234405518
hsa-miR-6736-3p,rhabdomyosarcomas,0.8142483234405518
hsa-miR-1266-5p,papillary thyroid carcinoma,0.8142269849777222
hsa-miR-320e,pilocytic astrocytoma,0.8142049908638
hsa-miR-4272,rhabdomyosarcomas,0.8141400814056396
hsa-miR-6722-5p,rhabdomyosarcomas,0.8141400814056396
hsa-miR-1914,rhabdomyosarcomas,0.8141400814056396
hsa-miR-6886-5p,ovarian carcinoma,0.8141394257545471
hsa-miR-593-5p,ovarian carcinoma,0.8141394257545471
hsa-miR-6511b-5p,ovarian carcinoma,0.8141394257545471
hsa-miR-885-5p,ovarian carcinoma,0.8141394257545471
hsa-miR-10b*,ovarian carcinoma,0.8141394257545471
hsa-miR-4707-5p,ovarian carcinoma,0.8141394257545471
hsa-miR-183,ovarian carcinoma,0.8141394257545471
hsa-miR-4746-3p,ovarian carcinoma,0.8141394257545471
hsa-miR-6787-5p,papillary thyroid carcinoma,0.8141353726387024
hsa-miR-548av-3p,papillary thyroid carcinoma,0.8141353726387024
hsa-let-7b_c,Luminal B Her2+,0.814111590385437
hsa-miR-665,high grade serous papillary ovarian cancer,0.8141000866889954
hsa-miR-186*,high grade serous papillary ovarian cancer,0.8141000866889954
hsa-miR-525*,high grade serous papillary ovarian cancer,0.8141000866889954
hsa-miR-502-3p,high grade serous papillary ovarian cancer,0.8141000866889954
hsa-miR-6856-3p,high grade serous papillary ovarian cancer,0.8141000866889954
hsa-miR-1306,miR-142-y,0.8140909671783447
hsa-miR-291-3p,miR-142-y,0.8140909671783447
hsa-miR-200b*,miR-142-y,0.8140909671783447
hsa-miR-3692-5p,miR-142-y,0.8140909671783447
hsa-miR-30a-3p,miR-142-y,0.8140909671783447
hsa-miR-3115,miR-142-y,0.8140909671783447
hsa-miR-1285-2,miR-142-y,0.8140909671783447
hsa-miR-3935,miR-142-y,0.8140909671783447
hsa-miR-6772-5p,miR-142-y,0.8140909671783447
hsa-miR-6785-3p,miR-142-y,0.8140909671783447
hsa-miR-339-3p,rhabdomyosarcomas,0.8140431642532349
hsa-miR-302f,breast cancer brain metastasis,0.8140039443969727
hsa-miR-3155b,breast cancer brain metastasis,0.8140039443969727
hsa-miR-30e,rhabdomyosarcomas,0.8139588832855225
hsa-miR-6802-3p,rhabdomyosarcomas,0.8139588832855225
hsa-miR-514,rhabdomyosarcomas,0.8139588832855225
hsa-miR-940,aryngeal squamous cell carcinoma,0.8139100670814514
hsa-miR-933,aryngeal squamous cell carcinoma,0.8139100670814514
hsa-miR-208b,aryngeal squamous cell carcinoma,0.8139100670814514
hsa-miR-4701-5p,aryngeal squamous cell carcinoma,0.8139100670814514
hsa-miR-4427,aryngeal squamous cell carcinoma,0.8139100670814514
hsa-miR-4534,Leptomeningeal metastasis,0.813873827457428
hsa-miR-3142,Leptomeningeal metastasis,0.813873827457428
hsa-miR-6894-5p,high grade serous papillary ovarian cancer,0.8138556480407715
hsa-miR-4527,high grade serous papillary ovarian cancer,0.8138556480407715
hsa-miR-5587-3p,high grade serous papillary ovarian cancer,0.8138556480407715
hsa-miR-3150b-5p,high grade serous papillary ovarian cancer,0.8138556480407715
hsa-miR-660-5p,high grade serous papillary ovarian cancer,0.8138399124145508
hsa-miR-5708,high grade serous papillary ovarian cancer,0.8138399124145508
hsa-miR-451a,high grade serous papillary ovarian cancer,0.8138399124145508
hsa-miR-141-5p,high grade serous papillary ovarian cancer,0.8138399124145508
hsa-miR-1302,high grade serous papillary ovarian cancer,0.8138399124145508
hsa-miR-548f-3p,high grade serous papillary ovarian cancer,0.8138399124145508
hsa-miR-6739-5p,high grade serous papillary ovarian cancer,0.8138399124145508
hsa-miR-148b,pilocytic astrocytoma,0.8138312697410583
hsa-miR-892a,pilocytic astrocytoma,0.8138312697410583
hsa-miR-3180-5p,high grade serous papillary ovarian cancer,0.8137710690498352
hsa-let-7a*,high grade serous papillary ovarian cancer,0.8137710690498352
hsa-miR-922,high grade serous papillary ovarian cancer,0.8137710690498352
hsa-miR-4322,high grade serous papillary ovarian cancer,0.8137710690498352
hsa-miR-4483,high grade serous papillary ovarian cancer,0.8137710690498352
hsa-miR-4650-5p,high grade serous papillary ovarian cancer,0.8137710690498352
hsa-miR-196a-5p,high grade serous papillary ovarian cancer,0.8137710690498352
hsa-miR-4266,high grade serous papillary ovarian cancer,0.8137710690498352
hsa-miR-571,ovarian carcinoma,0.813745379447937
hsa-miR-539,ovarian carcinoma,0.813745379447937
hsa-miR-1295,ovarian carcinoma,0.813745379447937
hsa-miR-32,ovarian carcinoma,0.813745379447937
hsa-miR-199a*-1,ovarian carcinoma,0.813745379447937
hsa-miR-3692-5p,ovarian carcinoma,0.813745379447937
hsa-miR-561,ovarian carcinoma,0.813745379447937
hsa-miR-4263,ovarian carcinoma,0.813745379447937
hsa-miR-4749-5p,ovarian carcinoma,0.813745379447937
hsa-miR-766-3p,ovarian carcinoma,0.813745379447937
hsa-miR-374b,ovarian carcinoma,0.813745379447937
hsa-miR-5698,ovarian carcinoma,0.813745379447937
hsa-miR-6826-5p,aryngeal squamous cell carcinoma,0.8137344121932983
hsa-miR-4419a,aryngeal squamous cell carcinoma,0.8137344121932983
hsa-miR-4683,breast cancer brain metastasis,0.8136801719665527
hsa-miR-520d*,breast cancer brain metastasis,0.8136801719665527
hsa-miR-659-5p,primary central nervous system lymphomas,0.8136719465255737
hsa-miR-4251,rhabdomyosarcomas,0.813643217086792
hsa-miR-523,rhabdomyosarcomas,0.813643217086792
hsa-miR-6777-3p,miR-142-y,0.813640296459198
hsa-miR-615,miR-142-y,0.813640296459198
hsa-miR-513c,miR-142-y,0.813640296459198
hsa-miR-3121,miR-142-y,0.813640296459198
hsa-miR-4536-3p,miR-142-y,0.813640296459198
hsa-miR-643,high grade serous papillary ovarian cancer,0.8136110305786133
hsa-miR-1283-1,high grade serous papillary ovarian cancer,0.8136110305786133
hsa-miR-24-2,high grade serous papillary ovarian cancer,0.8136110305786133
hsa-miR-3162-5p,high grade serous papillary ovarian cancer,0.8136110305786133
hsa-miR-660-3p,high grade serous papillary ovarian cancer,0.8136110305786133
hsa-miR-8069,follicular thyroid carcinoma,0.8136017322540283
hsa-miR-4529-5p,high grade serous papillary ovarian cancer,0.8135925531387329
hsa-miR-1258,high grade serous papillary ovarian cancer,0.8135925531387329
hsa-miR-1914-5p,high grade serous papillary ovarian cancer,0.8135925531387329
hsa-miR-203a-3p,high grade serous papillary ovarian cancer,0.8135925531387329
hsa-miR-3139,high grade serous papillary ovarian cancer,0.8135925531387329
hsa-miR-2682-3p,high grade serous papillary ovarian cancer,0.8135925531387329
hsa-miR-514,papillary thyroid carcinoma,0.8135892748832703
hsa-miR-379-3p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-455-5p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-550b-2-5p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-892b,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-4437,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-376c,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-3191-5p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-32*,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-4781-3p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-6872-5p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-3944-3p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-376b-3p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-8066,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-3677-5p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-6833-5p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-548ad-3p,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-5092,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-4532,castration-resistant prostate cancer,0.8135890364646912
hsa-miR-369,ovarian carcinoma,0.8135764002799988
hsa-miR-556-3p,ovarian carcinoma,0.8135764002799988
hsa-miR-4268,ovarian carcinoma,0.8135764002799988
hsa-miR-4676-3p,ovarian carcinoma,0.8135764002799988
hsa-miR-453,ovarian carcinoma,0.8135764002799988
hsa-miR-518b,ovarian carcinoma,0.8135764002799988
hsa-miR-22,ovarian carcinoma,0.8135764002799988
hsa-miR-3172,ovarian carcinoma,0.8135764002799988
hsa-miR-30d-3p,ovarian carcinoma,0.8135764002799988
hsa-miR-1913,ovarian carcinoma,0.8135764002799988
hsa-miR-24-2-5p,ovarian carcinoma,0.8135764002799988
hsa-miR-513-5p,primary central nervous system lymphomas,0.8135576844215393
hsa-miR-3916,rhabdomyosarcomas,0.8134976625442505
hsa-miR-625*,rhabdomyosarcomas,0.8134976625442505
hsa-miR-873,rhabdomyosarcomas,0.8134976625442505
hsa-miR-516-1,rhabdomyosarcomas,0.8134976625442505
hsa-miR-582-5p,rhabdomyosarcomas,0.8134976625442505
hsa-miR-1182,breast cancer brain metastasis,0.813495934009552
hsa-miR-8052,breast cancer brain metastasis,0.813495934009552
hsa-miR-208b,breast cancer brain metastasis,0.813495934009552
hsa-miR-15a*,breast cancer brain metastasis,0.813495934009552
hsa-miR-6893-3p,distal cholangiocarcinoma,0.8134781718254089
hsa-miR-6878-5p,primary central nervous system lymphomas,0.8134468197822571
hsa-miR-584-5p,rhabdomyosarcomas,0.813428521156311
hsa-miR-4775,aryngeal squamous cell carcinoma,0.8134201169013977
hsa-miR-6512-5p,miR-142-y,0.8133761882781982
hsa-miR-1226-5p,miR-142-y,0.8133761882781982
hsa-miR-1288,miR-142-y,0.8133761882781982
hsa-miR-017,miR-142-y,0.8133761882781982
hsa-miR-3158-5p,miR-142-y,0.8133761882781982
hsa-miR-3942-5p,miR-142-y,0.8133761882781982
hsa-miR-5006-5p,high grade serous papillary ovarian cancer,0.8133761882781982
hsa-miR-423-5p_2,ovarian carcinoma,0.8133700489997864
hsa-miR-144-5p,ovarian carcinoma,0.8133700489997864
hsa-miR-376b-5p,ovarian carcinoma,0.8133700489997864
hsa-miR-6889-5p,ovarian carcinoma,0.8133700489997864
hsa-miR-192-5p,breast cancer brain metastasis,0.813342273235321
hsa-miR-8076,rhabdomyosarcomas,0.8133125901222229
hsa-miR-5187-3p,rhabdomyosarcomas,0.8133125901222229
hsa-miR-219-1-3p,rhabdomyosarcomas,0.8133125901222229
hsa-miR-744*,primary central nervous system lymphomas,0.8132874369621277
hsa-miR-1243,high grade serous papillary ovarian cancer,0.8132756948471069
hsa-miR-670-3p,high grade serous papillary ovarian cancer,0.8132756948471069
hsa-miR-5194,high grade serous papillary ovarian cancer,0.8132653832435608
hsa-miR-603,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-138-2,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-576-3p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-148a*,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-125b-1,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-378h,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-1185-2-3p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-3648,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-3148,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-565,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-16-5p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-4476,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-491-5p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-490,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-1251-5p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-5590-3p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-6758-3p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-300,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-548az-5p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-6813-3p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-32-5p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-208a-5p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-874-3p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-519a-1,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-4694-3p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-5089-3p,castration-resistant prostate cancer,0.8132409453392029
hsa-miR-548ay-3p,Leptomeningeal metastasis,0.8132351040840149
hsa-let-7b_c,Leptomeningeal metastasis,0.8132351040840149
hsa-miR-6513-3p,aryngeal squamous cell carcinoma,0.8132290244102478
hsa-miR-6879-5p,aryngeal squamous cell carcinoma,0.8132290244102478
hsa-miR-6846-5p,aryngeal squamous cell carcinoma,0.8132290244102478
hsa-miR-4289,aryngeal squamous cell carcinoma,0.8132290244102478
hsa-miR-4451,primary central nervous system lymphomas,0.8131764531135559
hsa-miR-292-3p,primary central nervous system lymphomas,0.8131764531135559
hsa-miR-18b-3p,high grade serous papillary ovarian cancer,0.8131328821182251
hsa-miR-135-2,high grade serous papillary ovarian cancer,0.8131328821182251
hsa-miR-6822-3p,high grade serous papillary ovarian cancer,0.8131328821182251
hsa-miR-488*,rhabdomyosarcomas,0.8131024241447449
hsa-miR-616,rhabdomyosarcomas,0.8131024241447449
hsa-miR-4720-3p,rhabdomyosarcomas,0.8131024241447449
hsa-miR-4269,rhabdomyosarcomas,0.8131024241447449
hsa-miR-4664-3p,rhabdomyosarcomas,0.8131024241447449
hsa-miR-513a-1,rhabdomyosarcomas,0.8131024241447449
hsa-miR-1185,rhabdomyosarcomas,0.8131024241447449
hsa-miR-323-3p,aryngeal squamous cell carcinoma,0.8130955696105957
hsa-miR-3162,pilocytic astrocytoma,0.8130866289138794
hsa-miR-5700,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-6806-5p,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-548ad,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-449b-3p,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-424-3p,castration-resistant prostate cancer,0.8130569458007812
hsa-let-7i-5p,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-9-5p,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-34a*,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-99b*,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-3178,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-200c,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-6840-5p,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-7-2-3p,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-4539,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-4684-5p,castration-resistant prostate cancer,0.8130569458007812
hsa-miR-3609,aryngeal squamous cell carcinoma,0.8130553364753723
hsa-miR-593-3p,aryngeal squamous cell carcinoma,0.8130553364753723
hsa-miR-593,distal cholangiocarcinoma,0.8130403757095337
hsa-miR-623,ovarian carcinoma,0.8130295276641846
hsa-miR-130a-5p,ovarian carcinoma,0.8130295276641846
hsa-miR-4693-5p,ovarian carcinoma,0.8130295276641846
hsa-miR-1226-5p,ovarian carcinoma,0.8130295276641846
hsa-miR-6828-5p,ovarian carcinoma,0.8130295276641846
hsa-miR-452*,ovarian carcinoma,0.8130295276641846
hsa-miR-3619-5p,ovarian carcinoma,0.8130295276641846
hsa-miR-2116*,ovarian carcinoma,0.8130295276641846
hsa-miR-1184,ovarian carcinoma,0.8130295276641846
hsa-miR-3944-3p,ovarian carcinoma,0.8130295276641846
hsa-miR-3976,ovarian carcinoma,0.8130295276641846
hsa-miR-6165,ovarian carcinoma,0.8130295276641846
hsa-miR-4420,miR-142-y,0.8130277991294861
hsa-miR-3202,miR-142-y,0.8130277991294861
hsa-miR-6506-3p,miR-142-y,0.8130277991294861
hsa-miR-194,miR-142-y,0.8130277991294861
hsa-miR-8079,miR-142-y,0.8130277991294861
hsa-miR-6813-3p,miR-142-y,0.8130277991294861
hsa-miR-2681-5p,miR-142-y,0.8130277991294861
hsa-miR-5010-3p,miR-142-y,0.8130277991294861
hsa-miR-92a-1*,rhabdomyosarcomas,0.8130103349685669
hsa-miR-582-3p,rhabdomyosarcomas,0.8130103349685669
hsa-miR-3679-5p,rhabdomyosarcomas,0.8130103349685669
hsa-miR-4796-5p,rhabdomyosarcomas,0.8130103349685669
hsa-miR-6509-3p,rhabdomyosarcomas,0.8130103349685669
hsa-miR-218-1*,ovarian carcinoma,0.8130015134811401
hsa-miR-3157-3p,ovarian carcinoma,0.8130015134811401
hsa-miR-487b,ovarian carcinoma,0.8130015134811401
hsa-miR-352,ovarian carcinoma,0.8130015134811401
hsa-miR-550a,ovarian carcinoma,0.8130015134811401
hsa-miR-34a*,ovarian carcinoma,0.8130015134811401
hsa-miR-4741,ovarian carcinoma,0.8130015134811401
hsa-miR-200c,ovarian carcinoma,0.8130015134811401
hsa-miR-181b-3p,ovarian carcinoma,0.8130015134811401
hsa-miR-4282,ovarian carcinoma,0.8130015134811401
hsa-miR-214,rhabdomyosarcomas,0.812932550907135
hsa-miR-139-3p,rhabdomyosarcomas,0.812932550907135
hsa-miR-6083,rhabdomyosarcomas,0.812932550907135
hsa-miR-4430,miR-142-y,0.8129121661186218
hsa-miR-199a-5p,miR-142-y,0.8129121661186218
hsa-miR-6827-5p,miR-142-y,0.8129121661186218
hsa-miR-6824-5p,miR-142-y,0.8129121661186218
hsa-miR-551a,miR-142-y,0.8129121661186218
hsa-miR-200b-3p,miR-142-y,0.8129121661186218
hsa-miR-509-3-5p,miR-142-y,0.8129121661186218
hsa-miR-1300,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-556-3p,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-3658,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-4268,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-3192-3p,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-4291,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-500a-3p,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-518b,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-22,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-510,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-218-2-3p,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-4464,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-3928-3p,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-5692b,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-6800-3p,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-518e-5p,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-4800-3p,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-29a-5p,castration-resistant prostate cancer,0.8128896355628967
hsa-miR-937,ovarian carcinoma,0.8128848075866699
hsa-miR-1343,ovarian carcinoma,0.8128848075866699
hsa-miR-1268a,ovarian carcinoma,0.8128848075866699
hsa-miR-1182,ovarian carcinoma,0.8128848075866699
hsa-miR-193b-3p,ovarian carcinoma,0.8128848075866699
hsa-miR-8052,ovarian carcinoma,0.8128848075866699
hsa-miR-103a,ovarian carcinoma,0.8128848075866699
hsa-miR-3186-5p,ovarian carcinoma,0.8128848075866699
hsa-miR-3672,ovarian carcinoma,0.8128848075866699
hsa-miR-411-5p,high grade serous papillary ovarian cancer,0.8128811717033386
hsa-miR-1537-5p,high grade serous papillary ovarian cancer,0.8128811717033386
hsa-miR-3124-5p,Luminal B Her2+,0.8128602504730225
hsa-miR-146a-3p,miR-142-y,0.8128436803817749
hsa-miR-4703-3p,miR-142-y,0.8128436803817749
hsa-miR-6784-5p,miR-142-y,0.8128436803817749
hsa-miR-4482-5p,miR-142-y,0.8128436803817749
hsa-miR-6508-5p,miR-142-y,0.8128436803817749
hsa-miR-6844,miR-142-y,0.8128436803817749
hsa-miR-1292-5p,primary central nervous system lymphomas,0.81281977891922
hsa-miR-520a-3p,primary central nervous system lymphomas,0.81281977891922
hsa-miR-6728-3p,aryngeal squamous cell carcinoma,0.8127806186676025
hsa-miR-93*,primary central nervous system lymphomas,0.812774658203125
hsa-miR-526b-5p,rhabdomyosarcomas,0.8127418160438538
hsa-miR-5692b,rhabdomyosarcomas,0.8127418160438538
hsa-miR-4470,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-4465,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-582-3p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-6746-3p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-6796-3p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-6803-5p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-662,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-1322,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-102,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-888,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-5096,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-526a,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-744-3p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-208b-3p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-497-5p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-548h-3p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-877-3p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-585-5p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-3194-5p,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-128a,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-4675,castration-resistant prostate cancer,0.8127353191375732
hsa-miR-361-5p,high grade serous papillary ovarian cancer,0.8126856088638306
hsa-miR-3684,high grade serous papillary ovarian cancer,0.8126856088638306
hsa-miR-589-5p,high grade serous papillary ovarian cancer,0.8126856088638306
hsa-miR-4254,high grade serous papillary ovarian cancer,0.8126856088638306
hsa-miR-6843-3p,high grade serous papillary ovarian cancer,0.8126856088638306
hsa-miR-22*,high grade serous papillary ovarian cancer,0.8126856088638306
hsa-miR-603,ovarian carcinoma,0.8126806020736694
hsa-miR-378j,ovarian carcinoma,0.8126806020736694
hsa-miR-138-2,ovarian carcinoma,0.8126806020736694
hsa-miR-330-5p,ovarian carcinoma,0.8126806020736694
hsa-miR-432,ovarian carcinoma,0.8126806020736694
hsa-miR-18a-3p,ovarian carcinoma,0.8126806020736694
hsa-miR-302d*,ovarian carcinoma,0.8126806020736694
hsa-miR-378f,ovarian carcinoma,0.8126806020736694
hsa-miR-651-3p,ovarian carcinoma,0.8126806020736694
hsa-miR-425-5p,ovarian carcinoma,0.8126806020736694
hsa-miR-4476,ovarian carcinoma,0.8126806020736694
hsa-miR-888-3p,ovarian carcinoma,0.8126806020736694
hsa-let-7d-5p,ovarian carcinoma,0.8126806020736694
hsa-miR-300,ovarian carcinoma,0.8126806020736694
hsa-miR-644a,ovarian carcinoma,0.8126806020736694
hsa-miR-4701-3p,ovarian carcinoma,0.8126806020736694
hsa-miR-519a-1,ovarian carcinoma,0.8126806020736694
hsa-miR-3124-5p,miR-142-y,0.812676191329956
hsa-miR-500a-3p,miR-142-y,0.812676191329956
hsa-miR-6805-5p,miR-142-y,0.812676191329956
hsa-miR-139-5p,miR-142-y,0.812676191329956
hsa-miR-3925-3p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-187*,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-8076,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-6793-3p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-329,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-320,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-25-5p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-185-3p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-2110,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-3928-5p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-190a-5p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-4761-3p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-3686,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-4717-3p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-1233-1-5p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-654-3p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-520a,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-6766-3p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-873-5p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-4760-5p,castration-resistant prostate cancer,0.8126645088195801
hsa-miR-511-2,ovarian carcinoma,0.8126409649848938
hsa-miR-199a-5p,ovarian carcinoma,0.8126409649848938
hsa-miR-8064,ovarian carcinoma,0.8126409649848938
hsa-miR128a,ovarian carcinoma,0.8126409649848938
hsa-miR-636,ovarian carcinoma,0.8126409649848938
hsa-miR-496,ovarian carcinoma,0.8126409649848938
hsa-miR-6838-3p,ovarian carcinoma,0.8126409649848938
hsa-miR-23a-3p,ovarian carcinoma,0.8126409649848938
hsa-miR-628,ovarian carcinoma,0.8126409649848938
hsa-miR-551a,ovarian carcinoma,0.8126409649848938
hsa-miR-361-3p,ovarian carcinoma,0.8126409649848938
hsa-miR-8087,ovarian carcinoma,0.8126409649848938
hsa-miR-6822-5p,breast cancer brain metastasis,0.8126396536827087
hsa-miR-1262,breast cancer brain metastasis,0.8126396536827087
hsa-miR-513-5p,breast cancer brain metastasis,0.8126230835914612
hsa-miR-6882-3p,breast cancer brain metastasis,0.8126230835914612
hsa-miR-4298,high grade serous papillary ovarian cancer,0.8126175403594971
hsa-miR-219-5p,high grade serous papillary ovarian cancer,0.8126175403594971
hsa-miR-3184-3p,high grade serous papillary ovarian cancer,0.8126175403594971
hsa-miR-219-1,high grade serous papillary ovarian cancer,0.8126175403594971
hsa-miR-383-5p,high grade serous papillary ovarian cancer,0.8126175403594971
hsa-miR-5195-5p,high grade serous papillary ovarian cancer,0.8126175403594971
hsa-miR-6083,high grade serous papillary ovarian cancer,0.8126175403594971
hsa-miR-3164,high grade serous papillary ovarian cancer,0.8126175403594971
hsa-miR-3975,high grade serous papillary ovarian cancer,0.8126175403594971
hsa-miR-1915*,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-6511b-3p,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-628-5p,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-523,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-574-3p,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-150-5p,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-449b,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-371a-5p,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-664-5p,castration-resistant prostate cancer,0.8126055002212524
hsa-let-7a-3,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-3171,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-4540,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-351,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-6876-3p,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-216b-5p,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-1252-5p,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-519d-3p,castration-resistant prostate cancer,0.8126055002212524
hsa-miR-4757-3p,castration-resistant prostate cancer,0.8126055002212524
hsa-let-7a-3,Leptomeningeal metastasis,0.8125958442687988
hsa-miR-365,primary central nervous system lymphomas,0.8125869631767273
hsa-miR-3143,papillary thyroid carcinoma,0.8125752210617065
hsa-let-7e*,Luminal B Her2+,0.812574565410614
hsa-miR-874,miR-675-y,0.8125604391098022
hsa-miR-604,miR-675-y,0.8125604391098022
hsa-miR-4509,miR-675-y,0.8125604391098022
hsa-miR-429,miR-675-y,0.8125604391098022
hsa-miR-4711-5p,miR-675-y,0.8125604391098022
hsa-miR-4772-5p,miR-675-y,0.8125604391098022
hsa-miR-3118,miR-675-y,0.8125604391098022
hsa-miR-3123,aryngeal squamous cell carcinoma,0.8125423192977905
hsa-miR-4796-5p,miR-142-y,0.8125216960906982
hsa-miR-548p,miR-142-y,0.8125216960906982
hsa-miR-374a-5p,miR-142-y,0.8125216960906982
hsa-miR-4535,miR-142-y,0.8125216960906982
hsa-miR-497-5p,miR-142-y,0.8125216960906982
hsa-miR-181b-5p,miR-142-y,0.8125216960906982
hsa-miR-5696,miR-142-y,0.8125216960906982
hsa-miR-585-5p,miR-142-y,0.8125216960906982
hsa-miR-3183,miR-142-y,0.8125216960906982
hsa-miR-369,pilocytic astrocytoma,0.8125210404396057
hsa-miR-6895-5p,pilocytic astrocytoma,0.8125210404396057
hsa-miR-4471,breast cancer brain metastasis,0.8125112056732178
hsa-miR-362-5p,breast cancer brain metastasis,0.8125050067901611
hsa-miR-30e,castration-resistant prostate cancer,0.8124996423721313
hsa-miR-6802-3p,castration-resistant prostate cancer,0.8124996423721313
hsa-miR-6778-3p,castration-resistant prostate cancer,0.8124996423721313
hsa-miR-3611,castration-resistant prostate cancer,0.8124996423721313
hsa-miR-320b-1,castration-resistant prostate cancer,0.8124996423721313
hsa-miR-323-5p,castration-resistant prostate cancer,0.8124996423721313
hsa-miR-412,castration-resistant prostate cancer,0.8124996423721313
hsa-miR-6499-5p,castration-resistant prostate cancer,0.8124996423721313
hsa-miRPlus-C1110,ovarian carcinoma,0.8124961256980896
hsa-miR-3197,ovarian carcinoma,0.8124961256980896
hsa-miR-5700,ovarian carcinoma,0.8124961256980896
hsa-miR-518c-5p,ovarian carcinoma,0.8124961256980896
hsa-miR-548as-5p,ovarian carcinoma,0.8124961256980896
hsa-let-7i-5p,ovarian carcinoma,0.8124961256980896
hsa-miR-6784-5p,ovarian carcinoma,0.8124961256980896
hsa-miR-7855-5p,ovarian carcinoma,0.8124961256980896
hsa-miR-6753-3p,ovarian carcinoma,0.8124961256980896
hsa-miR-1-2,ovarian carcinoma,0.8124961256980896
hsa-miR-7704,ovarian carcinoma,0.8124961256980896
hsa-miR-3679-3p,ovarian carcinoma,0.8124961256980896
hsa-miR-218-1*,rhabdomyosarcomas,0.8124855756759644
hsa-miR-10a*,rhabdomyosarcomas,0.8124855756759644
hsa-miR-122,rhabdomyosarcomas,0.8124855756759644
hsa-miR-143*,rhabdomyosarcomas,0.8124855756759644
hsa-miR-518c-5p,rhabdomyosarcomas,0.8124855756759644
hsa-miR-449b-3p,rhabdomyosarcomas,0.8124855756759644
hsa-miR-6792-3p,aryngeal squamous cell carcinoma,0.8124796748161316
hsa-miR-4664-3p,papillary thyroid carcinoma,0.8124752640724182
hsa-miR-373-5p,miR-142-y,0.8124507069587708
hsa-miR-1237,miR-142-y,0.8124507069587708
hsa-miR-1233-1-5p,miR-142-y,0.8124507069587708
hsa-miR-7843-3p,miR-142-y,0.8124507069587708
hsa-miR-132*,ovarian carcinoma,0.8124445080757141
hsa-miR-4420,ovarian carcinoma,0.8124445080757141
hsa-miR-125b-1,ovarian carcinoma,0.8124445080757141
hsa-miR-382,ovarian carcinoma,0.8124445080757141
hsa-miR-1295b-5p,ovarian carcinoma,0.8124445080757141
hsa-miR-548au-5p,ovarian carcinoma,0.8124445080757141
hsa-miR-122a,ovarian carcinoma,0.8124445080757141
hsa-miR-565,ovarian carcinoma,0.8124445080757141
hsa-let-7f-5p,ovarian carcinoma,0.8124445080757141
hsa-miR-578,ovarian carcinoma,0.8124445080757141
hsa-miR-491-5p,ovarian carcinoma,0.8124445080757141
hsa-miR-132-5p,ovarian carcinoma,0.8124445080757141
hsa-miR-548i,ovarian carcinoma,0.8124445080757141
hsa-miR-490,ovarian carcinoma,0.8124445080757141
hsa-miR-548t,ovarian carcinoma,0.8124445080757141
hsa-miR-5010-3p,ovarian carcinoma,0.8124445080757141
hsa-miR-30a*,rhabdomyosarcomas,0.8124209046363831
hsa-miR-548ah-3p,rhabdomyosarcomas,0.8124209046363831
hsa-miR-7111-3p,rhabdomyosarcomas,0.8124209046363831
hsa-miR-292-5p,rhabdomyosarcomas,0.8124209046363831
hsa-miR-4736,rhabdomyosarcomas,0.8124209046363831
hsa-miR-5089,rhabdomyosarcomas,0.8124209046363831
hsa-miR-3195,rhabdomyosarcomas,0.8124209046363831
hsa-miR-30a-5p,rhabdomyosarcomas,0.8124209046363831
hsa-miR-374c-3p,aryngeal squamous cell carcinoma,0.8124034404754639
hsa-miR-25-3p,aryngeal squamous cell carcinoma,0.8124034404754639
hsa-miR-4651,miR-142-y,0.8123917579650879
hsa-miR-4440,miR-142-y,0.8123917579650879
hsa-miR-3171,miR-142-y,0.8123917579650879
hsa-miR-5187-3p,papillary thyroid carcinoma,0.8123798966407776
hsa-miR-4475,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-335*,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-26b*,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-1255a,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-664a-5p,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-548j-3p,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-589-5p,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-4742-3p,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-7853-5p,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-6866-5p,castration-resistant prostate cancer,0.8123633861541748
hsa-miR-5195-3p,castration-resistant prostate cancer,0.8123633861541748
hsa-let-7a_c,breast cancer brain metastasis,0.8123519420623779
hsa-miR-4783-3p,high grade serous papillary ovarian cancer,0.8123466372489929
hsa-miR-3142,high grade serous papillary ovarian cancer,0.8123466372489929
hsa-miR-520c-3p,rhabdomyosarcomas,0.8123415112495422
hsa-miR-548am-3p,rhabdomyosarcomas,0.8123415112495422
hsa-miR-516a-3p,primary central nervous system lymphomas,0.8123409748077393
hsa-miR-1300,ovarian carcinoma,0.8123284578323364
hsa-miR-3124-5p,ovarian carcinoma,0.8123284578323364
hsa-miR-1253,ovarian carcinoma,0.8123284578323364
hsa-miR-1307,ovarian carcinoma,0.8123284578323364
hsa-miR-548ag,ovarian carcinoma,0.8123284578323364
hsa-miR-194-2,ovarian carcinoma,0.8123284578323364
hsa-miR-3928-3p,ovarian carcinoma,0.8123284578323364
hsa-miR-5579-5p,ovarian carcinoma,0.8123284578323364
hsa-miR-33a-3p,ovarian carcinoma,0.8123284578323364
hsa-miR-3615,miR-142-y,0.8122857213020325
hsa-miR-4804-3p,miR-142-y,0.8122857213020325
hsa-miR-412,miR-142-y,0.8122857213020325
hsa-miR-125b-2*,rhabdomyosarcomas,0.8122624754905701
hsa-miR-4503,rhabdomyosarcomas,0.8122624754905701
hsa-miR-3927-5p,rhabdomyosarcomas,0.8122624754905701
hsa-miR-5693,rhabdomyosarcomas,0.8122624754905701
hsa-miR-548az-5p,rhabdomyosarcomas,0.8122624754905701
hsa-miR-129-2-3p,breast cancer brain metastasis,0.812240481376648
hsa-miR-604,high grade serous papillary ovarian cancer,0.8122375011444092
hsa-miR-1976,high grade serous papillary ovarian cancer,0.8122375011444092
hsa-miR-3129-5p,high grade serous papillary ovarian cancer,0.8122375011444092
hsa-miR-509-5p,high grade serous papillary ovarian cancer,0.8122375011444092
hsa-miR-454-3p,high grade serous papillary ovarian cancer,0.8122375011444092
hsa-miR-195-5p,high grade serous papillary ovarian cancer,0.8122375011444092
hsa-miR-487a-5p,high grade serous papillary ovarian cancer,0.8122375011444092
hsa-miR-7114-3p,high grade serous papillary ovarian cancer,0.8122375011444092
hsa-miR-3661,high grade serous papillary ovarian cancer,0.8122375011444092
hsa-miR-570-3p,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-6769b-3p,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-4315,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-409,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-139-3p,castration-resistant prostate cancer,0.8122367858886719
hsa-miRPlus-J1002,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-3120-5p,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-369-3p,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-1287-5p,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-4672,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-6752-3p,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-3164,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-3975,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-3133,castration-resistant prostate cancer,0.8122367858886719
hsa-miR-1267,breast cancer brain metastasis,0.8122245669364929
hsa-miR-214-3p,Leptomeningeal metastasis,0.8122196793556213
hsa-miR-941,Leptomeningeal metastasis,0.8122196793556213
hsa-miR-3545-3p,Leptomeningeal metastasis,0.8122196793556213
hsa-miR-6512-5p,rhabdomyosarcomas,0.8121823668479919
hsa-miR-4801,rhabdomyosarcomas,0.8121823668479919
hsa-miR-3613-5p,rhabdomyosarcomas,0.8121823668479919
hsa-miR-376c,rhabdomyosarcomas,0.8121823668479919
hsa-miR-3132,rhabdomyosarcomas,0.8121823668479919
hsa-miR-4532,rhabdomyosarcomas,0.8121823668479919
hsa-miR-3162,ovarian carcinoma,0.8121737241744995
hsa-miR-4470,ovarian carcinoma,0.8121737241744995
hsa-miR-1914*,ovarian carcinoma,0.8121737241744995
hsa-miR-4796-5p,ovarian carcinoma,0.8121737241744995
hsa-miR-6746-3p,ovarian carcinoma,0.8121737241744995
hsa-miR-3622b-3p,ovarian carcinoma,0.8121737241744995
hsa-miR-6796-3p,ovarian carcinoma,0.8121737241744995
hsa-miR-450a-2-3p,ovarian carcinoma,0.8121737241744995
hsa-miR-483-3p,ovarian carcinoma,0.8121737241744995
hsa-miR-770-5p,ovarian carcinoma,0.8121737241744995
hsa-miR-1234-5p,ovarian carcinoma,0.8121737241744995
hsa-miR-544,ovarian carcinoma,0.8121737241744995
hsa-miR-3183,ovarian carcinoma,0.8121737241744995
hsa-miR-4475,miR-142-y,0.8121494650840759
hsa-miR-7161-3p,miR-142-y,0.8121494650840759
hsa-miR-6879-3p,miR-142-y,0.8121494650840759
hsa-miR-3912,miR-142-y,0.8121494650840759
hsa-miR-4790-5p,miR-142-y,0.8121494650840759
hsa-miR-548d-5p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-520d-3p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-372-5p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-7843-5p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-6811-5p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-516-1,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-194-5p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-4638-5p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-193b,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-6813-5p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-135b-5p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-548ae,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-3591-3p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-6739-5p,castration-resistant prostate cancer,0.8121189475059509
hsa-miR-671,ovarian carcinoma,0.812102735042572
hsa-miR-524-3p,ovarian carcinoma,0.812102735042572
hsa-miR-219-1-3p,ovarian carcinoma,0.812102735042572
hsa-miRPlus-A1015,ovarian carcinoma,0.812102735042572
hsa-miR-4785,ovarian carcinoma,0.812102735042572
hsa-miR-3616-3p,ovarian carcinoma,0.812102735042572
hsa-miR-185-3p,ovarian carcinoma,0.812102735042572
hsa-miR-373-5p,ovarian carcinoma,0.812102735042572
hsa-miR-3690,primary central nervous system lymphomas,0.8120836615562439
hsa-miR-675,aryngeal squamous cell carcinoma,0.8120778799057007
hsa-miR-199a-3p,aryngeal squamous cell carcinoma,0.8120778799057007
hsa-miR-3607-3p,aryngeal squamous cell carcinoma,0.8120778799057007
hsa-miR-4492,aryngeal squamous cell carcinoma,0.8120778799057007
hsa-miR-021,breast cancer brain metastasis,0.8120630979537964
hsa-miR-3611,high grade serous papillary ovarian cancer,0.8120548725128174
hsa-miR-30c-5p,high grade serous papillary ovarian cancer,0.8120548725128174
hsa-miR-323-5p,high grade serous papillary ovarian cancer,0.8120548725128174
hsa-miR-4657,high grade serous papillary ovarian cancer,0.8120548725128174
hsa-miR-5088-5p,high grade serous papillary ovarian cancer,0.8120548725128174
hsa-miR-153-3p,high grade serous papillary ovarian cancer,0.8120548725128174
hsa-let-7b_c,high grade serous papillary ovarian cancer,0.8120437860488892
hsa-miR-1206,high grade serous papillary ovarian cancer,0.8120437860488892
hsa-miR-185,ovarian carcinoma,0.8120435476303101
hsa-miR-491,ovarian carcinoma,0.8120435476303101
hsa-miR-3676-5p,ovarian carcinoma,0.8120435476303101
hsa-miR-6782-5p,ovarian carcinoma,0.8120435476303101
hsa-miR-378b,ovarian carcinoma,0.8120435476303101
hsa-miR-766-5p,ovarian carcinoma,0.8120435476303101
hsa-miR-4519,ovarian carcinoma,0.8120435476303101
hsa-miR-3925-3p,Leptomeningeal metastasis,0.8120240569114685
hsa-miR-483-5p,miR-142-y,0.8120228052139282
hsa-miR-5195-5p,miR-142-y,0.8120228052139282
hsa-miR-4721,miR-142-y,0.8120228052139282
hsa-miR-485-3p,primary central nervous system lymphomas,0.81201171875
hsa-miR-7154-5p,castration-resistant prostate cancer,0.8120080232620239
hsa-miR-339-3p,castration-resistant prostate cancer,0.8120080232620239
hsa-miR-146b,castration-resistant prostate cancer,0.8120080232620239
hsa-miR-148a-5p,castration-resistant prostate cancer,0.8120080232620239
hsa-miR-767-3p,castration-resistant prostate cancer,0.8120080232620239
hsa-miR-6776-3p,castration-resistant prostate cancer,0.8120080232620239
hsa-miR-6822-3p,castration-resistant prostate cancer,0.8120080232620239
hsa-miR-2277-5p,castration-resistant prostate cancer,0.8120080232620239
hsa-miR-1468-5p,castration-resistant prostate cancer,0.8120080232620239
hsa-miR-483,aryngeal squamous cell carcinoma,0.8119693994522095
hsa-miR-608,pilocytic astrocytoma,0.8119543194770813
hsa-miR-1231,pilocytic astrocytoma,0.8119543194770813
hsa-miR-3154,pilocytic astrocytoma,0.8119543194770813
hsa-miR-3669,pilocytic astrocytoma,0.8119543194770813
hsa-miR-509-3p,ovarian carcinoma,0.8119375705718994
hsa-miR-6802-3p,ovarian carcinoma,0.8119375705718994
hsa-miR-524,ovarian carcinoma,0.8119375705718994
hsa-miR-769-3p,ovarian carcinoma,0.8119375705718994
hsa-let-7b_c,ovarian carcinoma,0.8119375705718994
hsa-miR-3615,ovarian carcinoma,0.8119375705718994
hsa-miR-4275,ovarian carcinoma,0.8119375705718994
hsa-miR-4310,ovarian carcinoma,0.8119196891784668
hsa-miR-637,ovarian carcinoma,0.8119196891784668
hsa-miR-433,ovarian carcinoma,0.8119196891784668
hsa-miR-670,ovarian carcinoma,0.8119196891784668
hsa-miR-3974,ovarian carcinoma,0.8119196891784668
hsa-miR-550b,ovarian carcinoma,0.8119196891784668
hsa-miR-017,ovarian carcinoma,0.8119196891784668
hsa-miR-4778-5p,ovarian carcinoma,0.8119196891784668
hsa-miR-1286,ovarian carcinoma,0.8119196891784668
hsa-miR-4792,ovarian carcinoma,0.8119196891784668
hsa-miR-4799-3p,ovarian carcinoma,0.8119196891784668
hsa-miR-873,miR-142-y,0.8119048476219177
hsa-miR-140-5p,miR-142-y,0.8119048476219177
hsa-miR-124*,miR-142-y,0.8119048476219177
hsa-miR-411-5p,miR-142-y,0.8119048476219177
hsa-miR-6739-5p,miR-142-y,0.8119048476219177
hsa-miR-4775,breast cancer brain metastasis,0.8119006752967834
hsa-miR-876-3p,breast cancer brain metastasis,0.8119006752967834
hsa-miR-186-3p,breast cancer brain metastasis,0.8119006752967834
hsa-miR-33a,castration-resistant prostate cancer,0.8118995428085327
hsa-miR-377-3p,castration-resistant prostate cancer,0.8118995428085327
hsa-miR-548k,castration-resistant prostate cancer,0.8118995428085327
hsa-miR-297,castration-resistant prostate cancer,0.8118995428085327
hsa-let-7b-3p,castration-resistant prostate cancer,0.8118995428085327
hsa-miR-433-5p,castration-resistant prostate cancer,0.8118995428085327
hsa-miR-4312,castration-resistant prostate cancer,0.8118995428085327
hsa-miR-548u,castration-resistant prostate cancer,0.8118995428085327
hsa-miR-645,"Luminal A,Luminal B",0.8118909001350403
hsa-miR-676-5p,"Luminal A,Luminal B",0.8118909001350403
hsa-miR-129-2,"Luminal A,Luminal B",0.8118909001350403
hsa-miR-3657,aryngeal squamous cell carcinoma,0.8118687868118286
hsa-miR-190a,aryngeal squamous cell carcinoma,0.8118687868118286
hsa-miR-1306,aryngeal squamous cell carcinoma,0.8118687868118286
hsa-miR-200b*,aryngeal squamous cell carcinoma,0.8118687868118286
hsa-miR-147a,aryngeal squamous cell carcinoma,0.8118687868118286
hsa-miR-574,aryngeal squamous cell carcinoma,0.8118687868118286
hsa-miR-6885-3p,aryngeal squamous cell carcinoma,0.8118687868118286
hsa-miR-548aq-5p,primary central nervous system lymphomas,0.8118584752082825
hsa-miR-1185-5p,breast cancer brain metastasis,0.8118370771408081
hsa-miR-4790-5p,ovarian carcinoma,0.811801016330719
hsa-miR-4254,ovarian carcinoma,0.811801016330719
hsa-miR-6076,miR-142-y,0.8117937445640564
hsa-miR-6786-3p,miR-142-y,0.8117937445640564
hsa-miR-548aq-3p,miR-142-y,0.8117937445640564
hsa-miR-6822-3p,miR-142-y,0.8117937445640564
hsa-miR-4671-3p,castration-resistant prostate cancer,0.8117871284484863
hsa-miR-335-5p,castration-resistant prostate cancer,0.8117871284484863
hsa-miR-1277-5p,castration-resistant prostate cancer,0.8117871284484863
hsa-miR-145-3p,castration-resistant prostate cancer,0.8117871284484863
hsa-miR-3074-3p,castration-resistant prostate cancer,0.8117871284484863
hsa-miR-6514-5p,castration-resistant prostate cancer,0.8117871284484863
hsa-miR-2277,castration-resistant prostate cancer,0.8117871284484863
hsa-miR-2964a-3p,papillary thyroid carcinoma,0.811786413192749
hsa-miR-552,aryngeal squamous cell carcinoma,0.8117806315422058
hsa-miR-196-2,aryngeal squamous cell carcinoma,0.811764121055603
hsa-let-7a-3,high grade serous papillary ovarian cancer,0.8117367029190063
hsa-miR-525*-524,high grade serous papillary ovarian cancer,0.8117367029190063
hsa-miR-3676-5p,high grade serous papillary ovarian cancer,0.8117367029190063
hsa-miR-93-5p,high grade serous papillary ovarian cancer,0.8117367029190063
hsa-miR-892c-5p,high grade serous papillary ovarian cancer,0.8117367029190063
hsa-miR-6764-5p,high grade serous papillary ovarian cancer,0.8117367029190063
hsa-miR-1252-5p,high grade serous papillary ovarian cancer,0.8117367029190063
hsa-miR-766-5p,high grade serous papillary ovarian cancer,0.8117367029190063
hsa-miR-4519,high grade serous papillary ovarian cancer,0.8117367029190063
hsa-miR-367-5p,breast cancer brain metastasis,0.8117304444313049
hsa-miR-349,castration-resistant prostate cancer,0.8117155432701111
hsa-miR-516a-3p,castration-resistant prostate cancer,0.8117155432701111
hsa-miR-6887-5p,castration-resistant prostate cancer,0.8117155432701111
hsa-miR-4522,castration-resistant prostate cancer,0.8117155432701111
hsa-miR-663b,ovarian carcinoma,0.8117021322250366
hsa-miR-26a-2*,ovarian carcinoma,0.8117021322250366
hsa-miR-4495,ovarian carcinoma,0.8117021322250366
hsa-miR-8089,ovarian carcinoma,0.8117021322250366
hsa-miR-6766-5p,ovarian carcinoma,0.8117021322250366
hsa-miR-3675-3p,ovarian carcinoma,0.8117021322250366
hsa-miR-584,ovarian carcinoma,0.8117021322250366
hsa-miR-5579-3p,ovarian carcinoma,0.8117021322250366
hsa-miR-6752-5p,ovarian carcinoma,0.8117021322250366
hsa-miR-4293,miR-142-y,0.8116851449012756
hsa-miR-934,miR-142-y,0.8116851449012756
hsa-miR-5006-5p,miR-142-y,0.8116851449012756
hsa-miR-3185,miR-142-y,0.8116851449012756
hsa-miR-1270,miR-142-y,0.8116851449012756
hsa-miR-483-5p,ovarian carcinoma,0.811674177646637
hsa-miR-6890-3p,ovarian carcinoma,0.811674177646637
hsa-miR-3120-5p,ovarian carcinoma,0.811674177646637
hsa-miR-431-3p,ovarian carcinoma,0.811674177646637
hsa-miR-10a-5p,ovarian carcinoma,0.811674177646637
hsa-miR-5581-5p,ovarian carcinoma,0.811674177646637
hsa-miR-3671,ovarian carcinoma,0.811674177646637
hsa-miR-3164,ovarian carcinoma,0.811674177646637
hsa-miR-3975,ovarian carcinoma,0.811674177646637
hsa-miR-1295a,castration-resistant prostate cancer,0.8116657137870789
hsa-miR-186*,castration-resistant prostate cancer,0.8116657137870789
hsa-miR-28-5p,castration-resistant prostate cancer,0.8116657137870789
hsa-miR-363*,castration-resistant prostate cancer,0.8116657137870789
hsa-miR-499a-5p,breast cancer brain metastasis,0.811660647392273
hsa-let-7i*,breast cancer brain metastasis,0.811660647392273
hsa-miR-584,breast cancer brain metastasis,0.811660647392273
hsa-miR-8088,breast cancer brain metastasis,0.811660647392273
hsa-miR-4726-3p,aryngeal squamous cell carcinoma,0.8116523623466492
hsa-miR-328,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-1911-5p,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-523-3p,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-423-5p_1,castration-resistant prostate cancer,0.8116182088851929
hsa-let-7f-2,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-4723-3p,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-3920,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-512-5p-1105,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-6126,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-9-3p,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-520g-520h,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-4433a-3p,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-7108-5p,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-381-5p,castration-resistant prostate cancer,0.8116182088851929
hsa-miR-374b*,primary central nervous system lymphomas,0.8116137385368347
hsa-miR-148a-5p,primary central nervous system lymphomas,0.8116137385368347
hsa-miR-519c-3p,aryngeal squamous cell carcinoma,0.811581015586853
hsa-miR-4647,castration-resistant prostate cancer,0.8115750551223755
hsa-miR-26a-2-3p,castration-resistant prostate cancer,0.8115750551223755
hsa-miR-4782-5p,castration-resistant prostate cancer,0.8115750551223755
hsa-miR-27b*,castration-resistant prostate cancer,0.8115750551223755
hsa-miR-4720-5p,miR-142-y,0.8115726709365845
hsa-miR-548an,miR-142-y,0.8115726709365845
hsa-miR-24-2,miR-142-y,0.8115726709365845
hsa-miR-3180-3p,miR-142-y,0.8115726709365845
hsa-miR-520d-3p,ovarian carcinoma,0.8115559816360474
hsa-miR-625*,ovarian carcinoma,0.8115559816360474
hsa-miR-516-1,ovarian carcinoma,0.8115559816360474
hsa-miR-5091,ovarian carcinoma,0.8115559816360474
hsa-miR-30c-1-3p,ovarian carcinoma,0.8115559816360474
hsa-miR-193b,ovarian carcinoma,0.8115559816360474
hsa-miR-91,breast cancer brain metastasis,0.8115519881248474
hsa-miR-136-3p,castration-resistant prostate cancer,0.8115354776382446
hsa-miR-324-3p,castration-resistant prostate cancer,0.8114957213401794
hsa-miR-208a,castration-resistant prostate cancer,0.8114957213401794
hsa-miR-711,castration-resistant prostate cancer,0.8114957213401794
hsa-miR-302e,castration-resistant prostate cancer,0.8114957213401794
hsa-miR-617,castration-resistant prostate cancer,0.8114957213401794
hsa-miR-4768-3p,castration-resistant prostate cancer,0.8114957213401794
hsa-miR-4669,castration-resistant prostate cancer,0.8114957213401794
hsa-miR-4656,castration-resistant prostate cancer,0.8114957213401794
hsa-miR-4292,castration-resistant prostate cancer,0.8114957213401794
hsa-miR-370,Leptomeningeal metastasis,0.8114700317382812
hsa-miR-582-3p,Leptomeningeal metastasis,0.8114700317382812
hsa-miR-6514-3p,Leptomeningeal metastasis,0.8114700317382812
hsa-miR-192-5p,castration-resistant prostate cancer,0.8114604353904724
hsa-miR-6086,castration-resistant prostate cancer,0.8114604353904724
hsa-let-7f-1-3p,castration-resistant prostate cancer,0.8114604353904724
hsa-miR-216b-3p,castration-resistant prostate cancer,0.8114604353904724
hsa-miR-665,miR-142-y,0.8114511370658875
hsa-miR-4713-5p,primary central nervous system lymphomas,0.8114504218101501
hsa-miR-517c,ovarian carcinoma,0.8114448189735413
hsa-miR-4733-3p,ovarian carcinoma,0.8114448189735413
hsa-miR-6776-3p,ovarian carcinoma,0.8114448189735413
hsa-miR-3177-3p,ovarian carcinoma,0.8114448189735413
hsa-miR-4683,castration-resistant prostate cancer,0.811434805393219
hsa-miR-6757-3p,castration-resistant prostate cancer,0.811434805393219
hsa-miR-3157-5p,follicular thyroid carcinoma,0.8114333748817444
hsa-miR-518a-5p,breast cancer brain metastasis,0.8114111423492432
hsa-miR-890,castration-resistant prostate cancer,0.8114098906517029
hsa-miR-6852-5p,castration-resistant prostate cancer,0.8114098906517029
hsa-miR-663a,castration-resistant prostate cancer,0.8114098906517029
hsa-miR-423-5p_1,miR-142-y,0.8114036321640015
hsa-miR-9-3p,miR-142-y,0.8114036321640015
hsa-miR-93*,miR-142-y,0.8114036321640015
hsa-miR-2278,miR-142-y,0.8114036321640015
hsa-miR-4462,miR-142-y,0.8114036321640015
hsa-miR-4467,high grade serous papillary ovarian cancer,0.8114034533500671
hsa-miR-5586-5p,high grade serous papillary ovarian cancer,0.8114034533500671
hsa-miR-2113,high grade serous papillary ovarian cancer,0.8114034533500671
hsa-miR-6730-5p,high grade serous papillary ovarian cancer,0.8114034533500671
hsa-miR-4524a-3p,high grade serous papillary ovarian cancer,0.8114034533500671
hsa-miR-6766-3p,high grade serous papillary ovarian cancer,0.8114034533500671
hsa-miR-4276,high grade serous papillary ovarian cancer,0.8114013671875
hsa-miR-18a*,high grade serous papillary ovarian cancer,0.8114013671875
hsa-miR-424-5p,high grade serous papillary ovarian cancer,0.8114013671875
hsa-miR-548i-1,high grade serous papillary ovarian cancer,0.8114013671875
hsa-miR-6716-3p,high grade serous papillary ovarian cancer,0.8114013671875
hsa-miR-5699,high grade serous papillary ovarian cancer,0.8114013671875
hsa-miR-6773-3p,high grade serous papillary ovarian cancer,0.8114013671875
hsa-miR-6765-5p,high grade serous papillary ovarian cancer,0.8114013671875
hsa-miR-4271,castration-resistant prostate cancer,0.8113997578620911
hsa-miR-6826-5p,castration-resistant prostate cancer,0.8113870024681091
hsa-miR-6837-3p,castration-resistant prostate cancer,0.8113870024681091
hsa-miR-4293,primary central nervous system lymphomas,0.8113858103752136
hsa-miRPlus-A1073,pilocytic astrocytoma,0.8113843202590942
hsa-miR-132*,pilocytic astrocytoma,0.8113843202590942
hsa-miR-128b,pilocytic astrocytoma,0.8113843202590942
hsa-miR-106a*,castration-resistant prostate cancer,0.8113768696784973
hsa-miR-6729-3p,castration-resistant prostate cancer,0.8113768696784973
hsa-miR-1304-3p,ovarian carcinoma,0.8113768696784973
hsa-miR-380,ovarian carcinoma,0.8113768696784973
hsa-miR-3195,ovarian carcinoma,0.8113768696784973
hsa-miR-377-5p,ovarian carcinoma,0.8113768696784973
hsa-miR-4469,ovarian carcinoma,0.8113768696784973
hsa-miR-4764-5p,ovarian carcinoma,0.8113768696784973
hsa-miR-624,ovarian carcinoma,0.8113768696784973
hsa-miR-377*,ovarian carcinoma,0.8113768696784973
hsa-miR-599,ovarian carcinoma,0.8113768696784973
hsa-miR-3935,ovarian carcinoma,0.8113768696784973
hsa-miR-4252,ovarian carcinoma,0.8113768696784973
hsa-miR-3145,ovarian carcinoma,0.8113768696784973
hsa-miR-6817-5p,castration-resistant prostate cancer,0.8113729357719421
hsa-miR-516b-5p,castration-resistant prostate cancer,0.8113729357719421
hsa-miR-6769a-3p,castration-resistant prostate cancer,0.8113718628883362
hsa-miR-3144-5p,castration-resistant prostate cancer,0.8113718628883362
hsa-miR-3609,castration-resistant prostate cancer,0.8113711476325989
hsa-miR-7845-5p,castration-resistant prostate cancer,0.8113711476325989
hsa-miR-520h,castration-resistant prostate cancer,0.8113711476325989
hsa-miR-593-3p,castration-resistant prostate cancer,0.8113711476325989
hsa-miR-1262,castration-resistant prostate cancer,0.8113711476325989
hsa-miR-4772-3p,castration-resistant prostate cancer,0.8113700151443481
hsa-miR-138-2-3p,castration-resistant prostate cancer,0.8113700151443481
hsa-miR-4668-5p,castration-resistant prostate cancer,0.8113700151443481
hsa-miR-876-5p,castration-resistant prostate cancer,0.8113700151443481
hsa-miR-4680-5p,castration-resistant prostate cancer,0.8113700151443481
hsa-miR-581,castration-resistant prostate cancer,0.8113691210746765
hsa-miR-6777-5p,castration-resistant prostate cancer,0.8113691210746765
hsa-miR-7155-3p,castration-resistant prostate cancer,0.811369001865387
hsa-miR-3175,castration-resistant prostate cancer,0.8113682866096497
hsa-miR-486-3p,castration-resistant prostate cancer,0.8113682866096497
hsa-miR-6740-5p,castration-resistant prostate cancer,0.8113682866096497
hsa-miR-493-3p,castration-resistant prostate cancer,0.8113682866096497
hsa-miR-545-3p,castration-resistant prostate cancer,0.811367392539978
hsa-miR-3688-3p,castration-resistant prostate cancer,0.8113667964935303
hsa-miR-3911,castration-resistant prostate cancer,0.8113667964935303
hsa-miR-1228-3p,castration-resistant prostate cancer,0.8113667964935303
hsa-miR-5009-3p,castration-resistant prostate cancer,0.8113667964935303
hsa-miR-196b-5p,castration-resistant prostate cancer,0.8113657236099243
hsa-miR-6764-3p,castration-resistant prostate cancer,0.8113657236099243
hsa-miR-3651,castration-resistant prostate cancer,0.8113657236099243
hsa-miR-100-5p,castration-resistant prostate cancer,0.8113657236099243
hsa-miR-6883-5p,castration-resistant prostate cancer,0.8113657236099243
hsa-miR-34b,castration-resistant prostate cancer,0.8113649487495422
hsa-miR-196a-1,castration-resistant prostate cancer,0.8113649487495422
hsa-miR-4516,castration-resistant prostate cancer,0.8113649487495422
hsa-miR-629-5p,castration-resistant prostate cancer,0.8113649487495422
hsa-miR-3928,castration-resistant prostate cancer,0.8113642930984497
hsa-miR-5691,castration-resistant prostate cancer,0.811363697052002
hsa-miR-617,breast cancer brain metastasis,0.8113629221916199
hsa-miR-330,breast cancer brain metastasis,0.8113629221916199
hsa-miR-205-5p,castration-resistant prostate cancer,0.8113622665405273
hsa-miR-1245b-5p,castration-resistant prostate cancer,0.8113614916801453
hsa-miR-6820-5p,castration-resistant prostate cancer,0.8113614916801453
hsa-miR-888-5p,castration-resistant prostate cancer,0.8113614916801453
hsa-miR-4787-3p,miR-142-y,0.8113604784011841
hsa-miR-6834-3p,miR-142-y,0.8113604784011841
hsa-miR-6867-3p,castration-resistant prostate cancer,0.8113604784011841
hsa-miR-4731-3p,miR-142-y,0.8113604784011841
hsa-miR-4794,castration-resistant prostate cancer,0.8113604784011841
hsa-miR-873,primary central nervous system lymphomas,0.8113603591918945
hsa-miR-8059,primary central nervous system lymphomas,0.8113603591918945
hsa-miR-140-5p,primary central nervous system lymphomas,0.8113603591918945
hsa-miR-124*,primary central nervous system lymphomas,0.8113603591918945
hsa-miR-520d-5p,primary central nervous system lymphomas,0.8113603591918945
hsa-miR-548q,castration-resistant prostate cancer,0.8113582134246826
hsa-miR-587,ovarian carcinoma,0.8113360404968262
hsa-miR-548aq-5p,ovarian carcinoma,0.8113360404968262
hsa-miR-548k,ovarian carcinoma,0.8113360404968262
hsa-miR-127-3p,miR-142-y,0.8113207817077637
hsa-miR-3176,miR-142-y,0.8113207817077637
hsa-miR-935,primary central nervous system lymphomas,0.8113173246383667
hsa-miR-5192,Leptomeningeal metastasis,0.811312198638916
hsa-miR-615-3p,Leptomeningeal metastasis,0.811312198638916
hsa-miR-4510,Leptomeningeal metastasis,0.811312198638916
hsa-miR-4658,primary central nervous system lymphomas,0.8112844228744507
hsa-miR-1909-3p,papillary thyroid carcinoma,0.81125807762146
hsa-miR-4259,papillary thyroid carcinoma,0.81125807762146
hsa-miR-4715-3p,aryngeal squamous cell carcinoma,0.8112479448318481
hsa-miR-2277-3p,ovarian carcinoma,0.8112233281135559
hsa-miR-1273e,ovarian carcinoma,0.8112233281135559
hsa-miR-191-5p,ovarian carcinoma,0.8112233281135559
hsa-miR-3180-3p,ovarian carcinoma,0.8112233281135559
hsa-miR-4513,ovarian carcinoma,0.8112233281135559
hsa-miR-519e*,ovarian carcinoma,0.8112233281135559
hsa-miR-8083,ovarian carcinoma,0.8112233281135559
hsa-miR-374a,miR-142-y,0.8112199306488037
hsa-miR-636,primary central nervous system lymphomas,0.8112172484397888
hsa-miR-450a,miR-142-y,0.8111950755119324
hsa-miR-4775,miR-142-y,0.8111950755119324
hsa-miR-876-3p,miR-142-y,0.8111950755119324
hsa-miR-1974,high grade serous papillary ovarian cancer,0.8111916184425354
hsa-miR-4789-3p,high grade serous papillary ovarian cancer,0.8111916184425354
hsa-miR-29b-2-5p,high grade serous papillary ovarian cancer,0.8111916184425354
hsa-miR-4755-3p,high grade serous papillary ovarian cancer,0.8111916184425354
hsa-miR-1178,high grade serous papillary ovarian cancer,0.8111916184425354
hsa-miR-5093,high grade serous papillary ovarian cancer,0.8111916184425354
hsa-miR-4289,high grade serous papillary ovarian cancer,0.8111916184425354
hsa-miR-16-1*,high grade serous papillary ovarian cancer,0.8111916184425354
hsa-miR-021,miR-142-y,0.8111721873283386
hsa-miR-122-3p,miR-142-y,0.8111721873283386
hsa-miR-548ar-5p,miR-142-y,0.8111721873283386
hsa-miR-139-3p,primary central nervous system lymphomas,0.811170756816864
hsa-miR-374a-3p,primary central nervous system lymphomas,0.811170756816864
hsa-miR-8071,miR-142-y,0.8111581206321716
hsa-miR-149-3p,miR-142-y,0.8111571073532104
hsa-miR-6720-5p,miR-142-y,0.8111571073532104
hsa-miR-3606-5p,miR-142-y,0.8111563324928284
hsa-miR-125a-5p,miR-142-y,0.8111563324928284
hsa-miR-6875-3p,miR-142-y,0.8111543655395508
hsa-miR-3175,miR-142-y,0.8111535906791687
hsa-miR-323a-3p,miR-142-y,0.8111525774002075
hsa-miR-631,miR-142-y,0.8111525774002075
hsa-miR-4431,ovarian carcinoma,0.8111518025398254
hsa-miR-6748-5p,ovarian carcinoma,0.8111518025398254
hsa-miR-3929,ovarian carcinoma,0.8111518025398254
hsa-miR-3651,miR-142-y,0.8111509084701538
hsa-miR-632,miR-142-y,0.8111494779586792
hsa-miR-4670-5p,miR-142-y,0.8111494779586792
hsa-miR-767,aryngeal squamous cell carcinoma,0.8111492395401001
hsa-miR-4723-3p,aryngeal squamous cell carcinoma,0.8111492395401001
hsa-miR-4693-5p,aryngeal squamous cell carcinoma,0.8111473917961121
hsa-miR-6512-5p,aryngeal squamous cell carcinoma,0.8111473917961121
hsa-miR-6799-3p,aryngeal squamous cell carcinoma,0.8111473917961121
hsa-miR-550a*,aryngeal squamous cell carcinoma,0.8111473917961121
hsa-miR-6741-3p,miR-142-y,0.8111461400985718
hsa-miR-6727-3p,miR-142-y,0.8111419677734375
hsa-miR-573,breast cancer brain metastasis,0.8111213445663452
hsa-miR-292-5p,papillary thyroid carcinoma,0.8111108541488647
hsa-miR-618,ovarian carcinoma,0.8111016750335693
hsa-miR-3681-3p,ovarian carcinoma,0.8111016750335693
hsa-miR-1238-3p,high grade serous papillary ovarian cancer,0.8110988140106201
hsa-miR-4796-5p,high grade serous papillary ovarian cancer,0.8110988140106201
hsa-miR-4283,high grade serous papillary ovarian cancer,0.8110988140106201
hsa-miR-888*,high grade serous papillary ovarian cancer,0.8110988140106201
hsa-miR-744-3p,high grade serous papillary ovarian cancer,0.8110988140106201
hsa-miR-347,high grade serous papillary ovarian cancer,0.8110988140106201
hsa-miR-6854-3p,high grade serous papillary ovarian cancer,0.8110988140106201
hsa-miR-26b*,primary central nervous system lymphomas,0.8110908269882202
hsa-miR-4790-5p,primary central nervous system lymphomas,0.8110908269882202
hsa-miR-22*,primary central nervous system lymphomas,0.8110908269882202
hsa-miR-4737,ovarian carcinoma,0.8110882639884949
hsa-miR-4695-5p,ovarian carcinoma,0.8110882639884949
hsa-miR-645,ovarian carcinoma,0.8110882639884949
hsa-miR-676-5p,ovarian carcinoma,0.8110882639884949
hsa-miR-5704,ovarian carcinoma,0.8110882639884949
hsa-miR-129-2,ovarian carcinoma,0.8110882639884949
hsa-miR-345-3p,ovarian carcinoma,0.8110882639884949
hsa-miR-6068,ovarian carcinoma,0.8110882639884949
hsa-miR-3187,ovarian carcinoma,0.8110882639884949
hsa-miR-3934-5p,ovarian carcinoma,0.8110882639884949
hsa-miR-1264,ovarian carcinoma,0.8110882639884949
hsa-miR-3667-5p,ovarian carcinoma,0.8110882639884949
hsa-miR-3120,ovarian carcinoma,0.8110882639884949
hsa-miR-1233-3p,rhabdomyosarcomas,0.8110555410385132
hsa-miR-124a-2,rhabdomyosarcomas,0.8110555410385132
hsa-miR-767,ovarian carcinoma,0.8110541105270386
hsa-miR-24-2*,ovarian carcinoma,0.8110541105270386
hsa-miR-512-5p-1105,ovarian carcinoma,0.8110541105270386
hsa-miR-520a-3p,ovarian carcinoma,0.8110541105270386
hsa-miR-6795-3p,high grade serous papillary ovarian cancer,0.8110232353210449
hsa-miR-202-5p,high grade serous papillary ovarian cancer,0.8110232353210449
hsa-miR-3545-3p,high grade serous papillary ovarian cancer,0.8110232353210449
hsa-miR-6505-5p,high grade serous papillary ovarian cancer,0.8110232353210449
hsa-miR-6857-3p,high grade serous papillary ovarian cancer,0.8110232353210449
hsa-miR-337-5p,ovarian carcinoma,0.8110108375549316
hsa-miR-1245b-5p,breast cancer brain metastasis,0.8109951615333557
hsa-miR-6820-5p,breast cancer brain metastasis,0.8109951615333557
hsa-miR-4499,ovarian carcinoma,0.810971200466156
hsa-miR-6871-5p,ovarian carcinoma,0.810971200466156
hsa-miR-616,ovarian carcinoma,0.8109477162361145
hsa-miR-4720-3p,ovarian carcinoma,0.8109477162361145
hsa-miR-4664-3p,ovarian carcinoma,0.8109477162361145
hsa-miR-3663-3p,ovarian carcinoma,0.8109477162361145
hsa-miR-1179,ovarian carcinoma,0.8109477162361145
hsa-miR-6779-3p,ovarian carcinoma,0.8109477162361145
hsa-miR-4289,ovarian carcinoma,0.8109477162361145
hsa-miR-652-3p,ovarian carcinoma,0.8109313249588013
hsa-miR-4292,ovarian carcinoma,0.8109313249588013
hsa-miR-33b-3p,ovarian carcinoma,0.8109313249588013
hsa-miR-665,aryngeal squamous cell carcinoma,0.8109148144721985
hsa-miR-106b-3p,aryngeal squamous cell carcinoma,0.8109148144721985
hsa-miR-544b,aryngeal squamous cell carcinoma,0.8109148144721985
hsa-miR-1252-5p,primary central nervous system lymphomas,0.810905933380127
hsa-miR-483,ovarian carcinoma,0.8108959794044495
hsa-miR-4687-3p,ovarian carcinoma,0.8108959794044495
hsa-miR-5095,ovarian carcinoma,0.8108959794044495
hsa-miR-513a-1,miR-675-y,0.8108895421028137
hsa-miR-3663-3p,miR-675-y,0.8108895421028137
hsa-miR-1273c,miR-675-y,0.8108895421028137
hsa-miR-4643,miR-675-y,0.8108895421028137
hsa-miR-4305,miR-675-y,0.8108895421028137
hsa-miR-465,miR-675-y,0.8108895421028137
hsa-miR-4797-5p,miR-675-y,0.8108895421028137
hsa-miR-26b-3p,ovarian carcinoma,0.8108702301979065
hsa-miR-367-5p,ovarian carcinoma,0.8108702301979065
hsa-miR-212-3p,ovarian carcinoma,0.8108702301979065
hsa-miR-4285,ovarian carcinoma,0.8108702301979065
hsa-miR-637,pilocytic astrocytoma,0.8108571767807007
hsa-miR-450a,ovarian carcinoma,0.8108452558517456
hsa-miR-6769b-5p,ovarian carcinoma,0.8108452558517456
hsa-miR-1201,ovarian carcinoma,0.8108423352241516
hsa-miR-548av-3p,ovarian carcinoma,0.8108423352241516
hsa-miR-6882-5p,ovarian carcinoma,0.8108423352241516
hsa-miR-6722-5p,ovarian carcinoma,0.8108423352241516
hsa-miRPlus-J1004,ovarian carcinoma,0.8108423352241516
hsa-miR-874,ovarian carcinoma,0.8108423352241516
hsa-miR-559,ovarian carcinoma,0.8108423352241516
hsa-miR-3129-5p,ovarian carcinoma,0.8108423352241516
hsa-miR-450a-5p,ovarian carcinoma,0.8108423352241516
hsa-miR-625-3p,ovarian carcinoma,0.8108423352241516
hsa-miR-223-5p,ovarian carcinoma,0.8108423352241516
hsa-miR-363,ovarian carcinoma,0.8108423352241516
hsa-miR-4772-5p,ovarian carcinoma,0.8108423352241516
hsa-miR-3680-3p,ovarian carcinoma,0.8108423352241516
hsa-miR-325,high grade serous papillary ovarian cancer,0.8108282089233398
hsa-miR-3192-3p,high grade serous papillary ovarian cancer,0.8108282089233398
hsa-miR-453,high grade serous papillary ovarian cancer,0.8108282089233398
hsa-miR-548ag,high grade serous papillary ovarian cancer,0.8108282089233398
hsa-miR-4523,high grade serous papillary ovarian cancer,0.8108282089233398
hsa-miR-1252-3p,high grade serous papillary ovarian cancer,0.8108282089233398
hsa-miR-7155-5p,high grade serous papillary ovarian cancer,0.8108267784118652
hsa-miR-30b*,high grade serous papillary ovarian cancer,0.8108267784118652
hsa-miR-520a,high grade serous papillary ovarian cancer,0.8108267784118652
hsa-miR-6826-5p,ovarian carcinoma,0.8108223080635071
hsa-miR-6863,ovarian carcinoma,0.8108223080635071
hsa-miR-28-5p,aryngeal squamous cell carcinoma,0.8108208179473877
hsa-miR-1266,aryngeal squamous cell carcinoma,0.8108208179473877
hsa-miR-451,ovarian carcinoma,0.81081223487854
hsa-miR-218-5p,ovarian carcinoma,0.8108071684837341
hsa-miR-149-3p,ovarian carcinoma,0.8108071684837341
hsa-miR-7845-5p,ovarian carcinoma,0.8108065128326416
hsa-miR-3141,ovarian carcinoma,0.8108065128326416
hsa-miR-1262,ovarian carcinoma,0.8108065128326416
hsa-miR-3175,ovarian carcinoma,0.8108037710189819
hsa-miR-5010-5p,ovarian carcinoma,0.8108037710189819
hsa-miR-193a,ovarian carcinoma,0.8108028173446655
hsa-miR-3911,ovarian carcinoma,0.8108022809028625
hsa-miR-502-5p,ovarian carcinoma,0.810798168182373
hsa-miR-8065,ovarian carcinoma,0.8107976317405701
hsa-miR-142,ovarian carcinoma,0.810796856880188
hsa-miR-1245b-5p,ovarian carcinoma,0.810796856880188
hsa-miR-888-5p,ovarian carcinoma,0.810796856880188
hsa-miR-603,aryngeal squamous cell carcinoma,0.8107958436012268
hsa-miR-425-5p,aryngeal squamous cell carcinoma,0.8107958436012268
hsa-miR-432-3p,aryngeal squamous cell carcinoma,0.8107958436012268
hsa-miR-565,aryngeal squamous cell carcinoma,0.8107958436012268
hsa-miR-132-5p,aryngeal squamous cell carcinoma,0.8107958436012268
hsa-miR-568,aryngeal squamous cell carcinoma,0.8107958436012268
hsa-miR-506-3p,aryngeal squamous cell carcinoma,0.8107958436012268
hsa-miR-3125,aryngeal squamous cell carcinoma,0.8107958436012268
hsa-miR-1244,ovarian carcinoma,0.8107951283454895
hsa-miR-6747-3p,ovarian carcinoma,0.8107941150665283
hsa-miR-1247-5p,breast cancer brain metastasis,0.8107548356056213
hsa-miR-486-3p,breast cancer brain metastasis,0.8107548356056213
hsa-miR-548av-3p,primary central nervous system lymphomas,0.8107126951217651
hsa-miR-6885-5p,primary central nervous system lymphomas,0.8107126951217651
hsa-miR-4772-5p,primary central nervous system lymphomas,0.8107126951217651
hsa-miR-676-5p,primary central nervous system lymphomas,0.8107070326805115
hsa-miR-425-3p,primary central nervous system lymphomas,0.8107070326805115
hsa-miR-376a-5p,primary central nervous system lymphomas,0.8107070326805115
hsa-miR-548ap-5p,primary central nervous system lymphomas,0.8107070326805115
hsa-miR-138-2-3p,breast cancer brain metastasis,0.8106935024261475
hsa-miR-543,papillary thyroid carcinoma,0.8106776475906372
hsa-miR-214-3p,rhabdomyosarcomas,0.8106769919395447
hsa-miR-6798-3p,rhabdomyosarcomas,0.8106769919395447
hsa-miR-3200,rhabdomyosarcomas,0.8106769919395447
hsa-miR-1306-3p,rhabdomyosarcomas,0.8106769919395447
hsa-miR-4791,primary central nervous system lymphomas,0.8106730580329895
hsa-miR-6831-3p,primary central nervous system lymphomas,0.8106730580329895
hsa-miR-374a-5p,primary central nervous system lymphomas,0.8106730580329895
hsa-miR-539,Luminal B Her2+,0.81065434217453
hsa-miR-10b,pilocytic astrocytoma,0.8106384873390198
hsa-miR-1263,pilocytic astrocytoma,0.8106384873390198
hsa-miR-3690,breast cancer brain metastasis,0.8106269836425781
hsa-miR-511-2,synovial sarcoma,0.8106173276901245
hsa-miR-4430,synovial sarcoma,0.8106173276901245
hsa-miR-6827-5p,synovial sarcoma,0.8106173276901245
hsa-miR-21-3p,synovial sarcoma,0.8106173276901245
hsa-miR-3190,synovial sarcoma,0.8106173276901245
hsa-miR-3647-3p,synovial sarcoma,0.8106173276901245
hsa-miR-513b,synovial sarcoma,0.8106173276901245
hsa-miR-3691-3p,synovial sarcoma,0.8106173276901245
hsa-miR-6823-5p,synovial sarcoma,0.8106173276901245
hsa-miR-5700,aryngeal squamous cell carcinoma,0.8106099963188171
hsa-miR-6769a-5p,aryngeal squamous cell carcinoma,0.8106099963188171
hsa-miR-200c,aryngeal squamous cell carcinoma,0.8106099963188171
hsa-miR-509,aryngeal squamous cell carcinoma,0.8106099963188171
hsa-let-7f-1,high grade serous papillary ovarian cancer,0.8105699419975281
hsa-miR-1b-1,high grade serous papillary ovarian cancer,0.8105699419975281
hsa-miR-3680-5p,high grade serous papillary ovarian cancer,0.8105699419975281
hsa-miR-4282,high grade serous papillary ovarian cancer,0.8105699419975281
hsa-miR-6840-5p,high grade serous papillary ovarian cancer,0.8105699419975281
hsa-miR-1245a,high grade serous papillary ovarian cancer,0.8105699419975281
hsa-miR-593*,papillary thyroid carcinoma,0.8105599284172058
hsa-miR-4668-3p,papillary thyroid carcinoma,0.8105599284172058
hsa-miR-6792-3p,breast cancer brain metastasis,0.8105157613754272
hsa-miR-199a*-1,high grade serous papillary ovarian cancer,0.8105047941207886
hsa-miR-3195,high grade serous papillary ovarian cancer,0.8105047941207886
hsa-miR-291-3p,high grade serous papillary ovarian cancer,0.8105047941207886
hsa-miR-224*,high grade serous papillary ovarian cancer,0.8105047941207886
hsa-miR-5698,high grade serous papillary ovarian cancer,0.8105047941207886
hsa-miR-520f-3p,high grade serous papillary ovarian cancer,0.8105047941207886
hsa-miR-885,high grade serous papillary ovarian cancer,0.8105047941207886
hsa-miR-6825-5p,high grade serous papillary ovarian cancer,0.8105047941207886
hsa-miR-1273e,breast cancer brain metastasis,0.8104828596115112
hsa-miR-302a*,rhabdomyosarcomas,0.8104801177978516
hsa-miR-3925-3p,rhabdomyosarcomas,0.8104801177978516
hsa-miR-4257,rhabdomyosarcomas,0.8104801177978516
hsa-miR-6793-3p,rhabdomyosarcomas,0.8104801177978516
hsa-miR-4760-5p,rhabdomyosarcomas,0.8104801177978516
hsa-miR-450a,breast cancer brain metastasis,0.8104753494262695
hsa-miR-3658,aryngeal squamous cell carcinoma,0.8104408979415894
hsa-miR-466,aryngeal squamous cell carcinoma,0.8104408979415894
hsa-miR-1307,aryngeal squamous cell carcinoma,0.8104408979415894
hsa-miR-33a-3p,aryngeal squamous cell carcinoma,0.8104408979415894
hsa-miR-374a,breast cancer brain metastasis,0.8104323744773865
hsa-miR-548j,aryngeal squamous cell carcinoma,0.8104192018508911
hsa-miR-519d-5p,primary central nervous system lymphomas,0.8104184865951538
hsa-miR-4695-5p,aryngeal squamous cell carcinoma,0.8104006052017212
hsa-miR-676-5p,aryngeal squamous cell carcinoma,0.8104006052017212
hsa-miR-21*,aryngeal squamous cell carcinoma,0.8104006052017212
hsa-miR-3150b-3p,aryngeal squamous cell carcinoma,0.8104006052017212
hsa-miR-548ar-3p,aryngeal squamous cell carcinoma,0.8104006052017212
hsa-miR-4688,primary central nervous system lymphomas,0.8103986978530884
hsa-miR-1229-5p,primary central nervous system lymphomas,0.8103986978530884
hsa-miR-580,papillary thyroid carcinoma,0.8103871941566467
hsa-miR-145-5p,breast cancer brain metastasis,0.810387134552002
hsa-miR-4431,aryngeal squamous cell carcinoma,0.8103690147399902
hsa-miR-136,aryngeal squamous cell carcinoma,0.8103690147399902
hsa-miR-363,primary central nervous system lymphomas,0.8103650212287903
hsa-miR-3927-5p,high grade serous papillary ovarian cancer,0.8103450536727905
hsa-miR-5011-5p,high grade serous papillary ovarian cancer,0.8103450536727905
hsa-miR-490,high grade serous papillary ovarian cancer,0.8103450536727905
hsa-miR-4494,high grade serous papillary ovarian cancer,0.8103450536727905
hsa-miR-6833-3p,high grade serous papillary ovarian cancer,0.8103450536727905
hsa-miR-642a-3p,high grade serous papillary ovarian cancer,0.8103450536727905
hsa-miR-194,primary central nervous system lymphomas,0.8103194832801819
hsa-miR-4699-5p,primary central nervous system lymphomas,0.8103194832801819
hsa-miR-5681a,primary central nervous system lymphomas,0.8103194832801819
hsa-miR-548as-5p,Leptomeningeal metastasis,0.8103194236755371
hsa-miR-15a-2,pilocytic astrocytoma,0.8103119730949402
hsa-miR-6796-3p,aryngeal squamous cell carcinoma,0.8102850317955017
hsa-miR-885-5p,aryngeal squamous cell carcinoma,0.8102850317955017
hsa-miR-497-5p,aryngeal squamous cell carcinoma,0.8102850317955017
hsa-miR-24-1-5p,aryngeal squamous cell carcinoma,0.8102850317955017
hsa-miR-4470,high grade serous papillary ovarian cancer,0.8102700114250183
hsa-miR-885-5p,high grade serous papillary ovarian cancer,0.8102700114250183
hsa-miR-4535,high grade serous papillary ovarian cancer,0.8102700114250183
hsa-miR-183,high grade serous papillary ovarian cancer,0.8102700114250183
hsa-miR-181b-5p,high grade serous papillary ovarian cancer,0.8102700114250183
hsa-miR-5696,high grade serous papillary ovarian cancer,0.8102700114250183
hsa-miR-6846-3p,high grade serous papillary ovarian cancer,0.8102700114250183
hsa-miR-4693-5p,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-1226-5p,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-4781-3p,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-3944-3p,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-1268,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-3190-3p,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-1282,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-6783-5p,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-4799-3p,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-517*,high grade serous papillary ovarian cancer,0.8102644085884094
hsa-miR-4431,breast cancer brain metastasis,0.8102474212646484
hsa-miR-136,breast cancer brain metastasis,0.8102474212646484
hsa-miR-6165,primary central nervous system lymphomas,0.8102376461029053
hsa-miR-292-3p,breast cancer brain metastasis,0.8102307915687561
hsa-miR-7-2,aryngeal squamous cell carcinoma,0.810213565826416
hsa-miR-6861-3p,primary central nervous system lymphomas,0.8102087378501892
hsa-miR-449b,primary central nervous system lymphomas,0.8102087378501892
hsa-miRPlus-A1087,primary central nervous system lymphomas,0.8102087378501892
hsa-miR-2116-5p,primary central nervous system lymphomas,0.8102087378501892
hsa-miR-106a:9.1,primary central nervous system lymphomas,0.8102034330368042
hsa-miR-1296,primary central nervous system lymphomas,0.8102034330368042
hsa-miR-672,Leptomeningeal metastasis,0.8102015256881714
hsa-miR-8052,Leptomeningeal metastasis,0.8102015256881714
hsa-miR-1308,miR-675-y,0.8101963996887207
hsa-miR-548k,aryngeal squamous cell carcinoma,0.8101812601089478
hsa-miR-3185,aryngeal squamous cell carcinoma,0.8101812601089478
hsa-miR-9-3p,breast cancer brain metastasis,0.8101726174354553
hsa-miR-215,breast cancer brain metastasis,0.8101726174354553
hsa-miR-4650-3p,breast cancer brain metastasis,0.8101726174354553
hsa-miR-520f-520c,aryngeal squamous cell carcinoma,0.8101539611816406
hsa-miR-490-3p,distal cholangiocarcinoma,0.8101310133934021
hsa-miR-665,breast cancer brain metastasis,0.8101129531860352
hsa-miR-186*,breast cancer brain metastasis,0.8101129531860352
hsa-miR-363*,breast cancer brain metastasis,0.8101129531860352
hsa-miR-148b,rhabdomyosarcomas,0.8100890517234802
hsa-miR-892a,rhabdomyosarcomas,0.8100890517234802
hsa-miR-7-2*,rhabdomyosarcomas,0.8100890517234802
hsa-miR-4518,rhabdomyosarcomas,0.8100890517234802
hsa-miR-624-3p,rhabdomyosarcomas,0.8100890517234802
hsa-miR-092,aryngeal squamous cell carcinoma,0.8100690841674805
hsa-miR-658,aryngeal squamous cell carcinoma,0.8100690841674805
hsa-miR-499,aryngeal squamous cell carcinoma,0.8100690841674805
hsa-miR-514b-5p,aryngeal squamous cell carcinoma,0.8100470304489136
hsa-miR-4747-5p,papillary thyroid carcinoma,0.8100345730781555
hsa-miR-7850-5p,breast cancer brain metastasis,0.8099991679191589
hsa-miR-621,breast cancer brain metastasis,0.8099896907806396
hsa-miR-1224,breast cancer brain metastasis,0.8099804520606995
hsa-miR-376a-5p,breast cancer brain metastasis,0.8099804520606995
hsa-miR-3150b-3p,breast cancer brain metastasis,0.8099804520606995
hsa-miR-6892-3p,aryngeal squamous cell carcinoma,0.8099348545074463
hsa-miR-548k,breast cancer brain metastasis,0.8099247217178345
hsa-miR-519e-3p,rhabdomyosarcomas,0.8099226951599121
hsa-miR-4791,rhabdomyosarcomas,0.8099226951599121
hsa-miR-26b*,aryngeal squamous cell carcinoma,0.809909462928772
hsa-miR-1255a,aryngeal squamous cell carcinoma,0.809909462928772
hsa-miR-5589-5p,aryngeal squamous cell carcinoma,0.8098903894424438
hsa-miR-1277-5p,aryngeal squamous cell carcinoma,0.8098903894424438
hsa-miR-4720-3p,pilocytic astrocytoma,0.8098809719085693
hsa-miR-6848-3p,pilocytic astrocytoma,0.8098809719085693
hsa-miR-518d-5p,primary central nervous system lymphomas,0.8098734617233276
hsa-miR-1237,primary central nervous system lymphomas,0.8098734617233276
hsa-miR-5687,"Luminal A,Luminal B",0.8098645806312561
hsa-miR-135-2,breast cancer brain metastasis,0.8098558783531189
hsa-miR-518c-5p,papillary thyroid carcinoma,0.8098480701446533
hsa-miR-6777-3p,solid pseudopapillary neoplasm of pancreas,0.8098390102386475
hsa-miR-1197,solid pseudopapillary neoplasm of pancreas,0.8098390102386475
hsa-miR-3607-3p,breast cancer brain metastasis,0.8098227381706238
hsa-miR-185-5p,breast cancer brain metastasis,0.8098227381706238
hsa-miR-516b*,breast cancer brain metastasis,0.8097836375236511
hsa-miR-520d-5p,breast cancer brain metastasis,0.8097836375236511
hsa-miR-196-1,aryngeal squamous cell carcinoma,0.8097817301750183
hsa-miR-6890-3p,aryngeal squamous cell carcinoma,0.8097817301750183
hsa-miR-219-5p,aryngeal squamous cell carcinoma,0.8097817301750183
hsa-miR-4296,aryngeal squamous cell carcinoma,0.8097817301750183
hsa-miR-587,breast cancer brain metastasis,0.8097608089447021
hsa-miR-3202,Leptomeningeal metastasis,0.8097563982009888
hsa-miR-194,Leptomeningeal metastasis,0.8097563982009888
hsa-miR-29b-3p,Leptomeningeal metastasis,0.8097563982009888
hsa-miR-614,Leptomeningeal metastasis,0.8097563982009888
hsa-miR-374a-3p,breast cancer brain metastasis,0.8097085356712341
hsa-miR-1260b,high grade serous papillary ovarian cancer,0.8096979260444641
hsa-miR-3172,high grade serous papillary ovarian cancer,0.8096979260444641
hsa-miR-5692b,high grade serous papillary ovarian cancer,0.8096979260444641
hsa-miR-199b-3p,high grade serous papillary ovarian cancer,0.8096979260444641
hsa-miR-24-2-5p,high grade serous papillary ovarian cancer,0.8096979260444641
hsa-miR-1301,aryngeal squamous cell carcinoma,0.8096798658370972
hsa-miR-6760-3p,aryngeal squamous cell carcinoma,0.8096627593040466
hsa-miR-8059,aryngeal squamous cell carcinoma,0.8096627593040466
hsa-miR-1343-5p,aryngeal squamous cell carcinoma,0.8096627593040466
hsa-miR-145*,primary central nervous system lymphomas,0.8096603155136108
hsa-miR-455-3p,breast cancer brain metastasis,0.809648334980011
hsa-miR-7161-3p,breast cancer brain metastasis,0.809627890586853
hsa-miR-4661-3p,breast cancer brain metastasis,0.809627890586853
hsa-miR-5001-5p,primary central nervous system lymphomas,0.8095669150352478
hsa-miR-6076,aryngeal squamous cell carcinoma,0.8095505237579346
hsa-miR-148a-5p,aryngeal squamous cell carcinoma,0.8095505237579346
hsa-miR-3942-3p,aryngeal squamous cell carcinoma,0.8095505237579346
hsa-miR-4632-5p,aryngeal squamous cell carcinoma,0.8095505237579346
hsa-miR-187-3p,breast cancer brain metastasis,0.8095420002937317
hsa-miR-3622b-3p,papillary thyroid carcinoma,0.8095221519470215
hsa-miR-769-5p,miR-675-y,0.8095163106918335
hsa-miR-293,miR-675-y,0.8095163106918335
hsa-miR-6734-5p,miR-675-y,0.8095163106918335
hsa-miR-6818-3p,miR-675-y,0.8095163106918335
hsa-miR-6776-3p,breast cancer brain metastasis,0.8095139861106873
hsa-miR-187,rhabdomyosarcomas,0.8094636797904968
hsa-miR-200a-3p,rhabdomyosarcomas,0.8094636797904968
hsa-miR-195*,rhabdomyosarcomas,0.8094636797904968
hsa-miR-6793-3p,papillary thyroid carcinoma,0.8094504475593567
hsa-miR-320e,breast cancer brain metastasis,0.8094421029090881
hsa-miR-4276,breast cancer brain metastasis,0.8094421029090881
hsa-miR-449b,breast cancer brain metastasis,0.8094421029090881
hsa-miR-93-5p,breast cancer brain metastasis,0.8094421029090881
hsa-miR-6889-3p,aryngeal squamous cell carcinoma,0.8094127178192139
hsa-miR-3120-5p,aryngeal squamous cell carcinoma,0.8094127178192139
hsa-miR-4251,papillary thyroid carcinoma,0.809390664100647
hsa-miR-574-3p,papillary thyroid carcinoma,0.809390664100647
hsa-miR-548c,papillary thyroid carcinoma,0.809390664100647
hsa-miR-6814-5p,aryngeal squamous cell carcinoma,0.809383749961853
hsa-miR-934,aryngeal squamous cell carcinoma,0.809383749961853
hsa-miR-484,papillary thyroid carcinoma,0.8093658685684204
hsa-miR-626,rhabdomyosarcomas,0.8093496561050415
hsa-miR-556-3p,rhabdomyosarcomas,0.8093496561050415
hsa-miR-4317,rhabdomyosarcomas,0.8093496561050415
hsa-miR-1253,rhabdomyosarcomas,0.8093496561050415
hsa-miR-3619-3p,breast cancer brain metastasis,0.8093295097351074
hsa-miR-654-3p,breast cancer brain metastasis,0.8093295097351074
hsa-miR-1307,primary central nervous system lymphomas,0.809294581413269
hsa-miR-6802-3p,papillary thyroid carcinoma,0.809283435344696
hsa-miR-450b-3p,Luminal B Her2+,0.8092676401138306
hsa-miR-2861,breast cancer brain metastasis,0.8092585206031799
hsa-miR-3682-3p,aryngeal squamous cell carcinoma,0.8092552423477173
hsa-miRPlus-G1246-3p,breast cancer brain metastasis,0.8092420697212219
hsa-miR-4763-3p,breast cancer brain metastasis,0.8092420697212219
hsa-miR-6734-3p,Leptomeningeal metastasis,0.8092256784439087
hsa-miR-888*,breast cancer brain metastasis,0.8092078566551208
hsa-miR-4746-3p,breast cancer brain metastasis,0.8092078566551208
hsa-miR-6133,breast cancer brain metastasis,0.8092078566551208
hsa-miR-29a,aryngeal squamous cell carcinoma,0.8091567158699036
hsa-miR-1269,aryngeal squamous cell carcinoma,0.8091567158699036
hsa-miR-26b-5p,aryngeal squamous cell carcinoma,0.8091567158699036
hsa-miR-4534,aryngeal squamous cell carcinoma,0.8091382384300232
hsa-miR-549,aryngeal squamous cell carcinoma,0.8091382384300232
hsa-miR-6749-5p,aryngeal squamous cell carcinoma,0.8091382384300232
hsa-miR-3144-3p,high grade serous papillary ovarian cancer,0.8091137409210205
hsa-miR-3157-3p,high grade serous papillary ovarian cancer,0.8091137409210205
hsa-miR-5584-5p,high grade serous papillary ovarian cancer,0.8091137409210205
hsa-let-7i-5p,high grade serous papillary ovarian cancer,0.8091137409210205
hsa-miR-8077,high grade serous papillary ovarian cancer,0.8091137409210205
hsa-miR-4704-3p,high grade serous papillary ovarian cancer,0.8091137409210205
hsa-miR-148a,rhabdomyosarcomas,0.8091119527816772
hsa-miR-500a-3p,breast cancer brain metastasis,0.8090739250183105
hsa-miR-22,breast cancer brain metastasis,0.8090739250183105
hsa-miR-1913,breast cancer brain metastasis,0.8090739250183105
hsa-miR-4800-3p,breast cancer brain metastasis,0.8090739250183105
hsa-miR-4733-5p,aryngeal squamous cell carcinoma,0.8090732097625732
hsa-miR-1295,papillary thyroid carcinoma,0.8090377449989319
hsa-miR-4743,papillary thyroid carcinoma,0.8090377449989319
hsa-miR-130b*,papillary thyroid carcinoma,0.8090377449989319
hsa-miR-1249,papillary thyroid carcinoma,0.8090377449989319
hsa-miR-302e,aryngeal squamous cell carcinoma,0.8090330362319946
hsa-miR-4656,aryngeal squamous cell carcinoma,0.8090330362319946
hsa-miR-517a-3p,aryngeal squamous cell carcinoma,0.8090277314186096
hsa-miR-1281,aryngeal squamous cell carcinoma,0.8090277314186096
hsa-miR-201,aryngeal squamous cell carcinoma,0.8090277314186096
hsa-miR-4711-5p,aryngeal squamous cell carcinoma,0.8090277314186096
hsa-miR-4772-5p,aryngeal squamous cell carcinoma,0.8090277314186096
hsa-miR-675,Leptomeningeal metastasis,0.8090057373046875
hsa-miR-595,Leptomeningeal metastasis,0.8090057373046875
hsa-miR-181a*,Leptomeningeal metastasis,0.8090057373046875
hsa-miR-185-5p,Leptomeningeal metastasis,0.8090057373046875
hsa-miR-584,Leptomeningeal metastasis,0.8090057373046875
hsa-miR-491-3p,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-885-3p,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-548g,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-330-3p,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-933,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-323b-3p,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-3200-3p,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-18a,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-4773,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-548bb-5p,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-15a*,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-3672,high grade serous papillary ovarian cancer,0.8089954257011414
hsa-miR-4315,breast cancer brain metastasis,0.808991014957428
hsa-miR-219-5p,breast cancer brain metastasis,0.808991014957428
hsa-miRPlus-J1002,breast cancer brain metastasis,0.808991014957428
hsa-miR-4683,aryngeal squamous cell carcinoma,0.8089714646339417
hsa-miR-6769a-5p,breast cancer brain metastasis,0.808951735496521
hsa-miR-3157-3p,breast cancer brain metastasis,0.808951735496521
hsa-miR-4326,breast cancer brain metastasis,0.808951735496521
hsa-miR-4756-5p,aryngeal squamous cell carcinoma,0.8089463114738464
hsa-miR-021,aryngeal squamous cell carcinoma,0.8089233040809631
hsa-miR-122-3p,aryngeal squamous cell carcinoma,0.8089233040809631
hsa-miR-6863,aryngeal squamous cell carcinoma,0.8089233040809631
hsa-miR-3175,aryngeal squamous cell carcinoma,0.8089044690132141
hsa-miR-548av-3p,breast cancer brain metastasis,0.8088980317115784
hsa-miR-26a-1*,breast cancer brain metastasis,0.8088980317115784
hsa-miR-1245b-5p,aryngeal squamous cell carcinoma,0.8088976144790649
hsa-miR-639,breast cancer brain metastasis,0.8088960647583008
hsa-miR-548q,aryngeal squamous cell carcinoma,0.808894157409668
hsa-miR-602,diffuse large B-cell lymphoma,0.8088728189468384
hsa-miR-1231,diffuse large B-cell lymphoma,0.8088728189468384
hsa-miR-7-1*,diffuse large B-cell lymphoma,0.8088728189468384
hsa-miR-615-5p,diffuse large B-cell lymphoma,0.8088728189468384
hsa-miR-548o,diffuse large B-cell lymphoma,0.8088728189468384
hsa-miR-1537-3p,diffuse large B-cell lymphoma,0.8088728189468384
hsa-miR-181a-3p,diffuse large B-cell lymphoma,0.8088728189468384
hsa-miR-4765,diffuse large B-cell lymphoma,0.8088728189468384
hsa-miR-935,aryngeal squamous cell carcinoma,0.8088571429252625
hsa-miR-6836-3p,aryngeal squamous cell carcinoma,0.8088571429252625
hsa-miR-6506-3p,breast cancer brain metastasis,0.8088521361351013
hsa-miR-372,breast cancer brain metastasis,0.8088521361351013
hsa-miR-29b-3p,breast cancer brain metastasis,0.8088521361351013
hsa-let-7f-5p,breast cancer brain metastasis,0.8088521361351013
hsa-miR-578,breast cancer brain metastasis,0.8088521361351013
hsa-miR-491-5p,breast cancer brain metastasis,0.8088521361351013
hsa-miR-4678,breast cancer brain metastasis,0.8088521361351013
hsa-miR-412-3p,breast cancer brain metastasis,0.8088521361351013
hsa-miR-323-5p,aryngeal squamous cell carcinoma,0.8088427186012268
hsa-miR-5088-5p,aryngeal squamous cell carcinoma,0.8088427186012268
hsa-miR-646,breast cancer brain metastasis,0.8088258504867554
hsa-miR-128b,primary central nervous system lymphomas,0.8088085651397705
hsa-miR-130a-5p,miR-675-y,0.8087879419326782
hsa-miR-6799-3p,miR-675-y,0.8087879419326782
hsa-miR-433,miR-675-y,0.8087879419326782
hsa-miR-4309,miR-675-y,0.8087879419326782
hsa-miR-3132,miR-675-y,0.8087879419326782
hsa-miR-3192,miR-675-y,0.8087879419326782
hsa-miR-218-2*,miR-675-y,0.8087879419326782
hsa-miR-624-5p,miR-675-y,0.8087879419326782
hsa-miR-6871-3p,miR-675-y,0.8087879419326782
hsa-miR-4693-5p,breast cancer brain metastasis,0.8087700009346008
hsa-miR-376c,breast cancer brain metastasis,0.8087700009346008
hsa-miR-4778-5p,breast cancer brain metastasis,0.8087700009346008
hsa-miR-1286,breast cancer brain metastasis,0.8087700009346008
hsa-miRPlus-C1110,rhabdomyosarcomas,0.8087648153305054
hsa-miR-1257,rhabdomyosarcomas,0.8087648153305054
hsa-miR-6767-5p,rhabdomyosarcomas,0.8087648153305054
hsa-miR-3606-3p,rhabdomyosarcomas,0.8087648153305054
hsa-miR-548ad,rhabdomyosarcomas,0.8087648153305054
hsa-miR-519d-5p,rhabdomyosarcomas,0.8087648153305054
hsa-miR-3157-3p,rhabdomyosarcomas,0.8087648153305054
hsa-miR-543,rhabdomyosarcomas,0.8087648153305054
hsa-miR-1b-1,rhabdomyosarcomas,0.8087648153305054
hsa-miR-627-3p,rhabdomyosarcomas,0.8087648153305054
hsa-miR-5011-3p,rhabdomyosarcomas,0.8087648153305054
hsa-miR-3945,breast cancer brain metastasis,0.8087592124938965
hsa-miR-4305,breast cancer brain metastasis,0.8087592124938965
hsa-miR-3657,breast cancer brain metastasis,0.8087353110313416
hsa-miR-16-1-3p,breast cancer brain metastasis,0.8087353110313416
hsa-miR-3907,breast cancer brain metastasis,0.8087353110313416
hsa-miR-1226-5p,primary central nervous system lymphomas,0.8087273240089417
hsa-miR-624-5p,primary central nervous system lymphomas,0.8087273240089417
hsa-miR-138-2*,Leptomeningeal metastasis,0.8086770176887512
hsa-miR-291-3p,Leptomeningeal metastasis,0.8086770176887512
hsa-miR-224*,Leptomeningeal metastasis,0.8086770176887512
hsa-miR-374b,Leptomeningeal metastasis,0.8086770176887512
hsa-miR-4475,primary central nervous system lymphomas,0.8086716532707214
hsa-miR-3154,rhabdomyosarcomas,0.8086684942245483
hsa-miR-548b-3p,rhabdomyosarcomas,0.8086684942245483
hsa-miR-3157-5p,rhabdomyosarcomas,0.8086684942245483
hsa-miR-2115-5p,rhabdomyosarcomas,0.8086684942245483
hsa-miR-1275,rhabdomyosarcomas,0.8086461424827576
hsa-miR-943,rhabdomyosarcomas,0.8086461424827576
hsa-miR-616*,rhabdomyosarcomas,0.8086461424827576
hsa-miR-937,rhabdomyosarcomas,0.8086461424827576
hsa-miR-612,rhabdomyosarcomas,0.8086461424827576
hsa-miR-3200-3p,rhabdomyosarcomas,0.8086461424827576
hsa-miR-320c,breast cancer brain metastasis,0.8086053729057312
hsa-miR-508-3p,distal cholangiocarcinoma,0.8085648417472839
hsa-miR-4747-5p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-29b-3p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-565,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-16-5p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-5589-3p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-let-7d-5p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-132-5p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-8079,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-5739,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-6775-5p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-506-3p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-6880-3p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-6820-3p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-208a-5p,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-4718,high grade serous papillary ovarian cancer,0.808548092842102
hsa-miR-4651,aryngeal squamous cell carcinoma,0.8085204362869263
hsa-miR-4525,aryngeal squamous cell carcinoma,0.8085204362869263
hsa-miR-150-5p,aryngeal squamous cell carcinoma,0.8085204362869263
hsa-miR-449b,aryngeal squamous cell carcinoma,0.8085204362869263
hsa-miRPlus-A1087,aryngeal squamous cell carcinoma,0.8085204362869263
hsa-miR-4461,papillary thyroid carcinoma,0.8084980845451355
hsa-miR-655,papillary thyroid carcinoma,0.8084980845451355
hsa-miR-545,papillary thyroid carcinoma,0.8084980845451355
hsa-miR-349,papillary thyroid carcinoma,0.8084892630577087
hsa-miR-6884-3p,papillary thyroid carcinoma,0.8084385991096497
hsa-miR-6506-3p,miR-675-y,0.8084331750869751
hsa-miR-520d,miR-675-y,0.8084331750869751
hsa-miR-500,miR-675-y,0.8084331750869751
hsa-miR-5739,miR-675-y,0.8084331750869751
hsa-miR-6813-3p,miR-675-y,0.8084331750869751
hsa-miR-3653,breast cancer brain metastasis,0.8084200024604797
hsa-miR-5088-5p,breast cancer brain metastasis,0.8084200024604797
hsa-miR-3151-5p,Leptomeningeal metastasis,0.8083909153938293
hsa-miR-17,Leptomeningeal metastasis,0.8083909153938293
hsa-miR-887-3p,Leptomeningeal metastasis,0.8083851933479309
hsa-miR-4298,breast cancer brain metastasis,0.8083205223083496
hsa-miR-873,aryngeal squamous cell carcinoma,0.8082998991012573
hsa-let-7d-3p,aryngeal squamous cell carcinoma,0.8082998991012573
hsa-miR-556-5p,pilocytic astrocytoma,0.8082988858222961
hsa-miR-6806-5p,miR-675-y,0.8082455396652222
hsa-miR-548as-5p,miR-675-y,0.8082455396652222
hsa-miR-550a,miR-675-y,0.8082455396652222
hsa-miR-34a*,miR-675-y,0.8082455396652222
hsa-miR-6511a-3p,miR-675-y,0.8082455396652222
hsa-miR-570,Leptomeningeal metastasis,0.8082430958747864
hsa-miR-1909-5p,aryngeal squamous cell carcinoma,0.8082294464111328
hsa-miR-6859-3p,aryngeal squamous cell carcinoma,0.8082294464111328
hsa-miR-603,rhabdomyosarcomas,0.8081983327865601
hsa-miR-106,rhabdomyosarcomas,0.8081983327865601
hsa-miR-6506-3p,rhabdomyosarcomas,0.8081983327865601
hsa-miR-378*,rhabdomyosarcomas,0.8081983327865601
hsa-miR-3165,rhabdomyosarcomas,0.8081983327865601
hsa-miR-6793-3p,aryngeal squamous cell carcinoma,0.8081828355789185
hsa-miR-4776-3p,"Luminal A,Luminal B",0.8081753253936768
hsa-miR-181a-2-3p,"Luminal A,Luminal B",0.8081753253936768
hsa-miR-20b-3p,"Luminal A,Luminal B",0.8081753253936768
hsa-miR-4781-5p,papillary thyroid carcinoma,0.8081614971160889
hsa-miRPlus-A1031,papillary thyroid carcinoma,0.8081614971160889
hsa-miR-4520a-3p,papillary thyroid carcinoma,0.8081614971160889
hsa-miR-339-5p,papillary thyroid carcinoma,0.8081614971160889
hsa-miR-423-3p,papillary thyroid carcinoma,0.8081614971160889
hsa-miR-213,Leptomeningeal metastasis,0.8081366419792175
hsa-miR-548aw,Leptomeningeal metastasis,0.8081366419792175
hsa-miR-26a-1*,Leptomeningeal metastasis,0.8081366419792175
hsa-miR-502-5p,papillary thyroid carcinoma,0.8081319332122803
hsa-miR-1304,breast cancer brain metastasis,0.8080971240997314
hsa-miR-325,miR-675-y,0.808074951171875
hsa-miR-3192-3p,miR-675-y,0.808074951171875
hsa-miR-500a-3p,miR-675-y,0.808074951171875
hsa-miR-345,miR-675-y,0.808074951171875
hsa-miR-518e-5p,miR-675-y,0.808074951171875
hsa-miR-017,high grade serous papillary ovarian cancer,0.8080148100852966
hsa-miR-3192,high grade serous papillary ovarian cancer,0.8080148100852966
hsa-miR-4693-3p,high grade serous papillary ovarian cancer,0.8080148100852966
hsa-miR-6833-5p,high grade serous papillary ovarian cancer,0.8080148100852966
hsa-miR-6839-3p,high grade serous papillary ovarian cancer,0.8080148100852966
hsa-miR-3944-5p,high grade serous papillary ovarian cancer,0.8080148100852966
hsa-miR-5703,high grade serous papillary ovarian cancer,0.8080148100852966
hsa-miR-449c-3p,high grade serous papillary ovarian cancer,0.8080148100852966
hsa-miR-7977,aryngeal squamous cell carcinoma,0.8079683184623718
hsa-miR-3162,miR-675-y,0.8079174757003784
hsa-miR-770-5p,miR-675-y,0.8079174757003784
hsa-miR-548p,miR-675-y,0.8079174757003784
hsa-miR-4746-3p,miR-675-y,0.8079174757003784
hsa-miR-644,miR-675-y,0.8079174757003784
hsa-miR-1914*,aryngeal squamous cell carcinoma,0.8078742027282715
hsa-miR-4418,aryngeal squamous cell carcinoma,0.8078742027282715
hsa-miR-877-3p,aryngeal squamous cell carcinoma,0.8078742027282715
hsa-miRPlus-A1015,miR-675-y,0.8078452944755554
hsa-miR-132-3p,miR-675-y,0.8078452944755554
hsa-miR-133a-5p,miR-675-y,0.8078452944755554
hsa-miR-1233-1-5p,miR-675-y,0.8078452944755554
hsa-miR-675,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-8069,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-2681,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-4670-3p,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-let-7i*,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-3927,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-6827-3p,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-580-3p,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-619-3p,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-6735-3p,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-202-3p,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-5692c,high grade serous papillary ovarian cancer,0.8077938556671143
hsa-miR-548h,miR-675-y,0.8077849745750427
hsa-miR-5196-3p,miR-675-y,0.8077849745750427
hsa-miR-4251,miR-675-y,0.8077849745750427
hsa-miR-491,miR-675-y,0.8077849745750427
hsa-miR-4440,miR-675-y,0.8077849745750427
hsa-miR-944,miR-675-y,0.8077849745750427
hsa-miR-351,miR-675-y,0.8077849745750427
hsa-miR-4425,miR-675-y,0.8077849745750427
hsa-miR-25-5p,breast cancer brain metastasis,0.8077589869499207
hsa-miR-124,breast cancer brain metastasis,0.8077589869499207
hsa-miR-1233-1-5p,breast cancer brain metastasis,0.8077589869499207
hsa-miR-1539,aryngeal squamous cell carcinoma,0.8077229261398315
hsa-miR-1243,aryngeal squamous cell carcinoma,0.8077229261398315
hsa-miR-26b*,breast cancer brain metastasis,0.8077182769775391
hsa-miR-26a-5p,breast cancer brain metastasis,0.8077182769775391
hsa-miR-4740-5p,breast cancer brain metastasis,0.8077182769775391
hsa-miR-514,miR-675-y,0.8076772689819336
hsa-miR-323-5p,miR-675-y,0.8076772689819336
hsa-miR-3978,miR-675-y,0.8076772689819336
hsa-miR-129*,rhabdomyosarcomas,0.8076643347740173
hsa-miR-4310,rhabdomyosarcomas,0.8076643347740173
hsa-miR-3130-3p,rhabdomyosarcomas,0.8076643347740173
hsa-miR-301b,rhabdomyosarcomas,0.8076643347740173
hsa-miR-017,rhabdomyosarcomas,0.8076643347740173
hsa-miRPlus-A1083,Leptomeningeal metastasis,0.8076471090316772
hsa-miR-8064,Leptomeningeal metastasis,0.8076471090316772
hsa-miR-6824-5p,Leptomeningeal metastasis,0.8076471090316772
hsa-miR-369,aryngeal squamous cell carcinoma,0.8075999617576599
hsa-miR-4635,aryngeal squamous cell carcinoma,0.8075999617576599
hsa-miR-6798-5p,aryngeal squamous cell carcinoma,0.8075999617576599
hsa-miR-3613-3p,aryngeal squamous cell carcinoma,0.8075999617576599
hsa-miR-145*,breast cancer brain metastasis,0.8075440526008606
hsa-miR-4643,breast cancer brain metastasis,0.8075440526008606
hsa-miR-16-2-3p,breast cancer brain metastasis,0.8075440526008606
hsa-miR-519b,breast cancer brain metastasis,0.8075440526008606
hsa-miR-7161-3p,miR-675-y,0.8075382709503174
hsa-miR-549,miR-675-y,0.8075382709503174
hsa-miR-4790-5p,miR-675-y,0.8075382709503174
hsa-miR-4443,miR-675-y,0.8075382709503174
hsa-miR-548j-3p,miR-675-y,0.8075382709503174
hsa-miR-4254,miR-675-y,0.8075382709503174
hsa-miR-548x-3p,miR-675-y,0.8075382709503174
hsa-miR-26a-5p,miR-675-y,0.8075382709503174
hsa-miR-744*,"Luminal A,Luminal B",0.8074744939804077
hsa-miR-30a-5p,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-4749-5p,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-766-3p,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-4753-3p,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-365a-3p,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-5000-5p,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-1285-2,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-545*,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-6817-3p,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-8086,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-6510-3p,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-6853-3p,high grade serous papillary ovarian cancer,0.807463526725769
hsa-miR-4791,breast cancer brain metastasis,0.8074498772621155
hsa-miR-548p,breast cancer brain metastasis,0.8074498772621155
hsa-miR-663b,rhabdomyosarcomas,0.8074429035186768
hsa-miR-199a-1,rhabdomyosarcomas,0.8074429035186768
hsa-miR-8089,rhabdomyosarcomas,0.8074429035186768
hsa-miR-4298,miR-675-y,0.8074092268943787
hsa-let-7a-3,primary central nervous system lymphomas,0.8073662519454956
hsa-miR-4425,primary central nervous system lymphomas,0.8073662519454956
hsa-miR-766-5p,primary central nervous system lymphomas,0.8073662519454956
hsa-miR-548as-5p,aryngeal squamous cell carcinoma,0.8073384165763855
hsa-miR-7855-5p,aryngeal squamous cell carcinoma,0.8073384165763855
hsa-miR-1252,aryngeal squamous cell carcinoma,0.8073384165763855
hsa-miR-3681-5p,aryngeal squamous cell carcinoma,0.8073384165763855
hsa-miR-646,rhabdomyosarcomas,0.8073219060897827
hsa-miR-511,rhabdomyosarcomas,0.8073219060897827
hsa-miR-3180-5p,rhabdomyosarcomas,0.8073219060897827
hsa-miR-6762-3p,rhabdomyosarcomas,0.8073219060897827
hsa-miR-593,rhabdomyosarcomas,0.8073219060897827
hsa-miR-7150,rhabdomyosarcomas,0.8073219060897827
hsa-miR-1181,rhabdomyosarcomas,0.807303786277771
hsa-miR-8069,rhabdomyosarcomas,0.807303786277771
hsa-miR-2681,rhabdomyosarcomas,0.807303786277771
hsa-miR-3134,rhabdomyosarcomas,0.807303786277771
hsa-miR-331-3p,rhabdomyosarcomas,0.807303786277771
hsa-miR-124*,miR-675-y,0.8072891235351562
hsa-miR-2861,miR-675-y,0.8072891235351562
hsa-miR-6739-5p,miR-675-y,0.8072891235351562
hsa-miR-624,aryngeal squamous cell carcinoma,0.8072724938392639
hsa-miR-224*,aryngeal squamous cell carcinoma,0.8072724938392639
hsa-miR-7-1,aryngeal squamous cell carcinoma,0.8072724938392639
hsa-miR-545*,aryngeal squamous cell carcinoma,0.8072724938392639
hsa-miR-6513-5p,distal cholangiocarcinoma,0.807251513004303
hsa-miR-517c,miR-675-y,0.8071759939193726
hsa-miR-6776-3p,miR-675-y,0.8071759939193726
hsa-miR-548aq-3p,miR-675-y,0.8071759939193726
hsa-miR-4688,miR-675-y,0.8071759939193726
hsa-miR-325,breast cancer brain metastasis,0.8071752190589905
hsa-miR-3124-5p,breast cancer brain metastasis,0.8071752190589905
hsa-miR-199b-3p,breast cancer brain metastasis,0.8071752190589905
hsa-miR-96-3p,high grade serous papillary ovarian cancer,0.8071703314781189
hsa-miR-1224,high grade serous papillary ovarian cancer,0.8071703314781189
hsa-miR-467,high grade serous papillary ovarian cancer,0.8071703314781189
hsa-miR-4498,high grade serous papillary ovarian cancer,0.8071703314781189
hsa-miR-1185-1,high grade serous papillary ovarian cancer,0.8071703314781189
hsa-miR-1273g-3p,high grade serous papillary ovarian cancer,0.8071703314781189
hsa-miR-4472,high grade serous papillary ovarian cancer,0.8071703314781189
hsa-miR-4327,high grade serous papillary ovarian cancer,0.8071703314781189
hsa-miR-7-1-3p,high grade serous papillary ovarian cancer,0.807170033454895
hsa-miR-409-5p,high grade serous papillary ovarian cancer,0.807170033454895
hsa-miR-4798-3p,high grade serous papillary ovarian cancer,0.807170033454895
hsa-miR-498,high grade serous papillary ovarian cancer,0.807170033454895
hsa-miR-218-2,aryngeal squamous cell carcinoma,0.8071193695068359
hsa-let-7f-2-3p,aryngeal squamous cell carcinoma,0.8071193695068359
hsa-let-7e*,rhabdomyosarcomas,0.8071120977401733
hsa-miRPlus-C1099,rhabdomyosarcomas,0.8071120977401733
hsa-miR-29a-3p,rhabdomyosarcomas,0.8071120977401733
hsa-miR-3657,rhabdomyosarcomas,0.8071120977401733
hsa-miR-16-1-3p,rhabdomyosarcomas,0.8071120977401733
hsa-miR-194,aryngeal squamous cell carcinoma,0.8071106672286987
hsa-miR-29b-3p,aryngeal squamous cell carcinoma,0.8071106672286987
hsa-miR-491-5p,aryngeal squamous cell carcinoma,0.8071106672286987
hsa-miR-8079,aryngeal squamous cell carcinoma,0.8071106672286987
hsa-miR-7108-3p,aryngeal squamous cell carcinoma,0.8071106672286987
hsa-miR-934,miR-675-y,0.8070653080940247
hsa-miR-297,miR-675-y,0.8070653080940247
hsa-miR-376c-5p,aryngeal squamous cell carcinoma,0.8070290088653564
hsa-miR-376c,aryngeal squamous cell carcinoma,0.8070290088653564
hsa-miR-3158-5p,aryngeal squamous cell carcinoma,0.8070290088653564
hsa-miR-3190-3p,aryngeal squamous cell carcinoma,0.8070290088653564
hsa-miR-532,high grade serous papillary ovarian cancer,0.8070275187492371
hsa-miR-1-1,high grade serous papillary ovarian cancer,0.8070275187492371
hsa-miR-302a-3p,high grade serous papillary ovarian cancer,0.8070275187492371
hsa-miR-520f-5p,high grade serous papillary ovarian cancer,0.8070275187492371
hsa-miR-1238,high grade serous papillary ovarian cancer,0.8070275187492371
hsa-miR-5571-5p,high grade serous papillary ovarian cancer,0.8070275187492371
hsa-miR-4305,high grade serous papillary ovarian cancer,0.8070275187492371
hsa-miR-376a,high grade serous papillary ovarian cancer,0.8070275187492371
hsa-miR-465,high grade serous papillary ovarian cancer,0.8070275187492371
hsa-miR-326,primary central nervous system lymphomas,0.8069821000099182
hsa-miR-4667-3p,miR-675-y,0.8069507479667664
hsa-miRPlus-J1004,high grade serous papillary ovarian cancer,0.8069204688072205
hsa-miR-500b-5p,high grade serous papillary ovarian cancer,0.8069204688072205
hsa-miR-208b-5p,high grade serous papillary ovarian cancer,0.8069204688072205
hsa-miR-370-5p,high grade serous papillary ovarian cancer,0.8069204688072205
hsa-miR-1288-5p,high grade serous papillary ovarian cancer,0.8069204688072205
hsa-miR-5588-3p,high grade serous papillary ovarian cancer,0.8069204688072205
hsa-miR-181b-2-3p,high grade serous papillary ovarian cancer,0.8069204688072205
hsa-miR-7107-3p,high grade serous papillary ovarian cancer,0.8069204688072205
hsa-miR-6767-5p,breast cancer brain metastasis,0.8069131970405579
hsa-miR-3606-3p,breast cancer brain metastasis,0.8069131970405579
hsa-miR-200c,breast cancer brain metastasis,0.8069131970405579
hsa-miR-3146,breast cancer brain metastasis,0.8069131970405579
hsa-miR-6808-5p,miR-675-y,0.806877851486206
hsa-miR-5587-3p,miR-675-y,0.806877851486206
hsa-miR-522,distal cholangiocarcinoma,0.8068668246269226
hsa-miR-30a-5p,breast cancer brain metastasis,0.8068470358848572
hsa-miR-516a-5p,breast cancer brain metastasis,0.8068470358848572
hsa-miR-29a*,breast cancer brain metastasis,0.8068470358848572
hsa-miR-365,miR-675-y,0.8068268895149231
hsa-miR-548am-5p,rhabdomyosarcomas,0.8068184852600098
hsa-miR-503,rhabdomyosarcomas,0.8068184852600098
hsa-miR-1915,rhabdomyosarcomas,0.8068184852600098
hsa-miR-644b-5p,rhabdomyosarcomas,0.8068184852600098
hsa-miR-7111-3p,"Luminal A,Luminal B",0.8067871332168579
hsa-miR-130a*,"Luminal A,Luminal B",0.8067871332168579
hsa-miR-3616-3p,primary central nervous system lymphomas,0.8067824840545654
hsa-miR-124,primary central nervous system lymphomas,0.8067824840545654
hsa-miR-6829-3p,miR-675-y,0.8067784309387207
hsa-miR-1226-3p,miR-675-y,0.806734561920166
hsa-miR-4748,high grade serous papillary ovarian cancer,0.8067231774330139
hsa-miR-4281,high grade serous papillary ovarian cancer,0.8067231774330139
hsa-miR-302b*,high grade serous papillary ovarian cancer,0.8067231774330139
hsa-miRPlus-G1065-5p,high grade serous papillary ovarian cancer,0.8067231774330139
hsa-miR-345-5p,high grade serous papillary ovarian cancer,0.8067231774330139
hsa-miR-6499-3p,high grade serous papillary ovarian cancer,0.8067231774330139
hsa-miR-5003-3p,high grade serous papillary ovarian cancer,0.8067231774330139
hsa-miR-603,breast cancer brain metastasis,0.8066850304603577
hsa-miR-122a,breast cancer brain metastasis,0.8066850304603577
hsa-miR-132-5p,breast cancer brain metastasis,0.8066850304603577
hsa-miR-128b,breast cancer brain metastasis,0.8066850304603577
hsa-miR-548az-5p,breast cancer brain metastasis,0.8066850304603577
hsa-miR-1203,rhabdomyosarcomas,0.8066754937171936
hsa-miR-3945,rhabdomyosarcomas,0.8066754937171936
hsa-miR-4681,rhabdomyosarcomas,0.8066754937171936
hsa-miR-6513-3p,rhabdomyosarcomas,0.8066754937171936
hsa-miR-548e,rhabdomyosarcomas,0.8066754937171936
hsa-miR-340-3p,miR-675-y,0.806653618812561
hsa-miR-4318,miR-675-y,0.806653618812561
hsa-miR-330,miR-675-y,0.806653618812561
hsa-miR-588,miR-675-y,0.8066177368164062
hsa-miR-508-3p,rhabdomyosarcomas,0.806568443775177
hsa-miR-5580-3p,rhabdomyosarcomas,0.806568443775177
hsa-miR-6774-5p,rhabdomyosarcomas,0.806568443775177
hsa-miR-4461,rhabdomyosarcomas,0.806568443775177
hsa-miR-6882-5p,rhabdomyosarcomas,0.806568443775177
hsa-miR-545,rhabdomyosarcomas,0.806568443775177
hsa-miR-515-3p,rhabdomyosarcomas,0.806568443775177
hsa-miR-6509-5p,rhabdomyosarcomas,0.806568443775177
hsa-miR-509-5p,rhabdomyosarcomas,0.806568443775177
hsa-miR-4711-5p,rhabdomyosarcomas,0.806568443775177
hsa-miR-6823-3p,rhabdomyosarcomas,0.806568443775177
hsa-miR-4772-5p,rhabdomyosarcomas,0.806568443775177
hsa-miR-4775,miR-675-y,0.8065661191940308
hsa-miR-4271,miR-675-y,0.8065559267997742
hsa-miR-6792-3p,miR-675-y,0.806542694568634
hsa-miR-1298-5p,miR-675-y,0.8065323829650879
hsa-miR-6817-5p,miR-675-y,0.8065285086631775
hsa-miR-378a-5p,miR-675-y,0.8065285086631775
hsa-miR-519c,miR-675-y,0.8065272569656372
hsa-miR-3137,miR-675-y,0.8065266609191895
hsa-miR-876-5p,miR-675-y,0.8065255284309387
hsa-miR-6740-5p,miR-675-y,0.8065237402915955
hsa-miR-133a-3p,miR-675-y,0.806519627571106
hsa-miR-5691,miR-675-y,0.8065189123153687
hsa-miR-4502,miR-675-y,0.8065162897109985
hsa-miR-1244,miR-675-y,0.8065150380134583
hsa-miR-5701,breast cancer brain metastasis,0.8064080476760864
hsa-miR-4273,breast cancer brain metastasis,0.8064080476760864
hsa-miR-491,breast cancer brain metastasis,0.8064080476760864
hsa-let-7a-3,breast cancer brain metastasis,0.8064080476760864
hsa-miR-351,breast cancer brain metastasis,0.8064080476760864
hsa-miR-6133,primary central nervous system lymphomas,0.8062164783477783
hsa-miR-6801-5p,primary central nervous system lymphomas,0.8062164783477783
hsa-miR-623,"Luminal A,Luminal B",0.806050717830658
hsa-miR-1226-5p,"Luminal A,Luminal B",0.806050717830658
hsa-miR-6894-3p,"Luminal A,Luminal B",0.806050717830658
hsa-miR-199b-5p,diffuse large B-cell lymphoma,0.8060252666473389
hsa-miR-4301,breast cancer brain metastasis,0.8060224652290344
hsa-miR-200a-5p,Luminal B Her2+,0.8058738708496094
hsa-miR-3652,breast cancer brain metastasis,0.8058220744132996
hsa-miR-1237,breast cancer brain metastasis,0.8058220744132996
hsa-miR-1913,primary central nervous system lymphomas,0.8056352138519287
hsa-miR-1257,"Luminal A,Luminal B",0.8055023550987244
hsa-miR-10a*,"Luminal A,Luminal B",0.8055023550987244
hsa-miR-143*,"Luminal A,Luminal B",0.8055023550987244
hsa-miR-449b-3p,"Luminal A,Luminal B",0.8055023550987244
hsa-miR-1260,"Luminal A,Luminal B",0.8055023550987244
hsa-miR-30a*,distal cholangiocarcinoma,0.8054714202880859
hsa-miR-4518,aryngeal squamous cell carcinoma,0.8054195642471313
hsa-miR-4705,aryngeal squamous cell carcinoma,0.8054195642471313
hsa-miR-1260b,"Luminal A,Luminal B",0.8053299188613892
hsa-miR-936,"Luminal A,Luminal B",0.8053299188613892
hsa-miR-519e-3p,breast cancer brain metastasis,0.8052539825439453
hsa-miR-3679-5p,breast cancer brain metastasis,0.8052539825439453
hsa-miR-6514-3p,breast cancer brain metastasis,0.8052539825439453
hsa-miR-183,breast cancer brain metastasis,0.8052539825439453
hsa-miR-128a,breast cancer brain metastasis,0.8052539825439453
hsa-let-7g*,breast cancer brain metastasis,0.8052539825439453
hsa-miRPlus-A1015,aryngeal squamous cell carcinoma,0.8052185773849487
hsa-miR-519e-3p,"Luminal A,Luminal B",0.8051707744598389
hsa-miR-582-3p,"Luminal A,Luminal B",0.8051707744598389
hsa-miR-520a-5p,"Luminal A,Luminal B",0.8051707744598389
hsa-miR-4791,"Luminal A,Luminal B",0.8051707744598389
hsa-miR-362-3p,primary central nervous system lymphomas,0.8051643371582031
hsa-miR-642,primary central nervous system lymphomas,0.8051643371582031
hsa-miR-129-1-3p,primary central nervous system lymphomas,0.8051643371582031
hsa-let-7g-5p,primary central nervous system lymphomas,0.8051643371582031
hsa-miR-187*,"Luminal A,Luminal B",0.8050978183746338
hsa-miR-34a*,primary central nervous system lymphomas,0.8050417304039001
hsa-miR-4539,primary central nervous system lymphomas,0.8050417304039001
hsa-miR-567,rhabdomyosarcomas,0.8049643635749817
hsa-miR-202*,rhabdomyosarcomas,0.8049643635749817
hsa-miR-569,rhabdomyosarcomas,0.8049643635749817
hsa-miR-30e,"Luminal A,Luminal B",0.8049280047416687
hsa-miR-23b*,"Luminal A,Luminal B",0.8049280047416687
hsa-miR-1182,primary central nervous system lymphomas,0.8049212694168091
hsa-miR-422b,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-657,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-3614-5p,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-6893-3p,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-92a,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-671-5p,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-606,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-6507-3p,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-7856-5p,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-6874-5p,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-6874-3p,castration-resistant prostate cancer,0.8048879504203796
hsa-miR-4695-5p,rhabdomyosarcomas,0.8048269152641296
hsa-miR-5002-5p,rhabdomyosarcomas,0.8048269152641296
hsa-miR-548am-3p,"Luminal A,Luminal B",0.8047874569892883
hsa-miR-637,distal cholangiocarcinoma,0.8047313094139099
hsa-miR-6880-5p,distal cholangiocarcinoma,0.8047313094139099
hsa-miR-4676-3p,breast cancer brain metastasis,0.8046704530715942
hsa-miR-466,breast cancer brain metastasis,0.8046704530715942
hsa-miR-936,breast cancer brain metastasis,0.8046704530715942
hsa-miR-222*,breast cancer brain metastasis,0.8046704530715942
hsa-miR-607,miR-142-y,0.8046674728393555
hsa-miR-4804-5p,miR-142-y,0.8046674728393555
hsa-miR-4788,miR-142-y,0.8046674728393555
hsa-miR-3162,aryngeal squamous cell carcinoma,0.804649293422699
hsa-miR-4470,aryngeal squamous cell carcinoma,0.804649293422699
hsa-miR-6511b-5p,aryngeal squamous cell carcinoma,0.804649293422699
hsa-miR-33a-5p,synovial sarcoma,0.8045446872711182
hsa-miR-19b-2*,synovial sarcoma,0.8045446872711182
hsa-miR-183*,synovial sarcoma,0.8045446872711182
hsa-miR-708-3p,synovial sarcoma,0.8045446872711182
hsa-miR-4714-5p,synovial sarcoma,0.8045446872711182
hsa-miR-410,synovial sarcoma,0.8045446872711182
hsa-miR-616-5p,synovial sarcoma,0.8045446872711182
hsa-miR-520d-3p,"Luminal A,Luminal B",0.8045356869697571
hsa-miR-873,"Luminal A,Luminal B",0.8045356869697571
hsa-miR-548i,primary central nervous system lymphomas,0.804466724395752
hsa-miR-568,primary central nervous system lymphomas,0.804466724395752
hsa-miR-138-2,distal cholangiocarcinoma,0.8043708205223083
hsa-miR-4324,"Luminal A,Luminal B",0.8043094873428345
hsa-miR-532-5p,ovarian carcinoma,0.8043085336685181
hsa-miR-3614-5p,ovarian carcinoma,0.8043085336685181
hsa-miR-3622a-5p,ovarian carcinoma,0.8043085336685181
hsa-miR-6071,ovarian carcinoma,0.8043085336685181
hsa-miR-4661-5p,ovarian carcinoma,0.8043085336685181
hsa-miR-92a,ovarian carcinoma,0.8043085336685181
hsa-miR-301a,ovarian carcinoma,0.8043085336685181
hsa-miR-607,ovarian carcinoma,0.8043085336685181
hsa-miR-20a*,ovarian carcinoma,0.8043085336685181
hsa-miR-499-5p,ovarian carcinoma,0.8043085336685181
hsa-miR-2355,ovarian carcinoma,0.8043085336685181
hsa-miR-517,"Luminal A,Luminal B",0.8041936159133911
hsa-miR-6850-5p,"Luminal A,Luminal B",0.8041936159133911
hsa-miR-6806-5p,breast cancer brain metastasis,0.8040747046470642
hsa-miR-99b*,breast cancer brain metastasis,0.8040747046470642
hsa-miR-665,"Luminal A,Luminal B",0.8040684461593628
hsa-miR-3124-5p,aryngeal squamous cell carcinoma,0.8040642738342285
hsa-miR-3928-3p,aryngeal squamous cell carcinoma,0.8040642738342285
hsa-miR-380-5p,aryngeal squamous cell carcinoma,0.8040642738342285
hsa-miR-5579-5p,aryngeal squamous cell carcinoma,0.8040642738342285
hsa-miR-577,aryngeal squamous cell carcinoma,0.8040642738342285
hsa-miR-1913,aryngeal squamous cell carcinoma,0.8040642738342285
hsa-miR-1185-5p,"Luminal A,Luminal B",0.804019570350647
hsa-miR-4787-3p,"Luminal A,Luminal B",0.8039750456809998
hsa-miR-516b,breast cancer brain metastasis,0.8039538264274597
hsa-miR-4433b-5p,aryngeal squamous cell carcinoma,0.8038945198059082
hsa-miR-4671-5p,aryngeal squamous cell carcinoma,0.8038945198059082
hsa-miR-324-3p,"Luminal A,Luminal B",0.8038932681083679
hsa-miR-208a,"Luminal A,Luminal B",0.8038932681083679
hsa-miR-3607-5p,testicular cancer,0.8038878440856934
hsa-miR-4470,distal cholangiocarcinoma,0.8038468360900879
hsa-miR-302f,"Luminal A,Luminal B",0.8038047552108765
hsa-miR-122-3p,"Luminal A,Luminal B",0.803781270980835
hsa-miR-513,distal cholangiocarcinoma,0.8037735223770142
hsa-miR-151-3p,"Luminal A,Luminal B",0.8037656545639038
hsa-miR-4772-3p,"Luminal A,Luminal B",0.8037638068199158
hsa-miRPlus-A1086,"Luminal A,Luminal B",0.8037620186805725
hsa-miR-3911,"Luminal A,Luminal B",0.8037604689598083
hsa-miR-374b-3p,high grade serous papillary ovarian cancer,0.8037480711936951
hsa-miR-548c-3p,high grade serous papillary ovarian cancer,0.8037480711936951
hsa-miR-1271-3p,high grade serous papillary ovarian cancer,0.8037480711936951
hsa-miR-144-5p,high grade serous papillary ovarian cancer,0.8037480711936951
hsa-miR-720,high grade serous papillary ovarian cancer,0.8037480711936951
hsa-miR-513c,high grade serous papillary ovarian cancer,0.8037480711936951
hsa-miR-6819-5p,high grade serous papillary ovarian cancer,0.8037480711936951
hsa-miR-7974,high grade serous papillary ovarian cancer,0.8037480711936951
hsa-miR-584,primary central nervous system lymphomas,0.8037002682685852
hsa-miR-525-5p,Leptomeningeal metastasis,0.8035312294960022
hsa-miR-194,breast cancer brain metastasis,0.8034976720809937
hsa-miR-3157-3p,aryngeal squamous cell carcinoma,0.8034672141075134
hsa-miR-99b*,aryngeal squamous cell carcinoma,0.8034672141075134
hsa-miR-3680-5p,aryngeal squamous cell carcinoma,0.8034672141075134
hsa-miR-141*,aryngeal squamous cell carcinoma,0.8034672141075134
hsa-miR-4282,aryngeal squamous cell carcinoma,0.8034672141075134
hsa-miR-7158-3p,breast cancer brain metastasis,0.8034635782241821
hsa-miR-105-1,aryngeal squamous cell carcinoma,0.8034419417381287
hsa-miR-5587-5p,aryngeal squamous cell carcinoma,0.8034419417381287
hsa-miR-615-5p,aryngeal squamous cell carcinoma,0.8034419417381287
hsa-miR-3913-3p,aryngeal squamous cell carcinoma,0.8034419417381287
hsa-miR-7152-3p,aryngeal squamous cell carcinoma,0.8034419417381287
hsa-miR-6865-5p,aryngeal squamous cell carcinoma,0.8034419417381287
hsa-miR-30a-5p,primary central nervous system lymphomas,0.8033647537231445
hsa-miR-561,primary central nervous system lymphomas,0.8033647537231445
hsa-miR-6772-5p,primary central nervous system lymphomas,0.8033647537231445
hsa-miR-200a-3p,aryngeal squamous cell carcinoma,0.8033461570739746
hsa-miR-2116,aryngeal squamous cell carcinoma,0.8033461570739746
hsa-miR-5572,aryngeal squamous cell carcinoma,0.8033461570739746
hsa-miR-339-3p,distal cholangiocarcinoma,0.8030933737754822
hsa-miR-148b-3p,distal cholangiocarcinoma,0.8030863404273987
hsa-miR-138-1*,primary central nervous system lymphomas,0.8030668497085571
hsa-miR-105-1,breast cancer brain metastasis,0.8030102252960205
hsa-miR-511-2,high grade serous papillary ovarian cancer,0.8029905557632446
hsa-miR-4430,high grade serous papillary ovarian cancer,0.8029905557632446
hsa-miR-29b-1,high grade serous papillary ovarian cancer,0.8029905557632446
hsa-miR-496,high grade serous papillary ovarian cancer,0.8029905557632446
hsa-miR-6838-3p,high grade serous papillary ovarian cancer,0.8029905557632446
hsa-miR-363-5p,high grade serous papillary ovarian cancer,0.8029905557632446
hsa-miR-628,high grade serous papillary ovarian cancer,0.8029905557632446
hsa-miR-6823-5p,high grade serous papillary ovarian cancer,0.8029905557632446
hsa-miR-1184,breast cancer brain metastasis,0.802953839302063
hsa-miR-125b-1,aryngeal squamous cell carcinoma,0.802888810634613
hsa-miR-4476,aryngeal squamous cell carcinoma,0.802888810634613
hsa-miR-875-5p,aryngeal squamous cell carcinoma,0.802888810634613
hsa-miR-874-3p,aryngeal squamous cell carcinoma,0.802888810634613
hsa-miRPlus-J1004,primary central nervous system lymphomas,0.8028128147125244
hsa-miR-6803-3p,distal cholangiocarcinoma,0.8027905225753784
hsa-miR-6738-3p,Leptomeningeal metastasis,0.8027623295783997
hsa-miR-1b-2,rhabdomyosarcomas,0.8027428388595581
hsa-miR-550*,rhabdomyosarcomas,0.8027428388595581
hsa-miR-1274a,rhabdomyosarcomas,0.8027428388595581
hsa-miR-3118,rhabdomyosarcomas,0.8027428388595581
hsa-miR-665,distal cholangiocarcinoma,0.8027386665344238
hsa-miR-675,breast cancer brain metastasis,0.8027284145355225
hsa-miR-484,breast cancer brain metastasis,0.8027284145355225
hsa-miR-181a*,breast cancer brain metastasis,0.8027284145355225
hsa-miR-371-3p,breast cancer brain metastasis,0.8027284145355225
hsa-miR-106a.1,breast cancer brain metastasis,0.8027284145355225
hsa-miR-3675-3p,breast cancer brain metastasis,0.8027284145355225
hsa-miR-126-5p,distal cholangiocarcinoma,0.8025397658348083
hsa-miR-675,distal cholangiocarcinoma,0.8025056719779968
hsa-miR-151-3p,distal cholangiocarcinoma,0.802461564540863
hsa-miR-596,distal cholangiocarcinoma,0.8024299144744873
hsa-miR-6741-3p,distal cholangiocarcinoma,0.8024232387542725
hsa-miR-292-5p,breast cancer brain metastasis,0.8023914694786072
hsa-miR-200b*,breast cancer brain metastasis,0.8023914694786072
hsa-miR-561,breast cancer brain metastasis,0.8023914694786072
hsa-miR-1296,breast cancer brain metastasis,0.8023914694786072
hsa-miR-3115,breast cancer brain metastasis,0.8023914694786072
hsa-miR-433,aryngeal squamous cell carcinoma,0.8023435473442078
hsa-miR-27b-5p,aryngeal squamous cell carcinoma,0.8023435473442078
hsa-miR-4658,aryngeal squamous cell carcinoma,0.802117645740509
hsa-miR-5002-5p,breast cancer brain metastasis,0.8020925521850586
hsa-miR-548ap-5p,breast cancer brain metastasis,0.8020925521850586
hsa-miR-671,distal cholangiocarcinoma,0.8019983172416687
hsa-miR-6793-3p,distal cholangiocarcinoma,0.8019983172416687
hsa-miR-1203,breast cancer brain metastasis,0.8019468784332275
hsa-miR-1185,breast cancer brain metastasis,0.8019468784332275
hsa-let-7a-2-3p,breast cancer brain metastasis,0.8019468784332275
hsa-miR-3622b-3p,distal cholangiocarcinoma,0.8018730282783508
hsa-miRPlus-J1004,breast cancer brain metastasis,0.8018375635147095
hsa-miR-363,breast cancer brain metastasis,0.8018375635147095
hsa-miR-3118,breast cancer brain metastasis,0.8018375635147095
hsa-miR-1204,breast cancer brain metastasis,0.8018375635147095
hsa-miR-292-5p,aryngeal squamous cell carcinoma,0.8017799854278564
hsa-miR-106a:9.1,aryngeal squamous cell carcinoma,0.8017799854278564
hsa-miR-1248,aryngeal squamous cell carcinoma,0.8017799854278564
hsa-miR-374b,aryngeal squamous cell carcinoma,0.8017799854278564
hsa-miR-5698,aryngeal squamous cell carcinoma,0.8017799854278564
hsa-miR-488-3p,aryngeal squamous cell carcinoma,0.8017799854278564
hsa-miR-4291,distal cholangiocarcinoma,0.8017351627349854
hsa-miR-10a*,distal cholangiocarcinoma,0.801609456539154
hsa-miR-33b*,papillary thyroid carcinoma,0.8015729784965515
hsa-miR-218-1-3p,papillary thyroid carcinoma,0.8015729784965515
hsa-miR-345-3p,aryngeal squamous cell carcinoma,0.801480233669281
hsa-miR-149-5p,aryngeal squamous cell carcinoma,0.801480233669281
hsa-miR-4693-5p,distal cholangiocarcinoma,0.8014221787452698
hsa-miR-339-5p,primary central nervous system lymphomas,0.8014090061187744
hsa-miR-509-3-5p,primary central nervous system lymphomas,0.8014090061187744
hsa-miR-550,aryngeal squamous cell carcinoma,0.8013341426849365
hsa-miR-324,aryngeal squamous cell carcinoma,0.8013341426849365
hsa-miR-450a-5p,aryngeal squamous cell carcinoma,0.8012247085571289
hsa-miR-194-3p,aryngeal squamous cell carcinoma,0.8012247085571289
hsa-miR-625,serous ovarian cancers,0.8011899590492249
hsa-miR-6730-3p,rhabdomyosarcomas,0.8010059595108032
hsa-miR-1-1,rhabdomyosarcomas,0.8010059595108032
hsa-miR-1273c,rhabdomyosarcomas,0.8010059595108032
hsa-miR-1908,rhabdomyosarcomas,0.8002852201461792
hsa-miR-551b,rhabdomyosarcomas,0.8002852201461792
hsa-miR-320B,rhabdomyosarcomas,0.8002852201461792
hsa-miR-294,sarcoma,0.8002445697784424
hsa-miR-3687,sarcoma,0.8002445697784424
hsa-miR-3189-3p,sarcoma,0.8002445697784424
hsa-miR-651-5p,sarcoma,0.8002445697784424
hsa-miR-6505-5p,sarcoma,0.8002445697784424
hsa-miR-615,breast cancer brain metastasis,0.7999920845031738
hsa-miR-3614-5p,miR-675-y,0.7999179363250732
hsa-miR-6780b-5p,miR-675-y,0.7999179363250732
hsa-miR128a,aryngeal squamous cell carcinoma,0.7996616959571838
hsa-miR-628,aryngeal squamous cell carcinoma,0.7996616959571838
hsa-miR-222-3p,sarcoma,0.7995949387550354
hsa-miR-7703,sarcoma,0.7995949387550354
hsa-miR-4504,sarcoma,0.7995949387550354
hsa-miR-571,rhabdomyosarcomas,0.7995786070823669
hsa-miR-6726-3p,rhabdomyosarcomas,0.7995786070823669
hsa-miR-6805-3p,rhabdomyosarcomas,0.7995786070823669
hsa-miR-32,rhabdomyosarcomas,0.7995786070823669
hsa-miR-517b,rhabdomyosarcomas,0.7995786070823669
hsa-miR-1306,rhabdomyosarcomas,0.7995786070823669
hsa-miR-6785-5p,rhabdomyosarcomas,0.7995786070823669
hsa-miR-380,rhabdomyosarcomas,0.7995786070823669
hsa-miR-106a*,serous ovarian cancers,0.7994458079338074
hsa-miR-199a-5p,breast cancer brain metastasis,0.7992237210273743
hsa-miR-6824-5p,breast cancer brain metastasis,0.7992237210273743
hsa-miR-4297,breast cancer brain metastasis,0.7992237210273743
hsa-miR-124a,breast cancer brain metastasis,0.7992237210273743
hsa-miR-6824-5p,diffuse large B-cell lymphoma,0.7992061376571655
hsa-miR-425*,diffuse large B-cell lymphoma,0.7992061376571655
hsa-miR-379-3p,rhabdomyosarcomas,0.798821747303009
hsa-miR-637,rhabdomyosarcomas,0.798821747303009
hsa-miR-6880-5p,rhabdomyosarcomas,0.798821747303009
hsa-miR-4693-5p,rhabdomyosarcomas,0.798821747303009
hsa-miR-519a-3p,rhabdomyosarcomas,0.798821747303009
hsa-miR-6799-3p,rhabdomyosarcomas,0.798821747303009
hsa-miR-23b,rhabdomyosarcomas,0.798821747303009
hsa-miR-433,rhabdomyosarcomas,0.798821747303009
hsa-miR-3944-5p,rhabdomyosarcomas,0.798821747303009
hsa-miR-3614-5p,serous ovarian cancers,0.7987604737281799
hsa-miR-5088-3p,serous ovarian cancers,0.7987604737281799
hsa-miR-124*,serous ovarian cancers,0.7986410856246948
hsa-miR-508-5p,rhabdomyosarcomas,0.7984529137611389
hsa-miR-132*,rhabdomyosarcomas,0.7984529137611389
hsa-miR-18a-3p,rhabdomyosarcomas,0.7984529137611389
hsa-miR-106b*,rhabdomyosarcomas,0.7984529137611389
hsa-miR-432-3p,rhabdomyosarcomas,0.7984529137611389
hsa-miR-4524a-5p,serous ovarian cancers,0.7983888983726501
hsa-miR-3940,rhabdomyosarcomas,0.7982580661773682
hsa-miR-3151-3p,rhabdomyosarcomas,0.7982580661773682
hsa-miR-352,rhabdomyosarcomas,0.7982580661773682
hsa-miR-30e,serous ovarian cancers,0.7982016801834106
hsa-miR-4518,pilocytic astrocytoma,0.7981983423233032
hsa-miR-197,pilocytic astrocytoma,0.7981983423233032
hsa-miRPlus-A1015,serous ovarian cancers,0.7981670498847961
hsa-miR-1255b-5p,serous ovarian cancers,0.7981230020523071
hsa-miR-325,rhabdomyosarcomas,0.7980806231498718
hsa-miR-1300,rhabdomyosarcomas,0.7980806231498718
hsa-miR-4747-3p,rhabdomyosarcomas,0.7980806231498718
hsa-miR-7153-3p,rhabdomyosarcomas,0.7980806231498718
hsa-miR-4529-3p,rhabdomyosarcomas,0.7980806231498718
hsa-miR-6726-5p,rhabdomyosarcomas,0.7980806231498718
hsa-miR-500a-3p,rhabdomyosarcomas,0.7980806231498718
hsa-miR-6895-5p,rhabdomyosarcomas,0.7980806231498718
hsa-miR-376a-5p,serous ovarian cancers,0.7980758547782898
hsa-miR-4793-5p,serous ovarian cancers,0.7980716824531555
hsa-miR-138-1,serous ovarian cancers,0.7980478405952454
hsa-miR-370,rhabdomyosarcomas,0.7979171872138977
hsa-miR-4470,rhabdomyosarcomas,0.7979171872138977
hsa-miR-1914*,rhabdomyosarcomas,0.7979171872138977
hsa-miR-301a-3p,rhabdomyosarcomas,0.7979171872138977
hsa-miR-1322,rhabdomyosarcomas,0.7979171872138977
hsa-miR-483-3p,rhabdomyosarcomas,0.7979171872138977
hsa-let-7g*,rhabdomyosarcomas,0.7979171872138977
hsa-miR-663b,serous ovarian cancers,0.797885537147522
hsa-miR-219a-1-3p,serous ovarian cancers,0.7978731989860535
hsa-miR-187*,rhabdomyosarcomas,0.7978422045707703
hsa-miR-585,rhabdomyosarcomas,0.7978422045707703
hsa-miR-586,rhabdomyosarcomas,0.7978422045707703
hsa-miR-520f,rhabdomyosarcomas,0.7978422045707703
hsa-miRPlus-A1015,rhabdomyosarcomas,0.7978422045707703
hsa-miR-185,rhabdomyosarcomas,0.7977796196937561
hsa-miR-320e,rhabdomyosarcomas,0.7977796196937561
hsa-miR-384,serous ovarian cancers,0.7977726459503174
hsa-miR-432-5p,serous ovarian cancers,0.7977165579795837
hsa-miR-138-2,serous ovarian cancers,0.7976686954498291
hsa-miR-4524a-5p,rhabdomyosarcomas,0.7976675033569336
hsa-miR-23b*,rhabdomyosarcomas,0.7976675033569336
hsa-miR-675-3p,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-302d-5p,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-3169,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-3545-3p,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-4727-3p,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-3200,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-92a-1-5p,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-4704-5p,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-6868-3p,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-6756-3p,"squamous cell breast carcinoma, acantholytic variant",0.7975956797599792
hsa-miR-612,serous ovarian cancers,0.7975911498069763
hsa-miR-920,serous ovarian cancers,0.7975829839706421
hsa-miR-7977,serous ovarian cancers,0.7975717782974243
hsa-miR-1304-3p,serous ovarian cancers,0.7975468635559082
hsa-miR-187,pilocytic astrocytoma,0.7975436449050903
hsa-miR-516-3p,pilocytic astrocytoma,0.7975436449050903
hsa-miR-943,pilocytic astrocytoma,0.7975436449050903
hsa-miR-6804-3p,rhabdomyosarcomas,0.7975232601165771
hsa-miR-4782-3p,rhabdomyosarcomas,0.7973890900611877
hsa-miR-3663-5p,sarcoma,0.7973698973655701
hsa-miR-7150,sarcoma,0.7973698973655701
hsa-miR-1249-3p,sarcoma,0.7973698973655701
hsa-miR-499a-5p,sarcoma,0.7973511219024658
hsa-miR-580-3p,sarcoma,0.7973511219024658
hsa-miR-4422,sarcoma,0.7973511219024658
hsa-miR-8059,rhabdomyosarcomas,0.7972643375396729
hsa-miR-422b,"Luminal A,Luminal B",0.7970854043960571
hsa-miR-923,"Luminal A,Luminal B",0.7970854043960571
hsa-miR-1268a,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-885-3p,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-193b-3p,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-940,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-5586-3p,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-8052,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-6773-5p,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-7160-5p,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-1268b,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-6754-3p,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-1469,"squamous cell breast carcinoma, acantholytic variant",0.7969395518302917
hsa-miR-328,rhabdomyosarcomas,0.7967339158058167
hsa-miR-24-2*,rhabdomyosarcomas,0.7967339158058167
hsa-miR-423-5p_1,rhabdomyosarcomas,0.7967339158058167
hsa-miR-18b*,rhabdomyosarcomas,0.7967339158058167
hsa-miR-512-5p-1105,rhabdomyosarcomas,0.7967339158058167
hsa-miR-93*,rhabdomyosarcomas,0.7967339158058167
hsa-miR-1226-3p,rhabdomyosarcomas,0.7966881394386292
hsa-miR-4318,rhabdomyosarcomas,0.7966039776802063
hsa-miR-25-3p,rhabdomyosarcomas,0.7966039776802063
hsa-miR-876-3p,testicular cancer,0.7965686321258545
hsa-miR-3621,rhabdomyosarcomas,0.7965393662452698
hsa-miR-1227-3p,rhabdomyosarcomas,0.7964781522750854
hsa-miR-581,rhabdomyosarcomas,0.7964699864387512
hsa-miRPlus-A1086,rhabdomyosarcomas,0.7964692115783691
hsa-miR-545-3p,rhabdomyosarcomas,0.7964683175086975
hsa-miR-181a-2*,rhabdomyosarcomas,0.7964676022529602
hsa-miR-196b-5p,rhabdomyosarcomas,0.7964664697647095
hsa-miR-34b,rhabdomyosarcomas,0.7964655756950378
hsa-miR-632,rhabdomyosarcomas,0.7964648008346558
hsa-miR-4505,rhabdomyosarcomas,0.7964640855789185
hsa-miR-502-5p,rhabdomyosarcomas,0.7964634299278259
hsa-miR-654,rhabdomyosarcomas,0.7964591383934021
hsa-miR-6132,synovial sarcoma,0.7962924242019653
hsa-miR-4530,synovial sarcoma,0.7962924242019653
hsa-miR-4761-5p,synovial sarcoma,0.7962924242019653
hsa-miR-1468,synovial sarcoma,0.7962924242019653
hsa-miR-4518,high grade serous papillary ovarian cancer,0.7957379221916199
hsa-miR-941,high grade serous papillary ovarian cancer,0.7957379221916199
hsa-miR-3169,high grade serous papillary ovarian cancer,0.7957379221916199
hsa-miR-378i,high grade serous papillary ovarian cancer,0.7957379221916199
hsa-miR-3927-3p,synovial sarcoma,0.7955023646354675
hsa-miR-1200,synovial sarcoma,0.7955023646354675
hsa-miR-103-2,synovial sarcoma,0.7955023646354675
hsa-miR-548ax,synovial sarcoma,0.7955023646354675
hsa-miR-342-3p,synovial sarcoma,0.7955023646354675
hsa-miR-483,serous ovarian cancers,0.7954209446907043
hsa-miR-511,pilocytic astrocytoma,0.7953017354011536
hsa-miR-1285,pilocytic astrocytoma,0.7953017354011536
hsa-miR-4325,pilocytic astrocytoma,0.7953017354011536
hsa-miR-801,distal cholangiocarcinoma,0.79526287317276
hsa-miR-1267,distal cholangiocarcinoma,0.79526287317276
hsa-miR-1244,distal cholangiocarcinoma,0.7951443791389465
hsa-miR-1343,high grade serous papillary ovarian cancer,0.7950772643089294
hsa-miR-6741-5p,high grade serous papillary ovarian cancer,0.7950772643089294
hsa-miR-3918,high grade serous papillary ovarian cancer,0.7950772643089294
hsa-miR-7703,high grade serous papillary ovarian cancer,0.7950772643089294
hsa-miR-3065-5p,high grade serous papillary ovarian cancer,0.7950772643089294
hsa-miR-4701-5p,high grade serous papillary ovarian cancer,0.7950772643089294
hsa-miR-3126-3p,high grade serous papillary ovarian cancer,0.7950772643089294
hsa-miR-1185-1,sarcoma,0.7947788834571838
hsa-miR-644b-5p,sarcoma,0.7947788834571838
hsa-miR-1264,sarcoma,0.7947788834571838
hsa-miR-3150b-3p,sarcoma,0.7947788834571838
hsa-miR-8074,sarcoma,0.7947788834571838
hsa-miR-5088,"squamous cell breast carcinoma, acantholytic variant",0.7946926355361938
hsa-miR-642a,"squamous cell breast carcinoma, acantholytic variant",0.7946926355361938
hsa-miR-1224-3p,"squamous cell breast carcinoma, acantholytic variant",0.7946926355361938
hsa-miR-146b-5p,"squamous cell breast carcinoma, acantholytic variant",0.7946926355361938
hsa-miR-7150,"squamous cell breast carcinoma, acantholytic variant",0.7946926355361938
hsa-miR-7978,"squamous cell breast carcinoma, acantholytic variant",0.7946926355361938
hsa-miR-518c*,"squamous cell breast carcinoma, acantholytic variant",0.7946926355361938
hsa-miR-151a-3p,testicular cancer,0.7946814894676208
hsa-miR-4495,"squamous cell breast carcinoma, acantholytic variant",0.7946737408638
hsa-miR-6859-5p,"squamous cell breast carcinoma, acantholytic variant",0.7946737408638
hsa-miR-1273a,"squamous cell breast carcinoma, acantholytic variant",0.7946737408638
hsa-miR-3607-3p,"squamous cell breast carcinoma, acantholytic variant",0.7946737408638
hsa-miR-584,"squamous cell breast carcinoma, acantholytic variant",0.7946737408638
hsa-miR-548n,"squamous cell breast carcinoma, acantholytic variant",0.7946737408638
hsa-miR-202-3p,"squamous cell breast carcinoma, acantholytic variant",0.7946737408638
hsa-miR-6753-5p,"squamous cell breast carcinoma, acantholytic variant",0.7946737408638
hsa-miR-3682-5p,serous ovarian cancers,0.7941847443580627
hsa-miR-5196-5p,breast cancer brain metastasis,0.7932729721069336
hsa-miR-1915*,distal cholangiocarcinoma,0.7932361364364624
hsa-miR-3074,distal cholangiocarcinoma,0.7932361364364624
hsa-miR-23a*,distal cholangiocarcinoma,0.7932131886482239
hsa-miR-214-3p,distal cholangiocarcinoma,0.7928308844566345
hsa-miR-4695-3p,high grade serous papillary ovarian cancer,0.7928151488304138
hsa-miR-3681,high grade serous papillary ovarian cancer,0.7928151488304138
hsa-miR-3934,high grade serous papillary ovarian cancer,0.7928151488304138
hsa-miR-5571-3p,high grade serous papillary ovarian cancer,0.7928151488304138
hsa-miR-3124,high grade serous papillary ovarian cancer,0.7928151488304138
hsa-miR-6830-3p,high grade serous papillary ovarian cancer,0.7928151488304138
hsa-miR-4734,high grade serous papillary ovarian cancer,0.7928151488304138
hsa-miR-6854-5p,high grade serous papillary ovarian cancer,0.7928151488304138
hsa-miR-3134,high grade serous papillary ovarian cancer,0.7927959561347961
hsa-miR-181a*,high grade serous papillary ovarian cancer,0.7927959561347961
hsa-miR-558,high grade serous papillary ovarian cancer,0.7927959561347961
hsa-miR-5706,high grade serous papillary ovarian cancer,0.7927959561347961
hsa-miR-3190-5p,high grade serous papillary ovarian cancer,0.7927959561347961
hsa-miR-939,pilocytic astrocytoma,0.7926910519599915
hsa-miR-509-3-5p,testicular cancer,0.7926334142684937
hsa-miR-302a*,distal cholangiocarcinoma,0.7926203012466431
hsa-miR-192-2/3,distal cholangiocarcinoma,0.7926203012466431
hsa-miR-329,distal cholangiocarcinoma,0.7926203012466431
hsa-miRPlus-J1004,sarcoma,0.7926151752471924
hsa-miR-3129-5p,sarcoma,0.7926151752471924
hsa-miR-450a-5p,sarcoma,0.7926151752471924
hsa-miR-500b-5p,sarcoma,0.7926151752471924
hsa-miR-3118,sarcoma,0.7926151752471924
hsa-miR-8072,castration-resistant prostate cancer,0.7923861742019653
hsa-miR-411-3p,castration-resistant prostate cancer,0.7923861742019653
hsa-miR-545-5p,castration-resistant prostate cancer,0.7923861742019653
hsa-miR-523-5p,castration-resistant prostate cancer,0.7923861742019653
hsa-miR-188-3p,Leptomeningeal metastasis,0.7922489047050476
hsa-miR-3607-5p,miR-142-y,0.7921553254127502
hsa-miR-660,miR-142-y,0.7921553254127502
hsa-miR-6512-3p,miR-142-y,0.7921553254127502
hsa-miR-341,miR-142-y,0.7921553254127502
hsa-miR-6831-5p,miR-142-y,0.7921553254127502
hsa-miR-676-5p,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-376a-5p,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-3150b-3p,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-6505-3p,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-4327,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-4754,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-548ar-3p,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-1250-5p,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-3667-5p,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-136-5p,"squamous cell breast carcinoma, acantholytic variant",0.7920763492584229
hsa-miR-144*,ovarian carcinoma,0.7917792201042175
hsa-miR-660,ovarian carcinoma,0.7917792201042175
hsa-miR-3714,ovarian carcinoma,0.7917792201042175
hsa-miR-1587,ovarian carcinoma,0.7917792201042175
hsa-miR-339-3p,serous ovarian cancers,0.7912530899047852
hsa-miR-548am-3p,distal cholangiocarcinoma,0.7908209562301636
hsa-miR-1-1,sarcoma,0.7908123135566711
hsa-miR-505-3p,sarcoma,0.7908123135566711
hsa-miR-4746-5p,sarcoma,0.7908123135566711
hsa-miR-562,sarcoma,0.7908123135566711
hsa-miR-1185,sarcoma,0.7908123135566711
hsa-miR-8061,sarcoma,0.7908123135566711
hsa-miR-937,distal cholangiocarcinoma,0.790658175945282
hsa-miR-5091,serous ovarian cancers,0.7906578183174133
hsa-miR-4524a-5p,distal cholangiocarcinoma,0.7905043959617615
hsa-miR-223-3p,high grade serous papillary ovarian cancer,0.7901812195777893
hsa-miR-21*,high grade serous papillary ovarian cancer,0.7901812195777893
hsa-miR-6818-5p,high grade serous papillary ovarian cancer,0.7901812195777893
hsa-miR-3685,high grade serous papillary ovarian cancer,0.7901812195777893
hsa-miR-1323,high grade serous papillary ovarian cancer,0.7901812195777893
hsa-miR-1261,sarcoma,0.7900643944740295
hsa-miR-220a,sarcoma,0.7900643944740295
hsa-miR-744*,sarcoma,0.7900643944740295
hsa-miR-548av-3p,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-99b-3p,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-1281,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-5003-5p,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-6885-5p,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-3129-5p,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-509-5p,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-320c,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-3118,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-4493,"squamous cell breast carcinoma, acantholytic variant",0.7898915410041809
hsa-miR-4444,aryngeal squamous cell carcinoma,0.7897385954856873
hsa-miR-2355,rhabdomyosarcomas,0.7896095514297485
hsa-miR-642,testicular cancer,0.789334774017334
hsa-miR-1277,sarcoma,0.7893311977386475
hsa-miR-30a-5p,sarcoma,0.7893311977386475
hsa-miR-4749-5p,sarcoma,0.7893311977386475
hsa-miR-4766-5p,sarcoma,0.7893311977386475
hsa-miR-766-3p,sarcoma,0.7893311977386475
hsa-miR-4764-5p,sarcoma,0.7893311977386475
hsa-miR-92a-1,sarcoma,0.7893311977386475
hsa-miR-190a-3p,sarcoma,0.7893311977386475
hsa-miR-522-3p,sarcoma,0.7893311977386475
hsa-miR-369,distal cholangiocarcinoma,0.7891734838485718
hsa-miRPlus-C1110,distal cholangiocarcinoma,0.788893461227417
hsa-miR-6802-3p,serous ovarian cancers,0.7886959314346313
hsa-miR-6866-3p,serous ovarian cancers,0.7886959314346313
hsa-miR-6814-3p,sarcoma,0.7885457277297974
hsa-miR-4755-5p,sarcoma,0.7885457277297974
hsa-miR-597-3p,sarcoma,0.7885457277297974
hsa-miR-4461,distal cholangiocarcinoma,0.7884361147880554
hsa-miR-641,sarcoma,0.7881631255149841
hsa-miR-432-3p,sarcoma,0.7881631255149841
hsa-miR-5589-3p,sarcoma,0.7881631255149841
hsa-miR-1251-5p,sarcoma,0.7881631255149841
hsa-miR-5590-3p,sarcoma,0.7881631255149841
hsa-miR-3165,sarcoma,0.7881631255149841
hsa-miR-1911-3p,sarcoma,0.7881631255149841
hsa-miR-4269,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-532,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-let-7a-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-589-3p,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-4758-5p,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-10b-3p,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-1238,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-5571-5p,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-16-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-6511a-5p,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-1178,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-877*,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-4289,"squamous cell breast carcinoma, acantholytic variant",0.78807133436203
hsa-miR-941,testicular cancer,0.7880337834358215
hsa-miR-5003-5p,high grade serous papillary ovarian cancer,0.7879819273948669
hsa-miR-187-5p,high grade serous papillary ovarian cancer,0.7879819273948669
hsa-miR-6862-5p,high grade serous papillary ovarian cancer,0.7879819273948669
hsa-miR-2276-5p,high grade serous papillary ovarian cancer,0.7879819273948669
hsa-miR-3680-3p,high grade serous papillary ovarian cancer,0.7879819273948669
hsa-miR-653-3p,high grade serous papillary ovarian cancer,0.7879819273948669
hsa-miR-23b-5p,high grade serous papillary ovarian cancer,0.7879819273948669
hsa-miR-6748-3p,high grade serous papillary ovarian cancer,0.7879819273948669
hsa-miR-5700,sarcoma,0.7879608869552612
hsa-let-7f-1,sarcoma,0.7879608869552612
hsa-miR-3157-3p,sarcoma,0.7879608869552612
hsa-miR-4482-5p,sarcoma,0.7879608869552612
hsa-miRPlus-J1003,sarcoma,0.7879608869552612
hsa-miR-8077,sarcoma,0.7879608869552612
hsa-miR-6840-5p,sarcoma,0.7879608869552612
hsa-miR-548a,pilocytic astrocytoma,0.7879413366317749
hsa-miR-380-5p,sarcoma,0.7877768874168396
hsa-miR-4780,sarcoma,0.7877768874168396
hsa-miR-4715-5p,sarcoma,0.7877768874168396
hsa-miR-3679-5p,sarcoma,0.7876072525978088
hsa-miR-526a,sarcoma,0.7876072525978088
hsa-miR-372-3p,sarcoma,0.7876072525978088
hsa-miR-5001-5p,sarcoma,0.7876072525978088
hsa-miR-30b*,sarcoma,0.787529468536377
hsa-miR-4524a-3p,sarcoma,0.787529468536377
hsa-miR-290,sarcoma,0.7874644994735718
hsa-miR-4651,sarcoma,0.7874644994735718
hsa-miR-424-5p,sarcoma,0.7874644994735718
hsa-miR-143-3p,sarcoma,0.7874644994735718
hsa-miR-586,serous ovarian cancers,0.7873675227165222
hsa-miR-4797-3p,sarcoma,0.787348210811615
hsa-miR-6737-3p,sarcoma,0.787348210811615
hsa-miR-6499-5p,sarcoma,0.787348210811615
hsa-miR-600,"squamous cell breast carcinoma, acantholytic variant",0.7873163223266602
hsa-miR-1261,"squamous cell breast carcinoma, acantholytic variant",0.7873163223266602
hsa-let-7a_c,"squamous cell breast carcinoma, acantholytic variant",0.7873163223266602
hsa-miR-219a-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.7873163223266602
hsa-let-7e*,pilocytic astrocytoma,0.7872027158737183
hsa-miR-3684,sarcoma,0.7871984839439392
hsa-miR-196b,sarcoma,0.7871984839439392
hsa-miR-4254,sarcoma,0.7871984839439392
hsa-miR-3607-5p,miR-675-y,0.7871820330619812
hsa-miR-660,miR-675-y,0.7871820330619812
hsa-miR-219-5p,sarcoma,0.7870595455169678
hsa-miR-1539,sarcoma,0.7870595455169678
hsa-miR-4296,sarcoma,0.7870595455169678
hsa-miR-510-5p,sarcoma,0.7870595455169678
hsa-miR-519c-5p,sarcoma,0.7869299054145813
hsa-miR-635,sarcoma,0.7869299054145813
hsa-miR-135b-5p,sarcoma,0.7869299054145813
hsa-miR-141-5p,sarcoma,0.7869299054145813
hsa-miR-892c-3p,sarcoma,0.7869299054145813
hsa-miR-7154-5p,sarcoma,0.7868079543113708
hsa-miR-9-1*,sarcoma,0.7868079543113708
hsa-miR-4688,sarcoma,0.7868079543113708
hsa-miR-4293,sarcoma,0.7866886854171753
hsa-miR-325,testicular cancer,0.7865895628929138
hsa-miR-7111-3p,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-1306,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-200b*,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-561,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-30a-3p,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-516a-5p,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-3907,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-3115,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-517a,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-6130,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-376c-3p,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-6504-5p,"squamous cell breast carcinoma, acantholytic variant",0.786575973033905
hsa-miR-1283-1,sarcoma,0.7865652441978455
hsa-miR-3188,sarcoma,0.7865652441978455
hsa-miR-660-3p,sarcoma,0.7865652441978455
hsa-miR-193b-5p,sarcoma,0.7864866852760315
hsa-miR-618,sarcoma,0.7864317297935486
hsa-miR-28-5p,sarcoma,0.7864317297935486
hsa-miR-1910-5p,sarcoma,0.7864317297935486
hsa-miR-152,pilocytic astrocytoma,0.7864115238189697
hsa-miR-518f*,pilocytic astrocytoma,0.7864115238189697
hsa-miR-3190-3p,pilocytic astrocytoma,0.7864115238189697
hsa-miR-9-3p,sarcoma,0.786379873752594
hsa-miR-1269,sarcoma,0.786379873752594
hsa-miR-7108-5p,sarcoma,0.786379873752594
hsa-miR-2278,sarcoma,0.786379873752594
hsa-miR-4782-5p,sarcoma,0.7863323092460632
hsa-miR-4318,sarcoma,0.7862450480461121
hsa-miR-27a-5p,sarcoma,0.7862450480461121
hsa-miR-6755-3p,sarcoma,0.7861508131027222
hsa-miR-493-5p,sarcoma,0.7861508131027222
hsa-miR-1203,high grade serous papillary ovarian cancer,0.7861496210098267
hsa-miR-338-5p,high grade serous papillary ovarian cancer,0.7861496210098267
hsa-miR-1185,high grade serous papillary ovarian cancer,0.7861496210098267
hsa-miR-1273c,high grade serous papillary ovarian cancer,0.7861496210098267
hsa-miR-3921,high grade serous papillary ovarian cancer,0.7861496210098267
hsa-miR-886-3p,high grade serous papillary ovarian cancer,0.7861496210098267
hsa-miR-374c-5p,high grade serous papillary ovarian cancer,0.7861496210098267
hsa-miR-758-3p,sarcoma,0.786125659942627
hsa-miR-6729-3p,sarcoma,0.7861144542694092
hsa-miR-6847-3p,sarcoma,0.7861144542694092
hsa-miR-6825-3p,sarcoma,0.7861144542694092
hsa-miR-6728-3p,sarcoma,0.7861102819442749
hsa-miR-516b-5p,sarcoma,0.7861102819442749
hsa-miR-7155-3p,sarcoma,0.7861059904098511
hsa-miR-3934-3p,sarcoma,0.7861034870147705
hsa-miR-632,sarcoma,0.7861006855964661
hsa-miR-5089-5p,sarcoma,0.7861006855964661
hsa-miR-6875-5p,sarcoma,0.7860992550849915
hsa-miR-6884-5p,sarcoma,0.7860971093177795
hsa-miR-4799-5p,sarcoma,0.7860965728759766
hsa-miR-194,pilocytic astrocytoma,0.7860262393951416
hsa-miR-4763-5p,"squamous cell breast carcinoma, acantholytic variant",0.7857831716537476
hsa-miR-4437,"squamous cell breast carcinoma, acantholytic variant",0.7857831716537476
hsa-miR-670,"squamous cell breast carcinoma, acantholytic variant",0.7857831716537476
hsa-miR-2116*,"squamous cell breast carcinoma, acantholytic variant",0.7857831716537476
hsa-miR-3677-5p,"squamous cell breast carcinoma, acantholytic variant",0.7857831716537476
hsa-miR-4659b-5p,"squamous cell breast carcinoma, acantholytic variant",0.7857831716537476
hsa-miR-4792,"squamous cell breast carcinoma, acantholytic variant",0.7857831716537476
hsa-miR-548b-3p,serous ovarian cancers,0.785629153251648
hsa-miR-193a-5p,serous ovarian cancers,0.785629153251648
hsa-miR-6806-5p,serous ovarian cancers,0.7854982614517212
hsa-miR-4503,"squamous cell breast carcinoma, acantholytic variant",0.785396933555603
hsa-miR-1185-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.785396933555603
hsa-miR-565,"squamous cell breast carcinoma, acantholytic variant",0.785396933555603
hsa-miR-132-5p,"squamous cell breast carcinoma, acantholytic variant",0.785396933555603
hsa-miR-4494,"squamous cell breast carcinoma, acantholytic variant",0.785396933555603
hsa-miR-4678,"squamous cell breast carcinoma, acantholytic variant",0.785396933555603
hsa-miR-3165,"squamous cell breast carcinoma, acantholytic variant",0.785396933555603
hsa-miR-6813-3p,"squamous cell breast carcinoma, acantholytic variant",0.785396933555603
hsa-miR-4500,"squamous cell breast carcinoma, acantholytic variant",0.785396933555603
hsa-miR-2964a-3p,high grade serous papillary ovarian cancer,0.7853896021842957
hsa-miR-548au-3p,high grade serous papillary ovarian cancer,0.7853896021842957
hsa-miR-220a,high grade serous papillary ovarian cancer,0.7853896021842957
hsa-miR-5004-3p,high grade serous papillary ovarian cancer,0.7853896021842957
hsa-miR-1225,high grade serous papillary ovarian cancer,0.7853896021842957
hsa-miR-219a-2-3p,high grade serous papillary ovarian cancer,0.7853896021842957
hsa-miR-503-3p,high grade serous papillary ovarian cancer,0.7853896021842957
hsa-miR-3116,high grade serous papillary ovarian cancer,0.7853896021842957
hsa-miR-3925-3p,pilocytic astrocytoma,0.7853878736495972
hsa-miR-614,testicular cancer,0.7853372693061829
hsa-miR-214*,pilocytic astrocytoma,0.7852051854133606
hsa-miR-3606-3p,"squamous cell breast carcinoma, acantholytic variant",0.7851927280426025
hsa-miR-6806-5p,"squamous cell breast carcinoma, acantholytic variant",0.7851927280426025
hsa-miR-146a-3p,"squamous cell breast carcinoma, acantholytic variant",0.7851927280426025
hsa-miR-7855-5p,"squamous cell breast carcinoma, acantholytic variant",0.7851927280426025
hsa-miR-7-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.7851927280426025
hsa-miR-1245a,"squamous cell breast carcinoma, acantholytic variant",0.7851927280426025
hsa-miR-144-5p,breast cancer brain metastasis,0.7851356267929077
hsa-miR-518b,"squamous cell breast carcinoma, acantholytic variant",0.785007119178772
hsa-miR-5579-5p,"squamous cell breast carcinoma, acantholytic variant",0.785007119178772
hsa-miR-4780,"squamous cell breast carcinoma, acantholytic variant",0.785007119178772
hsa-miR-4715-5p,"squamous cell breast carcinoma, acantholytic variant",0.785007119178772
hsa-miR-504-5p,"squamous cell breast carcinoma, acantholytic variant",0.785007119178772
hsa-miR-6805-5p,"squamous cell breast carcinoma, acantholytic variant",0.785007119178772
hsa-miR-6895-5p,"squamous cell breast carcinoma, acantholytic variant",0.785007119178772
hsa-miRPlus-A1073,serous ovarian cancers,0.784881055355072
hsa-miR-3162,"squamous cell breast carcinoma, acantholytic variant",0.7848358154296875
hsa-miR-4796-5p,"squamous cell breast carcinoma, acantholytic variant",0.7848358154296875
hsa-miR-372-3p,"squamous cell breast carcinoma, acantholytic variant",0.7848358154296875
hsa-miR-124-3p,"squamous cell breast carcinoma, acantholytic variant",0.7848358154296875
hsa-miR-5001-5p,"squamous cell breast carcinoma, acantholytic variant",0.7848358154296875
hsa-miR-128a,"squamous cell breast carcinoma, acantholytic variant",0.7848358154296875
hsa-miR-347,"squamous cell breast carcinoma, acantholytic variant",0.7848358154296875
hsa-miR-4675,"squamous cell breast carcinoma, acantholytic variant",0.7848358154296875
hsa-miR-133b,pilocytic astrocytoma,0.7847838401794434
hsa-miR-1236-3p,"squamous cell breast carcinoma, acantholytic variant",0.7847572565078735
hsa-miR-25-5p,"squamous cell breast carcinoma, acantholytic variant",0.7847572565078735
hsa-miR-1255b-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.7847572565078735
hsa-miR-2113,"squamous cell breast carcinoma, acantholytic variant",0.7847572565078735
hsa-miR-597-5p,"squamous cell breast carcinoma, acantholytic variant",0.7847572565078735
hsa-miR-1237,"squamous cell breast carcinoma, acantholytic variant",0.7847572565078735
hsa-let-7d-v2,"squamous cell breast carcinoma, acantholytic variant",0.7847572565078735
hsa-miR-642,distal cholangiocarcinoma,0.7847234606742859
hsa-miR-5582-3p,synovial sarcoma,0.7847057580947876
hsa-miR-092,synovial sarcoma,0.7847057580947876
hsa-miR-4753-5p,synovial sarcoma,0.7847057580947876
hsa-miR-658,synovial sarcoma,0.7847057580947876
hsa-miR-141-3p,synovial sarcoma,0.7847057580947876
hsa-miR-761,synovial sarcoma,0.7847057580947876
hsa-miR-499,synovial sarcoma,0.7847057580947876
hsa-miR-181d-5p,synovial sarcoma,0.7847057580947876
hsa-miR-4777-3p,synovial sarcoma,0.7847057580947876
hsa-miR-6790-5p,synovial sarcoma,0.7847057580947876
hsa-miR-3074,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miR-6861-3p,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miR-4273,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miRPlus-A1087,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miR-4533,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miR-216b-5p,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miR-4425,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miR-4637,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miR-3168,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miR-520f-520c,"squamous cell breast carcinoma, acantholytic variant",0.7846916317939758
hsa-miR-935,pilocytic astrocytoma,0.784661054611206
hsa-miR-1306,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-292-5p,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-223*,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-200b*,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-4779,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-370-3p,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-130a*,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-1304-5p,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-516a-5p,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-7-1,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-3115,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-293,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-6130,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-574,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-6504-5p,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-6818-3p,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-548ba,high grade serous papillary ovarian cancer,0.784644365310669
hsa-miR-323-5p,"squamous cell breast carcinoma, acantholytic variant",0.7845742702484131
hsa-miR-4446-5p,"squamous cell breast carcinoma, acantholytic variant",0.7845742702484131
hsa-miR-153-3p,"squamous cell breast carcinoma, acantholytic variant",0.7845742702484131
hsa-miR-26b*,"squamous cell breast carcinoma, acantholytic variant",0.7844232320785522
hsa-miR-4661-3p,"squamous cell breast carcinoma, acantholytic variant",0.7844232320785522
hsa-miR-4640-5p,"squamous cell breast carcinoma, acantholytic variant",0.7844232320785522
hsa-miR-7846-3p,"squamous cell breast carcinoma, acantholytic variant",0.7844232320785522
hsa-miR-4254,"squamous cell breast carcinoma, acantholytic variant",0.7844232320785522
hsa-miR-26a-5p,"squamous cell breast carcinoma, acantholytic variant",0.7844232320785522
hsa-miR-1307-5p,"squamous cell breast carcinoma, acantholytic variant",0.7844232320785522
hsa-miR-369-3p,"squamous cell breast carcinoma, acantholytic variant",0.784282922744751
hsa-miR-383-5p,"squamous cell breast carcinoma, acantholytic variant",0.784282922744751
hsa-miR-676-3p,"squamous cell breast carcinoma, acantholytic variant",0.784282922744751
hsa-miR-3164,"squamous cell breast carcinoma, acantholytic variant",0.784282922744751
hsa-let-7f-2*,diffuse large B-cell lymphoma,0.784247875213623
hsa-miR-144*,"Luminal A,Luminal B",0.7842181324958801
hsa-miR-1280,pilocytic astrocytoma,0.7841818928718567
hsa-miR-1296,testicular cancer,0.7841562032699585
hsa-miR-7-1,testicular cancer,0.7841562032699585
hsa-miR-8059,"squamous cell breast carcinoma, acantholytic variant",0.784152090549469
hsa-miR-516-1,"squamous cell breast carcinoma, acantholytic variant",0.784152090549469
hsa-miR-141-5p,"squamous cell breast carcinoma, acantholytic variant",0.784152090549469
hsa-miR-6739-5p,"squamous cell breast carcinoma, acantholytic variant",0.784152090549469
hsa-miR-181c*,Leptomeningeal metastasis,0.7840821743011475
hsa-miR-548aj-5p,Leptomeningeal metastasis,0.7840821743011475
hsa-miR-517c,"squamous cell breast carcinoma, acantholytic variant",0.784028947353363
hsa-miR-4707-3p,"squamous cell breast carcinoma, acantholytic variant",0.784028947353363
hsa-miR-548aq-3p,"squamous cell breast carcinoma, acantholytic variant",0.784028947353363
hsa-miR-4688,"squamous cell breast carcinoma, acantholytic variant",0.784028947353363
hsa-miR-6797-3p,"squamous cell breast carcinoma, acantholytic variant",0.784028947353363
hsa-miR-3621,pilocytic astrocytoma,0.7840266227722168
hsa-miR-34b,pilocytic astrocytoma,0.7839494347572327
hsa-miR-4450,pilocytic astrocytoma,0.7839463949203491
hsa-miR-6814-5p,"squamous cell breast carcinoma, acantholytic variant",0.7839086651802063
hsa-miR-99a-3p,"squamous cell breast carcinoma, acantholytic variant",0.7839086651802063
hsa-miR-4320,"squamous cell breast carcinoma, acantholytic variant",0.7839086651802063
hsa-miR-4767,"squamous cell breast carcinoma, acantholytic variant",0.7839086651802063
hsa-miR-6799-3p,high grade serous papillary ovarian cancer,0.783846378326416
hsa-miR-4763-5p,high grade serous papillary ovarian cancer,0.783846378326416
hsa-miR-3132,high grade serous papillary ovarian cancer,0.783846378326416
hsa-miR-3677-5p,high grade serous papillary ovarian cancer,0.783846378326416
hsa-miR-4532,high grade serous papillary ovarian cancer,0.783846378326416
hsa-miR-550a*,high grade serous papillary ovarian cancer,0.783846378326416
hsa-miR-3152,high grade serous papillary ovarian cancer,0.783846378326416
hsa-miR-1283-1,"squamous cell breast carcinoma, acantholytic variant",0.7837839722633362
hsa-miR-335-5p,"squamous cell breast carcinoma, acantholytic variant",0.7837839722633362
hsa-miR-128,"squamous cell breast carcinoma, acantholytic variant",0.7837839722633362
hsa-miR-4653-5p,"squamous cell breast carcinoma, acantholytic variant",0.7837047576904297
hsa-miR-3657,serous ovarian cancers,0.783698320388794
hsa-miR-570,testicular cancer,0.7836816310882568
hsa-miR-365,"squamous cell breast carcinoma, acantholytic variant",0.7836492657661438
hsa-miR-215,"squamous cell breast carcinoma, acantholytic variant",0.7835966944694519
hsa-miR-1269,"squamous cell breast carcinoma, acantholytic variant",0.7835966944694519
hsa-miR-93*,"squamous cell breast carcinoma, acantholytic variant",0.7835966944694519
hsa-miR-520a-3p,"squamous cell breast carcinoma, acantholytic variant",0.7835966944694519
hsa-miR-7108-5p,"squamous cell breast carcinoma, acantholytic variant",0.7835966944694519
hsa-miR-6829-3p,"squamous cell breast carcinoma, acantholytic variant",0.7835966944694519
hsa-miRPlus-J1004,testicular cancer,0.7835649251937866
hsa-miR-129-2-3p,"squamous cell breast carcinoma, acantholytic variant",0.7835487723350525
hsa-miR-337-5p,"squamous cell breast carcinoma, acantholytic variant",0.7835487723350525
hsa-miR-4647,"squamous cell breast carcinoma, acantholytic variant",0.7835487723350525
hsa-miR-192-3p,"squamous cell breast carcinoma, acantholytic variant",0.7835487723350525
hsa-miR-519c-3p,"squamous cell breast carcinoma, acantholytic variant",0.783504843711853
hsa-miR-3176,"squamous cell breast carcinoma, acantholytic variant",0.783504843711853
hsa-miR-369-5p,"squamous cell breast carcinoma, acantholytic variant",0.783504843711853
hsa-miR-196b-3p,"squamous cell breast carcinoma, acantholytic variant",0.783504843711853
hsa-miR-552,"squamous cell breast carcinoma, acantholytic variant",0.7834606766700745
hsa-miR-520b-520c,"squamous cell breast carcinoma, acantholytic variant",0.7834606766700745
hsa-miR-154-5p,"squamous cell breast carcinoma, acantholytic variant",0.7834606766700745
hsa-miR-1295b-5p,high grade serous papillary ovarian cancer,0.7834576368331909
hsa-miR-122a,high grade serous papillary ovarian cancer,0.7834576368331909
hsa-miR-614,high grade serous papillary ovarian cancer,0.7834576368331909
hsa-miR-302c-5p,high grade serous papillary ovarian cancer,0.7834576368331909
hsa-miR-568,high grade serous papillary ovarian cancer,0.7834576368331909
hsa-miR-2116-3p,high grade serous papillary ovarian cancer,0.7834576368331909
hsa-miR-3125,high grade serous papillary ovarian cancer,0.7834576368331909
hsa-miR-941-1,high grade serous papillary ovarian cancer,0.7834576368331909
hsa-miR-30c-1*,high grade serous papillary ovarian cancer,0.7834576368331909
hsa-miR-192-5p,"squamous cell breast carcinoma, acantholytic variant",0.7834217548370361
hsa-miR-145-5p,"squamous cell breast carcinoma, acantholytic variant",0.7834217548370361
hsa-miR-145*,testicular cancer,0.78340744972229
hsa-miR-520d*,"squamous cell breast carcinoma, acantholytic variant",0.783393144607544
hsa-miR-017,testicular cancer,0.7833833694458008
hsa-miR-663a,"squamous cell breast carcinoma, acantholytic variant",0.7833655476570129
hsa-miR-6755-3p,"squamous cell breast carcinoma, acantholytic variant",0.7833655476570129
hsa-miR-6847-3p,"squamous cell breast carcinoma, acantholytic variant",0.7833290100097656
hsa-miR-378a-5p,"squamous cell breast carcinoma, acantholytic variant",0.783324658870697
hsa-miR-519c,"squamous cell breast carcinoma, acantholytic variant",0.7833234667778015
hsa-miR-149-3p,"squamous cell breast carcinoma, acantholytic variant",0.7833234667778015
hsa-miR-125a-5p,"squamous cell breast carcinoma, acantholytic variant",0.7833225727081299
hsa-miR-4473,"squamous cell breast carcinoma, acantholytic variant",0.783320426940918
hsa-miR-1909*,"squamous cell breast carcinoma, acantholytic variant",0.7833195328712463
hsa-miR-486-3p,"squamous cell breast carcinoma, acantholytic variant",0.7833195328712463
hsa-miR-489,"squamous cell breast carcinoma, acantholytic variant",0.7833177447319031
hsa-miR-632,"squamous cell breast carcinoma, acantholytic variant",0.7833150029182434
hsa-miR-142,"squamous cell breast carcinoma, acantholytic variant",0.7833119034767151
hsa-miR-1245b-5p,"squamous cell breast carcinoma, acantholytic variant",0.7833119034767151
hsa-miR-6820-5p,"squamous cell breast carcinoma, acantholytic variant",0.7833119034767151
hsa-miR-92b,"squamous cell breast carcinoma, acantholytic variant",0.7833119034767151
hsa-miR-6755-5p,"squamous cell breast carcinoma, acantholytic variant",0.7833108305931091
hsa-miR-130a-3p,"squamous cell breast carcinoma, acantholytic variant",0.7833094596862793
hsa-miR-15b-5p,"squamous cell breast carcinoma, acantholytic variant",0.7833072543144226
hsa-miR-1260,high grade serous papillary ovarian cancer,0.7832520008087158
hsa-miR-627-3p,high grade serous papillary ovarian cancer,0.7832520008087158
hsa-miR-29b-1-5p,high grade serous papillary ovarian cancer,0.7832520008087158
hsa-miR-4482-5p,high grade serous papillary ovarian cancer,0.7832520008087158
hsa-miR-7161-5p,high grade serous papillary ovarian cancer,0.7832520008087158
hsa-miR-1249-5p,high grade serous papillary ovarian cancer,0.7832520008087158
hsa-miR-3681-5p,high grade serous papillary ovarian cancer,0.7832520008087158
hsa-miR-3202,testicular cancer,0.7831997871398926
hsa-miR-520d,testicular cancer,0.7831997871398926
hsa-miR-510,high grade serous papillary ovarian cancer,0.7830651998519897
hsa-miR-4319,high grade serous papillary ovarian cancer,0.7830651998519897
hsa-miR-598,high grade serous papillary ovarian cancer,0.7830651998519897
hsa-miR-4646-3p,high grade serous papillary ovarian cancer,0.7830651998519897
hsa-miR-577,high grade serous papillary ovarian cancer,0.7830651998519897
hsa-miR-504-5p,high grade serous papillary ovarian cancer,0.7830651998519897
hsa-miR-526c,high grade serous papillary ovarian cancer,0.7830651998519897
hsa-miR-4423-3p,high grade serous papillary ovarian cancer,0.7828928232192993
hsa-miR-3184-5p,high grade serous papillary ovarian cancer,0.7828928232192993
hsa-miR-585-5p,high grade serous papillary ovarian cancer,0.7828928232192993
hsa-miR-6870-5p,high grade serous papillary ovarian cancer,0.7828928232192993
hsa-miR-3619-3p,high grade serous papillary ovarian cancer,0.7828137874603271
hsa-miR-520f,high grade serous papillary ovarian cancer,0.7828137874603271
hsa-miR-644b-3p,high grade serous papillary ovarian cancer,0.7828137874603271
hsa-miR-518d-5p,high grade serous papillary ovarian cancer,0.7828137874603271
hsa-miR-3653-3p,high grade serous papillary ovarian cancer,0.7828137874603271
hsa-miR-3652,high grade serous papillary ovarian cancer,0.7828137874603271
hsa-miR-124,high grade serous papillary ovarian cancer,0.7828137874603271
hsa-miR-497-3p,high grade serous papillary ovarian cancer,0.7828137874603271
hsa-miR-138-5p,high grade serous papillary ovarian cancer,0.7828137874603271
hsa-miR-5196-3p,high grade serous papillary ovarian cancer,0.782747745513916
hsa-miR-6861-3p,high grade serous papillary ovarian cancer,0.782747745513916
hsa-miR-138-1-3p,high grade serous papillary ovarian cancer,0.782747745513916
hsa-miR-4525,high grade serous papillary ovarian cancer,0.782747745513916
hsa-miR-27b-3p,high grade serous papillary ovarian cancer,0.782747745513916
hsa-miR-351,high grade serous papillary ovarian cancer,0.782747745513916
hsa-miR-605-5p,high grade serous papillary ovarian cancer,0.782747745513916
hsa-miR-4425,high grade serous papillary ovarian cancer,0.782747745513916
hsa-miR-769-3p,high grade serous papillary ovarian cancer,0.7826294898986816
hsa-miR-3117-3p,high grade serous papillary ovarian cancer,0.7826294898986816
hsa-miR-4804-3p,high grade serous papillary ovarian cancer,0.7826294898986816
hsa-miR-6849-3p,high grade serous papillary ovarian cancer,0.7824773788452148
hsa-miR-3912,high grade serous papillary ovarian cancer,0.7824773788452148
hsa-miR-1255a,high grade serous papillary ovarian cancer,0.7824773788452148
hsa-miR-4770,high grade serous papillary ovarian cancer,0.7824773788452148
hsa-miR-26a-5p,high grade serous papillary ovarian cancer,0.7824773788452148
hsa-miR-4470,testicular cancer,0.7824050784111023
hsa-miR-1197,serous ovarian cancers,0.7823366522789001
hsa-miR-4474-5p,high grade serous papillary ovarian cancer,0.7823361754417419
hsa-miR-874-5p,high grade serous papillary ovarian cancer,0.7823361754417419
hsa-miR-644b-5p,testicular cancer,0.7823286652565002
hsa-miR-5694,high grade serous papillary ovarian cancer,0.7822044491767883
hsa-miR-204-5p,high grade serous papillary ovarian cancer,0.7822044491767883
hsa-miR-4520-3p,high grade serous papillary ovarian cancer,0.7822044491767883
hsa-miR-524-3p,testicular cancer,0.7821325659751892
hsa-miR-1237,testicular cancer,0.7821325659751892
hsa-miR-6842-5p,high grade serous papillary ovarian cancer,0.7820807099342346
hsa-miR-3664-5p,high grade serous papillary ovarian cancer,0.7820807099342346
hsa-miR-182-3p,high grade serous papillary ovarian cancer,0.7820807099342346
hsa-miR-934,high grade serous papillary ovarian cancer,0.7819596529006958
hsa-miR-331-5p,high grade serous papillary ovarian cancer,0.7819596529006958
hsa-let-7a-3,testicular cancer,0.7818805575370789
hsa-miR-296-5p,high grade serous papillary ovarian cancer,0.7818340063095093
hsa-miR-335-5p,high grade serous papillary ovarian cancer,0.7818340063095093
hsa-miR-302b-5p,high grade serous papillary ovarian cancer,0.7818340063095093
hsa-miR-6842-3p,high grade serous papillary ovarian cancer,0.7818340063095093
hsa-miR-4431,high grade serous papillary ovarian cancer,0.7817542552947998
hsa-miR-136,high grade serous papillary ovarian cancer,0.7817542552947998
hsa-miR-937-5p,high grade serous papillary ovarian cancer,0.78169846534729
hsa-miR-28-5p,high grade serous papillary ovarian cancer,0.78169846534729
hsa-miR-29a,high grade serous papillary ovarian cancer,0.7816455364227295
hsa-miR-4462,high grade serous papillary ovarian cancer,0.7816455364227295
hsa-miR-292-3p,high grade serous papillary ovarian cancer,0.781597375869751
hsa-miR-205-3p,high grade serous papillary ovarian cancer,0.781597375869751
hsa-miR-151a-3p,high grade serous papillary ovarian cancer,0.781597375869751
hsa-miR-511-3p,high grade serous papillary ovarian cancer,0.781597375869751
hsa-miR-4706,high grade serous papillary ovarian cancer,0.7815531492233276
hsa-miR-127-3p,high grade serous papillary ovarian cancer,0.7815531492233276
hsa-miR-216b,brain cancer,0.781537652015686
hsa-miR-4318,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-711,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-6812-5p,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-5689,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-7851-3p,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-25-3p,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-330,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-4656,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-4662a-3p,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-3152-5p,high grade serous papillary ovarian cancer,0.78150874376297
hsa-miR-423-5p_2,distal cholangiocarcinoma,0.7815014123916626
hsa-miR-192-5p,high grade serous papillary ovarian cancer,0.7814694046974182
hsa-miR-361-5p,testicular cancer,0.7814628481864929
hsa-miR-4297,testicular cancer,0.7814528942108154
hsa-miR-323-3p,high grade serous papillary ovarian cancer,0.7814406156539917
hsa-miR-520d*,high grade serous papillary ovarian cancer,0.7814406156539917
hsa-miR-663a,high grade serous papillary ovarian cancer,0.7814128994941711
hsa-miR-6826-5p,high grade serous papillary ovarian cancer,0.7813875675201416
hsa-miR-6837-3p,high grade serous papillary ovarian cancer,0.7813875675201416
hsa-miR-320a,high grade serous papillary ovarian cancer,0.7813760638237
hsa-miR-6858-3p,high grade serous papillary ovarian cancer,0.7813760638237
hsa-miR-4295,high grade serous papillary ovarian cancer,0.7813718318939209
hsa-miR-149-3p,high grade serous papillary ovarian cancer,0.7813705205917358
hsa-miR-6720-5p,high grade serous papillary ovarian cancer,0.7813705205917358
hsa-miR-5686,high grade serous papillary ovarian cancer,0.7813705205917358
hsa-miR-6715b-3p,high grade serous papillary ovarian cancer,0.7813705205917358
hsa-miR-4639-3p,high grade serous papillary ovarian cancer,0.7813696265220642
hsa-miR-3135b,high grade serous papillary ovarian cancer,0.7813674807548523
hsa-miR-493-3p,high grade serous papillary ovarian cancer,0.7813665866851807
hsa-miR-629-5p,high grade serous papillary ovarian cancer,0.7813628315925598
hsa-miR-3928,high grade serous papillary ovarian cancer,0.781361997127533
hsa-miR-4450,high grade serous papillary ovarian cancer,0.7813596725463867
hsa-miR-4787-5p,high grade serous papillary ovarian cancer,0.7813583612442017
hsa-miR-365b-3p,high grade serous papillary ovarian cancer,0.7813583612442017
hsa-miR-656,high grade serous papillary ovarian cancer,0.7813577651977539
hsa-miR-6503-5p,high grade serous papillary ovarian cancer,0.7813577651977539
hsa-miR-371b-3p,high grade serous papillary ovarian cancer,0.7813560962677002
hsa-miR-6747-3p,high grade serous papillary ovarian cancer,0.7813560962677002
hsa-miR-433-3p,high grade serous papillary ovarian cancer,0.7813536524772644
hsa-miR-873,testicular cancer,0.781112551689148
hsa-miR-1231,castration-resistant prostate cancer,0.78110671043396
hsa-miR-99,castration-resistant prostate cancer,0.78110671043396
hsa-miR-299-3p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-4479,castration-resistant prostate cancer,0.78110671043396
hsa-miR-4636,castration-resistant prostate cancer,0.78110671043396
hsa-miR-105-1,castration-resistant prostate cancer,0.78110671043396
hsa-miR-344,castration-resistant prostate cancer,0.78110671043396
hsa-miR-601,castration-resistant prostate cancer,0.78110671043396
hsa-miR-4517,castration-resistant prostate cancer,0.78110671043396
hsa-miR-129-1-3p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-4480,castration-resistant prostate cancer,0.78110671043396
hsa-miR-431*,castration-resistant prostate cancer,0.78110671043396
hsa-miR-518f-5p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-3649,castration-resistant prostate cancer,0.78110671043396
hsa-miR-652-5p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-7152-3p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-7976,castration-resistant prostate cancer,0.78110671043396
hsa-miR-454,castration-resistant prostate cancer,0.78110671043396
hsa-miR-6865-5p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-1288-3p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-4687-5p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-508,castration-resistant prostate cancer,0.78110671043396
hsa-miR-556,castration-resistant prostate cancer,0.78110671043396
hsa-miR-6724-5p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-6788-3p,castration-resistant prostate cancer,0.78110671043396
hsa-miR-602,miR-142-y,0.7808667421340942
hsa-miR-5192,miR-142-y,0.7808667421340942
hsa-miR-3157-5p,miR-142-y,0.7808667421340942
hsa-miR-652-5p,miR-142-y,0.7808667421340942
hsa-miRPlus-G1065-5p,miR-142-y,0.7808667421340942
hsa-miR-548o,miR-142-y,0.7808667421340942
hsa-miR-4423-5p,miR-142-y,0.7808667421340942
hsa-miR-6865-5p,miR-142-y,0.7808667421340942
hsa-miR-450a-3p,miR-142-y,0.7808667421340942
hsa-miR-612,brain cancer,0.7808436751365662
hsa-miR-934,testicular cancer,0.7807937860488892
hsa-miR-99,ovarian carcinoma,0.7804760336875916
hsa-miR-548b-3p,ovarian carcinoma,0.7804760336875916
hsa-miR-579,ovarian carcinoma,0.7804760336875916
hsa-miR-557,ovarian carcinoma,0.7804760336875916
hsa-miR-4517,ovarian carcinoma,0.7804760336875916
hsa-miR-7-1*,ovarian carcinoma,0.7804760336875916
hsa-miR-3199,ovarian carcinoma,0.7804760336875916
hsa-miR-649,ovarian carcinoma,0.7804760336875916
hsa-miR-2115-5p,ovarian carcinoma,0.7804760336875916
hsa-miR-4684-3p,ovarian carcinoma,0.7804760336875916
hsa-miR-4441,ovarian carcinoma,0.7804760336875916
hsa-miR-7152-3p,ovarian carcinoma,0.7804760336875916
hsa-miR-454,ovarian carcinoma,0.7804760336875916
hsa-miR-3177-5p,ovarian carcinoma,0.7804760336875916
hsa-miR-548aj,ovarian carcinoma,0.7804760336875916
hsa-miR-4421,solid pseudopapillary neoplasm of pancreas,0.7800085544586182
hsa-miR-1267,"Luminal B,triple negative",0.779159426689148
hsa-miR-941,"Luminal B,triple negative",0.779159426689148
hsa-miR-7106-5p,"Luminal B,triple negative",0.779159426689148
hsa-miR-200a-3p,testicular cancer,0.778998851776123
hsa-miR-1274b,sarcoma,0.7789931297302246
hsa-miR-517c-3p,testicular cancer,0.778845489025116
hsa-miR-302a*,"Luminal A,Luminal B",0.778544545173645
hsa-miR-513,"Luminal A,Luminal B",0.778544545173645
hsa-miR-99a*,brain cancer,0.7784682512283325
hsa-miR-6513-5p,brain cancer,0.7784682512283325
hsa-let-7a-1,"Luminal B,triple negative",0.7784600853919983
hsa-miR-6741-5p,"Luminal B,triple negative",0.7784600853919983
hsa-miR-1295b-3p,"Luminal B,triple negative",0.7784600853919983
hsa-miR-519a-5p,"Luminal B,triple negative",0.7784600853919983
hsa-miR-8073,"Luminal B,triple negative",0.7784600853919983
hsa-miR-1245b-5p,testicular cancer,0.7783635258674622
hsa-miR-4265,aryngeal squamous cell carcinoma,0.7783555388450623
hsa-miR-302b*,aryngeal squamous cell carcinoma,0.7783555388450623
hsa-miR-6737-5p,aryngeal squamous cell carcinoma,0.7783555388450623
hsa-miR-4502,testicular cancer,0.7783117294311523
hsa-miR-4465,"Luminal A,Luminal B",0.7781005501747131
hsa-miR-593-5p,"Luminal A,Luminal B",0.7781005501747131
hsa-miR-6514-3p,"Luminal A,Luminal B",0.7781005501747131
hsa-miR-1322,"Luminal A,Luminal B",0.7781005501747131
hsa-miR-185,"Luminal A,Luminal B",0.7780147790908813
hsa-miR-5701,"Luminal A,Luminal B",0.7780147790908813
hsa-miR-518e-3p,castration-resistant prostate cancer,0.7779590487480164
hsa-miR-199b-5p,castration-resistant prostate cancer,0.7779590487480164
hsa-miR-886,castration-resistant prostate cancer,0.7779590487480164
hsa-miR-3136-3p,castration-resistant prostate cancer,0.7779590487480164
hsa-miR-1273h-3p,miR-142-y,0.7777166366577148
hsa-miR-642,papillary thyroid carcinoma,0.7774996161460876
hsa-miR-4795-5p,papillary thyroid carcinoma,0.7774996161460876
hsa-miR128b,papillary thyroid carcinoma,0.7774996161460876
hsa-miR-325,"Luminal A,Luminal B",0.7774580717086792
hsa-miR-802,"Luminal A,Luminal B",0.7774196267127991
hsa-miR-196b*,distal cholangiocarcinoma,0.7773654460906982
hsa-miR-6738-5p,ovarian carcinoma,0.7773219347000122
hsa-miR-4526,ovarian carcinoma,0.7773219347000122
hsa-miR-328-3p,ovarian carcinoma,0.7773219347000122
hsa-miR-7161-3p,"Luminal A,Luminal B",0.7768224477767944
hsa-miRPlus-C1110,"Luminal A,Luminal B",0.7768023014068604
hsa-miR-122,"Luminal A,Luminal B",0.7768023014068604
hsa-miR-3157-3p,"Luminal A,Luminal B",0.7768023014068604
hsa-miR-424-3p,"Luminal A,Luminal B",0.7768023014068604
hsa-miR-422b,pilocytic astrocytoma,0.7767898440361023
hsa-miR-33b*,pilocytic astrocytoma,0.7767898440361023
hsa-miR-518f-3p,"Luminal A,Luminal B",0.7766693830490112
hsa-miR-96*,"Luminal A,Luminal B",0.7766693830490112
hsa-miR-1343,"Luminal A,Luminal B",0.7766693830490112
hsa-miR-6088,synovial sarcoma,0.7763262391090393
hsa-miR-1292-3p,synovial sarcoma,0.7763262391090393
hsa-miR-720,synovial sarcoma,0.7763262391090393
hsa-miR-4709-5p,synovial sarcoma,0.7763262391090393
hsa-miR-7974,synovial sarcoma,0.7763262391090393
hsa-miR-508-5p,"Luminal A,Luminal B",0.7761672735214233
hsa-miR-3917,"Luminal A,Luminal B",0.7761672735214233
hsa-miR-3614-5p,"squamous cell breast carcinoma, acantholytic variant",0.7761412858963013
hsa-miR-6893-3p,"squamous cell breast carcinoma, acantholytic variant",0.7761412858963013
hsa-miR-520g,"squamous cell breast carcinoma, acantholytic variant",0.7761412858963013
hsa-miR-27a-3p,"squamous cell breast carcinoma, acantholytic variant",0.7761412858963013
hsa-miR-5088,"Luminal B,triple negative",0.7760661840438843
hsa-miR-1909-5p,"Luminal B,triple negative",0.7760661840438843
hsa-miR-6515-3p,"Luminal B,triple negative",0.7760661840438843
hsa-miR-8089,"Luminal B,triple negative",0.7760458588600159
hsa-miR-548n,"Luminal B,triple negative",0.7760458588600159
hsa-miR-216a-3p,"Luminal B,triple negative",0.7760458588600159
hsa-miR-202-3p,"Luminal B,triple negative",0.7760458588600159
hsa-miR-4748,miR-675-y,0.7756999135017395
hsa-miR-2467-3p,miR-675-y,0.7756999135017395
hsa-miR-920,"Luminal A,Luminal B",0.775568962097168
hsa-miR-4693-5p,"Luminal A,Luminal B",0.775568962097168
hsa-miR-4452,"Luminal A,Luminal B",0.775568962097168
hsa-miR-3545-3p,testicular cancer,0.7755347490310669
hsa-miR-6842-5p,"Luminal A,Luminal B",0.7752282023429871
hsa-miR-30a*,"Luminal A,Luminal B",0.774950385093689
hsa-miR-1295,"Luminal A,Luminal B",0.774950385093689
hsa-miR-548ah-3p,"Luminal A,Luminal B",0.774950385093689
hsa-miR-32,"Luminal A,Luminal B",0.774950385093689
hsa-miR-1249,"Luminal A,Luminal B",0.774950385093689
hsa-miR-5002-5p,"Luminal A,Luminal B",0.7746216058731079
hsa-miR-488*,"Luminal A,Luminal B",0.7744613289833069
hsa-miR-548d-3p,"Luminal A,Luminal B",0.7744613289833069
hsa-miR-455,"Luminal A,Luminal B",0.7744613289833069
hsa-miR-522,"Luminal A,Luminal B",0.7744613289833069
hsa-miR-1b-2,"Luminal A,Luminal B",0.7743412256240845
hsa-miR-213,"Luminal A,Luminal B",0.7743412256240845
hsa-miR-6787-5p,"Luminal A,Luminal B",0.7743412256240845
hsa-miR-548av-3p,"Luminal A,Luminal B",0.7743412256240845
hsa-miR-1914,"Luminal A,Luminal B",0.7743412256240845
hsa-miR-4772-5p,"Luminal A,Luminal B",0.7743412256240845
hsa-miR-26a-1*,"Luminal A,Luminal B",0.7743412256240845
hsa-miR-606,high grade serous papillary ovarian cancer,0.7741422653198242
hsa-miR-6507-3p,high grade serous papillary ovarian cancer,0.7741422653198242
hsa-miR-4740-3p,high grade serous papillary ovarian cancer,0.7741422653198242
hsa-miR-548z,high grade serous papillary ovarian cancer,0.7741422653198242
hsa-miR-580-5p,high grade serous papillary ovarian cancer,0.7741422653198242
hsa-miR-4527,"Luminal A,Luminal B",0.7738255858421326
hsa-miR-6078,serous ovarian cancers,0.7735567688941956
hsa-miR-1-1,serous ovarian cancers,0.7733932733535767
hsa-miR-432*,serous ovarian cancers,0.773327112197876
hsa-miR-1258,"Luminal B,triple negative",0.773280143737793
hsa-miR-525-5p,testicular cancer,0.7732366919517517
hsa-miR-1262,testicular cancer,0.7729429602622986
hsa-miR-220c,testicular cancer,0.7728869318962097
hsa-miR-518a-5p,testicular cancer,0.7727354764938354
hsa-miR-935,testicular cancer,0.7726410627365112
hsa-miR-199a-2,"Luminal A,Luminal B",0.7726233601570129
hsa-miR-1226-3p,"Luminal A,Luminal B",0.7726233601570129
hsa-miR-642,"Luminal A,Luminal B",0.7726222276687622
hsa-miR-26b*,testicular cancer,0.7725645899772644
hsa-miR-193a-3p,"Luminal A,Luminal B",0.7725181579589844
hsa-miR-3173-5p,"Luminal A,Luminal B",0.7725181579589844
hsa-miR-6728-5p,miR-675-y,0.7724969983100891
hsa-miR-888*,testicular cancer,0.7724436521530151
hsa-miR-30a-5p,testicular cancer,0.7723862528800964
hsa-miR-5196-5p,diffuse large B-cell lymphoma,0.7721720337867737
hsa-miR-320c,serous ovarian cancers,0.7721666097640991
hsa-miR-560,"Luminal A,Luminal B",0.7715799808502197
hsa-miR-3945,brain cancer,0.7714742422103882
hsa-miR-559,"Luminal B,triple negative",0.7709550857543945
hsa-miR-1908,brain cancer,0.7706772685050964
hsa-miR-519b-3p,"Luminal A,Luminal B",0.7705124616622925
hsa-miR-4743,"Luminal A,Luminal B",0.7705124616622925
hsa-miR-292-5p,"Luminal A,Luminal B",0.7705124616622925
hsa-miR-1-1,"Luminal A,Luminal B",0.7704571485519409
hsa-miR-513a-1,"Luminal A,Luminal B",0.7704571485519409
hsa-miR-638,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-6789-3p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-4781-5p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-199a-5p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-4520a-3p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-4448,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-3190,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-4795-3p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-1283,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-515-5p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-3691-3p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-628,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-4274,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-425*,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-96-5p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-6837-5p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-4726-5p,castration-resistant prostate cancer,0.7704343199729919
hsa-miR-376c-5p,"Luminal A,Luminal B",0.7704323530197144
hsa-miR-6814-3p,"Luminal A,Luminal B",0.7704323530197144
hsa-miR-32*,"Luminal A,Luminal B",0.7704323530197144
hsa-miR-451,"Luminal A,Luminal B",0.7703608274459839
hsa-miRPlus-A1073,"Luminal A,Luminal B",0.7702410221099854
hsa-miR-378f,"Luminal A,Luminal B",0.7702410221099854
hsa-miR-3202,"Luminal A,Luminal B",0.7702410221099854
hsa-miR-3201,"Luminal A,Luminal B",0.7702410221099854
hsa-miR-29b-3p,"Luminal A,Luminal B",0.7702410221099854
hsa-miR-511-2,miR-142-y,0.7701860666275024
hsa-miR-636,miR-142-y,0.7701860666275024
hsa-miR-496,miR-142-y,0.7701860666275024
hsa-miR-363-5p,miR-142-y,0.7701860666275024
hsa-miR-3691-3p,miR-142-y,0.7701860666275024
hsa-miR-5695,miR-142-y,0.7701860666275024
hsa-miR-96-5p,miR-142-y,0.7701860666275024
hsa-miR-6745,miR-142-y,0.7701860666275024
hsa-let-7f-1*,"Luminal A,Luminal B",0.7701346278190613
hsa-miR-5700,"Luminal A,Luminal B",0.7700093984603882
hsa-let-7f-1,"Luminal A,Luminal B",0.7700093984603882
hsa-miR-3155a,"Luminal A,Luminal B",0.7700093984603882
hsa-miR-6511a-3p,"Luminal A,Luminal B",0.7700093984603882
hsa-miR-630,ovarian carcinoma,0.7697819471359253
hsa-miR-196b*,ovarian carcinoma,0.7697819471359253
hsa-miR-4781-5p,ovarian carcinoma,0.7697819471359253
hsa-miRPlus-A1031,ovarian carcinoma,0.7697819471359253
hsa-miR-7705,ovarian carcinoma,0.7697819471359253
hsa-miR-3152-3p,ovarian carcinoma,0.7697819471359253
hsa-miR-522*,ovarian carcinoma,0.7697819471359253
hsa-miR-3647-3p,ovarian carcinoma,0.7697819471359253
hsa-miR-2115*,"Luminal A,Luminal B",0.7697254419326782
hsa-miR-4317,"Luminal A,Luminal B",0.7697254419326782
hsa-miR-4676-3p,"Luminal A,Luminal B",0.7697254419326782
hsa-miR-4259,"Luminal A,Luminal B",0.7697254419326782
hsa-miR-3609,"Luminal A,Luminal B",0.769564151763916
hsa-miR-199a-5p,testicular cancer,0.7694937586784363
hsa-miR-4470,"Luminal A,Luminal B",0.7694128751754761
hsa-miR-3679-5p,"Luminal A,Luminal B",0.7694128751754761
hsa-miR-6807-3p,"Luminal A,Luminal B",0.7694128751754761
hsa-miR-3620-3p,"Luminal A,Luminal B",0.7694128751754761
hsa-miR-662,"Luminal A,Luminal B",0.7694128751754761
hsa-miR-1272,"Luminal A,Luminal B",0.7694128751754761
hsa-miR-505,"Luminal A,Luminal B",0.7693883180618286
hsa-miR-15b,"Luminal A,Luminal B",0.7693332433700562
hsa-miR-503,"Luminal A,Luminal B",0.7693332433700562
hsa-miR-138-1*,"Luminal A,Luminal B",0.7693332433700562
hsa-miR-192-2/3,"Luminal A,Luminal B",0.7691287994384766
hsa-miR-3619-3p,"Luminal A,Luminal B",0.7691287994384766
hsa-miR-219-1-3p,"Luminal A,Luminal B",0.7691287994384766
hsa-miR-1203,"Luminal B,triple negative",0.7690186500549316
hsa-miR-513a-1,"Luminal B,triple negative",0.7690186500549316
hsa-miR-145*,"Luminal B,triple negative",0.7690186500549316
hsa-miR-4758-5p,"Luminal B,triple negative",0.7690186500549316
hsa-miR-340,"Luminal A,Luminal B",0.7686324715614319
hsa-miR-487b,brain cancer,0.7684363126754761
hsa-miR-520c-3p,"Luminal A,Luminal B",0.7684310078620911
hsa-miR-642a-5p,"Luminal A,Luminal B",0.7682420611381531
hsa-miR-626,brain cancer,0.7682404518127441
hsa-miR-1261,"Luminal B,triple negative",0.7682158350944519
hsa-miR-548au-3p,"Luminal B,triple negative",0.7682158350944519
hsa-miR-4778-3p,"Luminal B,triple negative",0.7682158350944519
hsa-miR-4800-5p,"Luminal B,triple negative",0.7682158350944519
hsa-miR-1826,serous ovarian cancers,0.7681440711021423
hsa-miR-548d-5p,"Luminal A,Luminal B",0.768065869808197
hsa-miR-625*,"Luminal A,Luminal B",0.768065869808197
hsa-miR-6811-5p,"Luminal A,Luminal B",0.768065869808197
hsa-miR-6807-3p,brain cancer,0.7680597305297852
hsa-miR-454*,"Luminal A,Luminal B",0.7680487036705017
hsa-miR-187*,brain cancer,0.7679769992828369
hsa-miR-585,brain cancer,0.7679769992828369
hsa-miR-30e-5p,brain cancer,0.7679769992828369
hsa-miR-26a-2*,"Luminal A,Luminal B",0.767973780632019
hsa-miR-333,"Luminal A,Luminal B",0.767973780632019
hsa-miR-548ay-5p,brain cancer,0.7679077386856079
hsa-miR-628-5p,brain cancer,0.7679077386856079
hsa-miR-382-5p,"Luminal A,Luminal B",0.7678958773612976
hsa-miR-339-3p,"Luminal A,Luminal B",0.7678958773612976
hsa-miR-6892-3p,"Luminal A,Luminal B",0.7678958773612976
hsa-miR-1229,"Luminal A,Luminal B",0.7676843404769897
hsa-miR-4448,aryngeal squamous cell carcinoma,0.7675889134407043
hsa-miR-1306,"Luminal B,triple negative",0.7674286961555481
hsa-miR-291-3p,"Luminal B,triple negative",0.7674286961555481
hsa-miR-16-1-3p,"Luminal B,triple negative",0.7674286961555481
hsa-miR-766-3p,"Luminal B,triple negative",0.7674286961555481
hsa-miR-6795-5p,"Luminal B,triple negative",0.7674286961555481
hsa-miR-3196,"Luminal A,Luminal B",0.7672907710075378
hsa-miR-548aq-5p,brain cancer,0.7670817971229553
hsa-miR-6741-3p,"Luminal A,Luminal B",0.7670218348503113
hsa-miR-6726-5p,serous ovarian cancers,0.7669916749000549
hsa-miR-6850-5p,brain cancer,0.7669503092765808
hsa-miR-7641,brain cancer,0.7668667435646057
hsa-miR-483,"Luminal A,Luminal B",0.766644299030304
hsa-miR-4693-3p,"Luminal B,triple negative",0.7665857672691345
hsa-miR-548ad-3p,"Luminal B,triple negative",0.7665857672691345
hsa-miR-3944-5p,"Luminal B,triple negative",0.7665857672691345
hsa-miR-4532,"Luminal B,triple negative",0.7665857672691345
hsa-miR-3152,"Luminal B,triple negative",0.7665857672691345
hsa-miR-122-3p,brain cancer,0.766482412815094
hsa-miR-106a*,brain cancer,0.7664704322814941
hsa-miR-4654,brain cancer,0.7664645910263062
hsa-miR-596,brain cancer,0.7664593458175659
hsa-miR-489,brain cancer,0.7664586901664734
hsa-miR-7113-3p,brain cancer,0.7664557695388794
hsa-miR-8065,brain cancer,0.7664533257484436
hsa-miR-6741-3p,brain cancer,0.766451895236969
hsa-miR-450a,"Luminal A,Luminal B",0.7664356231689453
hsa-miR-4700-5p,"Luminal A,Luminal B",0.7664356231689453
hsa-miR-582,"Luminal A,Luminal B",0.7663398385047913
hsa-miR-021,"Luminal A,Luminal B",0.7663398385047913
hsa-miR-1185-2-3p,"Luminal B,triple negative",0.7661752104759216
hsa-miR-4678,"Luminal B,triple negative",0.7661752104759216
hsa-miR-5697,"Luminal B,triple negative",0.7661752104759216
hsa-miR-6758-3p,"Luminal B,triple negative",0.7661752104759216
hsa-miR-3125,"Luminal B,triple negative",0.7661752104759216
hsa-miR-6833-3p,"Luminal B,triple negative",0.7661752104759216
hsa-miR-32-5p,"Luminal B,triple negative",0.7661752104759216
hsa-miR-202,"Luminal B,triple negative",0.7661752104759216
hsa-miR-548d-5p,serous ovarian cancers,0.7660862803459167
hsa-miR-1262,"Luminal A,Luminal B",0.7659961581230164
hsa-miR-550a,"Luminal B,triple negative",0.7659581303596497
hsa-miR-6504-3p,"Luminal B,triple negative",0.7659581303596497
hsa-miR-616*,"Luminal A,Luminal B",0.7658640742301941
hsa-miR-200a-3p,"Luminal A,Luminal B",0.7658640742301941
hsa-miR-937,"Luminal A,Luminal B",0.7658640742301941
hsa-miR-4715-5p,"Luminal B,triple negative",0.7657608389854431
hsa-miR-5696,"Luminal B,triple negative",0.7655787467956543
hsa-miR-3184-5p,"Luminal B,triple negative",0.7655787467956543
hsa-miR-516,"Luminal B,triple negative",0.7655787467956543
hsa-miR-196a-1,"Luminal A,Luminal B",0.765501856803894
hsa-miR-4445-3p,"Luminal B,triple negative",0.7654954195022583
hsa-miR-632,"Luminal A,Luminal B",0.76543790102005
hsa-miR-4251,"Luminal B,triple negative",0.7654256820678711
hsa-miR-381,"Luminal B,triple negative",0.7654256820678711
hsa-miR-4533,"Luminal B,triple negative",0.7654256820678711
hsa-miR-6716-3p,"Luminal B,triple negative",0.7654256820678711
hsa-miR-664b-5p,"Luminal B,triple negative",0.7654256820678711
hsa-miR-470,"Luminal B,triple negative",0.7654256820678711
hsa-miR-3194,sarcoma,0.7653160691261292
hsa-miR-30c-2-3p,sarcoma,0.7653160691261292
hsa-miR-5094,sarcoma,0.7653160691261292
hsa-miR-4677-5p,sarcoma,0.7653160691261292
hsa-miR-3714,sarcoma,0.7653160691261292
hsa-miR-374b-5p,serous ovarian cancers,0.7653070092201233
hsa-let-7b_c,"Luminal B,triple negative",0.765300989151001
hsa-miR-3653,"Luminal B,triple negative",0.765300989151001
hsa-miR-376b,serous ovarian cancers,0.765241801738739
hsa-miR-26b*,"Luminal B,triple negative",0.7651402354240417
hsa-miR-3671,"Luminal B,triple negative",0.764991283416748
hsa-miR-8075,"Luminal B,triple negative",0.764991283416748
hsa-miR-4454,testicular cancer,0.7649745941162109
hsa-miR-511-2,miR-675-y,0.7648431658744812
hsa-miR-636,miR-675-y,0.7648431658744812
hsa-miR-6127,miR-675-y,0.7648431658744812
hsa-miR-509-3-5p,miR-675-y,0.7648431658744812
hsa-miR-2277-5p,"Luminal B,triple negative",0.7647213935852051
hsa-miR-6797-3p,"Luminal B,triple negative",0.7647213935852051
hsa-miR-4271,"Luminal A,Luminal B",0.7646421194076538
hsa-miR-934,"Luminal B,triple negative",0.7645935416221619
hsa-miR-642,rhabdomyosarcomas,0.7645111680030823
hsa-miR-1277-5p,"Luminal B,triple negative",0.7644611597061157
hsa-miR-128,"Luminal B,triple negative",0.7644611597061157
hsa-miR-801,invasive lobular carcinoma,0.764387845993042
hsa-miR-624-3p,invasive lobular carcinoma,0.764387845993042
hsa-miR-193b-5p,"Luminal B,triple negative",0.7643768787384033
hsa-miR-502-3p,"Luminal B,triple negative",0.7643179297447205
hsa-miR-2278,"Luminal B,triple negative",0.7642620801925659
hsa-miR-292-3p,"Luminal B,triple negative",0.7642112970352173
hsa-miR-4647,"Luminal B,triple negative",0.7642112970352173
hsa-miR-6837-3p,"Luminal B,triple negative",0.7639896869659424
hsa-miR-149*,"Luminal B,triple negative",0.7639718651771545
hsa-miR-1909*,"Luminal B,triple negative",0.7639676928520203
hsa-miR-6077,"Luminal B,triple negative",0.7639620304107666
hsa-miR-1244,"Luminal B,triple negative",0.7639575600624084
hsa-miR-4768-5p,"Luminal B,triple negative",0.7639570236206055
hsa-miR-603,testicular cancer,0.7638700008392334
hsa-miR-3944-5p,testicular cancer,0.7638646960258484
hsa-miR-183,testicular cancer,0.7638011574745178
hsa-miR-320e,testicular cancer,0.7637050151824951
hsa-miR-1275,invasive lobular carcinoma,0.763655960559845
hsa-miR-200a-3p,invasive lobular carcinoma,0.763655960559845
hsa-miR-6881-3p,invasive lobular carcinoma,0.763655960559845
hsa-miR-4298,testicular cancer,0.7635610699653625
hsa-miR-8055,diffuse large B-cell lymphoma,0.7634516358375549
hsa-miR-548c-3p,diffuse large B-cell lymphoma,0.7634516358375549
hsa-miR-541,castration-resistant prostate cancer,0.7634491324424744
hsa-miR-655-3p,castration-resistant prostate cancer,0.7634491324424744
hsa-miR-4471,castration-resistant prostate cancer,0.7634491324424744
hsa-miR-22-5p,castration-resistant prostate cancer,0.7634491324424744
hsa-miR-6839-5p,castration-resistant prostate cancer,0.7634491324424744
hsa-miR-8053,castration-resistant prostate cancer,0.7634491324424744
hsa-miR-186*,testicular cancer,0.7633207440376282
hsa-miR-28-5p,testicular cancer,0.7633207440376282
hsa-miR-655-3p,miR-142-y,0.7631957530975342
hsa-miR-1260a,miR-142-y,0.7631957530975342
hsa-miR-150*,miR-142-y,0.7631957530975342
hsa-miR-588,testicular cancer,0.7631633877754211
hsa-miR-501-5p,pilocytic astrocytoma,0.7630179524421692
hsa-miR-3194,pilocytic astrocytoma,0.7630179524421692
hsa-miR-8052,testicular cancer,0.7629698514938354
hsa-miRPlus-C1114,ovarian carcinoma,0.7627830505371094
hsa-miR-640,testicular cancer,0.7627322673797607
hsa-miR-324-5p,testicular cancer,0.7625294923782349
hsa-miR-500a-5p,"squamous cell breast carcinoma, acantholytic variant",0.7623414397239685
hsa-miR-7975,"squamous cell breast carcinoma, acantholytic variant",0.7623414397239685
hsa-miR-341,"squamous cell breast carcinoma, acantholytic variant",0.7623414397239685
hsa-miR-892a,"Luminal A,Luminal B",0.7622570395469666
hsa-miR-202*,"Luminal A,Luminal B",0.7616622447967529
hsa-miR-6127,testicular cancer,0.7614530324935913
hsa-miR-3660,testicular cancer,0.761192798614502
hsa-miR-921,testicular cancer,0.761192798614502
hsa-miR-132,invasive lobular carcinoma,0.761151134967804
hsa-miR-22-5p,aryngeal squamous cell carcinoma,0.7605440616607666
hsa-miR-3607-5p,high grade serous papillary ovarian cancer,0.7602574229240417
hsa-miR-548ao-5p,high grade serous papillary ovarian cancer,0.7602574229240417
hsa-miR-923,brain cancer,0.7588955760002136
hsa-miR-3614-5p,brain cancer,0.7588955760002136
hsa-miR-6071,brain cancer,0.7588955760002136
hsa-miR-676-5p,invasive lobular carcinoma,0.7582374215126038
hsa-miRPlus-C1114,miR-675-y,0.7577413320541382
hsa-miR-553,"Luminal A,Luminal B",0.7568903565406799
hsa-miR-4453,"Luminal A,Luminal B",0.7568628787994385
hsa-miR-657,"Luminal A,Luminal B",0.7566479444503784
hsa-miR-3605-3p,"Luminal A,Luminal B",0.7566479444503784
hsa-miR-101-5p,"Luminal B,triple negative",0.75634765625
hsa-miR-378j,"Luminal A,Luminal B",0.7560216784477234
hsa-miR-500,"Luminal A,Luminal B",0.7560216784477234
hsa-miR-3197,"Luminal A,Luminal B",0.7560186386108398
hsa-miR-548ad,"Luminal A,Luminal B",0.7560186386108398
hsa-miR-4310,"Luminal A,Luminal B",0.7560162544250488
hsa-miR-637,"Luminal A,Luminal B",0.7560162544250488
hsa-miR-433,"Luminal A,Luminal B",0.7560162544250488
hsa-miR-626,"Luminal A,Luminal B",0.755997896194458
hsa-miR-1300,"Luminal A,Luminal B",0.755997896194458
hsa-miR-556-3p,"Luminal A,Luminal B",0.755997896194458
hsa-miR-4529-3p,"Luminal A,Luminal B",0.755997896194458
hsa-miR-33b,"Luminal A,Luminal B",0.755997896194458
hsa-miR-214-3p,"Luminal A,Luminal B",0.7559940814971924
hsa-let-7c_c,"Luminal A,Luminal B",0.7559906840324402
hsa-miR-539,"Luminal A,Luminal B",0.7559906840324402
hsa-miR-3657,"Luminal A,Luminal B",0.7559906840324402
hsa-miR-3162,"Luminal A,Luminal B",0.7559512853622437
hsa-miR-4269,"Luminal A,Luminal B",0.755935788154602
hsa-miR-145*,"Luminal A,Luminal B",0.755935788154602
hsa-miR-3925-3p,"Luminal A,Luminal B",0.7559024691581726
hsa-miR-655,"Luminal A,Luminal B",0.755827784538269
hsa-miR-4711-5p,"Luminal A,Luminal B",0.755827784538269
hsa-miR-4272,invasive lobular carcinoma,0.7558068633079529
hsa-miR-509-3p,"Luminal A,Luminal B",0.755800724029541
hsa-miR-361-5p,"Luminal A,Luminal B",0.7557525038719177
hsa-miR-581,"Luminal A,Luminal B",0.7557308673858643
hsa-miRPlus-A1025,"Luminal A,Luminal B",0.7557058334350586
hsa-miR-4737,"Luminal A,Luminal B",0.7556618452072144
hsa-miR-485-3p,"Luminal A,Luminal B",0.7556618452072144
hsa-miR-145,"Luminal A,Luminal B",0.7556191086769104
hsa-miR-675,"Luminal A,Luminal B",0.7556050419807434
hsa-miR-590,"Luminal A,Luminal B",0.7556050419807434
hsa-miR-587,"Luminal A,Luminal B",0.7555769681930542
hsa-miR-4706,"Luminal A,Luminal B",0.7555544376373291
hsa-miR-4723-3p,"Luminal A,Luminal B",0.7555105090141296
hsa-miR-3622b-5p,"Luminal A,Luminal B",0.7554987668991089
hsa-miR-3605-3p,testicular cancer,0.7554764747619629
hsa-miR-349,"Luminal A,Luminal B",0.7554616332054138
hsa-miR-1181,"Luminal A,Luminal B",0.755438506603241
hsa-miR-3134,"Luminal A,Luminal B",0.755438506603241
hsa-miR-5704,"Luminal A,Luminal B",0.755434513092041
hsa-miR-661,"Luminal A,Luminal B",0.7554243206977844
hsa-miR-24-2*,"Luminal A,Luminal B",0.7554243206977844
hsa-miR-891a,"Luminal A,Luminal B",0.7554123401641846
hsa-miR-760,"Luminal A,Luminal B",0.7553904056549072
hsa-miR-105*,"Luminal A,Luminal B",0.7553874254226685
hsa-miR-343,"Luminal A,Luminal B",0.7553274631500244
hsa-miR-4318,"Luminal A,Luminal B",0.7553274631500244
hsa-miR-609,"Luminal A,Luminal B",0.7553069591522217
hsa-miR-508-3p,"Luminal A,Luminal B",0.7552957534790039
hsa-miR-3925-5p,"Luminal A,Luminal B",0.7552957534790039
hsa-miR-320e,"Luminal A,Luminal B",0.7552446722984314
hsa-miR-628-5p,"Luminal A,Luminal B",0.7552446722984314
hsa-miR-585,"Luminal A,Luminal B",0.7552106380462646
hsa-miR-8076,"Luminal A,Luminal B",0.7552106380462646
hsa-miR-524-3p,"Luminal A,Luminal B",0.7552106380462646
hsa-miR-586,"Luminal A,Luminal B",0.7552106380462646
hsa-miR-106a*,"Luminal A,Luminal B",0.7551978826522827
hsa-miR-512-3p,"Luminal A,Luminal B",0.7551978826522827
hsa-miR-616,"Luminal A,Luminal B",0.7551891803741455
hsa-miR-6730-3p,"Luminal A,Luminal B",0.7551891803741455
hsa-miR-6781-5p,"Luminal A,Luminal B",0.7551891803741455
hsa-miR-4681,"Luminal A,Luminal B",0.7551891803741455
hsa-miR-6509-3p,"Luminal A,Luminal B",0.7551797032356262
hsa-miR-102,"Luminal A,Luminal B",0.7551797032356262
hsa-miR-3658,"Luminal A,Luminal B",0.75515216588974
hsa-miR-29b-2*,"Luminal A,Luminal B",0.7551333904266357
hsa-miR-218-1*,"Luminal A,Luminal B",0.7551259994506836
hsa-miRPlus-C1099,"Luminal A,Luminal B",0.7551194429397583
hsa-miR-29a-3p,"Luminal A,Luminal B",0.7551194429397583
hsa-miR-517b,"Luminal A,Luminal B",0.7551194429397583
hsa-miR-132*,"Luminal A,Luminal B",0.7551031708717346
hsa-miR-302d*,"Luminal A,Luminal B",0.7551031708717346
hsa-miR-4503,"Luminal A,Luminal B",0.7551031708717346
hsa-miR-593*,"Luminal A,Luminal B",0.755101203918457
hsa-miR-516-3p,"Luminal A,Luminal B",0.755101203918457
hsa-miR-129*,"Luminal A,Luminal B",0.7550950050354004
hsa-miR-892b,"Luminal A,Luminal B",0.7550950050354004
hsa-miR-4801,"Luminal A,Luminal B",0.7550950050354004
hsa-miR-3129-3p,"Luminal A,Luminal B",0.7550941705703735
hsa-miR-596,"Luminal A,Luminal B",0.7550567984580994
hsa-miR-3688-3p,"Luminal A,Luminal B",0.7550392150878906
hsa-miR-374b-5p,"Luminal A,Luminal B",0.7547612190246582
hsa-miR-362-3p,"Luminal A,Luminal B",0.7547383308410645
hsa-miR-801,"Luminal A,Luminal B",0.7546509504318237
hsa-miR-7-2*,"Luminal A,Luminal B",0.7546509504318237
hsa-miR-654-5p,"Luminal A,Luminal B",0.7544952034950256
hsa-miR-572,"Luminal A,Luminal B",0.7544952034950256
hsa-miR-8055,"Luminal A,Luminal B",0.7544422745704651
hsa-miR-4430,"Luminal A,Luminal B",0.7543673515319824
hsa-miR-507,"Luminal A,Luminal B",0.7543673515319824
hsa-miR-942,"Luminal A,Luminal B",0.7541413307189941
hsa-miR-616-3p,castration-resistant prostate cancer,0.7539921998977661
hsa-miR-181a-1,castration-resistant prostate cancer,0.7539921998977661
hsa-miR-4761-5p,castration-resistant prostate cancer,0.7539921998977661
hsa-miR-1468,castration-resistant prostate cancer,0.7539921998977661
hsa-miR-146a-5p,castration-resistant prostate cancer,0.7539921998977661
hsa-miR-1203,invasive lobular carcinoma,0.7537832260131836
hsa-miR-183-3p,invasive lobular carcinoma,0.7537832260131836
hsa-miR-4490,miR-142-y,0.7537319660186768
hsa-miR-518d,miR-142-y,0.7537319660186768
hsa-miR-519a,miR-142-y,0.7537319660186768
hsa-miR-6132,miR-142-y,0.7537319660186768
hsa-miR-33a*,miR-142-y,0.7537319660186768
hsa-let-7f-2*,miR-142-y,0.7537319660186768
hsa-miR-199a-5p,"Luminal A,Luminal B",0.7535502910614014
hsa-miR-525-5p,ovarian carcinoma,0.753308117389679
hsa-miR-4530,ovarian carcinoma,0.753308117389679
hsa-let-7f-2*,ovarian carcinoma,0.753308117389679
hsa-miR-519e-5p,ovarian carcinoma,0.753308117389679
hsa-miR-125b-1*,ovarian carcinoma,0.753308117389679
hsa-miR-6723-5p,ovarian carcinoma,0.753308117389679
hsa-miR-597,rhabdomyosarcomas,0.7532849907875061
hsa-miR-4781-5p,rhabdomyosarcomas,0.7532849907875061
hsa-miR-135a-1,rhabdomyosarcomas,0.7532849907875061
hsa-miR-6127,rhabdomyosarcomas,0.7532849907875061
hsa-miR-513a-3p,"Luminal A,Luminal B",0.753284215927124
hsa-miR-200a-5p,"Luminal A,Luminal B",0.753124475479126
hsa-miR-548J,castration-resistant prostate cancer,0.7530889511108398
hsa-miR-513-3p,castration-resistant prostate cancer,0.7530889511108398
hsa-miR-450b-5p,castration-resistant prostate cancer,0.7530889511108398
hsa-miR-5190,castration-resistant prostate cancer,0.7530889511108398
hsa-miR-548ax,castration-resistant prostate cancer,0.7530889511108398
hsa-miR-548av-5p,castration-resistant prostate cancer,0.7530889511108398
hsa-miR-342-3p,castration-resistant prostate cancer,0.7530889511108398
hsa-miR-19a-5p,castration-resistant prostate cancer,0.7530889511108398
hsa-miR-106b-5p,sarcoma,0.7530243396759033
hsa-miR-649,sarcoma,0.7530243396759033
hsa-miR-101-2,sarcoma,0.7530243396759033
hsa-miR-937-3p,sarcoma,0.7530243396759033
hsa-miR-6499-3p,sarcoma,0.7530243396759033
hsa-miR-506,sarcoma,0.7530243396759033
hsa-miR-3677-3p,miR-142-y,0.752828061580658
hsa-miR-4735-5p,miR-142-y,0.752828061580658
hsa-miR-450b-5p,ovarian carcinoma,0.752403199672699
hsa-miR-629-3p,ovarian carcinoma,0.752403199672699
hsa-miR-5190,ovarian carcinoma,0.752403199672699
hsa-miR-449,"Luminal A,Luminal B",0.7521474957466125
hsa-let-7e*,invasive lobular carcinoma,0.7521222233772278
hsa-miR-920,invasive lobular carcinoma,0.7512417435646057
hsa-miR-4693-5p,invasive lobular carcinoma,0.7512417435646057
hsa-miR-3926,"Luminal A,Luminal B",0.7512028217315674
hsa-miR-548b-5p,"Luminal A,Luminal B",0.7508577108383179
hsa-miRPlus-A1073,invasive lobular carcinoma,0.7508131265640259
hsa-miR-378j,invasive lobular carcinoma,0.7508131265640259
hsa-miR-3201,invasive lobular carcinoma,0.7508131265640259
hsa-miR-602,pilocytic astrocytoma,0.7506450414657593
hsa-miR-299-3p,pilocytic astrocytoma,0.7506450414657593
hsa-miR-653,pilocytic astrocytoma,0.7506450414657593
hsa-miR-143*,invasive lobular carcinoma,0.7505864500999451
hsa-miR-424-3p,invasive lobular carcinoma,0.7505864500999451
hsa-miR-4529-3p,invasive lobular carcinoma,0.750380277633667
hsa-miR-519e-3p,invasive lobular carcinoma,0.7501901388168335
hsa-miR-3620-3p,invasive lobular carcinoma,0.7501901388168335
hsa-miR-6816-3p,invasive lobular carcinoma,0.7501901388168335
hsa-miR-219-1-3p,invasive lobular carcinoma,0.7501030564308167
hsa-miR-4735-5p,aryngeal squamous cell carcinoma,0.7500982880592346
hsa-miR-362-3p,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-501-3p,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-136*,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-4686,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-1277-3p,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-6508-3p,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-410-5p,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-6865-5p,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-181a-3p,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-556,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-6832-3p,"squamous cell breast carcinoma, acantholytic variant",0.7499449253082275
hsa-miR-509-3p,invasive lobular carcinoma,0.7499001026153564
hsa-miR-6802-5p,"Luminal A,Luminal B",0.7498428225517273
hsa-miR-518e*,"Luminal A,Luminal B",0.7498428225517273
hsa-miR-381-3p,sarcoma,0.7496023774147034
hsa-miR-95-5p,sarcoma,0.7496023774147034
hsa-miR-4782-3p,invasive lobular carcinoma,0.7495766282081604
hsa-miR-548d-5p,invasive lobular carcinoma,0.7494315505027771
hsa-miR-587,invasive lobular carcinoma,0.7491615414619446
hsa-miR-633,invasive lobular carcinoma,0.7490231990814209
hsa-miR-4725-5p,invasive lobular carcinoma,0.7490231990814209
hsa-miR-349,invasive lobular carcinoma,0.7489352226257324
hsa-miR-328,invasive lobular carcinoma,0.7488154172897339
hsa-miR-661,invasive lobular carcinoma,0.7488154172897339
hsa-miR-4787-3p,invasive lobular carcinoma,0.748762309551239
hsa-miR-021,invasive lobular carcinoma,0.748530924320221
hsa-miR-29b-2*,invasive lobular carcinoma,0.7485114336013794
hsa-miR-138-2-3p,invasive lobular carcinoma,0.7485102415084839
hsa-miR-581,invasive lobular carcinoma,0.7485090494155884
hsa-miRPlus-A1086,invasive lobular carcinoma,0.748508095741272
hsa-miR-3688-3p,invasive lobular carcinoma,0.7485061287879944
hsa-miR-6829-5p,miR-675-y,0.7481315732002258
hsa-miR-125b-1*,miR-675-y,0.7481315732002258
hsa-miR-1275,B cell lymphoma,0.747974157333374
hsa-miR-516-3p,B cell lymphoma,0.747974157333374
hsa-miR-105-1,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-501-3p,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-7-1*,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-3649,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-6775-3p,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-1537-3p,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-6508-3p,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-5004-5p,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-6865-5p,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-615-3p,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-6858-5p,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-7706,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-548az-3p,high grade serous papillary ovarian cancer,0.7477880120277405
hsa-miR-513-3p,miR-675-y,0.7472139000892639
hsa-miR-548ax,miR-675-y,0.7472139000892639
hsa-miR-499-3p,pilocytic astrocytoma,0.7472012042999268
hsa-let-7d*,"squamous cell breast carcinoma, acantholytic variant",0.7464946508407593
hsa-miR-328-3p,"squamous cell breast carcinoma, acantholytic variant",0.7464946508407593
hsa-miR-6877-5p,"squamous cell breast carcinoma, acantholytic variant",0.7464946508407593
hsa-miR-572,rhabdomyosarcomas,0.7459502816200256
hsa-miR-1470,B cell lymphoma,0.7453585267066956
hsa-miR-333,B cell lymphoma,0.7453364729881287
hsa-miR-668-3p,brain cancer,0.744382917881012
hsa-miR-5584-3p,high grade serous papillary ovarian cancer,0.7443181276321411
hsa-miR-3170,high grade serous papillary ovarian cancer,0.7443181276321411
hsa-miR-350,high grade serous papillary ovarian cancer,0.7443181276321411
hsa-miR-4633-5p,high grade serous papillary ovarian cancer,0.7443181276321411
hsa-miR-3927-3p,"Luminal A,Luminal B",0.7438744306564331
hsa-miR-4538,primary central nervous system lymphomas,0.7436540722846985
hsa-miR-554,primary central nervous system lymphomas,0.7436540722846985
hsa-miR-6731-3p,synovial sarcoma,0.7429074645042419
hsa-miR-4433b-5p,synovial sarcoma,0.7429074645042419
hsa-miR-4538,synovial sarcoma,0.7429074645042419
hsa-miR-4798-3p,synovial sarcoma,0.7429074645042419
hsa-miR-203a,synovial sarcoma,0.7429074645042419
hsa-miR-092,"Luminal A,Luminal B",0.7421805262565613
hsa-miR-500a*,"Luminal A,Luminal B",0.7421805262565613
hsa-miR-1247,"Luminal A,Luminal B",0.7421805262565613
hsa-miR-188-3p,"Luminal A,Luminal B",0.7421805262565613
hsa-miR-668-3p,"Luminal B,triple negative",0.7417338490486145
hsa-miR-545-5p,"Luminal B,triple negative",0.7417338490486145
hsa-miR-6838-3p,sarcoma,0.7414359450340271
hsa-miR-1283,sarcoma,0.7414359450340271
hsa-miR-4639-5p,sarcoma,0.7414359450340271
hsa-miR-3691-3p,sarcoma,0.7414359450340271
hsa-miR-6515-5p,sarcoma,0.7414359450340271
hsa-miR-6127,sarcoma,0.7414359450340271
hsa-miR-200b-3p,sarcoma,0.7414359450340271
hsa-miR-092,castration-resistant prostate cancer,0.7407829165458679
hsa-miRPlus-C1087,castration-resistant prostate cancer,0.7407829165458679
hsa-miR-1247,castration-resistant prostate cancer,0.7407829165458679
hsa-miR-708*,castration-resistant prostate cancer,0.7407829165458679
hsa-miR-658,castration-resistant prostate cancer,0.7407829165458679
hsa-miR-499,castration-resistant prostate cancer,0.7407829165458679
hsa-miR-653-5p,castration-resistant prostate cancer,0.7407829165458679
hsa-miR-4777-3p,castration-resistant prostate cancer,0.7407829165458679
hsa-miR-923,invasive lobular carcinoma,0.740558385848999
hsa-miR-4753-5p,miR-142-y,0.7405133843421936
hsa-miR-5196-5p,miR-142-y,0.7405133843421936
hsa-miR-6740-3p,miR-142-y,0.7405133843421936
hsa-miR-4454,ovarian carcinoma,0.740074634552002
hsa-miR-3678-3p,ovarian carcinoma,0.740074634552002
hsa-miR-4655-5p,ovarian carcinoma,0.740074634552002
hsa-miR-4753-5p,ovarian carcinoma,0.740074634552002
hsa-miR-517-5p,ovarian carcinoma,0.740074634552002
hsa-miR-658,ovarian carcinoma,0.740074634552002
hsa-miR-5196-5p,ovarian carcinoma,0.740074634552002
hsa-miR-1b-2,B cell lymphoma,0.7397816181182861
hsa-miR-1251,B cell lymphoma,0.7397816181182861
hsa-miR-550*,B cell lymphoma,0.7397816181182861
hsa-miR-213,B cell lymphoma,0.7397816181182861
hsa-miR-5687,B cell lymphoma,0.7397816181182861
hsa-miR-23a-3p,"squamous cell breast carcinoma, acantholytic variant",0.7382622361183167
hsa-miR-3691-3p,"squamous cell breast carcinoma, acantholytic variant",0.7382622361183167
hsa-miR-628,"squamous cell breast carcinoma, acantholytic variant",0.7382622361183167
hsa-miR-3177,"squamous cell breast carcinoma, acantholytic variant",0.7382622361183167
hsa-miR-551a,"squamous cell breast carcinoma, acantholytic variant",0.7382622361183167
hsa-miR-4274,"squamous cell breast carcinoma, acantholytic variant",0.7382622361183167
hsa-miR-181d,"squamous cell breast carcinoma, acantholytic variant",0.7382622361183167
hsa-miR-509-3-5p,"squamous cell breast carcinoma, acantholytic variant",0.7382622361183167
hsa-miR-361-3p,"squamous cell breast carcinoma, acantholytic variant",0.7382622361183167
hsa-miR-488*,B cell lymphoma,0.7376716136932373
hsa-miR-455,B cell lymphoma,0.7376716136932373
hsa-miR-1908,B cell lymphoma,0.7367969751358032
hsa-miR-199a-5p,high grade serous papillary ovarian cancer,0.7360401153564453
hsa-miR-7156-3p,high grade serous papillary ovarian cancer,0.7360401153564453
hsa-miR-6127,high grade serous papillary ovarian cancer,0.7360401153564453
hsa-miR-96-5p,high grade serous papillary ovarian cancer,0.7360401153564453
hsa-miR-6745,high grade serous papillary ovarian cancer,0.7360401153564453
hsa-miR-4490,rhabdomyosarcomas,0.7360356450080872
hsa-miR-518d,rhabdomyosarcomas,0.7360356450080872
hsa-let-7e*,B cell lymphoma,0.7359396815299988
hsa-miR-571,B cell lymphoma,0.7359396815299988
hsa-miR-1249,B cell lymphoma,0.7359396815299988
hsa-miR-1304-3p,B cell lymphoma,0.7359396815299988
hsa-miR-199b-5p,testicular cancer,0.7356628179550171
hsa-miR-637,B cell lymphoma,0.7350221872329712
hsa-miR-6814-3p,B cell lymphoma,0.7350221872329712
hsa-miR-092,miR-675-y,0.7347181439399719
hsa-miR-378j,B cell lymphoma,0.7345752716064453
hsa-miR-508-5p,B cell lymphoma,0.7345752716064453
hsa-miR-132*,B cell lymphoma,0.7345752716064453
hsa-miR-138-2,B cell lymphoma,0.7345752716064453
hsa-miR-605,B cell lymphoma,0.7345752716064453
hsa-miR-576-3p,B cell lymphoma,0.7345752716064453
hsa-miR-3606-3p,B cell lymphoma,0.7343390583992004
hsa-miR-3151-3p,B cell lymphoma,0.7343390583992004
hsa-miR-325,B cell lymphoma,0.7341241836547852
hsa-miR-4747-3p,B cell lymphoma,0.7341241836547852
hsa-miR-6803-5p,B cell lymphoma,0.7339262366294861
hsa-miR-4791,B cell lymphoma,0.7339262366294861
hsa-miR-431-5p,sarcoma,0.733873188495636
hsa-miR-6839-5p,sarcoma,0.733873188495636
hsa-miR-1915*,B cell lymphoma,0.7337595820426941
hsa-miR-381,B cell lymphoma,0.7337595820426941
hsa-miR-4524a-5p,B cell lymphoma,0.7336239218711853
hsa-miR-23b*,B cell lymphoma,0.7336239218711853
hsa-miR-214,B cell lymphoma,0.73328697681427
hsa-miR-483-5p,B cell lymphoma,0.73328697681427
hsa-miR-34a-5p,B cell lymphoma,0.7322916388511658
hsa-miR-450a,B cell lymphoma,0.7322267889976501
hsa-miR-106a*,B cell lymphoma,0.7321845293045044
hsa-miR-4716-3p,B cell lymphoma,0.7321634888648987
hsa-miR-654,B cell lymphoma,0.7321615219116211
hsa-miR-566,"Luminal A,Luminal B",0.7314004302024841
hsa-miR-548b-3p,brain cancer,0.7313795685768127
hsa-miR-374b-3p,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-6777-3p,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-1197,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-30e*,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-3151-5p,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-181c*,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-7974,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-4442,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-5585-5p,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-17,castration-resistant prostate cancer,0.7312792539596558
hsa-miR-5582-3p,"Luminal A,Luminal B",0.7312729358673096
hsa-miR-374b-3p,miR-142-y,0.7310033440589905
hsa-miR-17,miR-142-y,0.7310033440589905
hsa-miR-4714-5p,"squamous cell breast carcinoma, acantholytic variant",0.7306404709815979
hsa-miR-2467-5p,"squamous cell breast carcinoma, acantholytic variant",0.7306404709815979
hsa-let-7e-5p,"squamous cell breast carcinoma, acantholytic variant",0.7306404709815979
hsa-miR-1292-3p,ovarian carcinoma,0.7305542826652527
hsa-miR-512-5p-384,ovarian carcinoma,0.7305542826652527
hsa-miR-720,ovarian carcinoma,0.7305542826652527
hsa-miR-5582-3p,distal cholangiocarcinoma,0.7296155095100403
hsa-miR-548c-5p,diffuse large B-cell lymphoma,0.7287814021110535
hsa-miR-20b-5p,"Luminal B,triple negative",0.7286449670791626
hsa-miR-548o,"Luminal B,triple negative",0.7286449670791626
hsa-miR-454,"Luminal B,triple negative",0.7286449670791626
hsa-miR-4758-3p,"Luminal B,triple negative",0.7286449670791626
hsa-miR-6724-5p,"Luminal B,triple negative",0.7286449670791626
hsa-miRPlus-C1114,high grade serous papillary ovarian cancer,0.7283773422241211
hsa-miR-616-5p,high grade serous papillary ovarian cancer,0.7283773422241211
hsa-miR-92-1,infantile hemangioma,0.7282506823539734
hsa-miR-1298,brain cancer,0.7277661561965942
hsa-miR-374b-3p,papillary thyroid carcinoma,0.7271377444267273
hsa-miR-3692*,Luminal B Her2+,0.7268641591072083
hsa-miR-494-5p,Luminal B Her2+,0.7263515591621399
hsa-miR-411*,Luminal B Her2+,0.7263515591621399
hsa-miR-196-1,Luminal B Her2+,0.7257933616638184
hsa-miR-374b-3p,miR-675-y,0.7250746488571167
hsa-miR-6069,"Luminal B,triple negative",0.7250084280967712
hsa-miR-664b-3p,"Luminal B,triple negative",0.7250084280967712
hsa-miR-5088-3p,B cell lymphoma,0.7238982319831848
hsa-miR-4530,sarcoma,0.7236618995666504
hsa-miR-24-3p,sarcoma,0.7226883172988892
hsa-miR-342-3p,sarcoma,0.7226883172988892
hsa-miR-1826,rhabdomyosarcomas,0.7222172021865845
hsa-miR-1197,"Luminal A,Luminal B",0.7215517163276672
hsa-miR-518d,"squamous cell breast carcinoma, acantholytic variant",0.7203524708747864
hsa-miR-542-3p,"squamous cell breast carcinoma, acantholytic variant",0.7203524708747864
hsa-miR-525-5p,"squamous cell breast carcinoma, acantholytic variant",0.7203524708747864
hsa-miR-15a-5p,"squamous cell breast carcinoma, acantholytic variant",0.7203524708747864
hsa-miR-125b-1*,"squamous cell breast carcinoma, acantholytic variant",0.7203524708747864
hsa-miR-8063,"squamous cell breast carcinoma, acantholytic variant",0.7203524708747864
hsa-miR-24-3p,"squamous cell breast carcinoma, acantholytic variant",0.7193716168403625
hsa-miR-342-3p,"squamous cell breast carcinoma, acantholytic variant",0.7193716168403625
hsa-miR-33a*,high grade serous papillary ovarian cancer,0.7180361747741699
hsa-miR-676*,B cell lymphoma,0.7173949480056763
hsa-miR-589,B cell lymphoma,0.7170706391334534
hsa-miR-3927-3p,high grade serous papillary ovarian cancer,0.7170503735542297
hsa-miR-513-3p,high grade serous papillary ovarian cancer,0.7170503735542297
hsa-miR-337,high grade serous papillary ovarian cancer,0.7170503735542297
hsa-miR-638,B cell lymphoma,0.7169886231422424
hsa-miR-199a-5p,B cell lymphoma,0.7169886231422424
hsa-miR-6827-5p,"Luminal B,triple negative",0.7163436412811279
hsa-miR-363-5p,"Luminal B,triple negative",0.7163436412811279
hsa-miR-1827,"Luminal B,triple negative",0.7163436412811279
hsa-miR-551a,"Luminal B,triple negative",0.7163436412811279
hsa-miR-6823-5p,"Luminal B,triple negative",0.7163436412811279
hsa-miR-623,B cell lymphoma,0.7158492803573608
hsa-miR-130a-5p,B cell lymphoma,0.7158492803573608
hsa-miR-3202,B cell lymphoma,0.7158023715019226
hsa-let-7c_c,B cell lymphoma,0.7157095074653625
hsa-miR-020,B cell lymphoma,0.7157095074653625
hsa-miR-449b-3p,B cell lymphoma,0.7156715393066406
hsa-miR-556-3p,B cell lymphoma,0.7155211567878723
hsa-miR-8055,invasive lobular carcinoma,0.7154395580291748
hsa-miR-92a-1*,B cell lymphoma,0.7153632044792175
hsa-miR-593-5p,B cell lymphoma,0.7153632044792175
hsa-miR-4681,B cell lymphoma,0.7153089642524719
hsa-miR-4795-5p,invasive lobular carcinoma,0.715275764465332
hsa-miR-513,B cell lymphoma,0.7151851654052734
hsa-miR-185,B cell lymphoma,0.7149901986122131
hsa-miR-4651,B cell lymphoma,0.7149901986122131
hsa-miR-509-3p,B cell lymphoma,0.7148036360740662
hsa-miR-766,B cell lymphoma,0.7146322727203369
hsa-miR-570-3p,B cell lymphoma,0.7144730091094971
hsa-miR-642a-5p,B cell lymphoma,0.7144730091094971
hsa-miR-183-5p,B cell lymphoma,0.7143176794052124
hsa-miR-6840-3p,B cell lymphoma,0.7143176794052124
hsa-miR-145,B cell lymphoma,0.7141692042350769
hsa-miR-15b,B cell lymphoma,0.7138975858688354
hsa-miR-517,B cell lymphoma,0.7138867378234863
hsa-miR-591,B cell lymphoma,0.7135968804359436
hsa-miR-328,B cell lymphoma,0.7134594917297363
hsa-miR-767,B cell lymphoma,0.7134594917297363
hsa-miR-23b,invasive lobular carcinoma,0.7132250070571899
hsa-miR-512-5p,B cell lymphoma,0.7130886912345886
hsa-miR-432*,invasive lobular carcinoma,0.7130843997001648
hsa-miR-29a-3p,invasive lobular carcinoma,0.7130843997001648
hsa-miR-020,invasive lobular carcinoma,0.7130843997001648
hsa-miR-3914,invasive lobular carcinoma,0.7130462527275085
hsa-miR-1234-3p,B cell lymphoma,0.7129775881767273
hsa-miR-663b,B cell lymphoma,0.7129136919975281
hsa-miR-590,B cell lymphoma,0.7129136919975281
hsa-miR-626,invasive lobular carcinoma,0.7128950357437134
hsa-miR-526b-5p,invasive lobular carcinoma,0.7128950357437134
hsa-miR-370,invasive lobular carcinoma,0.712736189365387
hsa-miR-4465,invasive lobular carcinoma,0.712736189365387
hsa-miR-1468,testicular cancer,0.7127026319503784
hsa-miR-4269,invasive lobular carcinoma,0.7126817107200623
hsa-miR-6730-3p,invasive lobular carcinoma,0.7126817107200623
hsa-miR-522,invasive lobular carcinoma,0.7126817107200623
hsa-miR-329,invasive lobular carcinoma,0.7125572562217712
hsa-miR-23b*,invasive lobular carcinoma,0.7121735215187073
hsa-miRPlus-A1086,B cell lymphoma,0.7121158838272095
hsa-miR-508-3p,invasive lobular carcinoma,0.7120657563209534
hsa-miR-6787-5p,invasive lobular carcinoma,0.7120657563209534
hsa-miR-7106-3p,invasive lobular carcinoma,0.7120657563209534
hsa-miR-664,invasive lobular carcinoma,0.7120657563209534
hsa-miR-5687,invasive lobular carcinoma,0.7120657563209534
hsa-miR-655,invasive lobular carcinoma,0.7120657563209534
hsa-miR-548am-3p,invasive lobular carcinoma,0.7120012640953064
hsa-miRPlus-C1099,B cell lymphoma,0.7118423581123352
hsa-miR-519b-3p,B cell lymphoma,0.7118423581123352
hsa-miR-1306,B cell lymphoma,0.7118423581123352
hsa-miR-593*,B cell lymphoma,0.7118289470672607
hsa-miR-1233,B cell lymphoma,0.7117782235145569
hsa-miR-379-3p,B cell lymphoma,0.711749255657196
hsa-miR-152,B cell lymphoma,0.711749255657196
hsa-miR-1238-5p,B cell lymphoma,0.711749255657196
hsa-miR-452*,B cell lymphoma,0.711749255657196
hsa-miR-362-3p,invasive lobular carcinoma,0.7117446660995483
hsa-miR-6811-5p,invasive lobular carcinoma,0.7116850018501282
hsa-miR-101b,B cell lymphoma,0.7115273475646973
hsa-miR-361,B cell lymphoma,0.7115273475646973
hsa-miR-432,B cell lymphoma,0.7115273475646973
hsa-miR-663,B cell lymphoma,0.7115273475646973
hsa-miR-5582-3p,invasive lobular carcinoma,0.7114570736885071
hsa-miR-4324,invasive lobular carcinoma,0.7113912105560303
hsa-miR-1257,B cell lymphoma,0.7112588286399841
hsa-miR-218-1*,B cell lymphoma,0.7112588286399841
hsa-miR-122,B cell lymphoma,0.7112588286399841
hsa-miR-302d,invasive lobular carcinoma,0.7112516164779663
hsa-miR-291-5p,brain cancer,0.7111937999725342
hsa-miR-3622b-5p,invasive lobular carcinoma,0.7111059427261353
hsa-miR-665,invasive lobular carcinoma,0.7109602093696594
hsa-miR-369,B cell lymphoma,0.7109295725822449
hsa-miR-526b-5p,B cell lymphoma,0.7109295725822449
hsa-miR-129-2-3p,invasive lobular carcinoma,0.7106912732124329
hsa-miR-892a,B cell lymphoma,0.7106600403785706
hsa-miR-4262,B cell lymphoma,0.7106600403785706
hsa-miR-370,B cell lymphoma,0.7105671763420105
hsa-miR-1914*,B cell lymphoma,0.7105671763420105
hsa-miR-450a-2-3p,B cell lymphoma,0.7105671763420105
hsa-miR-4737,B cell lymphoma,0.7104748487472534
hsa-miR-423-5p,B cell lymphoma,0.7104748487472534
hsa-miR-483,invasive lobular carcinoma,0.7103375196456909
hsa-miR-5701,B cell lymphoma,0.709933340549469
hsa-miR-4655-5p,sarcoma,0.7094515562057495
hsa-miR-335*,B cell lymphoma,0.7094293236732483
hsa-miR-187,invasive lobular carcinoma,0.709182620048523
hsa-miR-96*,invasive lobular carcinoma,0.709182620048523
hsa-miR-548d-5p,B cell lymphoma,0.7090064287185669
hsa-miR-520d-3p,B cell lymphoma,0.7090064287185669
hsa-miR-4324,B cell lymphoma,0.7086220979690552
hsa-miR-4271,invasive lobular carcinoma,0.708427906036377
hsa-miR-19b-2*,"Luminal B,triple negative",0.7083354592323303
hsa-miR-708-3p,"Luminal B,triple negative",0.7083354592323303
hsa-miR-501-5p,B cell lymphoma,0.7080891728401184
hsa-miR-216b,invasive lobular carcinoma,0.7080073952674866
hsa-miR-219a-1-3p,B cell lymphoma,0.7079466581344604
hsa-miR-4260,B cell lymphoma,0.707632839679718
hsa-miR-343,B cell lymphoma,0.7074902653694153
hsa-miR-483,B cell lymphoma,0.7073607444763184
hsa-miR-5192,"Luminal A,Luminal B",0.707252025604248
hsa-miR-582,B cell lymphoma,0.7070086598396301
hsa-miR-451,B cell lymphoma,0.7069026827812195
hsa-miR-422b,B cell lymphoma,0.7068426609039307
hsa-miR-923,B cell lymphoma,0.7068426609039307
hsa-miR-532-5p,B cell lymphoma,0.7068426609039307
hsa-miR-5582-3p,pilocytic astrocytoma,0.7068158388137817
hsa-miR-99a*,invasive lobular carcinoma,0.7067409753799438
hsa-miR-3137,B cell lymphoma,0.706610918045044
hsa-miR-187,B cell lymphoma,0.7064581513404846
hsa-miR-3129-3p,B cell lymphoma,0.7064353823661804
hsa-miR-659-3p,B cell lymphoma,0.7062731385231018
hsa-miR-4753-5p,"squamous cell breast carcinoma, acantholytic variant",0.7060407996177673
hsa-miR-566,B cell lymphoma,0.7058397531509399
hsa-miR-4310,astrocytoma,0.705048680305481
hsa-miR-3657,invasive lobular carcinoma,0.7043437957763672
hsa-miR-1324,invasive lobular carcinoma,0.7043437957763672
hsa-miR-3945,invasive lobular carcinoma,0.7042786478996277
hsa-miR-6734-3p,invasive lobular carcinoma,0.7042490839958191
hsa-miR-532-5p,invasive lobular carcinoma,0.7041695713996887
hsa-miR-508-5p,invasive lobular carcinoma,0.7040240168571472
hsa-miR-132*,invasive lobular carcinoma,0.7040240168571472
hsa-miR-605,invasive lobular carcinoma,0.7040240168571472
hsa-miR-1914,invasive lobular carcinoma,0.7038988471031189
hsa-miR-548J,"Luminal A,Luminal B",0.7037397623062134
hsa-miR-6740-3p,high grade serous papillary ovarian cancer,0.703654944896698
hsa-miR-654-5p,invasive lobular carcinoma,0.7034820914268494
hsa-miR-1300,invasive lobular carcinoma,0.7034170031547546
hsa-miR-3925-3p,invasive lobular carcinoma,0.7027149796485901
hsa-miR-801,B cell lymphoma,0.7022916674613953
hsa-miR-1267,B cell lymphoma,0.7022916674613953
hsa-miR-3665,astrocytoma,0.7016240954399109
hsa-miR-625*,invasive lobular carcinoma,0.701464831829071
hsa-miR-675,invasive lobular carcinoma,0.7013565897941589
hsa-miR-145,invasive lobular carcinoma,0.7012652158737183
hsa-miR-105*,invasive lobular carcinoma,0.7012652158737183
hsa-miR-1273e,invasive lobular carcinoma,0.7008954286575317
hsa-miR-423-5p_1,invasive lobular carcinoma,0.7003894448280334
hsa-miR-4272,B cell lymphoma,0.700264573097229
hsa-miR-515-3p,B cell lymphoma,0.700264573097229
hsa-miR-616,B cell lymphoma,0.7001463770866394
hsa-miR-939,B cell lymphoma,0.6999887824058533
hsa-miR-801,astrocytoma,0.6997449994087219
hsa-miR-138-2*,B cell lymphoma,0.6996644139289856
hsa-miR-4700-5p,invasive lobular carcinoma,0.6995495557785034
hsa-miR-129*,B cell lymphoma,0.699053168296814
hsa-miR-920,B cell lymphoma,0.699053168296814
hsa-miR-2116,invasive lobular carcinoma,0.6988787055015564
hsa-miRPlus-A1073,B cell lymphoma,0.698460042476654
hsa-miR-302b,B cell lymphoma,0.698460042476654
hsa-miR-3927-3p,serous ovarian cancers,0.6979721188545227
hsa-miR-96*,B cell lymphoma,0.6979610323905945
hsa-miR-143*,B cell lymphoma,0.6978286504745483
hsa-miR-4530,"Luminal B,triple negative",0.6975482106208801
hsa-miR-15a-5p,"Luminal B,triple negative",0.6975482106208801
hsa-miR-382-3p,"Luminal B,triple negative",0.6975482106208801
hsa-miR-626,B cell lymphoma,0.6971745491027832
hsa-miR-1300,B cell lymphoma,0.6971745491027832
hsa-miR-2115*,B cell lymphoma,0.6971745491027832
hsa-miR-4529-3p,B cell lymphoma,0.6971745491027832
hsa-let-7f-2*,"Luminal A,Luminal B",0.6971590518951416
hsa-miR-377,pilocytic astrocytoma,0.6965769529342651
hsa-miR-299,pilocytic astrocytoma,0.6965769529342651
hsa-miR-483-3p,B cell lymphoma,0.6965314745903015
hsa-miR-1272,B cell lymphoma,0.6965314745903015
hsa-miR-548ax,"Luminal B,triple negative",0.6965210437774658
hsa-miR-4453,B cell lymphoma,0.6960794925689697
hsa-miR-586,B cell lymphoma,0.6959035396575928
hsa-miR-615,"squamous cell breast carcinoma, acantholytic variant",0.6957865357398987
hsa-miR-144-5p,"squamous cell breast carcinoma, acantholytic variant",0.6957865357398987
hsa-miR-3121,"squamous cell breast carcinoma, acantholytic variant",0.6957865357398987
hsa-miR-135a*,"squamous cell breast carcinoma, acantholytic variant",0.6957865357398987
hsa-miR-548aj-5p,"squamous cell breast carcinoma, acantholytic variant",0.6957865357398987
hsa-miR-6500-5p,"squamous cell breast carcinoma, acantholytic variant",0.6957865357398987
hsa-miR-148b,B cell lymphoma,0.6956814527511597
hsa-miR-548h,B cell lymphoma,0.6952532529830933
hsa-miR-6511b-3p,B cell lymphoma,0.6952532529830933
hsa-miR-3194,astrocytoma,0.6948208808898926
hsa-miR-148b,invasive lobular carcinoma,0.6946510672569275
hsa-miR-892a,invasive lobular carcinoma,0.6946510672569275
hsa-miR-30e,B cell lymphoma,0.6945233941078186
hsa-miR-214*,B cell lymphoma,0.6945233941078186
hsa-miR-99,B cell lymphoma,0.6939985752105713
hsa-miR-3154,B cell lymphoma,0.6939985752105713
hsa-miR-5192,B cell lymphoma,0.6939985752105713
hsa-miR-181a-2-3p,infantile hemangioma,0.6939380168914795
hsa-miR-522,infantile hemangioma,0.6939380168914795
hsa-miR-609,B cell lymphoma,0.6937915086746216
hsa-miR-409-5p,castration-resistant prostate cancer,0.6937846541404724
hsa-miR-7158-3p,castration-resistant prostate cancer,0.6937846541404724
hsa-miR-4685-5p,castration-resistant prostate cancer,0.6937846541404724
hsa-miR-15b*,melanoma brain metastasis,0.6937496066093445
hsa-miR-554,miR-142-y,0.6934865713119507
hsa-miR-548at-3p,miR-142-y,0.6934865713119507
hsa-miR-4685-5p,miR-142-y,0.6934865713119507
hsa-miR-6834-5p,miR-142-y,0.6934865713119507
hsa-miR-4264,B cell lymphoma,0.6931158900260925
hsa-miR-4298,B cell lymphoma,0.6931158900260925
hsa-miR-449,ovarian carcinoma,0.6930012106895447
hsa-miR-939-5p,ovarian carcinoma,0.6930012106895447
hsa-miR-548c-5p,ovarian carcinoma,0.6930012106895447
hsa-miR-213,invasive lobular carcinoma,0.6929026246070862
hsa-miR-3610,invasive lobular carcinoma,0.6926230192184448
hsa-miR-603,B cell lymphoma,0.6926156878471375
hsa-miR-5591-5p,B cell lymphoma,0.6926156878471375
hsa-miR-148a*,B cell lymphoma,0.6926156878471375
hsa-miR-4420,B cell lymphoma,0.6926156878471375
hsa-miR-4503,B cell lymphoma,0.6926156878471375
hsa-miR-5693,B cell lymphoma,0.6926156878471375
hsa-miRPlus-C1110,B cell lymphoma,0.6926121115684509
hsa-miR-10a*,B cell lymphoma,0.6926121115684509
hsa-miR-3914,B cell lymphoma,0.6926121115684509
hsa-miR-6851-3p,B cell lymphoma,0.6926121115684509
hsa-miR-301b,B cell lymphoma,0.6926093697547913
hsa-miR-1260b,B cell lymphoma,0.6925882697105408
hsa-miR-30a*,B cell lymphoma,0.6925799250602722
hsa-miR-6762-3p,B cell lymphoma,0.6925468444824219
hsa-miR-6807-3p,B cell lymphoma,0.6925344467163086
hsa-miR-3620-3p,B cell lymphoma,0.6925344467163086
hsa-miR-302a*,B cell lymphoma,0.6924780011177063
hsa-miR-6787-5p,B cell lymphoma,0.6923918128013611
hsa-miR-340,B cell lymphoma,0.6923606395721436
hsa-miR-571,invasive lobular carcinoma,0.6922942399978638
hsa-miR-517b,invasive lobular carcinoma,0.6922942399978638
hsa-miR-1207,B cell lymphoma,0.6922511458396912
hsa-miR-3916,B cell lymphoma,0.6922008991241455
hsa-miR-503,B cell lymphoma,0.6922003030776978
hsa-miR-3681-3p,infantile hemangioma,0.6921526789665222
hsa-miR-374b*,B cell lymphoma,0.6921510696411133
hsa-miR-339-3p,B cell lymphoma,0.6921510696411133
hsa-miR-5586-3p,invasive breast ductal carcinoma,0.6920518279075623
hsa-miR-4748,testicular cancer,0.6920180320739746
hsa-miR-513a-5p,B cell lymphoma,0.6919675469398499
hsa-miR-296-3p,B cell lymphoma,0.6919675469398499
hsa-miR-1181,B cell lymphoma,0.6919426918029785
hsa-miR-3131,invasive lobular carcinoma,0.6919232606887817
hsa-miR-26a-2*,invasive lobular carcinoma,0.6919232606887817
hsa-miR-105*,B cell lymphoma,0.6918393969535828
hsa-miR-324-3p,B cell lymphoma,0.691814661026001
hsa-miR-25*,B cell lymphoma,0.6917818784713745
hsa-miR-3621,B cell lymphoma,0.6917506456375122
hsa-miR-6832-5p,B cell lymphoma,0.6917506456375122
hsa-miR-200c-5p,B cell lymphoma,0.6912438273429871
hsa-miR-378f,invasive lobular carcinoma,0.6910732388496399
hsa-miR-3605-5p,invasive lobular carcinoma,0.6910732388496399
hsa-miR-15b*,B cell lymphoma,0.6910342574119568
hsa-miR-216b,B cell lymphoma,0.6910342574119568
hsa-miR-593*,invasive lobular carcinoma,0.6905674934387207
hsa-miR-616*,invasive lobular carcinoma,0.6905674934387207
hsa-miR-132,B cell lymphoma,0.6904467344284058
hsa-miR-646,B cell lymphoma,0.6904467344284058
hsa-miR-99a*,B cell lymphoma,0.6904467344284058
hsa-miR-642a,B cell lymphoma,0.6904467344284058
hsa-miR-10a*,invasive lobular carcinoma,0.6904333829879761
hsa-miR-4538,aryngeal squamous cell carcinoma,0.690371036529541
hsa-miR-3622b-5p,B cell lymphoma,0.6901244521141052
hsa-miR-575,B cell lymphoma,0.6901244521141052
hsa-miR-4453,melanoma brain metastasis,0.6899362206459045
hsa-miR-1250,B cell lymphoma,0.6898205280303955
hsa-miR-4317,invasive lobular carcinoma,0.6897703409194946
hsa-miR-556-5p,B cell lymphoma,0.6897656321525574
hsa-miR-507,B cell lymphoma,0.6897656321525574
hsa-miR-3196,B cell lymphoma,0.6896086931228638
hsa-miR-608,B cell lymphoma,0.6894590258598328
hsa-miR-1273,B cell lymphoma,0.6894590258598328
hsa-miR-501-3p,B cell lymphoma,0.6894590258598328
hsa-miR-148a,papillary thyroid carcinoma,0.6893109083175659
hsa-miR-33b*,B cell lymphoma,0.6891535520553589
hsa-miR-523-3p,B cell lymphoma,0.6891200542449951
hsa-miR-3162,invasive lobular carcinoma,0.6891186237335205
hsa-miR-4470,invasive lobular carcinoma,0.6891186237335205
hsa-miR-6514-3p,invasive lobular carcinoma,0.6891186237335205
hsa-miR-3622b-3p,invasive lobular carcinoma,0.6891186237335205
hsa-miR-3654,B cell lymphoma,0.688656210899353
hsa-miR-600,B cell lymphoma,0.6885278820991516
hsa-miR-513,invasive lobular carcinoma,0.6884821057319641
hsa-miR-585,invasive lobular carcinoma,0.6884821057319641
hsa-miR-4497,B cell lymphoma,0.6884599328041077
hsa-miR-6731-3p,B cell lymphoma,0.6881499886512756
hsa-miR-193a-3p,B cell lymphoma,0.6880276799201965
hsa-miR-490-3p,B cell lymphoma,0.6880276799201965
hsa-miR-5580-5p,B cell lymphoma,0.6880276799201965
hsa-miR-3173-5p,B cell lymphoma,0.6880276799201965
hsa-miR-320e,invasive lobular carcinoma,0.6878231167793274
hsa-miR-3074,invasive lobular carcinoma,0.6878231167793274
hsa-miR-148b-3p,B cell lymphoma,0.6873835325241089
hsa-miR-218-1*,invasive lobular carcinoma,0.6873754262924194
hsa-miR-122,invasive lobular carcinoma,0.6873754262924194
hsa-miR-2115*,invasive lobular carcinoma,0.6873513460159302
hsa-miR-1253,invasive lobular carcinoma,0.6873513460159302
hsa-miR-519b-3p,invasive lobular carcinoma,0.6873430013656616
hsa-miR-138-2*,invasive lobular carcinoma,0.6873430013656616
hsa-miR-1295,invasive lobular carcinoma,0.6873430013656616
hsa-miR-301a-3p,invasive lobular carcinoma,0.6872971057891846
hsa-miR-593-5p,invasive lobular carcinoma,0.6872971057891846
hsa-miR-4776-3p,invasive lobular carcinoma,0.6872789263725281
hsa-miR-548d-3p,invasive lobular carcinoma,0.6872789263725281
hsa-miR-187*,invasive lobular carcinoma,0.6872401237487793
hsa-miR-192-2/3,invasive lobular carcinoma,0.6872401237487793
hsa-miR-8076,invasive lobular carcinoma,0.6872401237487793
hsa-miR-5681b,invasive lobular carcinoma,0.6871825456619263
hsa-miR-628-5p,invasive lobular carcinoma,0.6871825456619263
hsa-miR-574-3p,invasive lobular carcinoma,0.6871825456619263
hsa-miR-654-5p,B cell lymphoma,0.6870900392532349
hsa-miR-463,miR-675-y,0.6870849132537842
hsa-miR-3926,B cell lymphoma,0.6870627999305725
hsa-miR-092,B cell lymphoma,0.6870627999305725
hsa-miR-3196,invasive lobular carcinoma,0.686724841594696
hsa-miR-92-1,invasive lobular carcinoma,0.6866998076438904
hsa-miR-24-2*,invasive lobular carcinoma,0.686683177947998
hsa-miR-760,invasive lobular carcinoma,0.6866437792778015
hsa-miR-4700-5p,B cell lymphoma,0.686614990234375
hsa-miR-4499,invasive lobular carcinoma,0.6866061687469482
hsa-miR-151-3p,invasive lobular carcinoma,0.6863684058189392
hsa-miR-609,invasive lobular carcinoma,0.6863417625427246
hsa-miR-362-3p,astrocytoma,0.6852951645851135
hsa-miR-548b-3p,astrocytoma,0.6852951645851135
hsa-miR-151-3p,B cell lymphoma,0.6852380633354187
hsa-miR-3180-5p,invasive lobular carcinoma,0.685189962387085
hsa-miR-511,invasive lobular carcinoma,0.6850805282592773
hsa-miR-183-5p,invasive lobular carcinoma,0.6850001811981201
hsa-miR-193a-3p,invasive lobular carcinoma,0.6845579743385315
hsa-miR-490-3p,invasive lobular carcinoma,0.6845579743385315
hsa-miR-4454,"Luminal A,Luminal B",0.6845224499702454
hsa-miR-382-5p,invasive lobular carcinoma,0.6843637824058533
hsa-miR-602,invasive lobular carcinoma,0.6841931939125061
hsa-miR-3925-5p,melanoma brain metastasis,0.6836605668067932
hsa-miR-4665-5p,melanoma brain metastasis,0.6836605668067932
hsa-miR-181a-2*,B cell lymphoma,0.6835602521896362
hsa-miR-4720-3p,melanoma brain metastasis,0.681291401386261
hsa-miR-23a*,invasive lobular carcinoma,0.6811390519142151
hsa-miR-1908,invasive lobular carcinoma,0.6810088753700256
hsa-miR-212-5p,invasive lobular carcinoma,0.6810088753700256
hsa-miR-433-3p,B cell lymphoma,0.6805038452148438
hsa-miR-6802-5p,melanoma brain metastasis,0.6803101897239685
hsa-miR-208a,invasive lobular carcinoma,0.6802632212638855
hsa-miR-3173-5p,invasive lobular carcinoma,0.6801877617835999
hsa-miR-1296-3p,invasive lobular carcinoma,0.6801877617835999
hsa-miR-511-2,testicular cancer,0.6797425150871277
hsa-miR-657,B cell lymphoma,0.6784024834632874
hsa-miR-451,invasive lobular carcinoma,0.678345263004303
hsa-miR-129*,melanoma brain metastasis,0.6783208847045898
hsa-miR-152,melanoma brain metastasis,0.6783208847045898
hsa-miR-138-2,melanoma brain metastasis,0.6778203845024109
hsa-miR-101b,melanoma brain metastasis,0.6778203845024109
hsa-miR-576-3p,melanoma brain metastasis,0.6778203845024109
hsa-miR-148a*,melanoma brain metastasis,0.6778203845024109
hsa-miR-3144-3p,melanoma brain metastasis,0.6775557398796082
hsa-miR-3162,melanoma brain metastasis,0.6770935654640198
hsa-miR-1914*,melanoma brain metastasis,0.6770935654640198
hsa-miR-602,melanoma brain metastasis,0.6769119501113892
hsa-miR-509-3p,melanoma brain metastasis,0.6767550706863403
hsa-miR-23b*,melanoma brain metastasis,0.6767550706863403
hsa-miR-657,invasive lobular carcinoma,0.676158607006073
hsa-miR-6857-5p,melanoma brain metastasis,0.6760494112968445
hsa-miR-579,"Luminal A,Luminal B",0.6758647561073303
hsa-miR-3676,melanoma brain metastasis,0.6757326126098633
hsa-miR-101-1,melanoma brain metastasis,0.6757326126098633
hsa-miR-2277-3p,melanoma brain metastasis,0.6757326126098633
hsa-miR-4260,melanoma brain metastasis,0.6753717660903931
hsa-miR-324-3p,melanoma brain metastasis,0.675314724445343
hsa-miR-1244,melanoma brain metastasis,0.6751199960708618
hsa-miR-519a-3p,melanoma brain metastasis,0.6747105121612549
hsa-miR-106,melanoma brain metastasis,0.6746599078178406
hsa-miR-30a*,melanoma brain metastasis,0.6745597124099731
hsa-miR-571,melanoma brain metastasis,0.6745597124099731
hsa-miR-1257,melanoma brain metastasis,0.6745187640190125
hsa-miR-3914,melanoma brain metastasis,0.6745187640190125
hsa-miR-488*,melanoma brain metastasis,0.6741275787353516
hsa-miR-513,melanoma brain metastasis,0.6739940643310547
hsa-miR-6731-5p,melanoma brain metastasis,0.6737837195396423
hsa-miR-5580-3p,melanoma brain metastasis,0.6734669208526611
hsa-miR-642a-5p,melanoma brain metastasis,0.6732259392738342
hsa-miR-126-5p,melanoma brain metastasis,0.6728983521461487
hsa-miR-15b,melanoma brain metastasis,0.6726055145263672
hsa-miR-6850-5p,melanoma brain metastasis,0.6725937724113464
hsa-miR-6815-5p,melanoma brain metastasis,0.6725937724113464
hsa-miR-1291,melanoma brain metastasis,0.6724376082420349
hsa-miR-7641,melanoma brain metastasis,0.6724376082420349
hsa-miR-1273h-3p,B cell lymphoma,0.6723232269287109
hsa-miR-296-3p,melanoma brain metastasis,0.6722813844680786
hsa-miR-374b-5p,invasive lobular carcinoma,0.6719308495521545
hsa-miR-208a,melanoma brain metastasis,0.6715174913406372
hsa-miR-25*,melanoma brain metastasis,0.6712918281555176
hsa-miR-34a-5p,melanoma brain metastasis,0.6712918281555176
hsa-miR-220b,melanoma brain metastasis,0.6711620688438416
hsa-miR-501-5p,invasive lobular carcinoma,0.6708457469940186
hsa-miR-451,melanoma brain metastasis,0.6704954504966736
hsa-miR-148a,"Luminal A,Luminal B",0.6695172786712646
hsa-miR-659-3p,melanoma brain metastasis,0.6694028973579407
hsa-miR-181a-2*,melanoma brain metastasis,0.669269859790802
hsa-miR-616*,melanoma brain metastasis,0.6689578890800476
hsa-miR-144*,B cell lymphoma,0.6670518517494202
hsa-miR-3194,B cell lymphoma,0.6670518517494202
hsa-miR-216b,melanoma brain metastasis,0.6665799021720886
hsa-miR-33b*,melanoma brain metastasis,0.6658985614776611
hsa-miR-105-2,melanoma brain metastasis,0.6658985614776611
hsa-miR-23a-3p,"Luminal A,triple negative",0.665695309638977
hsa-miR-548c-3p,"Luminal A,Luminal B",0.6650010347366333
hsa-miR-1181,astrocytoma,0.6645997762680054
hsa-miR-4725-5p,astrocytoma,0.66410893201828
hsa-miR-1202,melanoma brain metastasis,0.6640141606330872
hsa-miR-3180-5p,melanoma brain metastasis,0.6640141606330872
hsa-miR-630,"Luminal A,Luminal B",0.6632585525512695
hsa-miR-567,"Luminal A,Luminal B",0.6632585525512695
hsa-miR-4520a-3p,"Luminal A,Luminal B",0.6632585525512695
hsa-miR-600,melanoma brain metastasis,0.6612803936004639
hsa-miR-3617,melanoma brain metastasis,0.6612803936004639
hsa-miR-3657,melanoma brain metastasis,0.6601972579956055
hsa-miR-616,melanoma brain metastasis,0.6601271629333496
hsa-miR-4269,melanoma brain metastasis,0.6601271629333496
hsa-miR-550a-5p,melanoma brain metastasis,0.6601271629333496
hsa-miR-378j,melanoma brain metastasis,0.6598526835441589
hsa-miR-508-5p,melanoma brain metastasis,0.6598526835441589
hsa-miR-378f,melanoma brain metastasis,0.6598526835441589
hsa-miR-1201,melanoma brain metastasis,0.659717857837677
hsa-miR-500b,melanoma brain metastasis,0.6595593094825745
hsa-miR-5189-5p,melanoma brain metastasis,0.6595593094825745
hsa-miR-4538,sarcoma,0.6593847870826721
hsa-miR-4484,sarcoma,0.6593847870826721
hsa-miR-7158-3p,sarcoma,0.6593847870826721
hsa-miR-369,melanoma brain metastasis,0.6591989994049072
hsa-miR-1300,melanoma brain metastasis,0.6591989994049072
hsa-miR-2115*,melanoma brain metastasis,0.6591989994049072
hsa-miR-516a-5p,"Luminal A,triple negative",0.6588273644447327
hsa-miR-6780b-5p,melanoma brain metastasis,0.6587949991226196
hsa-miR-302a*,melanoma brain metastasis,0.6584433913230896
hsa-miR-361-5p,melanoma brain metastasis,0.6575597524642944
hsa-miR-541,melanoma brain metastasis,0.6573973894119263
hsa-miR-4264,melanoma brain metastasis,0.6573207378387451
hsa-miR-4298,melanoma brain metastasis,0.6573207378387451
hsa-miR-145,melanoma brain metastasis,0.6568828821182251
hsa-miR-3194,melanoma brain metastasis,0.656745195388794
hsa-miR-4720-5p,melanoma brain metastasis,0.6564851403236389
hsa-miR-328,melanoma brain metastasis,0.6559410095214844
hsa-miR-4538,"squamous cell breast carcinoma, acantholytic variant",0.6556716561317444
hsa-miR-7-1-3p,"squamous cell breast carcinoma, acantholytic variant",0.6556716561317444
hsa-miR-554,"squamous cell breast carcinoma, acantholytic variant",0.6556716561317444
hsa-miR-463,"squamous cell breast carcinoma, acantholytic variant",0.6556716561317444
hsa-miR-939-5p,"squamous cell breast carcinoma, acantholytic variant",0.6556716561317444
hsa-miR-877-5p,"squamous cell breast carcinoma, acantholytic variant",0.6556716561317444
hsa-miR-4685-5p,"squamous cell breast carcinoma, acantholytic variant",0.6556716561317444
hsa-miR-204-3p,melanoma brain metastasis,0.6555983424186707
hsa-miR-343,melanoma brain metastasis,0.655442476272583
hsa-miR-1298,B cell lymphoma,0.6551939249038696
hsa-miR-3621,melanoma brain metastasis,0.6551663279533386
hsa-miR-582,melanoma brain metastasis,0.6549170017242432
hsa-miR-4654,melanoma brain metastasis,0.6545851230621338
hsa-miR-548ab,melanoma brain metastasis,0.6544833779335022
hsa-miR-138-2-3p,melanoma brain metastasis,0.6543858051300049
hsa-let-7c-5p,melanoma brain metastasis,0.6543166637420654
hsa-miR-200a-5p,invasive lobular carcinoma,0.6531392335891724
hsa-miR-194-1,high grade serous papillary ovarian cancer,0.6530777215957642
hsa-miR-4314,high grade serous papillary ovarian cancer,0.6530777215957642
hsa-miR-1-1,infantile hemangioma,0.6525077223777771
hsa-miR-3668,melanoma brain metastasis,0.6523303389549255
hsa-miR-3200-3p,adenocarcinoma,0.6509074568748474
hsa-miR-651,melanoma brain metastasis,0.649776816368103
hsa-miR-553,invasive lobular carcinoma,0.6469521522521973
hsa-miR-500a*,B cell lymphoma,0.6449225544929504
hsa-miR-222-5p,adenocarcinoma,0.6441085934638977
hsa-miR-6804-5p,adenocarcinoma,0.6441085934638977
hsa-miR-7977,melanoma brain metastasis,0.6427395939826965
hsa-miR-4737,melanoma brain metastasis,0.6425670981407166
hsa-miR-6749-3p,melanoma brain metastasis,0.6425670981407166
hsa-let-7e*,melanoma brain metastasis,0.6422125101089478
hsa-miR-642b,melanoma brain metastasis,0.6422125101089478
hsa-miR-623,melanoma brain metastasis,0.6415441632270813
hsa-miR-603,melanoma brain metastasis,0.6414827704429626
hsa-miRPlus-A1073,melanoma brain metastasis,0.6414827704429626
hsa-miR-218-1*,melanoma brain metastasis,0.641478955745697
hsa-miR-143*,melanoma brain metastasis,0.641478955745697
hsa-miR-379-3p,melanoma brain metastasis,0.641476035118103
hsa-let-7c_c,melanoma brain metastasis,0.641444206237793
hsa-miR-432*,melanoma brain metastasis,0.641444206237793
hsa-miR-29a-3p,melanoma brain metastasis,0.641444206237793
hsa-miR-4465,melanoma brain metastasis,0.641395092010498
hsa-miR-1915*,melanoma brain metastasis,0.6412725448608398
hsa-miR-1b-2,melanoma brain metastasis,0.6412410140037537
hsa-miR-4524a-5p,melanoma brain metastasis,0.6412072777748108
hsa-miR-570-3p,melanoma brain metastasis,0.6410890817642212
hsa-miR-548d-5p,melanoma brain metastasis,0.6410348415374756
hsa-miR-6727-5p,melanoma brain metastasis,0.6410341858863831
hsa-miR-6836-3p,melanoma brain metastasis,0.6409808993339539
hsa-miR-605,melanoma brain metastasis,0.6408959031105042
hsa-miR-330-5p,melanoma brain metastasis,0.6408959031105042
hsa-miR-3917,melanoma brain metastasis,0.6408959031105042
hsa-miR-125b-2*,melanoma brain metastasis,0.6408959031105042
hsa-miR-185,astrocytoma,0.6408461928367615
hsa-miR-6790-3p,melanoma brain metastasis,0.6407559514045715
hsa-miR-3665,melanoma brain metastasis,0.6404281258583069
hsa-miR-151-3p,melanoma brain metastasis,0.6404014229774475
hsa-miR-4668-3p,melanoma brain metastasis,0.6403506994247437
hsa-miR-367-3p,melanoma brain metastasis,0.6403506994247437
hsa-miR-6780b-5p,"Luminal A,triple negative",0.6403205394744873
hsa-miR-4771,melanoma brain metastasis,0.6403032541275024
hsa-miR-7113-3p,melanoma brain metastasis,0.6401973366737366
hsa-miR-654,melanoma brain metastasis,0.6400474905967712
hsa-miR-646,melanoma brain metastasis,0.6391410827636719
hsa-miR-497*,melanoma brain metastasis,0.6391410827636719
hsa-miR-4470,melanoma brain metastasis,0.638789713382721
hsa-miR-519e-3p,melanoma brain metastasis,0.638789713382721
hsa-miR-6886-5p,melanoma brain metastasis,0.638789713382721
hsa-miR-6742-5p,melanoma brain metastasis,0.638789713382721
hsa-miR-597,melanoma brain metastasis,0.6384061574935913
hsa-miR-6872-3p,melanoma brain metastasis,0.6384061574935913
hsa-miR-3925-3p,melanoma brain metastasis,0.638104259967804
hsa-miR-4257,melanoma brain metastasis,0.638104259967804
hsa-miR-21-5p,melanoma brain metastasis,0.638104259967804
hsa-miR-671,melanoma brain metastasis,0.638104259967804
hsa-miR-4262,melanoma brain metastasis,0.6378620266914368
hsa-miR-449c-5p,melanoma brain metastasis,0.6378620266914368
hsa-miR-4689,melanoma brain metastasis,0.6373948454856873
hsa-miR-566,melanoma brain metastasis,0.6369980573654175
hsa-miR-129*,astrocytoma,0.6361111998558044
hsa-miR-4524b-3p,astrocytoma,0.6360881328582764
hsa-miR-302a*,astrocytoma,0.6359683275222778
hsa-miR-520c-3p,melanoma brain metastasis,0.6358008980751038
hsa-miR-4324,astrocytoma,0.6355600953102112
hsa-miR-5011-3p,invasive breast ductal carcinoma,0.6352394223213196
hsa-miR-548m,melanoma brain metastasis,0.6350297927856445
hsa-miR-6862-3p,adenocarcinoma,0.6348671913146973
hsa-miR-1470,melanoma brain metastasis,0.6344447135925293
hsa-miR-5692b,adenocarcinoma,0.6343311071395874
hsa-miR-1908,melanoma brain metastasis,0.6343072056770325
hsa-miR-935,melanoma brain metastasis,0.6336742043495178
hsa-miR-619-5p,melanoma brain metastasis,0.6336742043495178
hsa-miR-6842-5p,melanoma brain metastasis,0.6336742043495178
hsa-miR-200a-5p,B cell lymphoma,0.6336425542831421
hsa-miR-374b-3p,B cell lymphoma,0.6336425542831421
hsa-miR-635,adenocarcinoma,0.633156955242157
hsa-miR-935,adenocarcinoma,0.6329880952835083
hsa-miR-676*,melanoma brain metastasis,0.6329032182693481
hsa-miR-513a-3p,melanoma brain metastasis,0.6329032182693481
hsa-miR-4634,melanoma brain metastasis,0.6329032182693481
hsa-miRPlus-A1072,astrocytoma,0.6326888799667358
hsa-miR-1287-3p,adenocarcinoma,0.6326519250869751
hsa-miR-6811-3p,adenocarcinoma,0.6322087645530701
hsa-miR-123,adenocarcinoma,0.6320139169692993
hsa-miR-422b,astrocytoma,0.6318714618682861
hsa-miR-575,melanoma brain metastasis,0.6318079829216003
hsa-miR-8078,melanoma brain metastasis,0.6307157278060913
hsa-miR-6506-3p,infantile hemangioma,0.6306849718093872
hsa-miR-1287,"Luminal B,triple negative",0.630299985408783
hsa-miR-129-2-3p,melanoma brain metastasis,0.6302114725112915
hsa-miR-636,adenocarcinoma,0.6300920248031616
hsa-miR-3926,astrocytoma,0.6300895810127258
hsa-miR-5580-5p,melanoma brain metastasis,0.6300719380378723
hsa-miR-212-5p,melanoma brain metastasis,0.6300719380378723
hsa-miR-521,melanoma brain metastasis,0.6286376118659973
hsa-miR-148a,B cell lymphoma,0.6285605430603027
hsa-miR-19b-1,melanoma brain metastasis,0.6279940009117126
hsa-miR-1305,infantile hemangioma,0.62751704454422
hsa-miR-939-3p,melanoma brain metastasis,0.625529944896698
hsa-miR-4538,adenocarcinoma,0.6249415278434753
hsa-miR-422b,melanoma brain metastasis,0.6239303350448608
hsa-miR-4446-3p,melanoma brain metastasis,0.6228143572807312
hsa-miR-7108-3p,adenocarcinoma,0.620952308177948
hsa-miR-449,invasive lobular carcinoma,0.6203921437263489
hsa-miR-374b-5p,melanoma brain metastasis,0.6203522682189941
hsa-miR-3620-5p,adenocarcinoma,0.6199952960014343
hsa-miR-4750-3p,adenocarcinoma,0.6187759637832642
hsa-miR-6502-5p,adenocarcinoma,0.6187759637832642
hsa-miR-638,melanoma brain metastasis,0.6185338497161865
hsa-miR-1539,adenocarcinoma,0.6180553436279297
hsa-miR-338-3p,adenocarcinoma,0.617716908454895
hsa-miR-524-3p,adenocarcinoma,0.6175853610038757
hsa-miR-7-2,adenocarcinoma,0.6175853610038757
hsa-miR-639,adenocarcinoma,0.617277979850769
hsa-miR-1283-1,adenocarcinoma,0.6171174049377441
hsa-miR-6774-3p,adenocarcinoma,0.6169917583465576
hsa-miR-15b-5p,adenocarcinoma,0.6158847212791443
hsa-miR-1269,adenocarcinoma,0.6158467531204224
hsa-miR-199a-2,adenocarcinoma,0.615563154220581
hsa-miR-374c,B cell lymphoma,0.6148570775985718
hsa-miR-378a-5p,adenocarcinoma,0.6137075424194336
hsa-miR-1225,adenocarcinoma,0.6117755174636841
hsa-miR-5695,adenocarcinoma,0.6116281747817993
hsa-miR-519a-5p,adenocarcinoma,0.61138516664505
hsa-miR-513a-3p,B cell lymphoma,0.6112894415855408
hsa-miR-602,B cell lymphoma,0.6112894415855408
hsa-miR-105-1,B cell lymphoma,0.6112894415855408
hsa-miR-6888-3p,adenocarcinoma,0.6108062863349915
hsa-miR-4716-5p,adenocarcinoma,0.6082693934440613
hsa-miR-4454,invasive lobular carcinoma,0.6062306761741638
hsa-miR-132-5p,adenocarcinoma,0.6055149435997009
hsa-miR-4735-3p,adenocarcinoma,0.6055149435997009
hsa-miR-1231,B cell lymphoma,0.6053894758224487
hsa-miR-208b-5p,adenocarcinoma,0.605371356010437
hsa-miR-6509-3p,adenocarcinoma,0.6043980121612549
hsa-miR-548b-3p,invasive lobular carcinoma,0.6029812693595886
hsa-miR-584,adenocarcinoma,0.6024611592292786
hsa-miR-148a-5p,adenocarcinoma,0.6023565530776978
hsa-miR-9-3p,adenocarcinoma,0.6013557314872742
hsa-miR-135b-3p,adenocarcinoma,0.6008263230323792
hsa-miR-7703,adenocarcinoma,0.5996309518814087
hsa-miR-4433b-5p,B cell lymphoma,0.5984817147254944
hsa-miR-640,adenocarcinoma,0.5983439683914185
hsa-miR-597,B cell lymphoma,0.5916981101036072
hsa-miR-630,B cell lymphoma,0.5916981101036072
hsa-miR-4430,B cell lymphoma,0.5916981101036072
hsa-miR-95-5p,adenocarcinoma,0.5831599235534668
hsa-miR-525-3p,invasive lobular carcinoma,0.582905113697052
hsa-miR-675-5p,adenocarcinoma,0.5813655853271484
hsa-miR-514a-3p,adenocarcinoma,0.577925980091095
hsa-miR-373-3p,adenocarcinoma,0.5732473731040955
hsa-miR-1261,adenocarcinoma,0.5679842829704285
hsa-miR-558,"Luminal A,triple negative",0.5627503991127014
hsa-miR-584,"Luminal A,triple negative",0.5627503991127014
hsa-miR-548w,adenocarcinoma,0.5625194907188416
hsa-miR-124-3,invasive breast ductal carcinoma,0.5570284724235535
hsa-miR-3926,melanoma brain metastasis,0.5566555857658386
hsa-miR-505*,melanoma brain metastasis,0.5566555857658386
hsa-miR-24-3p,adenocarcinoma,0.5491165518760681
hsa-miR-1231,melanoma brain metastasis,0.547856867313385
hsa-miR-6722-3p,melanoma brain metastasis,0.5468118190765381
hsa-miR-381-3p,adenocarcinoma,0.5418103337287903
hsa-miR-630,melanoma brain metastasis,0.5362484455108643
hsa-miR-377,melanoma brain metastasis,0.5346013307571411
hsa-miR-4480,infantile hemangioma,0.5342801809310913
hsa-miR-567,melanoma brain metastasis,0.5326571464538574
hsa-miR-630,infantile hemangioma,0.5226268768310547
hsa-miR-23a-3p,invasive breast ductal carcinoma,0.5205529928207397
hsa-miR-6510-5p,adenocarcinoma,0.4832867980003357
hsa-miR-652-5p,adenocarcinoma,0.4729931950569153
hsa-miRPlus-G1065-5p,adenocarcinoma,0.4729931950569153
